,Unnamed: 0.1,Unnamed: 0,title,date,stock,Text_Cleaned,Score,label,score
695587,695587,706794.0,Moderna On Track To Start Phase 3 Coronavirus Vaccine Trial In July,2020-06-11 10:37:00-04:00,JNJ,moderna on track to start phase 3 coronavirus vaccine trial in july,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998358488082886
695588,695588,706795.0,"Shares of several healthcare companies are trading lower in sympathy with the overall market following an increase in coronavirus cases in some US states that have reopened, leading to concerns of a second wave of the virus.",2020-06-11 10:22:00-04:00,JNJ,shares of several healthcare companies are trading lower in sympathy with the overall market following an increase in coronavirus cases in some us states that have reopened leading to concerns of a second wave of the virus,"{'neg': 0.052, 'neu': 0.782, 'pos': 0.166, 'compound': 0.5859}",negative,0.9986187219619751
695589,695589,706796.0,"It's Not All COVID-19 And The Fed: Lululemon Reports After Close, And Airline Stocks Dive",2020-06-11 09:38:00-04:00,JNJ,its not all covid 19 and the fed lululemon reports after close and airline stocks dive,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9483081698417664
695590,695590,706797.0,A Peek Into The Markets: US Stock Futures Tumble Ahead Of Jobless Claims Report,2020-06-11 05:56:00-04:00,JNJ,a peek into the markets us stock futures tumble ahead of jobless claims report,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9976267218589783
695591,695591,706798.0,Johnson & Johnson To Start Coronavirus Vaccine Human Trials Ahead Of Schedule In July,2020-06-11 00:16:00-04:00,JNJ,johnson and johnson to start coronavirus vaccine human trials ahead of schedule in july,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998063445091248
695592,695592,706799.0,"J&J Moves Up Human Clinical Trails Of its COVID-19 Vaccine To Start In July, Ahead Of Planned September Start",2020-06-10 13:05:00-04:00,JNJ,j and j moves up human clinical trails of its covid 19 vaccine to start in july ahead of planned september start,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9980683922767639
695593,695593,706800.0,"J&J Is In Talks To Begin Phase 3 Coronavirus Vaccine Trial Ahead Of Schedule, Pending Phase 1 Studies Outcome, Regulatory Approval",2020-06-10 09:30:00-04:00,JNJ,j and j is in talks to begin phase 3 coronavirus vaccine trial ahead of schedule pending phase 1 studies outcome regulatory approval,"{'neg': 0.0, 'neu': 0.876, 'pos': 0.124, 'compound': 0.4767}",neutral,0.9998121857643127
695594,695594,706801.0,"NIH Official Says U.S. Plans 3 Large Studies of Experimental Coronavirus Vaccines  From Moderna, AstraZeneca Johnson & Johnson Starting in July, August, September",2020-06-10 05:34:00-04:00,JNJ,nih official says u s plans 3 large studies of experimental coronavirus vaccines from moderna astrazeneca johnson and johnson starting in july august september,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998784065246582
695595,695595,706802.0,"Revlon, Chanel, L'Oréal Are Quietly Removing Talc From Their Products As Cancer Lawsuits Mount: Report",2020-06-09 10:15:00-04:00,JNJ,revlon chanel loréal are quietly removing talc from their products as cancer lawsuits mount report,"{'neg': 0.316, 'neu': 0.684, 'pos': 0.0, 'compound': -0.7184}",neutral,0.998659610748291
695596,695596,706803.0,Travel Stocks Lose Momentum In Pre-Market After Leading Yesterday's Sharp Rally,2020-06-09 09:49:00-04:00,JNJ,travel stocks lose momentum in pre market after leading yesterdays sharp rally,"{'neg': 0.197, 'neu': 0.803, 'pos': 0.0, 'compound': -0.4019}",positive,0.7109043598175049
695597,695597,706804.0,"Navarro: China Is 'Trying To Steal Our Vaccines, As We Speak'",2020-06-08 10:28:00-04:00,JNJ,navarro china is trying to steal our vaccines as we speak,"{'neg': 0.242, 'neu': 0.758, 'pos': 0.0, 'compound': -0.4939}",neutral,0.9986529350280762
695598,695598,706805.0,Halozyme Announces J&J's Janssen Receives European Marketing Authorization For Subcutaneous DARZALEX Utilizing Halozyme's ENHANZE Technology For The Treatment Of Patients With Multiple Myeloma,2020-06-04 12:38:00-04:00,JNJ,halozyme announces j and js janssen receives european marketing authorization for subcutaneous darzalex utilizing halozymes enhanze technology for the treatment of patients with multiple myeloma,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9990979433059692
695599,695599,706806.0,Ex-FDA Chief On White House's Coronavirus Vaccine Shortlist: 'They Chose Very Novel Platforms',2020-06-04 11:02:00-04:00,JNJ,ex fda chief on white houses coronavirus vaccine shortlist they chose very novel platforms,"{'neg': 0.0, 'neu': 0.834, 'pos': 0.166, 'compound': 0.3804}",neutral,0.9998428821563721
695600,695600,706807.0,Genmab Reports European Marketing Authorization For Subcutaneous Formulation Of DARZALEX For Treatment Of Patients With Multiple Myeloma,2020-06-04 09:44:00-04:00,JNJ,genmab reports european marketing authorization for subcutaneous formulation of darzalex for treatment of patients with multiple myeloma,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9988088607788086
695601,695601,706808.0,Revisiting The Coronavirus Vaccine Race: Updates On The 10 Candidates In Clinics,2020-06-03 17:53:00-04:00,JNJ,revisiting the coronavirus vaccine race updates on the 10 candidates in clinics,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999884843826294
695602,695602,706809.0,"UPDATE: Five Companies Chosen For 'Vaccine Finalist' Are Moderna, Johnson & Johnson, Merck, Pfizer And AstraZeneca",2020-06-03 13:09:00-04:00,JNJ,update five companies chosen for vaccine finalist are moderna johnson and johnson merck pfizer and astrazeneca,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998862743377686
695603,695603,706810.0,Pharma Large And Mid-Caps Race Against COVID-19,2020-06-02 14:50:00-04:00,JNJ,pharma large and mid caps race against covid 19,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999848484992981
695604,695604,706811.0,4 Blue Chips That Lived Up To Their Title During the Pandemic,2020-06-02 14:17:00-04:00,JNJ,4 blue chips that lived up to their title during the pandemic,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998890161514282
695605,695605,706812.0,"U.S. Army Planning To Test Vaccines From Moderna, Astrazeneca, Johnson & Johnson And Sanofi; Army Will Test Its Own Vaccine Candidate In Human Trials Later This Summer",2020-06-02 12:03:00-04:00,JNJ,u s army planning to test vaccines from moderna astrazeneca johnson and johnson and sanofi army will test its own vaccine candidate in human trials later this summer,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998764991760254
695606,695606,706813.0,4 Sector ETFs To Buy And Sell In June,2020-06-01 13:35:00-04:00,JNJ,4 sector etfs to buy and sell in june,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998785257339478
695607,695607,706814.0,Novavax Begins Phase 1 Clinical Trial Of Its Coronavirus Vaccine,2020-05-26 02:48:00-04:00,JNJ,novavax begins phase 1 clinical trial of its coronavirus vaccine,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998865127563477
695608,695608,706815.0,"US Health Official Says Vaccines From J&J, Sanofi, Merck May Be Added This Summer As They Complete Phase 1 Safety Studies",2020-05-22 13:50:00-04:00,JNJ,us health official says vaccines from j and j sanofi merck may be added this summer as they complete phase 1 safety studies,"{'neg': 0.0, 'neu': 0.887, 'pos': 0.113, 'compound': 0.4215}",neutral,0.9998648166656494
695609,695609,706816.0,"US Says Will Test Experimental Coronavirus Vaccines In 100,000+ People, Health Official Says Oxford Vaccine May Be Tested ""Side By Side"" With Moderna's Starting In July",2020-05-22 13:50:00-04:00,JNJ,us says will test experimental coronavirus vaccines in 100000 people health official says oxford vaccine may be tested side by side with modernas starting in july,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998661279678345
695610,695610,706817.0,"Johnson & Johnson Pulls Talc-Based Baby Powder From US, Canada As Cancer Claims Kill Demand",2020-05-20 01:09:00-04:00,JNJ,johnson and johnson pulls talc based baby powder from us canada as cancer claims kill demand,"{'neg': 0.449, 'neu': 0.551, 'pos': 0.0, 'compound': -0.891}",negative,0.9783318042755127
695611,695611,706818.0,Johnson & Johnson Consumer Health Will Wind Down Commercialization Of Talc-based Johnson's Baby Powder In The U.S. And Canada In Coming Months,2020-05-19 16:39:00-04:00,JNJ,johnson and johnson consumer health will wind down commercialization of talc based johnsons baby powder in the u s and canada in coming months,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9875673055648804
695612,695612,706819.0,"In The Midst Of Pandemic, Traders Pin Their Hopes On These Healthcare ETFs",2020-05-19 09:38:00-04:00,JNJ,in the midst of pandemic traders pin their hopes on these healthcare etfs,"{'neg': 0.0, 'neu': 0.811, 'pos': 0.189, 'compound': 0.4215}",neutral,0.9998432397842407
695613,695613,706820.0,Moncef Slaoui To Divest Moderna Stake As He Joins White House Vaccine Accelerator,2020-05-19 09:00:00-04:00,JNJ,moncef slaoui to divest moderna stake as he joins white house vaccine accelerator,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997367262840271
695614,695614,706821.0,"These 6 Coronavirus Vaccine Candidates Are The Likeliest To Succeed, Says Morgan Stanley",2020-05-18 12:07:00-04:00,JNJ,these 6 coronavirus vaccine candidates are the likeliest to succeed says morgan stanley,"{'neg': 0.0, 'neu': 0.789, 'pos': 0.211, 'compound': 0.4939}",neutral,0.9576868414878845
695615,695615,706822.0,Janssen Gives an Update on its Phase 1 Study on Teclistamab in patients with Multiple Myeloma,2020-05-18 07:10:00-04:00,JNJ,janssen gives an update on its phase 1 study on teclistamab in patients with multiple myeloma,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998724460601807
695616,695616,706823.0,"Barron's Picks And Pans: Cisco, Gilead, Netflix, Wayfair And More",2020-05-17 11:00:00-04:00,JNJ,barrons picks and pans cisco gilead netflix wayfair and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998670816421509
695617,695617,706824.0,"Avicanna Combines Sustainable Cultivation Methods, R&D, and Pharmaceutical Standards to Offer API's with the Aureus Brand",2020-05-15 12:15:00-04:00,JNJ,avicanna combines sustainable cultivation methods r and d and pharmaceutical standards to offer apis with the aureus brand,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998745918273926
695618,695618,706825.0,Novavax Analysts Say CEPI Funding 'Speaks Volumes' About Coronavirus Vaccine Development,2020-05-12 14:08:00-04:00,JNJ,novavax analysts say cepi funding speaks volumes about coronavirus vaccine development,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9990319013595581
695619,695619,706826.0,Cruise Line Earnings Later This Week Could Provide Insight On Brutal Quarter For Industry,2020-05-11 11:27:00-04:00,JNJ,cruise line earnings later this week could provide insight on brutal quarter for industry,"{'neg': 0.24, 'neu': 0.76, 'pos': 0.0, 'compound': -0.6249}",positive,0.9809561371803284
695620,695620,706827.0,Provention Bio's CEO On Identifying Autoimmune Diseases 'Before It's Too Late',2020-05-05 11:28:00-04:00,JNJ,provention bios ceo on identifying autoimmune diseases before its too late,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998606443405151
695621,695621,706828.0,What You Should Know About Alexion's $1.4B Proposed Buyout Of Portola Pharma,2020-05-05 09:10:00-04:00,JNJ,what you should know about alexions dollars .4 billion proposed buyout of portola pharma,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998747110366821
695622,695622,706829.0,"The Daily Biotech Pulse: Bio-Rad's Coronavirus Test Gets EUA, Beat-And-Raise Quarter From GenMark, Adverum's Positive Gene Therapy Readout",2020-05-05 08:00:00-04:00,JNJ,the daily biotech pulse bio rads coronavirus test gets eua beat and raise quarter from genmark adverums positive gene therapy readout,"{'neg': 0.0, 'neu': 0.847, 'pos': 0.153, 'compound': 0.5574}",positive,0.9995465874671936
695623,695623,706830.0,Attention Biotech Investors: Mark Your Calendar For These May PDUFA Dates,2020-05-03 09:25:00-04:00,JNJ,attention biotech investors mark your calendar for these may pdufa dates,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998875856399536
695624,695624,706831.0,"Moderna, Lonza Strike Deal To Manufacture Up To 1 Billion Doses Of Coronavirus Vaccine Candidate Annually",2020-05-01 09:11:00-04:00,JNJ,moderna lonza strike deal to manufacture up to 1 billion doses of coronavirus vaccine candidate annually,"{'neg': 0.091, 'neu': 0.909, 'pos': 0.0, 'compound': -0.128}",neutral,0.9509504437446594
695625,695625,706832.0,"The Daily Biotech Pulse: Gilead Slips Despite Forecast-Beating Q1, Moderna Partners With Lonza For Coronavirus Vaccine Production, Lyra Therapeutics IPO",2020-05-01 07:54:00-04:00,JNJ,the daily biotech pulse gilead slips despite forecast beating first quarter moderna partners with lonza for coronavirus vaccine production lyra therapeutics ipo,"{'neg': 0.0, 'neu': 0.894, 'pos': 0.106, 'compound': 0.357}",negative,0.9986220598220825
695626,695626,706833.0,Halozyme Highlights Janssen's Receipt Of CHMP Positive Opinion For DARZALEX Subcutaneous Formulation Utilizing Halozyme's ENHANZE Technology For Patients With Multiple Myeloma,2020-04-30 16:56:00-04:00,JNJ,halozyme highlights janssens receipt of chmp positive opinion for darzalex subcutaneous formulation utilizing halozymes enhanze technology for patients with multiple myeloma,"{'neg': 0.0, 'neu': 0.847, 'pos': 0.153, 'compound': 0.5574}",positive,0.9994687438011169
695627,695627,706834.0,Johnson & Johnson Announces Committee For Medicinal Products For Human Use Of Ema Has Issued A Positive Opinion Recommending Approval For Darzalex,2020-04-30 15:39:00-04:00,JNJ,johnson and johnson announces committee for medicinal products for human use of ema has issued a positive opinion recommending approval for darzalex,"{'neg': 0.0, 'neu': 0.749, 'pos': 0.251, 'compound': 0.7717}",positive,0.9995001554489136
695628,695628,706835.0,"Barclays Maintains Overweight on Johnson & Johnson, Raises Price Target to $182",2020-04-29 11:14:00-04:00,JNJ,barclays maintains overweight on johnson and johnson raises price target to dollars 82,"{'neg': 0.172, 'neu': 0.828, 'pos': 0.0, 'compound': -0.3612}",negative,0.7362464070320129
695629,695629,706836.0,"Morgan Stanley Maintains Overweight on Johnson & Johnson, Raises Price Target to $170",2020-04-29 09:02:00-04:00,JNJ,morgan stanley maintains overweight on johnson and johnson raises price target to dollars 70,"{'neg': 0.161, 'neu': 0.839, 'pos': 0.0, 'compound': -0.3612}",positive,0.7035118341445923
695630,695630,706837.0,Catalent Signs Agreement With Johnson & Johnson To Be US Manufacturing Partner For Lead Coronavirus Vaccine Candidate,2020-04-29 08:04:00-04:00,JNJ,catalent signs agreement with johnson and johnson to be us manufacturing partner for lead coronavirus vaccine candidate,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.4939}",positive,0.9992138147354126
695631,695631,706838.0,"Pfizer Says Coronavirus Vaccine Could Be Available By Fall, US Clinical Trials To Begin Next Week",2020-04-29 00:09:00-04:00,JNJ,pfizer says coronavirus vaccine could be available by fall us clinical trials to begin next week,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998799562454224
695632,695632,706839.0,"UBS Downgrades Johnson & Johnson to Neutral, Lowers Price Target to $160",2020-04-28 06:05:00-04:00,JNJ,ubs downgrades johnson and johnson to neutral lowers price target to dollars 60,"{'neg': 0.111, 'neu': 0.889, 'pos': 0.0, 'compound': -0.128}",positive,0.8514909744262695
695633,695633,706840.0,"J&J Says Federal Judge Excludes Certain Plaintiff Expert Testimony from Talc Ovarian Cancer Trials, Deeming Them Not Scientifically Sound",2020-04-28 05:39:00-04:00,JNJ,j and j says federal judge excludes certain plaintiff expert testimony from talc ovarian cancer trials deeming them not scientifically sound,"{'neg': 0.173, 'neu': 0.745, 'pos': 0.082, 'compound': -0.5106}",neutral,0.9927283525466919
695634,695634,706841.0,U.S. Judge Rules J&J Must Defend Federal Talc Lawsuits,2020-04-27 13:35:00-04:00,JNJ,u s judge rules j and j must defend federal talc lawsuits,"{'neg': 0.127, 'neu': 0.873, 'pos': 0.0, 'compound': -0.1531}",neutral,0.9998723268508911
695635,695635,706842.0,Halozyme Announces Janssen Submits NDA In Japan For Daratumumab Subcutaneous Formulation Utilizing Halozyme's ENHANZE® Technology For Patients With Multiple Myeloma,2020-04-27 05:45:00-04:00,JNJ,halozyme announces janssen submits nda in japan for daratumumab subcutaneous formulation utilizing halozymes enhanze® technology for patients with multiple myeloma,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998619556427002
695636,695636,706843.0,"Barron's Picks And Pans: Albertsons, Carnival, Harley-Davidson And More",2020-04-25 15:32:00-04:00,JNJ,barrons picks and pans albertsons carnival harley davidson and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998657703399658
695637,695637,706844.0,J&J's Janssen Pharma Reports Submission Of 2 Applicats Seeking Approval Of SIMPONI ARIA For Treatment Of Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis,2020-04-24 09:19:00-04:00,JNJ,j and js janssen pharma reports submission of 2 applicats seeking approval of simponi aria for treatment of polyarticular juvenile idiopathic arthritis and juvenile psoriatic arthritis,"{'neg': 0.0, 'neu': 0.89, 'pos': 0.11, 'compound': 0.4767}",neutral,0.997282862663269
695638,695638,706845.0,"The Daily Biotech Pulse: FDA Approves Sanofi's Meningococcal Vaccine, Pluristem Secures $54M In Funding For COVID-19 Treatment, Oric Pharma Prices IPO",2020-04-24 08:38:00-04:00,JNJ,the daily biotech pulse fda approves sanofis meningococcal vaccine pluristem secures dollars 4 million in funding for covid 19 treatment oric pharma prices ipo,"{'neg': 0.0, 'neu': 0.815, 'pos': 0.185, 'compound': 0.6124}",neutral,0.9997525811195374
695639,695639,706846.0,"UPDATE: TRACON Says Is Seeking A Licensing Partner To Develop, Commercialize TRC253 In China",2020-04-24 08:16:00-04:00,JNJ,update tracon says is seeking a licensing partner to develop commercialize trc253 in china,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9996007084846497
695640,695640,706847.0,TRACON Pharma Reports Retained Global Rights To TRC253 Following Completion Of Phase 1/2 Trial,2020-04-24 08:15:00-04:00,JNJ,tracon pharma reports retained global rights to trc253 following completion of phase .5 trial,"{'neg': 0.0, 'neu': 0.922, 'pos': 0.078, 'compound': 0.0258}",neutral,0.9994006156921387
695641,695641,706848.0,"Six Coronavirus Vaccines Under Clinical Trials, WHO Says",2020-04-24 05:52:00-04:00,JNJ,six coronavirus vaccines under clinical trials who says,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998795986175537
695642,695642,706849.0,Inovio CEO Says 'It's Possible' For Coronavirus Vaccine To Be Ready In 12 To 18 Months,2020-04-23 22:19:00-04:00,JNJ,inovio ceo says its possible for coronavirus vaccine to be ready in 12 to 18 months,"{'neg': 0.0, 'neu': 0.857, 'pos': 0.143, 'compound': 0.3612}",neutral,0.9998762607574463
695643,695643,706850.0,Stocks That Hit 52-Week Highs On Thursday,2020-04-23 10:41:00-04:00,JNJ,stocks that hit 52 week highs on thursday,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9955268502235413
695644,695644,706851.0,"The Daily Biotech Pulse: FDA Nod For Immunomedics, Lilly's Solid Q1 Beat, Predictive Oncology Restructures Debt",2020-04-23 07:53:00-04:00,JNJ,the daily biotech pulse fda nod for immunomedics lillys solid first quarter beat predictive oncology restructures debt,"{'neg': 0.131, 'neu': 0.785, 'pos': 0.084, 'compound': -0.2263}",positive,0.9991648197174072
695645,695645,706852.0,Why Johnson & Johnson's Stock Is Trading Higher Today,2020-04-22 12:06:00-04:00,JNJ,why johnson and johnsons stock is trading higher today,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9995810389518738
695646,695646,706853.0,"Benzinga's Top Upgrades, Downgrades For April 22, 2020",2020-04-22 09:40:00-04:00,JNJ,benzingas top upgrades downgrades for april 22 2020,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.2023}",positive,0.8908352255821228
695647,695647,706854.0,Johnson & Johnson shares are higher after Bank of America upgraded the stock from Neutral to Buy.,2020-04-22 09:13:00-04:00,JNJ,johnson and johnson shares are higher after bank of america upgraded the stock from neutral to buy,"{'neg': 0.0, 'neu': 0.879, 'pos': 0.121, 'compound': 0.296}",positive,0.9996687173843384
695648,695648,706855.0,B of A Securities Upgrades Johnson & Johnson to Buy,2020-04-22 07:24:00-04:00,JNJ,b of a securities upgrades johnson and johnson to buy,"{'neg': 0.0, 'neu': 0.804, 'pos': 0.196, 'compound': 0.296}",neutral,0.9998335838317871
695649,695649,706856.0,Oxford University Coronavirus Vaccine Clinical Trial To Start Thursday With $24.6M Government Funding,2020-04-22 05:46:00-04:00,JNJ,oxford university coronavirus vaccine clinical trial to start thursday with dollars 4.6 million government funding,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998853206634521
695650,695650,706857.0,FDA Says Expanded The Indication Of Ibrutinib (Imbruvica),2020-04-21 14:55:00-04:00,JNJ,fda says expanded the indication of ibrutinib imbruvica,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9984285235404968
695651,695651,706858.0,How The COVID-19 Pandemic Could End,2020-04-20 16:33:00-04:00,JNJ,how the covid 19 pandemic could end,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998041987419128
695652,695652,706859.0,"The Week Ahead In Biotech (April 19-25): Eli Lilly, Biogen Earnings On Tap, Sanofi Awaits FDA Decision",2020-04-19 17:22:00-04:00,JNJ,the week ahead in biotech april 19 to 25 eli lilly biogen earnings on tap sanofi awaits fda decision,"{'neg': 0.0, 'neu': 0.933, 'pos': 0.067, 'compound': 0.0772}",neutral,0.9983727335929871
695653,695653,706860.0,"Barron's Picks And Pans: Dropbox, Ford, Johnson & Johnson, Teladoc And More",2020-04-19 14:44:00-04:00,JNJ,barrons picks and pans dropbox ford johnson and johnson teladoc and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998855590820312
695654,695654,706861.0,"Big Earnings Day As Honeywell, Procter & Gamble, Schlumberger Among Those Reporting",2020-04-17 09:46:00-04:00,JNJ,big earnings day as honeywell procter and gamble schlumberger among those reporting,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9792770743370056
695655,695655,706862.0,Moderna Gets $483M Federal Funding For Its Coronavirus Vaccine,2020-04-17 02:09:00-04:00,JNJ,moderna gets dollars 83 million federal funding for its coronavirus vaccine,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9996975660324097
695656,695656,706863.0,S&P 500 Futures Up 3.2% After Hours; Many Other Stocks Moving Higher With Futures; Investors Reacting Favorably To White Phase Guidelines On Reopening Economy,2020-04-16 18:11:00-04:00,JNJ,SP500 500 futures up 3.2 percent after hours many other stocks moving higher with futures investors reacting favorably to white phase guidelines on reopening economy,"{'neg': 0.0, 'neu': 0.902, 'pos': 0.098, 'compound': 0.3818}",positive,0.9996968507766724
695657,695657,706864.0,"Alibaba, Tesla Among Cramer's Stay-At-Home Stock Ideas",2020-04-16 11:48:00-04:00,JNJ,alibaba tesla among cramers stay at home stock ideas,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997057318687439
695658,695658,706865.0,"Why Johnson & Johnson Inspires Cramer's Bullishness On Disney, Visa, Mastercard",2020-04-16 10:19:00-04:00,JNJ,why johnson and johnson inspires cramers bullishness on disney visa mastercard,"{'neg': 0.0, 'neu': 0.775, 'pos': 0.225, 'compound': 0.4404}",positive,0.999536395072937
695659,695659,706866.0,Every Member Of Trump's 'Great American Economic Revival' Industry Groups,2020-04-15 13:09:00-04:00,JNJ,every member of trumps great american economic revival industry groups,"{'neg': 0.0, 'neu': 0.687, 'pos': 0.313, 'compound': 0.6249}",neutral,0.9998745918273926
695660,695660,706867.0,"Stifel Maintains Hold on Johnson & Johnson, Raises Price Target to $155",2020-04-15 10:14:00-04:00,JNJ,stifel maintains hold on johnson and johnson raises price target to dollars 55,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9995198249816895
695661,695661,706868.0,"Wells Fargo Maintains Overweight on Johnson & Johnson, Raises Price Target to $162",2020-04-15 09:17:00-04:00,JNJ,wells fargo maintains overweight on johnson and johnson raises price target to dollars 62,"{'neg': 0.152, 'neu': 0.727, 'pos': 0.121, 'compound': -0.128}",positive,0.533088743686676
695662,695662,706869.0,10 Biggest Price Target Changes For Wednesday,2020-04-15 08:35:00-04:00,JNJ,10 biggest price target changes for wednesday,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998117089271545
695663,695663,706870.0,"Credit Suisse Reiterates Outperform on Johnson & Johnson, Raises Price Target to $161",2020-04-15 08:27:00-04:00,JNJ,credit suisse reiterates outperform on johnson and johnson raises price target to dollars 61,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.3818}",positive,0.9996927976608276
695664,695664,706871.0,"Citigroup Maintains Buy on Johnson & Johnson, Raises Price Target to $165",2020-04-15 08:21:00-04:00,JNJ,citigroup maintains buy on johnson and johnson raises price target to dollars 65,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996265172958374
695665,695665,706872.0,"Raymond James Reiterates Outperform on Johnson & Johnson, Raises Price Target to $157",2020-04-15 07:20:00-04:00,JNJ,raymond james reiterates outperform on johnson and johnson raises price target to dollars 57,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.999687671661377
695666,695666,706873.0,"J&J Expects Procedure Volumes In Areas Such As Oncology, General Surgery To Rebound Sooner",2020-04-14 10:08:00-04:00,JNJ,j and j expects procedure volumes in areas such as oncology general surgery to rebound sooner,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996539354324341
695667,695667,706874.0,"JPMorgan, Wells Fargo Earnings Lower Than Expected, But Positive Tone Helps Shares",2020-04-14 09:56:00-04:00,JNJ,jpmorgan wells fargo earnings lower than expected but positive tone helps shares,"{'neg': 0.075, 'neu': 0.33, 'pos': 0.594, 'compound': 0.9001}",negative,0.9979268312454224
695668,695668,706875.0,J&J CEO Says China Business Starting To Return To Normalcy,2020-04-14 09:53:00-04:00,JNJ,j and j ceo says china business starting to return to normalcy,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.998712420463562
695669,695669,706876.0,Tuesday's Market Minute: Earnings Season Begins Again,2020-04-14 09:33:00-04:00,JNJ,tuesdays market minute earnings season begins again,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998663663864136
695670,695670,706877.0,"The Daily Biotech Pulse: Amarin Reports Strong Q1 Vascepa Sales, BeiGene Aces Late-Stage Lung Cancer Study, Glaxo, Sanofi Strike COVID-19 Vaccine Partnership",2020-04-14 07:59:00-04:00,JNJ,the daily biotech pulse amarin reports strong first quarter vascepa sales beigene aces late stage lung cancer study glaxo sanofi strike covid 19 vaccine partnership,"{'neg': 0.189, 'neu': 0.705, 'pos': 0.106, 'compound': -0.3818}",positive,0.9995582699775696
695671,695671,706878.0,Johnson & Johnson shares are trading higher after the company reported better-than-expected Q1 EPS and sales results.,2020-04-14 07:40:00-04:00,JNJ,johnson and johnson shares are trading higher after the company reported better than expected first quarter eps and sales results,"{'neg': 0.0, 'neu': 0.779, 'pos': 0.221, 'compound': 0.6249}",positive,0.9997127652168274
695672,695672,706879.0,Mike Khouw Saw Unusual Options Activity In Johnson & Johnson Ahead Of Earnings,2020-04-14 07:30:00-04:00,JNJ,mike khouw saw unusual options activity in johnson and johnson ahead of earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9984422326087952
695673,695673,706880.0,Johnson & Johnson: Q1 Earnings Insights,2020-04-14 07:18:00-04:00,JNJ,johnson and johnson first quarter earnings insights,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9996920824050903
695674,695674,706881.0,ImmunoPrecise Announces Research License Agreement With Janssen,2020-04-14 07:07:00-04:00,JNJ,immunoprecise announces research license agreement with janssen,"{'neg': 0.0, 'neu': 0.652, 'pos': 0.348, 'compound': 0.4939}",positive,0.9956240057945251
695675,695675,706882.0,Genmab Highlights Q1 Net Sales Of DARZALEX By Johnson And Johnson Were $937M; Genmab Will Receive Royalties On Sales Under Exclusive Worldwide License,2020-04-14 06:37:00-04:00,JNJ,genmab highlights first quarter net sales of darzalex by johnson and johnson were dollars 37 million genmab will receive royalties on sales under exclusive worldwide license,"{'neg': 0.0, 'neu': 0.943, 'pos': 0.057, 'compound': 0.128}",neutral,0.9998654127120972
695676,695676,706883.0,"Johnson & Johnson Cuts FY20 Adj. EPS Guidance From $8.95-$9.10 To $7.50-$7.90, Cuts Operational Sales Guidance From $85.8B-$86.6B To $77.5B-$80.5B; Guidance Includes Impact Of Coronavirus And Related Investments",2020-04-14 06:35:00-04:00,JNJ,johnson and johnson cuts fy20 adj eps guidance from dollars .95 dollars .10 to dollars .50 dollars .90 cuts operational sales guidance from dollars 5.8 billion dollars 6.6 billion to dollars 7.5 billion dollars 0.5 billion guidance includes impact of coronavirus and related investments,"{'neg': 0.095, 'neu': 0.905, 'pos': 0.0, 'compound': -0.5267}",negative,0.991756796836853
695677,695677,706884.0,"Johnson & Johnson Q1 Adj. EPS $2.300 Beats $1.990 Estimate, Sales $20.691B Beat $19.440B Estimate",2020-04-14 06:32:00-04:00,JNJ,johnson and johnson first quarter adj eps dollars .300 beats dollars .990 estimate sales dollars 0.691 billion beat dollars 9.440 billion estimate,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998225569725037
695678,695678,706885.0,Johnson & Johnson Raises Quarterly Dividend From $0.95 To $1.01/Share,2020-04-14 06:30:00-04:00,JNJ,johnson and johnson raises quarterly dividend from dollars .95 to dollars,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.6935279369354248
695679,695679,706886.0,"5 Stocks To Watch For April 14, 2020",2020-04-14 05:07:00-04:00,JNJ,5 stocks to watch for april 14 2020,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999860405921936
695680,695680,706887.0,"Earnings Scheduled For April 14, 2020",2020-04-14 04:55:00-04:00,JNJ,earnings scheduled for april 14 2020,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998867511749268
695681,695681,706888.0,"Financials, Healthcare In Eye Of Earnings Hurricane Ahead, With Bank CEOs In Spotlight",2020-04-13 10:01:00-04:00,JNJ,financials healthcare in eye of earnings hurricane ahead with bank ceos in spotlight,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998047947883606
695682,695682,706889.0,Monday's Market Minute: OPEC Production Cut To Avoid A Glut,2020-04-13 09:32:00-04:00,JNJ,mondays market minute opec production cut to avoid a glut,"{'neg': 0.35, 'neu': 0.65, 'pos': 0.0, 'compound': -0.5106}",negative,0.9937130808830261
695683,695683,706890.0,"The Week Ahead In Biotech: Urogen FDA Decision, Amarin, J&J Earnings And More COVID-19 Updates",2020-04-12 10:05:00-04:00,JNJ,the week ahead in biotech urogen fda decision amarin j and j earnings and more covid 19 updates,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998766183853149
695684,695684,706891.0,FTC Closes Investigation of Johnson & Johnson's Proposed Acquisition of TachoSil from Takeda Pharmaceutical; FTC Says JNJ Abandoned Proposed Acquisition,2020-04-10 10:55:00-04:00,JNJ,ftc closes investigation of johnson and johnsons proposed acquisition of tachosil from takeda pharmaceutical ftc says jnj abandoned proposed acquisition,"{'neg': 0.136, 'neu': 0.864, 'pos': 0.0, 'compound': -0.4588}",neutral,0.9932371973991394
695685,695685,706892.0,"Coronavirus Vaccine Developed In Short Time Unlikely To Be Safe, International Vaccine Institute Says",2020-04-09 06:50:00-04:00,JNJ,coronavirus vaccine developed in short time unlikely to be safe international vaccine institute says,"{'neg': 0.0, 'neu': 0.818, 'pos': 0.182, 'compound': 0.4404}",negative,0.9692330956459045
695686,695686,706893.0,"SVB Leerink Maintains Outperform on Johnson & Johnson, Lowers Price Target to $160",2020-04-08 11:29:00-04:00,JNJ,svb leerink maintains outperform on johnson and johnson lowers price target to dollars 60,"{'neg': 0.103, 'neu': 0.897, 'pos': 0.0, 'compound': -0.128}",positive,0.9996719360351562
695687,695687,706894.0,Materials Stocks See More Interest Amid Hopes for Federal Infrastructure Spending,2020-04-08 10:05:00-04:00,JNJ,materials stocks see more interest amid hopes for federal infrastructure spending,"{'neg': 0.0, 'neu': 0.586, 'pos': 0.414, 'compound': 0.7474}",positive,0.999599277973175
695688,695688,706895.0,Inovio Pharmaceuticals Begins Phase 1 Human Testing Of Its COVID-19 Vaccine,2020-04-07 04:02:00-04:00,JNJ,inovio pharmaceuticals begins phase 1 human testing of its covid 19 vaccine,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998887777328491
695689,695689,706896.0,Shares of several healthcare companies are trading higher as markets gain amid optimism that coronavirus cases in several US hotspots may be peaking. A sooner peak could mean a sooner return to economic activity.,2020-04-06 09:42:00-04:00,JNJ,shares of several healthcare companies are trading higher as markets gain amid optimism that coronavirus cases in several us hotspots may be peaking a sooner peak could mean a sooner return to economic activity,"{'neg': 0.0, 'neu': 0.773, 'pos': 0.227, 'compound': 0.8442}",positive,0.9996675252914429
695690,695690,706897.0,"Cramer Gives His Opinion Alteryx, Johnson & Johnson And More",2020-04-06 07:28:00-04:00,JNJ,cramer gives his opinion alteryx johnson and johnson and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998563528060913
695691,695691,706898.0,"Barron's Picks And Pans: Post-Pandemic Ideas, Safe Dividends And More",2020-04-04 14:25:00-04:00,JNJ,barrons picks and pans post pandemic ideas safe dividends and more,"{'neg': 0.0, 'neu': 0.775, 'pos': 0.225, 'compound': 0.4404}",neutral,0.5956264138221741
695692,695692,706899.0,"The Daily Biotech Pulse: Fate Therapeutics Inks Cell Therapy Deal With J&J, Zentalis IPO",2020-04-03 07:36:00-04:00,JNJ,the daily biotech pulse fate therapeutics inks cell therapy deal with j and j zentalis ipo,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999895453453064
695693,695693,706900.0,"Global Coronavirus Cases Surge Past 1M, Medical Equipment Remains In Shortage",2020-04-03 06:40:00-04:00,JNJ,global coronavirus cases surge past 1 million medical equipment remains in shortage,"{'neg': 0.154, 'neu': 0.846, 'pos': 0.0, 'compound': -0.25}",negative,0.9934555888175964
695694,695694,706901.0,"Moderna Coronavirus Vaccine Phase 2 Trials Could Start In Spring, Chairman Says",2020-04-03 03:29:00-04:00,JNJ,moderna coronavirus vaccine phase 2 trials could start in spring chairman says,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998856782913208
695695,695695,706902.0,Fate Therapeutics Announces Worldwide Collaboration With Janssen For Novel IPSC-derived Cell-Based Cancer Immunotherapies; Co. To Receive $50M Upfront And $50M Equity Investment And Eligible To Receive Up To $1.8B,2020-04-02 16:47:00-04:00,JNJ,fate therapeutics announces worldwide collaboration with janssen for novel ipsc derived cell based cancer immunotherapies co to receive dollars 0 million upfront and dollars 0 million equity investment and eligible to receive up to dollars .8 billion,"{'neg': 0.106, 'neu': 0.839, 'pos': 0.055, 'compound': -0.4767}",neutral,0.9989595413208008
695696,695696,706903.0,"Wells Fargo Maintains Overweight on Johnson & Johnson, Lowers Price Target to $150",2020-04-02 09:07:00-04:00,JNJ,wells fargo maintains overweight on johnson and johnson lowers price target to dollars 50,"{'neg': 0.235, 'neu': 0.647, 'pos': 0.118, 'compound': -0.25}",positive,0.9992232322692871
695697,695697,706904.0,Credit Suisse Compiles List Of Corporations With Most And Least Cash,2020-04-02 06:57:00-04:00,JNJ,credit suisse compiles list of corporations with most and least cash,"{'neg': 0.0, 'neu': 0.794, 'pos': 0.206, 'compound': 0.3818}",neutral,0.9998714923858643
695698,695698,706905.0,"Stifel Maintains Hold on Johnson & Johnson, Lowers Price Target to $140",2020-04-01 10:19:00-04:00,JNJ,stifel maintains hold on johnson and johnson lowers price target to dollars 40,"{'neg': 0.111, 'neu': 0.889, 'pos': 0.0, 'compound': -0.128}",positive,0.999349057674408
695699,695699,706906.0,Shares of several healthcare companies are trading lower amid market weakness as growing coronavirus concerns in the US weigh on equities.,2020-04-01 09:20:00-04:00,JNJ,shares of several healthcare companies are trading lower amid market weakness as growing coronavirus concerns in the us weigh on equities,"{'neg': 0.193, 'neu': 0.656, 'pos': 0.151, 'compound': -0.2732}",negative,0.9986056685447693
695700,695700,706907.0,The Prize No One Wanted: Dow On Pace For Steepest Q1 Loss Ever As Quarter Finally Ends,2020-03-31 09:50:00-04:00,JNJ,the prize no one wanted dow on pace for steepest first quarter loss ever as quarter finally ends,"{'neg': 0.197, 'neu': 0.658, 'pos': 0.145, 'compound': -0.0516}",negative,0.9239597320556641
695701,695701,706908.0,Johnson & Johnson shares are trading higher on continued strength after the company announced a Coronavirus vaccine candidate. The company anticipates the first batches of the vaccine could be available for emergency use as early as 2021.,2020-03-31 09:05:00-04:00,JNJ,johnson and johnson shares are trading higher on continued strength after the company announced a coronavirus vaccine candidate the company anticipates the first batches of the vaccine could be available for emergency use as early as 2021,"{'neg': 0.062, 'neu': 0.81, 'pos': 0.129, 'compound': 0.4215}",positive,0.9997053742408752
695702,695702,706909.0,Afternoon Market Stats in 5 Minutes,2020-03-30 14:05:00-04:00,JNJ,afternoon market stats in 5 minutes,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999882698059082
695703,695703,706910.0,"UPDATE On BZ NOTE For J&J, Abbott Headline: J&J Earlier Suggested Promise For Potential Coronavirus Vaccine Candidate, Sees Phase 1 Human Trials Starting Sept. 2020 With Results From Phase 3 Trials By End Of 2020",2020-03-30 12:10:00-04:00,JNJ,update on bz note for j and j abbott headline j and j earlier suggested promise for potential coronavirus vaccine candidate sees phase 1 human trials starting sept 2020 with results from phase 3 trials by end of 2020,"{'neg': 0.0, 'neu': 0.909, 'pos': 0.091, 'compound': 0.4019}",positive,0.8698946237564087
695704,695704,706911.0,"J&J, Abbott Shares Unaffected Amid Circulation Of Headline From FT Suggesting Co.'s Announce A Potential Coronavirus Vaccine, Rapid Test; BZ NOTE: Reminder J&J Announced Details About An Isolated Coronavirus Candidate At 7 a.m. EDT Mon.",2020-03-30 12:09:00-04:00,JNJ,j and j abbott shares unaffected amid circulation of headline from ft suggesting co s announce a potential coronavirus vaccine rapid test bz note reminder j and j announced details about an isolated coronavirus candidate at 7 a m edt mon,"{'neg': 0.052, 'neu': 0.866, 'pos': 0.082, 'compound': 0.0772}",neutral,0.9150595664978027
695705,695705,706912.0,"COVID-19 Vaccine Updates: J&J Identifies Lead Candidate, IMV Eyes Clinical Testing In Summer, Altimmune Partners With University Of Alabama",2020-03-30 09:59:00-04:00,JNJ,covid 19 vaccine updates j and j identifies lead candidate imv eyes clinical testing in summer altimmune partners with university of alabama,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998791217803955
695706,695706,706913.0,Johnson & Johnson Gets Boost After Announcing September Trials Of Vaccine Planned,2020-03-30 09:40:00-04:00,JNJ,johnson and johnson gets boost after announcing september trials of vaccine planned,"{'neg': 0.0, 'neu': 0.803, 'pos': 0.197, 'compound': 0.4019}",positive,0.9996241331100464
695707,695707,706914.0,Johnson & Johnson shares are trading higher after the company announces a Coronavirus vaccine candidate. The company anticipates the first batches of the vaccine could be available for emergency use as early as 2021.,2020-03-30 08:53:00-04:00,JNJ,johnson and johnson shares are trading higher after the company announces a coronavirus vaccine candidate the company anticipates the first batches of the vaccine could be available for emergency use as early as 2021,"{'neg': 0.071, 'neu': 0.87, 'pos': 0.06, 'compound': -0.1027}",positive,0.9995434880256653
695708,695708,706915.0,"Benzinga Pro's Stock To Watch For Mon., Mar. 30, 2020: Johnson & Johnson (JNJ)",2020-03-30 08:11:00-04:00,JNJ,benzinga pros stock to watch for mon mar 30 2020 johnson and johnson jnj,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998630285263062
695709,695709,706916.0,UPDATE: Johnson & Johnson Anticipates First Batches Of A Vaccine Could Be Available For Emergency Use Authorization In Early 2021,2020-03-30 07:25:00-04:00,JNJ,update johnson and johnson anticipates first batches of a vaccine could be available for emergency use authorization in early 2021,"{'neg': 0.12, 'neu': 0.88, 'pos': 0.0, 'compound': -0.3818}",neutral,0.9998646974563599
695710,695710,706917.0,Johnson & Johnson Announces Coronavirus Vaccine Candidate,2020-03-30 07:23:00-04:00,JNJ,johnson and johnson announces coronavirus vaccine candidate,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998785257339478
695711,695711,706918.0,"Morgan Stanley Maintains Overweight on Johnson & Johnson, Lowers Price Target to $160",2020-03-27 09:44:00-04:00,JNJ,morgan stanley maintains overweight on johnson and johnson lowers price target to dollars 60,"{'neg': 0.25, 'neu': 0.75, 'pos': 0.0, 'compound': -0.4588}",positive,0.999271810054779
695712,695712,706919.0,"Shares of several healthcare companies are trading lower, selling off from this week's strength. While the US stimulus legislation has boosted economic optimism, demand concerns still exist amid the coronavirus outbreak.",2020-03-27 09:22:00-04:00,JNJ,shares of several healthcare companies are trading lower selling off from this weeks strength while the us stimulus legislation has boosted economic optimism demand concerns still exist amid the coronavirus outbreak,"{'neg': 0.092, 'neu': 0.623, 'pos': 0.284, 'compound': 0.8271}",negative,0.9929678440093994
695713,695713,706920.0,"Argus Research Reiterates Buy on Johnson & Johnson, Lowers Price Target to $155",2020-03-27 09:02:00-04:00,JNJ,argus research reiterates buy on johnson and johnson lowers price target to dollars 55,"{'neg': 0.103, 'neu': 0.897, 'pos': 0.0, 'compound': -0.128}",positive,0.999636173248291
695714,695714,706921.0,"Citigroup Maintains Buy on Johnson & Johnson, Lowers Price Target to $150",2020-03-27 08:50:00-04:00,JNJ,citigroup maintains buy on johnson and johnson lowers price target to dollars 50,"{'neg': 0.111, 'neu': 0.889, 'pos': 0.0, 'compound': -0.128}",positive,0.9995551705360413
695715,695715,706922.0,"Shares of several healthcare companies are trading higher following Senate passage of a $2 trillion economic stimulus package, which has lifted stocks across sectors.",2020-03-26 11:49:00-04:00,JNJ,shares of several healthcare companies are trading higher following senate passage of a dollars trillion economic stimulus package which has lifted stocks across sectors,"{'neg': 0.0, 'neu': 0.913, 'pos': 0.087, 'compound': 0.296}",positive,0.9996453523635864
695716,695716,706923.0,"EU Antitrust Regulators Open In-depth Investigation Into Johnson & Johnson's Buy Of Takeda's Surgical Patch Product Tachosil; Say Deal May Reduce Potential Competition, Innovation For The Supply Of Dual Haemostatic, Set Aug. 10 Deadline For Decision",2020-03-25 11:03:00-04:00,JNJ,eu antitrust regulators open in depth investigation into johnson and johnsons buy of takedas surgical patch product tachosil say deal may reduce potential competition innovation for the supply of dual haemostatic set aug 10 deadline for decision,"{'neg': 0.0, 'neu': 0.933, 'pos': 0.067, 'compound': 0.3818}",negative,0.992192804813385
695717,695717,706924.0,"Shares of several healthcare companies are trading higher as equities gain amid hopes of a US stimulus agreement. Additionally, the coronavirus outbreak has increased demand for certain medical supplies.",2020-03-24 12:20:00-04:00,JNJ,shares of several healthcare companies are trading higher as equities gain amid hopes of a us stimulus agreement additionally the coronavirus outbreak has increased demand for certain medical supplies,"{'neg': 0.038, 'neu': 0.56, 'pos': 0.402, 'compound': 0.9231}",positive,0.9996757507324219
695718,695718,706925.0,"The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark's COVID-19 Test",2020-03-24 08:20:00-04:00,JNJ,the daily biotech pulse milestone pharma flunks late stage study cytomx strikes cancer drug collaboration barda grant for genmarks covid 19 test,"{'neg': 0.321, 'neu': 0.596, 'pos': 0.083, 'compound': -0.802}",negative,0.9757373332977295
695719,695719,706926.0,Shares of several healthcare companies are trading lower amid market volatility. Sunday's fiscal stimulus bill failed a procedural senate vote while the Fed Monday morning announced further stimulus measures to support liquidity.,2020-03-23 11:31:00-04:00,JNJ,shares of several healthcare companies are trading lower amid market volatility sundays fiscal stimulus bill failed a procedural senate vote while the fed monday morning announced further stimulus measures to support liquidity,"{'neg': 0.143, 'neu': 0.729, 'pos': 0.128, 'compound': -0.1531}",negative,0.9975161552429199
695720,695720,706927.0,Stocks That Hit 52-Week Lows On Monday,2020-03-23 10:34:00-04:00,JNJ,stocks that hit 52 week lows on monday,"{'neg': 0.205, 'neu': 0.795, 'pos': 0.0, 'compound': -0.2023}",negative,0.9978522062301636
695721,695721,706928.0,COVID-19: Where It's From And Where We're Going,2020-03-20 15:21:00-04:00,JNJ,covid 19 where its from and where were going,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998842477798462
695722,695722,706929.0,"Janssen Announces Health Canada Approval Of Cabenuva, First Long-acting Regimen For Treatment Of HIV; Studies Showed Cabenuva Was As Effective As Continuing Daily, Oral, Antiretroviral Regimens In Maintaining Viral Suppression During 48-week Study",2020-03-20 09:49:00-04:00,JNJ,janssen announces health canada approval of cabenuva first long acting regimen for treatment of hiv studies showed cabenuva was as effective as continuing daily oral antiretroviral regimens in maintaining viral suppression during 48 week study,"{'neg': 0.0, 'neu': 0.842, 'pos': 0.158, 'compound': 0.7351}",positive,0.9993657469749451
695723,695723,706930.0,"The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection",2020-03-19 07:37:00-04:00,JNJ,the daily biotech pulse pfizers eczema drug aces latestage study orphan drug designation for dicerna dyadics covid 19 connection,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998396635055542
695724,695724,706931.0,J&J's Janssen Submits Ponesimod New Drug Application As Treatment For Adults With Relapsing Multiple Sclerosis,2020-03-18 16:01:00-04:00,JNJ,j and js janssen submits ponesimod new drug application as treatment for adults with relapsing multiple sclerosis,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998149275779724
695725,695725,706932.0,'J&J hopes to start human trials for coronavirus vaccine in November' -CNBC,2020-03-17 15:45:00-04:00,JNJ,j and j hopes to start human trials for coronavirus vaccine in november cnbc,"{'neg': 0.0, 'neu': 0.823, 'pos': 0.177, 'compound': 0.4215}",neutral,0.999862790107727
695726,695726,706933.0,8 Biotechs With Coronavirus Vaccines In Development,2020-03-16 10:42:00-04:00,JNJ,8 biotechs with coronavirus vaccines in development,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998934268951416
695727,695727,706934.0,Shares of several healthcare companies are trading lower in sympathy with the overall market on continued downward momentum caused by the coronavirus. The virus has had a negative impact on the global economy.,2020-03-16 09:40:00-04:00,JNJ,shares of several healthcare companies are trading lower in sympathy with the overall market on continued downward momentum caused by the coronavirus the virus has had a negative impact on the global economy,"{'neg': 0.149, 'neu': 0.732, 'pos': 0.119, 'compound': -0.296}",negative,0.9988462924957275
695728,695728,706935.0,J&J Says Sees No Evidence Darunavir Has Effect Against Coronavirus Infection,2020-03-16 09:39:00-04:00,JNJ,j and j says sees no evidence darunavir has effect against coronavirus infection,"{'neg': 0.155, 'neu': 0.845, 'pos': 0.0, 'compound': -0.296}",neutral,0.9992826581001282
695729,695729,706936.0,"J&J Says Experiencing Increased Consumer-Driven Demand For Products, Particularly Within Our Self Care Portfolio, Including Tylenol; Says It Is Shipping Stock Of Tylenol In A Controlled Manner",2020-03-13 12:38:00-04:00,JNJ,j and j says experiencing increased consumer driven demand for products particularly within our self care portfolio including tylenol says it is shipping stock of tylenol in a controlled manner,"{'neg': 0.044, 'neu': 0.799, 'pos': 0.157, 'compound': 0.5859}",positive,0.9994341731071472
695730,695730,706937.0,J&J Reports Collaboration With Beth Israel Deaconness Medical Center To Accelerate Coronavirus Vaccine Development,2020-03-13 09:42:00-04:00,JNJ,j and j reports collaboration with beth israel deaconness medical center to accelerate coronavirus vaccine development,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9979197382926941
695731,695731,706938.0,Shares of several healthcare companies are trading higher as the market rebounds following Thursday's selloff. NOTE: Since the coronavirus outbreak the healthcare sector has been extremely volatile.,2020-03-13 09:29:00-04:00,JNJ,shares of several healthcare companies are trading higher as the market rebounds following thursdays selloff note since the coronavirus outbreak the healthcare sector has been extremely volatile,"{'neg': 0.0, 'neu': 0.922, 'pos': 0.078, 'compound': 0.296}",positive,0.9947782754898071
695732,695732,706939.0,J&J Says Does Not Expect Pharma Supply Interruptions Related To Coronavirus,2020-03-13 08:59:00-04:00,JNJ,j and j says does not expect pharma supply interruptions related to coronavirus,"{'neg': 0.184, 'neu': 0.816, 'pos': 0.0, 'compound': -0.4019}",neutral,0.8965791463851929
695733,695733,706940.0,Stocks That Hit 52-Week Lows On Thursday,2020-03-12 12:10:00-04:00,JNJ,stocks that hit 52 week lows on thursday,"{'neg': 0.205, 'neu': 0.795, 'pos': 0.0, 'compound': -0.2023}",negative,0.998155415058136
695734,695734,706941.0,Shares of several healthcare companies are trading lower as equities sell off amid continued global coronavirus concerns. The virus has caused global economic disruption and negatively impacted stocks across sectors.,2020-03-12 09:26:00-04:00,JNJ,shares of several healthcare companies are trading lower as equities sell off amid continued global coronavirus concerns the virus has caused global economic disruption and negatively impacted stocks across sectors,"{'neg': 0.139, 'neu': 0.796, 'pos': 0.065, 'compound': -0.3612}",negative,0.9984208345413208
695735,695735,706942.0,"The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment",2020-03-11 08:03:00-04:00,JNJ,the daily biotech pulse ny state endorses mallinckrodts opioid settlement kamada to work on covid 19 treatment,"{'neg': 0.0, 'neu': 0.87, 'pos': 0.13, 'compound': 0.34}",neutral,0.9997619986534119
695736,695736,706943.0,Shares of several healthcare companies are trading lower. Movement appears market related amid selloff in equities. The global coronavirus outbreak has caused volatility in global markets and impacted stocks across sectors.,2020-03-11 07:15:00-04:00,JNJ,shares of several healthcare companies are trading lower movement appears market related amid selloff in equities the global coronavirus outbreak has caused volatility in global markets and impacted stocks across sectors,"{'neg': 0.066, 'neu': 0.868, 'pos': 0.066, 'compound': 0.0}",negative,0.9983373880386353
695737,695737,706944.0,How Close Are Biotechs To Bringing A COVID-19 Treatment To Market?,2020-03-10 17:24:00-04:00,JNJ,how close are biotechs to bringing a covid 19 treatment to market,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998617172241211
695738,695738,706945.0,J&J's Janssen Announces FDA Breakthrough Therapy Designation Granted For JNJ-6372 For The Treatment Of Non-Small Cell Lung Cancer,2020-03-10 16:03:00-04:00,JNJ,j and js janssen announces fda breakthrough therapy designation granted for jnj 6372 for the treatment of non small cell lung cancer,"{'neg': 0.167, 'neu': 0.758, 'pos': 0.076, 'compound': -0.5267}",positive,0.9991100430488586
695739,695739,706946.0,Shares of several healthcare companies are trading higher as markets rebound following Monday's selloff. US President Trump on Monday indicated the US may implement payroll tax cuts and other measures to support the economy amid the coronavirus outbreak.,2020-03-10 07:54:00-04:00,JNJ,shares of several healthcare companies are trading higher as markets rebound following mondays selloff us president trump on monday indicated the us may implement payroll tax cuts and other measures to support the economy amid the coronavirus outbreak,"{'neg': 0.052, 'neu': 0.831, 'pos': 0.116, 'compound': 0.4019}",positive,0.999333918094635
695740,695740,706947.0,52 Healthcare Stocks Moving In Monday's Pre-Market Session,2020-03-09 08:04:00-04:00,JNJ,52 healthcare stocks moving in mondays pre market session,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999866247177124
695741,695741,706948.0,What You Need To Know About Publicly-Traded Psychedelics Companies,2020-03-06 13:49:00-05:00,JNJ,what you need to know about publicly traded psychedelics companies,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999873161315918
695742,695742,706949.0,"Credit Suisse Maintains Outperform on Johnson & Johnson, Lowers Price Target to $159",2020-03-06 10:30:00-05:00,JNJ,credit suisse maintains outperform on johnson and johnson lowers price target to dollars 59,"{'neg': 0.093, 'neu': 0.745, 'pos': 0.161, 'compound': 0.2732}",positive,0.9996455907821655
695743,695743,706950.0,"Benzinga's Top Upgrades, Downgrades For March 5, 2020",2020-03-05 10:05:00-05:00,JNJ,benzingas top upgrades downgrades for march 5 2020,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.2023}",neutral,0.9130644798278809
695744,695744,706951.0,"Citigroup Initiates Coverage On Johnson & Johnson with Buy Rating, Announces $163 Price Target",2020-03-05 04:52:00-05:00,JNJ,citigroup initiates coverage on johnson and johnson with buy rating announces dollars 63 price target,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.7587448358535767
695745,695745,706952.0,"Hearing Citi Initiates Coverage On J&J, Boston Scientific, Zimmer Biomet, Stryker, Medtronic, Insulet With Buy Ratings",2020-03-04 17:47:00-05:00,JNJ,hearing citi initiates coverage on j and j boston scientific zimmer biomet stryker medtronic insulet with buy ratings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998767375946045
695746,695746,706953.0,"The Daily Biotech Pulse: Takeda Jumps Into The COVID-19 Fray, Exact Sciences Buys Cancer Diagnostics Companies",2020-03-04 07:37:00-05:00,JNJ,the daily biotech pulse takeda jumps into the covid 19 fray exact sciences buys cancer diagnostics companies,"{'neg': 0.216, 'neu': 0.784, 'pos': 0.0, 'compound': -0.6597}",neutral,0.9987996816635132
695747,695747,706954.0,Shares of several healthcare-related companies are trading higher after Joe Biden secured several key wins in Super Tuesday. Biden's more 'moderate' healthcare policies have been seen as more favorable for the sector.,2020-03-04 07:16:00-05:00,JNJ,shares of several healthcare related companies are trading higher after joe biden secured several key wins in super tuesday bidens more moderate healthcare policies have been seen as more favorable for the sector,"{'neg': 0.0, 'neu': 0.638, 'pos': 0.362, 'compound': 0.9422}",positive,0.9996908903121948
695748,695748,706955.0,Janssen Submits EMA Application for Ponesimod for Treatment of Adults with Relapsing MS,2020-03-04 05:17:00-05:00,JNJ,janssen submits ema application for ponesimod for treatment of adults with relapsing ms,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998632669448853
695749,695749,706956.0,Shares of several healthcare companies are trading lower in sympathy with the overall market. The Fed cut rates to combat the coronavirus outbreak which caused an initial spike but then continued to trade lower.,2020-03-03 11:55:00-05:00,JNJ,shares of several healthcare companies are trading lower in sympathy with the overall market the fed cut rates to combat the coronavirus outbreak which caused an initial spike but then continued to trade lower,"{'neg': 0.196, 'neu': 0.718, 'pos': 0.086, 'compound': -0.5106}",negative,0.9983160495758057
695750,695750,706957.0,Pfizer Works On Compounds That May Help Stop Coronaviruses,2020-03-03 06:53:00-05:00,JNJ,pfizer works on compounds that may help stop coronaviruses,"{'neg': 0.185, 'neu': 0.588, 'pos': 0.227, 'compound': 0.128}",neutral,0.9995220899581909
695751,695751,706958.0,How The COVID-19 Outbreak Is Benefiting Biotech Investors,2020-03-02 14:27:00-05:00,JNJ,how the covid 19 outbreak is benefiting biotech investors,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9988539218902588
695752,695752,706959.0,Shares of several healthcare companies are trading lower as the global coronavirus spread continues to cause equities across sectors to sell off amid worsened economic outlook.,2020-02-28 09:06:00-05:00,JNJ,shares of several healthcare companies are trading lower as the global coronavirus spread continues to cause equities across sectors to sell off amid worsened economic outlook,"{'neg': 0.168, 'neu': 0.759, 'pos': 0.073, 'compound': -0.4404}",negative,0.9985425472259521
695753,695753,706960.0,"J&J Issues Press Release To Highlight Launch Of Janssen Pharma's Open Enrollment for Heartline Study With Apple, Will Explore If Heartline Study App On iPhone, Heart Health Features On Apple Watch Can Improve Health Outcomes",2020-02-25 08:33:00-05:00,JNJ,j and j issues press release to highlight launch of janssen pharmas open enrollment for heartline study with apple will explore if heartline study app on iphone heart health features on apple watch can improve health outcomes,"{'neg': 0.0, 'neu': 0.782, 'pos': 0.218, 'compound': 0.8591}",neutral,0.7068240642547607
695754,695754,706961.0,Some Market Stats In 5 Minutes,2020-02-21 14:30:00-05:00,JNJ,some market stats in 5 minutes,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999887228012085
695755,695755,706962.0,J&J Shares At Session Highs With Broader Stock Market; Hearing Co.'s Janssen Pharma To Expand Its Existing Partnership With BARDA To Seek Treatment Solutions For Coronavirus,2020-02-18 10:11:00-05:00,JNJ,j and j shares at session highs with broader stock market hearing co s janssen pharma to expand its existing partnership with barda to seek treatment solutions for coronavirus,"{'neg': 0.0, 'neu': 0.807, 'pos': 0.193, 'compound': 0.6369}",positive,0.999620795249939
695756,695756,706963.0,21 States Reject $18B Offer From Drug Wholesalers To Settle Opioid Litigation,2020-02-14 10:10:00-05:00,JNJ,21 states reject dollars 8 billion offer from drug wholesalers to settle opioid litigation,"{'neg': 0.273, 'neu': 0.727, 'pos': 0.0, 'compound': -0.5423}",negative,0.9214332699775696
695757,695757,706964.0,"The Daily Biotech Pulse: Epizyme's Tazemetostat sNDA Accepted For Priority Review, Eisai To Withdraw Weight Loss Drug, Sol-Gel Prices Offering",2020-02-14 08:23:00-05:00,JNJ,the daily biotech pulse epizymes tazemetostat snda accepted for priority review eisai to withdraw weight loss drug sol gel prices offering,"{'neg': 0.098, 'neu': 0.812, 'pos': 0.09, 'compound': -0.0516}",neutral,0.9947468638420105
695758,695758,706965.0,"The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data",2020-02-12 09:18:00-05:00,JNJ,the daily biotech pulse j and j intensifies efforts on covid 19 cure adamas reports positive long term gocovri data,"{'neg': 0.0, 'neu': 0.841, 'pos': 0.159, 'compound': 0.5574}",positive,0.9996071457862854
695759,695759,706966.0,Johnson & Johnson Announces Collaboration With US Department of Health & Human Services To 'Accelerate Development of a Potential Novel Coronavirus Vaccine',2020-02-11 16:30:00-05:00,JNJ,johnson and johnson announces collaboration with us department of health and human services to accelerate development of a potential novel coronavirus vaccine,"{'neg': 0.0, 'neu': 0.901, 'pos': 0.099, 'compound': 0.3182}",positive,0.9992533326148987
695760,695760,706967.0,"The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology",2020-02-11 07:23:00-05:00,JNJ,the daily biotech pulse logicbio slapped with clinical hold agile inks debt deal ahead of twirla approval gilead builds stake in sierra oncology,"{'neg': 0.094, 'neu': 0.789, 'pos': 0.117, 'compound': 0.1531}",positive,0.994504988193512
695761,695761,706968.0,"New York Opioid Case A Significant Risk For Pharma Stocks, Says Bearish BofA",2020-02-10 14:43:00-05:00,JNJ,new york opioid case a significant risk for pharma stocks says bearish bofa,"{'neg': 0.141, 'neu': 0.738, 'pos': 0.121, 'compound': -0.0772}",negative,0.9982457160949707
695762,695762,706969.0,3 Leveraged Healthcare ETFs Soaring This Month,2020-02-10 09:39:00-05:00,JNJ,3 leveraged healthcare etfs soaring this month,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9995782971382141
695763,695763,706970.0,Johnson & Johnson Hit with $750M Punitive Damages Verdict for Failing to Warn about Cancer-Causing Asbestos in Talc Products,2020-02-07 12:36:00-05:00,JNJ,johnson and johnson hit with dollars 50 million punitive damages verdict for failing to warn about cancer causing asbestos in talc products,"{'neg': 0.465, 'neu': 0.486, 'pos': 0.049, 'compound': -0.9287}",negative,0.9930431842803955
695764,695764,706971.0,"The Daily Biotech Pulse: Assertio To Sell Opioid Pain Drug, Milestone Payment For Aduro, Myriad Genetics CEO Resigns",2020-02-07 07:32:00-05:00,JNJ,the daily biotech pulse assertio to sell opioid pain drug milestone payment for aduro myriad genetics ceo resigns,"{'neg': 0.259, 'neu': 0.741, 'pos': 0.0, 'compound': -0.6808}",neutral,0.9973586201667786
695765,695765,706972.0,J&J Says Judge Reducing NJ Talc Verdict To $185M,2020-02-06 15:36:00-05:00,JNJ,j and j says judge reducing nj talc verdict to dollars 85 million,"{'neg': 0.0, 'neu': 0.882, 'pos': 0.118, 'compound': 0.1531}",neutral,0.9933614730834961
695766,695766,706973.0,J&J Ordered To Pay $750M In Punitive Damage Over Talc Case,2020-02-06 14:52:00-05:00,JNJ,j and j ordered to pay dollars 50 million in punitive damage over talc case,"{'neg': 0.397, 'neu': 0.603, 'pos': 0.0, 'compound': -0.7845}",negative,0.5437954664230347
695767,695767,706974.0,Stocks That Hit 52-Week Highs On Thursday,2020-02-06 10:39:00-05:00,JNJ,stocks that hit 52 week highs on thursday,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9955268502235413
695768,695768,706975.0,"The Daily Biotech Pulse: Tonix Slumps On Failed Study, Applied Genetic Announces Offering, Beam Therapeutics, PPD Price IPOs",2020-02-06 07:47:00-05:00,JNJ,the daily biotech pulse tonix slumps on failed study applied genetic announces offering beam therapeutics ppd price ipos,"{'neg': 0.163, 'neu': 0.837, 'pos': 0.0, 'compound': -0.5106}",negative,0.9971047043800354
695769,695769,706976.0,WHO Says There's No Effective Coronavirus Treatment Yet,2020-02-05 15:00:00-05:00,JNJ,who says theres no effective coronavirus treatment yet,"{'neg': 0.267, 'neu': 0.733, 'pos': 0.0, 'compound': -0.3724}",neutral,0.9985450506210327
695770,695770,706977.0,Stocks That Hit 52-Week Highs On Wednesday,2020-02-05 10:16:00-05:00,JNJ,stocks that hit 52 week highs on wednesday,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9923027753829956
695771,695771,706978.0,"The Daily Biotech Pulse: Merck Spins Off Slow-Growth Businesses, ZioPharm Announces Offering, PhaseBio Data",2020-02-05 07:43:00-05:00,JNJ,the daily biotech pulse merck spins off slow growth businesses ziopharm announces offering phasebio data,"{'neg': 0.0, 'neu': 0.843, 'pos': 0.157, 'compound': 0.3818}",neutral,0.9998468160629272
695772,695772,706979.0,Stocks That Hit 52-Week Highs On Tuesday,2020-02-04 10:18:00-05:00,JNJ,stocks that hit 52 week highs on tuesday,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9955780506134033
695773,695773,706980.0,"Barron's Picks And Pans: Intel, Johnson & Johnson, T-Mobile And More",2020-02-01 15:28:00-05:00,JNJ,barrons picks and pans intel johnson and johnson t mobile and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998791217803955
695774,695774,706981.0,"The Daily Biotech Pulse: Sanofi Reports Positive Readout, Tonix Vaccine Candidate Aces Animal Study, Hologix's Weak Guidance",2020-01-30 09:26:00-05:00,JNJ,the daily biotech pulse sanofi reports positive readout tonix vaccine candidate aces animal study hologixs weak guidance,"{'neg': 0.135, 'neu': 0.698, 'pos': 0.167, 'compound': 0.1779}",negative,0.9758273363113403
695775,695775,706982.0,Johnson & Johnson Also Says Providing Supplies Of Antiviral Medicines To China For Investigational Use,2020-01-29 08:50:00-05:00,JNJ,johnson and johnson also says providing supplies of antiviral medicines to china for investigational use,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998747110366821
695776,695776,706983.0,Johnson & Johnson Says Initiating Coronavirus Vaccine Development,2020-01-29 08:49:00-05:00,JNJ,johnson and johnson says initiating coronavirus vaccine development,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998670816421509
695777,695777,706984.0,"The Daily Biotech Pulse: Novartis Earnings, Hepion's NASH Candidate Beats Rival Drugs, Annovis Bio To Debut",2020-01-29 08:30:00-05:00,JNJ,the daily biotech pulse novartis earnings hepions nash candidate beats rival drugs annovis bio to debut,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9989566802978516
695778,695778,706985.0,Health Canada Approves New Indication For Invokana To Reduce Risks Associated With Diabetic Kidney Disease In Patients With Type 2 Diabetes,2020-01-28 07:33:00-05:00,JNJ,health canada approves new indication for invokana to reduce risks associated with diabetic kidney disease in patients with type 2 diabetes,"{'neg': 0.088, 'neu': 0.798, 'pos': 0.113, 'compound': 0.1531}",positive,0.9995679259300232
695779,695779,706986.0,"Johnson & Johnson Is 'Confident' In Ability To Treat Coronavirus, But Vaccine Could Take Time",2020-01-27 09:16:00-05:00,JNJ,johnson and johnson is confident in ability to treat coronavirus but vaccine could take time,"{'neg': 0.0, 'neu': 0.682, 'pos': 0.318, 'compound': 0.5574}",positive,0.9986257553100586
695780,695780,706987.0,10 Biggest Price Target Changes For Monday,2020-01-27 08:56:00-05:00,JNJ,10 biggest price target changes for monday,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998207688331604
695781,695781,706988.0,Health Canada Has Approved Janssen's Stelara For Treatment Of Adult Patients With Moderately To Severely Active Ulcerative Colitis,2020-01-27 07:35:00-05:00,JNJ,health canada has approved janssens stelara for treatment of adult patients with moderately to severely active ulcerative colitis,"{'neg': 0.128, 'neu': 0.638, 'pos': 0.234, 'compound': 0.3612}",positive,0.9984143972396851
695782,695782,706989.0,"Credit Suisse Maintains Outperform on Johnson & Johnson, Raises Price Target to $170",2020-01-27 07:27:00-05:00,JNJ,credit suisse maintains outperform on johnson and johnson raises price target to dollars 70,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.3818}",positive,0.9996767044067383
695783,695783,706990.0,Janssen Announces European Commission Approves Expanded Use Of Stelara For Treatment Of Paediatric Patients With Moderate To Severe Plaque Psoriasis,2020-01-23 11:22:00-05:00,JNJ,janssen announces european commission approves expanded use of stelara for treatment of paediatric patients with moderate to severe plaque psoriasis,"{'neg': 0.112, 'neu': 0.773, 'pos': 0.116, 'compound': 0.0258}",positive,0.9963823556900024
695784,695784,706991.0,10 Biggest Price Target Changes For Thursday,2020-01-23 08:13:00-05:00,JNJ,10 biggest price target changes for thursday,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998113512992859
695785,695785,706992.0,"Raymond James Maintains Outperform on Johnson & Johnson, Raises Price Target to $161",2020-01-23 07:51:00-05:00,JNJ,raymond james maintains outperform on johnson and johnson raises price target to dollars 61,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996788501739502
695786,695786,706993.0,Mid-Afternoon Market Update: FuelCell Energy Falls On Downbeat Q4 Results; Neurotrope Shares Rise,2020-01-22 14:24:00-05:00,JNJ,mid afternoon market update fuelcell energy falls on downbeat fourth quarter results neurotrope shares rise,"{'neg': 0.0, 'neu': 0.751, 'pos': 0.249, 'compound': 0.5106}",negative,0.9949159622192383
695787,695787,706994.0,Mid-Day Market Update: Crude Oil Down Over 2%; One Stop Systems Shares Surge,2020-01-22 12:26:00-05:00,JNJ,mid day market update crude oil down over 2 percent one stop systems shares surge,"{'neg': 0.294, 'neu': 0.597, 'pos': 0.109, 'compound': -0.5719}",negative,0.9982703924179077
695788,695788,706995.0,Mid-Morning Market Update: Markets Open Higher; Johnson & Johnson Posts Mixed Q4 Results,2020-01-22 10:13:00-05:00,JNJ,mid morning market update markets open higher johnson and johnson posts mixed fourth quarter results,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9977186918258667
695789,695789,706996.0,"IBM, Netflix Earnings Greeted With Enthusiasm, And Texas Instruments Up Later Today",2020-01-22 09:53:00-05:00,JNJ,ibm netflix earnings greeted with enthusiasm and texas instruments up later today,"{'neg': 0.0, 'neu': 0.667, 'pos': 0.333, 'compound': 0.6124}",positive,0.9995972514152527
695790,695790,706997.0,Johnson & Johnson Says Independent Research Continues To Find No Link Between Talc And Cancer,2020-01-22 08:59:00-05:00,JNJ,johnson and johnson says independent research continues to find no link between talc and cancer,"{'neg': 0.337, 'neu': 0.663, 'pos': 0.0, 'compound': -0.765}",neutral,0.995924711227417
695791,695791,706998.0,"Johnson & Johnson Says Off-Patent Drugs Were Able To Retain Business A Little Longer Than Expected In 2019, And Expects It To Continue In 2020",2020-01-22 08:54:00-05:00,JNJ,johnson and johnson says off patent drugs were able to retain business a little longer than expected in 2019 and expects it to continue in 2020,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996497631072998
695792,695792,706999.0,Johnson & Johnson Exec Says 2020 Forecast Does Not Assume Any Major Acquisitions Or Other Major Uses Of Cash,2020-01-22 08:53:00-05:00,JNJ,johnson and johnson exec says 2020 forecast does not assume any major acquisitions or other major uses of cash,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998748302459717
695793,695793,707000.0,"The Daily Biotech Pulse: Johnson & Johnson Earnings, FDA Nod For Horizon Therapeutics, Slew Of Secondary Offerings",2020-01-22 08:25:00-05:00,JNJ,the daily biotech pulse johnson and johnson earnings fda nod for horizon therapeutics slew of secondary offerings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998464584350586
695794,695794,707001.0,Here's How Much Investing $100 In Johnson & Johnson Stock Back In 2010 Would Be Worth Today,2020-01-22 08:22:00-05:00,JNJ,heres how much investing dollars 00 in johnson and johnson stock back in 2010 would be worth today,"{'neg': 0.0, 'neu': 0.899, 'pos': 0.101, 'compound': 0.2263}",neutral,0.999613344669342
695795,695795,707002.0,Johnson & Johnson Reports Mixed Q4 Earnings,2020-01-22 07:19:00-05:00,JNJ,johnson and johnson reports mixed fourth quarter earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9451026320457458
695796,695796,707003.0,A Peek Into The Markets: US Stock Futures Climb Ahead Of Earnings,2020-01-22 06:54:00-05:00,JNJ,a peek into the markets us stock futures climb ahead of earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.7935472130775452
695797,695797,707004.0,Genmab Highlights 2019 Net DARZALEX Sales By Johnson & Johnson Of $2.998B,2020-01-22 06:35:00-05:00,JNJ,genmab highlights 2019 net darzalex sales by johnson and johnson of dollars .998 billion,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998940229415894
695798,695798,707005.0,"Johnson & Johnson Sees FY20 Adj. Operational EPS $9.00-$9.15, Operational Sales $85.8B-$86.6B",2020-01-22 06:32:00-05:00,JNJ,johnson and johnson sees fy20 adj operational eps dollars .00 dollars .15 operational sales dollars 5.8 billion dollars 6.6 billion,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999879002571106
695799,695799,707006.0,"Johnson & Johnson Q4 Adj. EPS $1.88 Beats $1.87 Estimate, Sales $20.75B Miss $20.78B Estimate",2020-01-22 06:31:00-05:00,JNJ,johnson and johnson fourth quarter adj eps dollars .88 beats dollars .87 estimate sales dollars 0.75 billion miss dollars 0.78 billion estimate,"{'neg': 0.071, 'neu': 0.929, 'pos': 0.0, 'compound': -0.1531}",neutral,0.9998712539672852
695800,695800,707007.0,"8 Stocks To Watch For January 22, 2020",2020-01-22 04:17:00-05:00,JNJ,8 stocks to watch for january 22 2020,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998711347579956
695801,695801,707008.0,"Earnings Scheduled For January 22, 2020",2020-01-22 04:06:00-05:00,JNJ,earnings scheduled for january 22 2020,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998844861984253
695802,695802,707009.0,Johnson & Johnson's Q4 Earnings Outlook,2020-01-21 13:43:00-05:00,JNJ,johnson and johnsons fourth quarter earnings outlook,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9994422793388367
695803,695803,707010.0,Stocks That Hit 52-Week Highs On Tuesday,2020-01-21 10:11:00-05:00,JNJ,stocks that hit 52 week highs on tuesday,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9955780506134033
695804,695804,707011.0,"Coronavirus Outbreak, IMF Forecast, Impeachment Trial Weigh On Investor Sentiment",2020-01-21 09:58:00-05:00,JNJ,coronavirus outbreak imf forecast impeachment trial weigh on investor sentiment,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9970951080322266
695805,695805,707012.0,"3 ETFs To Consider For The Week Ahead: Big Earnings For Airlines, Chips And Consumers",2020-01-21 07:28:00-05:00,JNJ,3 etfs to consider for the week ahead big earnings for airlines chips and consumers,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9351508617401123
695806,695806,707013.0,"The Week Ahead In Biotech: Focus On Epizyme, Merck Ahead Of PDUFA Dates, J&J To Kickstart Big Pharma Earnings",2020-01-20 14:04:00-05:00,JNJ,the week ahead in biotech focus on epizyme merck ahead of pdufa dates j and j to kickstart big pharma earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.5034917593002319
695807,695807,707014.0,Hearing Johnson & Johnson's Risperdal Verdict Lowered From $8B to $6.8B,2020-01-17 13:32:00-05:00,JNJ,hearing johnson and johnsons risperdal verdict lowered from dollars b to dollars .8 billion,"{'neg': 0.099, 'neu': 0.795, 'pos': 0.106, 'compound': 0.0258}",negative,0.9975714087486267
695808,695808,707015.0,Stocks That Hit 52-Week Highs On Friday,2020-01-17 13:23:00-05:00,JNJ,stocks that hit 52 week highs on friday,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9989919066429138
695809,695809,707016.0,"Record Run: Stocks Keep Rolling To New Highs as Housing Data, Earnings Look Solid",2020-01-17 09:43:00-05:00,JNJ,record run stocks keep rolling to new highs as housing data earnings look solid,"{'neg': 0.0, 'neu': 0.89, 'pos': 0.11, 'compound': 0.1531}",positive,0.9996505975723267
695810,695810,707017.0,J&N's Janssen Announced Submission Of A Type II Variation Application To European Medicines Agency For Spravato Nasal Spray,2020-01-15 07:46:00-05:00,JNJ,j and ns janssen announced submission of a type ii variation application to european medicines agency for spravato nasal spray,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998537302017212
695811,695811,707018.0,"'California Gov. Gavin Newsom wants the state to become the first to create its own generic drug label, an attempt to create more competition and bring down prices.' -Axios, From Earlier",2020-01-10 12:55:00-05:00,JNJ,california gov gavin newsom wants the state to become the first to create its own generic drug label an attempt to create more competition and bring down prices axios from earlier,"{'neg': 0.0, 'neu': 0.873, 'pos': 0.127, 'compound': 0.4939}",positive,0.9983933568000793
695812,695812,707019.0,"Wells Fargo Maintains Overweight on Johnson & Johnson, Raises Price Target to $165",2020-01-09 08:39:00-05:00,JNJ,wells fargo maintains overweight on johnson and johnson raises price target to dollars 65,"{'neg': 0.152, 'neu': 0.727, 'pos': 0.121, 'compound': -0.128}",positive,0.5170880556106567
695813,695813,707020.0,"Kaleido Biosciences Announces Collaboration With Janssen To Explore Potential For Microbiome Metabolic Therapies To Prevent Childhood-Onset Of Atopic, Immune And Metabolic Conditions By Promoting Healthy Function Of The Gut Microbiome",2020-01-09 08:01:00-05:00,JNJ,kaleido biosciences announces collaboration with janssen to explore potential for microbiome metabolic therapies to prevent childhood onset of atopic immune and metabolic conditions by promoting healthy function of the gut microbiome,"{'neg': 0.0, 'neu': 0.761, 'pos': 0.239, 'compound': 0.7579}",positive,0.946395218372345
695814,695814,707021.0,J&J Shares Briefly Turn Positive After U.S. Researchers Find No Clear Talc Link To Ovarian Cancer In Largest Study Yet,2020-01-07 11:09:00-05:00,JNJ,j and j shares briefly turn positive after u s researchers find no clear talc link to ovarian cancer in largest study yet,"{'neg': 0.21, 'neu': 0.605, 'pos': 0.185, 'compound': -0.1984}",positive,0.9995013475418091
695815,695815,707022.0,Investor Movement Index Summary: December 2019,2020-01-07 07:40:00-05:00,JNJ,investor movement index summary december 2019,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998873472213745
695816,695816,707023.0,"Protagonist Therapeutics Achieves Milestone In Janssen Collaboration, Triggering $5M Payment",2020-01-07 07:10:00-05:00,JNJ,protagonist therapeutics achieves milestone in janssen collaboration triggering dollars m payment,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9993988275527954
695817,695817,707024.0,Johnson & Johnson Reportedly Settles California Talc Case Midtrial,2020-01-06 14:18:00-05:00,JNJ,johnson and johnson reportedly settles california talc case midtrial,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.8697596192359924
695818,695818,707025.0,"'Johnson & Johnson Settles California Talc Case Midtrial, likely avoiding a huge judgement against them' -Law 360",2020-01-06 13:40:00-05:00,JNJ,johnson and johnson settles california talc case midtrial likely avoiding a huge judgement against them law 360,"{'neg': 0.122, 'neu': 0.761, 'pos': 0.117, 'compound': -0.0258}",positive,0.9981728792190552
695819,695819,707026.0,"Speaker Of The House Nancy Pelosi Says ""Enough is enough. @HouseDemocrats passed the bipartisan #LowerDrugCosts Now Act last year to stop Big Pharma from charging Americans more for our medicines than what they charge for the same drugs overseas.""",2020-01-02 16:36:00-05:00,JNJ,speaker of the house nancy pelosi says enough is enough passed the bipartisan now act last year to stop big pharma from charging americans more for our medicines than what they charge for the same drugs overseas,"{'neg': 0.058, 'neu': 0.942, 'pos': 0.0, 'compound': -0.296}",positive,0.9898325204849243
695820,695820,707027.0,Washington State Sues Johnson & Johnson Over Opioid Epidemic,2020-01-02 14:05:00-05:00,JNJ,washington state sues johnson and johnson over opioid epidemic,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9099305868148804
695821,695821,707028.0,Pulmatrix Shares Soar On Licensing Agreement With Johnson & Johnson,2020-01-02 13:45:00-05:00,JNJ,pulmatrix shares soar on licensing agreement with johnson and johnson,"{'neg': 0.0, 'neu': 0.597, 'pos': 0.403, 'compound': 0.6597}",positive,0.9996529817581177
695822,695822,707029.0,Pulmatrix Announces Kinase Inhibitor Licensing Agreement with Lung Cancer Initiative at Johnson & Johnson,2020-01-02 09:00:00-05:00,JNJ,pulmatrix announces kinase inhibitor licensing agreement with lung cancer initiative at johnson and johnson,"{'neg': 0.286, 'neu': 0.553, 'pos': 0.161, 'compound': -0.3612}",positive,0.9994418025016785
695823,695823,707030.0,Provention Bio 8-K Shows Co. Was Informed By J&J's Janssen Pharma It No Longer Intends To Take Up Option To Buy Back Rights For PRV-6527 Compound,2019-12-26 16:43:00-05:00,JNJ,provention bio 8 k shows co was informed by j and js janssen pharma it no longer intends to take up option to buy back rights for prv 6527 compound,"{'neg': 0.071, 'neu': 0.929, 'pos': 0.0, 'compound': -0.296}",neutral,0.5351290106773376
695824,695824,707031.0,How The Dow Jones Industrial Average Changed Over The Past Decade,2019-12-22 10:00:00-05:00,JNJ,how the dow jones industrial average changed over the past decade,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9989330172538757
695825,695825,707032.0,Stocks That Hit 52-Week Highs On Friday,2019-12-20 11:59:00-05:00,JNJ,stocks that hit 52 week highs on friday,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9989919066429138
695826,695826,707033.0,"The Daily Biotech Pulse: Axovant Surges On Gene Therapy Study Results, FDA Approves Merck's Ebola Vaccine, Abeona Announces Offering",2019-12-20 08:12:00-05:00,JNJ,the daily biotech pulse axovant surges on gene therapy study results fda approves mercks ebola vaccine abeona announces offering,"{'neg': 0.0, 'neu': 0.87, 'pos': 0.13, 'compound': 0.4019}",positive,0.9955374002456665
695827,695827,707034.0,"J&J To Purchase Remaining Stake In Verb Surgical, No Terms Disclosed",2019-12-20 06:46:00-05:00,JNJ,j and j to purchase remaining stake in verb surgical no terms disclosed,"{'neg': 0.155, 'neu': 0.845, 'pos': 0.0, 'compound': -0.296}",neutral,0.999889612197876
695828,695828,707035.0,"PreMarket Prep Recap: Earnings Movers, Finding Sellers In Johnson & Johnson",2019-12-19 12:37:00-05:00,JNJ,premarket prep recap earnings movers finding sellers in johnson and johnson,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9994316697120667
695829,695829,707036.0,"Benzinga's Top Upgrades, Downgrades For December 19, 2019",2019-12-19 09:51:00-05:00,JNJ,benzingas top upgrades downgrades for december 19 2019,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.2023}",neutral,0.9753205180168152
695830,695830,707037.0,"Barclays Upgrades Johnson & Johnson to Overweight, Raises Price Target to $173",2019-12-19 06:37:00-05:00,JNJ,barclays upgrades johnson and johnson to overweight raises price target to dollars 73,"{'neg': 0.172, 'neu': 0.828, 'pos': 0.0, 'compound': -0.3612}",positive,0.9991297125816345
695831,695831,707038.0,"UPDATE: Morgan Stanley Upgrades Johnson & Johnson To Overweight, Raises Target To $170 Notes Co's 'defensiveness is down but not out. Legal liabilities appear more than reflected, the pharma segment should accelerate and the business is now more balanced'",2019-12-17 12:24:00-05:00,JNJ,update morgan stanley upgrades johnson and johnson to overweight raises target to dollars 70 notes cos defensiveness is down but not out legal liabilities appear more than reflected the pharma segment should accelerate and the business is now more balanced,"{'neg': 0.106, 'neu': 0.849, 'pos': 0.045, 'compound': -0.1573}",positive,0.9996480941772461
695832,695832,707039.0,"Benzinga's Top Upgrades, Downgrades For December 17, 2019",2019-12-17 11:16:00-05:00,JNJ,benzingas top upgrades downgrades for december 17 2019,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.2023}",neutral,0.9764720797538757
695833,695833,707040.0,"Benzinga Pro's Top 5 Stocks To Watch For Tues., Dec. 17, 2019: BA, AAPL, BLPH, JNJ, LLY",2019-12-17 08:50:00-05:00,JNJ,benzinga pros top 5 stocks to watch for tues dec 17 2019 ba aapl blph jnj lly,"{'neg': 0.0, 'neu': 0.899, 'pos': 0.101, 'compound': 0.2023}",neutral,0.9998505115509033
695834,695834,707041.0,"Morgan Stanley Upgrades Johnson & Johnson to Overweight, Announces $170 Price Target",2019-12-17 06:25:00-05:00,JNJ,morgan stanley upgrades johnson and johnson to overweight announces dollars 70 price target,"{'neg': 0.172, 'neu': 0.828, 'pos': 0.0, 'compound': -0.3612}",positive,0.9994581341743469
695835,695835,707042.0,Janssen Announces Results From Phase 3 CANDOR Study; DARZALEX Regimen Showed 'Significant Increase in Progression-Free Survival in Treatment of Patients with Relapsed/Refractory Multiple Myeloma',2019-12-10 08:00:00-05:00,JNJ,janssen announces results from phase 3 candor study darzalex regimen showed significant increase in progression free survival in treatment of patients with relapsed and refractory multiple myeloma,"{'neg': 0.0, 'neu': 0.764, 'pos': 0.236, 'compound': 0.7506}",positive,0.9996637105941772
695836,695836,707043.0,"The Daily Biotech Pulse: ASH Meeting Wraps, Fast Track Designation For Equillium, Pfizer To Buy $3M In ContraFect Shares",2019-12-10 07:56:00-05:00,JNJ,the daily biotech pulse ash meeting wraps fast track designation for equillium pfizer to buy dollars m in contrafect shares,"{'neg': 0.0, 'neu': 0.896, 'pos': 0.104, 'compound': 0.296}",neutral,0.9997302889823914
695837,695837,707044.0,Johnson & Johnson Emerging Out Of A Dark Place,2019-12-09 11:56:00-05:00,JNJ,johnson and johnson emerging out of a dark place,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997373223304749
695838,695838,707045.0,Janssen and Hitgent to Collaborate on Novel DNA-Encoded Libraries,2019-12-09 08:12:00-05:00,JNJ,janssen and hitgent to collaborate on novel dna encoded libraries,"{'neg': 0.0, 'neu': 0.796, 'pos': 0.204, 'compound': 0.3182}",neutral,0.9998712539672852
695839,695839,707046.0,Vaccine Regimen from Janssen and Bavarian Nordic to Support Republic of Rwanda's Preparedness Against Ebola Outbreak,2019-12-09 05:26:00-05:00,JNJ,vaccine regimen from janssen and bavarian nordic to support republic of rwandas preparedness against ebola outbreak,"{'neg': 0.0, 'neu': 0.847, 'pos': 0.153, 'compound': 0.4019}",neutral,0.9992966651916504
695840,695840,707047.0,"Janssen Presents Initial Results for BCMA CAR-T Therapy JNJ-4528 Showing Early, Deep and High Responses in the Treatment of Relapsed or Refractory Multiple Myeloma at ASH 2019",2019-12-07 13:42:00-05:00,JNJ,janssen presents initial results for bcma car t therapy jnj 4528 showing early deep and high responses in the treatment of relapsed or refractory multiple myeloma at ash 2019,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9443580508232117
695841,695841,707048.0,"The Week Ahead In Biotech: ASH Presentations Pick Up Steam, Correvio Awaits Adcom Ruling",2019-12-07 08:35:00-05:00,JNJ,the week ahead in biotech ash presentations pick up steam correvio awaits adcom ruling,"{'neg': 0.0, 'neu': 0.909, 'pos': 0.091, 'compound': 0.0772}",positive,0.9966523051261902
695842,695842,707049.0,XBiotech Announces Agreement to Sell True Human Antibody Bermekimab Targeting IL-1a to Janssen for $750M in Cash Plus Milestone Payments Up to $600M,2019-12-07 07:40:00-05:00,JNJ,xbiotech announces agreement to sell true human antibody bermekimab targeting il 1 a to janssen for dollars 50 million in cash plus milestone payments up to dollars 00 million,"{'neg': 0.0, 'neu': 0.818, 'pos': 0.182, 'compound': 0.7184}",positive,0.9981482028961182
695843,695843,707050.0,Johnson & Johnson Option Alert: Jan 17 $145 Calls Sweep (2) near the Ask: 3425 @ $1.44 vs 13950 OI; Earnings 1/21 Before Open [est] Ref=$141.31,2019-12-06 09:52:00-05:00,JNJ,johnson and johnson option alert jan 17 dollars 45 calls sweep 2 near the ask 3425 dollars .44 vs 13950 oi earnings before open est ref equals dollars 41.31,"{'neg': 0.0, 'neu': 0.927, 'pos': 0.073, 'compound': 0.296}",neutral,0.9998579025268555
695844,695844,707051.0,Genmab Achieves $100M Sales Milestone in DARZALEX Collaboration with Janssen,2019-12-05 05:04:00-05:00,JNJ,genmab achieves dollars 00 million sales milestone in darzalex collaboration with janssen,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9990707635879517
695845,695845,707052.0,Johnson & Johnson Option Alert: Dec 20 $140 Calls at the Ask: 2650 @ $1.41 vs 10265 OI; Earnings 1/21 Before Open [est] Ref=$139.22,2019-12-04 14:24:00-05:00,JNJ,johnson and johnson option alert dec 20 dollars 40 calls at the ask 2650 dollars .41 vs 10265 oi earnings before open est ref equals dollars 39.22,"{'neg': 0.0, 'neu': 0.922, 'pos': 0.078, 'compound': 0.296}",neutral,0.9998577833175659
695846,695846,707053.0,J&J Shares Tick Lower On Slighty Uptick In Volume Amid Headline FDA Says It Stands By Study Showing Asbestos In J&J's Baby Powder,2019-12-04 13:39:00-05:00,JNJ,j and j shares tick lower on slighty uptick in volume amid headline fda says it stands by study showing asbestos in j and js baby powder,"{'neg': 0.075, 'neu': 0.85, 'pos': 0.075, 'compound': 0.0}",positive,0.9990655779838562
695847,695847,707054.0,Johnson & Johnson Says Investigation Reaffirmed FDA Finding Of No Asbestos In Baby Powder,2019-12-03 17:47:00-05:00,JNJ,johnson and johnson says investigation reaffirmed fda finding of no asbestos in baby powder,"{'neg': 0.145, 'neu': 0.855, 'pos': 0.0, 'compound': -0.296}",positive,0.9983158111572266
695848,695848,707055.0,U.S. Considers Scaling Back IP Protections For Big Drugmakers To Help Win Democratic Support For New Trade Pact With Mexico And Canada,2019-12-02 16:09:00-05:00,JNJ,u s considers scaling back ip protections for big drugmakers to help win democratic support for new trade pact with mexico and canada,"{'neg': 0.0, 'neu': 0.685, 'pos': 0.315, 'compound': 0.8481}",positive,0.9992356300354004
695849,695849,707056.0,Attention Biotech Investors: Mark Your Calendar For These December PDUFA Dates,2019-11-29 08:13:00-05:00,JNJ,attention biotech investors mark your calendar for these december pdufa dates,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998856782913208
695850,695850,707057.0,"National Business Daily Reports Drugmakers including Johnson & Johnson, Roche, Novartis and Merck have Agreed to Massively Cut the Prices of Some Drugs to Get Included in China's Medical Reimbursement List",2019-11-29 05:38:00-05:00,JNJ,national business daily reports drugmakers including johnson and johnson roche novartis and merck have agreed to massively cut the prices of some drugs to get included in chinas medical reimbursement list,"{'neg': 0.063, 'neu': 0.873, 'pos': 0.063, 'compound': 0.0}",positive,0.9995738863945007
695851,695851,707058.0,"Health Care ETFs Are Breaking Out, But Political Risks Linger In 2020",2019-11-27 09:35:00-05:00,JNJ,health care etfs are breaking out but political risks linger in 2020,"{'neg': 0.18, 'neu': 0.678, 'pos': 0.142, 'compound': -0.1406}",neutral,0.9994423985481262
695852,695852,707059.0,Pharma Companies Shares Tank As Feds Investigate Opioid Crisis,2019-11-27 06:14:00-05:00,JNJ,pharma companies shares tank as feds investigate opioid crisis,"{'neg': 0.308, 'neu': 0.526, 'pos': 0.165, 'compound': -0.4404}",negative,0.9972820281982422
695853,695853,707060.0,"McKesson, In Response To Report On Probe Of Opioid Makers, Distributors, Says Information About Co Getting A Subpoena Was Disclosed In Most Recent 10-Q",2019-11-26 15:53:00-05:00,JNJ,mckesson in response to report on probe of opioid makers distributors says information about co getting a subpoena was disclosed in most recent 10 q,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998792409896851
695854,695854,707061.0,Meg Tirrell On CNBC Says Opioid Investigation Is Not New,2019-11-26 14:20:00-05:00,JNJ,meg tirrell on cnbc says opioid investigation is not new,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998168349266052
695855,695855,707062.0,"J&J $70 Million Award Upheld In Court, May Face Addition Court Hearing For Punitive Damages",2019-11-26 13:34:00-05:00,JNJ,j and j dollars 0 million award upheld in court may face addition court hearing for punitive damages,"{'neg': 0.251, 'neu': 0.607, 'pos': 0.142, 'compound': -0.4019}",neutral,0.9996272325515747
695856,695856,707063.0,Shares of opioid-related drugmakers are trading lower on reports federal prosecutors have opened a criminal probe of opioid manufacturers.,2019-11-26 13:08:00-05:00,JNJ,shares of opioid related drugmakers are trading lower on reports federal prosecutors have opened a criminal probe of opioid manufacturers,"{'neg': 0.226, 'neu': 0.685, 'pos': 0.089, 'compound': -0.5267}",negative,0.9974576830863953
695857,695857,707064.0,"Brooklyn Federal Prosecutors Open Criminal Probe Of Opioid Manufacturers, Distributors; Mallinckrodt, AmerisourceBergen, Johnson & Johnson and Amneal Say They Have Received Subpoenas",2019-11-26 12:51:00-05:00,JNJ,brooklyn federal prosecutors open criminal probe of opioid manufacturers distributors mallinckrodt amerisourcebergen johnson and johnson and amneal say they have received subpoenas,"{'neg': 0.139, 'neu': 0.861, 'pos': 0.0, 'compound': -0.5267}",neutral,0.9996658563613892
695858,695858,707065.0,"Trump Says he Will Release a Plan to Let States Import Prescription Drugs Which are ""MUCH CHEAPER""",2019-11-22 14:08:00-05:00,JNJ,trump says he will release a plan to let states import prescription drugs which are much cheaper,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.7531196475028992
695859,695859,707066.0,This Dividend ETF Is Having Its Day,2019-11-21 08:00:00-05:00,JNJ,this dividend etf is having its day,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998683929443359
695860,695860,707067.0,"Benzinga's Top Upgrades, Downgrades For November 20, 2019",2019-11-20 09:37:00-05:00,JNJ,benzingas top upgrades downgrades for november 20 2019,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.2023}",positive,0.811097264289856
695861,695861,707068.0,"Cantor Fitzgerald Initiates Coverage On Johnson & Johnson with Overweight Rating, Announces $160 Price Target",2019-11-20 06:41:00-05:00,JNJ,cantor fitzgerald initiates coverage on johnson and johnson with overweight rating announces dollars 60 price target,"{'neg': 0.143, 'neu': 0.857, 'pos': 0.0, 'compound': -0.3612}",neutral,0.5119725465774536
695862,695862,707069.0,Janssen Receives EU Marketing Authorisation For Darzalex In Combination With Lenalidomide And Dexamethasone For Patients With Newly Diagnosed Multiple Myeloma Who Are Transplant Ineligible,2019-11-19 14:17:00-05:00,JNJ,janssen receives eu marketing authorisation for darzalex in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma who are transplant ineligible,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998663663864136
695863,695863,707070.0,"Barron's Picks And Pans: Medtronic, Tesla, Walmart And More",2019-11-17 12:49:00-05:00,JNJ,barrons picks and pans medtronic tesla walmart and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998867511749268
695864,695864,707071.0,"J&J To Appeal Revised Oklahoma Judgment In Opioid Case, Argues Judgment Not Supported By Facts Or The Law",2019-11-15 15:21:00-05:00,JNJ,j and j to appeal revised oklahoma judgment in opioid case argues judgment not supported by facts or the law,"{'neg': 0.202, 'neu': 0.798, 'pos': 0.0, 'compound': -0.5517}",neutral,0.9848003387451172
695865,695865,707072.0,Oklahoma Judge Reduces $572M J&J Owes In Opioid Case To $465M,2019-11-15 14:56:00-05:00,JNJ,oklahoma judge reduces dollars 72 million j and j owes in opioid case to dollars 65 million,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.7634711265563965
695866,695866,707073.0,Shares of several healthcare companies are trading higher after President Trump discussed transparency around pricing & processing in the healthcare industry,2019-11-15 14:51:00-05:00,JNJ,shares of several healthcare companies are trading higher after president trump discussed transparency around pricing and processing in the healthcare industry,"{'neg': 0.0, 'neu': 0.901, 'pos': 0.099, 'compound': 0.296}",positive,0.9992173910140991
695867,695867,707074.0,Johnson & Johnson Ebola Vaccine Begins Rollout in Congo,2019-11-14 06:46:00-05:00,JNJ,johnson and johnson ebola vaccine begins rollout in congo,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998810291290283
695868,695868,707075.0,12 Dow Stocks With At Least 2% Dividend Yields,2019-11-13 15:45:00-05:00,JNJ,12 dow stocks with at least 2 percent dividend yields,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999884843826294
695869,695869,707076.0,J&J's Actelion Pharmaceuticals Withdraws Regulatory Filings To Extend Indication Of OPSUMIT In CTEPH,2019-11-12 08:34:00-05:00,JNJ,j and js actelion pharmaceuticals withdraws regulatory filings to extend indication of opsumit in cteph,"{'neg': 0.0, 'neu': 0.892, 'pos': 0.108, 'compound': 0.1779}",neutral,0.974469780921936
695870,695870,707077.0,Janssen Announces New Analysis from Landmark CREDENCE Study Shows the Efficacy and Safety Profiles of INVOKANA are Consistent Across Various Levels of Kidney Function,2019-11-09 17:06:00-05:00,JNJ,janssen announces new analysis from landmark credence study shows the efficacy and safety profiles of invokana are consistent across various levels of kidney function,"{'neg': 0.0, 'neu': 0.843, 'pos': 0.157, 'compound': 0.4767}",positive,0.7554602026939392
695871,695871,707078.0,Biotech Stock On The Radar: Alkermes At A Crossroads,2019-11-07 11:53:00-05:00,JNJ,biotech stock on the radar alkermes at a crossroads,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9994737505912781
695872,695872,707079.0,Johnson & Johnson Announces Submission of European Marketing Authorisation Applications for Janssen's Investigational Ebola Vaccine Regimen,2019-11-07 06:14:00-05:00,JNJ,johnson and johnson announces submission of european marketing authorisation applications for janssens investigational ebola vaccine regimen,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998613595962524
695873,695873,707080.0,Estee Lauder Reports Outstanding First Quarter Results But Cuts Estimates,2019-11-04 08:57:00-05:00,JNJ,estee lauder reports outstanding first quarter results but cuts estimates,"{'neg': 0.211, 'neu': 0.602, 'pos': 0.188, 'compound': -0.0772}",negative,0.7498023509979248
695874,695874,707081.0,"J&J Shares Unaffected As Hearing Co. Has Recalled Surgical Tool After Death Of Patient, Serious Injuries",2019-10-31 10:44:00-04:00,JNJ,j and j shares unaffected as hearing co has recalled surgical tool after death of patient serious injuries,"{'neg': 0.232, 'neu': 0.67, 'pos': 0.098, 'compound': -0.4588}",neutral,0.992660641670227
695875,695875,707082.0,Johnson & Johnson Says Independent Labs Found No Asbestos In Recalled Powder,2019-10-30 09:50:00-04:00,JNJ,johnson and johnson says independent labs found no asbestos in recalled powder,"{'neg': 0.167, 'neu': 0.833, 'pos': 0.0, 'compound': -0.296}",neutral,0.9994020462036133
695876,695876,707083.0,Johnson & Johnson shares are trading higher after the company announced several tests from the same bottle of the company's baby powder that was previously tested by the FDA had no Asbestos.,2019-10-30 08:22:00-04:00,JNJ,johnson and johnson shares are trading higher after the company announced several tests from the same bottle of the companys baby powder that was previously tested by the fda had no asbestos,"{'neg': 0.064, 'neu': 0.872, 'pos': 0.064, 'compound': 0.0}",positive,0.9994872808456421
695877,695877,707084.0,J&J's Janssen Announces Health Canada Approval Of Darzalex In Combination With Lenalidomide And Dexamethasone For Newly Diagnosed Patients With Multiple Myeloma Who Are Transplant Ineligible,2019-10-30 07:36:00-04:00,JNJ,j and js janssen announces health canada approval of darzalex in combination with lenalidomide and dexamethasone for newly diagnosed patients with multiple myeloma who are transplant ineligible,"{'neg': 0.0, 'neu': 0.893, 'pos': 0.107, 'compound': 0.4767}",positive,0.7043868899345398
695878,695878,707085.0,13 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-10-30 07:32:00-04:00,JNJ,13 healthcare stocks moving in wednesdays pre market session,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998764991760254
695879,695879,707086.0,22 Stocks Moving in Wednesday's Pre-Market Session,2019-10-30 07:15:00-04:00,JNJ,22 stocks moving in wednesdays pre market session,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998754262924194
695880,695880,707087.0,"J&J's Own Expert, Working for FDA, Found Asbestos in Baby Powder",2019-10-30 06:10:00-04:00,JNJ,j and js own expert working for fda found asbestos in baby powder,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9994988441467285
695881,695881,707088.0,8 Stocks Moving In Tuesday's After-Hours Session,2019-10-29 17:05:00-04:00,JNJ,8 stocks moving in tuesdays after hours session,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998745918273926
695882,695882,707089.0,Johnson & Johnson shares are trading higher after the company announced several tests from the same bottle of the company's baby powder that was previously tested by the FDA had no Asbestos.,2019-10-29 16:53:00-04:00,JNJ,johnson and johnson shares are trading higher after the company announced several tests from the same bottle of the companys baby powder that was previously tested by the fda had no asbestos,"{'neg': 0.064, 'neu': 0.872, 'pos': 0.064, 'compound': 0.0}",positive,0.9994872808456421
695883,695883,707090.0,Johnson & Johnson Shares Resume Trade,2019-10-29 16:15:00-04:00,JNJ,johnson and johnson shares resume trade,"{'neg': 0.0, 'neu': 0.694, 'pos': 0.306, 'compound': 0.296}",neutral,0.9995231628417969
695884,695884,707091.0,UPDATE: Lab Undertook Probe And Determined That Portable Air Conditioner In Use In Auxiliary Room Was Contaminated With Asbestos,2019-10-29 15:59:00-04:00,JNJ,update lab undertook probe and determined that portable air conditioner in use in auxiliary room was contaminated with asbestos,"{'neg': 0.0, 'neu': 0.882, 'pos': 0.118, 'compound': 0.34}",neutral,0.9979096055030823
695885,695885,707092.0,"UPDATE: Additional 48 New Tests Of Samples From Single Lot Of Oct. 18 Recalled J&J Baby Powder Confirm It Does Not Contain Asbestos; Following Recall, Co. Contracted 2 3rd-party Laboratories To Expedite Large Number Of Tests Of Recalled Lot Of Baby Powder",2019-10-29 15:55:00-04:00,JNJ,update additional 48 new tests of samples from single lot of oct 18 recalled j and j baby powder confirm it does not contain asbestos following recall co contracted 2 3 party laboratories to expedite large number of tests of recalled lot of baby powder,"{'neg': 0.0, 'neu': 0.915, 'pos': 0.085, 'compound': 0.4588}",neutral,0.9997003078460693
695886,695886,707093.0,Johnson & Johnson Says 15 New Tests From Same Bottle Of Co.'s Baby Powder Previously Tested By FDA Find No Asbestos; Over 60 New Tests Of Recalled Lot Conducted By Two Third Party Laboratories Find No Asbestos,2019-10-29 15:52:00-04:00,JNJ,johnson and johnson says 15 new tests from same bottle of co s baby powder previously tested by fda find no asbestos over 60 new tests of recalled lot conducted by two third party laboratories find no asbestos,"{'neg': 0.105, 'neu': 0.831, 'pos': 0.064, 'compound': -0.1779}",neutral,0.9382704496383667
695887,695887,707094.0,"Johnson & Johnson Shares Halted, News Pending",2019-10-29 15:33:00-04:00,JNJ,johnson and johnson shares halted news pending,"{'neg': 0.0, 'neu': 0.732, 'pos': 0.268, 'compound': 0.296}",neutral,0.9995520710945129
695888,695888,707095.0,"J&J Says All Product Returned To Company, Whether From Recalled Lot Or Not, Will Be Removed From Marketplace Permanently",2019-10-25 12:07:00-04:00,JNJ,j and j says all product returned to company whether from recalled lot or not will be removed from marketplace permanently,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998657703399658
695889,695889,707096.0,Target Says Has Removed All J&J Baby Powder 22 oz Bottles From Stores And Website,2019-10-25 10:59:00-04:00,JNJ,target says has removed all j and j baby powder 22 oz bottles from stores and website,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9990548491477966
695890,695890,707097.0,"Rite Aid Informed Its Stores To Pull All 22-ounce J&J Baby Powder Bottles On Oct. 18, Immediately After The Recall Was Announced",2019-10-24 16:44:00-04:00,JNJ,rite aid informed its stores to pull all 22 ounce j and j baby powder bottles on oct 18 immediately after the recall was announced,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998047947883606
695891,695891,707098.0,"J&J, On CVS Health Removing J&J Baby Powder, Says Co Has Been Informed By CVS It Is A Temporary Removal In Response To The One SKU Of 22 oz Bottles",2019-10-24 15:37:00-04:00,JNJ,j and j on cvs health removing j and j baby powder says co has been informed by cvs it is a temporary removal in response to the one sku of 22 oz bottles,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999704897403717
695892,695892,707099.0,CVS Pulling All 22oz Johnson & Johnson Baby Powder From Shelves Amid Recall,2019-10-24 14:44:00-04:00,JNJ,cvs pulling all 22 oz johnson and johnson baby powder from shelves amid recall,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9989296793937683
695893,695893,707100.0,"Credit Suisse Maintains Outperform on Johnson & Johnson, Raises Price Target to $163",2019-10-24 07:20:00-04:00,JNJ,credit suisse maintains outperform on johnson and johnson raises price target to dollars 63,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.3818}",positive,0.9996820688247681
695894,695894,707101.0,"J&J Confirms Deal In Principle To Settle Opioid Litigation As Publicly Announced, Outlined By Committee Of State Attorneys General",2019-10-23 17:28:00-04:00,JNJ,j and j confirms deal in principle to settle opioid litigation as publicly announced outlined by committee of state attorneys general,"{'neg': 0.083, 'neu': 0.917, 'pos': 0.0, 'compound': -0.2023}",neutral,0.5244948267936707
695895,695895,707102.0,'Fast Money Halftime Report' Picks From October 23,2019-10-23 16:47:00-04:00,JNJ,fast money halftime report picks from october 23,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998838901519775
695896,695896,707103.0,Biotech Stock On The Radar: Immunomedics' Long Wait For Redemption,2019-10-23 16:27:00-04:00,JNJ,biotech stock on the radar immunomedics long wait for redemption,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.7970922589302063
695897,695897,707104.0,"J&J Medical Devices Unit Auris Health Reports Results From BENEFIT Study Showing Safety, Feasibility Of Monarch Platform",2019-10-23 11:00:00-04:00,JNJ,j and j medical devices unit auris health reports results from benefit study showing safety feasibility of monarch platform,"{'neg': 0.0, 'neu': 0.746, 'pos': 0.254, 'compound': 0.7003}",positive,0.9991476535797119
695898,695898,707105.0,"Mixed Bag: Better Outlooks From Lockheed, United Technologies, But McDonald's Misses",2019-10-22 10:14:00-04:00,JNJ,mixed bag better outlooks from lockheed united technologies but mcdonalds misses,"{'neg': 0.165, 'neu': 0.563, 'pos': 0.271, 'compound': 0.128}",positive,0.999466598033905
695899,695899,707106.0,How Much Litigation Risk Is Priced Into Johnson & Johnson?,2019-10-21 11:40:00-04:00,JNJ,how much litigation risk is priced into johnson and johnson,"{'neg': 0.328, 'neu': 0.672, 'pos': 0.0, 'compound': -0.4404}",neutral,0.999829888343811
695900,695900,707107.0,"Earnings Roll On With Light Schedule Today But McDonald's, Biogen On Tuesday Calendar",2019-10-21 10:00:00-04:00,JNJ,earnings roll on with light schedule today but mcdonalds biogen on tuesday calendar,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998821020126343
695901,695901,707108.0,"J&J's Actelion Pharma Reports Safety, Tolerability Findings From Trial Of Opsumit, Tadalafil Combo Therapy Consistent vs Previous Trials, Was Well Tolerated",2019-10-21 09:09:00-04:00,JNJ,j and js actelion pharma reports safety tolerability findings from trial of opsumit tadalafil combo therapy consistent vs previous trials was well tolerated,"{'neg': 0.0, 'neu': 0.811, 'pos': 0.189, 'compound': 0.5994}",positive,0.9993593096733093
695902,695902,707109.0,"4 Pharma Companies Settle Opioid Lawsuits Ahead Of Trial With Ohio Counties; 2,300 Cases Remain",2019-10-21 09:08:00-04:00,JNJ,4 pharma companies settle opioid lawsuits ahead of trial with ohio counties 2300 cases remain,"{'neg': 0.103, 'neu': 0.897, 'pos': 0.0, 'compound': -0.1531}",neutral,0.9990087151527405
695903,695903,707110.0,46 Biggest Movers From Friday,2019-10-21 05:37:00-04:00,JNJ,46 biggest movers from friday,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999879002571106
695904,695904,707111.0,"Barron's Picks And Pans: Boeing, Comcast, Conoco, Emerson And More",2019-10-20 08:13:00-04:00,JNJ,barrons picks and pans boeing comcast conoco emerson and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998830556869507
695905,695905,707112.0,"Benzinga's Bulls And Bears Of The Week: Beyond Meat, Netflix, Johnson & Johnson And More",2019-10-19 12:40:00-04:00,JNJ,benzingas bulls and bears of the week beyond meat netflix johnson and johnson and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998760223388672
695906,695906,707113.0,WeTrader Competition: Round Two Wrap-up,2019-10-18 16:05:00-04:00,JNJ,wetrader competition round two wrap up,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998514652252197
695907,695907,707114.0,"FDA Alerts Consumers Of Voluntary Recall Of Johnson & Johnson's Baby Powder; Says That Testing Has Found That A Sample For One Lot Of The Product Contains Chrysotile Fibers, A Type Of Asbestos",2019-10-18 14:26:00-04:00,JNJ,fda alerts consumers of voluntary recall of johnson and johnsons baby powder says that testing has found that a sample for one lot of the product contains chrysotile fibers a type of asbestos,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.5679524540901184
695908,695908,707115.0,38 Stocks Moving In Friday's Mid-Day Session,2019-10-18 12:30:00-04:00,JNJ,38 stocks moving in fridays mid day session,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998722076416016
695909,695909,707116.0,From J&J Conference Call To Discuss Powder Recall: Probe Into Asbestos Contamination Of Talc Could Take Up To 30 Days Or More,2019-10-18 11:40:00-04:00,JNJ,from j and j conference call to discuss powder recall probe into asbestos contamination of talc could take up to 30 days or more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998063445091248
695910,695910,707117.0,Johnson & Johnson Voluntarily Recalls A Batch Of Baby Powder,2019-10-18 09:10:00-04:00,JNJ,johnson and johnson voluntarily recalls a batch of baby powder,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998708963394165
695911,695911,707118.0,Johnson & Johnson shares are trading lower after the company recalled 1 lot of baby powder due to trace levels of asbestos.,2019-10-18 09:09:00-04:00,JNJ,johnson and johnson shares are trading lower after the company recalled 1 lot of baby powder due to trace levels of asbestos,"{'neg': 0.09, 'neu': 0.82, 'pos': 0.09, 'compound': 0.0}",negative,0.9981004595756531
695912,695912,707119.0,UPDATE: J&J Reports Its Consumer Unit's Recall Of Baby Powder Related To 'test indicating the presence of sub-trace levels of chrysotile asbestos contamination',2019-10-18 08:45:00-04:00,JNJ,update j and j reports its consumer units recall of baby powder related to test indicating the presence of sub trace levels of chrysotile asbestos contamination,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9988133907318115
695913,695913,707120.0,J&J's Consumer Unit To Voluntarily Recall1 Lot Of Johnson's Baby Powder,2019-10-18 08:40:00-04:00,JNJ,j and js consumer unit to voluntarily recall1 lot of johnsons baby powder,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999674916267395
695914,695914,707121.0,"The Daily Biotech Pulse: Intuitive Surgical Earnings, Paratek Pulls Out European Application For Antibiotic, Amgen's Evenity In Europe",2019-10-18 07:07:00-04:00,JNJ,the daily biotech pulse intuitive surgical earnings paratek pulls out european application for antibiotic amgens evenity in europe,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9925755262374878
695915,695915,707122.0,European Medicines Agency Reports Positive Opinion From CHMP For J&J's Combo Treatment In Adults With Treatment-Resistant Major Depressive Disorder,2019-10-18 06:52:00-04:00,JNJ,european medicines agency reports positive opinion from chmp for j and js combo treatment in adults with treatment resistant major depressive disorder,"{'neg': 0.206, 'neu': 0.667, 'pos': 0.126, 'compound': -0.3119}",positive,0.9995666146278381
695916,695916,707123.0,J&J's Janssen Presents Four-Year TREMFYA Data Showing Maintained Rates Of Skin Clearance In Adult Patients With Moderate To Severe Plaque Psoriasis,2019-10-17 16:05:00-04:00,JNJ,j and js janssen presents four year tremfya data showing maintained rates of skin clearance in adult patients with moderate to severe plaque psoriasis,"{'neg': 0.102, 'neu': 0.898, 'pos': 0.0, 'compound': -0.3818}",neutral,0.9998050332069397
695917,695917,707124.0,"Ohio AG Yost Says Multi-State Settlement Requires Johnson & Johnson, Ethicon Inc To Pay About $117M For 'Deceptive Marketing Of Transvaginal Surgical Mesh Devices'",2019-10-17 12:11:00-04:00,JNJ,ohio ag yost says multi state settlement requires johnson and johnson ethicon inc to pay about dollars 17 million for deceptive marketing of transvaginal surgical mesh devices,"{'neg': 0.051, 'neu': 0.949, 'pos': 0.0, 'compound': -0.1027}",neutral,0.9749812483787537
695918,695918,707125.0,Ohio AG Dave Yost Announces $117M Multi-State Settlement With Johnson & Johnson,2019-10-17 12:09:00-04:00,JNJ,ohio ag dave yost announces dollars 17 million multi state settlement with johnson and johnson,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9874997735023499
695919,695919,707126.0,"PreMarket Prep Recap: Stormy Outlook For Cloud Stocks, Opioid Makers Rally On Settlement Talks",2019-10-16 17:24:00-04:00,JNJ,premarket prep recap stormy outlook for cloud stocks opioid makers rally on settlement talks,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9983747005462646
695920,695920,707127.0,Large Option Traders Aren't Buying The Johnson & Johnson Rally,2019-10-16 15:19:00-04:00,JNJ,large option traders arent buying the johnson and johnson rally,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9996240139007568
695921,695921,707128.0,"Benzinga's Top Upgrades, Downgrades For October 16, 2019",2019-10-16 14:57:00-04:00,JNJ,benzingas top upgrades downgrades for october 16 2019,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.2023}",neutral,0.751408576965332
695922,695922,707129.0,"Analysts, Investors Like Johnson & Johnson's Improvement, But Lawsuits Loom",2019-10-16 14:26:00-04:00,JNJ,analysts investors like johnson and johnsons improvement but lawsuits loom,"{'neg': 0.304, 'neu': 0.429, 'pos': 0.268, 'compound': -0.128}",neutral,0.9906079769134521
695923,695923,707130.0,Opioid Drug Companies Rally On Hopes of Broader Settlement,2019-10-16 11:56:00-04:00,JNJ,opioid drug companies rally on hopes of broader settlement,"{'neg': 0.0, 'neu': 0.741, 'pos': 0.259, 'compound': 0.4215}",positive,0.999543309211731
695924,695924,707131.0,"Bank Of America Results Keep Financial Sector Flowing, With Netflix In Focus Later",2019-10-16 10:27:00-04:00,JNJ,bank of america results keep financial sector flowing with netflix in focus later,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9944309592247009
695925,695925,707132.0,"Credit Suisse Maintains Outperform on Johnson & Johnson, Raises Price Target to $158",2019-10-16 09:50:00-04:00,JNJ,credit suisse maintains outperform on johnson and johnson raises price target to dollars 58,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.3818}",positive,0.9996811151504517
695926,695926,707133.0,"Wells Fargo Maintains Outperform on Johnson & Johnson, Lowers Price Target to $155",2019-10-16 09:20:00-04:00,JNJ,wells fargo maintains outperform on johnson and johnson lowers price target to dollars 55,"{'neg': 0.097, 'neu': 0.774, 'pos': 0.129, 'compound': 0.128}",positive,0.9996775388717651
695927,695927,707134.0,Johnson & Johnson shares are trading higher after it was reported the company has offered $4 billion to settle opioid claims. Atlantic Equities analysts also upgraded the company's stock from Underweight to Neutral.,2019-10-16 08:31:00-04:00,JNJ,johnson and johnson shares are trading higher after it was reported the company has offered dollars billion to settle opioid claims atlantic equities analysts also upgraded the companys stock from underweight to neutral,"{'neg': 0.0, 'neu': 0.936, 'pos': 0.064, 'compound': 0.296}",positive,0.999687910079956
695928,695928,707135.0,17 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-10-16 07:57:00-04:00,JNJ,17 healthcare stocks moving in wednesdays pre market session,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998738765716553
695929,695929,707136.0,A Peek Into The Markets: US Stock Futures Down; Bank of America Profit Tops Estimates,2019-10-16 06:58:00-04:00,JNJ,a peek into the markets us stock futures down bank of america profit tops estimates,"{'neg': 0.0, 'neu': 0.677, 'pos': 0.323, 'compound': 0.7351}",positive,0.957902729511261
695930,695930,707137.0,Atlantic Equities Upgrades Johnson & Johnson to Neutral,2019-10-16 06:37:00-04:00,JNJ,atlantic equities upgrades johnson and johnson to neutral,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9995660185813904
695931,695931,707138.0,J&J Makes $4B Offer to Settle Opioid Claims,2019-10-16 03:43:00-04:00,JNJ,j and j makes dollars b offer to settle opioid claims,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.984680712223053
695932,695932,707139.0,UPDATE: J&J Also In Talks To Contribute Added Money For Opioid Litigation,2019-10-15 16:20:00-04:00,JNJ,update j and j also in talks to contribute added money for opioid litigation,"{'neg': 0.122, 'neu': 0.878, 'pos': 0.0, 'compound': -0.2023}",neutral,0.9547760486602783
695933,695933,707140.0,Missouri Appeals Court Overturns Talc Case In Which Jury Had Awarded $110M To Virginia Woman,2019-10-15 15:15:00-04:00,JNJ,missouri appeals court overturns talc case in which jury had awarded dollars 10 million to virginia woman,"{'neg': 0.0, 'neu': 0.856, 'pos': 0.144, 'compound': 0.4019}",positive,0.7304486632347107
695934,695934,707141.0,"PreMarket Prep Recap: Impressive Bank Earnings, Aphria Sparks Rally In Marijuana Sector",2019-10-15 15:01:00-04:00,JNJ,premarket prep recap impressive bank earnings aphria sparks rally in marijuana sector,"{'neg': 0.0, 'neu': 0.769, 'pos': 0.231, 'compound': 0.5106}",positive,0.9995267391204834
695935,695935,707142.0,"Bank Earnings Quartet Mostly In Tune, Led By Strength At JPMorgan, Citigroup",2019-10-15 10:13:00-04:00,JNJ,bank earnings quartet mostly in tune led by strength at jpmorgan citigroup,"{'neg': 0.0, 'neu': 0.775, 'pos': 0.225, 'compound': 0.4939}",positive,0.9993290901184082
695936,695936,707143.0,Relmada Shares Hit 4-Year High As Depression Drug Aces Midstage Trial,2019-10-15 10:00:00-04:00,JNJ,relmada shares hit 4 year high as depression drug aces midstage trial,"{'neg': 0.233, 'neu': 0.629, 'pos': 0.138, 'compound': -0.3612}",positive,0.9994145631790161
695937,695937,707144.0,"Johnson & Johnson Trades Higher On Q3 Beat-And-Raise, Despite Legal Entanglements",2019-10-15 08:08:00-04:00,JNJ,johnson and johnson trades higher on third quarter beat and raise despite legal entanglements,"{'neg': 0.095, 'neu': 0.905, 'pos': 0.0, 'compound': -0.0951}",positive,0.9996922016143799
695938,695938,707145.0,22 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-10-15 08:04:00-04:00,JNJ,22 healthcare stocks moving in tuesdays pre market session,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998711347579956
695939,695939,707146.0,"The Daily Biotech Pulse: Reata Leaps On Positive Readout, Takeda Divests, FDA Nod For Akorn, J&J Earnings",2019-10-15 07:50:00-04:00,JNJ,the daily biotech pulse reata leaps on positive readout takeda divests fda nod for akorn j and j earnings,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.5574}",positive,0.9993570446968079
695940,695940,707147.0,Johnson & Johnson shares are trading higher after the company reported better-than-expected Q3 EPS and sales results. The company also raised its FY19 EPS guidance.,2019-10-15 07:25:00-04:00,JNJ,johnson and johnson shares are trading higher after the company reported better than expected third quarter eps and sales results the company also raised its fy19 eps guidance,"{'neg': 0.0, 'neu': 0.836, 'pos': 0.164, 'compound': 0.6249}",positive,0.9997296929359436
695941,695941,707148.0,"A Peek Into The Markets: US Stock Futures Rise Ahead Of Goldman Sachs, Citigroup Earnings",2019-10-15 06:58:00-04:00,JNJ,a peek into the markets us stock futures rise ahead of goldman sachs citigroup earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.833652138710022
695942,695942,707149.0,Johnson & Johnson Raises FY19 Adj. Operational EPS Guidance From $8.73-$8.83 To $8.84-$8.89,2019-10-15 06:46:00-04:00,JNJ,johnson and johnson raises fy19 adj operational eps guidance from dollars .73 dollars .83 to dollars .84 dollars .89,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9992238283157349
695943,695943,707150.0,"Johnson & Johnson Q3 Adj. EPS $2.12 Beats $2 Estimate, Sales $20.73B Beat $20.09B Estimate",2019-10-15 06:44:00-04:00,JNJ,johnson and johnson third quarter adj eps dollars .12 beats dollars estimate sales dollars 0.73 billion beat dollars 0.09 billion estimate,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998480081558228
695944,695944,707151.0,"10 Stocks To Watch For October 15, 2019",2019-10-15 04:34:00-04:00,JNJ,10 stocks to watch for october 15 2019,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998615980148315
695945,695945,707152.0,"Earnings Scheduled For October 15, 2019",2019-10-15 04:23:00-04:00,JNJ,earnings scheduled for october 15 2019,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998809099197388
695946,695946,707153.0,"Earnings, Econ Numbers And The Beige Book Pepper The Second Round of The WeTrader Competition",2019-10-14 10:06:00-04:00,JNJ,earnings econ numbers and the beige book pepper the second round of the wetrader competition,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998905658721924
695947,695947,707154.0,"Raymond James Maintains Outperform on Johnson & Johnson, Lowers Price Target to $145",2019-10-14 08:34:00-04:00,JNJ,raymond james maintains outperform on johnson and johnson lowers price target to dollars 45,"{'neg': 0.103, 'neu': 0.897, 'pos': 0.0, 'compound': -0.128}",positive,0.9996556043624878
695948,695948,707155.0,Congo to Begin Using J&J Ebola Vaccine in November,2019-10-14 04:59:00-04:00,JNJ,congo to begin using j and j ebola vaccine in november,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998724460601807
695949,695949,707156.0,"The Week Ahead In Biotech: FDA Decisions, Johnson & Johnson Among Big Pharma Earnings",2019-10-13 16:33:00-04:00,JNJ,the week ahead in biotech fda decisions johnson and johnson among big pharma earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998206496238708
695950,695950,707157.0,"Barron's Picks And Pans: Apple, Boeing, GE, Kellogg And More",2019-10-12 16:59:00-04:00,JNJ,barrons picks and pans apple boeing ge kellogg and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999871015548706
695951,695951,707158.0,"Benzinga's Bulls And Bears Of The Week: Apple, Boeing, Facebook, Nike And More",2019-10-12 16:17:00-04:00,JNJ,benzingas bulls and bears of the week apple boeing facebook nike and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998699426651001
695952,695952,707159.0,Shares of several healthcare companies are trading higher after President Trump made positive remarks on the U.S.-China trade talks as traders grew more optimistic over the possibility of a limited trade deal. Trump is scheduled to meet with Chinese Vice Premier Liu He at the White House today.,2019-10-11 11:19:00-04:00,JNJ,shares of several healthcare companies are trading higher after president trump made positive remarks on the us china trade talks as traders grew more optimistic over the possibility of a limited trade deal trump is scheduled to meet with chinese vice premier liu he at the white house today,"{'neg': 0.034, 'neu': 0.814, 'pos': 0.152, 'compound': 0.7574}",positive,0.9996929168701172
695953,695953,707160.0,"Benzinga's Top Upgrades, Downgrades For October 11, 2019",2019-10-11 10:10:00-04:00,JNJ,benzingas top upgrades downgrades for october 11 2019,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.2023}",neutral,0.5681828260421753
695954,695954,707161.0,28 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-10-11 08:42:00-04:00,JNJ,28 healthcare stocks moving in fridays pre market session,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998533725738525
695955,695955,707162.0,"The Daily Biotech Pulse: Therapix Extends Merger Deadline, Five Prime Restructures, Gilead-Galapagos Rheumatism Drug Readout",2019-10-11 08:14:00-04:00,JNJ,the daily biotech pulse therapix extends merger deadline five prime restructures gilead galapagos rheumatism drug readout,"{'neg': 0.0, 'neu': 0.909, 'pos': 0.091, 'compound': 0.128}",neutral,0.9989482760429382
695956,695956,707163.0,Bernstein Upgrades Johnson & Johnson to Outperform,2019-10-11 07:41:00-04:00,JNJ,bernstein upgrades johnson and johnson to outperform,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996287822723389
695957,695957,707164.0,Mid-Afternoon Market Update: Dow Rises Over 200 Points; Ocugen Shares Spike Higher,2019-10-09 15:25:00-04:00,JNJ,mid afternoon market update dow rises over 200 points ocugen shares spike higher,"{'neg': 0.0, 'neu': 0.845, 'pos': 0.155, 'compound': 0.296}",positive,0.9994939565658569
695958,695958,707165.0,Mid-Day Market Update: Crude Oil Up 1%; James River Group Shares Plunge,2019-10-09 12:55:00-04:00,JNJ,mid day market update crude oil up 1 percent james river group shares plunge,"{'neg': 0.207, 'neu': 0.67, 'pos': 0.123, 'compound': -0.3612}",positive,0.9982971549034119
695959,695959,707166.0,Mid-Morning Market Update: Markets Open Higher; Johnson & Johnson Hit With $8B Verdict In Risperdal Lawsuit,2019-10-09 10:27:00-04:00,JNJ,mid morning market update markets open higher johnson and johnson hit with dollars b verdict in risperdal lawsuit,"{'neg': 0.097, 'neu': 0.821, 'pos': 0.082, 'compound': -0.0772}",positive,0.9919567108154297
695960,695960,707167.0,Johnson & Johnson Hit With $8B Verdict In Risperdal Lawsuit,2019-10-09 09:05:00-04:00,JNJ,johnson and johnson hit with dollars b verdict in risperdal lawsuit,"{'neg': 0.152, 'neu': 0.72, 'pos': 0.128, 'compound': -0.0772}",negative,0.98687344789505
695961,695961,707168.0,13 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-10-09 07:54:00-04:00,JNJ,13 healthcare stocks moving in wednesdays pre market session,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998764991760254
695962,695962,707169.0,Jury Says J&J Must Pay $8B In Case Over Male Breast Growth Linked To Risperdal,2019-10-09 07:49:00-04:00,JNJ,jury says j and j must pay dollars b in case over male breast growth linked to risperdal,"{'neg': 0.07, 'neu': 0.8, 'pos': 0.13, 'compound': 0.296}",neutral,0.9985496401786804
695963,695963,707170.0,"The Daily Biotech Pulse: Arbutus Halts Hepatitis B Study, Positive Readout For MEI Pharma's Blood Cancer Drug, Ovid Offering",2019-10-04 07:32:00-04:00,JNJ,the daily biotech pulse arbutus halts hepatitis b study positive readout for mei pharmas blood cancer drug ovid offering,"{'neg': 0.176, 'neu': 0.68, 'pos': 0.144, 'compound': -0.2023}",negative,0.9748324751853943
695964,695964,707171.0,J&J's Janssen Reports FDA Breakthrough Therapy Designation Granted For Niraparib For Treatment Of Metastatic Castration-Resistant Prostate Cancer,2019-10-03 16:18:00-04:00,JNJ,j and js janssen reports fda breakthrough therapy designation granted for niraparib for treatment of metastatic castration resistant prostate cancer,"{'neg': 0.18, 'neu': 0.738, 'pos': 0.082, 'compound': -0.5267}",positive,0.9994712471961975
695965,695965,707172.0,J&J's Janssen Submits Supplemental New Drug Application To FDA For SPRAVATO CIII Nasal Spray For The Rapid Reduction Of Depressive Symptoms In Adults With Major Depressive Disorder Who Have Active Suicidal Ideation With Intent,2019-10-02 16:04:00-04:00,JNJ,j and js janssen submits supplemental new drug application to fda for spravato ciii nasal spray for the rapid reduction of depressive symptoms in adults with major depressive disorder who have active suicidal ideation with intent,"{'neg': 0.278, 'neu': 0.664, 'pos': 0.058, 'compound': -0.8826}",neutral,0.9930551648139954
695966,695966,707173.0,Sell-Side Positive On Johnson & Johnson's Unexpected Ohio Opioid Settlement,2019-10-02 15:06:00-04:00,JNJ,sell side positive on johnson and johnsons unexpected ohio opioid settlement,"{'neg': 0.0, 'neu': 0.735, 'pos': 0.265, 'compound': 0.5574}",positive,0.9993870258331299
695967,695967,707174.0,Johnson & Johnson shares are trading higher after the company reached a settlement agreement with two Ohio counties ahead of upcoming opioid trial. The company will pay a total of $20.4 million in relation to the settlement.,2019-10-02 09:42:00-04:00,JNJ,johnson and johnson shares are trading higher after the company reached a settlement agreement with two ohio counties ahead of upcoming opioid trial the company will pay a total of dollars 0.4 million in relation to the settlement,"{'neg': 0.033, 'neu': 0.806, 'pos': 0.161, 'compound': 0.6597}",positive,0.9996329545974731
695968,695968,707175.0,UPDATE: JNJ To Pay $5M Of Ohio Counties' Legal Fees And Will Direct $5.4M To Opiod-Related Charitable Programs,2019-10-02 08:21:00-04:00,JNJ,update jnj to pay dollars m of ohio counties legal fees and will direct dollars .4 million to opiod related charitable programs,"{'neg': 0.057, 'neu': 0.772, 'pos': 0.171, 'compound': 0.4215}",neutral,0.9998675584793091
695969,695969,707176.0,"The Daily Biotech Pulse: J&J Settles Ohio Opioid Lawsuit, Teligent Explores Options For Certain Assets, Novartis Reports Cosentyx Data",2019-10-02 07:17:00-04:00,JNJ,the daily biotech pulse j and j settles ohio opioid lawsuit teligent explores options for certain assets novartis reports cosentyx data,"{'neg': 0.08, 'neu': 0.759, 'pos': 0.16, 'compound': 0.2263}",neutral,0.999258816242218
695970,695970,707177.0,Johnson & Johnson Reaches Settlement Agreement with Two Ohio Counties Ahead of Upcoming Opioid Trial; JNJ to Pay $10M to Cuyahoga and Summit Counties,2019-10-01 20:07:00-04:00,JNJ,johnson and johnson reaches settlement agreement with two ohio counties ahead of upcoming opioid trial jnj to pay dollars 0 million to cuyahoga and summit counties,"{'neg': 0.049, 'neu': 0.799, 'pos': 0.153, 'compound': 0.4588}",positive,0.9994284510612488
695971,695971,707178.0,Attention Biotech Investors: Mark Your Calendar For These October PDUFA Dates,2019-09-30 16:32:00-04:00,JNJ,attention biotech investors mark your calendar for these october pdufa dates,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998869895935059
695972,695972,707179.0,California Jury Returns $40M Talc Verdict Against Johnson & Johnson,2019-09-30 11:22:00-04:00,JNJ,california jury returns dollars 0 million talc verdict against johnson and johnson,"{'neg': 0.0, 'neu': 0.873, 'pos': 0.127, 'compound': 0.1531}",neutral,0.9985313415527344
695973,695973,707180.0,"Credit Suisse Reiterates Outperform, $156 Target On Johnson & Johnson As Firm Notes Co. 'appears to be tracking ahead of our Q3 US Pharma estimates, based on our updated analysis of intra-quarter scrips and IMS-reported sales trends for both July and Aug'",2019-09-30 10:19:00-04:00,JNJ,credit suisse reiterates outperform dollars 56 target on johnson and johnson as firm notes co appears to be tracking ahead of our third quarter us pharma estimates based on our updated analysis of intra quarter scrips and ims reported sales trends for both july and aug,"{'neg': 0.0, 'neu': 0.945, 'pos': 0.055, 'compound': 0.3818}",positive,0.9996813535690308
695974,695974,707181.0,"The Daily Biotech Pulse: ESMO Conference Gets Underway, J&J's Darzalex Snags Another Approval, Kaleido Biosciences CFO To Leave",2019-09-27 07:56:00-04:00,JNJ,the daily biotech pulse esmo conference gets underway j and js darzalex snags another approval kaleido biosciences cfo to leave,"{'neg': 0.054, 'neu': 0.807, 'pos': 0.139, 'compound': 0.4404}",negative,0.9963968396186829
695975,695975,707182.0,"J&N's Janssen Announces Receives FDA Approval For Of Darzalex (Daratumumab) Combination Regimen For Newly Diagnosed, Transplant-Eligible Patients With Multiple Myeloma",2019-09-26 14:15:00-04:00,JNJ,j and ns janssen announces receives fda approval for of darzalex daratumumab combination regimen for newly diagnosed transplant eligible patients with multiple myeloma,"{'neg': 0.0, 'neu': 0.876, 'pos': 0.124, 'compound': 0.4767}",positive,0.999220609664917
695976,695976,707183.0,"The Daily Biotech Pulse: Enanta Aces Midstage NASH Study, Takeda's Ulcerative Colitis Drug Found Superior To AbbVie's, Decision Day For J&J",2019-09-26 07:54:00-04:00,JNJ,the daily biotech pulse enanta aces midstage nash study takedas ulcerative colitis drug found superior to abbvies decision day for j and j,"{'neg': 0.0, 'neu': 0.863, 'pos': 0.137, 'compound': 0.5423}",positive,0.999396800994873
695977,695977,707184.0,"Biotech Stock On The Radar: Anavex, A Neurology-Focused Precision Medicine Company",2019-09-25 17:32:00-04:00,JNJ,biotech stock on the radar anavex a neurology focused precision medicine company,"{'neg': 0.0, 'neu': 0.809, 'pos': 0.191, 'compound': 0.3818}",neutral,0.9998767375946045
695978,695978,707185.0,"Barron's Picks And Pans: Coca-Cola, McDonald's, Ford, Nike And More",2019-09-22 16:48:00-04:00,JNJ,barrons picks and pans coca cola mcdonalds ford nike and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998782873153687
695979,695979,707186.0,The Week Ahead In Biotech: Spotlight On ESMO Conference,2019-09-22 16:22:00-04:00,JNJ,the week ahead in biotech spotlight on esmo conference,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998661279678345
695980,695980,707187.0,Shares of several drug companies are trading higher after Senate Majority Leader McConnell suggested a new Democratic drug price reform proposal would be dead on arrival.,2019-09-20 13:00:00-04:00,JNJ,shares of several drug companies are trading higher after senate majority leader mcconnell suggested a new democratic drug price reform proposal would be dead on arrival,"{'neg': 0.141, 'neu': 0.787, 'pos': 0.072, 'compound': -0.4767}",positive,0.9902991056442261
695981,695981,707188.0,J&J's Janssen Announced New Real-World Evidence Confirming Xarelto Reduced Risk Of Recurrent Venous Thromboembolism In Patients Who Are Morbidly Obese,2019-09-20 08:36:00-04:00,JNJ,j and js janssen announced new real world evidence confirming xarelto reduced risk of recurrent venous thromboembolism in patients who are morbidly obese,"{'neg': 0.087, 'neu': 0.913, 'pos': 0.0, 'compound': -0.2732}",positive,0.9996501207351685
695982,695982,707189.0,"J&J To Report Q3 Earnings On Tues., Oct 15, 2019 Before Market Open",2019-09-18 16:07:00-04:00,JNJ,j and j to report third quarter earnings on tues oct 15 2019 before market open,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998724460601807
695983,695983,707190.0,Axsome Shares Flirt With Record High: How Much Upside Is Left?,2019-09-18 14:08:00-04:00,JNJ,axsome shares flirt with record high how much upside is left,"{'neg': 0.0, 'neu': 0.82, 'pos': 0.18, 'compound': 0.296}",positive,0.9991399049758911
695984,695984,707191.0,"The Daily Biotech Pulse: NewLink Genetics Rallies, Breakthrough Designation For Roche, IGM Biosciences Debuts",2019-09-18 07:39:00-04:00,JNJ,the daily biotech pulse newlink genetics rallies breakthrough designation for roche igm biosciences debuts,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9967418313026428
695985,695985,707192.0,Purdue Pharma Files For Bankruptcy: What You Need To Know,2019-09-16 10:58:00-04:00,JNJ,purdue pharma files for bankruptcy what you need to know,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998112320899963
695986,695986,707193.0,MorphoSys Reports Licensee Janssen R&D Issued Press Release Highlighting Submission Of Supplemental Biologics License Application Seeking Approval Of Tremfya,2019-09-16 08:18:00-04:00,JNJ,morphosys reports licensee janssen r and d issued press release highlighting submission of supplemental biologics license application seeking approval of tremfya,"{'neg': 0.0, 'neu': 0.866, 'pos': 0.134, 'compound': 0.4767}",neutral,0.9998472929000854
695987,695987,707194.0,Janssen Pharmaceutical Announces New DARZALEX Data from GRIFFIN Study Show High Response Rate and Depth of Response in Patients with Newly Diagnosed Multiple Myeloma Who are Transplant-Eligible,2019-09-15 08:12:00-04:00,JNJ,janssen pharmaceutical announces new darzalex data from griffin study show high response rate and depth of response in patients with newly diagnosed multiple myeloma who are transplant eligible,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9870807528495789
695988,695988,707195.0,"J&J, McKesson Face $8B Damage Demand in Ohio Opioid Trial",2019-09-14 15:06:00-04:00,JNJ,j and j mckesson face dollars b damage demand in ohio opioid trial,"{'neg': 0.299, 'neu': 0.701, 'pos': 0.0, 'compound': -0.5719}",negative,0.9922119379043579
695989,695989,707196.0,J&J Spokesperson Says A New Jersey Jury Has Found Co. Liable For $37M In Trial Claiming Talc Powder Caused Cancer,2019-09-11 12:15:00-04:00,JNJ,j and j spokesperson says a new jersey jury has found co liable for dollars 7 million in trial claiming talc powder caused cancer,"{'neg': 0.161, 'neu': 0.839, 'pos': 0.0, 'compound': -0.6597}",negative,0.9703373312950134
695990,695990,707197.0,Johnson & Johnson To Pay $37.2M To Group Blaming Powder For Cancers,2019-09-11 11:53:00-04:00,JNJ,johnson and johnson to pay dollars 7.2 million to group blaming powder for cancers,"{'neg': 0.277, 'neu': 0.723, 'pos': 0.0, 'compound': -0.5574}",neutral,0.9996292591094971
695991,695991,707198.0,Watching J&J Shares Amid Report New Head-To-Head Phase 3 Data For Janssen's Ponesimod Was Superior Compared To Aubagio 14 mg in Adults With Relapsing Multiple Sclerosis,2019-09-11 10:05:00-04:00,JNJ,watching j and j shares amid report new head to head phase 3 data for janssens ponesimod was superior compared to aubagio 14 mg in adults with relapsing multiple sclerosis,"{'neg': 0.0, 'neu': 0.831, 'pos': 0.169, 'compound': 0.6908}",positive,0.9995869994163513
695992,695992,707199.0,J&J Says New Data From Spravato CIII Nasal Spray Phase 3 Studies Showed Rapid Reduction Of Depressive Symptoms In Adult Patients With Major Depressive Disorder,2019-09-09 09:04:00-04:00,JNJ,j and j says new data from spravato ciii nasal spray phase 3 studies showed rapid reduction of depressive symptoms in adult patients with major depressive disorder,"{'neg': 0.261, 'neu': 0.739, 'pos': 0.0, 'compound': -0.8162}",positive,0.9995989203453064
695993,695993,707200.0,European Commission Has Approved Expanded Use Of J&J's Janssen's Ustekinumab For Treatment Of Adults With Moderately To Sever Ulcerative Colitis,2019-09-04 09:16:00-04:00,JNJ,european commission has approved expanded use of j and js janssens ustekinumab for treatment of adults with moderately to sever ulcerative colitis,"{'neg': 0.0, 'neu': 0.882, 'pos': 0.118, 'compound': 0.4215}",positive,0.9991349577903748
695994,695994,707201.0,"Cardinal Health, J&J Shares Tick Lower As Hearing Cos. Must Face Cities Opioid-Conspiracy Claims",2019-09-03 14:50:00-04:00,JNJ,cardinal health j and j shares tick lower as hearing cos must face cities opioid conspiracy claims,"{'neg': 0.257, 'neu': 0.642, 'pos': 0.101, 'compound': -0.5267}",negative,0.9982165694236755
695995,695995,707202.0,"The Week Ahead In Biotech: Cardiology, Analyst Conferences In The Spotlight",2019-09-02 15:13:00-04:00,JNJ,the week ahead in biotech cardiology analyst conferences in the spotlight,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998770952224731
695996,695996,707203.0,"Bulls And Bears Of The Week: Altria, Apple, Netflix, Slack And More",2019-08-31 15:37:00-04:00,JNJ,bulls and bears of the week altria apple netflix slack and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9685506224632263
695997,695997,707204.0,"Citi Turns Bullish On Jabil, Says Customer Risk Concentration 'Played Out'",2019-08-29 17:18:00-04:00,JNJ,citi turns bullish on jabil says customer risk concentration played out,"{'neg': 0.156, 'neu': 0.667, 'pos': 0.178, 'compound': 0.0772}",positive,0.999525785446167
695998,695998,707205.0,'Fast Money' Traders Give Their Opinion On Johnson & Johnson And Papa John's,2019-08-29 07:23:00-04:00,JNJ,fast money traders give their opinion on johnson and johnson and papa johns,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998383522033691
695999,695999,707206.0,Fitch Says Oklahoma's Ruling On J&J May Not Set  Standard For Other Companies As Other States Could Employ Legal Approaches Other Than Public Nuisance Law,2019-08-28 14:59:00-04:00,JNJ,fitch says oklahomas ruling on j and j may not set standard for other companies as other states could employ legal approaches other than public nuisance law,"{'neg': 0.0, 'neu': 0.945, 'pos': 0.055, 'compound': 0.128}",neutral,0.9997592568397522
696000,696000,707207.0,Attention Biotech Investors: Mark Your Calendar For These September PDUFA Dates,2019-08-28 08:02:00-04:00,JNJ,attention biotech investors mark your calendar for these september pdufa dates,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998854398727417
696001,696001,707208.0,Arrowhead Collaborator Janssen Begins REEF-1 Phase 2b Combination Study in Patients With Chronic Hepatitis B Infection; Arrowhead Earns $25M Milestone Payment In Connection With Trial Initiation,2019-08-28 07:32:00-04:00,JNJ,arrowhead collaborator janssen begins reef 1 phase 2 billion combination study in patients with chronic hepatitis b infection arrowhead earns dollars 5 million milestone payment in connection with trial initiation,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9959207773208618
696002,696002,707209.0,46 Stocks Moving In Tuesday's Mid-Day Session,2019-08-27 14:47:00-04:00,JNJ,46 stocks moving in tuesdays mid day session,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998798370361328
696003,696003,707210.0,"Barclays Maintains Equal Weight, $140 Target On Johnson & Johnson As Firm Believes 'shares are likely to continue to trade at a discount to its sum-of-the-parts valuation due to the litigation overhang'",2019-08-27 13:28:00-04:00,JNJ,barclays maintains equal weight dollars 40 target on johnson and johnson as firm believes shares are likely to continue to trade at a discount to its sum of the parts valuation due to the litigation overhang,"{'neg': 0.047, 'neu': 0.895, 'pos': 0.058, 'compound': 0.1027}",negative,0.8362194895744324
696004,696004,707211.0,"BMO Maintains Outperform On Johnson & Johnson, Maintains $157 Target As Firm Notes 'We remind investors that litigation is long, lengthy, and difficult to read, and while the amount is less than it could have been, we would expect an extended resolution'",2019-08-27 13:15:00-04:00,JNJ,bmo maintains outperform on johnson and johnson maintains dollars 57 target as firm notes we remind investors that litigation is long lengthy and difficult to read and while the amount is less than it could have been we would expect an extended resolution,"{'neg': 0.095, 'neu': 0.905, 'pos': 0.0, 'compound': -0.5106}",positive,0.9983283877372742
696005,696005,707212.0,Why One Johnson & Johnson Analyst Sees Oklahoma Opioid Ruling As Near-Term Sentiment Positive,2019-08-27 13:03:00-04:00,JNJ,why one johnson and johnson analyst sees oklahoma opioid ruling as near term sentiment positive,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.5574}",positive,0.9994764924049377
696006,696006,707213.0,Raymond James On Johnson & Johnson Also Notes The 'judge ordered J&J to pay ~$572M for an abatement plan' And 'The state was looking for $17B from J&J and we believe investor expectations were for ~$2-3B. J&J ended 2Q19 with ~$14B in net cash',2019-08-27 12:03:00-04:00,JNJ,raymond james on johnson and johnson also notes the judge ordered j and j to pay dollars 72 million for an abatement plan and the state was looking for dollars 7 billion from j and j and we believe investor expectations were for dollars to 3 billion j and j ended second quarter 19 with dollars 4 billion in net cash,"{'neg': 0.023, 'neu': 0.977, 'pos': 0.0, 'compound': -0.1027}",neutral,0.9987396597862244
696007,696007,707214.0,"Raymond James Maintains Outperform On Johnson & Johnson As Firm Notes 'After speaking with management, we remain optimistic in the defense case for J&J when heading to the appellate courts'",2019-08-27 12:03:00-04:00,JNJ,raymond james maintains outperform on johnson and johnson as firm notes after speaking with management we remain optimistic in the defense case for j and j when heading to the appellate courts,"{'neg': 0.0, 'neu': 0.888, 'pos': 0.112, 'compound': 0.4215}",positive,0.9996281862258911
696008,696008,707215.0,"A Look At Benzinga Pro's Most-Searched Tickers For August 27, 2019",2019-08-27 11:42:00-04:00,JNJ,a look at benzinga pros most searched tickers for august 27 2019,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998824596405029
696009,696009,707216.0,"Chubb, Salesforce And More 'Fast Money' Picks For August 27",2019-08-27 11:15:00-04:00,JNJ,chubb salesforce and more fast money picks for august 27,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.998264491558075
696010,696010,707217.0,"Johnson & Johnson shares are trading higher after an Oklahoma Judge finds the company liable in the lawsuit claiming that it helped fuel opioid epidemic, will pay $572 million in damages. Investors were potentially expecting the company to pay more in fin",2019-08-27 10:46:00-04:00,JNJ,johnson and johnson shares are trading higher after an oklahoma judge finds the company liable in the lawsuit claiming that it helped fuel opioid epidemic will pay dollars 72 million in damages investors were potentially expecting the company to pay more in fin,"{'neg': 0.159, 'neu': 0.795, 'pos': 0.046, 'compound': -0.5267}",positive,0.9993323683738708
696011,696011,707218.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Tuesday., August 27, 2019",2019-08-27 10:29:00-04:00,JNJ,benzinga pros top 10 most searched tickers for morning of tuesday august 27 2019,"{'neg': 0.0, 'neu': 0.878, 'pos': 0.122, 'compound': 0.2023}",neutral,0.9997250437736511
696012,696012,707219.0,"Neutral Zone: Stocks, Bonds Both Up As Next Moves In Trade War Anxiously Awaited",2019-08-27 10:09:00-04:00,JNJ,neutral zone stocks bonds both up as next moves in trade war anxiously awaited,"{'neg': 0.385, 'neu': 0.615, 'pos': 0.0, 'compound': -0.7096}",positive,0.9978975057601929
696013,696013,707220.0,"UPDATE: Morgan Stanley On Johnson & Johnson Also Notes 'Given that many investors feared a more substantial judgment against J&J, we expect opioid-exposed specialty pharmaceutical companies to trade higher on Tuesday Aug 27'",2019-08-27 08:50:00-04:00,JNJ,update morgan stanley on johnson and johnson also notes given that many investors feared a more substantial judgment against j and j we expect opioid exposed specialty pharmaceutical companies to trade higher on tuesday aug 27,"{'neg': 0.114, 'neu': 0.833, 'pos': 0.053, 'compound': -0.3415}",positive,0.9974164962768555
696014,696014,707221.0,"UPDATE: Morgan Stanley Maintains Equal-Weight On Johnson & Johnson, Maintains $145 Target As Firm Notes 'we suggested Base case exposure of $6bn and Bear case exposure of $16bn and yesterday's judgement does not alter our view'",2019-08-27 08:50:00-04:00,JNJ,update morgan stanley maintains equal weight on johnson and johnson maintains dollars 45 target as firm notes we suggested base case exposure of dollars bn and bear case exposure of dollars 6 billion n and yesterdays judgement does not alter our view,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999613344669342
696015,696015,707222.0,"Morgan Stanley Maintains Equal-Weight on Johnson & Johnson, Maintains $145 Price Target",2019-08-27 08:46:00-04:00,JNJ,morgan stanley maintains equal weight on johnson and johnson maintains dollars 45 price target,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9987099170684814
696016,696016,707223.0,26 Stocks Moving in Tuesday's Pre-Market Session,2019-08-27 08:05:00-04:00,JNJ,26 stocks moving in tuesdays pre market session,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998726844787598
696017,696017,707224.0,"The Daily Biotech Pulse: Nuvectra Explores Strategic Options, J&J To Contend Opioid Ruling, Sesen Bio Gets New CFO",2019-08-27 07:29:00-04:00,JNJ,the daily biotech pulse nuvectra explores strategic options j and j to contend opioid ruling sesen bio gets new cfo,"{'neg': 0.0, 'neu': 0.941, 'pos': 0.059, 'compound': 0.0516}",positive,0.6094633340835571
696018,696018,707225.0,"Everyday Health Group Acquires BabyCenter From Johnson & Johnson, Terms Not Disclosed",2019-08-27 07:05:00-04:00,JNJ,everyday health group acquires babycenter from johnson and johnson terms not disclosed,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999876856803894
696019,696019,707226.0,Judge Orders Johnson & Johnson To Pay $572M In Opioid Case,2019-08-26 16:27:00-04:00,JNJ,judge orders johnson and johnson to pay dollars 72 million in opioid case,"{'neg': 0.104, 'neu': 0.896, 'pos': 0.0, 'compound': -0.1027}",neutral,0.998783528804779
696020,696020,707227.0,"Johnson & Johnson shares are trading higher after an Oklahoma Judge finds the company liable in the lawsuit claiming that it helped fuel opioid epidemic, will pay $572 million in damages. Investors were potentially expecting the company to pay more in fines.",2019-08-26 16:15:00-04:00,JNJ,johnson and johnson shares are trading higher after an oklahoma judge finds the company liable in the lawsuit claiming that it helped fuel opioid epidemic will pay dollars 72 million in damages investors were potentially expecting the company to pay more in fines,"{'neg': 0.159, 'neu': 0.795, 'pos': 0.046, 'compound': -0.5267}",positive,0.998860239982605
696021,696021,707228.0,Johnson & Johnson Says It Will Appeal Oklahoma Judge's Ruling In Opioid Case,2019-08-26 16:13:00-04:00,JNJ,johnson and johnson says it will appeal oklahoma judges ruling in opioid case,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.998218834400177
696022,696022,707229.0,Oklahoma Judge Finds Johnson & Johnson Liable In Lawsuit Claiming Drugmaker Helped Fuel Opioid Epidemic; Co. To Pay $572M In Damages,2019-08-26 16:05:00-04:00,JNJ,oklahoma judge finds johnson and johnson liable in lawsuit claiming drugmaker helped fuel opioid epidemic co to pay dollars 72 million in damages,"{'neg': 0.237, 'neu': 0.763, 'pos': 0.0, 'compound': -0.6369}",negative,0.5955715179443359
696023,696023,707230.0,"Johnson & Johnson Shares Now Falling, Reversing From Spike",2019-08-26 16:04:00-04:00,JNJ,johnson and johnson shares now falling reversing from spike,"{'neg': 0.148, 'neu': 0.648, 'pos': 0.204, 'compound': 0.1531}",negative,0.9987063407897949
696024,696024,707231.0,Johnson & Johnson Shares Spike; Oklahoma Judge Preparing To Reveal Decision In Opioid Lawsuit,2019-08-26 16:03:00-04:00,JNJ,johnson and johnson shares spike oklahoma judge preparing to reveal decision in opioid lawsuit,"{'neg': 0.118, 'neu': 0.745, 'pos': 0.137, 'compound': 0.0772}",positive,0.9191074371337891
696025,696025,707232.0,"Kohl's, Snap And More 'Fast Money' Picks For August 22",2019-08-22 10:58:00-04:00,JNJ,kohls snap and more fast money picks for august 22,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9991528987884521
696026,696026,707233.0,"The Daily Biotech Pulse: ViiV's Long-Acting HIV Drug Meets Study Goal, Chinese Cheer For FibroGen, Retrophin Flunks Late-Stage Study",2019-08-22 07:18:00-04:00,JNJ,the daily biotech pulse viivs long acting hiv drug meets study goal chinese cheer for fibrogen retrophin flunks late stage study,"{'neg': 0.112, 'neu': 0.757, 'pos': 0.131, 'compound': 0.128}",positive,0.9988027811050415
696027,696027,707234.0,'Oklahoma judge to rule on Monday in opioid lawsuit against J&J ' -Reuters,2019-08-21 16:43:00-04:00,JNJ,oklahoma judge to rule on monday in opioid lawsuit against j and j reuters,"{'neg': 0.128, 'neu': 0.872, 'pos': 0.0, 'compound': -0.2263}",neutral,0.9997817873954773
696028,696028,707235.0,"'Trump says his solution to the epidemic of veteran suicides is some new ""stimulant"" produced by Johnson & Johnson that he's instructed the government to buy in large quantities' -Tweets Aaron Rupar",2019-08-21 13:23:00-04:00,JNJ,trump says his solution to the epidemic of veteran suicides is some new stimulant produced by johnson and johnson that hes instructed the government to buy in large quantities tweets aaron rupar,"{'neg': 0.0, 'neu': 0.931, 'pos': 0.069, 'compound': 0.3182}",neutral,0.9998032450675964
696029,696029,707236.0,'It's A Huge Thing': Avicanna Receives Unique Canadian Cannabinoid Research License,2019-08-20 14:45:00-04:00,JNJ,its a huge thing avicanna receives unique canadian cannabinoid research license,"{'neg': 0.0, 'neu': 0.813, 'pos': 0.187, 'compound': 0.3182}",positive,0.7982075810432434
696030,696030,707237.0,﻿Shares of several healthcare companies are trading higher with the overall market after the U.S. announced it is excluding and delaying the additional 10% tariff on certain products.,2019-08-13 11:53:00-04:00,JNJ,﻿shares of several healthcare companies are trading higher with the overall market after the u s announced it is excluding and delaying the additional 10 percent tariff on certain products,"{'neg': 0.0, 'neu': 0.932, 'pos': 0.068, 'compound': 0.2732}",positive,0.9996516704559326
696031,696031,707238.0,Lilly's Psoriasis Drug Found Superior To J&J's Tremfya In Phase 4 Study,2019-08-13 11:40:00-04:00,JNJ,lillys psoriasis drug found superior to j and js tremfya in phase 4 study,"{'neg': 0.0, 'neu': 0.788, 'pos': 0.212, 'compound': 0.5423}",positive,0.9975008368492126
696032,696032,707239.0,"XOMA Reports J&J's Janssen Has Elected to Accelerate Base Annual License Fee Obligation, Will Make 1-Time $2.5M Payment To Co.",2019-08-12 07:34:00-04:00,JNJ,xoma reports j and js janssen has elected to accelerate base annual license fee obligation will make 1 time dollars .5 million payment to co,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9981162548065186
696033,696033,707240.0,"Biotech Stock On The Radar: Veru, A Catalyst-Rich Biopharma",2019-07-31 13:50:00-04:00,JNJ,biotech stock on the radar veru a catalyst rich biopharma,"{'neg': 0.0, 'neu': 0.714, 'pos': 0.286, 'compound': 0.5574}",positive,0.9422650337219238
696034,696034,707241.0,"In June, FTC Issued Civil Investigative Demand To J&J On Investigation Of Whether Janssen's Remicade Contracting Practices Violate Antitrust Laws",2019-07-29 16:30:00-04:00,JNJ,in june ftc issued civil investigative demand to j and j on investigation of whether janssens remicade contracting practices violate antitrust laws,"{'neg': 0.19, 'neu': 0.81, 'pos': 0.0, 'compound': -0.5719}",neutral,0.9988998174667358
696035,696035,707242.0,"Host Of Earnings Loom With Beyond Meat, Apple Among Highlights Ahead Of Fed, Payrolls",2019-07-29 09:50:00-04:00,JNJ,host of earnings loom with beyond meat apple among highlights ahead of fed payrolls,"{'neg': 0.128, 'neu': 0.872, 'pos': 0.0, 'compound': -0.2263}",neutral,0.9998120665550232
696036,696036,707243.0,KBL Merger Corp Acquires Cannabis-Focused Biotech Company,2019-07-28 16:36:00-04:00,JNJ,kbl merger corp acquires cannabis focused biotech company,"{'neg': 0.0, 'neu': 0.729, 'pos': 0.271, 'compound': 0.3818}",neutral,0.9898706078529358
696037,696037,707244.0,"The Daily Biotech Pulse: Obseva Gets The Greenlight, Verastem Climbs On Licensing Deal, Merit Medical Earnings Disappoint",2019-07-26 07:26:00-04:00,JNJ,the daily biotech pulse obseva gets the greenlight verastem climbs on licensing deal merit medical earnings disappoint,"{'neg': 0.132, 'neu': 0.732, 'pos': 0.137, 'compound': 0.0258}",positive,0.9996238946914673
696038,696038,707245.0,Social Media Earnings: Facebook And Twitter Prepare To Share,2019-07-23 16:35:00-04:00,JNJ,social media earnings facebook and twitter prepare to share,"{'neg': 0.0, 'neu': 0.784, 'pos': 0.216, 'compound': 0.296}",neutral,0.9998419284820557
696039,696039,707246.0,"With Earnings On Tap, A Stir In This Leveraged Pharmaceuticals ETF",2019-07-23 09:27:00-04:00,JNJ,with earnings on tap a stir in this leveraged pharmaceuticals etf,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.6089506149291992
696040,696040,707247.0,"Benzinga's Bulls And Bears: Apple, Boeing, Disney, Johnson & Johnson And More",2019-07-21 14:15:00-04:00,JNJ,benzingas bulls and bears apple boeing disney johnson and johnson and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999854564666748
696041,696041,707248.0,The Week Ahead In Biotech: Pharma Earnings Pick Up Pace,2019-07-20 09:53:00-04:00,JNJ,the week ahead in biotech pharma earnings pick up pace,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996731281280518
696042,696042,707249.0,From Coffee To Cannabis: Colombia's Choice Between Economic Development And 'CannaMercantilism',2019-07-19 11:30:00-04:00,JNJ,from coffee to cannabis colombias choice between economic development and cannamercantilism,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998637437820435
696043,696043,707250.0,Intuitive Surgical's Q2 Performance Lauded By Bullish Analysts,2019-07-19 10:23:00-04:00,JNJ,intuitive surgicals second quarter performance lauded by bullish analysts,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9995481371879578
696044,696044,707251.0,Halozyme Reports J&J's Janssen Submitted Extension Application To EMA For Subcutaneous Formulation Of DARZALEX Utilizing ENHANZE Technology,2019-07-19 07:03:00-04:00,JNJ,halozyme reports j and js janssen submitted extension application to ema for subcutaneous formulation of darzalex utilizing enhanze technology,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9995357990264893
696045,696045,707252.0,Janssen Seeks EMA Approval for Novel Subcutaneous Formulation of Darzalex,2019-07-19 06:00:00-04:00,JNJ,janssen seeks ema approval for novel subcutaneous formulation of darzalex,"{'neg': 0.0, 'neu': 0.597, 'pos': 0.403, 'compound': 0.6597}",positive,0.9889799356460571
696046,696046,707253.0,FlexShares Makes A Big Low Vol ETF Splash,2019-07-17 13:33:00-04:00,JNJ,flexshares makes a big low volume etf splash,"{'neg': 0.231, 'neu': 0.769, 'pos': 0.0, 'compound': -0.2732}",negative,0.9098793268203735
696047,696047,707254.0,"After Earnings Beat, Wall Street Talks Johnson & Johnson Litigation Risk",2019-07-17 13:24:00-04:00,JNJ,after earnings beat wall street talks johnson and johnson litigation risk,"{'neg': 0.302, 'neu': 0.698, 'pos': 0.0, 'compound': -0.4404}",positive,0.9961668848991394
696048,696048,707255.0,"Raymond James Maintains Outperform on Johnson & Johnson, Lowers Price Target to $146",2019-07-17 07:46:00-04:00,JNJ,raymond james maintains outperform on johnson and johnson lowers price target to dollars 46,"{'neg': 0.103, 'neu': 0.897, 'pos': 0.0, 'compound': -0.128}",positive,0.9996603727340698
696049,696049,707256.0,"Mostly Strong Results For Big Banks, And J&J Another Solid Earnings Performer",2019-07-16 10:06:00-04:00,JNJ,mostly strong results for big banks and j and j another solid earnings performer,"{'neg': 0.0, 'neu': 0.71, 'pos': 0.29, 'compound': 0.5994}",positive,0.9996150732040405
696050,696050,707257.0,J&J Executive Says Taking A $190M Charge In The Quarter Related To Talc Litigation For Defense Costs Only,2019-07-16 10:06:00-04:00,JNJ,j and j executive says taking a dollars 90 million charge in the quarter related to talc litigation for defense costs only,"{'neg': 0.077, 'neu': 0.858, 'pos': 0.064, 'compound': -0.0772}",neutral,0.9998811483383179
696051,696051,707258.0,From J&J Q2 Earnings Conference Call: Exec Commenting On Oklahoma Opioid Case Says Facts Do Not Align With What State Is Claiming,2019-07-16 09:37:00-04:00,JNJ,from j and j second quarter earnings conference call exec commenting on oklahoma opioid case says facts do not align with what state is claiming,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9762862920761108
696052,696052,707259.0,"From J&J Q2 Earnings Conference Call: Sees Largest Impact From Generic, Biosimilars In Q3, Has Resumed Distribution Of Its Surgical Staplers To Customers In Jun. Following Recall",2019-07-16 09:10:00-04:00,JNJ,from j and j second quarter earnings conference call sees largest impact from generic biosimilars in third quarter has resumed distribution of its surgical staplers to customers in jun following recall,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.998345136642456
696053,696053,707260.0,"A Peek Into The Markets: US Stock Futures Edge Lower Ahead Of Citigroup, Wells Fargo Earnings",2019-07-16 07:14:00-04:00,JNJ,a peek into the markets us stock futures edge lower ahead of citigroup wells fargo earnings,"{'neg': 0.121, 'neu': 0.769, 'pos': 0.11, 'compound': -0.0516}",negative,0.9979531764984131
696054,696054,707261.0,Johnson & Johnson Trades Higher On Q2 Earnings Beat,2019-07-16 06:55:00-04:00,JNJ,johnson and johnson trades higher on second quarter earnings beat,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996911287307739
696055,696055,707262.0,Johnson & Johnson Reaffirms FY19 Adj. EPS Guidance Of $8.53-$8.63 vs $8.60 Est.,2019-07-16 06:43:00-04:00,JNJ,johnson and johnson reaffirms fy19 adj eps guidance of dollars .53 dollars .63 vs dollars .60 est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9202479720115662
696056,696056,707263.0,Johnson & Johnson Raises FY19 Operational Sales Guidance From $82B-$82.8B To $82.4B-$83.2B; Raises Est. Reported Sales From $80.4B-$81.2B To $80.8B-$81.6B,2019-07-16 06:43:00-04:00,JNJ,johnson and johnson raises fy19 operational sales guidance from dollars 2 billion dollars 2.8 billion to dollars 2.4 billion dollars 3.2 billion raises est reported sales from dollars 0.4 billion dollars 1.2 billion to dollars 0.8 billion dollars 1.6 billion,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9991280436515808
696057,696057,707264.0,"Johnson & Johnson Q2 Adj. EPS $2.58 Beats $2.43 Estimate, Sales $20.56B Beat $20.29B Estimate",2019-07-16 06:41:00-04:00,JNJ,johnson and johnson second quarter adj eps dollars .58 beats dollars .43 estimate sales dollars 0.56 billion beat dollars 0.29 billion estimate,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999862551689148
696058,696058,707265.0,"11 Stocks To Watch For July 16, 2019",2019-07-16 04:54:00-04:00,JNJ,11 stocks to watch for july 16 2019,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998561143875122
696059,696059,707266.0,"Earnings Scheduled For July 16, 2019",2019-07-16 04:12:00-04:00,JNJ,earnings scheduled for july 16 2019,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998818635940552
696060,696060,707267.0,Johnson & Johnson Q2 Earnings Outlook,2019-07-15 14:37:00-04:00,JNJ,johnson and johnson second quarter earnings outlook,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9995647072792053
696061,696061,707268.0,"Earnings Season Starts With Beat From Citigroup; Other Banks, Netflix Report Later In Week",2019-07-15 10:24:00-04:00,JNJ,earnings season starts with beat from citigroup other banks netflix report later in week,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998260140419006
696062,696062,707269.0,The Week Ahead In Biotech: Johnson & Johnson Kickstarts Big Pharma Earnings,2019-07-13 17:04:00-04:00,JNJ,the week ahead in biotech johnson and johnson kickstarts big pharma earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9753995537757874
696063,696063,707270.0,Johnson & Johnson Falls On Report Of Justice Department Probe,2019-07-12 14:47:00-04:00,JNJ,johnson and johnson falls on report of justice department probe,"{'neg': 0.0, 'neu': 0.726, 'pos': 0.274, 'compound': 0.5267}",neutral,0.9652495980262756
696064,696064,707271.0,"J&J, In Response To Report About Criminal Probe In Talc Case, Says Implication That There Has Been A New Development In This Matter Is Flatly Wrong",2019-07-12 12:44:00-04:00,JNJ,j and j in response to report about criminal probe in talc case says implication that there has been a new development in this matter is flatly wrong,"{'neg': 0.199, 'neu': 0.766, 'pos': 0.034, 'compound': -0.7488}",neutral,0.5451383590698242
696065,696065,707272.0,Halozyme Therapeutics Reports J&J's Janssen Submitted Biologics License Application To FDA For Subcutaneous Delivery Of DARZALEX For Patients With Multiple Myeloma,2019-07-12 12:01:00-04:00,JNJ,halozyme therapeutics reports j and js janssen submitted biologics license application to fda for subcutaneous delivery of darzalex for patients with multiple myeloma,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9926052093505859
696066,696066,707273.0,Johnson & Johnson shares are trading lower following reports of a US criminal probe into the company's denial of asbestos in baby powder.,2019-07-12 11:54:00-04:00,JNJ,johnson and johnson shares are trading lower following reports of a us criminal probe into the companys denial of asbestos in baby powder,"{'neg': 0.201, 'neu': 0.719, 'pos': 0.079, 'compound': -0.5267}",negative,0.9975333213806152
696067,696067,707274.0,J&J Shares Fall As Hearing Co. Denials Of Asbestos In Baby Powder Have Spurred A US Criminal Probe,2019-07-12 11:45:00-04:00,JNJ,j and j shares fall as hearing co denials of asbestos in baby powder have spurred a us criminal probe,"{'neg': 0.144, 'neu': 0.763, 'pos': 0.093, 'compound': -0.296}",negative,0.9982635378837585
696068,696068,707275.0,J&J's Janssen Says Is In the Process Of Submitting Regulatory Applications To Respective Health Authorities Related To Preventive HIV Vaccine,2019-07-12 10:27:00-04:00,JNJ,j and js janssen says is in the process of submitting regulatory applications to respective health authorities related to preventive hiv vaccine,"{'neg': 0.0, 'neu': 0.882, 'pos': 0.118, 'compound': 0.4215}",neutral,0.9998804330825806
696069,696069,707276.0,"Novartis, Amgen Scrap Pivotal Study Of Alzheimer's Prevention Drug",2019-07-12 10:19:00-04:00,JNJ,novartis amgen scrap pivotal study of alzheimers prevention drug,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997995495796204
696070,696070,707277.0,"Benzinga's Top Upgrades, Downgrades For July 12, 2019",2019-07-12 08:55:00-04:00,JNJ,benzingas top upgrades downgrades for july 12 2019,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.2023}",positive,0.6203728318214417
696071,696071,707278.0,"Credit Suisse Initiates Coverage On Johnson & Johnson with Outperform Rating, Announces $156 Price Target",2019-07-12 07:59:00-04:00,JNJ,credit suisse initiates coverage on johnson and johnson with outperform rating announces dollars 56 price target,"{'neg': 0.0, 'neu': 0.852, 'pos': 0.148, 'compound': 0.3818}",positive,0.9995754361152649
696072,696072,707279.0,Avicanna Gets Conditional Approval To List On Toronto Stock Exchange Senior Board As R&D Issuer,2019-07-11 14:00:00-04:00,JNJ,avicanna gets conditional approval to list on toronto stock exchange senior board as r and d issuer,"{'neg': 0.0, 'neu': 0.838, 'pos': 0.162, 'compound': 0.4767}",positive,0.975741982460022
696073,696073,707280.0,'Johnson & Johnson's stranglehold on the blockbuster drug Remicade' -Recent Axios Article,2019-07-11 08:33:00-04:00,JNJ,johnson and johnsons stranglehold on the blockbuster drug remicade recent axios article,"{'neg': 0.0, 'neu': 0.738, 'pos': 0.262, 'compound': 0.5994}",neutral,0.8671614527702332
696074,696074,707281.0,Johnson & Johnson Wins New Trial In Talc Case,2019-07-10 14:40:00-04:00,JNJ,johnson and johnson wins new trial in talc case,"{'neg': 0.0, 'neu': 0.684, 'pos': 0.316, 'compound': 0.5719}",positive,0.9685737490653992
696075,696075,707282.0,"J&J Says ""Pleased With The California Appellate Court's Review"" Of The Talc Case; Says Pleased That Court Agreed With Judge Nelson's Finding That Punitive Damages Should Not Have Been Awarded",2019-07-10 13:25:00-04:00,JNJ,j and j says pleased with the california appellate courts review of the talc case says pleased that court agreed with judge nelsons finding that punitive damages should not have been awarded,"{'neg': 0.2, 'neu': 0.614, 'pos': 0.187, 'compound': -0.1426}",positive,0.9995207786560059
696076,696076,707283.0,Johnson & Johnson To Get Trial After $417M Verdict In Talc Case,2019-07-10 12:31:00-04:00,JNJ,johnson and johnson to get trial after dollars 17 million verdict in talc case,"{'neg': 0.0, 'neu': 0.89, 'pos': 0.11, 'compound': 0.1531}",neutral,0.9997929930686951
696077,696077,707284.0,Vaxart Enters Into Research Collaboration With Janssen To Evaluate Oral Universal Influenza Vaccine,2019-07-09 08:21:00-04:00,JNJ,vaxart enters into research collaboration with janssen to evaluate oral universal influenza vaccine,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998347759246826
696078,696078,707285.0,Johnson & Johnson Janssen Announces Results From Phase 3 Einstein-Jr Study Of Xarelto; Study Met All Pre Specified Endpoints,2019-07-08 08:41:00-04:00,JNJ,johnson and johnson janssen announces results from phase 3 einstein jr study of xarelto study met all pre specified endpoints,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998897314071655
696079,696079,707286.0,J&J's Janssen Reports Received Positive CHMP Opinion Recommending Expanded Use Of Imbruvica For 2 Indications,2019-06-28 07:55:00-04:00,JNJ,j and js janssen reports received positive chmp opinion recommending expanded use of imbruvica for 2 indications,"{'neg': 0.0, 'neu': 0.816, 'pos': 0.184, 'compound': 0.5574}",positive,0.9995643496513367
696080,696080,707287.0,Morphic Holding IPO: What You Need To Know,2019-06-26 14:31:00-04:00,JNJ,morphic holding ipo what you need to know,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998815059661865
696081,696081,707288.0,Minerva Spikes Higher After Novel Insomnia Drug Aces Mid-Stage Trial,2019-06-24 11:00:00-04:00,JNJ,minerva spikes higher after novel insomnia drug aces mid stage trial,"{'neg': 0.0, 'neu': 0.813, 'pos': 0.187, 'compound': 0.3182}",positive,0.9994939565658569
696082,696082,707289.0,Fitch Affirms J&J 'AAA' Rating,2019-06-19 16:11:00-04:00,JNJ,fitch affirms j and j aaa rating,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9559177160263062
696083,696083,707290.0,Janssen Reports Top-Line Phase 3 Results For Tremfya In Adults With Active Psoriatic Arthritis,2019-06-14 16:03:00-04:00,JNJ,janssen reports top line phase 3 results for tremfya in adults with active psoriatic arthritis,"{'neg': 0.0, 'neu': 0.743, 'pos': 0.257, 'compound': 0.5423}",neutral,0.999874472618103
696084,696084,707291.0,UPDATE: Recent Bloomberg Report Indicates J&J And Colgate Ordered To Pay Almost $10M In Talc Case,2019-06-12 15:52:00-04:00,JNJ,update recent bloomberg report indicates j and j and colgate ordered to pay almost dollars 0 million in talc case,"{'neg': 0.069, 'neu': 0.931, 'pos': 0.0, 'compound': -0.1027}",neutral,0.8677719235420227
696085,696085,707292.0,"J&J, Colgate-Palmolive Lose Verdict In Talc-Cancer Case",2019-06-12 15:50:00-04:00,JNJ,j and j colgate palmolive lose verdict in talc cancer case,"{'neg': 0.425, 'neu': 0.479, 'pos': 0.096, 'compound': -0.7579}",negative,0.9844303727149963
696086,696086,707293.0,J&J Says Co 'Will Pursue An Appeal Because Johnson's Baby Powder Does Not Contain Asbestos Or Cause Cancer',2019-06-12 14:50:00-04:00,JNJ,j and j says co will pursue an appeal because johnsons baby powder does not contain asbestos or cause cancer,"{'neg': 0.188, 'neu': 0.812, 'pos': 0.0, 'compound': -0.6597}",neutral,0.9997815489768982
696087,696087,707294.0,Hearing Johnson & Johnson And Colgate-Palmolive Have Closed Jury Verdict In Talc Cancer Case,2019-06-12 14:02:00-04:00,JNJ,hearing johnson and johnson and colgate palmolive have closed jury verdict in talc cancer case,"{'neg': 0.232, 'neu': 0.684, 'pos': 0.084, 'compound': -0.5859}",neutral,0.962942361831665
696088,696088,707295.0,Janssen Invokana Incidence Rates Of Adverse Events & Serious Adverse Events Were Numerically Lower For Patients Treated With Invokana Vs Placebo,2019-06-11 12:34:00-04:00,JNJ,janssen invokana incidence rates of adverse events and serious adverse events were numerically lower for patients treated with invokana vs placebo,"{'neg': 0.333, 'neu': 0.667, 'pos': 0.0, 'compound': -0.7579}",positive,0.9991514682769775
696089,696089,707296.0,Janssen Invokana Significantly Reduced Major Cardiovascular Events & Kidney Failure In Patients With Type 2 Diabetes & Chronic Kidney Disease In New Credence Analysis,2019-06-11 12:33:00-04:00,JNJ,janssen invokana significantly reduced major cardiovascular events and kidney failure in patients with type 2 diabetes and chronic kidney disease in new credence analysis,"{'neg': 0.125, 'neu': 0.875, 'pos': 0.0, 'compound': -0.5106}",positive,0.9996311664581299
696090,696090,707297.0,"The Daily Biotech Pulse: Lilly Reports Positive Long-Term Efficacy Data For Psoriasis Drug, Provention Bio Offering",2019-06-11 07:34:00-04:00,JNJ,the daily biotech pulse lilly reports positive long term efficacy data for psoriasis drug provention bio offering,"{'neg': 0.0, 'neu': 0.816, 'pos': 0.184, 'compound': 0.5574}",positive,0.9994902610778809
696091,696091,707298.0,Shares of several healthcare companies are trading higher with the overall US market. Recent comments out of China and Mexico has renewed trade optimism and lifted economic outlook.,2019-06-04 13:07:00-04:00,JNJ,shares of several healthcare companies are trading higher with the overall us market recent comments out of china and mexico has renewed trade optimism and lifted economic outlook,"{'neg': 0.0, 'neu': 0.82, 'pos': 0.18, 'compound': 0.6908}",positive,0.9996715784072876
696092,696092,707299.0,'I believe it is wrong to charge Americans astronomical prices for life-saving drugs developed with taxpayer dollars. You will not find me encouraging pharmaceutical companies to continue ripping off Americans like my Republican colleagues.' -Sen Sanders,2019-06-04 11:42:00-04:00,JNJ,i believe it is wrong to charge americans astronomical prices for life saving drugs developed with taxpayer dollars you will not find me encouraging pharmaceutical companies to continue ripping off americans like my republican colleagues sen sanders,"{'neg': 0.139, 'neu': 0.802, 'pos': 0.059, 'compound': -0.5229}",negative,0.9192805886268616
696093,696093,707300.0,Obalon Clinches First US Patent For Obesity Treatment Placement System,2019-06-04 11:42:00-04:00,JNJ,obalon clinches first us patent for obesity treatment placement system,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.6952425837516785
696094,696094,707301.0,Johnson & Johnson's Janssen Pharmaceutical Highlights Presentation Of Imbruvica Long-Term Data From Two Pivotal Phase 3 Studies At ASCO And EHA Demonstrating Sustained Efficacy And Safety In Patients With Chronic Lymphocytic Leukemia,2019-06-03 09:07:00-04:00,JNJ,johnson and johnsons janssen pharmaceutical highlights presentation of imbruvica long term data from two pivotal phase 3 studies at asco and eha demonstrating sustained efficacy and safety in patients with chronic lymphocytic leukemia,"{'neg': 0.0, 'neu': 0.92, 'pos': 0.08, 'compound': 0.4215}",positive,0.9973496198654175
696095,696095,707302.0,Johnson & Johnson To Pay $300M In Punitive Damages In Olson Talc Cancer Case,2019-05-31 13:30:00-04:00,JNJ,johnson and johnson to pay dollars 00 million in punitive damages in olson talc cancer case,"{'neg': 0.5, 'neu': 0.5, 'pos': 0.0, 'compound': -0.9001}",neutral,0.9771242737770081
696096,696096,707303.0,UPDATE: J&J Spokesperson Says Talc Trial Had 'Significant Legal And Evidentiary Errors' Which Co. Believes Will Warrant Reversal Amid Appeal,2019-05-31 12:54:00-04:00,JNJ,update j and j spokesperson says talc trial had significant legal and evidentiary errors which co believes will warrant reversal amid appeal,"{'neg': 0.097, 'neu': 0.769, 'pos': 0.134, 'compound': -0.0258}",negative,0.9947125911712646
696097,696097,707304.0,UPDATE: J&J Says $300M Punitive Award In Solson Talc Trial Is On Top Of $25M Compensatory Damages Awarded Last Week,2019-05-31 12:50:00-04:00,JNJ,update j and j says dollars 00 million punitive award in solson talc trial is on top of dollars 5 million compensatory damages awarded last week,"{'neg': 0.176, 'neu': 0.597, 'pos': 0.227, 'compound': 0.2023}",neutral,0.9951819777488708
696098,696098,707305.0,Hearing J&J To Pay $300M Punitive Award In New York Calc Case,2019-05-31 12:30:00-04:00,JNJ,hearing j and j to pay dollars 00 million punitive award in new york calc case,"{'neg': 0.222, 'neu': 0.613, 'pos': 0.165, 'compound': -0.0516}",neutral,0.7765560150146484
696099,696099,707306.0,Johnson & Johnson Analyst: 3 Takeaways On Opioid Litigation,2019-05-30 13:56:00-04:00,JNJ,johnson and johnson analyst 3 takeaways on opioid litigation,"{'neg': 0.184, 'neu': 0.816, 'pos': 0.0, 'compound': -0.2023}",neutral,0.9998760223388672
696100,696100,707307.0,64 Biggest Movers From Yesterday,2019-05-30 05:08:00-04:00,JNJ,64 biggest movers from yesterday,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998531341552734
696101,696101,707308.0,Obalon Closes Above $1 Following Questionable Takeover Rumor,2019-05-29 16:57:00-04:00,JNJ,obalon closes above dollars following questionable takeover rumor,"{'neg': 0.239, 'neu': 0.761, 'pos': 0.0, 'compound': -0.296}",neutral,0.9998594522476196
696102,696102,707309.0,42 Stocks Moving In Wednesday's Mid-Day Session,2019-05-29 12:36:00-04:00,JNJ,42 stocks moving in wednesdays mid day session,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998784065246582
696103,696103,707310.0,Shares of several healthcare companies are trading lower after the US state of Oklahoma filed a multi-billion dollar lawsuit against Johnson & Johnson relating to opioid abuse; Oklahoma settled an opioid lawsuit with Teva Pharmaceuticals earlier this week,2019-05-29 10:47:00-04:00,JNJ,shares of several healthcare companies are trading lower after the us state of oklahoma filed a multi billion dollar lawsuit against johnson and johnson relating to opioid abuse oklahoma settled an opioid lawsuit with teva pharmaceuticals earlier this week,"{'neg': 0.22, 'neu': 0.733, 'pos': 0.047, 'compound': -0.7906}",negative,0.9976430535316467
696104,696104,707311.0,Johnson & Johnson shares are trading lower after the company's trial in Oklahoma regarding its role in opioid addiction began on Tuesday.,2019-05-29 10:35:00-04:00,JNJ,johnson and johnson shares are trading lower after the companys trial in oklahoma regarding its role in opioid addiction began on tuesday,"{'neg': 0.09, 'neu': 0.82, 'pos': 0.09, 'compound': 0.0}",negative,0.997238039970398
696105,696105,707312.0,"Obalon Therapeutics Shares Up 15% Just After Wednesday's Open; Chatter Of Earlier Questionable, Unconfirmed Seeking Alpha Blogpost From Stellar Wealth Mgmt. 'JNJ Makes Bid For OBLN At $8/Share'",2019-05-29 09:44:00-04:00,JNJ,obalon therapeutics shares up 15 percent just after wednesdays open chatter of earlier questionable unconfirmed seeking alpha blogpost from stellar wealth mgmt jnj makes bid for obln at dollars share,"{'neg': 0.102, 'neu': 0.689, 'pos': 0.209, 'compound': 0.5994}",positive,0.9996651411056519
696106,696106,707313.0,FDA Grants Priority Review For J&J's Janssen Pharma's INVOKANA,2019-05-22 09:10:00-04:00,JNJ,fda grants priority review for j and js janssen pharmas invokana,"{'neg': 0.0, 'neu': 0.84, 'pos': 0.16, 'compound': 0.2263}",positive,0.9046090245246887
696107,696107,707314.0,"The Daily Biotech Pulse: Tocagen Tumbles, OncoSec Offering, Novartis Asthma Combo Drug Study",2019-05-22 07:34:00-04:00,JNJ,the daily biotech pulse tocagen tumbles oncosec offering novartis asthma combo drug study,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9962410926818848
696108,696108,707315.0,J&J Shares Indicated Slightly Lower On No Volume Amid Report Co. Said South Carolina Jury Cleared Co. Of Its Liability In Suit Alleging Asbestos In Talc Caused Women's Cancer,2019-05-21 17:22:00-04:00,JNJ,j and j shares indicated slightly lower on no volume amid report co said south carolina jury cleared co of its liability in suit alleging asbestos in talc caused womens cancer,"{'neg': 0.26, 'neu': 0.647, 'pos': 0.093, 'compound': -0.7538}",negative,0.998029887676239
696109,696109,707316.0,Johnson & Johnson Issues Statement On May 21 Verdict In New York; Says The Trial Suffered From Significant Legal And Evidentiary Errors; Says It Believes The Errors Will Warrant A Reversal On Appeal,2019-05-21 14:06:00-04:00,JNJ,johnson and johnson issues statement on may 21 verdict in new york says the trial suffered from significant legal and evidentiary errors says it believes the errors will warrant a reversal on appeal,"{'neg': 0.201, 'neu': 0.677, 'pos': 0.123, 'compound': -0.6249}",negative,0.9969507455825806
696110,696110,707317.0,J&J Shares Fall Midday Amid Report Co. Lost A $25M Verdict In New York Over Talc Powder,2019-05-21 12:28:00-04:00,JNJ,j and j shares fall midday amid report co lost a dollars 5 million verdict in new york over talc powder,"{'neg': 0.095, 'neu': 0.747, 'pos': 0.158, 'compound': 0.128}",negative,0.9985479712486267
696111,696111,707318.0,PreMarket Prep Opening NYSE Imbalance Update: GE 215k Shares To Sell; Alibaba 69k To Sell; Pfizer 131k To Sell; Coca-Cola 58k To Sell; J&J 32k To Sell,2019-05-20 08:33:00-04:00,JNJ,premarket prep opening nyse imbalance update ge 215 thousand shares to sell alibaba 69 thousand to sell pfizer 131 thousand to sell coca cola 58 thousand to sell j and j 32 thousand to sell,"{'neg': 0.0, 'neu': 0.939, 'pos': 0.061, 'compound': 0.296}",neutral,0.9998656511306763
696112,696112,707319.0,"Bulls And Bears Of The Week: Apple, Chevron, FedEx, Uber And More",2019-05-18 15:18:00-04:00,JNJ,bulls and bears of the week apple chevron fedex uber and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998780488967896
696113,696113,707320.0,FDA Has Identified Ethicon's Recall Of Circular Staplers As Class I Recall,2019-05-17 10:23:00-04:00,JNJ,fda has identified ethicons recall of circular staplers as class i recall,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998900890350342
696114,696114,707321.0,"'FBI targets Johnson & Johnson, Siemens, GE, Philips in Brazil graft case' -Reuters",2019-05-17 06:35:00-04:00,JNJ,fbi targets johnson and johnson siemens ge philips in brazil graft case reuters,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997237324714661
696115,696115,707322.0,Johnson & Johnson Analysts Laud Accelerating Pharma Business,2019-05-16 10:20:00-04:00,JNJ,johnson and johnson analysts laud accelerating pharma business,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9993382096290588
696116,696116,707323.0,"Credit Suisse Maintains Outperform on Johnson & Johnson Common Stock, Raises Price Target to $156",2019-05-16 09:03:00-04:00,JNJ,credit suisse maintains outperform on johnson and johnson common stock raises price target to dollars 56,"{'neg': 0.0, 'neu': 0.852, 'pos': 0.148, 'compound': 0.3818}",positive,0.9996832609176636
696117,696117,707324.0,"J&J Highlights Will Host Meeting Today With Industry Analysts 'to review the strategy of its Janssen Pharmaceutical Companies to deliver above-market, compound annual growth through 2023'",2019-05-15 06:45:00-04:00,JNJ,j and j highlights will host meeting today with industry analysts to review the strategy of its janssen pharmaceutical companies to deliver above market compound annual growth through 2023,"{'neg': 0.0, 'neu': 0.915, 'pos': 0.085, 'compound': 0.3818}",positive,0.9962215423583984
696118,696118,707325.0,J&J Patent On Zytiga Ruled Invalid By US Appeals Court,2019-05-14 10:21:00-04:00,JNJ,j and j patent on zytiga ruled invalid by us appeals court,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.8938546776771545
696119,696119,707326.0,Minerva Neurosciences Sinks To Lowest Level In A Year On Cloudy Midstage Trial Results For Depression Drug,2019-05-13 11:01:00-04:00,JNJ,minerva neurosciences sinks to lowest level in a year on cloudy midstage trial results for depression drug,"{'neg': 0.296, 'neu': 0.704, 'pos': 0.0, 'compound': -0.743}",negative,0.9987972974777222
696120,696120,707327.0,"The Daily Biotech Pulse: FibroGen Kidney Disease Trial Disappoints, Medtronic To Buy Titan Spine, Puma's Weak Breast Cancer Drug Sales",2019-05-10 08:00:00-04:00,JNJ,the daily biotech pulse fibrogen kidney disease trial disappoints medtronic to buy titan spine pumas weak breast cancer drug sales,"{'neg': 0.368, 'neu': 0.632, 'pos': 0.0, 'compound': -0.872}",negative,0.9984879493713379
696121,696121,707328.0,Drug Prices Will Be Included In TV Ads Under New Trump Admin Rule,2019-05-09 15:13:00-04:00,JNJ,drug prices will be included in tv ads under new trump admin rule,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998908042907715
696122,696122,707329.0,"J&J Shares Unaffected As WHO's Strategic Advisory Group Recommended A Change In Ebola Vaccine Strategy, Has Expanded Eligible Population And Introduced Co.'s Experimental Vaccine",2019-05-07 11:57:00-04:00,JNJ,j and j shares unaffected as whos strategic advisory group recommended a change in ebola vaccine strategy has expanded eligible population and introduced co s experimental vaccine,"{'neg': 0.0, 'neu': 0.862, 'pos': 0.138, 'compound': 0.4588}",positive,0.9989340901374817
696123,696123,707330.0,J&J Will Pay $1B To Resolve Pinnacle-Hip Suits,2019-05-07 10:54:00-04:00,JNJ,j and j will pay dollars b to resolve pinnacle hip suits,"{'neg': 0.1, 'neu': 0.714, 'pos': 0.186, 'compound': 0.296}",neutral,0.9998040795326233
696124,696124,707331.0,Shares of several healthcare companies are trading lower after several companies in the space reported weak earnings with Mylan leading the selloff.,2019-05-07 10:25:00-04:00,JNJ,shares of several healthcare companies are trading lower after several companies in the space reported weak earnings with mylan leading the selloff,"{'neg': 0.194, 'neu': 0.722, 'pos': 0.084, 'compound': -0.4404}",negative,0.9986579418182373
696125,696125,707332.0,PreMarket Prep Opening NYSE Imbalance Update: Alibaba 316k Shares To Sell; Citigroup 67k To Sell; Bank Of America 319k To Sell; JP Morgan 110K To Sell; GE 557k To Sell; Johnson & Johnson 32k To Sell,2019-05-06 08:31:00-04:00,JNJ,premarket prep opening nyse imbalance update alibaba 316 thousand shares to sell citigroup 67 thousand to sell bank of america 319 thousand to sell jp morgan 110 thousand to sell ge 557 thousand to sell johnson and johnson 32 thousand to sell,"{'neg': 0.0, 'neu': 0.909, 'pos': 0.091, 'compound': 0.4588}",neutral,0.9998711347579956
696126,696126,707333.0,2 New ETFS For 'Biblically Responsible Investing',2019-05-02 16:33:00-04:00,JNJ,2 new etfs for biblically responsible investing,"{'neg': 0.0, 'neu': 0.723, 'pos': 0.277, 'compound': 0.3182}",neutral,0.9998898506164551
696127,696127,707334.0,Vistagen Shares Fall Under $1 After Depression Drug Flunks Midstage Trial,2019-05-02 12:13:00-04:00,JNJ,vistagen shares fall under dollars after depression drug flunks midstage trial,"{'neg': 0.389, 'neu': 0.479, 'pos': 0.132, 'compound': -0.6486}",negative,0.9984050393104553
696128,696128,707335.0,Attention Biotech Investors: Mark Your Calendar For These May PDUFA Dates,2019-04-30 13:00:00-04:00,JNJ,attention biotech investors mark your calendar for these may pdufa dates,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998875856399536
696129,696129,707336.0,J&J Raises Qtr. Dividend From $0.90 To $0.95/Share,2019-04-25 10:41:00-04:00,JNJ,j and j raises qtr dividend from dollars .90 to dollars,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9991682767868042
696130,696130,707337.0,"Jim Cramer Gives His Opinion On Barrick Gold, Canopy Growth, EA, Johnson & Johnson And More",2019-04-24 07:51:00-04:00,JNJ,jim cramer gives his opinion on barrick gold canopy growth ea johnson and johnson and more,"{'neg': 0.0, 'neu': 0.852, 'pos': 0.148, 'compound': 0.3818}",neutral,0.9998456239700317
696131,696131,707338.0,"Shares of several healthcare stocks are trading higher in a potential rebound from last week's selloff. In an upgrade of HCA Healthcare, Raymond James analysts noted the selloff was 'based on legislation that has almost no chance of passing'",2019-04-23 11:52:00-04:00,JNJ,shares of several healthcare stocks are trading higher in a potential rebound from last weeks selloff in an upgrade of hca healthcare raymond james analysts noted the selloff was based on legislation that has almost no chance of passing,"{'neg': 0.067, 'neu': 0.879, 'pos': 0.054, 'compound': 0.1142}",positive,0.9994731545448303
696132,696132,707339.0,"UroGen Pharma Reports Early-Stage Feasibility Deal With J&J's Janssen, No Terms Disclosed",2019-04-23 08:00:00-04:00,JNJ,urogen pharma reports early stage feasibility deal with j and js janssen no terms disclosed,"{'neg': 0.136, 'neu': 0.864, 'pos': 0.0, 'compound': -0.296}",neutral,0.9998689889907837
696133,696133,707340.0,6 Cannabis Execs On The Strengths Of Their Businesses,2019-04-22 11:45:00-04:00,JNJ,6 cannabis execs on the strengths of their businesses,"{'neg': 0.0, 'neu': 0.748, 'pos': 0.252, 'compound': 0.4019}",neutral,0.9997748732566833
696134,696134,707341.0,3 Options Trading Ideas For The Upcoming Earnings Season,2019-04-22 10:07:00-04:00,JNJ,3 options trading ideas for the upcoming earnings season,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998735189437866
696135,696135,707342.0,"The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs",2019-04-21 14:06:00-04:00,JNJ,the week ahead in biotech conferences clinical trial readouts earnings and ipos,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997137188911438
696136,696136,707343.0,Buyer's Remorse? OTC Stock Zoom Technologies Zooms Higher Amid Potential Buyer Confusion,2019-04-18 12:11:00-04:00,JNJ,buyers remorse otc stock zoom technologies zooms higher amid potential buyer confusion,"{'neg': 0.301, 'neu': 0.699, 'pos': 0.0, 'compound': -0.5106}",positive,0.9995183944702148
696137,696137,707344.0,Analysts View Johnson & Johnson's Organic Growth Guidance As Conservative,2019-04-17 10:55:00-04:00,JNJ,analysts view johnson and johnsons organic growth guidance as conservative,"{'neg': 0.0, 'neu': 0.776, 'pos': 0.224, 'compound': 0.3818}",positive,0.8986409306526184
696138,696138,707345.0,"BMO Capital Maintains Outperform on Johnson & Johnson, Raises Price Target to $157",2019-04-17 10:40:00-04:00,JNJ,bmo capital maintains outperform on johnson and johnson raises price target to dollars 57,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996927976608276
696139,696139,707346.0,"Credit Suisse Maintains Outperform on Johnson & Johnson, Raises Price Target to $152",2019-04-17 10:06:00-04:00,JNJ,credit suisse maintains outperform on johnson and johnson raises price target to dollars 52,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.3818}",positive,0.9996844530105591
696140,696140,707347.0,"Morgan Stanley Maintains Equal-Weight on Johnson & Johnson, Raises Price Target to $145",2019-04-17 09:56:00-04:00,JNJ,morgan stanley maintains equal weight on johnson and johnson raises price target to dollars 45,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9995658993721008
696141,696141,707348.0,"Hot, Fresh Earnings On The Menu As Netflix, Morgan Stanley Results In Focus",2019-04-17 09:56:00-04:00,JNJ,hot fresh earnings on the menu as netflix morgan stanley results in focus,"{'neg': 0.0, 'neu': 0.839, 'pos': 0.161, 'compound': 0.3182}",positive,0.9969172477722168
696142,696142,707349.0,"Raymond James Maintains Outperform on Johnson & Johnson, Raises Price Target to $147",2019-04-17 08:50:00-04:00,JNJ,raymond james maintains outperform on johnson and johnson raises price target to dollars 47,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996808767318726
696143,696143,707350.0,"FDA Determines Boston Scientific Hasn't Showed Reasonable Assurance Of Safety, Effectiveness For Surgical Meshes",2019-04-16 14:27:00-04:00,JNJ,fda determines boston scientific hasnt showed reasonable assurance of safety effectiveness for surgical meshes,"{'neg': 0.121, 'neu': 0.713, 'pos': 0.166, 'compound': 0.1935}",positive,0.9992057681083679
696144,696144,707351.0,Banks On Parade: Bank of America Becomes Latest Big Financial Company To Report,2019-04-16 10:19:00-04:00,JNJ,banks on parade bank of america becomes latest big financial company to report,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998894929885864
696145,696145,707352.0,J&J Expects To See Largest Impact From Generic And Biosimilar Erosion In 2019,2019-04-16 09:38:00-04:00,JNJ,j and j expects to see largest impact from generic and biosimilar erosion in 2019,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9979988932609558
696146,696146,707353.0,J&J Says 800 Sites Now Certified For New Depression Drug SPRAVATO,2019-04-16 09:38:00-04:00,JNJ,j and j says 800 sites now certified for new depression drug spravato,"{'neg': 0.236, 'neu': 0.764, 'pos': 0.0, 'compound': -0.5719}",positive,0.5088220834732056
696147,696147,707354.0,Johnson & Johnson shares are trading higher after the company reported better-than-expected Q1 EPS and revenue results and issued FY19 adjusted EPS guidance above the analyst estimate.,2019-04-16 08:20:00-04:00,JNJ,johnson and johnson shares are trading higher after the company reported better than expected first quarter eps and revenue results and issued fy19 adjusted eps guidance above the analyst estimate,"{'neg': 0.0, 'neu': 0.846, 'pos': 0.154, 'compound': 0.6249}",positive,0.9996585845947266
696148,696148,707355.0,"The Daily Biotech Pulse: J&J Earnings, FDA Nod For Medicinova, Proteon To Explore Strategic Alternatives",2019-04-16 08:10:00-04:00,JNJ,the daily biotech pulse j and j earnings fda nod for medicinova proteon to explore strategic alternatives,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999852180480957
696149,696149,707356.0,A Peek Into The Markets: US Stock Futures Higher Ahead Of Earnings,2019-04-16 06:47:00-04:00,JNJ,a peek into the markets us stock futures higher ahead of earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9995330572128296
696150,696150,707357.0,"Johnson & Johnson Raises FY19 Adj. EPS Guidance From $8.65-$8.80 To $8.73-$8.83 vs $8.58 Est., Raises Sales Guidance From $81.6B-$82.4B To $82.0B-$82.8B vs $81.05B Est.",2019-04-16 06:43:00-04:00,JNJ,johnson and johnson raises fy19 adj eps guidance from dollars .65 dollars .80 to dollars .73 dollars .83 vs dollars .58 est raises sales guidance from dollars 1.6 billion dollars 2.4 billion to dollars 2.0 billion dollars 2.8 billion vs dollars 1.05 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9994150400161743
696151,696151,707358.0,"Johnson & Johnson Q1 Adj. EPS $2.1 Beats $2.08 Estimate, Sales $20.02B Beat $19.63B Estimate",2019-04-16 06:40:00-04:00,JNJ,johnson and johnson first quarter adj eps dollars .1 beats dollars .08 estimate sales dollars 0.02 billion beat dollars 9.63 billion estimate,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998201727867126
696152,696152,707359.0,"10 Stocks To Watch For April 16, 2019",2019-04-16 05:24:00-04:00,JNJ,10 stocks to watch for april 16 2019,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998571872711182
696153,696153,707360.0,"Earnings Scheduled For April 16, 2019",2019-04-16 05:01:00-04:00,JNJ,earnings scheduled for april 16 2019,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998832941055298
696154,696154,707361.0,"Earnings Parade Rolls Along As Citigroup, Goldman Sachs Report And SPX Now Tops 2900",2019-04-15 10:02:00-04:00,JNJ,earnings parade rolls along as citigroup goldman sachs report and spx now tops 2900,"{'neg': 0.0, 'neu': 0.798, 'pos': 0.202, 'compound': 0.5106}",positive,0.6082310080528259
696155,696155,707362.0,Granted Accelerated Approval To Johnson & Johnson's Balversa Targeted Therapy For Metastatic Bladder Cancer,2019-04-12 13:31:00-04:00,JNJ,granted accelerated approval to johnson and johnsons balversa targeted therapy for metastatic bladder cancer,"{'neg': 0.215, 'neu': 0.537, 'pos': 0.249, 'compound': -0.0772}",positive,0.9995842576026917
696156,696156,707363.0,Nanocap Biotech Tracon Falls 50% After Shelving Study,2019-04-12 09:21:00-04:00,JNJ,nanocap biotech tracon falls 50 percent after shelving study,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9982763528823853
696157,696157,707364.0,J&J's Janssen Presents New Data From First Phase 3 Trial Of Single-Tablet Regimen In Rapid Initiation Model Of Care,2019-04-11 08:00:00-04:00,JNJ,j and js janssen presents new data from first phase 3 trial of single tablet regimen in rapid initiation model of care,"{'neg': 0.0, 'neu': 0.868, 'pos': 0.132, 'compound': 0.4939}",neutral,0.9997182488441467
696158,696158,707365.0,"Geron's Blood Cancer Candidate Creates Buying Opportunity, Needham Says In Upgrade",2019-04-09 14:50:00-04:00,JNJ,gerons blood cancer candidate creates buying opportunity needham says in upgrade,"{'neg': 0.254, 'neu': 0.462, 'pos': 0.283, 'compound': -0.128}",positive,0.998968243598938
696159,696159,707366.0,PreMarket Prep Opening NYSE Imbalance Update: GE 652k Shares To Sell; ExxonMobil 66k Shares To Sell; BofA 123 To Sell; Citi 52k To Sell; P&G 40k sell; J&J 41k To sell; Pfizer 96k To Sell,2019-04-09 08:34:00-04:00,JNJ,premarket prep opening nyse imbalance update ge 652 thousand shares to sell exxonmobil 66 thousand shares to sell bofa 123 to sell citi 52 thousand to sell p and g 40 thousand sell j and j 41 thousand to sell pfizer 96 thousand to sell,"{'neg': 0.0, 'neu': 0.907, 'pos': 0.093, 'compound': 0.5267}",neutral,0.9998705387115479
696160,696160,707367.0,What's Been Going On With Emerald Bioscience?,2019-04-08 15:26:00-04:00,JNJ,whats been going on with emerald bioscience,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998855590820312
696161,696161,707368.0,Immunomedics Reports Promotion Deal In Which Co. Will Provide Detailing Services To J&J's Janssen For Erdafitinib In US,2019-04-08 09:02:00-04:00,JNJ,immunomedics reports promotion deal in which co will provide detailing services to j and js janssen for erdafitinib in us,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998576641082764
696162,696162,707369.0,Janssen Announces Investigational CAR-T Therapy JNJ-68284528 Granted PRIME Designation by EMA,2019-04-04 06:00:00-04:00,JNJ,janssen announces investigational car t therapy jnj 68284528 granted prime designation by ema,"{'neg': 0.0, 'neu': 0.857, 'pos': 0.143, 'compound': 0.25}",neutral,0.9988411068916321
696163,696163,707370.0,Johnson & Johnson Says TV Ads For Bloodthinner Xarelto To Give $448 A Month List Price Starting Friday,2019-03-28 11:25:00-04:00,JNJ,johnson and johnson says tv ads for bloodthinner xarelto to give dollars 48 a month list price starting friday,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998801946640015
696164,696164,707371.0,J&J's Janssen Reports FDA Submission Of Supplemental New Drug Application For INVOKANA For Treatment Of Chronic Kidney Disease In Patients With Type 2 Diabetes,2019-03-28 08:32:00-04:00,JNJ,j and js janssen reports fda submission of supplemental new drug application for invokana for treatment of chronic kidney disease in patients with type 2 diabetes,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9996212720870972
696165,696165,707372.0,Plaintiff Lawyer Says Johnson & Johnson Has Settled Three Mesothelioma Talc Cases Brought In State Courts,2019-03-27 18:13:00-04:00,JNJ,plaintiff lawyer says johnson and johnson has settled three mesothelioma talc cases brought in state courts,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9976170659065247
696166,696166,707373.0,J&J Spokesperson Says Jersey Jury Cleared Co. Of Liability In Mesothelioma Talc Trial,2019-03-27 12:53:00-04:00,JNJ,j and j spokesperson says jersey jury cleared co of liability in mesothelioma talc trial,"{'neg': 0.111, 'neu': 0.802, 'pos': 0.086, 'compound': -0.1027}",positive,0.6999024748802185
696167,696167,707374.0,6 Gene Therapy M&A Targets On The Radar,2019-03-27 12:45:00-04:00,JNJ,6 gene therapy m and a targets on the radar,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998911619186401
696168,696168,707375.0,Axsome Adds To Strong Gains After FDA Grants Breakthrough Designation For Depression Drug,2019-03-27 10:44:00-04:00,JNJ,axsome adds to strong gains after fda grants breakthrough designation for depression drug,"{'neg': 0.182, 'neu': 0.443, 'pos': 0.374, 'compound': 0.4404}",positive,0.9996077418327332
696169,696169,707376.0,"Janssen Seeks Expanded Use of DARZALEX®▼ (daratumumab) Combination Therapy for Newly Diagnosed, Transplant Eligible Patients with Multiple Myeloma",2019-03-27 06:12:00-04:00,JNJ,janssen seeks expanded use of darzalex®▼ daratumumab combination therapy for newly diagnosed transplant eligible patients with multiple myeloma,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9986239671707153
696170,696170,707377.0,J&J's Janssen Reports Submission Of Application For Darzalex Combo Thearpy,2019-03-26 09:53:00-04:00,JNJ,j and js janssen reports submission of application for darzalex combo thearpy,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998764991760254
696171,696171,707378.0,"Genmab Reports FDA Submission Of Supplemental Biologics License Application For Daratumumab In Combo With Bortezomib, Thalidomide, Dexamethasone, Says J&J Sees Publishing Detailed Data From Phase 3 CASSIOPEIA Study This Year",2019-03-26 09:34:00-04:00,JNJ,genmab reports fda submission of supplemental biologics license application for daratumumab in combo with bortezomib thalidomide dexamethasone says j and j sees publishing detailed data from phase 3 cassiopeia study this year,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997932314872742
696172,696172,707379.0,OxyContin Manufacturer Purdue Agrees to Settlement in Oklahoma Lawsuit,2019-03-26 04:30:00-04:00,JNJ,oxycontin manufacturer purdue agrees to settlement in oklahoma lawsuit,"{'neg': 0.178, 'neu': 0.654, 'pos': 0.168, 'compound': -0.0258}",positive,0.9994016885757446
696173,696173,707380.0,Raymond James Expects Johnson & Johnson's Growth To Accelerate Into 2020,2019-03-25 15:04:00-04:00,JNJ,raymond james expects johnson and johnsons growth to accelerate into 2020,"{'neg': 0.0, 'neu': 0.794, 'pos': 0.206, 'compound': 0.3818}",positive,0.9996960163116455
696174,696174,707381.0,"Court Records Show Bayer, J&J Have Settled XARELTO Litigation For $775M",2019-03-25 10:32:00-04:00,JNJ,court records show bayer j and j have settled xarelto litigation for dollars 75 million,"{'neg': 0.114, 'neu': 0.886, 'pos': 0.0, 'compound': -0.2023}",neutral,0.9190481305122375
696175,696175,707382.0,A New Look For The Barron's 400 ETF,2019-03-19 08:51:00-04:00,JNJ,a new look for the barrons 400 etf,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998680353164673
696176,696176,707383.0,"Actelion Pharmaceuticals-Patients Treated With Opsumit Showed Significant Improvement In Right Ventricular Function, Reduced Pulmonary Vascular Resistance",2019-03-15 11:21:00-04:00,JNJ,actelion pharmaceuticals patients treated with opsumit showed significant improvement in right ventricular function reduced pulmonary vascular resistance,"{'neg': 0.0, 'neu': 0.758, 'pos': 0.242, 'compound': 0.5859}",positive,0.9996556043624878
696177,696177,707384.0,"The Daily Biotech Pulse: AEterna Zentaris Explores Options, Verastem Plunges On Weak Copiktra Sales, FDA Nod For Aerie",2019-03-13 07:27:00-04:00,JNJ,the daily biotech pulse aeterna zentaris explores options verastem plunges on weak copiktra sales fda nod for aerie,"{'neg': 0.146, 'neu': 0.854, 'pos': 0.0, 'compound': -0.4404}",negative,0.9985878467559814
696178,696178,707385.0,J&J's Janssen Submits Application Seeking Approval Of Darzalex Combo For Patients With Newly-Diagnosed Multiple Myeloma Who Are Transplant Ineligible,2019-03-12 16:33:00-04:00,JNJ,j and js janssen submits application seeking approval of darzalex combo for patients with newly diagnosed multiple myeloma who are transplant ineligible,"{'neg': 0.0, 'neu': 0.871, 'pos': 0.129, 'compound': 0.4767}",neutral,0.9994980096817017
696179,696179,707386.0,"'Oklahoma says Johnson & Johnson was the ""kingpin"" behind the opioid crisis' -Axios",2019-03-12 07:00:00-04:00,JNJ,oklahoma says johnson and johnson was the kingpin behind the opioid crisis axios,"{'neg': 0.255, 'neu': 0.745, 'pos': 0.0, 'compound': -0.6249}",neutral,0.9998533725738525
696180,696180,707387.0,Janssen's Phase 3 Study of STELARA Met its Primary and Some Secondary Endpoints,2019-03-11 08:10:00-04:00,JNJ,janssens phase 3 study of stelara met its primary and some secondary endpoints,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998922348022461
696181,696181,707388.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings, IPOs",2019-03-10 14:32:00-04:00,JNJ,the week ahead in biotech conferences pdufa dates earnings ipos,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998739957809448
696182,696182,707389.0,Another ESG ETF Enters The Fold,2019-03-07 14:48:00-05:00,JNJ,another esg etf enters the fold,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998779296875
696183,696183,707390.0,"J&J's Janssen Reports Results Of 2 Phase 3 Studies Which Showed Long-Acting Injectable HIV Treatment Regimen Of Rilpivirine, Cabotegravir Showed Comparable Safety, Efficacy To Daily Oral HIV Therapy",2019-03-07 13:47:00-05:00,JNJ,j and js janssen reports results of 2 phase 3 studies which showed long acting injectable hiv treatment regimen of rilpivirine cabotegravir showed comparable safety efficacy to daily oral hiv therapy,"{'neg': 0.0, 'neu': 0.915, 'pos': 0.085, 'compound': 0.4215}",positive,0.9986918568611145
696184,696184,707391.0,Allergan's Depression Drug Letdown Largely Expected: Analysts Focus On Remainder Of Pipeline,2019-03-07 10:54:00-05:00,JNJ,allergans depression drug letdown largely expected analysts focus on remainder of pipeline,"{'neg': 0.252, 'neu': 0.748, 'pos': 0.0, 'compound': -0.5719}",neutral,0.5173525214195251
696185,696185,707392.0,"Daily Biotech Pulse: Allergan's Depression Drug Flunks Late-Stage Trial, Apellis Offering, ShockWave Medical IPO",2019-03-07 07:48:00-05:00,JNJ,daily biotech pulse allergans depression drug flunks late stage trial apellis offering shockwave medical ipo,"{'neg': 0.333, 'neu': 0.667, 'pos': 0.0, 'compound': -0.7579}",negative,0.9943100214004517
696186,696186,707393.0,J&J Says Weighted Average Cost Of Spravato Is $590-$885/Treatment Session,2019-03-06 11:52:00-05:00,JNJ,j and j says weighted average cost of spravato is dollars 90 dollars session,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998924732208252
696187,696187,707394.0,Johnson & Johnson Option Alert: Mar 15 $142 Calls Sweep (2) near the Ask: 1000 @ $0.201 vs 260 OI; Earnings 4/16 Before Open [est] Ref=$138.94,2019-03-06 11:52:00-05:00,JNJ,johnson and johnson option alert mar 15 dollars 42 calls sweep 2 near the ask 1000 dollars .201 vs 260 oi earnings before open est ref equals dollars 38.94,"{'neg': 0.0, 'neu': 0.927, 'pos': 0.073, 'compound': 0.296}",neutral,0.9998581409454346
696188,696188,707395.0,FDA Approves Major Novel Depression Drug For First Time In 3 Decades,2019-03-06 09:25:00-05:00,JNJ,fda approves major novel depression drug for first time in 3 decades,"{'neg': 0.218, 'neu': 0.493, 'pos': 0.29, 'compound': 0.081}",positive,0.7661012411117554
696189,696189,707396.0,"The Daily Biotech Pulse: Horizon Pharma Under DoJ Radar, FDA Greenlights J&J's Depression Drug, Endologix Reverse Split",2019-03-06 07:39:00-05:00,JNJ,the daily biotech pulse horizon pharma under doj radar fda greenlights j and js depression drug endologix reverse split,"{'neg': 0.171, 'neu': 0.829, 'pos': 0.0, 'compound': -0.5719}",neutral,0.9998694658279419
696190,696190,707397.0,"The Daily Biotech Pulse: Novartis Psoriasis Drug Found Superior, Ascendis Offering, Adamas Earnings",2019-03-05 07:24:00-05:00,JNJ,the daily biotech pulse novartis psoriasis drug found superior ascendis offering adamas earnings,"{'neg': 0.0, 'neu': 0.774, 'pos': 0.226, 'compound': 0.5423}",positive,0.9992073178291321
696191,696191,707398.0,Attention Biotech Investors: Mark Your Calendar For These March PDUFA Dates,2019-03-04 11:50:00-05:00,JNJ,attention biotech investors mark your calendar for these march pdufa dates,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998832941055298
696192,696192,707399.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs",2019-03-03 09:41:00-05:00,JNJ,the week ahead in biotech conferences pdufa dates clinical trials earnings ipos,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998695850372314
696193,696193,707400.0,It Could Be Time For This Pharma ETF,2019-02-26 09:42:00-05:00,JNJ,it could be time for this pharma etf,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997547268867493
696194,696194,707401.0,"Citigroup Maintains Neutral on Johnson & Johnson, Raises Price Target to $147",2019-02-25 10:33:00-05:00,JNJ,citigroup maintains neutral on johnson and johnson raises price target to dollars 47,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9995622038841248
696195,696195,707402.0,The Latest From Johnson & Johnson's Asbestos Scandal,2019-02-21 10:00:00-05:00,JNJ,the latest from johnson and johnsons asbestos scandal,"{'neg': 0.293, 'neu': 0.707, 'pos': 0.0, 'compound': -0.4404}",neutral,0.9998438358306885
696196,696196,707403.0,'Johnson & Johnson receives federal subpoenas related to baby powder litigation' -Reuters Earlier Reported,2019-02-21 07:54:00-05:00,JNJ,johnson and johnson receives federal subpoenas related to baby powder litigation reuters earlier reported,"{'neg': 0.122, 'neu': 0.878, 'pos': 0.0, 'compound': -0.2023}",neutral,0.9998648166656494
696197,696197,707404.0,A Chat With The CEO Behind The Cannabis Company With The 'BOSS' Ticker: 'There Isn't A Single Route To Success',2019-02-21 07:37:00-05:00,JNJ,a chat with the ceo behind the cannabis company with the boss ticker there isnt a single route to success,"{'neg': 0.0, 'neu': 0.837, 'pos': 0.163, 'compound': 0.5719}",neutral,0.9998226761817932
696198,696198,707405.0,"Morphic Therapeutic Reports Integrin R&D Collaboration With J&J's Janssen; Janssen To Pay Co. Undisclosed Upfront Payment, Will Fund Research Activities; Co. Will Receive From Janssen Multiple Preclinical Development, Clinical, Commercial Milestones",2019-02-21 06:44:00-05:00,JNJ,morphic therapeutic reports integrin r and d collaboration with j and js janssen janssen to pay co undisclosed upfront payment will fund research activities co will receive from janssen multiple preclinical development clinical commercial milestones,"{'neg': 0.04, 'neu': 0.96, 'pos': 0.0, 'compound': -0.1027}",neutral,0.998839795589447
696199,696199,707406.0,"Supreme Court Rejects Maryland's Bid To Revive A Law Aimed At Preventing Price Gouging By Pharmaceutical Companies, Reuters Reports",2019-02-19 10:04:00-05:00,JNJ,supreme court rejects marylands bid to revive a law aimed at preventing price gouging by pharmaceutical companies reuters reports,"{'neg': 0.17, 'neu': 0.593, 'pos': 0.237, 'compound': 0.4019}",neutral,0.9551630616188049
696200,696200,707407.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2019-02-15 16:31:00-05:00,JNJ,pot stocks etfs top news and data from the cannabis industry this week,"{'neg': 0.0, 'neu': 0.87, 'pos': 0.13, 'compound': 0.2023}",neutral,0.9998798370361328
696201,696201,707408.0,"The Week Ahead In Biotech: Conferences, Clinical Trials And Earnings",2019-02-15 14:00:00-05:00,JNJ,the week ahead in biotech conferences clinical trials and earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998761415481567
696202,696202,707409.0,J&J's Talc Supplier Seeks Bankruptcy,2019-02-13 12:39:00-05:00,JNJ,j and js talc supplier seeks bankruptcy,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.8359862565994263
696203,696203,707410.0,Penny Stock Auris Medical Spikes On Case Of Mistaken Identity,2019-02-13 10:57:00-05:00,JNJ,penny stock auris medical spikes on case of mistaken identity,"{'neg': 0.217, 'neu': 0.783, 'pos': 0.0, 'compound': -0.3612}",positive,0.7041229605674744
696204,696204,707411.0,Johnson & Johnson Wins FDA Panel Backing For Nasal Spray Depression Drug; PDUFA Date Awaits,2019-02-13 09:38:00-05:00,JNJ,johnson and johnson wins fda panel backing for nasal spray depression drug pdufa date awaits,"{'neg': 0.178, 'neu': 0.529, 'pos': 0.293, 'compound': 0.1027}",positive,0.9980165958404541
696205,696205,707412.0,"Johnson & Johnson To Acquire Auris Health For $3.4B In Cash, with Additional Contingent Payments Of $2.5B Upon Certain Milestones",2019-02-13 09:01:00-05:00,JNJ,johnson and johnson to acquire auris health for dollars .4 billion in cash with additional contingent payments of dollars .5 billion upon certain milestones,"{'neg': 0.0, 'neu': 0.916, 'pos': 0.084, 'compound': 0.2732}",neutral,0.9998936653137207
696206,696206,707413.0,"The Daily Biotech Pulse: Exelixis Q4 Results, FDA Panel Greenlights J&J's Depression Drug, MacroGenics Prices Offering",2019-02-13 07:49:00-05:00,JNJ,the daily biotech pulse exelixis fourth quarter results fda panel greenlights j and js depression drug macrogenics prices offering,"{'neg': 0.171, 'neu': 0.829, 'pos': 0.0, 'compound': -0.5719}",neutral,0.9998478889465332
696207,696207,707414.0,FDA Panel Votes In Favor Of Johnson & Johnson's Nasal Spray For Treatment-Resistant Depression; Says Benefits Outweigh Risks,2019-02-12 14:45:00-05:00,JNJ,fda panel votes in favor of johnson and johnsons nasal spray for treatment resistant depression says benefits outweigh risks,"{'neg': 0.222, 'neu': 0.575, 'pos': 0.203, 'compound': -0.128}",positive,0.9973341226577759
696208,696208,707415.0,"The Daily Biotech Pulse: NASH Disappointment For Gilead, Xeris To Offer Shares",2019-02-12 08:04:00-05:00,JNJ,the daily biotech pulse nash disappointment for gilead xeris to offer shares,"{'neg': 0.213, 'neu': 0.645, 'pos': 0.142, 'compound': -0.2732}",negative,0.844599187374115
696209,696209,707416.0,FDA Panel Reviews Johnson & Johnson's Treatment-Resistant Depression Candidate: What To Expect,2019-02-11 16:00:00-05:00,JNJ,fda panel reviews johnson and johnsons treatment resistant depression candidate what to expect,"{'neg': 0.236, 'neu': 0.764, 'pos': 0.0, 'compound': -0.5719}",neutral,0.9998168349266052
696210,696210,707417.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials",2019-02-10 17:37:00-05:00,JNJ,the week ahead in biotech conferences pdufa dates and clinical trials,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998906850814819
696211,696211,707418.0,"The Daily Biotech Pulse: Big Miss For Seattle Genetics; Hematology Conference Presentations; Gossamer Bio, Harpoon IPOs",2019-02-08 09:17:00-05:00,JNJ,the daily biotech pulse big miss for seattle genetics hematology conference presentations gossamer bio harpoon ipos,"{'neg': 0.096, 'neu': 0.904, 'pos': 0.0, 'compound': -0.1531}",negative,0.9593419432640076
696212,696212,707419.0,Drugmakers Offered C$9.6B in Price Cuts; Freeze of Drug Prices in Response to Proposed Crackdown by Canada Regulator,2019-02-06 04:18:00-05:00,JNJ,drugmakers offered c dollars .6 billion in price cuts freeze of drug prices in response to proposed crackdown by canada regulator,"{'neg': 0.098, 'neu': 0.848, 'pos': 0.054, 'compound': -0.25}",neutral,0.8234726786613464
696213,696213,707420.0,'Research Announcement: Moody's - Talc-related lawsuits could increase risk to Johnson & Johnson's strong credit profile' -Moody's,2019-02-05 10:56:00-05:00,JNJ,research announcement moodys to talc related lawsuits could increase risk to johnson and johnsons strong credit profile moodys,"{'neg': 0.149, 'neu': 0.522, 'pos': 0.329, 'compound': 0.6705}",negative,0.9980677962303162
696214,696214,707421.0,Johnson & Johnson Talc-related Lawsuits Could Increase Risk To Johnson & Johnson's Strong Credit Profile,2019-02-05 10:54:00-05:00,JNJ,johnson and johnson talc related lawsuits could increase risk to johnson and johnsons strong credit profile,"{'neg': 0.162, 'neu': 0.48, 'pos': 0.358, 'compound': 0.6705}",negative,0.9981697797775269
696215,696215,707422.0,"J&J's Janssen Reports Global Collaboration, License Deal With MeiraGTx To Develop Gene Therapy Programs For Inherited Retinal Diseases",2019-01-31 06:38:00-05:00,JNJ,j and js janssen reports global collaboration license deal with meiragtx to develop gene therapy programs for inherited retinal diseases,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9993321299552917
696216,696216,707423.0,Janssen Enters Worldwide Collaboration And License Agreement With Meiragtx To Develop Gene Therapy Programs For Inherited Retinal Diseases,2019-01-31 06:32:00-05:00,JNJ,janssen enters worldwide collaboration and license agreement with meiragtx to develop gene therapy programs for inherited retinal diseases,"{'neg': 0.0, 'neu': 0.842, 'pos': 0.158, 'compound': 0.4939}",positive,0.9994980096817017
696217,696217,707424.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings",2019-01-27 16:07:00-05:00,JNJ,the week ahead in biotech conferences pdufa dates clinical trials and earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999884843826294
696218,696218,707425.0,"Geopolitics Aside, How About Those Earnings? Investors Appear To Switch Focus",2019-01-23 10:15:00-05:00,JNJ,geopolitics aside how about those earnings investors appear to switch focus,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997759461402893
696219,696219,707426.0,Analysts Stand By Johnson & Johnson Despite Earnings Pullback,2019-01-23 08:50:00-05:00,JNJ,analysts stand by johnson and johnson despite earnings pullback,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.961799144744873
696220,696220,707427.0,Johnson & Johnson Said to be Pursuing Acquisition of Auris Health,2019-01-23 04:22:00-05:00,JNJ,johnson and johnson said to be pursuing acquisition of auris health,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999871015548706
696221,696221,707428.0,Mid-Afternoon Market Update: Dow Down Over 400 Points; UQM Technologies Shares Spike Higher,2019-01-22 14:44:00-05:00,JNJ,mid afternoon market update dow down over 400 points uqm technologies shares spike higher,"{'neg': 0.0, 'neu': 0.855, 'pos': 0.145, 'compound': 0.296}",negative,0.9969397783279419
696222,696222,707429.0,Mid-Day Market Update: Crude Oil Down Over 3%; Staffing 360 Solutions Shares Jump,2019-01-22 12:02:00-05:00,JNJ,mid day market update crude oil down over 3 percent staffing 360 solutions shares jump,"{'neg': 0.189, 'neu': 0.612, 'pos': 0.199, 'compound': -0.2023}",negative,0.9982231259346008
696223,696223,707430.0,"Wakeup Call: World, China Growth Data Fail To Impress, Pushing Down Global Markets",2019-01-22 10:18:00-05:00,JNJ,wakeup call world china growth data fail to impress pushing down global markets,"{'neg': 0.184, 'neu': 0.526, 'pos': 0.289, 'compound': 0.25}",negative,0.9985268115997314
696224,696224,707431.0,Mid-Morning Market Update: Markets Open Lower; Johnson & Johnson Profit Tops Expectations,2019-01-22 10:17:00-05:00,JNJ,mid morning market update markets open lower johnson and johnson profit tops expectations,"{'neg': 0.12, 'neu': 0.543, 'pos': 0.337, 'compound': 0.6124}",negative,0.9920576214790344
696225,696225,707432.0,J&J Executive Says Does Not See Long-run Strategic Impact To Its Consumer Business Related To Talc,2019-01-22 09:55:00-05:00,JNJ,j and j executive says does not see long run strategic impact to its consumer business related to talc,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9962273836135864
696226,696226,707433.0,From J&J Conference Call: CFO Says Co. Plans For Continued Price Decreases On A Net Basis In The Near Future,2019-01-22 09:40:00-05:00,JNJ,from j and j conference call cfo says co plans for continued price decreases on a net basis in the near future,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.951395571231842
696227,696227,707434.0,J&J CFO Says Stronger US Dollar Will Likely Result In Negative Impact On Reported Results In 2019,2019-01-22 09:33:00-05:00,JNJ,j and j cfo says stronger us dollar will likely result in negative impact on reported results in 2019,"{'neg': 0.159, 'neu': 0.73, 'pos': 0.112, 'compound': -0.2732}",negative,0.995564877986908
696228,696228,707435.0,A Peek Into The Markets: US Stock Futures Drop Ahead Of Earnings,2019-01-22 06:44:00-05:00,JNJ,a peek into the markets us stock futures drop ahead of earnings,"{'neg': 0.16, 'neu': 0.84, 'pos': 0.0, 'compound': -0.2732}",negative,0.9866808652877808
696229,696229,707436.0,"Johnson & Johnson Sees FY19 Adj. EPS $8.50-$8.65 vs $8.61 Est., Sales $80.4B-$81.2B vs $82.68B Est.",2019-01-22 06:43:00-05:00,JNJ,johnson and johnson sees fy19 adj eps dollars .50 dollars .65 vs dollars .61 est sales dollars 0.4 billion dollars 1.2 billion vs dollars 2.68 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998793601989746
696230,696230,707437.0,"Johnson & Johnson Q4 Adj. EPS $1.97 Beats $1.95 Estimate, Sales $20.4B Beat $20.17B Estimate",2019-01-22 06:42:00-05:00,JNJ,johnson and johnson fourth quarter adj eps dollars .97 beats dollars .95 estimate sales dollars 0.4 billion beat dollars 0.17 billion estimate,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998581409454346
696231,696231,707438.0,"10 Stocks To Watch For January 22, 2019",2019-01-22 04:35:00-05:00,JNJ,10 stocks to watch for january 22 2019,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998562335968018
696232,696232,707439.0,"Earnings Scheduled For January 22, 2019",2019-01-22 04:01:00-05:00,JNJ,earnings scheduled for january 22 2019,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998787641525269
696233,696233,707440.0,"The Daily Biotech Pulse: Regulatory Roadblock For Immunomedics, AdCom Split On Lexicon's Diabetes Drug",2019-01-18 07:49:00-05:00,JNJ,the daily biotech pulse regulatory roadblock for immunomedics adcom split on lexicons diabetes drug,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999862551689148
696234,696234,707441.0,"MediPharm Labs, Pure Global Cannabis, Weekend Unlimited, Plus Products, Trulieve Make Elevator Pitches",2019-01-17 17:20:00-05:00,JNJ,medipharm labs pure global cannabis weekend unlimited plus products trulieve make elevator pitches,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998857975006104
696235,696235,707442.0,Johnson & Johnson Announces Research Study With Apple Watch To Help Improve AFib Outcomes Including Stroke Prevention,2019-01-17 08:35:00-05:00,JNJ,johnson and johnson announces research study with apple watch to help improve afib outcomes including stroke prevention,"{'neg': 0.0, 'neu': 0.728, 'pos': 0.272, 'compound': 0.6808}",positive,0.9801267385482788
696236,696236,707443.0,"The Daily Biotech Pulse: FDA Panel Backs Amgen's Hypertension Drug, Adamis Allergy Drug Launched In US",2019-01-17 08:06:00-05:00,JNJ,the daily biotech pulse fda panel backs amgens hypertension drug adamis allergy drug launched in us,"{'neg': 0.072, 'neu': 0.838, 'pos': 0.09, 'compound': 0.0772}",neutral,0.9998871088027954
696237,696237,707444.0,Johnson & Johnson's Actelion Pharmaceuticals Receives Complete Response Letter From FDA Regarding Its New Drug Application For OPSUMIT; Letter Indicates Additional Data Needed To Evaluate Drug For CTEPH Treatment,2019-01-16 16:32:00-05:00,JNJ,johnson and johnsons actelion pharmaceuticals receives complete response letter from fda regarding its new drug application for opsumit letter indicates additional data needed to evaluate drug for cteph treatment,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9558030366897583
696238,696238,707445.0,J&J's Janssen Pharma Says European Commission Approved Erleada For Non-Metastatic Castration-Resistance Prostate Cancer Patients,2019-01-16 08:26:00-05:00,JNJ,j and js janssen pharma says european commission approved erleada for non metastatic castration resistance prostate cancer patients,"{'neg': 0.19, 'neu': 0.69, 'pos': 0.121, 'compound': -0.3818}",positive,0.9968022108078003
696239,696239,707446.0,Cannabis Company Avicanna Eyes Canadian IPO,2019-01-15 11:42:00-05:00,JNJ,cannabis company avicanna eyes canadian ipo,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998815059661865
696240,696240,707447.0,Hearing Dealreporter Says JNJ May Be 'Gearing Up' For A Takeover Of Boston Scientific,2019-01-15 09:37:00-05:00,JNJ,hearing dealreporter says jnj may be gearing up for a takeover of boston scientific,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9992836117744446
696241,696241,707448.0,How To Approach Q4 Earnings: The Global Perspective,2019-01-14 11:29:00-05:00,JNJ,how to approach fourth quarter earnings the global perspective,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998589754104614
696242,696242,707449.0,10 Biggest Price Target Changes For Monday,2019-01-14 09:56:00-05:00,JNJ,10 biggest price target changes for monday,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998207688331604
696243,696243,707450.0,"Wells Fargo Maintains Outperform on Johnson & Johnson, Lowers Price Target to $152",2019-01-14 09:16:00-05:00,JNJ,wells fargo maintains outperform on johnson and johnson lowers price target to dollars 52,"{'neg': 0.097, 'neu': 0.774, 'pos': 0.129, 'compound': 0.128}",positive,0.9996769428253174
696244,696244,707451.0,"J&J Recommends Rejection Of  Below-Market ""Mini-Tender"" Offer By Peer & Peri LLC",2019-01-11 17:00:00-05:00,JNJ,j and j recommends rejection of below market mini tender offer by peer and peri llc,"{'neg': 0.18, 'neu': 0.722, 'pos': 0.098, 'compound': -0.3818}",neutral,0.9979435801506042
696245,696245,707452.0,Johnson & Johnson Raised U.S. Prices On ~Two Dozen Prescription Drugs On Thursday,2019-01-11 04:55:00-05:00,JNJ,johnson and johnson raised u s prices on two dozen prescription drugs on thursday,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.4070329964160919
696246,696246,707453.0,20 Women Set To Dominate The International Cannabis Space In 2019,2019-01-10 13:54:00-05:00,JNJ,20 women set to dominate the international cannabis space in 2019,"{'neg': 0.13, 'neu': 0.87, 'pos': 0.0, 'compound': -0.128}",neutral,0.9998520612716675
696247,696247,707454.0,"'Halftime Report' Picks For January 7: Mastercard, Twilio And More",2019-01-07 14:40:00-05:00,JNJ,halftime report picks for january 7 mastercard twilio and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998762607574463
696248,696248,707455.0,"Jon Najarian Sees Big Options Activity In Johnson & Johnson, Nvidia",2019-01-07 14:24:00-05:00,JNJ,jon najarian sees big options activity in johnson and johnson nvidia,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9867920875549316
696249,696249,707456.0,"Barron's Picks And Pans: Apple, Exxon, Morgan Stanley And More",2019-01-06 09:06:00-05:00,JNJ,barrons picks and pans apple exxon morgan stanley and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998706579208374
696250,696250,707457.0,India Government May Offer More Compensation To J&J Faulty Hip Implant Patients,2019-01-04 04:54:00-05:00,JNJ,india government may offer more compensation to j and j faulty hip implant patients,"{'neg': 0.15, 'neu': 0.85, 'pos': 0.0, 'compound': -0.3182}",positive,0.9884814023971558
696251,696251,707458.0,Veracyte shares are trading up after the company announced a strategic collaboration with J&J Innovation for lung cancer detection.,2019-01-03 11:00:00-05:00,JNJ,veracyte shares are trading up after the company announced a strategic collaboration with j and j innovation for lung cancer detection,"{'neg': 0.162, 'neu': 0.662, 'pos': 0.176, 'compound': -0.1531}",positive,0.9996250867843628
696252,696252,707459.0,"UPDATE: Veracyte Reports Will Combine Clinical Study Cohorts Involving 5K+ Patients, Multiple Years Of Clinical Outcome Data",2019-01-03 07:16:00-05:00,JNJ,update veracyte reports will combine clinical study cohorts involving 5 thousand patients multiple years of clinical outcome data,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998900890350342
696253,696253,707460.0,Veracyte Reports Strategic Collaboration With J&J Innovation For Lung Cancer Detection,2019-01-03 07:15:00-05:00,JNJ,veracyte reports strategic collaboration with j and j innovation for lung cancer detection,"{'neg': 0.244, 'neu': 0.611, 'pos': 0.144, 'compound': -0.4215}",neutral,0.9925406575202942
696254,696254,707461.0,"Morgan Stanley Maintains Equal-Weight on Johnson & Johnson, Lowers Price Target to $130",2019-01-02 09:46:00-05:00,JNJ,morgan stanley maintains equal weight on johnson and johnson lowers price target to dollars 30,"{'neg': 0.097, 'neu': 0.903, 'pos': 0.0, 'compound': -0.128}",positive,0.9995038509368896
696255,696255,707462.0,Johnson & Johnson Option Alert: Jan 18 $150 Calls at the Ask: 10000 @ $0.03 vs 28534 OI; Earnings 1/22 Before Open Ref=$124.33,2018-12-27 12:14:00-05:00,JNJ,johnson and johnson option alert jan 18 dollars 50 calls at the ask 10000 dollars .03 vs 28534 oi earnings before open ref equals dollars 24.33,"{'neg': 0.0, 'neu': 0.919, 'pos': 0.081, 'compound': 0.296}",neutral,0.9998608827590942
696256,696256,707463.0,"Barron's Picks And Pans: Unicorns, European Treasures, Health Care Bargains And More",2018-12-23 09:25:00-05:00,JNJ,barrons picks and pans unicorns european treasures health care bargains and more,"{'neg': 0.0, 'neu': 0.625, 'pos': 0.375, 'compound': 0.7184}",neutral,0.9998453855514526
696257,696257,707464.0,"The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial",2018-12-21 07:58:00-05:00,JNJ,the daily biotech pulse proteostasis delays data akron gets new ceo pfizer halts vaccine trial,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9949693083763123
696258,696258,707465.0,"Bangladesh To Collect, Test Samples Of Johnson & Johnson Baby Powder",2018-12-21 05:31:00-05:00,JNJ,bangladesh to collect test samples of johnson and johnson baby powder,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999882698059082
696259,696259,707466.0,J&J's Janssen Reports Submission Of Application For STELARA For Treatment Of Moderately To Severely Active Ulcerative Colitis,2018-12-20 16:35:00-05:00,JNJ,j and js janssen reports submission of application for stelara for treatment of moderately to severely active ulcerative colitis,"{'neg': 0.132, 'neu': 0.749, 'pos': 0.119, 'compound': -0.0772}",neutral,0.999847412109375
696260,696260,707467.0,"J&J Says Is In Full Compliance With Current Regulatory Requirements For Manufacturing, Testing Of Its Talc In India",2018-12-20 13:39:00-05:00,JNJ,j and j says is in full compliance with current regulatory requirements for manufacturing testing of its talc in india,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.8647093176841736
696261,696261,707468.0,"Indian Drugs Regulator Orders Johnson & Johnson To Stop Using Raw Material At Two Baby Power Factories In India, Says Co. Can't Produce Baby Powder With Current Raw Materials Until It Is Shown To Be Free Of Asbestos",2018-12-20 09:46:00-05:00,JNJ,indian drugs regulator orders johnson and johnson to stop using raw material at two baby power factories in india says co cant produce baby powder with current raw materials until it is shown to be free of asbestos,"{'neg': 0.053, 'neu': 0.867, 'pos': 0.08, 'compound': 0.2732}",neutral,0.8323825597763062
696262,696262,707469.0,'$JNJ --that was not an appeal in MO it was a request to overturn to the same judge who first ruled against them. Now it will be appealed to a higher court -CNBC's Jim Cramer Tweets,2018-12-19 14:29:00-05:00,JNJ,jnj that was not an appeal in mo it was a request to overturn to the same judge who first ruled against them now it will be appealed to a higher court cnbcs jim cramer tweets,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998225569725037
696263,696263,707470.0,"Hearing Morgan Stanley On Johnson & Johnson Baby Powder Verdict Clarifies That Co. Lost Some Post Trials Motions Which Are Customary After Verdict, But Notes Co. Has Been Successful In Other Post Trial Motions.",2018-12-19 14:21:00-05:00,JNJ,hearing morgan stanley on johnson and johnson baby powder verdict clarifies that co lost some post trials motions which are customary after verdict but notes co has been successful in other post trial motions,"{'neg': 0.041, 'neu': 0.727, 'pos': 0.232, 'compound': 0.765}",positive,0.999262273311615
696264,696264,707471.0,Jury Upholds $4.69B Verdict In Johnson & Johnson Baby Powder Case,2018-12-19 13:49:00-05:00,JNJ,jury upholds dollars .69 billion verdict in johnson and johnson baby powder case,"{'neg': 0.0, 'neu': 0.882, 'pos': 0.118, 'compound': 0.1531}",positive,0.9273799657821655
696265,696265,707472.0,J&J Shares Fall ~0.5% Following NY Times Article 'Johnson & Johnson Loses Bid to Overturn a $4.7 Billion Baby Powder Verdict',2018-12-19 12:47:00-05:00,JNJ,j and j shares fall 0.5 percent following ny times article johnson and johnson loses bid to overturn a dollars .7 billion baby powder verdict,"{'neg': 0.082, 'neu': 0.783, 'pos': 0.135, 'compound': 0.128}",negative,0.9984287619590759
696266,696266,707473.0,J&J Shares Unaffected Midday Amid NY Times Report 'Johnson & Johnson Loses Bid to Overturn a $4.7 Billion Baby Powder Verdict',2018-12-19 12:45:00-05:00,JNJ,j and j shares unaffected midday amid ny times report johnson and johnson loses bid to overturn a dollars .7 billion baby powder verdict,"{'neg': 0.085, 'neu': 0.775, 'pos': 0.14, 'compound': 0.128}",negative,0.9897254109382629
696267,696267,707474.0,"J&J To Report Q4 Earnings On Tues., Jan. 22, 2019 Before Market Open",2018-12-19 11:17:00-05:00,JNJ,j and j to report fourth quarter earnings on tues jan 22 2019 before market open,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998711347579956
696268,696268,707475.0,"J&J Says Indian Authorities Visited Some Of Its Facilities On Wednesday; Says  ""Unequivocally Stand By The Safety Of Our Products, Are Fully Compliant With Regulatory Standards And Requirements In India""",2018-12-19 04:56:00-05:00,JNJ,j and j says indian authorities visited some of its facilities on wednesday says unequivocally stand by the safety of our products are fully compliant with regulatory standards and requirements in india,"{'neg': 0.0, 'neu': 0.917, 'pos': 0.083, 'compound': 0.4215}",positive,0.5531607270240784
696269,696269,707476.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Tues., Dec. 18, 2018",2018-12-18 15:26:00-05:00,JNJ,benzinga pros top 10 most searched tickers for afternoon of tues dec 18 2018,"{'neg': 0.0, 'neu': 0.878, 'pos': 0.122, 'compound': 0.2023}",neutral,0.9998237490653992
696270,696270,707477.0,Johnson & Johnson And Imerys To Pay More Than $1.5M In Talc Case,2018-12-18 13:33:00-05:00,JNJ,johnson and johnson and imerys to pay more than dollars .5 million in talc case,"{'neg': 0.091, 'neu': 0.909, 'pos': 0.0, 'compound': -0.1027}",neutral,0.9993748068809509
696271,696271,707478.0,Fed Meeting Starts With Market Off To Worst December Start in 38 Years,2018-12-18 11:37:00-05:00,JNJ,fed meeting starts with market off to worst december start in 38 years,"{'neg': 0.255, 'neu': 0.745, 'pos': 0.0, 'compound': -0.6249}",negative,0.9855526089668274
696272,696272,707479.0,"Hearing CNBC's Jim Cramer, On 'Squawk On The Street,' Called J&J 'Absolutely A Buy'",2018-12-18 09:20:00-05:00,JNJ,hearing cnbcs jim cramer on squawk on the street called j and j absolutely a buy,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9993390440940857
696273,696273,707480.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning Of Tues., Dec. 18, 2018",2018-12-18 09:15:00-05:00,JNJ,benzinga pros top 10 most searched tickers for morning of tues dec 18 2018,"{'neg': 0.0, 'neu': 0.878, 'pos': 0.122, 'compound': 0.2023}",neutral,0.9998220801353455
696274,696274,707481.0,Johnson & Johnson CEO Tells Cramer 'Thousands Of Studies' Refute Asbestos Allegations,2018-12-18 08:45:00-05:00,JNJ,johnson and johnson ceo tells cramer thousands of studies refute asbestos allegations,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9886533617973328
696275,696275,707482.0,"The Daily Biotech Pulse: Puma Aces Late-Stage Trial, Chinese Cheer For FibroGen, J&J $5B Buyback Plan",2018-12-18 08:00:00-05:00,JNJ,the daily biotech pulse puma aces late stage trial chinese cheer for fibrogen j and j dollars b buyback plan,"{'neg': 0.0, 'neu': 0.852, 'pos': 0.148, 'compound': 0.5106}",positive,0.9910449981689453
696276,696276,707483.0,"'EXCLUSIVE: Johnson & Johnson CEO Alex Gorsky tells CNBC's @JimCramer that ""we unequivocally believe that our talc, our baby powder, does not contain asbestos"" ' -CNBC",2018-12-17 17:03:00-05:00,JNJ,exclusive johnson and johnson ceo alex gorsky tells cnbcs that we unequivocally believe that our talc our baby powder does not contain asbestos cnbc,"{'neg': 0.0, 'neu': 0.939, 'pos': 0.061, 'compound': 0.128}",neutral,0.9998111128807068
696277,696277,707484.0,"J&J Reaffirms FY18 Outlook: Adj. EPS $8.13-$8.18 vs $8.16 Estimate, Sales $81B-$81.4B vs $81.3B Est.",2018-12-17 16:50:00-05:00,JNJ,j and j reaffirms fy18 outlook adj eps dollars .13 dollars .18 vs dollars .16 estimate sales dollars 1 billion dollars 1.4 billion vs dollars 1.3 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9996871948242188
696278,696278,707485.0,Johnson & Johnson Reports $5B Buyback,2018-12-17 16:23:00-05:00,JNJ,johnson and johnson reports dollars b buyback,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999833345413208
696279,696279,707486.0,Johnson & Johnson CEO Alex Gorsky Issues Video Message In Defense Of Co.'s Baby Powder,2018-12-17 14:25:00-05:00,JNJ,johnson and johnson ceo alex gorsky issues video message in defense of co s baby powder,"{'neg': 0.0, 'neu': 0.909, 'pos': 0.091, 'compound': 0.128}",neutral,0.9998849630355835
696280,696280,707487.0,Johnson & Johnson shares are trading lower on continued weakness following Friday reports indicating the company did not disclose prior knowledge of asbestos in its baby powder products; NOTE: Some analysts have are out defending the stock.,2018-12-17 13:44:00-05:00,JNJ,johnson and johnson shares are trading lower on continued weakness following friday reports indicating the company did not disclose prior knowledge of asbestos in its baby powder products note some analysts have are out defending the stock,"{'neg': 0.121, 'neu': 0.825, 'pos': 0.053, 'compound': -0.4215}",negative,0.9981786012649536
696281,696281,707488.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning Of Mon., Dec. 17, 2018",2018-12-17 11:51:00-05:00,JNJ,benzinga pros top 10 most searched tickers for morning of mon dec 17 2018,"{'neg': 0.0, 'neu': 0.878, 'pos': 0.122, 'compound': 0.2023}",neutral,0.9997624754905701
696282,696282,707489.0,Johnson & Johnson's Asbestos Woes: Experts Speak Up,2018-12-17 11:05:00-05:00,JNJ,johnson and johnsons asbestos woes experts speak up,"{'neg': 0.293, 'neu': 0.707, 'pos': 0.0, 'compound': -0.4404}",neutral,0.9996436834335327
696283,696283,707490.0,Hearing Johnson & Johnson CEO Alex Gorsky To Appear On Jim Cramer's 'Mad Money' Tonight,2018-12-17 10:26:00-05:00,JNJ,hearing johnson and johnson ceo alex gorsky to appear on jim cramers mad money tonight,"{'neg': 0.186, 'neu': 0.814, 'pos': 0.0, 'compound': -0.4939}",neutral,0.9998683929443359
696284,696284,707491.0,"BMO On Johnson & Johnson: Firm Thinks The Stock Move Was An Overreaction; Notes The 'last time JNJ finished down more than 10% was on July 19, 2002, declining 16%; it recovered six days later'; Reiterates Outperform, $154 Target",2018-12-17 09:54:00-05:00,JNJ,bmo on johnson and johnson firm thinks the stock move was an overreaction notes the last time jnj finished down more than 10 percent was on july 19 2002 declining 16 percent it recovered six days later reiterates outperform dollars 54 target,"{'neg': 0.04, 'neu': 0.96, 'pos': 0.0, 'compound': -0.1779}",negative,0.9983431100845337
696285,696285,707492.0,"Morgan Stanley On Johnson & Johnson: Believes 'the stock reaction is not supported by science and may inflate potential legal exposure'; Sees Comparisons To Recent Legal Issues At Bayer (BAYRY) As Flawed; Maintains Overweight, $153 Target",2018-12-17 08:01:00-05:00,JNJ,morgan stanley on johnson and johnson believes the stock reaction is not supported by science and may inflate potential legal exposure sees comparisons to recent legal issues at bayer bayry as flawed maintains overweight dollars 53 target,"{'neg': 0.178, 'neu': 0.752, 'pos': 0.07, 'compound': -0.6769}",negative,0.998641312122345
696286,696286,707493.0,41 Biggest Movers From Friday,2018-12-17 05:35:00-05:00,JNJ,41 biggest movers from friday,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998747110366821
696287,696287,707494.0,Wells Fargo Note Cites Bausch Health Acquiring Shower to Shower Body Powder from J&J; Named as Defendant in 160+ Lawsuits,2018-12-14 14:36:00-05:00,JNJ,wells fargo note cites bausch health acquiring shower to shower body powder from j and j named as defendant in 160 lawsuits,"{'neg': 0.068, 'neu': 0.847, 'pos': 0.085, 'compound': 0.1027}",neutral,0.999879002571106
696288,696288,707495.0,Hearing Wells Fargo Out Negative on Bausch Health Off J&J Reuters Report,2018-12-14 14:34:00-05:00,JNJ,hearing wells fargo out negative on bausch health off j and j reuters report,"{'neg': 0.209, 'neu': 0.678, 'pos': 0.113, 'compound': -0.4019}",negative,0.9968720078468323
696289,696289,707496.0,"J&J Issues Statement On Reuters Talc Report: '...article is one-sided, false and inflammatory. Simply put, the Reuters story is an absurd conspiracy theory'",2018-12-14 13:57:00-05:00,JNJ,j and j issues statement on reuters talc report article is one sided false and inflammatory simply put the reuters story is an absurd conspiracy theory,"{'neg': 0.12, 'neu': 0.88, 'pos': 0.0, 'compound': -0.5267}",neutral,0.9382479190826416
696290,696290,707497.0,Citi Says J&J Has Completely Refuted Premise Of Reuters Article Related To Talc,2018-12-14 12:35:00-05:00,JNJ,citi says j and j has completely refuted premise of reuters article related to talc,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9938981533050537
696291,696291,707498.0,Hearing JP Morgan Now Also Out Giving Defensive Comments On J&J,2018-12-14 12:21:00-05:00,JNJ,hearing jp morgan now also out giving defensive comments on j and j,"{'neg': 0.0, 'neu': 0.654, 'pos': 0.346, 'compound': 0.5106}",neutral,0.9998656511306763
696292,696292,707499.0,26 Stocks Moving In Friday's Mid-Day Session,2018-12-14 12:21:00-05:00,JNJ,26 stocks moving in fridays mid day session,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998747110366821
696293,696293,707500.0,Hearing Wells Fargo Analyst Said J&J Shares Appear Oversold Amid Talc Report,2018-12-14 11:48:00-05:00,JNJ,hearing wells fargo analyst said j and j shares appear oversold amid talc report,"{'neg': 0.0, 'neu': 0.741, 'pos': 0.259, 'compound': 0.4939}",negative,0.9981291890144348
696294,696294,707501.0,Johnson & Johnson Falls Following Baby Powder Asbestos Report,2018-12-14 11:47:00-05:00,JNJ,johnson and johnson falls following baby powder asbestos report,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9419058561325073
696295,696295,707502.0,Hearing Susquehanna Says J&J Has Been Facing Talc Litigation For Years,2018-12-14 10:27:00-05:00,JNJ,hearing susquehanna says j and j has been facing talc litigation for years,"{'neg': 0.13, 'neu': 0.87, 'pos': 0.0, 'compound': -0.2023}",neutral,0.9858095049858093
696296,696296,707503.0,Johnson & Johnson shares are trading lower following reports indicating the company did not disclose prior knowledge of asbestos in its baby powder products.,2018-12-14 10:18:00-05:00,JNJ,johnson and johnson shares are trading lower following reports indicating the company did not disclose prior knowledge of asbestos in its baby powder products,"{'neg': 0.083, 'neu': 0.833, 'pos': 0.083, 'compound': 0.0}",negative,0.9970300197601318
696297,696297,707504.0,Johnson & Johnson Option Alert: Fri $145 Puts Sweep (3) near the Ask: 1713 @ $1.5 vs 2434 OI; Earnings 1/22 Before Open [est] Ref=$143.711,2018-12-14 09:32:00-05:00,JNJ,johnson and johnson option alert fri dollars 45 puts sweep 3 near the ask 1713 dollars .5 vs 2434 oi earnings before open est ref equals dollars 43.711,"{'neg': 0.0, 'neu': 0.925, 'pos': 0.075, 'compound': 0.296}",neutral,0.9998117089271545
696298,696298,707505.0,J&J Says 'Thousands of independent tests' Show Talc Is Safe,2018-12-14 09:20:00-05:00,JNJ,j and j says thousands of independent tests show talc is safe,"{'neg': 0.0, 'neu': 0.791, 'pos': 0.209, 'compound': 0.4404}",positive,0.9945804476737976
696299,696299,707506.0,J&J Failed To Tell FDA Of Talc Tests Showing Asbestos From 1970s,2018-12-14 09:17:00-05:00,JNJ,j and j failed to tell fda of talc tests showing asbestos from 1970,"{'neg': 0.202, 'neu': 0.798, 'pos': 0.0, 'compound': -0.5106}",neutral,0.9760452508926392
696300,696300,707507.0,J&J's Janssen Reports Submitted Supplemental New Drug Application To FDA For XARELTO To Prevent Venous Thromboembolism In Acute Medically Ill Patients,2018-12-14 08:37:00-05:00,JNJ,j and js janssen reports submitted supplemental new drug application to fda for xarelto to prevent venous thromboembolism in acute medically ill patients,"{'neg': 0.112, 'neu': 0.843, 'pos': 0.044, 'compound': -0.4019}",neutral,0.9981156587600708
696301,696301,707508.0,"J&J Drafted Into A Fight Over Shareholder Suits, Co. Asked SEC To Omit Proposal From 2019 Proxy Statement",2018-12-13 16:37:00-05:00,JNJ,j and j drafted into a fight over shareholder suits co asked sec to omit proposal from 2019 proxy statement,"{'neg': 0.12, 'neu': 0.88, 'pos': 0.0, 'compound': -0.3818}",neutral,0.9997541308403015
696302,696302,707509.0,Hearing JNJ To Pay Average Of $125K Per Pinnacle-Hip Case,2018-12-12 15:08:00-05:00,JNJ,hearing jnj to pay average of dollars 25 thousand per pinnacle hip case,"{'neg': 0.104, 'neu': 0.896, 'pos': 0.0, 'compound': -0.1027}",neutral,0.9998527765274048
696303,696303,707510.0,Novartis Exec On J&J Call To Discuss TREMFYA Says 'We believe data from ECLIPSE trial...will have limited clinical relevance',2018-12-12 10:29:00-05:00,JNJ,novartis exec on j and j call to discuss tremfya says we believe data from eclipse trial will have limited clinical relevance,"{'neg': 0.083, 'neu': 0.917, 'pos': 0.0, 'compound': -0.2263}",negative,0.9849475026130676
696304,696304,707511.0,BiomX Enters Collaboration With Johnson & Johnson Innovation For Discovery Of Microbiome-Based Biomakers For IBD,2018-12-12 07:38:00-05:00,JNJ,biomx enters collaboration with johnson and johnson innovation for discovery of microbiome based biomakers for ibd,"{'neg': 0.0, 'neu': 0.852, 'pos': 0.148, 'compound': 0.3818}",neutral,0.9918971657752991
696305,696305,707512.0,"The Daily Biotech Pulse: AbbVie Halts Lung Cancer Trial, Oncomed Merges With Mereo, Momenta Offering",2018-12-06 07:56:00-05:00,JNJ,the daily biotech pulse abbvie halts lung cancer trial oncomed merges with mereo momenta offering,"{'neg': 0.239, 'neu': 0.761, 'pos': 0.0, 'compound': -0.6597}",negative,0.9873248338699341
696306,696306,707513.0,"J&J's Janssen Reports New Phase 3 CASSINI Data Presented On Use Of XARELTO, Composite Primary Endpoint Of VTE Occurrence Did Not Reach Statistical Significance During Full-Study Period",2018-12-04 10:33:00-05:00,JNJ,j and js janssen reports new phase 3 cassini data presented on use of xarelto composite primary endpoint of vte occurrence did not reach statistical significance during full study period,"{'neg': 0.093, 'neu': 0.907, 'pos': 0.0, 'compound': -0.2235}",neutral,0.977940022945404
696307,696307,707514.0,"J&J's Janssen Reports New Darzalex Phase 3 Study Showed Efficacy, Safety Data On Anti-CD38 Monoclonal Activity In Newly-Diagnosed Transplant Patients, Says Median Progression-Free Survival Has Not Yet been Reached",2018-12-04 10:31:00-05:00,JNJ,j and js janssen reports new darzalex phase 3 study showed efficacy safety data on anti cd38 monoclonal activity in newly diagnosed transplant patients says median progression free survival has not yet been reached,"{'neg': 0.091, 'neu': 0.756, 'pos': 0.154, 'compound': 0.5429}",positive,0.9956170320510864
696308,696308,707515.0,"The Daily Biotech Pulse: ASH Presentations Take The Spotlight, Eiger Gets A New CFO",2018-12-04 07:59:00-05:00,JNJ,the daily biotech pulse ash presentations take the spotlight eiger gets a new cfo,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998106360435486
696309,696309,707516.0,Janssen Affiliate Cilag GmbH International Enters Worldwide Collaboration and License Agreement with Argenx for Cancer Immunotherapy Cusatuzumab,2018-12-03 04:18:00-05:00,JNJ,janssen affiliate cilag gmbh international enters worldwide collaboration and license agreement with argenx for cancer immunotherapy cusatuzumab,"{'neg': 0.195, 'neu': 0.664, 'pos': 0.142, 'compound': -0.296}",positive,0.9995414018630981
696310,696310,707517.0,"The Week Ahead In Biotech: ASH Presentations Pick Up Pace, PDUFA Dates, Clinical Trials And IPOs",2018-12-02 17:51:00-05:00,JNJ,the week ahead in biotech ash presentations pick up pace pdufa dates clinical trials and ipos,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9981038570404053
696311,696311,707518.0,GlaxoSmithKline and J&J's HIV Drug Juluca Received Approval In Japan,2018-11-27 14:43:00-05:00,JNJ,glaxosmithkline and j and js hiv drug juluca received approval in japan,"{'neg': 0.0, 'neu': 0.78, 'pos': 0.22, 'compound': 0.4767}",positive,0.9983785152435303
696312,696312,707519.0,"Stocks Trading Ex Dividend For Mon., Nov. 26, 2018",2018-11-26 10:43:00-05:00,JNJ,stocks trading ex dividend for mon nov 26 2018,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998873472213745
696313,696313,707520.0,9 Policy Catalysts For Health Care Investors To Watch Before Year's End,2018-11-25 09:35:00-05:00,JNJ,9 policy catalysts for health care investors to watch before years end,"{'neg': 0.0, 'neu': 0.775, 'pos': 0.225, 'compound': 0.4939}",neutral,0.9998030066490173
696314,696314,707521.0,"Stocks That Will Be Trading Ex Dividend Mon., Nov. 26, 2018",2018-11-23 09:06:00-05:00,JNJ,stocks that will be trading ex dividend mon nov 26 2018,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998914003372192
696315,696315,707522.0,A US Appeals Court Has Declined To Block The Sale Of Generic Versions Of J&J's ZYTIGA,2018-11-21 14:28:00-05:00,JNJ,a us appeals court has declined to block the sale of generic versions of j and js zytiga,"{'neg': 0.146, 'neu': 0.854, 'pos': 0.0, 'compound': -0.4404}",neutral,0.9985301494598389
696316,696316,707523.0,"Stocks Which Set New 52-Week High Yesterday, Tues., Nov. 20, 2018",2018-11-21 08:38:00-05:00,JNJ,stocks which set new 52 week high yesterday tues nov 20 2018,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9989846348762512
696317,696317,707524.0,"Hearing Appeals Court Says JNJ Can't Prevent Sales Of Generic Zytiga; Says Teva, Mylan Can Enter Market",2018-11-20 16:02:00-05:00,JNJ,hearing appeals court says jnj cant prevent sales of generic zytiga says teva mylan can enter market,"{'neg': 0.063, 'neu': 0.937, 'pos': 0.0, 'compound': -0.0191}",neutral,0.8770342469215393
696318,696318,707525.0,"Stocks Which Set New 52-Week High Yesterday, Mon., Nov. 19, 2018",2018-11-20 09:11:00-05:00,JNJ,stocks which set new 52 week high yesterday mon nov 19 2018,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9992350339889526
696319,696319,707526.0,"The Daily Biotech Pulse: Denali's Positive Results, Novartis' Substance Abuse Therapy Launch, Medtronic Earnings",2018-11-20 08:29:00-05:00,JNJ,the daily biotech pulse denalis positive results novartis substance abuse therapy launch medtronic earnings,"{'neg': 0.212, 'neu': 0.606, 'pos': 0.182, 'compound': -0.1531}",positive,0.9916515946388245
696320,696320,707527.0,CHMP Says J&J's Janssen Pharma's ERLEADA Receive Positive Opinion For Treatment Of Non-Metastatic Castration Resistant Prostate Cancer,2018-11-16 07:57:00-05:00,JNJ,chmp says j and js janssen pharmas erleada receive positive opinion for treatment of non metastatic castration resistant prostate cancer,"{'neg': 0.169, 'neu': 0.692, 'pos': 0.138, 'compound': -0.2023}",positive,0.9995405673980713
696321,696321,707528.0,Johnson & Johnson Vision Announces Health Canada Has Announced Medical Device License For CUVUE OASYS Contact Lens With Transitions Light Intelligent Technology,2018-11-07 12:38:00-05:00,JNJ,johnson and johnson vision announces health canada has announced medical device license for cuvue oasys contact lens with transitions light intelligent technology,"{'neg': 0.0, 'neu': 0.8, 'pos': 0.2, 'compound': 0.6124}",positive,0.9950522780418396
696322,696322,707529.0,"Fundstrat, Reality Shares Partner On New Multi-Factor ETF",2018-11-05 14:22:00-05:00,JNJ,fundstrat reality shares partner on new multi factor etf,"{'neg': 0.0, 'neu': 0.784, 'pos': 0.216, 'compound': 0.296}",neutral,0.9998636245727539
696323,696323,707530.0,Eli Lilly Gets Ready For First Report Post-Elanco IPO,2018-11-05 12:09:00-05:00,JNJ,eli lilly gets ready for first report post elanco ipo,"{'neg': 0.0, 'neu': 0.783, 'pos': 0.217, 'compound': 0.3612}",neutral,0.9997844099998474
696324,696324,707531.0,Why Apple Will Likely Remain Sole Member Of $1 Trillion Club For A While,2018-11-04 13:58:00-05:00,JNJ,why apple will likely remain sole member of dollars trillion club for a while,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998857975006104
696325,696325,707532.0,"These Are The Biggest Stocks Reporting Earnings This Week, And Their Recent Track Records",2018-10-29 10:39:00-04:00,JNJ,these are the biggest stocks reporting earnings this week and their recent track records,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998747110366821
696326,696326,707533.0,Johnson & Johnson Late Friday Reported A US District Court Ruled Invalidated All Asserted Claims Of Patent For ZYTIGA; Johnson & Johnson Said 'Strongly Disagrees' With Courts Decision,2018-10-29 08:35:00-04:00,JNJ,johnson and johnson late friday reported a us district court ruled invalidated all asserted claims of patent for zytiga johnson and johnson said strongly disagrees with courts decision,"{'neg': 0.076, 'neu': 0.855, 'pos': 0.069, 'compound': -0.0516}",positive,0.6133698225021362
696327,696327,707534.0,TESARO Announces Achievement Of ZEJULA Prostate Cancer Development Milestones By Janssen; Receives $18M Milestone Payment From Janssen,2018-10-29 08:08:00-04:00,JNJ,tesaro announces achievement of zejula prostate cancer development milestones by janssen receives dollars 8 million milestone payment from janssen,"{'neg': 0.196, 'neu': 0.804, 'pos': 0.0, 'compound': -0.6597}",positive,0.9880120754241943
696328,696328,707535.0,'A New Way To Treat The Brain': Stanford University Scientists Launch Cannabis Pharma Company,2018-10-26 13:14:00-04:00,JNJ,a new way to treat the brain stanford university scientists launch cannabis pharma company,"{'neg': 0.0, 'neu': 0.828, 'pos': 0.172, 'compound': 0.4019}",neutral,0.9998206496238708
696329,696329,707536.0,Janssen's Stelara Demonstrated Sustained Efficiency In Improving Clinical Remission Rates In Chron's Patients Throughout Three Years; Safety Events Were Not Higher Amongst All Ustekinumab-Treated Patients Entering Long-Term Extension Study vs Placebo,2018-10-24 07:45:00-04:00,JNJ,janssens stelara demonstrated sustained efficiency in improving clinical remission rates in chrons patients throughout three years safety events were not higher amongst all ustekinumab treated patients entering long term extension study vs placebo,"{'neg': 0.0, 'neu': 0.787, 'pos': 0.213, 'compound': 0.7964}",positive,0.9996594190597534
696330,696330,707537.0,"'6 kids dead, 12 sick in viral outbreak at New Jersey rehabilitation center' -ABC 7 NY",2018-10-23 15:00:00-04:00,JNJ,6 kids dead 12 sick in viral outbreak at new jersey rehabilitation center abc 7 ny,"{'neg': 0.352, 'neu': 0.648, 'pos': 0.0, 'compound': -0.8225}",negative,0.6995230317115784
696331,696331,707538.0,"Johnson & Johnson Announces Offer to Acquire Ci:z Holdings Co.,  for ~ ¥230B",2018-10-23 04:14:00-04:00,JNJ,johnson and johnson announces offer to acquire ci z holdings co for ¥230 billion,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9996360540390015
696332,696332,707539.0,"Citigroup Maintains Neutral on Johnson & Johnson, Raises Price Target to $148",2018-10-22 11:43:00-04:00,JNJ,citigroup maintains neutral on johnson and johnson raises price target to dollars 48,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9995753169059753
696333,696333,707540.0,J&J's Janssen Reports 3-Year TREMFYA Data Showed 'Stably Maintained Rates of Skin Clearance in Patients with Moderate to Severe Plaque Psoriasis',2018-10-19 09:05:00-04:00,JNJ,j and js janssen reports 3 year tremfya data showed stably maintained rates of skin clearance in patients with moderate to severe plaque psoriasis,"{'neg': 0.102, 'neu': 0.898, 'pos': 0.0, 'compound': -0.3818}",positive,0.9993250370025635
696334,696334,707541.0,"Credit Suisse Maintains Outperform on Johnson & Johnson, Raises Price Target to $152",2018-10-17 11:09:00-04:00,JNJ,credit suisse maintains outperform on johnson and johnson raises price target to dollars 52,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.3818}",positive,0.9996844530105591
696335,696335,707542.0,"After Basking In The Glow Of Netflix Results And Tuesday Rally, Pressure Seems Possible",2018-10-17 10:24:00-04:00,JNJ,after basking in the glow of netflix results and tuesday rally pressure seems possible,"{'neg': 0.145, 'neu': 0.855, 'pos': 0.0, 'compound': -0.296}",positive,0.9993651509284973
696336,696336,707543.0,Watching Boston Scientific As Traders Circulate Speculation From Dealreporter J&J Could Be Interested In Co.,2018-10-17 09:41:00-04:00,JNJ,watching boston scientific as traders circulate speculation from dealreporter j and j could be interested in co,"{'neg': 0.0, 'neu': 0.856, 'pos': 0.144, 'compound': 0.4019}",neutral,0.9997482895851135
696337,696337,707544.0,"Raymond James Maintains Outperform on Johnson & Johnson, Raises Price Target to $149",2018-10-17 09:01:00-04:00,JNJ,raymond james maintains outperform on johnson and johnson raises price target to dollars 49,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996780157089233
696338,696338,707545.0,A Peek Into The Markets: US Stock Futures Down Ahead Of Fed Minutes,2018-10-17 07:16:00-04:00,JNJ,a peek into the markets us stock futures down ahead of fed minutes,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998514652252197
696339,696339,707547.0,Bank Earnings To The Rescue? Market Seeing Some Green After Strong Results,2018-10-16 10:43:00-04:00,JNJ,bank earnings to the rescue market seeing some green after strong results,"{'neg': 0.0, 'neu': 0.602, 'pos': 0.398, 'compound': 0.765}",positive,0.9996516704559326
696340,696340,707548.0,J&J CFO On Conference Call Says 'Not Satisfied With The Performance In Medical Devices',2018-10-16 09:28:00-04:00,JNJ,j and j cfo on conference call says not satisfied with the performance in medical devices,"{'neg': 0.135, 'neu': 0.865, 'pos': 0.0, 'compound': -0.3252}",negative,0.9945787191390991
696341,696341,707549.0,"The Daily Biotech Pulse: Enzo's Q4 Loss, Sanofi's Positive Trial Results, ImmunoCellular To Delist",2018-10-16 08:52:00-04:00,JNJ,the daily biotech pulse enzos fourth quarter loss sanofis positive trial results immunocellular to delist,"{'neg': 0.122, 'neu': 0.688, 'pos': 0.19, 'compound': 0.3182}",positive,0.9943550825119019
696342,696342,707550.0,A Peek Into The Markets: US Stock Futures Rise,2018-10-16 07:23:00-04:00,JNJ,a peek into the markets us stock futures rise,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.93264240026474
696343,696343,707551.0,"Johnson & Johnson Raises FY18 Adj. EPS Outlook From $8.07-$8.1 To $8.13-$8.18 vs $8.15 Est., Sees FY18 Sales $81.0B-$81.4B vs $81.21B Est.",2018-10-16 06:42:00-04:00,JNJ,johnson and johnson raises fy18 adj eps outlook from dollars .07 dollars .1 to dollars .13 dollars .18 vs dollars .15 est sees fy18 sales dollars 1.0 billion dollars 1.4 billion vs dollars 1.21 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9970760345458984
696344,696344,707552.0,J&J Raises Guidance,2018-10-16 06:40:00-04:00,JNJ,j and j raises guidance,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9995871186256409
696345,696345,707553.0,"Johnson & Johnson Q3 EPS $2.05 Beats $2.03 Estimate, Sales $20.348B Beat $20.03B Estimate",2018-10-16 06:40:00-04:00,JNJ,johnson and johnson third quarter eps dollars .05 beats dollars .03 estimate sales dollars 0.348 billion beat dollars 0.03 billion estimate,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998562335968018
696346,696346,707554.0,"12 Stocks To Watch For October 16, 2018",2018-10-16 05:21:00-04:00,JNJ,12 stocks to watch for october 16 2018,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998750686645508
696347,696347,707555.0,"Earnings Scheduled For October 16, 2018",2018-10-16 04:37:00-04:00,JNJ,earnings scheduled for october 16 2018,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998818635940552
696348,696348,707556.0,Johnson & Johnson Q3 Earnings Preview,2018-10-15 14:32:00-04:00,JNJ,johnson and johnson third quarter earnings preview,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999839186668396
696349,696349,707557.0,"The Week Ahead: Q3 Earnings Season, Canada Decriminalizes Cannabis",2018-10-15 12:06:00-04:00,JNJ,the week ahead third quarter earnings season canada decriminalizes cannabis,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997351765632629
696350,696350,707558.0,"As New Week Begins, Markets Still Seem To Be Playing ""D"" Amid Host of Earnings",2018-10-15 09:41:00-04:00,JNJ,as new week begins markets still seem to be playing d amid host of earnings,"{'neg': 0.0, 'neu': 0.886, 'pos': 0.114, 'compound': 0.2023}",neutral,0.9948729872703552
696351,696351,707559.0,4 Major Market Opportunities For The Cannabis Industry,2018-10-14 13:26:00-04:00,JNJ,4 major market opportunities for the cannabis industry,"{'neg': 0.0, 'neu': 0.709, 'pos': 0.291, 'compound': 0.4364}",neutral,0.9982436895370483
696352,696352,707560.0,FDA Approves Janssen Pharmaceuticals' Xarelto To Reduce Risk Of Major Cardiovascular Events,2018-10-11 15:54:00-04:00,JNJ,fda approves janssen pharmaceuticals xarelto to reduce risk of major cardiovascular events,"{'neg': 0.142, 'neu': 0.676, 'pos': 0.182, 'compound': 0.1531}",positive,0.9994764924049377
696353,696353,707561.0,"Morgan Stanley Maintains Equal-Weight on Johnson & Johnson, Raises Price Target to $153",2018-10-11 09:34:00-04:00,JNJ,morgan stanley maintains equal weight on johnson and johnson raises price target to dollars 53,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.999576985836029
696354,696354,707562.0,FDA Commissioner Scott Gottlieb Issues Statement On 'new efforts to advance the development of generic copies of complex drugs to improve patient access to medicines',2018-10-09 11:19:00-04:00,JNJ,fda commissioner scott gottlieb issues statement on new efforts to advance the development of generic copies of complex drugs to improve patient access to medicines,"{'neg': 0.0, 'neu': 0.892, 'pos': 0.108, 'compound': 0.4404}",positive,0.7473741769790649
696355,696355,707563.0,Analysts React To Arrowhead's Janssen Collaboration: Downside In Stock May Be 'Misguided',2018-10-04 13:53:00-04:00,JNJ,analysts react to arrowheads janssen collaboration downside in stock may be misguided,"{'neg': 0.154, 'neu': 0.846, 'pos': 0.0, 'compound': -0.25}",negative,0.9972240924835205
696356,696356,707564.0,Arrowhead Announces $3.7B License Agreement With Janssen For Gene-Silencing Drug,2018-10-04 10:12:00-04:00,JNJ,arrowhead announces dollars .7 billion license agreement with janssen for gene silencing drug,"{'neg': 0.096, 'neu': 0.701, 'pos': 0.204, 'compound': 0.4019}",positive,0.999158501625061
696357,696357,707565.0,"Arrowhead Pharmaceuticals On Conference Call Says Working On HBV With J&J, Not Going To Create A Competing HBV Product",2018-10-04 08:51:00-04:00,JNJ,arrowhead pharmaceuticals on conference call says working on hbv with j and j not going to create a competing hbv product,"{'neg': 0.083, 'neu': 0.917, 'pos': 0.0, 'compound': -0.2057}",neutral,0.9998587369918823
696358,696358,707566.0,"The Daily Biotech Pulse: AtriCure's Guidance, Guardant Health And Kodiak To Debut",2018-10-04 07:59:00-04:00,JNJ,the daily biotech pulse atricures guidance guardant health and kodiak to debut,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998780488967896
696359,696359,707567.0,"Jim Cramer Shares His Thoughts On AbbVie, Clorox, Sirius XM And More",2018-10-04 07:53:00-04:00,JNJ,jim cramer shares his thoughts on abbvie clorox sirius xm and more,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.296}",neutral,0.9998776912689209
696360,696360,707568.0,"Arrowhead Reports $3.7B License, Collaboration Deal With J&J's Janssen",2018-10-04 07:31:00-04:00,JNJ,arrowhead reports dollars .7 billion license collaboration deal with j and js janssen,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9663955569267273
696361,696361,707569.0,J&J's Janssen Pharmaceuticals Reports Switching To Symtuza Results In Maintained High Virologic Suppression And No Resistance Development Up To 96 Weeks In Virologically Suppressed Adults With HIV-1,2018-10-03 16:05:00-04:00,JNJ,j and js janssen pharmaceuticals reports switching to symtuza results in maintained high virologic suppression and no resistance development up to 96 weeks in virologically suppressed adults with hiv 1,"{'neg': 0.071, 'neu': 0.929, 'pos': 0.0, 'compound': -0.296}",positive,0.998145341873169
696362,696362,707570.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results And IPOs",2018-09-30 10:14:00-04:00,JNJ,the week ahead in biotech conferences pdufa dates clinical trial results and ipos,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999889612197876
696363,696363,707571.0,Geron Plunges As Johnson & Johnson Unit Discontinues Blood Cancer Drug Collaboration,2018-09-27 09:51:00-04:00,JNJ,geron plunges as johnson and johnson unit discontinues blood cancer drug collaboration,"{'neg': 0.286, 'neu': 0.714, 'pos': 0.0, 'compound': -0.6597}",negative,0.980747401714325
696364,696364,707572.0,"The Daily Biotech Pulse: Hologic Goes Shopping, Johnson & Johnson Snaps Ties With Geron",2018-09-27 08:20:00-04:00,JNJ,the daily biotech pulse hologic goes shopping johnson and johnson snaps ties with geron,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998464584350586
696365,696365,707573.0,Geron Reports Discontinuation OF Imetelstat Collaboration With Janssen,2018-09-27 06:03:00-04:00,JNJ,geron reports discontinuation of imetelstat collaboration with janssen,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9831064939498901
696366,696366,707574.0,"Geron to Provide an Update on the Imetelstat Collaboration with Janssen on September 27, 2018",2018-09-26 20:51:00-04:00,JNJ,geron to provide an update on the imetelstat collaboration with janssen on september 27 2018,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998855590820312
696367,696367,707575.0,"Hearing Johnson & Johnson California Talcum Powder Case Has Ended In Mistrial, Unconfirmed",2018-09-24 14:05:00-04:00,JNJ,hearing johnson and johnson california talcum powder case has ended in mistrial unconfirmed,"{'neg': 0.111, 'neu': 0.889, 'pos': 0.0, 'compound': -0.128}",neutral,0.9997956156730652
696368,696368,707576.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results And IPOs",2018-09-23 16:10:00-04:00,JNJ,the week ahead in biotech conferences pdufa dates clinical trial results and ipos,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999889612197876
696369,696369,707577.0,Johnson & Johnson Option Alert: Jun 21 $160 Calls at the Bid: 500 @ $2.0 vs 750 OI; Earnings 10/16 Before Open Ref=$141.87,2018-09-20 12:01:00-04:00,JNJ,johnson and johnson option alert jun 21 dollars 60 calls at the bid 500 dollars .0 vs 750 oi earnings before open ref equals dollars 41.87,"{'neg': 0.0, 'neu': 0.919, 'pos': 0.081, 'compound': 0.296}",neutral,0.9998668432235718
696370,696370,707578.0,"The Daily Biotech Pulse: Johnson & Johnson's Generic Unit Files NDA For Urinary Tract Cancer Drug, G1 Therapeutics Prices Offering",2018-09-19 08:47:00-04:00,JNJ,the daily biotech pulse johnson and johnsons generic unit files nda for urinary tract cancer drug g1 therapeutics prices offering,"{'neg': 0.177, 'neu': 0.726, 'pos': 0.097, 'compound': -0.4588}",neutral,0.9998779296875
696371,696371,707579.0,"The Week Ahead In Biotech (Sept. 16-22): Conferences, PDUFA Dates, Clinical Trial Results And IPOs",2018-09-16 14:22:00-04:00,JNJ,the week ahead in biotech sept 16 to 22 conferences pdufa dates clinical trial results and ipos,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998887777328491
696372,696372,707580.0,"Pacira Shares Look Expensive, Stifel Says In Bearish Initiation",2018-09-14 15:55:00-04:00,JNJ,pacira shares look expensive stifel says in bearish initiation,"{'neg': 0.0, 'neu': 0.784, 'pos': 0.216, 'compound': 0.296}",negative,0.9984332919120789
696373,696373,707581.0,"'I still believe $JNJ will drop $GERN imetelstat. I guess we wait for later this month to see if I'm right or wrong. Nothing today changes my bearish view. If anything, NOT focusing on imetelstat today is a negative.'-Stat's Adam Feuerstein Tweets",2018-09-13 11:30:00-04:00,JNJ,i still believe jnj will drop gern imetelstat i guess we wait for later this month to see if im right or wrong nothing today changes my bearish view if anything not focusing on imetelstat today is a negative stats adam feuerstein tweets,"{'neg': 0.182, 'neu': 0.818, 'pos': 0.0, 'compound': -0.836}",negative,0.9783557653427124
696374,696374,707582.0,"Stat News' Adam Feuerstein Retweets That Johnson and Johnson Looking At Imetelstat Data Right Now, No Decision Made Yet",2018-09-13 11:23:00-04:00,JNJ,stat news adam feuerstein retweets that johnson and johnson looking at imetelstat data right now no decision made yet,"{'neg': 0.109, 'neu': 0.891, 'pos': 0.0, 'compound': -0.296}",neutral,0.9998434782028198
696375,696375,707583.0,Johnson and Johnson Holding Investor Conference Call On Its Pharma Business Today,2018-09-13 05:53:00-04:00,JNJ,johnson and johnson holding investor conference call on its pharma business today,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998679161071777
696376,696376,707584.0,J&J's Janssen Reports TREMFYA Improves Long-Term Patient-reported Outcomes In Patients With Moderate To Severe Plaque Psoriasis,2018-09-12 08:36:00-04:00,JNJ,j and js janssen reports tremfya improves long term patient reported outcomes in patients with moderate to severe plaque psoriasis,"{'neg': 0.111, 'neu': 0.769, 'pos': 0.12, 'compound': 0.0516}",positive,0.9996774196624756
696377,696377,707585.0,PreMarket Prep Opening NYSE Imbalance Update: Alibaba 109k Shares To Sell; General Electric 163k To Sell; Taiwan Semiconductor 79k To Sell; AT&T 117K To Buy; Home Depot 15k To Buy; Johnson & Johnson 37k To Sell,2018-09-11 08:56:00-04:00,JNJ,premarket prep opening nyse imbalance update alibaba 109 thousand shares to sell general electric 163 thousand to sell taiwan semiconductor 79 thousand to sell at and t 117 thousand to buy home depot 15 thousand to buy johnson and johnson 37 thousand to sell,"{'neg': 0.0, 'neu': 0.951, 'pos': 0.049, 'compound': 0.296}",neutral,0.9998723268508911
696378,696378,707586.0,"The Week Ahead: Apple's Special Event, Mobile World Congress, US Inflation Data On Deck",2018-09-10 12:17:00-04:00,JNJ,the week ahead apples special event mobile world congress us inflation data on deck,"{'neg': 0.0, 'neu': 0.828, 'pos': 0.172, 'compound': 0.4019}",neutral,0.9998905658721924
696379,696379,707587.0,"The Week Ahead In Biotech: Conferences, Clinical Trial Results, Earnings And IPOs",2018-09-09 16:46:00-04:00,JNJ,the week ahead in biotech conferences clinical trial results earnings and ipos,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998588562011719
696380,696380,707588.0,Janssen Submits Esketamine Nasal Spray New Drug Application to U.S. FDA for Treatment-Resistant Depression,2018-09-04 08:05:00-04:00,JNJ,janssen submits esketamine nasal spray new drug application to u s fda for treatment resistant depression,"{'neg': 0.198, 'neu': 0.802, 'pos': 0.0, 'compound': -0.5719}",neutral,0.9996761083602905
696381,696381,707589.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings",2018-09-02 09:41:00-04:00,JNJ,the week ahead in biotech conferences pdufa dates clinical trials and earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999884843826294
696382,696382,707590.0,J&J's Janssen Reports European Commission Approval For Darzalex For Treatment Of Newly-Diagnosed Patients With Multiple Myeloma Who Are Transplant Ineligible,2018-08-31 16:15:00-04:00,JNJ,j and js janssen reports european commission approval for darzalex for treatment of newly diagnosed patients with multiple myeloma who are transplant ineligible,"{'neg': 0.0, 'neu': 0.876, 'pos': 0.124, 'compound': 0.4767}",positive,0.8630173206329346
696383,696383,707591.0,Sympathy Move: Portola Upgraded After Competitor Reports Sour Data,2018-08-27 10:31:00-04:00,JNJ,sympathy move portola upgraded after competitor reports sour data,"{'neg': 0.0, 'neu': 0.762, 'pos': 0.238, 'compound': 0.3612}",positive,0.9995747208595276
696384,696384,707592.0,AbbVie's Rare Blood Cancer Drug Combo Snags FDA Approval,2018-08-27 09:38:00-04:00,JNJ,abbvies rare blood cancer drug combo snags fda approval,"{'neg': 0.303, 'neu': 0.483, 'pos': 0.214, 'compound': -0.3182}",negative,0.9969620108604431
696385,696385,707593.0,"Stocks Trading Ex Dividend For Mon., Aug. 27, 2018",2018-08-27 09:13:00-04:00,JNJ,stocks trading ex dividend for mon aug 27 2018,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998899698257446
696386,696386,707594.0,FDA Approves Johnson & Johnson and Abbvie's IMBRUVICA Plus Rituximab As First Chemotherapy-Free Combo Treatment In Adults With Waldenstrom's Macroglobulinemia,2018-08-27 07:01:00-04:00,JNJ,fda approves johnson and johnson and abbvies imbruvica plus rituximab as first chemotherapy free combo treatment in adults with waldenstroms macroglobulinemia,"{'neg': 0.0, 'neu': 0.76, 'pos': 0.24, 'compound': 0.7184}",neutral,0.9997005462646484
696387,696387,707595.0,What's Going On With Geron?,2018-08-24 13:53:00-04:00,JNJ,whats going on with geron,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998743534088135
696388,696388,707596.0,"Geron Shares Fall Modestly, ~3.7%, As J&J Spokesperson Suggests Recent Job Posting Mentioning Imetelstat Is Not Related To An Expected Decision For A Licensing Deal, And Includes 'Responsibilities For A Variety Of Disease Areas'",2018-08-24 12:54:00-04:00,JNJ,geron shares fall modestly 3.7 percent as j and j spokesperson suggests recent job posting mentioning imetelstat is not related to an expected decision for a licensing deal and includes responsibilities for a variety of disease areas,"{'neg': 0.0, 'neu': 0.942, 'pos': 0.058, 'compound': 0.296}",negative,0.9980238676071167
696389,696389,707597.0,Hearing J&J Spokesperson Has Issued Response Related To Recent Job Posting: Says Posting Not Related To Expected Decision On Licensing Deal,2018-08-24 12:52:00-04:00,JNJ,hearing j and j spokesperson has issued response related to recent job posting says posting not related to expected decision on licensing deal,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998419284820557
696390,696390,707598.0,"Stocks That Will Be Trading Ex Dividend Mon., Aug. 27, 2018",2018-08-24 11:01:00-04:00,JNJ,stocks that will be trading ex dividend mon aug 27 2018,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999893069267273
696391,696391,707599.0,"Geron Shares Remain Elevated, Up 28.3% With Some Attributing Upside To Johnson & Johnson Job Posting For a Strategic Pricing Manager For Imbruvica & Imetelstat, Drugs Its Partnered On With AbbVie and Geron, Respectively",2018-08-24 10:42:00-04:00,JNJ,geron shares remain elevated up 28.3 percent with some attributing upside to johnson and johnson job posting for a strategic pricing manager for imbruvica and imetelstat drugs its partnered on with abbvie and geron respectively,"{'neg': 0.0, 'neu': 0.878, 'pos': 0.122, 'compound': 0.5574}",positive,0.9997096657752991
696392,696392,707600.0,"'$GERN trading +30% on a JNJ job posting that mentions imetelstat. Yes, it's that ridiculous. Summer Fridays!'-STAT's Adam Feuerstein Tweets",2018-08-24 10:17:00-04:00,JNJ,gern trading positive 30 percent on a jnj job posting that mentions imetelstat yes its that ridiculous summer fridays stats adam feuerstein tweets,"{'neg': 0.087, 'neu': 0.694, 'pos': 0.219, 'compound': 0.5859}",positive,0.9996102452278137
696393,696393,707602.0,5 Execs Talk Business Models At Cannabis Capital Conference,2018-08-20 14:37:00-04:00,JNJ,5 execs talk business models at cannabis capital conference,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998825788497925
696394,696394,707603.0,"Barron's Picks And Pans: AT&T, Starbucks, State Street, Verizon And More",2018-08-19 12:07:00-04:00,JNJ,barrons picks and pans at and t starbucks state street verizon and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998927116394043
696395,696395,707604.0,Johnson & Johnson Option Alert: Aug 31 $132 Calls Sweep (34) near the Ask: 787 @ $0.961 vs 385 OI; Ref=$131.58,2018-08-16 10:40:00-04:00,JNJ,johnson and johnson option alert aug 31 dollars 32 calls sweep 34 near the ask 787 dollars .961 vs 385 oi ref equals dollars 31.58,"{'neg': 0.0, 'neu': 0.916, 'pos': 0.084, 'compound': 0.296}",neutral,0.999855637550354
696396,696396,707605.0,"J&J's Janssen Reports Submission Of US, EU Regulatory Applications Seeking Approval For DARZALEX Split-Dosing Regimen",2018-08-08 07:39:00-04:00,JNJ,j and js janssen reports submission of us eu regulatory applications seeking approval for darzalex split dosing regimen,"{'neg': 0.0, 'neu': 0.846, 'pos': 0.154, 'compound': 0.4767}",neutral,0.9997915625572205
696397,696397,707606.0,"Daabon Strikes Deal With Avicanna, Becoming The Largest Agro Company To Enter The Cannabis Industry",2018-08-06 16:07:00-04:00,JNJ,daabon strikes deal with avicanna becoming the largest agro company to enter the cannabis industry,"{'neg': 0.152, 'neu': 0.848, 'pos': 0.0, 'compound': -0.3612}",positive,0.9989728927612305
696398,696398,707607.0,"Price Action In Several Major Healthcare Names Mixed, Stocks Appear Largely Unaffected Following Late-Tues. NY Times Article 'Justice Dept. Investigating Claims That Drug Companies Funded Terrorism in Iraq'",2018-08-01 10:59:00-04:00,JNJ,price action in several major healthcare names mixed stocks appear largely unaffected following late tues ny times article justice dept investigating claims that drug companies funded terrorism in iraq,"{'neg': 0.131, 'neu': 0.771, 'pos': 0.097, 'compound': -0.296}",neutral,0.9903562068939209
696399,696399,707608.0,Johnson & Johnson Wins a $227M Defense Contract,2018-07-30 07:10:00-04:00,JNJ,johnson and johnson wins a dollars 27 million defense contract,"{'neg': 0.0, 'neu': 0.606, 'pos': 0.394, 'compound': 0.6369}",positive,0.9993902444839478
696400,696400,707609.0,What It Takes To Be A Dividend King,2018-07-26 15:01:00-04:00,JNJ,what it takes to be a dividend king,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998819828033447
696401,696401,707610.0,Janssen Presents Switch Data for New HIV-1 Treatment SYMTUZA  and Second Study Supporting its Use in a Rapid Initiation Scenario at AIDS 2018,2018-07-24 06:09:00-04:00,JNJ,janssen presents switch data for new hiv 1 treatment symtuza and second study supporting its use in a rapid initiation scenario at aids 2018,"{'neg': 0.0, 'neu': 0.888, 'pos': 0.112, 'compound': 0.4404}",neutral,0.999688982963562
696402,696402,707611.0,"Benzinga's Daily Biotech Pulse: Novartis Earnings, J&J's HIV Combo Clears FDA Hurdle, Cara To Offer Shares",2018-07-18 08:42:00-04:00,JNJ,benzingas daily biotech pulse novartis earnings j and js hiv combo clears fda hurdle cara to offer shares,"{'neg': 0.0, 'neu': 0.821, 'pos': 0.179, 'compound': 0.3612}",positive,0.999299168586731
696403,696403,707612.0,J&J Reports FDA Approval Of Symtuza For Treatment Of HIV-1 Infection,2018-07-17 17:32:00-04:00,JNJ,j and j reports fda approval of symtuza for treatment of hiv 1 infection,"{'neg': 0.0, 'neu': 0.807, 'pos': 0.193, 'compound': 0.4767}",positive,0.9971809387207031
696404,696404,707613.0,Hearing Johnson & Johnson Nears Sale Of Sylvant To Eusa Pharma,2018-07-17 13:40:00-04:00,JNJ,hearing johnson and johnson nears sale of sylvant to eusa pharma,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998736381530762
696405,696405,707614.0,"Benzinga's Daily Biotech Pulse: Bellicum CFO Resigns, Roche's Trial Meets Endpoints, Avid Bioservices Turns To Black In Q4",2018-07-17 08:37:00-04:00,JNJ,benzingas daily biotech pulse bellicum cfo resigns roches trial meets endpoints avid bioservices turns to black in fourth quarter,"{'neg': 0.107, 'neu': 0.791, 'pos': 0.102, 'compound': -0.0258}",negative,0.9666094779968262
696406,696406,707615.0,A Peek Into The Markets: US Stock Futures Edge Lower Ahead Of Goldman Sachs Earnings,2018-07-17 06:48:00-04:00,JNJ,a peek into the markets us stock futures edge lower ahead of goldman sachs earnings,"{'neg': 0.136, 'neu': 0.864, 'pos': 0.0, 'compound': -0.296}",negative,0.9978041052818298
696407,696407,707616.0,"Johnson & Johnson Sees FY18 Of $80.5-$81.3B vs $81.47B Reflecting An Increase In Expected Operational Growth Of 4.5-5.5%, Sees FY18 Adj. EPS $8.07-$8.17 vs $8.12 Est.",2018-07-17 06:43:00-04:00,JNJ,johnson and johnson sees fy18 of dollars 0.5 dollars 1.3 billion vs dollars 1.47 billion reflecting an increase in expected operational growth of 4.5 to 5.5 percent sees fy18 adj eps dollars .07 dollars .17 vs dollars .12 est,"{'neg': 0.0, 'neu': 0.883, 'pos': 0.117, 'compound': 0.5994}",positive,0.9996820688247681
696408,696408,707617.0,"Johnson & Johnson Q2 EPS $2.10 Beats $2.06 Estimate, Sales $20.83B Beat $20.37B Estimate",2018-07-17 06:42:00-04:00,JNJ,johnson and johnson second quarter eps dollars .10 beats dollars .06 estimate sales dollars 0.83 billion beat dollars 0.37 billion estimate,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998675584793091
696409,696409,707618.0,"8 Stocks To Watch For July 17, 2018",2018-07-17 04:44:00-04:00,JNJ,8 stocks to watch for july 17 2018,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998524188995361
696410,696410,707619.0,"Earnings Scheduled For July 17, 2018",2018-07-17 04:04:00-04:00,JNJ,earnings scheduled for july 17 2018,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999881386756897
696411,696411,707620.0,Johnson & Johnson Q2 Earnings Preview,2018-07-16 17:20:00-04:00,JNJ,johnson and johnson second quarter earnings preview,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998362064361572
696412,696412,707621.0,"The Week Ahead: Netflix Earnings, Comic-Con, 'IPO Thursday' And More",2018-07-16 16:54:00-04:00,JNJ,the week ahead netflix earnings comic con ipo thursday and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998719692230225
696413,696413,707622.0,J&J's Janssen Pharma Reports Phase 3 CREDENCE Trial Of INVOKANA Stopped Early For Positive Efficacy Findings,2018-07-16 16:24:00-04:00,JNJ,j and js janssen pharma reports phase 3 credence trial of invokana stopped early for positive efficacy findings,"{'neg': 0.088, 'neu': 0.744, 'pos': 0.167, 'compound': 0.4019}",neutral,0.6836528182029724
696414,696414,707623.0,"Upcoming Earnings: Netflix To Report Monday, Subscriber Growth A Focus",2018-07-16 11:08:00-04:00,JNJ,upcoming earnings netflix to report monday subscriber growth a focus,"{'neg': 0.0, 'neu': 0.776, 'pos': 0.224, 'compound': 0.3818}",positive,0.6412484049797058
696415,696415,707624.0,Earnings Preview: Healthcare Giant Johnson & Johnson Set To Report Tuesday Morning,2018-07-16 10:31:00-04:00,JNJ,earnings preview healthcare giant johnson and johnson set to report tuesday morning,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998747110366821
696416,696416,707625.0,Back To Banks: More Financial Results In Ahead of Powell Testimony Later This Week,2018-07-16 10:14:00-04:00,JNJ,back to banks more financial results in ahead of powell testimony later this week,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997913241386414
696417,696417,707626.0,"Round Two Of Bank Earnings Coming Up With Bank of America, Goldman Sachs And Morgan Stanley",2018-07-16 09:35:00-04:00,JNJ,round two of bank earnings coming up with bank of america goldman sachs and morgan stanley,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998784065246582
696418,696418,707627.0,PreMarket Prep Opening NYSE Imbalance Update: ExxonMobil 55k Shares To Sell; Pfizer 50k To Sell; Merck 26k To Sell; Coca-Cola 54k To Sell; Johnson & Johnson 54k To Sell; Ford 103k To Sell; Kroger 90k To Sell,2018-07-16 09:02:00-04:00,JNJ,premarket prep opening nyse imbalance update exxonmobil 55 thousand shares to sell pfizer 50 thousand to sell merck 26 thousand to sell coca cola 54 thousand to sell johnson and johnson 54 thousand to sell ford 103 thousand to sell kroger 90 thousand to sell,"{'neg': 0.0, 'neu': 0.952, 'pos': 0.048, 'compound': 0.296}",neutral,0.999868631362915
696419,696419,707628.0,Jury Returns $4.7B Verdict Against Johnson & Johnson In Asbestos-Laced Talcum Case,2018-07-13 09:40:00-04:00,JNJ,jury returns dollars .7 billion verdict against johnson and johnson in asbestos laced talcum case,"{'neg': 0.0, 'neu': 0.897, 'pos': 0.103, 'compound': 0.1531}",neutral,0.9988715052604675
696420,696420,707629.0,PreMarket Prep Opening NYSE Imbalance Update: AT&T 167k Shares To Sell; Bank Of America 101k To Buy; JNJ 75k To Sell; Alibaba 55k To Buy,2018-07-13 09:01:00-04:00,JNJ,premarket prep opening nyse imbalance update at and t 167 thousand shares to sell bank of america 101 thousand to buy jnj 75 thousand to sell alibaba 55 thousand to buy,"{'neg': 0.0, 'neu': 0.932, 'pos': 0.068, 'compound': 0.296}",neutral,0.9998626708984375
696421,696421,707630.0,"The Market In 5 Minutes: AT&T-Time Warner Appeal, Johnson & Johnson Lawsuit, Theresa May And More",2018-07-13 08:19:00-04:00,JNJ,the market in 5 minutes at and t time warner appeal johnson and johnson lawsuit theresa may and more,"{'neg': 0.095, 'neu': 0.905, 'pos': 0.0, 'compound': -0.2263}",neutral,0.9998466968536377
696422,696422,707631.0,24 Stocks Moving In Friday's Mid-Day Session,2018-07-13 08:03:00-04:00,JNJ,24 stocks moving in fridays mid day session,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998767375946045
696423,696423,707632.0,"J&J Says Deeply Disappointed in Verdict of St Louis Court, Unfair Process",2018-07-12 21:17:00-04:00,JNJ,j and j says deeply disappointed in verdict of st louis court unfair process,"{'neg': 0.335, 'neu': 0.568, 'pos': 0.096, 'compound': -0.6838}",negative,0.9917137622833252
696424,696424,707633.0,J&J Ordered to Pay $4.14B in Punitive Damages in Talc Cancer Case,2018-07-12 19:10:00-04:00,JNJ,j and j ordered to pay dollars .14 billion in punitive damages in talc cancer case,"{'neg': 0.5, 'neu': 0.5, 'pos': 0.0, 'compound': -0.9001}",neutral,0.9028598666191101
696425,696425,707634.0,Courtroom Video Shows J&J Ordered To Pay $550M In Compensatory Damages In Missouri Trial Which Claimed Asbestos In Talc Caused Cancer In 22 Women,2018-07-12 16:14:00-04:00,JNJ,courtroom video shows j and j ordered to pay dollars 50 million in compensatory damages in missouri trial which claimed asbestos in talc caused cancer in 22 women,"{'neg': 0.258, 'neu': 0.742, 'pos': 0.0, 'compound': -0.8271}",negative,0.5791403651237488
696426,696426,707635.0,"Bank Earnings: JPMorgan, Wells Fargo And Citigroup Are Slated To Report Friday Morning",2018-07-12 13:42:00-04:00,JNJ,bank earnings jpmorgan wells fargo and citigroup are slated to report friday morning,"{'neg': 0.0, 'neu': 0.857, 'pos': 0.143, 'compound': 0.25}",neutral,0.9998760223388672
696427,696427,707636.0,"Goldman Sachs Swaps Perrigo, Johnson & Johnson Ratings",2018-07-12 10:28:00-04:00,JNJ,goldman sachs swaps perrigo johnson and johnson ratings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998729228973389
696428,696428,707637.0,"Benzinga's Top Upgrades, Downgrades For July 12, 2018",2018-07-12 09:20:00-04:00,JNJ,benzingas top upgrades downgrades for july 12 2018,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.2023}",positive,0.9417230486869812
696429,696429,707638.0,Goldman Sachs Upgrades Johnson & Johnson to Neutral,2018-07-12 08:20:00-04:00,JNJ,goldman sachs upgrades johnson and johnson to neutral,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9953060746192932
696430,696430,707639.0,"Benzinga's Daily Biotech Pulse: Pfizer To Defer Price Hikes, Idera-BioCryst Merger Falls Through, ArQule To Offer Shares",2018-07-11 08:15:00-04:00,JNJ,benzingas daily biotech pulse pfizer to defer price hikes idera biocryst merger falls through arqule to offer shares,"{'neg': 0.108, 'neu': 0.784, 'pos': 0.108, 'compound': 0.0}",negative,0.9957237243652344
696431,696431,707640.0,Johnson & Johnson Option Alert: Aug 17 $120 Puts Sweep (29) near the Bid: 932 @ $0.653 vs 3925 OI; Earnings 7/17 Before Open Ref=$127.295,2018-07-10 15:20:00-04:00,JNJ,johnson and johnson option alert aug 17 dollars 20 puts sweep 29 near the bid 932 dollars .653 vs 3925 oi earnings before open ref equals dollars 27.295,"{'neg': 0.0, 'neu': 0.925, 'pos': 0.075, 'compound': 0.296}",neutral,0.9998471736907959
696432,696432,707641.0,Health Care Sector Outlook: Checking In Ahead Of Q2 Earnings Reports,2018-07-09 14:39:00-04:00,JNJ,health care sector outlook checking in ahead of second quarter earnings reports,"{'neg': 0.0, 'neu': 0.775, 'pos': 0.225, 'compound': 0.4939}",neutral,0.999788224697113
696433,696433,707642.0,A Look At Biotech In 2018 And The Biggest Catalysts Coming Up In The Second Half Of The Year,2018-07-05 12:25:00-04:00,JNJ,a look at biotech in 2018 and the biggest catalysts coming up in the second half of the year,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998536109924316
696434,696434,707643.0,Johnson & Johnson Option Alert: Jul 13 $125 Calls Sweep (28) near the Ask: 539 @ $0.693 vs 660 OI; Earnings 7/17 Before Open Ref=$123.78,2018-07-05 10:03:00-04:00,JNJ,johnson and johnson option alert jul 13 dollars 25 calls sweep 28 near the ask 539 dollars .693 vs 660 oi earnings before open ref equals dollars 23.78,"{'neg': 0.0, 'neu': 0.925, 'pos': 0.075, 'compound': 0.296}",neutral,0.9998701810836792
696435,696435,707644.0,'The success of $XLRN luspatercept is bad for $GERN and another reason for $JNJ to sever the imetelstat relationship in Q3.'-STAT's Adam Feuerstein Tweets,2018-06-29 10:01:00-04:00,JNJ,the success of xlrn luspatercept is bad for gern and another reason for jnj to sever the imetelstat relationship in third quarter . stats adam feuerstein tweets,"{'neg': 0.109, 'neu': 0.776, 'pos': 0.115, 'compound': 0.0516}",negative,0.9986180067062378
696436,696436,707645.0,"Benzinga's Top Upgrades, Downgrades For June 27, 2018",2018-06-27 10:14:00-04:00,JNJ,benzingas top upgrades downgrades for june 27 2018,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.2023}",positive,0.764620304107666
696437,696437,707646.0,"Bernstein Initiates Coverage On Johnson & Johnson with Market Perform Rating, Announces $129 Price Target",2018-06-27 07:59:00-04:00,JNJ,bernstein initiates coverage on johnson and johnson with market perform rating announces dollars 29 price target,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997043013572693
696438,696438,707647.0,Janssen Pharmaceutical Signs License Agreement With Saladax Biomedical,2018-06-26 10:34:00-04:00,JNJ,janssen pharmaceutical signs license agreement with saladax biomedical,"{'neg': 0.0, 'neu': 0.686, 'pos': 0.314, 'compound': 0.4939}",positive,0.9994252920150757
696439,696439,707648.0,AbbVie Announces sNDA For Ibrutinib Accepted For Review By FDA,2018-06-25 09:00:00-04:00,JNJ,abbvie announces snda for ibrutinib accepted for review by fda,"{'neg': 0.0, 'neu': 0.811, 'pos': 0.189, 'compound': 0.2732}",neutral,0.9998689889907837
696440,696440,707649.0,A Look Back At What's Happened To Each Sector Through The First Half Of 2018 (Part 2),2018-06-19 11:57:00-04:00,JNJ,a look back at whats happened to each sector through the first half of 2018 part 2,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998780488967896
696441,696441,707650.0,"'$GERN wants $JNJ to continue a drug development partnership, but new data weaken its case'-STAT's Adam Feuerstein Tweets",2018-06-18 11:48:00-04:00,JNJ,gern wants jnj to continue a drug development partnership but new data weaken its case stats adam feuerstein tweets,"{'neg': 0.171, 'neu': 0.829, 'pos': 0.0, 'compound': -0.5719}",negative,0.997364342212677
696442,696442,707651.0,Johnson & Johnson Announces FDA Approval of iDESIGN Refractive Studio For LASIK Treatment,2018-06-18 08:28:00-04:00,JNJ,johnson and johnson announces fda approval of idesign refractive studio for lasik treatment,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.4767}",positive,0.9990571141242981
696443,696443,707652.0,"J&J's Janssen Reports XARELTO Associated with Significantly Reduced Hospital Time, Decreased Costs With Low-Risk Pulmonary Embolism",2018-06-14 08:33:00-04:00,JNJ,j and js janssen reports xarelto associated with significantly reduced hospital time decreased costs with low risk pulmonary embolism,"{'neg': 0.198, 'neu': 0.802, 'pos': 0.0, 'compound': -0.4939}",positive,0.9995859265327454
696444,696444,707653.0,"Johnson & Johnson Announces Acceptance Of Binding Offer From Platinum Equity To Acquire LifeScan, Inc.  For Approximately $2.1B",2018-06-12 16:01:00-04:00,JNJ,johnson and johnson announces acceptance of binding offer from platinum equity to acquire lifescan inc for approximately dollars .1 billion,"{'neg': 0.0, 'neu': 0.864, 'pos': 0.136, 'compound': 0.4588}",positive,0.9822116494178772
696445,696445,707654.0,"VIVUS Reports Has Met Closing Conditions For Purchase Of US, Canadian Rights To PANCREAZE Capsules For Treatment Of EPI From J&J's Janssen Pharma For $135M",2018-06-11 07:34:00-04:00,JNJ,vivus reports has met closing conditions for purchase of us canadian rights to pancreaze capsules for treatment of epi from j and js janssen pharma for dollars 35 million,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9440697431564331
696446,696446,707655.0,"Benzinga's Daily Biotech Pulse: Johnson & Johnson to Dispose Sterilization Products Business, Mixed Results From Protesostasis' Cystic Fibrosis Study",2018-06-07 07:58:00-04:00,JNJ,benzingas daily biotech pulse johnson and johnson to dispose sterilization products business mixed results from protesostasis cystic fibrosis study,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998668432235718
696447,696447,707656.0,Fortive Reports Binding Offer To Buy Advanced Sterilization Products Business From J&J for ~$2.7B In Cash,2018-06-06 16:30:00-04:00,JNJ,fortive reports binding offer to buy advanced sterilization products business from j and j for dollars .7 billion in cash,"{'neg': 0.0, 'neu': 0.905, 'pos': 0.095, 'compound': 0.25}",neutral,0.9998716115951538
696448,696448,707657.0,J&J Shares Ticker Slightly Higher Over Last Few Mins.; Hearing Jim Cramer Mentioned Stock/Co. Positively On CNBC,2018-06-04 12:52:00-04:00,JNJ,j and j shares ticker slightly higher over last few mins hearing jim cramer mentioned stock and co positively on cnbc,"{'neg': 0.0, 'neu': 0.772, 'pos': 0.228, 'compound': 0.6808}",positive,0.9996762275695801
696449,696449,707658.0,Janssen Says Phase 3 Study Shows Esketamine Nasal Spray Plus Oral Antidepressant Delayed Time To Relapse In Patients With Treatment-Resistant Depression,2018-05-31 12:42:00-04:00,JNJ,janssen says phase 3 study shows esketamine nasal spray plus oral antidepressant delayed time to relapse in patients with treatment resistant depression,"{'neg': 0.219, 'neu': 0.781, 'pos': 0.0, 'compound': -0.6808}",positive,0.9251152276992798
696450,696450,707659.0,J&J's Janssen Pharma Earlier Reported Initiation Of Phase 1b/2 Development Program Evaluating JNJ-68284528 Car-T Cells For Treatment Of Multiple Myeloma,2018-05-30 09:54:00-04:00,JNJ,j and js janssen pharma earlier reported initiation of phase development program evaluating jnj 68284528 car t cells for treatment of multiple myeloma,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9996080994606018
696451,696451,707660.0,"Stocks That Made New 52-Week Lows Today Include: Patterson Companies, Philip Morris, Coty, and Johnson & Johnson",2018-05-29 11:06:00-04:00,JNJ,stocks that made new 52 week lows today include patterson companies philip morris coty and johnson and johnson,"{'neg': 0.096, 'neu': 0.904, 'pos': 0.0, 'compound': -0.2023}",negative,0.9875606894493103
696452,696452,707661.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-05-27 11:38:00-04:00,JNJ,pot stocks etfs top news and data from the cannabis industry this week,"{'neg': 0.0, 'neu': 0.87, 'pos': 0.13, 'compound': 0.2023}",neutral,0.9998798370361328
696453,696453,707662.0,"Barron's Picks And Pans: Best CEOs, Altice USA, Micron Technology And More",2018-05-27 11:29:00-04:00,JNJ,barrons picks and pans best ceos altice usa micron technology and more,"{'neg': 0.0, 'neu': 0.724, 'pos': 0.276, 'compound': 0.6369}",neutral,0.9998774528503418
696454,696454,707663.0,Novartis Gets Approval For Remicade Biosimilar In Europe,2018-05-25 13:51:00-04:00,JNJ,novartis gets approval for remicade biosimilar in europe,"{'neg': 0.0, 'neu': 0.693, 'pos': 0.307, 'compound': 0.4767}",positive,0.9893779158592224
696455,696455,707664.0,An ETF Play For Quality Stocks At A Fair Price,2018-05-24 13:35:00-04:00,JNJ,an etf play for quality stocks at a fair price,"{'neg': 0.0, 'neu': 0.63, 'pos': 0.37, 'compound': 0.5719}",neutral,0.9793923497200012
696456,696456,707665.0,"The Week Ahead In Biotech: PDUFA Dates, IPOs And More",2018-05-21 07:40:00-04:00,JNJ,the week ahead in biotech pdufa dates ipos and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998878240585327
696457,696457,707666.0,Janssen Announces European Commission Approval of JULUCA,2018-05-21 06:15:00-04:00,JNJ,janssen announces european commission approval of juluca,"{'neg': 0.0, 'neu': 0.659, 'pos': 0.341, 'compound': 0.4767}",neutral,0.9998157620429993
696458,696458,707667.0,12 Dow 30 Companies With Above-Average Salaries,2018-05-19 17:21:00-04:00,JNJ,12 dow 30 companies with above average salaries,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998694658279419
696459,696459,707668.0,How To Get Quality In The Core,2018-05-17 13:19:00-04:00,JNJ,how to get quality in the core,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997784495353699
696460,696460,707669.0,"Jim Cramer Shares His Thoughts On Johnson & Johnson, Nike And More",2018-05-17 07:30:00-04:00,JNJ,jim cramer shares his thoughts on johnson and johnson nike and more,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.296}",neutral,0.9998757839202881
696461,696461,707670.0,Analyst: Morphosys Is Well-Positioned To Continue Success With Antibody Discovery Platforms,2018-05-14 15:26:00-04:00,JNJ,analyst morphosys is well positioned to continue success with antibody discovery platforms,"{'neg': 0.0, 'neu': 0.633, 'pos': 0.367, 'compound': 0.7003}",positive,0.9996083378791809
696462,696462,707671.0,"Benzinga's Daily Biotech Pulse: Valeant Earnings, Lipocine's FDA Watch, Invivo CFO Departure",2018-05-08 07:55:00-04:00,JNJ,benzingas daily biotech pulse valeant earnings lipocines fda watch invivo cfo departure,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998210072517395
696463,696463,707672.0,"Jim Cramer Advises His Viewers On Prestige Brands, CVS Health And More",2018-05-08 07:32:00-04:00,JNJ,jim cramer advises his viewers on prestige brands cvs health and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998453855514526
696464,696464,707673.0,Janssen Pharmaceuticals Announces New Phase 3 Data Show Esketamine Nasal Spray Demonstrated Rapid Improvements in Depressive Symptoms in Patients with Treatment-Resistant Depression,2018-05-06 07:40:00-04:00,JNJ,janssen pharmaceuticals announces new phase 3 data show esketamine nasal spray demonstrated rapid improvements in depressive symptoms in patients with treatment resistant depression,"{'neg': 0.22, 'neu': 0.699, 'pos': 0.08, 'compound': -0.6124}",positive,0.9996674060821533
696465,696465,707674.0,"Stocks That Made New 52-Week Lows Today Include Colgate-Palmolive, Philip Morris, Regeneron, Corning, Hanesbrands, Bed Bath & Beyond, Pepsi, Coca-Cola, Paccar, Johnson & Johnson, Mallinckrodt, CBS, DISH Network, Goodyear Tire, Chubb, Hershey, and AT&T",2018-05-03 11:31:00-04:00,JNJ,stocks that made new 52 week lows today include colgate palmolive philip morris regeneron corning hanesbrands bed bath and beyond pepsi coca cola paccar johnson and johnson mallinckrodt cbs dish network goodyear tire chubb hershey and at and t,"{'neg': 0.045, 'neu': 0.955, 'pos': 0.0, 'compound': -0.2023}",negative,0.9220458269119263
696466,696466,707675.0,HC2 Reports BeneVir Biopharm To Be Purchased By J&J's Janssen Biotech For Up To $1.04B,2018-05-02 07:05:00-04:00,JNJ,hc2 reports benevir biopharm to be purchased by j and js janssen biotech for up to dollars .04 billion,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998894929885864
696467,696467,707676.0,Attention Biotech Investors: Mark Your Calendar For These May PDUFA Action Dates,2018-05-01 15:39:00-04:00,JNJ,attention biotech investors mark your calendar for these may pdufa action dates,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998855590820312
696468,696468,707677.0,VIVUS Acquires PANCREAZE from Jannsen for $135M,2018-05-01 07:11:00-04:00,JNJ,vivus acquires pancreaze from jannsen for dollars 35 million,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997705817222595
696469,696469,707678.0,Johnson & Johnson Raises Qtr. Dividend From $0.84 To $0.90/Share,2018-04-26 10:27:00-04:00,JNJ,johnson and johnson raises qtr dividend from dollars .84 to dollars,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.998835027217865
696470,696470,707679.0,"Credit Suisse Maintains Outperform on Johnson & Johnson, Lowers Price Target to $151.00",2018-04-20 08:36:00-04:00,JNJ,credit suisse maintains outperform on johnson and johnson lowers price target to dollars 51.00,"{'neg': 0.093, 'neu': 0.745, 'pos': 0.161, 'compound': 0.2732}",positive,0.9996496438980103
696471,696471,707680.0,'An Incredible Signal': 4 Experts Weigh In On Positive FDA Panel Vote For GW Pharma's Epidiolex,2018-04-19 16:37:00-04:00,JNJ,an incredible signal 4 experts weigh in on positive fda panel vote for gw pharmas epidiolex,"{'neg': 0.0, 'neu': 0.806, 'pos': 0.194, 'compound': 0.5574}",positive,0.6905453205108643
696472,696472,707681.0,Big Bank Season Rolls On As Morgan Stanley Easily Beats Expectations,2018-04-18 10:08:00-04:00,JNJ,big bank season rolls on as morgan stanley easily beats expectations,"{'neg': 0.0, 'neu': 0.806, 'pos': 0.194, 'compound': 0.34}",positive,0.9995843768119812
696473,696473,707682.0,"Stifel Nicolaus Maintains Hold on Johnson & Johnson, Lowers Price Target to $135.00",2018-04-18 07:24:00-04:00,JNJ,stifel nicolaus maintains hold on johnson and johnson lowers price target to dollars 35.00,"{'neg': 0.103, 'neu': 0.897, 'pos': 0.0, 'compound': -0.128}",positive,0.9991173148155212
696474,696474,707683.0,"A Peek Into The Markets: US Stock Futures Surge, Goldman Sachs Earnings In Focus",2018-04-17 07:07:00-04:00,JNJ,a peek into the markets us stock futures surge goldman sachs earnings in focus,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9399322867393494
696475,696475,707684.0,"Johnson & Johnson Reaffirms FY 2018 Adj. EPS Guidance, Raises FY 2018 Sales Guidance From $80.6B-$81.4B to $81.0B-$81.8B vs $81.1B Est.",2018-04-17 06:42:00-04:00,JNJ,johnson and johnson reaffirms fy 2018 adj eps guidance raises fy 2018 sales guidance from dollars 0.6 billion dollars 1.4 billion to dollars 1.0 billion dollars 1.8 billion vs dollars 1.1 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996811151504517
696476,696476,707685.0,"Johnson & Johnson Reports Q1 Adj. EPS $2.06 Beats $2.01 Est., Sales $20.0B Beats $19.4B Est.",2018-04-17 06:41:00-04:00,JNJ,johnson and johnson reports first quarter adj eps dollars .06 beats dollars .01 est sales dollars 0.0 billion beats dollars 9.4 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998704195022583
696477,696477,707686.0,"12 Stocks To Watch For April 17, 2018",2018-04-17 04:35:00-04:00,JNJ,12 stocks to watch for april 17 2018,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998714923858643
696478,696478,707687.0,"Earnings Scheduled For April 17, 2018",2018-04-17 04:14:00-04:00,JNJ,earnings scheduled for april 17 2018,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998825788497925
696479,696479,707688.0,Bristol-Myers Announces Collaboration With Johnson & Johnson's Janssen to Develop and Commercialize Next-Gen Cardiovascular Therapy,2018-04-16 16:32:00-04:00,JNJ,bristol myers announces collaboration with johnson and johnsons janssen to develop and commercialize next gen cardiovascular therapy,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9966202974319458
696480,696480,707689.0,Upcoming Earnings: Johnson & Johnson And IBM Are Scheduled To Report This Week,2018-04-16 13:09:00-04:00,JNJ,upcoming earnings johnson and johnson and ibm are scheduled to report this week,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998819828033447
696481,696481,707690.0,"The Week Ahead: Netflix Earnings, Big Bank Results, FDA Actions Abound",2018-04-16 12:10:00-04:00,JNJ,the week ahead netflix earnings big bank results fda actions abound,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997428059577942
696482,696482,707691.0,"Earnings Parade Continues This Week After Missile Attacks, With Banks, Netflix On Way",2018-04-16 10:00:00-04:00,JNJ,earnings parade continues this week after missile attacks with banks netflix on way,"{'neg': 0.195, 'neu': 0.805, 'pos': 0.0, 'compound': -0.4404}",neutral,0.996756374835968
696483,696483,707692.0,Netflix Earnings Preview: International Subscriber Growth In Focus,2018-04-16 09:28:00-04:00,JNJ,netflix earnings preview international subscriber growth in focus,"{'neg': 0.0, 'neu': 0.729, 'pos': 0.271, 'compound': 0.3818}",positive,0.9993491768836975
696484,696484,707693.0,"Benzinga's Top Analyst Calls From April 13, 2018",2018-04-13 13:09:00-04:00,JNJ,benzingas top analyst calls from april 13 2018,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.2023}",neutral,0.9998855590820312
696485,696485,707694.0,"Next Week's Round Of Bank Earnings Includes Bank Of America, Goldman Sachs And Morgan Stanley",2018-04-13 13:06:00-04:00,JNJ,next weeks round of bank earnings includes bank of america goldman sachs and morgan stanley,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998846054077148
696486,696486,707695.0,"Chardan: Assembly Biosciences Hep B Antiviral Data 'Positive,' But Undifferentiated From Competitor Johnson & Johnson",2018-04-13 10:31:00-04:00,JNJ,chardan assembly biosciences hep b antiviral data positive but undifferentiated from competitor johnson and johnson,"{'neg': 0.0, 'neu': 0.859, 'pos': 0.141, 'compound': 0.3182}",positive,0.9901712536811829
696487,696487,707696.0,"Upcoming Earnings: Big Banks JP Morgan, Wells Fargo And Citigroup To Kick Off Q1 Season",2018-04-12 10:37:00-04:00,JNJ,upcoming earnings big banks jp morgan wells fargo and citigroup to kick off first quarter season,"{'neg': 0.0, 'neu': 0.787, 'pos': 0.213, 'compound': 0.4215}",neutral,0.998638927936554
696488,696488,707697.0,UPDATE: J&J's Janssen Says Canagliflozin Reduced Urinary Albumin To Creatinine Ratio,2018-04-12 08:08:00-04:00,JNJ,update j and js janssen says canagliflozin reduced urinary albumin to creatinine ratio,"{'neg': 0.0, 'neu': 0.896, 'pos': 0.104, 'compound': 0.1027}",positive,0.9990732669830322
696489,696489,707698.0,J&J's Janssen Pharma Says INVOKANA Showed Significant Renal Protective Benefits In Patients with Type-2 Diabetes,2018-04-12 08:08:00-04:00,JNJ,j and js janssen pharma says invokana showed significant renal protective benefits in patients with type 2 diabetes,"{'neg': 0.0, 'neu': 0.784, 'pos': 0.216, 'compound': 0.5267}",positive,0.9995875954627991
696490,696490,707699.0,"Courtroom Video Shows J&J, Imerys Subsidiary Ordered To Pay $80M In Punitive Damages In New Jersey Case Blaming Talc For Mesothelioma",2018-04-11 14:55:00-04:00,JNJ,courtroom video shows j and j imerys subsidiary ordered to pay dollars 0 million in punitive damages in new jersey case blaming talc for mesothelioma,"{'neg': 0.34, 'neu': 0.66, 'pos': 0.0, 'compound': -0.8689}",negative,0.9819430708885193
696491,696491,707700.0,FDA Cleared Acuvue Oasys Contact Lenses With Transitions Light Intelligent Tech To Johnson & Johnson,2018-04-10 13:11:00-04:00,JNJ,fda cleared acuvue oasys contact lenses with transitions light intelligent tech to johnson and johnson,"{'neg': 0.0, 'neu': 0.747, 'pos': 0.253, 'compound': 0.5267}",neutral,0.99395751953125
696492,696492,707701.0,"Morgan Stanley Maintains Equal-Weight on Johnson & Johnson, Lowers Price Target to $143.00",2018-04-10 10:35:00-04:00,JNJ,morgan stanley maintains equal weight on johnson and johnson lowers price target to dollars 43.00,"{'neg': 0.097, 'neu': 0.903, 'pos': 0.0, 'compound': -0.128}",positive,0.9994768500328064
696493,696493,707702.0,"Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week",2018-04-06 17:38:00-04:00,JNJ,pot stocks etfs top news and data from the cannabis industry this week,"{'neg': 0.0, 'neu': 0.87, 'pos': 0.13, 'compound': 0.2023}",neutral,0.9998798370361328
696494,696494,707703.0,DWS Quantifies Quality In A New ETF,2018-04-06 11:41:00-04:00,JNJ,dws quantifies quality in a new etf,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998624324798584
696495,696495,707704.0,"Smoking Is Just One Way To Use Marijuana: An Introduction To Vaporizers, Edibles, Oils, Tinctures, Dabs And Other Cannabis Products",2018-03-30 09:37:00-04:00,JNJ,smoking is just one way to use marijuana an introduction to vaporizers edibles oils tinctures dabs and other cannabis products,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998772144317627
696496,696496,707705.0,"ICYMI: GameStop, Omeros, Congress Impacts Biotechs",2018-03-23 06:56:00-04:00,JNJ,icymi gamestop omeros congress impacts biotechs,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998511075973511
696497,696497,707706.0,Biotech Winners And Losers From Congress' Latest Funding Bill,2018-03-22 11:46:00-04:00,JNJ,biotech winners and losers from congress latest funding bill,"{'neg': 0.252, 'neu': 0.519, 'pos': 0.23, 'compound': -0.0772}",neutral,0.9982481002807617
696498,696498,707707.0,Johnson & Johnson CFO Dominic Caruso to Retire,2018-03-20 16:15:00-04:00,JNJ,johnson and johnson cfo dominic caruso to retire,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9996849298477173
696499,696499,707708.0,Checking In On The Healthcare Sector Ahead Of Q1 Earnings Season,2018-03-20 11:29:00-04:00,JNJ,checking in on the healthcare sector ahead of first quarter earnings season,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998154044151306
696500,696500,707709.0,Johnson & Johnson Gets $2.1B Offer For LifeScan Diabetes Device Unit,2018-03-20 11:05:00-04:00,JNJ,johnson and johnson gets dollars .1 billion offer for lifescan diabetes device unit,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9040971994400024
696501,696501,707710.0,A Dividend Alternative To Broad Market Exposure,2018-03-20 09:38:00-04:00,JNJ,a dividend alternative to broad market exposure,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999887228012085
696502,696502,707711.0,Johnson & Johnson Receives Takeover Offer for its LifeScan Business to Platinum Equity for $2.1B,2018-03-16 07:32:00-04:00,JNJ,johnson and johnson receives takeover offer for its lifescan business to platinum equity for dollars .1 billion,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9977977275848389
696503,696503,707712.0,"J&J, Macleods in Talks for Licence Deal of Tuberculosis Drug Bedaquiline -Economic Times",2018-03-13 05:24:00-04:00,JNJ,j and j macleods in talks for licence deal of tuberculosis drug bedaquiline economic times,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9995439648628235
696504,696504,707713.0,Jannsen Announces INVOKANA Significantly Reduces Risk of Heart Failure-Related Outcomes in Type 2 Diabetes Patients at Risk for or With a History of Cardiovascular Disease,2018-03-11 17:10:00-04:00,JNJ,jannsen announces invokana significantly reduces risk of heart failure related outcomes in type 2 diabetes patients at risk for or with a history of cardiovascular disease,"{'neg': 0.223, 'neu': 0.653, 'pos': 0.125, 'compound': -0.3182}",positive,0.9994943141937256
696505,696505,707714.0,"Johnson & Johnson and Bayer Announce Judge's Order Sets 1,200 Xarelto Product Liability Lawsuits for Separate Jury Trials",2018-03-08 16:54:00-05:00,JNJ,johnson and johnson and bayer announce judges order sets 1200 xarelto product liability lawsuits for separate jury trials,"{'neg': 0.175, 'neu': 0.825, 'pos': 0.0, 'compound': -0.34}",neutral,0.9991101622581482
696506,696506,707715.0,Zosano Pharma Is The Latest Low Float Stock To Make A Huge Move,2018-03-08 15:43:00-05:00,JNJ,zosano pharma is the latest low float stock to make a huge move,"{'neg': 0.136, 'neu': 0.714, 'pos': 0.149, 'compound': 0.0516}",neutral,0.9775416851043701
696507,696507,707716.0,Height Casts 65% Odds That Congress Rolls Back Pharma Discounts,2018-03-07 11:31:00-05:00,JNJ,height casts 65 percent odds that congress rolls back pharma discounts,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9960726499557495
696508,696508,707717.0,Analyst: Insulet On Track For Profitability In 2018,2018-03-06 11:51:00-05:00,JNJ,analyst insulet on track for profitability in 2018,"{'neg': 0.0, 'neu': 0.769, 'pos': 0.231, 'compound': 0.2732}",positive,0.9916167855262756
696509,696509,707718.0,MedTech's Long-Term Prospects Outweigh Near-Term Risks,2018-03-01 10:55:00-05:00,JNJ,medtechs long term prospects outweigh near term risks,"{'neg': 0.204, 'neu': 0.583, 'pos': 0.214, 'compound': 0.0258}",positive,0.997768759727478
696510,696510,707719.0,"Jim Cramer Advises His Viewers On Johnson & Johnson, Nokia And More",2018-03-01 07:30:00-05:00,JNJ,jim cramer advises his viewers on johnson and johnson nokia and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998764991760254
696511,696511,707720.0,"Citigroup Maintains Neutral on Johnson & Johnson, Lowers Price Target to $146.00",2018-02-27 09:40:00-05:00,JNJ,citigroup maintains neutral on johnson and johnson lowers price target to dollars 46.00,"{'neg': 0.111, 'neu': 0.889, 'pos': 0.0, 'compound': -0.128}",positive,0.9984992742538452
696512,696512,707721.0,Aldeyra Therapeutics Announces Collaborative Agreement with Johnson & Johnson Innovation to Advance Novel Immune-Modulating Drugs for Systemic Inflammatory Diseases,2018-02-27 08:02:00-05:00,JNJ,aldeyra therapeutics announces collaborative agreement with johnson and johnson innovation to advance novel immune modulating drugs for systemic inflammatory diseases,"{'neg': 0.0, 'neu': 0.608, 'pos': 0.392, 'compound': 0.8519}",positive,0.9993676543235779
696513,696513,707722.0,Sierra Oncology and Janssen Sign Supply Agreement for Prostate Cancer Study,2018-02-27 07:42:00-05:00,JNJ,sierra oncology and janssen sign supply agreement for prostate cancer study,"{'neg': 0.265, 'neu': 0.542, 'pos': 0.193, 'compound': -0.296}",positive,0.9995144605636597
696514,696514,707723.0,PreMarket Prep Opening NYSE Imbalance Update: Bank Of America 379k Shares To Sell; Johnson & Johnson 25k Shares To Buy; General Electric 66k Shares To Sell; HPQ 49k Shares To Buy,2018-02-22 08:35:00-05:00,JNJ,premarket prep opening nyse imbalance update bank of america 379 thousand shares to sell johnson and johnson 25 thousand shares to buy general electric 66 thousand shares to sell hpq 49 thousand shares to buy,"{'neg': 0.0, 'neu': 0.779, 'pos': 0.221, 'compound': 0.7783}",neutral,0.9998652935028076
696515,696515,707724.0,Form 4 Filing Late Tuesday Showed Johnson & Johnson Chief Scientific Officer Paulus Stoffels Sold 155.342K Shares at $129.858,2018-02-21 11:03:00-05:00,JNJ,form 4 filing late tuesday showed johnson and johnson chief scientific officer paulus stoffels sold 155.342 thousand shares at dollars 29.858,"{'neg': 0.0, 'neu': 0.901, 'pos': 0.099, 'compound': 0.296}",neutral,0.999879002571106
696516,696516,707725.0,Quantifying Quality With An iShares ETF,2018-02-20 10:34:00-05:00,JNJ,quantifying quality with an ishares etf,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998781681060791
696517,696517,707726.0,J&J's Janssen Wins Health Canada Approval For New ZYTIGA Indication For Treatment Of Newly-Diagnosed Metastatic Prostate Cancer,2018-02-15 07:50:00-05:00,JNJ,j and js janssen wins health canada approval for new zytiga indication for treatment of newly diagnosed metastatic prostate cancer,"{'neg': 0.156, 'neu': 0.603, 'pos': 0.241, 'compound': 0.34}",positive,0.9995493292808533
696518,696518,707727.0,J&J Shares Unaffected As FDA Says Erleada By Co.'s Janssen Pharma Approved,2018-02-14 13:35:00-05:00,JNJ,j and j shares unaffected as fda says erleada by co s janssen pharma approved,"{'neg': 0.0, 'neu': 0.722, 'pos': 0.278, 'compound': 0.6124}",neutral,0.9496504664421082
696519,696519,707728.0,Cramer Looks At The Dow's Biggest Losers,2018-02-14 10:31:00-05:00,JNJ,cramer looks at the dows biggest losers,"{'neg': 0.362, 'neu': 0.638, 'pos': 0.0, 'compound': -0.5267}",negative,0.9795721173286438
696520,696520,707729.0,Janssen Submits Marketing Authorisation Application to EMA for Apalutamide to Treat Patients with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer,2018-02-09 04:23:00-05:00,JNJ,janssen submits marketing authorisation application to ema for apalutamide to treat patients with high risk non metastatic castration resistant prostate cancer,"{'neg': 0.239, 'neu': 0.662, 'pos': 0.099, 'compound': -0.5859}",neutral,0.9998605251312256
696521,696521,707730.0,19 Biotech Stocks With Clinical Trial Outcomes In February,2018-02-08 16:41:00-05:00,JNJ,19 biotech stocks with clinical trial outcomes in february,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998849630355835
696522,696522,707731.0,The Alzheimer's Drug Pipeline: High Failure Rates In Research On An Increasingly Common Disease,2018-02-08 09:41:00-05:00,JNJ,the alzheimers drug pipeline high failure rates in research on an increasingly common disease,"{'neg': 0.202, 'neu': 0.798, 'pos': 0.0, 'compound': -0.5106}",negative,0.9946730732917786
696523,696523,707732.0,Theravance Biopharma Reports Entered Global Collaboration With J&J's Janssen For TD-1473 In Inflammatory Intestinal Diseases,2018-02-07 07:38:00-05:00,JNJ,theravance biopharma reports entered global collaboration with j and js janssen for td 1473 in inflammatory intestinal diseases,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9991663694381714
696524,696524,707733.0,"J&J Shares Fall 3.5%, Quickly Rebound From Lows But Still Down ~2.5% For Session; Traders Circulate Mesothelioma.net Article 'Johnson & Johnson Mesothelioma Trial Likely to Expose Company Documents'",2018-02-05 11:50:00-05:00,JNJ,j and j shares fall 3.5 percent quickly rebound from lows but still down 2.5 percent for session traders circulate mesothelioma net article johnson and johnson mesothelioma trial likely to expose company documents,"{'neg': 0.095, 'neu': 0.86, 'pos': 0.046, 'compound': -0.1779}",negative,0.9984729886054993
696525,696525,707734.0,"Jim Cramer Weighs In On Johnson & Johnson, STMicroelectronics, And More",2018-02-01 07:43:00-05:00,JNJ,jim cramer weighs in on johnson and johnson stmicroelectronics and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998471736907959
696526,696526,707735.0,11 Dividend Growth Stocks To Watch In 2018,2018-01-29 13:23:00-05:00,JNJ,11 dividend growth stocks to watch in 2018,"{'neg': 0.0, 'neu': 0.729, 'pos': 0.271, 'compound': 0.3818}",neutral,0.9993438124656677
696527,696527,707736.0,"Protagonist Therapeutics 'Poised For Upside,' Stifel Says",2018-01-29 12:14:00-05:00,JNJ,protagonist therapeutics poised for upside stifel says,"{'neg': 0.0, 'neu': 0.75, 'pos': 0.25, 'compound': 0.25}",positive,0.9955461025238037
696528,696528,707737.0,"PFE, LLY, MRK Write Up 'Scripts For Q4",2018-01-29 10:52:00-05:00,JNJ,pfe lly mrk write up scripts for fourth quarter,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998632669448853
696529,696529,707738.0,Why GW Pharma's Epidiolex Results Could Shape The Future Of Cannabis-Based Therapeutics,2018-01-25 15:51:00-05:00,JNJ,why gw pharmas epidiolex results could shape the future of cannabis based therapeutics,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.6515154242515564
696530,696530,707739.0,"J&J No Longer Candidate For Purchase Of Pfizer's Consumer Unit; GlaxoSmithKline, Reckitt Benickser Working With Banks To Make A Bid",2018-01-25 09:34:00-05:00,JNJ,j and j no longer candidate for purchase of pfizers consumer unit glaxosmithkline reckitt benickser working with banks to make a bid,"{'neg': 0.095, 'neu': 0.905, 'pos': 0.0, 'compound': -0.296}",neutral,0.9996174573898315
696531,696531,707740.0,Mid-Afternoon Market Update: Crude Oil Up 1.4%; ResMed Shares Rise On Earnings Beat,2018-01-23 14:41:00-05:00,JNJ,mid afternoon market update crude oil up 1.4 percent resmed shares rise on earnings beat,"{'neg': 0.196, 'neu': 0.688, 'pos': 0.116, 'compound': -0.3612}",positive,0.9996925592422485
696532,696532,707741.0,Mid-Day Market Update: Netflix Climbs Following Q4 Results; Insmed Shares Plummet,2018-01-23 12:04:00-05:00,JNJ,mid day market update netflix climbs following fourth quarter results insmed shares plummet,"{'neg': 0.0, 'neu': 0.845, 'pos': 0.155, 'compound': 0.296}",positive,0.9995307922363281
696533,696533,707742.0,Biotech M&A Off To A Strong Start In 2018: More Deals To Follow?,2018-01-23 10:58:00-05:00,JNJ,biotech m and a off to a strong start in 2018 more deals to follow,"{'neg': 0.0, 'neu': 0.809, 'pos': 0.191, 'compound': 0.5106}",positive,0.999352753162384
696534,696534,707743.0,"J&J Shares Unaffected Amid Word US Appeals Court Invalidated Co. Patent On Remicade, Ruling Prevents Co. From Challenging Pfizer's '16 Launch Of Cheaper Version Of Remicade",2018-01-23 10:41:00-05:00,JNJ,j and j shares unaffected amid word us appeals court invalidated co patent on remicade ruling prevents co from challenging pfizers 16 launch of cheaper version of remicade,"{'neg': 0.0, 'neu': 0.831, 'pos': 0.169, 'compound': 0.4767}",negative,0.7854952216148376
696535,696535,707744.0,Mid-Morning Market Update: Markets Mixed; Johnson & Johnson Beats Q4 Views,2018-01-23 10:09:00-05:00,JNJ,mid morning market update markets mixed johnson and johnson beats fourth quarter views,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9861597418785095
696536,696536,707745.0,"Johnson & Johnson Shares Down 2.02%; Earlier Co. Reported Q4 Beat, Announced FY18 Guidance, Sees Adj. EPS $8-$8.20 vs $7.87 Est., Sales $80.6B-$81.4B vs $80.7B Est.",2018-01-23 10:08:00-05:00,JNJ,johnson and johnson shares down 2.02 percent earlier co reported fourth quarter beat announced fy18 guidance sees adj eps dollars dollars .20 vs dollars .87 est sales dollars 0.6 billion dollars 1.4 billion vs dollars 0.7 billion est,"{'neg': 0.0, 'neu': 0.944, 'pos': 0.056, 'compound': 0.296}",negative,0.998595654964447
696537,696537,707746.0,Johnson & Johnson On Conf. Call Says $12B Of Overseas Cash Will 'Come Back Immediately',2018-01-23 09:44:00-05:00,JNJ,johnson and johnson on conf call says dollars 2 billion of overseas cash will come back immediately,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998301267623901
696538,696538,707747.0,Benzinga Pro's 5 Stocks To Watch Today,2018-01-23 09:30:00-05:00,JNJ,benzinga pros 5 stocks to watch today,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998247027397156
696539,696539,707748.0,A Peek Into The Markets: U.S. Stock Futures Mostly Higher Ahead Of Earnings,2018-01-23 07:22:00-05:00,JNJ,a peek into the markets u s stock futures mostly higher ahead of earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996328353881836
696540,696540,707749.0,"Johnson & Johnson Reports Q4 Adj. EPS $1.74 vs $1.72 Est., Sales $20.20B vs $20.07B Est.",2018-01-23 06:48:00-05:00,JNJ,johnson and johnson reports fourth quarter adj eps dollars .74 vs dollars .72 est sales dollars 0.20 billion vs dollars 0.07 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998829364776611
696541,696541,707750.0,"Earnings Scheduled For January 23, 2018",2018-01-23 04:43:00-05:00,JNJ,earnings scheduled for january 23 2018,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998795986175537
696542,696542,707751.0,"10 Stocks To Watch For January 23, 2018",2018-01-23 04:38:00-05:00,JNJ,10 stocks to watch for january 23 2018,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.99985671043396
696543,696543,707752.0,A CURE For The Typical Healthcare Trade,2018-01-22 16:55:00-05:00,JNJ,a cure for the typical healthcare trade,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998216032981873
696544,696544,707753.0,"The Week Ahead: IPOs, Earnings, And FDA Actions Provide Catalysts",2018-01-22 15:35:00-05:00,JNJ,the week ahead ipos earnings and fda actions provide catalysts,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998177886009216
696545,696545,707754.0,Earnings Preview: Johnson & Johnson And Procter & Gamble Take The Stage Tomorrow Morning,2018-01-22 12:13:00-05:00,JNJ,earnings preview johnson and johnson and procter and gamble take the stage tomorrow morning,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998679161071777
696546,696546,707755.0,Upcoming Earnings: Verizon To Report Q4 Results Tomorrow Morning,2018-01-22 11:22:00-05:00,JNJ,upcoming earnings verizon to report fourth quarter results tomorrow morning,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998762607574463
696547,696547,707756.0,"Washington Shutdown Takes Center Stage, But Market Impact Only Slight So Far",2018-01-22 10:26:00-05:00,JNJ,washington shutdown takes center stage but market impact only slight so far,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.995561957359314
696548,696548,707757.0,Will Johnson & Johnson's Pharma Segment Pull Up Its Q4 Earnings?,2018-01-19 12:48:00-05:00,JNJ,will johnson and johnsons pharma segment pull up its fourth quarter earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996618032455444
696549,696549,707758.0,Upcoming Netflix Earnings: Subscriber Growth And Price Hikes In Focus,2018-01-19 11:16:00-05:00,JNJ,upcoming netflix earnings subscriber growth and price hikes in focus,"{'neg': 0.0, 'neu': 0.776, 'pos': 0.224, 'compound': 0.3818}",positive,0.9995505213737488
696550,696550,707759.0,"Intel, Johnson & Johnson, UPS: 'Fast Money' Picks For January 18",2018-01-18 07:15:00-05:00,JNJ,intel johnson and johnson ups fast money picks for january 18,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9992814660072327
696551,696551,707760.0,"BTG Says Previous Guidance on Zytiga Royalties Is Unchanged, Despite U.S. Administrative Court Decision to Invalidate Patent -Reuters",2018-01-18 04:45:00-05:00,JNJ,btg says previous guidance on zytiga royalties is unchanged despite u s administrative court decision to invalidate patent reuters,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9975554943084717
696552,696552,707761.0,UPDATE: J&J Says 'We believe the '438 patent is valid and will continue to vigorously defend it.',2018-01-17 17:06:00-05:00,JNJ,update j and j says we believe the 438 patent is valid and will continue to vigorously defend it,"{'neg': 0.0, 'neu': 0.923, 'pos': 0.077, 'compound': 0.128}",positive,0.5731833577156067
696553,696553,707762.0,J&J Issues Response Following ZYTIGA IPR: 'strongly disagree...are evaluating our options with respect to a request for rehearing and/or appeal.',2018-01-17 17:04:00-05:00,JNJ,j and j issues response following zytiga ipr strongly disagree are evaluating our options with respect to a request for rehearing and and or appeal,"{'neg': 0.087, 'neu': 0.738, 'pos': 0.174, 'compound': 0.3818}",neutral,0.9994072914123535
696554,696554,707763.0,UPDATE: Traders Attributing Move Lower In J&J Shares To News From Indonesian Source Suggesting Zytiga Received A Negative IPR Decision,2018-01-17 14:17:00-05:00,JNJ,update traders attributing move lower in j and j shares to news from indonesian source suggesting zytiga received a negative ipr decision,"{'neg': 0.218, 'neu': 0.701, 'pos': 0.081, 'compound': -0.5719}",negative,0.9985513091087341
696555,696555,707764.0,"J&J Shares Down ~$2 Over Last Min., Stock Down 0.6% For Session",2018-01-17 14:15:00-05:00,JNJ,j and j shares down dollars over last min stock down 0.6 percent for session,"{'neg': 0.0, 'neu': 0.864, 'pos': 0.136, 'compound': 0.296}",negative,0.9972123503684998
696556,696556,707765.0,"Earnings Preview: IBM to Report on Thursday, Strategic Imperatives in Focus",2018-01-17 13:12:00-05:00,JNJ,earnings preview ibm to report on thursday strategic imperatives in focus,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998667240142822
696557,696557,707766.0,Chinese Bidders Looking at JNJ Diabetes Business in Deal that Could be Valued at $4B -Reuters,2018-01-17 06:04:00-05:00,JNJ,chinese bidders looking at jnj diabetes business in deal that could be valued at dollars b reuters,"{'neg': 0.0, 'neu': 0.847, 'pos': 0.153, 'compound': 0.4404}",neutral,0.9994256496429443
696558,696558,707767.0,Dow Earnings: Analysts Expect Goldman Sachs Revenue Decline,2018-01-16 12:30:00-05:00,JNJ,dow earnings analysts expect goldman sachs revenue decline,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9982374906539917
696559,696559,707768.0,"Upcoming Earnings: Bank Of America, Goldman Sachs And Morgan Stanley To Report This Week",2018-01-16 11:26:00-05:00,JNJ,upcoming earnings bank of america goldman sachs and morgan stanley to report this week,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998766183853149
696560,696560,707769.0,Putting On The Brakes: Rally Takes Breather As Bond Yields Hit 10-Month High,2018-01-10 11:13:00-05:00,JNJ,putting on the brakes rally takes breather as bond yields hit 10 month high,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9976654052734375
696561,696561,707770.0,4 Tailwinds Driving Raymond James' Insulet Bull Case,2018-01-08 12:22:00-05:00,JNJ,4 tailwinds driving raymond james insulet bull case,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998302459716797
696562,696562,707771.0,The 'Bomb Cyclone' Portfolio: Winners And Losers,2018-01-05 11:58:00-05:00,JNJ,the bomb cyclone portfolio winners and losers,"{'neg': 0.482, 'neu': 0.292, 'pos': 0.226, 'compound': -0.5423}",neutral,0.9998233914375305
696563,696563,707772.0,"Benzinga's Top Upgrades, Downgrades For January 2, 2018",2018-01-02 09:29:00-05:00,JNJ,benzingas top upgrades downgrades for january 2 2018,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.2023}",positive,0.6884947419166565
696564,696564,707773.0,"The Market In 5 Minutes: Oil's Strong Open, Cohen's Comeback, And A Look Back At 2017's Best And Worst Stocks",2018-01-02 09:00:00-05:00,JNJ,the market in 5 minutes oils strong open cohens comeback and a look back at 2017 best and worst stocks,"{'neg': 0.143, 'neu': 0.594, 'pos': 0.262, 'compound': 0.5267}",positive,0.9994595646858215
696565,696565,707774.0,"Syros Announces Clinical Supply Agreement with Janssen to Evaluate SY-1425, Its First-in-Class Selective RARα Agonist",2018-01-02 08:18:00-05:00,JNJ,syros announces clinical supply agreement with janssen to evaluate sy 1425 its first in class selective rarα agonist,"{'neg': 0.0, 'neu': 0.842, 'pos': 0.158, 'compound': 0.4939}",positive,0.9985535740852356
696566,696566,707775.0,JP Morgan Downgrades Johnson & Johnson to Neutral,2018-01-02 06:19:00-05:00,JNJ,jp morgan downgrades johnson and johnson to neutral,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.2023}",negative,0.9982855916023254
696567,696567,707776.0,The Companies That Led 2017's Biotech Rally,2017-12-22 09:50:00-05:00,JNJ,the companies that led 2017 biotech rally,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998306035995483
696568,696568,707777.0,Vetr Upgrades Johnson & Johnson As The Stock Tests Resistance,2017-12-22 07:32:00-05:00,JNJ,vetr upgrades johnson and johnson as the stock tests resistance,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998062252998352
696569,696569,707778.0,J&J's Janssen Says J&J Reaffirmed FY17 Adj. EPS Outlook Of $7.25-$7.30 vs $7.28 Est.,2017-12-21 17:31:00-05:00,JNJ,j and js janssen says j and j reaffirmed fy17 adj eps outlook of dollars .25 dollars .30 vs dollars .28 est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9988452196121216
696570,696570,707779.0,"J&J's Janssen Reports Global Collaboration, License Deal With Units Of Genscript, Will Make Upfront Payment Of $350M",2017-12-21 17:31:00-05:00,JNJ,j and js janssen reports global collaboration license deal with units of genscript will make upfront payment of dollars 50 million,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9481337070465088
696571,696571,707780.0,"Earlier Chicago Tribune Report Detailed 5 Illinois Counties Suing Drug Cos. Over Opioid Abuses; Shares Of Cos. Mentioned Seem Largely Unaffected: TEVA +5.3%, ABT -0.33%, JNJ +0.03%, ENDP +0.12%",2017-12-21 14:42:00-05:00,JNJ,earlier chicago tribune report detailed 5 illinois counties suing drug cos over opioid abuses shares of cos mentioned seem largely unaffected teva positive 5.3 percent abt negative 0.33 percent jnj positive 0.03 percent endp positive 0.12 percent,"{'neg': 0.179, 'neu': 0.573, 'pos': 0.248, 'compound': 0.5574}",positive,0.9982265830039978
696572,696572,707781.0,"FDA Grants Priority Review For Johnson & Johnson's Janssen NDA For Apalutamide, PDUFA Target Date April 2018",2017-12-21 09:11:00-05:00,JNJ,fda grants priority review for johnson and johnsons janssen nda for apalutamide pdufa target date april 2018,"{'neg': 0.0, 'neu': 0.894, 'pos': 0.106, 'compound': 0.2263}",positive,0.9967139959335327
696573,696573,707782.0,3 Biotech Pipeline Areas To Keep An Eye On In 2018,2017-12-20 12:37:00-05:00,JNJ,3 biotech pipeline areas to keep an eye on in 2018,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998400211334229
696574,696574,707783.0,"ASH 2017 Highlights: Gilead, Novartis, Juno, Bluebird Bio And More",2017-12-13 12:31:00-05:00,JNJ,ash 2017 highlights gilead novartis juno bluebird bio and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998846054077148
696575,696575,707784.0,A Trendy New ETF From Pacer,2017-12-13 10:10:00-05:00,JNJ,a trendy new etf from pacer,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997584223747253
696576,696576,707785.0,3 Stocks In Focus As Biotech M&A Hopes For 2018 Rise,2017-12-11 12:52:00-05:00,JNJ,3 stocks in focus as biotech m and a hopes for 2018 rise,"{'neg': 0.0, 'neu': 0.811, 'pos': 0.189, 'compound': 0.4215}",positive,0.9995785355567932
696577,696577,707786.0,"Bayer, Johnson & Johnson Reportedly Ordered By Philadelphia Jury To Pay $29M In Xarelto Lawsuit",2017-12-05 12:53:00-05:00,JNJ,bayer johnson and johnson reportedly ordered by philadelphia jury to pay dollars 9 million in xarelto lawsuit,"{'neg': 0.18, 'neu': 0.82, 'pos': 0.0, 'compound': -0.3182}",neutral,0.9995985627174377
696578,696578,707787.0,"REMINDER: Tuesday Is Estimated FDA PDUFA Date For: Johnson & Johnson for Rilpivirine and In Partnership with GlaxoSmithKline For Dolutegravir, and Novo Nordisk for Semaglutide",2017-12-04 15:49:00-05:00,JNJ,reminder tuesday is estimated fda pdufa date for johnson and johnson for rilpivirine and in partnership with glaxosmithkline for dolutegravir and novo nordisk for semaglutide,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998893737792969
696579,696579,707788.0,Eli Lilly's Taltz Gets Approval For Label Expansion in US,2017-12-04 12:39:00-05:00,JNJ,eli lillys taltz gets approval for label expansion in us,"{'neg': 0.0, 'neu': 0.744, 'pos': 0.256, 'compound': 0.4767}",positive,0.9986622333526611
696580,696580,707789.0,"The Week Ahead For December 4: The Biggest Catalysts, Conferences, And Investor Events",2017-12-04 11:23:00-05:00,JNJ,the week ahead for december 4 the biggest catalysts conferences and investor events,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998888969421387
696581,696581,707790.0,GlaxoSmithKline Begins Phase III Study On Injection To Prevent HIV,2017-12-01 12:38:00-05:00,JNJ,glaxosmithkline begins phase iii study on injection to prevent hiv,"{'neg': 0.0, 'neu': 0.891, 'pos': 0.109, 'compound': 0.0258}",neutral,0.9998716115951538
696582,696582,707791.0,"Missouri Judge Upholds $110 Million Talc Verdict Awarded To Virgina Women Who Claims Decades Of Daily Use Of Johnson & Johnson's Talcum Powder Caused Her OVarian Cancer, Jurisdiction Established By New Evidence In Ovarian Cancer Claim",2017-11-30 10:47:00-05:00,JNJ,missouri judge upholds dollars 10 million talc verdict awarded to virgina women who claims decades of daily use of johnson and johnsons talcum powder caused her ovarian cancer jurisdiction established by new evidence in ovarian cancer claim,"{'neg': 0.191, 'neu': 0.716, 'pos': 0.093, 'compound': -0.7579}",positive,0.9976850748062134
696583,696583,707792.0,A Lazarus Act For This Pharma ETF,2017-11-29 17:03:00-05:00,JNJ,a lazarus act for this pharma etf,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998757839202881
696584,696584,707793.0,"Endpoint News Co-Founder John Carroll Tweets: J&J spokesperson says Telegraph story about axing JLABS in UK is ""completely unfounded"" asking for a retraction. 
$JNJ",2017-11-28 10:45:00-05:00,JNJ,endpoint news co founder john carroll tweets j and j spokesperson says telegraph story about axing jlabs in uk is completely unfounded asking for a retraction jnj,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.8605430722236633
696585,696585,707794.0,Stocks Going Ex Dividend The Fifth Week Of November,2017-11-22 11:41:00-05:00,JNJ,stocks going ex dividend the fifth week of november,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998877048492432
696586,696586,707795.0,J&J's Janssen Submits FDA Application For Expansion Of Indication For DARZALEX Combo Therapy For Patients With Newly-Diagnosed Multiple Myeloma Who Are Transplant Ineligible,2017-11-21 11:40:00-05:00,JNJ,j and js janssen submits fda application for expansion of indication for darzalex combo therapy for patients with newly diagnosed multiple myeloma who are transplant ineligible,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9895078539848328
696587,696587,707796.0,Johnson & Johnson's Janssen Gets European Commission Approval to Broaden Marketing Authorization for Zytiga,2017-11-20 08:38:00-05:00,JNJ,johnson and johnsons janssen gets european commission approval to broaden marketing authorization for zytiga,"{'neg': 0.0, 'neu': 0.807, 'pos': 0.193, 'compound': 0.4767}",positive,0.9994286894798279
696588,696588,707797.0,"PR Confirms Earlier Johnson & Johnson Legal Headline, Federal Jury Returns $247 Million Verdict in Defective Hip Implants Case; DePuy Orthopaedics Found Liable For Metal-on-Metal Implant Failures",2017-11-16 14:25:00-05:00,JNJ,pr confirms earlier johnson and johnson legal headline federal jury returns dollars 47 million verdict in defective hip implants case depuy orthopaedics found liable for metal on metal implant failures,"{'neg': 0.169, 'neu': 0.743, 'pos': 0.089, 'compound': -0.5859}",positive,0.9843740463256836
696589,696589,707798.0,Johnson & Johnson Wins Trial In Lawsuit Claiming Asbestos In Talc Products Caused Cancer,2017-11-16 13:28:00-05:00,JNJ,johnson and johnson wins trial in lawsuit claiming asbestos in talc products caused cancer,"{'neg': 0.3, 'neu': 0.524, 'pos': 0.176, 'compound': -0.3818}",positive,0.9700703620910645
696590,696590,707799.0,Watching J&J Shares Amid Report Jury Has Returned $247M Verdict Against Co. Unit Depuy Related To Defective Hip Implant Suit,2017-11-16 12:57:00-05:00,JNJ,watching j and j shares amid report jury has returned dollars 47 million verdict against co unit depuy related to defective hip implant suit,"{'neg': 0.105, 'neu': 0.758, 'pos': 0.137, 'compound': -0.0258}",positive,0.9981842637062073
696591,696591,707800.0,Pharma ETFs Down Post Q3 Earnings,2017-11-09 12:34:00-05:00,JNJ,pharma etfs down post third quarter earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.997852087020874
696592,696592,707801.0,J&J's Janssen R&D Reports STELARA Showed Positive Results In Treatment Of Systemic Lupus Erythematosus In Phase 2 Trial,2017-11-06 08:16:00-05:00,JNJ,j and js janssen r and d reports stelara showed positive results in treatment of systemic lupus erythematosus in phase 2 trial,"{'neg': 0.0, 'neu': 0.854, 'pos': 0.146, 'compound': 0.5574}",positive,0.9996410608291626
696593,696593,707802.0,A Dividend ETF For November And Beyond,2017-11-04 13:07:00-04:00,JNJ,a dividend etf for november and beyond,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998860359191895
696594,696594,707803.0,UPDATE: Halozyme Will Receive $15M Milestone Payment From J&J's Janssen Following Dosing Of 3rd Patient In Phase 3 Trial,2017-10-31 08:40:00-04:00,JNJ,update halozyme will receive dollars 5 million milestone payment from j and js janssen following dosing of 3 patient in phase 3 trial,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9699267148971558
696595,696595,707804.0,How Surgeons Are Responding To TransEnterix's Senhance Following FDA Approval,2017-10-30 10:40:00-04:00,JNJ,how surgeons are responding to transenterixs senhance following fda approval,"{'neg': 0.0, 'neu': 0.744, 'pos': 0.256, 'compound': 0.4767}",neutral,0.9998243451118469
696596,696596,707805.0,Johnson & Johnson's Janssen Gets FDA Approval for the 10MG Dose of Xarelto,2017-10-30 08:15:00-04:00,JNJ,johnson and johnsons janssen gets fda approval for the 10 million g dose of xarelto,"{'neg': 0.0, 'neu': 0.819, 'pos': 0.181, 'compound': 0.4767}",positive,0.9982313513755798
696597,696597,707806.0,Janssen Reports Imbruvica As First Approved Treatment For Chronic Graft-Versus-Host Disease Granted By Health Canada Priority Review,2017-10-30 07:34:00-04:00,JNJ,janssen reports imbruvica as first approved treatment for chronic graft versus host disease granted by health canada priority review,"{'neg': 0.0, 'neu': 0.78, 'pos': 0.22, 'compound': 0.5859}",positive,0.9024039506912231
696598,696598,707807.0,REMINDER: Johnson & Johnson Has PDUFA Date Expected For XARELTO Oct. 28,2017-10-27 17:00:00-04:00,JNJ,reminder johnson and johnson has pdufa date expected for xarelto oct 28,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998672008514404
696599,696599,707808.0,Vetr Upgrades Johnson & Johnson Following Post-Earnings Dip,2017-10-25 16:59:00-04:00,JNJ,vetr upgrades johnson and johnson following post earnings dip,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9926843047142029
696600,696600,707809.0,J&J's Janssen Reports Darunavir-Based Single Tablet Regimen Showed Effective Viral Suppression In HIV-1 Patients,2017-10-25 07:59:00-04:00,JNJ,j and js janssen reports darunavir based single tablet regimen showed effective viral suppression in hiv 1 patients,"{'neg': 0.0, 'neu': 0.846, 'pos': 0.154, 'compound': 0.4767}",positive,0.9976785778999329
696601,696601,707810.0,This Week's Most And Least Crowded Trades,2017-10-24 09:01:00-04:00,JNJ,this weeks most and least crowded trades,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999786913394928
696602,696602,707811.0,5 Biggest Price Target Changes For Monday,2017-10-23 09:50:00-04:00,JNJ,5 biggest price target changes for monday,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998231530189514
696603,696603,707812.0,The Week Ahead: Earnings Season Starts In Earnest,2017-10-23 09:00:00-04:00,JNJ,the week ahead earnings season starts in earnest,"{'neg': 0.0, 'neu': 0.68, 'pos': 0.32, 'compound': 0.5106}",neutral,0.9998811483383179
696604,696604,707813.0,This Factor ETF Could Be Ready To Shine,2017-10-23 08:22:00-04:00,JNJ,this factor etf could be ready to shine,"{'neg': 0.0, 'neu': 0.737, 'pos': 0.263, 'compound': 0.3612}",neutral,0.9760931730270386
696605,696605,707814.0,"J&J's Janssen Reports Received 2 FDA Approvals For SIMPONI ARIA For Treatment Of Adults with Active Psoriatic Arthritis, Active Ankylosing Spondyilitis",2017-10-20 16:25:00-04:00,JNJ,j and js janssen reports received 2 fda approvals for simponi aria for treatment of adults with active psoriatic arthritis active ankylosing spondyilitis,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.6597}",positive,0.9993491768836975
696606,696606,707815.0,White House 'Shenanigans' Represent A Buying Opportunity: Cramer,2017-10-19 12:02:00-04:00,JNJ,white house shenanigans represent a buying opportunity cramer,"{'neg': 0.0, 'neu': 0.714, 'pos': 0.286, 'compound': 0.4215}",positive,0.9988969564437866
696607,696607,707816.0,"Johnson & Johnson to Acquire Software Company Surgical Process Institute, Terms Not Disclosed",2017-10-19 06:09:00-04:00,JNJ,johnson and johnson to acquire software company surgical process institute terms not disclosed,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998774528503418
696608,696608,707817.0,Benzinga's Option Alert Recap From October 18,2017-10-18 17:01:00-04:00,JNJ,benzingas option alert recap from october 18,"{'neg': 0.0, 'neu': 0.732, 'pos': 0.268, 'compound': 0.296}",neutral,0.9998751878738403
696609,696609,707818.0,Cramer Breaks Down 3 Cheap Stocks That Crushed Earnings,2017-10-18 11:16:00-04:00,JNJ,cramer breaks down 3 cheap stocks that crushed earnings,"{'neg': 0.259, 'neu': 0.741, 'pos': 0.0, 'compound': -0.4215}",negative,0.9977523684501648
696610,696610,707819.0,5 Biggest Price Target Changes For Wednesday,2017-10-18 10:11:00-04:00,JNJ,5 biggest price target changes for wednesday,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998182654380798
696611,696611,707820.0,"J&J Option Alert: Jan, 2019 $140 Puts Sweep (27) at the Bid: 658 @ $9.504 vs 301 OI; Ref=$140.23",2017-10-18 10:10:00-04:00,JNJ,j and j option alert jan 2019 dollars 40 puts sweep 27 at the bid 658 dollars .504 vs 301 oi ref equals dollars 40.23,"{'neg': 0.0, 'neu': 0.916, 'pos': 0.084, 'compound': 0.296}",neutral,0.9998736381530762
696612,696612,707821.0,"Pre-Market Imbalance Update: IBM 219K Shares To Buy, Alibaba 133K To Buy, Coca-Cola 131K To Sell, Twitter 88K To Sell, Square 79K To Buy, AT&T 73K To Buy, Pfizer 71K To Sell, Ford 67K To Sell, J&J 55K To Sell",2017-10-18 09:06:00-04:00,JNJ,pre market imbalance update ibm 219 thousand shares to buy alibaba 133 thousand to buy coca cola 131 thousand to sell twitter 88 thousand to sell square 79 thousand to buy at and t 73 thousand to buy pfizer 71 thousand to sell ford 67 thousand to sell j and j 55 thousand to sell,"{'neg': 0.0, 'neu': 0.961, 'pos': 0.039, 'compound': 0.296}",neutral,0.9998747110366821
696613,696613,707822.0,Johnson & Johnson Makes New All-Time High By A Wide Margin,2017-10-17 15:15:00-04:00,JNJ,johnson and johnson makes new all time high by a wide margin,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9995452761650085
696614,696614,707823.0,Hearing Court Papers Show Missouri Appeals Court Has Overturned $72M Verdict Against J&J Related To Talc Case,2017-10-17 12:43:00-04:00,JNJ,hearing court papers show missouri appeals court has overturned dollars 2 million verdict against j and j related to talc case,"{'neg': 0.0, 'neu': 0.926, 'pos': 0.074, 'compound': 0.1531}",positive,0.9933405518531799
696615,696615,707824.0,"Can The Dow Pass Another Milestone? Financials Feed Frenzy, But Might It Be Enough?",2017-10-17 10:52:00-04:00,JNJ,can the dow pass another milestone financials feed frenzy but might it be enough,"{'neg': 0.113, 'neu': 0.887, 'pos': 0.0, 'compound': -0.1655}",positive,0.9849895238876343
696616,696616,707825.0,A Peek Into The Markets: U.S. Stock Futures Flat; Goldman Sachs Earnings In Focus,2017-10-17 07:20:00-04:00,JNJ,a peek into the markets u s stock futures flat goldman sachs earnings in focus,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998675584793091
696617,696617,707826.0,Johnson & Johnson Discontinues its Study of Talacotuzumab in Patients with Acute Myeloid Leukemia,2017-10-17 06:48:00-04:00,JNJ,johnson and johnson discontinues its study of talacotuzumab in patients with acute myeloid leukemia,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997732043266296
696618,696618,707827.0,Johnson & Johnson Says it Will Not Pursue Approvals of Sirukumab for Rheumatoid Arhritis,2017-10-17 06:43:00-04:00,JNJ,johnson and johnson says it will not pursue approvals of sirukumab for rheumatoid arhritis,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997370839118958
696619,696619,707828.0,"Johnson & Johnson Sees FY 2017 EPS $7.25-$7.30 from $7.12-$7.22, Sales $76.1B-$76.5B from $75.8B-$76.1B",2017-10-17 06:42:00-04:00,JNJ,johnson and johnson sees fy 2017 eps dollars .25 dollars .30 from dollars .12 dollars .22 sales dollars 6.1 billion dollars 6.5 billion from dollars 5.8 billion dollars 6.1 billion,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998793601989746
696620,696620,707829.0,Johnson & Johnson Raises Guidance,2017-10-17 06:41:00-04:00,JNJ,johnson and johnson raises guidance,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9478335976600647
696621,696621,707830.0,"Johnson & Johnson Q3 EPS $1.90 vs $1.80 Est., Sales $19.7B vs $19.3B Est.",2017-10-17 06:40:00-04:00,JNJ,johnson and johnson third quarter eps dollars .90 vs dollars .80 est sales dollars 9.7 billion vs dollars 9.3 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998835325241089
696622,696622,707831.0,"10 Stocks To Watch For October 17, 2017",2017-10-17 04:30:00-04:00,JNJ,10 stocks to watch for october 17 2017,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998576641082764
696623,696623,707832.0,"Earnings Scheduled For October 17, 2017",2017-10-17 04:06:00-04:00,JNJ,earnings scheduled for october 17 2017,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998795986175537
696624,696624,707833.0,10 Most/Least Crowded Trades Of Week Ended Oct. 13,2017-10-16 15:53:00-04:00,JNJ,10 most and least crowded trades of week ended oct 13,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999839186668396
696625,696625,707834.0,Cerveau Technologies Reports Research Collaboration With Janssen Pharmaceuticals For Use Of [F-18]MK-6240,2017-10-16 14:52:00-04:00,JNJ,cerveau technologies reports research collaboration with janssen pharmaceuticals for use of f 18 million k 6240,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998923540115356
696626,696626,707835.0,"The Week Ahead: Earnings, Earnings, And More Earnings",2017-10-16 10:49:00-04:00,JNJ,the week ahead earnings earnings and more earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.5104078054428101
696627,696627,707836.0,5 Biggest Price Target Changes For Monday,2017-10-16 09:49:00-04:00,JNJ,5 biggest price target changes for monday,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998231530189514
696628,696628,707837.0,"Pharma Stock Roundup: Pfizer Mulls Options For Consumer Healthcare, Eli Lilly's Pipeline Setback",2017-10-13 12:19:00-04:00,JNJ,pharma stock roundup pfizer mulls options for consumer healthcare eli lillys pipeline setback,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.678903341293335
696629,696629,707838.0,"REMINDER: Johnson & Johnson Has PDUFA Date For Stelara Over the Weekend, Oct. 15th",2017-10-13 11:35:00-04:00,JNJ,reminder johnson and johnson has pdufa date for stelara over the weekend oct 15,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998759031295776
696630,696630,707839.0,JNJ And IBM Report Q3 Earnings Early Next Week: What Might Be In Store?,2017-10-13 11:19:00-04:00,JNJ,jnj and ibm report third quarter earnings early next week what might be in store,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998393058776855
696631,696631,707840.0,Janssen-Cilag Intl. CHMP Issues Positive Opinion On Zytiga To Include Earlier Stage Prostate Patients,2017-10-13 07:52:00-04:00,JNJ,janssen cilag intl chmp issues positive opinion on zytiga to include earlier stage prostate patients,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.5574}",positive,0.9994233846664429
696632,696632,707841.0,"Pre-Market Imbalance Update: Verizon 60K Shares To Sell, J&J 42K To Sell",2017-10-12 09:05:00-04:00,JNJ,pre market imbalance update verizon 60 thousand shares to sell j and j 42 thousand to sell,"{'neg': 0.0, 'neu': 0.879, 'pos': 0.121, 'compound': 0.296}",neutral,0.9998759031295776
696633,696633,707842.0,"10 Of The Most Crowded Trades, And 10 Of The Least Crowded",2017-10-11 16:26:00-04:00,JNJ,10 of the most crowded trades and 10 of the least crowded,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9995676875114441
696634,696634,707843.0,Why Jefferies Upgraded Johnson & Johnson,2017-10-11 15:47:00-04:00,JNJ,why jefferies upgraded johnson and johnson,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998646974563599
696635,696635,707844.0,J&J's Janssen Earlier Reported Submission Of NDA For ARN-509 To Treat Men With Non-Metastatic Castration-Resistant Prostate Cancer,2017-10-11 09:13:00-04:00,JNJ,j and js janssen earlier reported submission of nda for arn 509 to treat men with non metastatic castration resistant prostate cancer,"{'neg': 0.162, 'neu': 0.738, 'pos': 0.1, 'compound': -0.4019}",neutral,0.9998552799224854
696636,696636,707845.0,"Benzinga's Top Upgrades, Downgrades For October 11, 2017",2017-10-11 09:13:00-04:00,JNJ,benzingas top upgrades downgrades for october 11 2017,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.2023}",positive,0.9304929375648499
696637,696637,707846.0,"The Market In 5 Minutes: Alibaba's Expansion, Uber's Warning",2017-10-11 08:31:00-04:00,JNJ,the market in 5 minutes alibabas expansion ubers warning,"{'neg': 0.231, 'neu': 0.769, 'pos': 0.0, 'compound': -0.34}",neutral,0.9080075621604919
696638,696638,707847.0,A Peek Into The Markets: U.S. Stock Futures Edge Lower Ahead Of Fed Minutes,2017-10-11 07:23:00-04:00,JNJ,a peek into the markets u s stock futures edge lower ahead of fed minutes,"{'neg': 0.136, 'neu': 0.864, 'pos': 0.0, 'compound': -0.296}",negative,0.9958226680755615
696639,696639,707848.0,Jefferies Upgrades Johnson & Johnson to Buy,2017-10-11 06:13:00-04:00,JNJ,jefferies upgrades johnson and johnson to buy,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9560168385505676
696640,696640,707849.0,Jefferies Upgrades J&J to Buy from Hold; Raises PT to $157 from $145,2017-10-11 04:31:00-04:00,JNJ,jefferies upgrades j and j to buy from hold raises point to dollars 57 from dollars 45,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9990826845169067
696641,696641,707850.0,"Benzinga's Top Upgrades, Downgrades For October 9, 2017",2017-10-09 09:15:00-04:00,JNJ,benzingas top upgrades downgrades for october 9 2017,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.2023}",positive,0.9275921583175659
696642,696642,707851.0,Wells Fargo Upgrades Johnson & Johnson to Outperform,2017-10-09 08:51:00-04:00,JNJ,wells fargo upgrades johnson and johnson to outperform,"{'neg': 0.0, 'neu': 0.778, 'pos': 0.222, 'compound': 0.25}",positive,0.9996544122695923
696643,696643,707852.0,Heaps Of Healthy Health Care ETFs,2017-10-06 10:02:00-04:00,JNJ,heaps of healthy health care etfs,"{'neg': 0.0, 'neu': 0.404, 'pos': 0.596, 'compound': 0.7096}",neutral,0.9998825788497925
696644,696644,707853.0,"J&J Diabetes Care Cos., Animas, Announces Intention To Discontinue Manufacturing, Sale Of Vibe, OneTouch Ping Insulin Pumps, Close Operations, Exit Insulin Pump Business",2017-10-05 07:12:00-04:00,JNJ,j and j diabetes care cos animas announces intention to discontinue manufacturing sale of vibe onetouch ping insulin pumps close operations exit insulin pump business,"{'neg': 0.0, 'neu': 0.882, 'pos': 0.118, 'compound': 0.4939}",neutral,0.9936034083366394
696645,696645,707854.0,Morgan Stanley Catches Flack For Colgate-Palmolive Upgrade,2017-10-02 14:49:00-04:00,JNJ,morgan stanley catches flack for colgate palmolive upgrade,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9108181595802307
696646,696646,707855.0,J&J's Janssen Reports Submission Of sNDA Seeking New Indication For INVOKANA To Reduce Risk Of Major Adverse Cardiovascular Events Based On Landmark CANVAS Program,2017-10-02 08:21:00-04:00,JNJ,j and js janssen reports submission of snda seeking new indication for invokana to reduce risk of major adverse cardiovascular events based on landmark canvas program,"{'neg': 0.168, 'neu': 0.788, 'pos': 0.045, 'compound': -0.5563}",positive,0.9968664050102234
696647,696647,707856.0,Janssen Submits sNDA To FDA Seeking New Indication For INVOKANA To Reduce Risk Of Major Adverse Cardiovascular Events Based On Landmark Canvas Programs,2017-10-02 08:17:00-04:00,JNJ,janssen submits snda to fda seeking new indication for invokana to reduce risk of major adverse cardiovascular events based on landmark canvas programs,"{'neg': 0.187, 'neu': 0.764, 'pos': 0.05, 'compound': -0.5563}",positive,0.7183983325958252
696648,696648,707857.0,"Attention Biotech Investors, Here's Your PDUFA Primer For October",2017-09-28 10:51:00-04:00,JNJ,attention biotech investors heres your pdufa primer for october,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998764991760254
696649,696649,707858.0,"A.I. Summit in San Francisco Concludes Today, Attendees Include Morgan Stanley, Johnson & Johnson, Bank of America, IBM, Nvidia, Microsoft, Amazon and Footlocker",2017-09-28 08:37:00-04:00,JNJ,a i summit in san francisco concludes today attendees include morgan stanley johnson and johnson bank of america ibm nvidia microsoft amazon and footlocker,"{'neg': 0.0, 'neu': 0.931, 'pos': 0.069, 'compound': 0.1779}",neutral,0.9998847246170044
696650,696650,707859.0,"Jim Cramer Weighs In On Johnson & Johnson, Ford And More",2017-09-28 08:24:00-04:00,JNJ,jim cramer weighs in on johnson and johnson ford and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998433589935303
696651,696651,707860.0,FTC Says It Requires Divestiture Of 5 Medical Device Product Lines As Condition Of Integra Acquiring Johnson & Johnson's Codman Neuro Division,2017-09-27 11:08:00-04:00,JNJ,ftc says it requires divestiture of 5 medical device product lines as condition of integra acquiring johnson and johnsons codman neuro division,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998624324798584
696652,696652,707861.0,"Bloomberg Earlier Reported Apple, Samsung, Roche Holding Will Participate In FDA Pilot Program For Digital Health Software",2017-09-26 14:10:00-04:00,JNJ,bloomberg earlier reported apple samsung roche holding will participate in fda pilot program for digital health software,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998716115951538
696653,696653,707862.0,Cramer's Guide To Profit From Market Rotations,2017-09-23 08:56:00-04:00,JNJ,cramers guide to profit from market rotations,"{'neg': 0.0, 'neu': 0.674, 'pos': 0.326, 'compound': 0.4404}",neutral,0.9998117089271545
696654,696654,707863.0,A Venerable Vanguard Dividend ETF,2017-09-21 09:08:00-04:00,JNJ,a venerable vanguard dividend etf,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998658895492554
696655,696655,707864.0,Johnson & Johnson Downgraded On Hefty Valuation Compared To Peers,2017-09-20 11:49:00-04:00,JNJ,johnson and johnson downgraded on hefty valuation compared to peers,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9987333416938782
696656,696656,707865.0,Goldman Sachs Downgrades Johnson & Johnson to Sell,2017-09-20 08:59:00-04:00,JNJ,goldman sachs downgrades johnson and johnson to sell,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9978846907615662
696657,696657,707866.0,Johnson & Johnson Shares Down 1.64% Premarket,2017-09-20 08:29:00-04:00,JNJ,johnson and johnson shares down 1.64 percent premarket,"{'neg': 0.0, 'neu': 0.761, 'pos': 0.239, 'compound': 0.296}",negative,0.9974892139434814
696658,696658,707867.0,"UPDATE: NY AG Schneiderman Served Subpoenas To Endo Int'l, J&J's Janssen Pharma, Teva, Allergan",2017-09-19 12:35:00-04:00,JNJ,update ny ag schneiderman served subpoenas to endo intl j and js janssen pharma teva allergan,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997932314872742
696659,696659,707868.0,Janssen's Guselkumab Drug for the Treatment of Plaque Psoriasis Recommended by the EU Medicines Agency for Approval,2017-09-15 07:41:00-04:00,JNJ,janssens guselkumab drug for the treatment of plaque psoriasis recommended by the eu medicines agency for approval,"{'neg': 0.0, 'neu': 0.754, 'pos': 0.246, 'compound': 0.5994}",neutral,0.9998562335968018
696660,696660,707869.0,Johnson & Johnson's Janssen Announces Submission of sNDA To FDA For Zytiga,2017-09-14 16:10:00-04:00,JNJ,johnson and johnsons janssen announces submission of snda to fda for zytiga,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998576641082764
696661,696661,707870.0,A Hidden Gem Among Dividend ETFs,2017-09-12 08:42:00-04:00,JNJ,a hidden gem among dividend etfs,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998389482498169
696662,696662,707871.0,"Wall Street's M&A Chatter From September 11: Western Digital-Toshiba, Pilgrim's Pride-Moy Park, Gigamon And More",2017-09-12 07:52:00-04:00,JNJ,wall streets m and a chatter from september 11 western digital toshiba pilgrims pride moy park gigamon and more,"{'neg': 0.0, 'neu': 0.882, 'pos': 0.118, 'compound': 0.34}",neutral,0.9998642206192017
696663,696663,707872.0,Your Easy Guide To Credit Suisse's New Top Stocks List,2017-09-11 09:21:00-04:00,JNJ,your easy guide to credit suisses new top stocks list,"{'neg': 0.0, 'neu': 0.49, 'pos': 0.51, 'compound': 0.743}",neutral,0.9998321533203125
696664,696664,707873.0,Janssen Terminates Worldwide Collaboration for Hepatitis C With Achillion Pharmaceuticals,2017-09-11 04:00:00-04:00,JNJ,janssen terminates worldwide collaboration for hepatitis c with achillion pharmaceuticals,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998487234115601
696665,696665,707874.0,What Pharmaceuticals Spend On Lobbying To Influence Trump,2017-09-09 16:28:00-04:00,JNJ,what pharmaceuticals spend on lobbying to influence trump,"{'neg': 0.157, 'neu': 0.843, 'pos': 0.0, 'compound': -0.0772}",neutral,0.9998573064804077
696666,696666,707875.0,"New Mexico Said To Be Suing Johnson & Johnson, Endo, Teva, Allergan & Others Over Their Role In Opioid Drug Epidemic",2017-09-07 15:05:00-04:00,JNJ,new mexico said to be suing johnson and johnson endo teva allergan and others over their role in opioid drug epidemic,"{'neg': 0.095, 'neu': 0.905, 'pos': 0.0, 'compound': -0.2732}",neutral,0.9996342658996582
696667,696667,707876.0,"This Drug, An Alternative To Marijuana And Ketamine, Could Treat Suicidal Depression And PTSD",2017-09-07 13:02:00-04:00,JNJ,this drug an alternative to marijuana and ketamine could treat suicidal depression and points d,"{'neg': 0.358, 'neu': 0.524, 'pos': 0.118, 'compound': -0.7579}",neutral,0.7644619345664978
696668,696668,707877.0,Attention Biotech Investors: September Ushers In Another Slew Of PDUFA Catalysts,2017-09-01 14:03:00-04:00,JNJ,attention biotech investors september ushers in another slew of pdufa catalysts,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998843669891357
696669,696669,707878.0,"MacroGenics Reports Termination Of Duvortuxizumab Collab., License Deal With J&J's Janssen",2017-08-31 16:30:00-04:00,JNJ,macrogenics reports termination of duvortuxizumab collab license deal with j and js janssen,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9925054907798767
696670,696670,707879.0,Johnson & Johnson Management Meetings Leave UBS Reiterating Stock As A Top Pick,2017-08-31 12:28:00-04:00,JNJ,johnson and johnson management meetings leave ubs reiterating stock as a top pick,"{'neg': 0.086, 'neu': 0.786, 'pos': 0.129, 'compound': 0.1531}",positive,0.8344811797142029
696671,696671,707880.0,Protagonist Therapeutics Announces Receipt Of $50M Upfront Payment From JNJ's Jansse License Deal For PTG-200,2017-08-24 16:02:00-04:00,JNJ,protagonist therapeutics announces receipt of dollars 0 million upfront payment from jnjs jansse license deal for point g 200,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9961512684822083
696672,696672,707881.0,"Playing The US Pharma Space: Buy Portola, Hold Corvus, Sell Teva",2017-08-24 13:46:00-04:00,JNJ,playing the us pharma space buy portola hold corvus sell teva,"{'neg': 0.0, 'neu': 0.847, 'pos': 0.153, 'compound': 0.2023}",neutral,0.9998722076416016
696673,696673,707882.0,"Explaining A 'Crowded Trade,' And The Top 10 Cramped Plays Right Now",2017-08-23 15:19:00-04:00,JNJ,explaining a crowded trade and the top 10 cramped plays right now,"{'neg': 0.0, 'neu': 0.725, 'pos': 0.275, 'compound': 0.4215}",neutral,0.9995633959770203
696674,696674,707883.0,"Pre-Market Imbalance Update: Sprint 223K Shares To Buy, Square 139K To Buy, GE 90K To Buy, Snap 54K To Buy, Coca-Cola 53K Shares To Sell, Alibaba 53K To Buy, J&J 49K To Sell",2017-08-22 08:56:00-04:00,JNJ,pre market imbalance update sprint 223 thousand shares to buy square 139 thousand to buy ge 90 thousand to buy snap 54 thousand to buy coca cola 53 thousand shares to sell alibaba 53 thousand to buy j and j 49 thousand to sell,"{'neg': 0.0, 'neu': 0.905, 'pos': 0.095, 'compound': 0.5267}",neutral,0.9998499155044556
696675,696675,707884.0,Jury Awards Woman $417 Million On Allegation Johnson & Johnson Talcum Powder Gave Her Cancer,2017-08-22 08:40:00-04:00,JNJ,jury awards woman dollars 17 million on allegation johnson and johnson talcum powder gave her cancer,"{'neg': 0.206, 'neu': 0.654, 'pos': 0.14, 'compound': -0.34}",neutral,0.9985154271125793
696676,696676,707885.0,"Premarket Prep Host Dennis Dick Tweets: Notable opening imbalances: $SNAP +354K, $GE -262K, $PFE -122K, $JNJ -92K, $BABA +81K",2017-08-21 09:25:00-04:00,JNJ,premarket prep host dennis dick tweets notable opening imbalances snap positive 354 thousand ge negative 262 thousand pfe negative 122 thousand jnj negative 92 thousand baba positive 81 thousand,"{'neg': 0.323, 'neu': 0.516, 'pos': 0.161, 'compound': -0.802}",negative,0.9590502381324768
696677,696677,707886.0,"Meg Tirrell Tweets: $JNJ says president's more recent comments ""changed our decision to participate in the White House Manufacturing Advisory Council""",2017-08-16 13:33:00-04:00,JNJ,meg tirrell tweets jnj says presidents more recent comments changed our decision to participate in the white house manufacturing advisory council,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9981008172035217
696678,696678,707887.0,Genmab CEO Says It's Moving Forward 'Aggressively' Together With Janssen On Subcutaneous Formulation Of daratumumab,2017-08-09 14:05:00-04:00,JNJ,genmab ceo says its moving forward aggressively together with janssen on subcutaneous formulation of daratumumab,"{'neg': 0.141, 'neu': 0.859, 'pos': 0.0, 'compound': -0.3182}",positive,0.904768168926239
696679,696679,707888.0,"Every Generation Has Its Drug: How People Are Dealing With Opioids, The New (Old) Thing",2017-08-07 11:55:00-04:00,JNJ,every generation has its drug how people are dealing with opioids the new old thing,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998564720153809
696680,696680,707889.0,"Wall Street's M&A Chatter From August 4-7: Acadia Pharma, United Technologies-Rockwell Collins, United Therapeutics",2017-08-07 07:19:00-04:00,JNJ,wall streets m and a chatter from august 4 to 7 acadia pharma united technologies rockwell collins united therapeutics,"{'neg': 0.0, 'neu': 0.752, 'pos': 0.248, 'compound': 0.6808}",neutral,0.9998724460601807
696681,696681,707890.0,Hearing FDA Panel Has Said Safety Profile Of J&J's Sirukumab Not Adequate To Support Approval,2017-08-02 14:59:00-04:00,JNJ,hearing fda panel has said safety profile of j and js sirukumab not adequate to support approval,"{'neg': 0.172, 'neu': 0.57, 'pos': 0.258, 'compound': 0.4545}",negative,0.9882198572158813
696682,696682,707891.0,Key FDA Events To Watch Out For In August 2017,2017-08-01 12:39:00-04:00,JNJ,key fda events to watch out for in august 2017,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998775720596313
696683,696683,707892.0,August PDUFA Dates: Biotech Investors Stay Tuned To A Month Of Plenty,2017-08-01 09:20:00-04:00,JNJ,august pdufa dates biotech investors stay tuned to a month of plenty,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999876856803894
696684,696684,707893.0,Johnson & Johnson Granted Orphan Drug Desiganation for Bedaquiline,2017-07-31 08:17:00-04:00,JNJ,johnson and johnson granted orphan drug desiganation for bedaquiline,"{'neg': 0.0, 'neu': 0.8, 'pos': 0.2, 'compound': 0.25}",positive,0.9359923005104065
696685,696685,707894.0,"On, Wisconsin: University Wins Half Billion In iPhone Patent Suit, Another Sign Schools Are Research Cash Cows",2017-07-27 16:11:00-04:00,JNJ,on wisconsin university wins half billion in iphone patent suit another sign schools are research cash cows,"{'neg': 0.0, 'neu': 0.812, 'pos': 0.188, 'compound': 0.5719}",positive,0.9993064403533936
696686,696686,707895.0,"Samsung, Amazon — Everyone Is Getting Into Pharmaceuticals",2017-07-27 08:36:00-04:00,JNJ,samsung amazon — everyone is getting into pharmaceuticals,"{'neg': 0.0, 'neu': 0.805, 'pos': 0.195, 'compound': 0.1779}",neutral,0.999887228012085
696687,696687,707896.0,"Wall Street's M&A Chatter From July 26: Biomarin, Sigma Designs, Colgate-Palmolive, Markel-State National",2017-07-27 07:24:00-04:00,JNJ,wall streets m and a chatter from july 26 biomarin sigma designs colgate palmolive markel state national,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998863935470581
696688,696688,707897.0,"Meet Avicanna, The First Marijuana Company To Be Accepted Into Johnson & Johnson Innovation, JLABS @ Toronto",2017-07-25 12:29:00-04:00,JNJ,meet avicanna the first marijuana company to be accepted into johnson and johnson innovation jlabs toronto,"{'neg': 0.0, 'neu': 0.749, 'pos': 0.251, 'compound': 0.5719}",neutral,0.9998679161071777
696689,696689,707898.0,4 Benefits ETF Investing May Add To Your Portfolio,2017-07-25 11:48:00-04:00,JNJ,4 benefits etf investing may add to your portfolio,"{'neg': 0.0, 'neu': 0.755, 'pos': 0.245, 'compound': 0.3818}",positive,0.977460503578186
696690,696690,707899.0,2 Ways To Trade This Week's Healthcare Earnings,2017-07-24 11:51:00-04:00,JNJ,2 ways to trade this weeks healthcare earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998635053634644
696691,696691,707900.0,JNJ Announces Encouraging First-In-Human Clinical Data For Investigational HIV Preventive Vaccine,2017-07-24 04:08:00-04:00,JNJ,jnj announces encouraging first in human clinical data for investigational hiv preventive vaccine,"{'neg': 0.0, 'neu': 0.779, 'pos': 0.221, 'compound': 0.5267}",positive,0.999542236328125
696692,696692,707901.0,"6 Months In, Trump Has Filled Only 27 Out Of More Than 200 Envoy Posts, Mostly With Cronies",2017-07-22 16:27:00-04:00,JNJ,6 months in trump has filled only 27 out of more than 200 envoy posts mostly with cronies,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998873472213745
696693,696693,707902.0,"Dow 30 Earnings Score Card From The Past Week: IBM, Visa, Goldman And More",2017-07-22 16:09:00-04:00,JNJ,dow 30 earnings score card from the past week ibm visa goldman and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9991186261177063
696694,696694,707903.0,Johnson & Johnson Shares Might Break Lower Before They Break Out,2017-07-21 09:53:00-04:00,JNJ,johnson and johnson shares might break lower before they break out,"{'neg': 0.164, 'neu': 0.672, 'pos': 0.164, 'compound': 0.0}",negative,0.995046854019165
696695,696695,707904.0,Atlantic Equities Downgrades Johnson & Johnson to Underweight,2017-07-21 08:26:00-04:00,JNJ,atlantic equities downgrades johnson and johnson to underweight,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9982275366783142
696696,696696,707905.0,BTIG Research Downgrades Johnson & Johnson to Sell,2017-07-21 07:43:00-04:00,JNJ,btig research downgrades johnson and johnson to sell,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9979686141014099
696697,696697,707906.0,"Johnson & Johnson Shares Strong Since Actelion Acquisition, But Potential For Upside Remains",2017-07-20 11:40:00-04:00,JNJ,johnson and johnson shares strong since actelion acquisition but potential for upside remains,"{'neg': 0.0, 'neu': 0.746, 'pos': 0.254, 'compound': 0.4118}",positive,0.999619722366333
696698,696698,707907.0,The Market In 5 Minutes,2017-07-20 09:05:00-04:00,JNJ,the market in 5 minutes,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998767375946045
696699,696699,707908.0,"Credit Suisse Reinstates Outperform on Johnson & Johnson, Announces $148.00 Price Target",2017-07-20 07:52:00-04:00,JNJ,credit suisse reinstates outperform on johnson and johnson announces dollars 48.00 price target,"{'neg': 0.0, 'neu': 0.822, 'pos': 0.178, 'compound': 0.3818}",positive,0.9996718168258667
696700,696700,707909.0,Caution Still The Watchword But Stocks Hit Record Highs As Earnings Mostly Strong,2017-07-19 10:08:00-04:00,JNJ,caution still the watchword but stocks hit record highs as earnings mostly strong,"{'neg': 0.0, 'neu': 0.729, 'pos': 0.271, 'compound': 0.6652}",positive,0.9996908903121948
696701,696701,707910.0,Finding A Way: Banks Beat Expectations Despite Struggles As Earnings Go Into High Gear,2017-07-18 10:51:00-04:00,JNJ,finding a way banks beat expectations despite struggles as earnings go into high gear,"{'neg': 0.0, 'neu': 0.86, 'pos': 0.14, 'compound': 0.2755}",positive,0.9994820952415466
696702,696702,707911.0,A Peek Into The Markets: U.S. Stock Futures Mostly Flat Ahead Of Goldman Sachs Earnings,2017-07-18 07:19:00-04:00,JNJ,a peek into the markets u s stock futures mostly flat ahead of goldman sachs earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.5860200524330139
696703,696703,707912.0,"Johnson & Johnson Sees FY 2017 EPS $7.12-$7.22 from $7.00-$7.15 vs $7.10 Est., See Sales $75.8B-$76.1B from $75.4B-$76.1B vs $75.7B Est.",2017-07-18 06:44:00-04:00,JNJ,johnson and johnson sees fy 2017 eps dollars .12 dollars .22 from dollars .00 dollars .15 vs dollars .10 est see sales dollars 5.8 billion dollars 6.1 billion from dollars 5.4 billion dollars 6.1 billion vs dollars 5.7 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998733997344971
696704,696704,707913.0,Johnson & Johnson Raises FY 2017 Guidance,2017-07-18 06:42:00-04:00,JNJ,johnson and johnson raises fy 2017 guidance,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9748738408088684
696705,696705,707914.0,"Johnson & Johnson Q2 EPS $1.83 vs $1.80 Est, Sales $18.84B vs $18.95B Est",2017-07-18 06:41:00-04:00,JNJ,johnson and johnson second quarter eps dollars .83 vs dollars .80 est sales dollars 8.84 billion vs dollars 8.95 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999883770942688
696706,696706,707915.0,"10 Stocks To Watch For July 18, 2017",2017-07-18 05:19:00-04:00,JNJ,10 stocks to watch for july 18 2017,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998440742492676
696707,696707,707916.0,"Earnings Scheduled For July 18, 2017",2017-07-18 04:29:00-04:00,JNJ,earnings scheduled for july 18 2017,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998810291290283
696708,696708,707917.0,"Earnings Roundup: JNJ, IBM, And LMT Report Q2 Results Tomorrow",2017-07-17 14:59:00-04:00,JNJ,earnings roundup jnj ibm and lmt report second quarter results tomorrow,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998823404312134
696709,696709,707918.0,"Earnings Preview: Financial Giants BAC, GS, And MS Report Q2 Results This Week",2017-07-17 14:42:00-04:00,JNJ,earnings preview financial giants bac gs and ms report second quarter results this week,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998843669891357
696710,696710,707919.0,4 Sell-Ranked Drug Stocks To Avoid Ahead Of Q2 Earnings,2017-07-17 14:21:00-04:00,JNJ,4 sell ranked drug stocks to avoid ahead of second quarter earnings,"{'neg': 0.167, 'neu': 0.833, 'pos': 0.0, 'compound': -0.296}",negative,0.9844008088111877
696711,696711,707920.0,FDA's 60-Day Extension For Medical Device Defects Not Likely Obstructive To Public Health,2017-07-14 08:26:00-04:00,JNJ,fdas 60 day extension for medical device defects not likely obstructive to public health,"{'neg': 0.172, 'neu': 0.828, 'pos': 0.0, 'compound': -0.4019}",neutral,0.9710434079170227
696712,696712,707921.0,J&J Announces FDA Approval For Janssen's Plaque Psoriasis Treatment TREMFYA,2017-07-13 16:13:00-04:00,JNJ,j and j announces fda approval for janssens plaque psoriasis treatment tremfya,"{'neg': 0.0, 'neu': 0.78, 'pos': 0.22, 'compound': 0.4767}",positive,0.9910784363746643
696713,696713,707922.0,J&J To Commence Pharma Q2 Earnings Season: What's Up?,2017-07-12 14:44:00-04:00,JNJ,j and j to commence pharma second quarter earnings season whats up,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9971500039100647
696714,696714,707923.0,The Royalty-Amassing Strategy Of Royalty Pharma,2017-07-10 16:11:00-04:00,JNJ,the royalty amassing strategy of royalty pharma,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998934268951416
696715,696715,707924.0,The Japanese Government's Pension Fund Made A Cool $70 Billion Last Year,2017-07-08 08:58:00-04:00,JNJ,the japanese governments pension fund made a cool dollars 0 billion last year,"{'neg': 0.0, 'neu': 0.839, 'pos': 0.161, 'compound': 0.3182}",positive,0.9964185953140259
696716,696716,707925.0,Focusing On An Alternative To S&P 500 ETFs,2017-07-06 09:19:00-04:00,JNJ,focusing on an alternative to SP500 500 etfs,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998857975006104
696717,696717,707926.0,"Pre-Market Imbalance Update: Sprint 84K Shares To Buy, GE 80K Shares To Sell, Twitter 41K To Sell, Coca-Cola 37K To Sell, P&G 35K To Buy, Citi 28K To Buy, BofA 26K To Buy, Wells Fargo 25K To Buy, J&J 22K To Sell",2017-07-06 09:17:00-04:00,JNJ,pre market imbalance update sprint 84 thousand shares to buy ge 80 thousand shares to sell twitter 41 thousand to sell coca cola 37 thousand to sell p and g 35 thousand to buy citi 28 thousand to buy bofa 26 thousand to buy wells fargo 25 thousand to buy j and j 22 thousand to sell,"{'neg': 0.0, 'neu': 0.894, 'pos': 0.106, 'compound': 0.6597}",neutral,0.9998677968978882
696718,696718,707927.0,5 Biggest Price Target Changes For Wednesday,2017-07-05 10:19:00-04:00,JNJ,5 biggest price target changes for wednesday,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998182654380798
696719,696719,707929.0,Janssen Says FDA Accepted For Priority Review A SNDA For Xarelto,2017-06-28 08:34:00-04:00,JNJ,janssen says fda accepted for priority review a snda for xarelto,"{'neg': 0.0, 'neu': 0.826, 'pos': 0.174, 'compound': 0.2732}",neutral,0.999681830406189
696720,696720,707930.0,Attention To Details: Neos' ADHD Portfolio,2017-06-26 09:05:00-04:00,JNJ,attention to details neos adhd portfolio,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998905658721924
696721,696721,707931.0,A New ETF For Low Vol ETFs,2017-06-23 12:11:00-04:00,JNJ,a new etf for low volume etfs,"{'neg': 0.259, 'neu': 0.741, 'pos': 0.0, 'compound': -0.2732}",neutral,0.9998738765716553
696722,696722,707932.0,"Benzinga PMP Host Dennis Dick Tweets: A few large imbalances this morning: $GE +825K, $JNJ -157K, $F -118K, $BAC +110K, $WFC +66K, $JPM +61K",2017-06-23 09:19:00-04:00,JNJ,benzinga pmp host dennis dick tweets a few large imbalances this morning ge positive 825 thousand jnj negative 157 thousand f negative 118 thousand bac positive 110 thousand wfc positive 66 thousand jpm positive 61 thousand,"{'neg': 0.198, 'neu': 0.536, 'pos': 0.266, 'compound': 0.5719}",negative,0.9677390456199646
696723,696723,707936.0,"If Colgate's Looking To Sell Itself, Would Berkshire Be Looking To Buy?",2017-06-22 15:38:00-04:00,JNJ,if colgates looking to sell itself would berkshire be looking to buy,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998273253440857
696724,696724,707937.0,"Wall Street's M&A Chatter From June 21: Staples-Sycamore Partners, Diageo-Casamigos, Bristol-Myers, Acadia Pharma",2017-06-22 07:06:00-04:00,JNJ,wall streets m and a chatter from june 21 staples sycamore partners diageo casamigos bristol myers acadia pharma,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998824596405029
696725,696725,707940.0,Non-Horrible Bosses: Meet The Best CEOs Of 2017,2017-06-21 07:06:00-04:00,JNJ,non horrible bosses meet the best ceos of 2017,"{'neg': 0.238, 'neu': 0.476, 'pos': 0.286, 'compound': 0.1779}",neutral,0.9987956285476685
696726,696726,707943.0,"FDA Reports Approval Of J&J's Janssen's Darzalex In Combo With Pomalidomide, Dexamethasone For Patients With Multiple Myeloma",2017-06-16 14:17:00-04:00,JNJ,fda reports approval of j and js janssens darzalex in combo with pomalidomide dexamethasone for patients with multiple myeloma,"{'neg': 0.0, 'neu': 0.853, 'pos': 0.147, 'compound': 0.4767}",positive,0.9975989460945129
696727,696727,707945.0,JNJ Completes Acquisition of Actelion,2017-06-16 04:27:00-04:00,JNJ,jnj completes acquisition of actelion,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9994606375694275
696728,696728,707946.0,"Johnson & Johnson's Janssen Present Phase 3 Data On Sirukumab, Says Long-Term Efficacy Is 'Encouraging'",2017-06-14 11:29:00-04:00,JNJ,johnson and johnsons janssen present phase 3 data on sirukumab says long term efficacy is encouraging,"{'neg': 0.0, 'neu': 0.815, 'pos': 0.185, 'compound': 0.5267}",positive,0.9995249509811401
696729,696729,707947.0,Cramer: 3M's Stock Quietly Hit All-Time Highs Thanks To Weak US Dollar,2017-06-14 09:58:00-04:00,JNJ,cramer 3 million s stock quietly hit all time highs thanks to weak us dollar,"{'neg': 0.154, 'neu': 0.691, 'pos': 0.154, 'compound': 0.0}",positive,0.9953658580780029
696730,696730,707949.0,UPDATE: Tesaro Says Janssen Anticipates Re-opening Enrollment for Galahad Trial Soon -8-K,2017-06-12 06:13:00-04:00,JNJ,update tesaro says janssen anticipates re opening enrollment for galahad trial soon negative 8 k,"{'neg': 0.209, 'neu': 0.791, 'pos': 0.0, 'compound': -0.5719}",neutral,0.9998506307601929
696731,696731,707950.0,"Tesaro Says on June Janssen Updated Clinicaltrials.gov Website to Reflect Janssen had Placed Temporary Enrollment Hold in  Galahad Trial; Says Galahad Trial Not on Clinical Hold, Temporary Enrollment Hold Not Due to Safety Concerns",2017-06-12 06:12:00-04:00,JNJ,tesaro says on june janssen updated clinicaltrials gov website to reflect janssen had placed temporary enrollment hold in galahad trial says galahad trial not on clinical hold temporary enrollment hold not due to safety concerns,"{'neg': 0.064, 'neu': 0.936, 'pos': 0.0, 'compound': -0.3252}",neutral,0.5248050093650818
696732,696732,707951.0,Janssen and TESARO GALAHAD Trial Puts Patient Enrollment on Temporary Hold,2017-06-12 06:12:00-04:00,JNJ,janssen and tesaro galahad trial puts patient enrollment on temporary hold,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.7508442997932434
696733,696733,707952.0,"Johnson & Johnson, Tesaro Niraparib Trial Enrollment Suspension Not Related To Safety",2017-06-09 12:18:00-04:00,JNJ,johnson and johnson tesaro niraparib trial enrollment suspension not related to safety,"{'neg': 0.175, 'neu': 0.825, 'pos': 0.0, 'compound': -0.3252}",neutral,0.8314947485923767
696734,696734,707953.0,Tesaro Volatile After Johnson & Johnson Suspends Enrollment In Prostate Cancer Trial,2017-06-09 12:10:00-04:00,JNJ,tesaro volatile after johnson and johnson suspends enrollment in prostate cancer trial,"{'neg': 0.286, 'neu': 0.714, 'pos': 0.0, 'compound': -0.6597}",negative,0.8991158604621887
696735,696735,707954.0,"JNJ Spokesperson Says, 'Our team put a temporarily hold on enrollment so we could assess the enrolled currently patients against the protocol criteria.  We need to make sure we don't over-enroll some patient types and under-enroll others.'",2017-06-09 12:01:00-04:00,JNJ,jnj spokesperson says our team put a temporarily hold on enrollment so we could assess the enrolled currently patients against the protocol criteria we need to make sure we dont over enroll some patient types and under enroll others,"{'neg': 0.0, 'neu': 0.943, 'pos': 0.057, 'compound': 0.3182}",neutral,0.996260404586792
696736,696736,707955.0,"Johnson & Johnson Spokesperson Tells Benzinga TESARO's Niraparib Study Enrollment Is, 'on temporary hold and we anticipate re-opening enrollment soon.  The hold is not related to safety.'",2017-06-09 11:59:00-04:00,JNJ,johnson and johnson spokesperson tells benzinga tesaros niraparib study enrollment is on temporary hold and we anticipate re opening enrollment soon the hold is not related to safety,"{'neg': 0.08, 'neu': 0.92, 'pos': 0.0, 'compound': -0.3252}",neutral,0.9994599223136902
696737,696737,707956.0,Johnson & Johnson Acquisition of Actelion is Approved by the EU,2017-06-09 07:32:00-04:00,JNJ,johnson and johnson acquisition of actelion is approved by the eu,"{'neg': 0.0, 'neu': 0.781, 'pos': 0.219, 'compound': 0.4215}",neutral,0.9998745918273926
696738,696738,707958.0,"Barron's Picks And Pans: AT&T, Express Scripts, Accenture And More",2017-06-04 18:27:00-04:00,JNJ,barrons picks and pans at and t express scripts accenture and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998780488967896
696739,696739,707959.0,Trial Results Show Johnson & Johnson's Zytiga Lowers Death Risk by 38% in Newly Diagnosed Advanced Prostate Cancer #ASCO2017,2017-06-03 11:42:00-04:00,JNJ,trial results show johnson and johnsons zytiga lowers death risk by 38 percent in newly diagnosed advanced prostate cancer,"{'neg': 0.427, 'neu': 0.502, 'pos': 0.072, 'compound': -0.872}",positive,0.9994542002677917
696740,696740,707960.0,States Are Firing Back At Opioid Drug Producers,2017-06-01 10:48:00-04:00,JNJ,states are firing back at opioid drug producers,"{'neg': 0.255, 'neu': 0.745, 'pos': 0.0, 'compound': -0.34}",negative,0.9427716732025146
696741,696741,707961.0,"Shares Of Johnons & Johnson, Teva Pharma, Endo Int'l, And Allergan All Higher Today Despite News State Of Ohio Has Sued These Companies For Alleged Role In Opioid Epidemic",2017-05-31 12:59:00-04:00,JNJ,shares of johnons and johnson teva pharma endo intl and allergan all higher today despite news state of ohio has sued these companies for alleged role in opioid epidemic,"{'neg': 0.0, 'neu': 0.927, 'pos': 0.073, 'compound': 0.296}",neutral,0.49476367235183716
696742,696742,707962.0,Protagonist Therapeutics Spikes to High of $14.85 Following Announcement of Worldwide Agreement with Janssen,2017-05-30 09:34:00-04:00,JNJ,protagonist therapeutics spikes to high of dollars 4.85 following announcement of worldwide agreement with janssen,"{'neg': 0.0, 'neu': 0.814, 'pos': 0.186, 'compound': 0.4939}",positive,0.9970701932907104
696743,696743,707963.0,Tracking The Busy June PDUFA Calendar,2017-05-30 08:58:00-04:00,JNJ,tracking the busy june pdufa calendar,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998844861984253
696744,696744,707964.0,"Protagonist Therapeutics Enters into Worldwide Agreement with Janssen to Co-Develop and Commercialize PTG-200, Protagonist to Gets $50M Upfront Payment",2017-05-30 07:03:00-04:00,JNJ,protagonist therapeutics enters into worldwide agreement with janssen to co develop and commercialize point g 200 protagonist to gets dollars 0 million upfront payment,"{'neg': 0.0, 'neu': 0.878, 'pos': 0.122, 'compound': 0.4939}",positive,0.995677649974823
696745,696745,707965.0,"3 Most Likely Suitors For Colgate-Palmolive, In Jefferies' View",2017-05-18 11:21:00-04:00,JNJ,3 most likely suitors for colgate palmolive in jefferies view,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998636245727539
696746,696746,707966.0,"Pre-Market Imbalance Update: GE 179K Shares to Sell, Twitter 167K to Sell, General Mills 114K to Sell, J&J 47K to Sell, Morgan Stanley 36K to Sell",2017-05-17 09:17:00-04:00,JNJ,pre market imbalance update ge 179 thousand shares to sell twitter 167 thousand to sell general mills 114 thousand to sell j and j 47 thousand to sell morgan stanley 36 thousand to sell,"{'neg': 0.0, 'neu': 0.937, 'pos': 0.062, 'compound': 0.296}",neutral,0.9998782873153687
696747,696747,707967.0,Johnson & Johnson Holding Pharmaceutical Business Review Today,2017-05-17 09:05:00-04:00,JNJ,johnson and johnson holding pharmaceutical business review today,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998669624328613
696748,696748,707968.0,Johnson & Johnson Says Expecting to Launch or File for Regulatory Approval for 10 New Products from 2017 to 2021 and 50 Line Extensions of Existing Products,2017-05-17 06:54:00-04:00,JNJ,johnson and johnson says expecting to launch or file for regulatory approval for 10 new products from 2017 to 2021 and 50 line extensions of existing products,"{'neg': 0.0, 'neu': 0.893, 'pos': 0.107, 'compound': 0.4767}",neutral,0.9998681545257568
696749,696749,707969.0,"Johnson & Johnson's Sales Slump Has Played Itself Out, Could Reaccelerate This Year",2017-05-15 11:10:00-04:00,JNJ,johnson and johnsons sales slump has played itself out could reaccelerate this year,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.34}",negative,0.997590184211731
696750,696750,707970.0,"Benzinga's Top Upgrades, Downgrades For May 15, 2017",2017-05-15 09:19:00-04:00,JNJ,benzingas top upgrades downgrades for may 15 2017,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.2023}",neutral,0.9479440450668335
696751,696751,707971.0,JP Morgan Upgrades Johnson & Johnson to Overweight,2017-05-15 06:05:00-04:00,JNJ,jp morgan upgrades johnson and johnson to overweight,"{'neg': 0.243, 'neu': 0.583, 'pos': 0.175, 'compound': -0.1779}",positive,0.9980308413505554
696752,696752,707972.0,"Top Picks For The Rest Of 2017, Courtesy Of UBS",2017-05-12 15:25:00-04:00,JNJ,top picks for the rest of 2017 courtesy of ubs,"{'neg': 0.0, 'neu': 0.65, 'pos': 0.35, 'compound': 0.5106}",neutral,0.9998859167098999
696753,696753,707973.0,Apple Is The World's Biggest Dividend Payer,2017-05-03 10:07:00-04:00,JNJ,apple is the worlds biggest dividend payer,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998830556869507
696754,696754,707974.0,Exclusive: Capricor CEO Talks Exondys Competition,2017-05-03 07:53:00-04:00,JNJ,exclusive capricor ceo talks exondys competition,"{'neg': 0.0, 'neu': 0.769, 'pos': 0.231, 'compound': 0.128}",neutral,0.9998812675476074
696755,696755,707975.0,"Weed Vs. Opioids: Nontraditional And Traditional Biotech Take On Wall Street, But Who's Winning?",2017-04-30 12:38:00-04:00,JNJ,weed vs opioids nontraditional and traditional biotech take on wall street but whos winning,"{'neg': 0.0, 'neu': 0.739, 'pos': 0.261, 'compound': 0.6808}",neutral,0.9997323155403137
696756,696756,707976.0,Johnson & Johnson Increases Qtr. Dividend From $0.80/Share To $0.84/Share,2017-04-27 10:47:00-04:00,JNJ,johnson and johnson increases qtr dividend from dollars . to dollars,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9991022348403931
696757,696757,707977.0,"Companies Holding Shareholder Meetings Today Include: Akorn, AstraZeneca, HCA Holdings, Johnson & Johnson, & Lockheed Martin",2017-04-27 08:41:00-04:00,JNJ,companies holding shareholder meetings today include akorn astrazeneca hca holdings johnson and johnson and lockheed martin,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998822212219238
696758,696758,707978.0,Janssen Holding Announces 92.51% of Actelion Shares Tendered,2017-04-27 04:11:00-04:00,JNJ,janssen holding announces 92.51 percent of actelion shares tendered,"{'neg': 0.0, 'neu': 0.654, 'pos': 0.346, 'compound': 0.4019}",neutral,0.9998791217803955
696759,696759,707979.0,"Earnings: Caterpillar, Lockheed Martin, and Eli Lilly Report Tomorrow",2017-04-24 13:45:00-04:00,JNJ,earnings caterpillar lockheed martin and eli lilly report tomorrow,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999868631362915
696760,696760,707980.0,How Family Office Manager Julio Gonzalez Is Helping Keep Jobs In The U.S. Using Tax Engineering,2017-04-24 09:13:00-04:00,JNJ,how family office manager julio gonzalez is helping keep jobs in the u s using tax engineering,"{'neg': 0.0, 'neu': 0.879, 'pos': 0.121, 'compound': 0.296}",neutral,0.7673357725143433
696761,696761,707981.0,Jim Cramer Gives His Opinion On Johnson & Johnson And PPG Industries,2017-04-24 06:54:00-04:00,JNJ,jim cramer gives his opinion on johnson and johnson and ppg industries,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998623132705688
696762,696762,707982.0,What Would A $5.8 Billion NIH Cut Look Like? Devastation,2017-04-20 13:38:00-04:00,JNJ,what would a dollars .8 billion nih cut look like devastation,"{'neg': 0.318, 'neu': 0.519, 'pos': 0.162, 'compound': -0.34}",neutral,0.5977082252502441
696763,696763,707983.0,The Lucky Beneficiaries Of Tax Day,2017-04-20 08:23:00-04:00,JNJ,the lucky beneficiaries of tax day,"{'neg': 0.0, 'neu': 0.417, 'pos': 0.583, 'compound': 0.6808}",neutral,0.9998704195022583
696764,696764,707984.0,"JMP Calls Alteryx A Compelling Investment, Sees 23% Upside",2017-04-18 12:12:00-04:00,JNJ,jmp calls alteryx a compelling investment sees 23 percent upside,"{'neg': 0.0, 'neu': 0.826, 'pos': 0.174, 'compound': 0.2263}",positive,0.9996041655540466
696765,696765,707985.0,Johnson & Johnson Pummeled After Mixed Q1 Report,2017-04-18 11:39:00-04:00,JNJ,johnson and johnson pummeled after mixed first quarter report,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9976279139518738
696766,696766,707986.0,"Meg Tirrell Tweets: $JNJ says it's seeing higher discounting on drugs for favorable coverage; increased rx assistance, discounts hit Q1 results by $200m per JPM",2017-04-18 08:45:00-04:00,JNJ,meg tirrell tweets jnj says its seeing higher discounting on drugs for favorable coverage increased rx assistance discounts hit first quarter results by dollars 00 million per jpm,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.6369}",positive,0.9996083378791809
696767,696767,707987.0,A Peek Into The Markets: U.S. Stock Futures Mostly Lower Ahead Of Earnings,2017-04-18 07:50:00-04:00,JNJ,a peek into the markets u s stock futures mostly lower ahead of earnings,"{'neg': 0.145, 'neu': 0.855, 'pos': 0.0, 'compound': -0.296}",negative,0.997570812702179
696768,696768,707988.0,Johnson & Johnson Sees FY 2017 EPS $7.00 to $7.15 vs $7.05 Est,2017-04-18 06:41:00-04:00,JNJ,johnson and johnson sees fy 2017 eps dollars .00 to dollars .15 vs dollars .05 est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998544454574585
696769,696769,707989.0,"Johnson & Johnson Q1 EPS $1.83 vs $1.77 Est, Sales $17.8B vs $18.0B Est",2017-04-18 06:40:00-04:00,JNJ,johnson and johnson first quarter eps dollars .83 vs dollars .77 est sales dollars 7.8 billion vs dollars 8.0 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998846054077148
696770,696770,707990.0,"10 Stocks To Watch For April 18, 2017",2017-04-18 05:47:00-04:00,JNJ,10 stocks to watch for april 18 2017,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998534917831421
696771,696771,707991.0,"Earnings Scheduled For April 18, 2017",2017-04-18 05:24:00-04:00,JNJ,earnings scheduled for april 18 2017,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998817443847656
696772,696772,707992.0,"Earnings: Another Financial Roundup With BAC, GS, and MS",2017-04-17 14:27:00-04:00,JNJ,earnings another financial roundup with bac gs and ms,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998728036880493
696773,696773,707993.0,Johnson & Johnson's Janssen Data From 2 Phase 3 Studies Supported New Approval Darzalex In Canada,2017-04-17 07:32:00-04:00,JNJ,johnson and johnsons janssen data from 2 phase 3 studies supported new approval darzalex in canada,"{'neg': 0.0, 'neu': 0.722, 'pos': 0.278, 'compound': 0.6597}",positive,0.9989810585975647
696774,696774,707994.0,United Airlines Should Learn From How These 6 Companies Handled PR Disasters,2017-04-14 16:50:00-04:00,JNJ,united airlines should learn from how these 6 companies handled pr disasters,"{'neg': 0.22, 'neu': 0.61, 'pos': 0.171, 'compound': -0.2023}",neutral,0.9998041987419128
696775,696775,707995.0,Healthcare Sector Earnings: Making A Comeback In Q1 2017?,2017-04-12 11:46:00-04:00,JNJ,healthcare sector earnings making a comeback in first quarter 2017,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996436834335327
696776,696776,707996.0,From Conf Call: Geron Says Jansen has Right to Terminate Agreement at Any Time for Any Reason,2017-04-10 08:19:00-04:00,JNJ,from conf call geron says jansen has right to terminate agreement at any time for any reason,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.4939}",neutral,0.9988794922828674
696777,696777,707997.0,"Adam Feuerstein Tweets: $JNJ reluctance to commit to imetelstat, disclosed in last sentence of $GERN PR, is most important point.",2017-04-10 07:41:00-04:00,JNJ,adam feuerstein tweets jnj reluctance to commit to imetelstat disclosed in last sentence of gern pr is most important point,"{'neg': 0.1, 'neu': 0.667, 'pos': 0.233, 'compound': 0.2944}",neutral,0.999777615070343
696778,696778,707998.0,There Is Value To Be Had With The Right Healthcare ETFs,2017-04-05 08:32:00-04:00,JNJ,there is value to be had with the right healthcare etfs,"{'neg': 0.0, 'neu': 0.806, 'pos': 0.194, 'compound': 0.34}",neutral,0.9993639588356018
696779,696779,707999.0,"50 Advertisers Boycott YouTube Advertising, And It Won't Mean More Than A 1% Dip In Google's Top Line",2017-04-01 08:45:00-04:00,JNJ,50 advertisers boycott youtube advertising and it wont mean more than a 1 percent dip in googles top line,"{'neg': 0.109, 'neu': 0.806, 'pos': 0.085, 'compound': -0.128}",negative,0.9983514547348022
696780,696780,708000.0,"Pre-Market Imbalance Update: AT&T 90K Shares to Buy, Salesforce 70K to Sell, BofA 64K to Buy, CVS 64K to Sell, Twitter 42K to Sell, J&J 38K to Sell, Walmart 25K to Sell",2017-03-31 09:12:00-04:00,JNJ,pre market imbalance update at and t 90 thousand shares to buy salesforce 70 thousand to sell bofa 64 thousand to buy cvs 64 thousand to sell twitter 42 thousand to sell j and j 38 thousand to sell walmart 25 thousand to sell,"{'neg': 0.0, 'neu': 0.951, 'pos': 0.049, 'compound': 0.296}",neutral,0.9998806715011597
696781,696781,708001.0,JNJ Subsidiary Janssen Declares Tender Offer for Actelion Successful,2017-03-31 04:19:00-04:00,JNJ,jnj subsidiary janssen declares tender offer for actelion successful,"{'neg': 0.0, 'neu': 0.678, 'pos': 0.322, 'compound': 0.5859}",positive,0.9994719624519348
696782,696782,708002.0,Here's Every Major Corporation That's Pulled Ads From YouTube,2017-03-27 08:59:00-04:00,JNJ,heres every major corporation thats pulled ads from youtube,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998493194580078
696783,696783,708003.0,Watch These 5 Huge Put Purchases In Monday Trade,2017-03-27 05:29:00-04:00,JNJ,watch these 5 huge put purchases in monday trade,"{'neg': 0.0, 'neu': 0.777, 'pos': 0.223, 'compound': 0.3182}",neutral,0.9997028708457947
696784,696784,708004.0,Benzinga's Option Alert Recap From March 24,2017-03-24 16:15:00-04:00,JNJ,benzingas option alert recap from march 24,"{'neg': 0.0, 'neu': 0.732, 'pos': 0.268, 'compound': 0.296}",neutral,0.9998689889907837
696785,696785,708005.0,Option Alert: JNJ May $120 Put; 2800 @ Bid @$0.90; Ref=$125.79,2017-03-24 12:30:00-04:00,JNJ,option alert jnj may dollars 20 put 2800 bid dollars .90 ref equals dollars 25.79,"{'neg': 0.0, 'neu': 0.864, 'pos': 0.136, 'compound': 0.296}",neutral,0.9998875856399536
696786,696786,708006.0,YouTube's Ad Controversy Not Going Away Yet; Will It Prove To Be Temporary?,2017-03-24 11:36:00-04:00,JNJ,youtubes ad controversy not going away yet will it prove to be temporary,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9991366267204285
696787,696787,708007.0,"Johnson & Johnson Unit Mentor Spokeswoman Tells Benzinga, 'We fully support the FDA's efforts to gather additional data and study BIA-ALCL in patients with breast implants,' Will Continue To Work To Understand Associated Risks And Causes",2017-03-24 09:37:00-04:00,JNJ,johnson and johnson unit mentor spokeswoman tells benzinga we fully support the fdas efforts to gather additional data and study bia alcl in patients with breast implants will continue to work to understand associated risks and causes,"{'neg': 0.052, 'neu': 0.873, 'pos': 0.075, 'compound': 0.2247}",neutral,0.7985308170318604
696788,696788,708008.0,"American Express, Johnson & Johnson, Square, Vale: Fast Money Picks For March 24",2017-03-24 07:07:00-04:00,JNJ,american express johnson and johnson square vale fast money picks for march 24,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998600482940674
696789,696789,708009.0,Allergan Continues Educational Strategy Amid FDA's Report Linking Breast Implants To Rare Cancer,2017-03-22 10:19:00-04:00,JNJ,allergan continues educational strategy amid fdas report linking breast implants to rare cancer,"{'neg': 0.268, 'neu': 0.732, 'pos': 0.0, 'compound': -0.6597}",neutral,0.9970458149909973
696790,696790,708010.0,"Premarket Prep Host Dennis Dick Tweets: $BAC -1.2M, $C -179K, $MS -82K, $WFC -48K, $NKE -113K, $BABA -67K, $TWTR -51K, $JNJ -84K, $GE -163K, $F +344K",2017-03-22 09:18:00-04:00,JNJ,premarket prep host dennis dick tweets bac negative 1.2 million c negative 179 thousand ms negative 82 thousand wfc negative 48 thousand nke negative 113 thousand baba negative 67 thousand twtr negative 51 thousand jnj negative 84 thousand ge negative 163 thousand f positive 344 thousand,"{'neg': 0.487, 'neu': 0.465, 'pos': 0.048, 'compound': -0.9872}",neutral,0.9998476505279541
696791,696791,708011.0,FDA Links Breast Implants To A Rare Form Of Cancer,2017-03-21 17:26:00-04:00,JNJ,fda links breast implants to a rare form of cancer,"{'neg': 0.328, 'neu': 0.672, 'pos': 0.0, 'compound': -0.6597}",neutral,0.9967262744903564
696792,696792,708012.0,"Watch For Weakness In Sientra, Johnson & Johnson, and Allergan NBC News  Reports That FDA Says Breast Implants Can Cause A Rare Form Of Cancer That May Have Killed At Least 9 People",2017-03-21 16:49:00-04:00,JNJ,watch for weakness in sientra johnson and johnson and allergan nbc news reports that fda says breast implants can cause a rare form of cancer that may have killed at least 9 people,"{'neg': 0.281, 'neu': 0.719, 'pos': 0.0, 'compound': -0.9136}",negative,0.9482664465904236
696793,696793,708013.0,That Was Fast: Healthcare ETF Races To New Highs,2017-03-16 08:09:00-04:00,JNJ,that was fast healthcare etf races to new highs,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9993676543235779
696794,696794,708014.0,"Barclays Global Healthcare Conference Begins Today; Presenters Include Johnson & Johnson, Alnylam, Axovant, Paraxel, Gilead, bluebird bio, Envision Healthcare, & Tenet Healthcare",2017-03-14 08:20:00-04:00,JNJ,barclays global healthcare conference begins today presenters include johnson and johnson alnylam axovant paraxel gilead bluebird bio envision healthcare and tenet healthcare,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998859167098999
696795,696795,708015.0,How The Ultra-Wealthy Are Helping Advance Health And Life Sciences,2017-03-10 15:58:00-05:00,JNJ,how the ultra wealthy are helping advance health and life sciences,"{'neg': 0.0, 'neu': 0.657, 'pos': 0.343, 'compound': 0.5719}",positive,0.7692853808403015
696796,696796,708016.0,"Jim Cramer Advises His Viewers On Johnson & Johnson, Corecivic, Urban Outfitters And Realty Income",2017-03-10 06:42:00-05:00,JNJ,jim cramer advises his viewers on johnson and johnson corecivic urban outfitters and realty income,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998863935470581
696797,696797,708017.0,Fast Money Picks For March 8,2017-03-08 08:59:00-05:00,JNJ,fast money picks for march 8,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998633861541748
696798,696798,708018.0,Concerns From Valeant's 10-K: $8 Billion Of Asset Sales Is Now A Mirage,2017-03-07 07:46:00-05:00,JNJ,concerns from valeants 10 k dollars billion of asset sales is now a mirage,"{'neg': 0.0, 'neu': 0.839, 'pos': 0.161, 'compound': 0.3612}",negative,0.9475104808807373
696799,696799,708019.0,"Benzinga Premarket Prep Host Dennis Dick Tweets: Notable opening imbalances: $XRX +467K, $BAC -353K, $PFE -133K, $CRM -129K, $PEP -89K, $JNJ -72K, $PG -50K",2017-03-06 09:18:00-05:00,JNJ,benzinga premarket prep host dennis dick tweets notable opening imbalances xrx positive 467 thousand bac negative 353 thousand pfe negative 133 thousand crm negative 129 thousand pep negative 89 thousand jnj negative 72 thousand pg negative 50 thousand,"{'neg': 0.431, 'neu': 0.508, 'pos': 0.061, 'compound': -0.9716}",negative,0.9971466660499573
696800,696800,708020.0,"J&J's Janssen Reports Results from Second Phase 3 Study of Guselkumab vs Humira for Treatment of Moderate-to-Severe Plaque Psoriasis Show Significant Efficacy, Superiority",2017-03-03 07:08:00-05:00,JNJ,j and js janssen reports results from second phase 3 study of guselkumab vs humira for treatment of moderate to severe plaque psoriasis show significant efficacy superiority,"{'neg': 0.084, 'neu': 0.779, 'pos': 0.136, 'compound': 0.1531}",positive,0.999234676361084
696801,696801,708021.0,Johnson & Johnson In 10-K Filing Says Janssen Pharma Subsidiary Received Civil Investigative Demand From DoJ Related To Allegations Concerning Sales & Marketing Practices Of Olysio,2017-02-27 17:08:00-05:00,JNJ,johnson and johnson in 10 k filing says janssen pharma subsidiary received civil investigative demand from doj related to allegations concerning sales and marketing practices of olysio,"{'neg': 0.055, 'neu': 0.945, 'pos': 0.0, 'compound': -0.128}",neutral,0.777562141418457
696802,696802,708022.0,J&J Reports Expected Charge Of $2B-$2.4B Related To Medical Devices Unit Restructuring,2017-02-27 17:07:00-05:00,JNJ,j and j reports expected charge of dollars b dollars .4 billion related to medical devices unit restructuring,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998437166213989
696803,696803,708023.0,Johnson & Johnson Received Subpoena From Massachusetts Seeking Records Related To Payments To Any 501(C)(3) Charitable Organizations That Provide Assistance To Medicare Patients,2017-02-27 17:05:00-05:00,JNJ,johnson and johnson received subpoena from massachusetts seeking records related to payments to any 501 calls 3 charitable organizations that provide assistance to medicare patients,"{'neg': 0.0, 'neu': 0.899, 'pos': 0.101, 'compound': 0.4019}",neutral,0.999630331993103
696804,696804,708024.0,How Trump's Tax Policy Could Affect Large Companies Like Apple,2017-02-27 12:05:00-05:00,JNJ,how trumps tax policy could affect large companies like apple,"{'neg': 0.0, 'neu': 0.783, 'pos': 0.217, 'compound': 0.3612}",neutral,0.9969044327735901
696805,696805,708025.0,Dan Nathan's Bearish Johnson & Johnson Trade,2017-02-26 15:27:00-05:00,JNJ,dan nathans bearish johnson and johnson trade,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998607635498047
696806,696806,708026.0,Hearing Johnson and Johnson Searching For Medical Device Partnerships At RBC Conf.,2017-02-23 10:19:00-05:00,JNJ,hearing johnson and johnson searching for medical device partnerships at rbc conf,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998776912689209
696807,696807,708027.0,"RBC Capital Markets Healthcare Conference Concludes Today; Presenters Include Spark Therapeutics, Johnson & Johnson, HCA Holdings, Ocular Therapeutix, Valeant & Agile Therapeutics",2017-02-23 08:04:00-05:00,JNJ,rbc capital markets healthcare conference concludes today presenters include spark therapeutics johnson and johnson hca holdings ocular therapeutix valeant and agile therapeutics,"{'neg': 0.0, 'neu': 0.917, 'pos': 0.083, 'compound': 0.2263}",neutral,0.9998810291290283
696808,696808,708028.0,10 Companies With The Best Corporate Reputations,2017-02-22 13:57:00-05:00,JNJ,10 companies with the best corporate reputations,"{'neg': 0.0, 'neu': 0.588, 'pos': 0.412, 'compound': 0.6369}",neutral,0.9994813799858093
696809,696809,708029.0,Icahn Takes Bristol-Myers Stake With M&A In Mind; Who Could Be The Acquirer?,2017-02-21 16:48:00-05:00,JNJ,icahn takes bristol myers stake with m and a in mind who could be the acquirer,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998775720596313
696810,696810,708030.0,"Exclusive: Following Up Akebia, Johnson & Johnson's Research And License Agreement",2017-02-17 10:21:00-05:00,JNJ,exclusive following up akebia johnson and johnsons research and license agreement,"{'neg': 0.0, 'neu': 0.657, 'pos': 0.343, 'compound': 0.5719}",neutral,0.9998040795326233
696811,696811,708031.0,"J&J Medical Devices' Ethicon Reports Deal to Buy Torax Medical, No Terms Disclosed",2017-02-17 10:03:00-05:00,JNJ,j and j medical devices ethicon reports deal to buy torax medical no terms disclosed,"{'neg': 0.136, 'neu': 0.864, 'pos': 0.0, 'compound': -0.296}",positive,0.8955681920051575
696812,696812,708032.0,Wall Street's M&A Chatter From February 16,2017-02-17 06:39:00-05:00,JNJ,wall streets m and a chatter from february 16,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998890161514282
696813,696813,708033.0,Swiss Takeover Commission Says J&J Offer for Actelion Meets Legal Requirements,2017-02-16 04:40:00-05:00,JNJ,swiss takeover commission says j and j offer for actelion meets legal requirements,"{'neg': 0.0, 'neu': 0.889, 'pos': 0.111, 'compound': 0.128}",neutral,0.9839438199996948
696814,696814,708034.0,J&J Publishes Prospectus for Actelion Tender Offer,2017-02-16 04:02:00-05:00,JNJ,j and j publishes prospectus for actelion tender offer,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998732805252075
696815,696815,708035.0,"A Peek Into The Markets: U.S. Stock Futures Mostly Higher Ahead Of Economic Data, Yellen Speech",2017-02-15 07:44:00-05:00,JNJ,a peek into the markets u s stock futures mostly higher ahead of economic data yellen speech,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9986200332641602
696816,696816,708036.0,Integra Acquires Codman Neurosurgery Business From Johnson & Johnson for $1.045B Cash,2017-02-15 07:02:00-05:00,JNJ,integra acquires codman neurosurgery business from johnson and johnson for dollars .045 billion cash,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9970163106918335
696817,696817,708037.0,ACADIA Shares Up $0.80 Over Last Min as Hearing Dealreporter Suggesting J&J Could Approach Co.,2017-02-14 13:26:00-05:00,JNJ,acadia shares up dollars .80 over last min as hearing dealreporter suggesting j and j could approach co,"{'neg': 0.0, 'neu': 0.885, 'pos': 0.115, 'compound': 0.296}",positive,0.9997143149375916
696818,696818,708038.0,Johnson & Johnson's Janssen Pharmaceuticals Enters Agreement To Give Investigational New Drug File For Stresscopin To Renova Therapeutics,2017-02-06 11:04:00-05:00,JNJ,johnson and johnsons janssen pharmaceuticals enters agreement to give investigational new drug file for stresscopin to renova therapeutics,"{'neg': 0.0, 'neu': 0.842, 'pos': 0.158, 'compound': 0.4939}",positive,0.9994992017745972
696819,696819,708039.0,Donald Trump Calls Johnson & Johnson A 'Good Company',2017-01-31 09:51:00-05:00,JNJ,donald trump calls johnson and johnson a good company,"{'neg': 0.0, 'neu': 0.734, 'pos': 0.266, 'compound': 0.4404}",neutral,0.5551860332489014
696820,696820,708040.0,A CEO Who's Who Of Trump's Manufacturing Council,2017-01-27 16:36:00-05:00,JNJ,a ceo whos who of trumps manufacturing council,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998822212219238
696821,696821,708041.0,Missouri Supreme Court Denies Request To Delay Johnson & Johnson Talc-Product Cancer Allegation Trials,2017-01-26 14:59:00-05:00,JNJ,missouri supreme court denies request to delay johnson and johnson talc product cancer allegation trials,"{'neg': 0.394, 'neu': 0.456, 'pos': 0.149, 'compound': -0.7096}",neutral,0.8098742365837097
696822,696822,708042.0,"Benzinga's Top Upgrades, Downgrades For January 26, 2017",2017-01-26 09:22:00-05:00,JNJ,benzingas top upgrades downgrades for january 26 2017,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.2023}",neutral,0.6829882264137268
696823,696823,708043.0,"The Market In 5 Minutes: Earnings, Trump And Dow20k",2017-01-26 09:02:00-05:00,JNJ,the market in 5 minutes earnings trump and dow20 thousand,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998779296875
696824,696824,708044.0,A Peek Into The Markets: U.S. Stock Futures Up Ahead Of Earnings,2017-01-26 07:24:00-05:00,JNJ,a peek into the markets u s stock futures up ahead of earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9937317967414856
696825,696825,708045.0,Wells Fargo Downgrades Johnson & Johnson To Market Perform,2017-01-26 06:46:00-05:00,JNJ,wells fargo downgrades johnson and johnson to market perform,"{'neg': 0.0, 'neu': 0.8, 'pos': 0.2, 'compound': 0.25}",negative,0.9983420372009277
696826,696826,708046.0,JNJ to Acquire Actelion for $280/Share in Cash; Actelion to Spin Out Drug Discovery Operations and Early-Stage Clinical Development Assets,2017-01-26 03:47:00-05:00,JNJ,jnj to acquire actelion for dollars in cash actelion to spin out drug discovery operations and early stage clinical development assets,"{'neg': 0.0, 'neu': 0.922, 'pos': 0.078, 'compound': 0.1779}",neutral,0.9998620748519897
696827,696827,708047.0,Dow 10K's Hottest Stocks: Where Are They Now?,2017-01-25 15:17:00-05:00,JNJ,dow 10 thousand s hottest stocks where are they now,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998807907104492
696828,696828,708048.0,Trump Helps Send Markets To New Highs With Keystone Pipeline Order,2017-01-25 10:59:00-05:00,JNJ,trump helps send markets to new highs with keystone pipeline order,"{'neg': 0.0, 'neu': 0.794, 'pos': 0.206, 'compound': 0.3818}",positive,0.999552309513092
696829,696829,708049.0,Q4 Earnings Thus Far A Reality Check For The Trump Rally?,2017-01-24 16:11:00-05:00,JNJ,q4 earnings thus far a reality check for the trump rally,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9980406165122986
696830,696830,708050.0,Q4 2016 Real-Time Call Brief,2017-01-24 14:56:00-05:00,JNJ,q4 2016 real time call brief,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998748302459717
696831,696831,708051.0,Johnson & Johnson Takes A Hit After Mixed Q4 Report,2017-01-24 11:42:00-05:00,JNJ,johnson and johnson takes a hit after mixed fourth quarter report,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9984226226806641
696832,696832,708052.0,Stocks Could Remain Range-Bound Until Trump Policy Details Become Clearer,2017-01-24 10:31:00-05:00,JNJ,stocks could remain range bound until trump policy details become clearer,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998708963394165
696833,696833,708053.0,Johnson and Johnson Says To Expect 10 New Product Launches By 2019 With $1B In Sales Potential,2017-01-24 09:04:00-05:00,JNJ,johnson and johnson says to expect 10 new product launches by 2019 with dollars b in sales potential,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9994545578956604
696834,696834,708054.0,"The Market In 5 Minutes: Alibaba Beats, Verizon Disappoints",2017-01-24 09:02:00-05:00,JNJ,the market in 5 minutes alibaba beats verizon disappoints,"{'neg': 0.245, 'neu': 0.755, 'pos': 0.0, 'compound': -0.3818}",positive,0.8458669185638428
696835,696835,708055.0,A Peek Into The Markets: U.S. Stock Futures Flat Ahead Of Earnings Reports,2017-01-24 07:29:00-05:00,JNJ,a peek into the markets u s stock futures flat ahead of earnings reports,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9985400438308716
696836,696836,708056.0,Johnson & Johnson Says Evaluating Strategic Options for Diabetes Care Companies,2017-01-24 06:42:00-05:00,JNJ,johnson and johnson says evaluating strategic options for diabetes care companies,"{'neg': 0.0, 'neu': 0.758, 'pos': 0.242, 'compound': 0.4939}",neutral,0.9996657371520996
696837,696837,708057.0,Johnson & Johnson Sees FY EPS $6.93 to $7.08 vs $7.11 Est,2017-01-24 06:41:00-05:00,JNJ,johnson and johnson sees fy eps dollars .93 to dollars .08 vs dollars .11 est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999854326248169
696838,696838,708058.0,"Johnson & Johnson Q4 EPS $1.58 vs $1.56 Est, Revenue $18.1B vs $18.3B Est",2017-01-24 06:40:00-05:00,JNJ,johnson and johnson fourth quarter eps dollars .58 vs dollars .56 est revenue dollars 8.1 billion vs dollars 8.3 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998784065246582
696839,696839,708059.0,12 Stocks You Should Be Watching Today,2017-01-24 05:53:00-05:00,JNJ,12 stocks you should be watching today,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998550415039062
696840,696840,708060.0,"Earnings Scheduled For January 24, 2017",2017-01-24 05:03:00-05:00,JNJ,earnings scheduled for january 24 2017,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998781681060791
696841,696841,708061.0,"J&J Chair, CEO, Alex Gorsky, Offers Statement Following Manufacturer Meeting with Trump",2017-01-23 16:42:00-05:00,JNJ,j and j chair ceo alex gorsky offers statement following manufacturer meeting with trump,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998729228973389
696842,696842,708062.0,"Earnings: Last Call for Yahoo? Johnson & Johnson, Alibaba Also Release This Week",2017-01-23 12:00:00-05:00,JNJ,earnings last call for yahoo johnson and johnson alibaba also release this week,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998875856399536
696843,696843,708063.0,"ReutersBiz Tweets: BREAKING: Executives from Whirlpool, Under Armour, Tesla, Lockheed Martin, Johnson & Johnson and more attend Trump meeting on manufacturing",2017-01-23 09:16:00-05:00,JNJ,reutersbiz tweets breaking executives from whirlpool under armour tesla lockheed martin johnson and johnson and more attend trump meeting on manufacturing,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998563528060913
696844,696844,708064.0,"Execs from Tesla, J&J, Lockheed, Under Armour, Whirlpool Attend Trump Meeting with Key US Manufacturers",2017-01-23 09:12:00-05:00,JNJ,execs from tesla j and j lockheed under armour whirlpool attend trump meeting with key us manufacturers,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998676776885986
696845,696845,708065.0,"Dow Earnings: High Hopes For Chevron, Johnson & Johnson",2017-01-23 08:31:00-05:00,JNJ,dow earnings high hopes for chevron johnson and johnson,"{'neg': 0.0, 'neu': 0.741, 'pos': 0.259, 'compound': 0.4215}",positive,0.99958735704422
696846,696846,708066.0,Health Canada Wants Warning Stickers on Prescription Painkillers -Reuters,2017-01-23 04:26:00-05:00,JNJ,health canada wants warning stickers on prescription painkillers reuters,"{'neg': 0.231, 'neu': 0.769, 'pos': 0.0, 'compound': -0.34}",neutral,0.9989953637123108
696847,696847,708067.0,Inauguration Day: Trump Speech In Focus As New President Prepares To Take Office,2017-01-20 10:00:00-05:00,JNJ,inauguration day trump speech in focus as new president prepares to take office,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998701810836792
696848,696848,708068.0,"Johnson and Johnson Unit Ethicon Acquires Megadyne Medical Products, Terms Not Disclosed",2017-01-20 08:30:00-05:00,JNJ,johnson and johnson unit ethicon acquires megadyne medical products terms not disclosed,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998862743377686
696849,696849,708069.0,Does Luxottica Now Have A Monopoly On The Eyeglass Space?,2017-01-17 15:15:00-05:00,JNJ,does luxottica now have a monopoly on the eyeglass space,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9996165037155151
696850,696850,708070.0,Quality Dividends On The Cheap With This ETF,2017-01-17 08:40:00-05:00,JNJ,quality dividends on the cheap with this etf,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9901201725006104
696851,696851,708071.0,Johnson & Johnson Deal With Actelion Said To Be Valued At $250-$260/Share,2017-01-12 12:57:00-05:00,JNJ,johnson and johnson deal with actelion said to be valued at dollars 50 dollars,"{'neg': 0.0, 'neu': 0.818, 'pos': 0.182, 'compound': 0.4404}",neutral,0.9998867511749268
696852,696852,708072.0,J&J and Actelion Said TO Reach Tentative Agreement On Price,2017-01-11 16:08:00-05:00,JNJ,j and j and actelion said to reach tentative agreement on price,"{'neg': 0.0, 'neu': 0.699, 'pos': 0.301, 'compound': 0.5106}",positive,0.9916669726371765
696853,696853,708073.0,The Fentanyl Abuse Epidemic,2017-01-10 07:02:00-05:00,JNJ,the fentanyl abuse epidemic,"{'neg': 0.583, 'neu': 0.417, 'pos': 0.0, 'compound': -0.6369}",neutral,0.9995620846748352
696854,696854,708074.0,"JP Morgan Healthcare Conf. Begins Today; Presenters Include Insulet, Teladoc, Incyte, Johnson & Johnson, Acadia Healthcare, & Teva Pharmaceuticals",2017-01-09 08:49:00-05:00,JNJ,jp morgan healthcare conf begins today presenters include insulet teladoc incyte johnson and johnson acadia healthcare and teva pharmaceuticals,"{'neg': 0.0, 'neu': 0.909, 'pos': 0.091, 'compound': 0.2023}",neutral,0.9998859167098999
696855,696855,708075.0,"J&J, Actelion Discuss Deal with Swiss Takeover Board -Tages-Anzeiger",2017-01-06 04:57:00-05:00,JNJ,j and j actelion discuss deal with swiss takeover board tages anzeiger,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999768078327179
696856,696856,708076.0,Execs Giving CES Keynote Speeches Could Create Volatility For Shareholders,2017-01-05 16:07:00-05:00,JNJ,execs giving ces keynote speeches could create volatility for shareholders,"{'neg': 0.0, 'neu': 0.64, 'pos': 0.36, 'compound': 0.5423}",negative,0.9959426522254944
696857,696857,708077.0,A Peek Into The Markets: U.S. Stock Futures Rise On Final Trading Day Of 2016,2016-12-30 07:27:00-05:00,JNJ,a peek into the markets u s stock futures rise on final trading day of 2016,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9943404197692871
696858,696858,708078.0,Wall Street's M&A Chatter From December 29,2016-12-30 06:38:00-05:00,JNJ,wall streets m and a chatter from december 29,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998914003372192
696859,696859,708079.0,Hearing J&J is Negotiating Placing Actelion's R&D Assets Into a Separate Co.,2016-12-29 10:54:00-05:00,JNJ,hearing j and j is negotiating placing actelions r and d assets into a separate co,"{'neg': 0.0, 'neu': 0.898, 'pos': 0.102, 'compound': 0.1779}",neutral,0.9998799562454224
696860,696860,708080.0,UPDATE: Achillion Receives $15M Milestone Payment from J&J's Janssen Research & Development,2016-12-28 06:07:00-05:00,JNJ,update achillion receives dollars 5 million milestone payment from j and js janssen research and development,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9990823268890381
696861,696861,708081.0,Achillion Reports Clinical Milestone for Advancement of JNJ-4178 in Phase 2B Development for Chronic HPV,2016-12-28 06:07:00-05:00,JNJ,achillion reports clinical milestone for advancement of jnj 4178 in phase 2 billion development for chronic hpv,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9899611473083496
696862,696862,708082.0,"The Market In 5 Minutes: GDP, Jobless Claims And Micron",2016-12-22 09:11:00-05:00,JNJ,the market in 5 minutes gdp jobless claims and micron,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998028874397278
696863,696863,708083.0,Wall Street's M&A Chatter From December 21,2016-12-22 06:35:00-05:00,JNJ,wall streets m and a chatter from december 21,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998903274536133
696864,696864,708084.0,Johnson & Johnson Confirms Exclusive Negotiations With Actelion In Press Release,2016-12-21 11:41:00-05:00,JNJ,johnson and johnson confirms exclusive negotiations with actelion in press release,"{'neg': 0.0, 'neu': 0.87, 'pos': 0.13, 'compound': 0.128}",neutral,0.9896969199180603
696865,696865,708085.0,Actelion and Johnson & Johnson Enter Into Exclusive Discussion,2016-12-21 11:37:00-05:00,JNJ,actelion and johnson and johnson enter into exclusive discussion,"{'neg': 0.0, 'neu': 0.842, 'pos': 0.158, 'compound': 0.128}",neutral,0.9998775720596313
696866,696866,708086.0,"J&J's Janssen Announces Submission of Two FDA Applications for Approval of SIMPONI ARIA for Treatment of Active Psoriatic Arthritis, Active Ankylosing Spondyllitis",2016-12-20 16:46:00-05:00,JNJ,j and js janssen announces submission of two fda applications for approval of simponi aria for treatment of active psoriatic arthritis active ankylosing spondyllitis,"{'neg': 0.0, 'neu': 0.712, 'pos': 0.288, 'compound': 0.8176}",neutral,0.9979141354560852
696867,696867,708087.0,Janssen Sciences Ireland UC Announces  Positive Results From First Phase III Studies of Investigational Two-Drug HIV Treatment Regimen,2016-12-19 18:16:00-05:00,JNJ,janssen sciences ireland uc announces positive results from first phase iii studies of investigational two drug hiv treatment regimen,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.5574}",positive,0.9995729327201843
696868,696868,708088.0,Jefferies' 2017 Global Pharma Outlook,2016-12-19 10:56:00-05:00,JNJ,jefferies 2017 global pharma outlook,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998619556427002
696869,696869,708089.0,Janssen Submits Application Seeking FDA Approval Of Stelara For Treatment Of Adolescents With Moderate-To-Severe Plaque Psoriasis,2016-12-16 07:46:00-05:00,JNJ,janssen submits application seeking fda approval of stelara for treatment of adolescents with moderate to severe plaque psoriasis,"{'neg': 0.12, 'neu': 0.737, 'pos': 0.143, 'compound': 0.128}",neutral,0.9995383024215698
696870,696870,708090.0,Wall Street's M&A Chatter From December 14,2016-12-15 06:57:00-05:00,JNJ,wall streets m and a chatter from december 14,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998905658721924
696871,696871,708091.0,Watch These 7 Huge Call Purchases In Thursday Trade,2016-12-15 04:03:00-05:00,JNJ,watch these 7 huge call purchases in thursday trade,"{'neg': 0.0, 'neu': 0.777, 'pos': 0.223, 'compound': 0.3182}",neutral,0.9977864027023315
696872,696872,708092.0,Who Else Might Johnson & Johnson Seek To Acquire With Actelion Now Out Of Its Crosshairs?,2016-12-14 13:56:00-05:00,JNJ,who else might johnson and johnson seek to acquire with actelion now out of its crosshairs,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998658895492554
696873,696873,708093.0,Option Alert: JNJ Dec16 119 Calls Sweep: 1482 @  ASK  $0.12: 1482 traded vs 230 OI:  Earnings 1/24 Before Open  $116.87 Ref,2016-12-14 09:36:00-05:00,JNJ,option alert jnj dec16 119 calls sweep 1482 ask dollars .12 1482 traded vs 230 oi earnings before open dollars 16.87 ref,"{'neg': 0.0, 'neu': 0.905, 'pos': 0.095, 'compound': 0.296}",neutral,0.9998784065246582
696874,696874,708094.0,The Market In 5 Minutes: All Eyes On The Fed,2016-12-14 09:02:00-05:00,JNJ,the market in 5 minutes all eyes on the fed,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998791217803955
696875,696875,708095.0,Wall Street's M&A Chatter From December 13,2016-12-14 07:04:00-05:00,JNJ,wall streets m and a chatter from december 13,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998904466629028
696876,696876,708096.0,Actelion  Confirms J&J has Withdrawn from Discussions With Actelion; Says Engaged in Discussions with Another Party,2016-12-13 20:12:00-05:00,JNJ,actelion confirms j and j has withdrawn from discussions with actelion says engaged in discussions with another party,"{'neg': 0.0, 'neu': 0.748, 'pos': 0.252, 'compound': 0.6597}",neutral,0.7662742733955383
696877,696877,708097.0,JNJ Confirms it Ended Discussions with Actelion,2016-12-13 19:23:00-05:00,JNJ,jnj confirms it ended discussions with actelion,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9985804557800293
696878,696878,708098.0,Vetr Calls For A Hold On Johnson & Johnson Amid Sector Competition,2016-12-12 14:32:00-05:00,JNJ,vetr calls for a hold on johnson and johnson amid sector competition,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.998138427734375
696879,696879,708099.0,"Barron's Picks And Pans: Goodyear, Johnson & Johnson And More",2016-12-12 06:50:00-05:00,JNJ,barrons picks and pans goodyear johnson and johnson and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999870777130127
696880,696880,708100.0,"Facebook, Google Make Glassdoor's List Of Top 50 Places To Work",2016-12-07 15:03:00-05:00,JNJ,facebook google make glassdoors list of top 50 places to work,"{'neg': 0.0, 'neu': 0.847, 'pos': 0.153, 'compound': 0.2023}",neutral,0.9998633861541748
696881,696881,708101.0,"Pfizer, J&J, Other Big Pharma Names Dip Lower Just After the Open",2016-12-07 09:34:00-05:00,JNJ,pfizer j and j other big pharma names dip lower just after the open,"{'neg': 0.145, 'neu': 0.855, 'pos': 0.0, 'compound': -0.296}",negative,0.9973522424697876
696882,696882,708102.0,Karyopharm Therapeutics' Top Execs Talk Recent Results In Multiple Myeloma And Acute Myeloid Leukemia,2016-12-06 15:41:00-05:00,JNJ,karyopharm therapeutics top execs talk recent results in multiple myeloma and acute myeloid leukemia,"{'neg': 0.0, 'neu': 0.878, 'pos': 0.122, 'compound': 0.2023}",neutral,0.9986311793327332
696883,696883,708103.0,"The Market In 5 Minutes: Lower Oil Prices, Higher Apple Watch Sales",2016-12-06 08:57:00-05:00,JNJ,the market in 5 minutes lower oil prices higher apple watch sales,"{'neg': 0.167, 'neu': 0.833, 'pos': 0.0, 'compound': -0.296}",positive,0.9993226528167725
696884,696884,708104.0,"Actelion Large Shareholder Would Back Johnson & Johnson Acquisition Takeover for 246 SFR or Higher, According to Reuters",2016-12-06 06:55:00-05:00,JNJ,actelion large shareholder would back johnson and johnson acquisition takeover for 246 sfr or higher according to reuters,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999756395816803
696885,696885,708105.0,Sanofi Said To Explore Actelion Counterbid To Johnson & Johnson,2016-12-05 16:12:00-05:00,JNJ,sanofi said to explore actelion counterbid to johnson and johnson,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.99985671043396
696886,696886,708106.0,Johnson & Johnson Shares Trading Down 0.3% Pre-Market on $1B Verdict On Faulty Pinnacle Hip Implants From Its DePuy Orthopedics Unit,2016-12-02 08:26:00-05:00,JNJ,johnson and johnson shares trading down 0.3 percent pre market on dollars b verdict on faulty pinnacle hip implants from its depuy orthopedics unit,"{'neg': 0.085, 'neu': 0.775, 'pos': 0.14, 'compound': 0.128}",negative,0.9977728724479675
696887,696887,708107.0,Achillion Says Dosing of Phase 2B Study Initiated by Janssen,2016-11-30 06:24:00-05:00,JNJ,achillion says dosing of phase 2 billion study initiated by janssen,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998701810836792
696888,696888,708108.0,"Barclays Downgrades 5 Biopharma Stocks, Upgrades Pfizer And Alexion",2016-11-29 10:39:00-05:00,JNJ,barclays downgrades 5 biopharma stocks upgrades pfizer and alexion,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9872888326644897
696889,696889,708109.0,J&J Said To Raise Actelion Takeover Offer As Talks Advance,2016-11-29 09:51:00-05:00,JNJ,j and j said to raise actelion takeover offer as talks advance,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.5181204676628113
696890,696890,708110.0,7 Biggest Price Target Changes For Tuesday,2016-11-29 09:39:00-05:00,JNJ,7 biggest price target changes for tuesday,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999804675579071
696891,696891,708111.0,Benzinga's Top Downgrades,2016-11-29 09:17:00-05:00,JNJ,benzingas top downgrades,"{'neg': 0.0, 'neu': 0.526, 'pos': 0.474, 'compound': 0.2023}",negative,0.9905633926391602
696892,696892,708112.0,"Jim Cramer Shares His Thoughts On Johnson & Johnson, Anheuser Busch And Starbucks",2016-11-29 06:36:00-05:00,JNJ,jim cramer shares his thoughts on johnson and johnson anhe busch and starbucks,"{'neg': 0.0, 'neu': 0.845, 'pos': 0.155, 'compound': 0.296}",neutral,0.9998732805252075
696893,696893,708113.0,Barclays Downgrades Johnson & Johnson to Equal-Weight,2016-11-29 05:56:00-05:00,JNJ,barclays downgrades johnson and johnson to equal weight,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9963474869728088
696894,696894,708114.0,"Financial Times Reporting, 'Actelion weighs complicated deal to combine with part of J&J'",2016-11-28 13:49:00-05:00,JNJ,financial times reporting actelion weighs complicated deal to combine with part of j and j,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9994137287139893
696895,696895,708115.0,"The Market In 5 Minutes: Castro, Trump And Oil In Focus",2016-11-28 08:59:00-05:00,JNJ,the market in 5 minutes castro trump and oil in focus,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998794794082642
696896,696896,708116.0,Wall Street's M&A Chatter From November 25-27,2016-11-28 06:54:00-05:00,JNJ,wall streets m and a chatter from november 25 to 27,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998834133148193
696897,696897,708117.0,Johnson & Johnson Press Release Confirms Prelim Discussions With Actelion Pharma Regarding To Potential Acquisition,2016-11-25 12:00:00-05:00,JNJ,johnson and johnson press release confirms prelim discussions with actelion pharma regarding to potential acquisition,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999556839466095
696898,696898,708118.0,Actelion Issues Press Release Confirming Co. Has Been Approached by J&J Related to Possible Transaction,2016-11-25 11:01:00-05:00,JNJ,actelion issues press release confirming co has been approached by j and j related to possible transaction,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998171925544739
696899,696899,708119.0,The Market In 5 Minutes: Black Friday Closes Shortened Trading Week,2016-11-25 09:33:00-05:00,JNJ,the market in 5 minutes black friday closes shortened trading week,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9280046224594116
696900,696900,708120.0,Johnson & Johnson Said to Approach Actelion Regarding Potential Takeover -Bloomberg,2016-11-25 06:32:00-05:00,JNJ,johnson and johnson said to approach actelion regarding potential takeover bloomberg,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998743534088135
696901,696901,708121.0,Technical Alert - Johnson & Johnson Lower For Third Day In A Row,2016-11-22 10:10:00-05:00,JNJ,technical alert to johnson and johnson lower for third day in a row,"{'neg': 0.143, 'neu': 0.714, 'pos': 0.143, 'compound': 0.0}",negative,0.9980567097663879
696902,696902,708122.0,Johnson & Johnson Opens Slightly Lower; JNJ's Janssen Reported FDA Approval Of DARZALEX Yesterday,2016-11-22 09:39:00-05:00,JNJ,johnson and johnson opens slightly lower jnjs janssen reported fda approval of darzalex yesterday,"{'neg': 0.112, 'neu': 0.706, 'pos': 0.182, 'compound': 0.2944}",positive,0.9987363219261169
696903,696903,708123.0,Janssen Submits Application To FDA Seeking guselkumab Approval For Treatment Of Plaque Psoriasis,2016-11-17 08:05:00-05:00,JNJ,janssen submits application to fda seeking guselkumab approval for treatment of plaque psoriasis,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.4767}",neutral,0.99969482421875
696904,696904,708124.0,UPDATE: Janssen Reports Safety Observations Through 24 Weeks For guselkumab Show 36% of Patients Experienced Adverse Events vs. 32.7% Of Placebo,2016-11-15 08:09:00-05:00,JNJ,update janssen reports safety observations through 24 weeks for guselkumab show 36 percent of patients experienced adverse events vs 32.7 percent of placebo,"{'neg': 0.095, 'neu': 0.798, 'pos': 0.106, 'compound': 0.0772}",neutral,0.9961817264556885
696905,696905,708125.0,"Janssen Reports guselkumab Phase 2 Results In Psoriatic Arthritis Follow Positive Phase 3 Study In Plaque Psoriasis, 2 Serious Adverse Events Were Reported, Safety Observations",2016-11-15 08:08:00-05:00,JNJ,janssen reports guselkumab phase 2 results in psoriatic arthritis follow positive phase 3 study in plaque psoriasis 2 serious adverse events were reported safety observations,"{'neg': 0.122, 'neu': 0.673, 'pos': 0.205, 'compound': 0.5574}",neutral,0.9425429701805115
696906,696906,708126.0,"13F from Paulson & Co. Shows New Stakes in eBay, HP Enterprises, Infblox, Carmike, Increased Stake in Facebook, Boston Scientific, Reduced Stake in J&J, Liquidated Stakes in EMC, B/E Aerospace",2016-11-14 17:46:00-05:00,JNJ,13 f from paulson and co shows new stakes in ebay hp enterprises infblox carmike increased stake in facebook boston scientific reduced stake in j and j liquidated stakes in emc b and e aerospace,"{'neg': 0.0, 'neu': 0.942, 'pos': 0.058, 'compound': 0.2732}",positive,0.9992156028747559
696907,696907,708127.0,Johnson And Johnson New Phase 3 Data Shows Simponi Aria Significantly Improved Signs & Symptoms In Patients With Ankylosing Spondylitis,2016-11-14 08:10:00-05:00,JNJ,johnson and johnson new phase 3 data shows simponi aria significantly improved signs and symptoms in patients with ankylosing spondylitis,"{'neg': 0.0, 'neu': 0.86, 'pos': 0.14, 'compound': 0.4767}",positive,0.9996871948242188
696908,696908,708128.0,9 Of The Most Successful Veterans Turned CEOs,2016-11-11 11:00:00-05:00,JNJ,9 of the most successful veterans turned ceos,"{'neg': 0.0, 'neu': 0.631, 'pos': 0.369, 'compound': 0.624}",neutral,0.999009370803833
696909,696909,708129.0,Janssen REports Clinical Trial Partnership And Supply Agreement With Amgen To Evaluate daratumumab In Combination With carfilzomib,2016-11-10 08:36:00-05:00,JNJ,janssen reports clinical trial partnership and supply agreement with amgen to evaluate daratumumab in combination with carfilzomib,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.4939}",positive,0.9838091135025024
696910,696910,708130.0,UPDATE: Bayer Says Statements Published in Handelsblatt are Misleading -Reuters,2016-11-09 06:28:00-05:00,JNJ,update bayer says statements published in handelsblatt are misleading reuters,"{'neg': 0.231, 'neu': 0.769, 'pos': 0.0, 'compound': -0.4019}",neutral,0.995315670967102
696911,696911,708131.0,Handlelsblatt Reports Test Equipment Used in Pivotal Trial of Bayer's Xarelto was Defective,2016-11-09 06:27:00-05:00,JNJ,handlelsblatt reports test equipment used in pivotal trial of bayers xarelto was defective,"{'neg': 0.195, 'neu': 0.805, 'pos': 0.0, 'compound': -0.4404}",negative,0.9882946014404297
696912,696912,708132.0,"In Latest Johnson & Johnson 10-Q, Company Reported A Patient Death In Janssen's IMBbark and IMerge With Adverse Events Associated With Geron's imetelstat",2016-11-04 10:00:00-04:00,JNJ,in latest johnson and johnson 10 q company reported a patient death in janssens imbbark and imerge with adverse events associated with gerons imetelstat,"{'neg': 0.225, 'neu': 0.775, 'pos': 0.0, 'compound': -0.7506}",negative,0.9895785450935364
696913,696913,708133.0,Are The Drugs Working? Pfizer Updates Financials And Disease Therapy Performances,2016-10-31 12:00:00-04:00,JNJ,are the drugs working pfizer updates financials and disease therapy performances,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998569488525391
696914,696914,708134.0,Can You Guess This Chart?,2016-10-28 07:44:00-04:00,JNJ,can you guess this chart,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998624324798584
696915,696915,708135.0,Jury Awards $70M in Johnson & Johnson Cancer Suit,2016-10-28 04:25:00-04:00,JNJ,jury awards dollars 0 million in johnson and johnson cancer suit,"{'neg': 0.268, 'neu': 0.549, 'pos': 0.183, 'compound': -0.34}",neutral,0.9938511848449707
696916,696916,708136.0,Goldman Says These 25 Healthcare Stocks Are Immune To The Election,2016-10-24 10:55:00-04:00,JNJ,goldman says these 25 healthcare stocks are immune to the election,"{'neg': 0.0, 'neu': 0.82, 'pos': 0.18, 'compound': 0.296}",neutral,0.9998713731765747
696917,696917,708137.0,"Fed Speakers And Beige Book, Bank Earnings, Rising Crude Take Center Stage",2016-10-19 12:38:00-04:00,JNJ,fed speakers and beige book bank earnings rising crude take center stage,"{'neg': 0.252, 'neu': 0.748, 'pos': 0.0, 'compound': -0.5719}",positive,0.9980562925338745
696918,696918,708138.0,Johnson & Johnson's Robust Pipeline Supports Its Above-Average Valuation,2016-10-19 12:07:00-04:00,JNJ,johnson and johnsons robust pipeline supports its above average valuation,"{'neg': 0.0, 'neu': 0.62, 'pos': 0.38, 'compound': 0.5994}",positive,0.9996411800384521
696919,696919,708139.0,Technical Alert: Johnson & Johnson Craters After Q3 Report,2016-10-18 13:49:00-04:00,JNJ,technical alert johnson and johnson craters after third quarter report,"{'neg': 0.0, 'neu': 0.804, 'pos': 0.196, 'compound': 0.296}",neutral,0.9998168349266052
696920,696920,708140.0,"Earnings Roll On, With Goldman, Netflix Results Giving Market A Lift",2016-10-18 11:46:00-04:00,JNJ,earnings roll on with goldman netflix results giving market a lift,"{'neg': 0.0, 'neu': 0.806, 'pos': 0.194, 'compound': 0.34}",positive,0.9996697902679443
696921,696921,708141.0,"The Market In 5 Minutes: Netflix Dominates, Goldman Sachs Keeps Banks Flowing",2016-10-18 08:57:00-04:00,JNJ,the market in 5 minutes netflix dominates goldman sachs keeps banks flowing,"{'neg': 0.0, 'neu': 0.902, 'pos': 0.098, 'compound': 0.0516}",neutral,0.7168093919754028
696922,696922,708142.0,A Peek Into The Markets: U.S. Stock Futures Surge; Goldman Sachs Earnings In Focus,2016-10-18 07:34:00-04:00,JNJ,a peek into the markets u s stock futures surge goldman sachs earnings in focus,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9900513291358948
696923,696923,708143.0,Johnson & Johnson Delivers Another Earnings Beat,2016-10-18 07:11:00-04:00,JNJ,johnson and johnson delivers another earnings beat,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9995651841163635
696924,696924,708144.0,"Johnson & Johnson Sees FY EPS $6.68 to $6.73 vs $6.69 est, Revenue $71.5B to $72.2B vs $72.2B est",2016-10-18 06:41:00-04:00,JNJ,johnson and johnson sees fy eps dollars .68 to dollars .73 vs dollars .69 est revenue dollars 1.5 billion to dollars 2.2 billion vs dollars 2.2 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998703002929688
696925,696925,708145.0,"Johnson & Johnson Q3 EPS $1.68 vs $1.65 est, Revenue $17.8B vs $17.7B est",2016-10-18 06:40:00-04:00,JNJ,johnson and johnson third quarter eps dollars .68 vs dollars .65 est revenue dollars 7.8 billion vs dollars 7.7 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998819828033447
696926,696926,708146.0,"10 Stocks To Watch For October 18, 2016",2016-10-18 05:18:00-04:00,JNJ,10 stocks to watch for october 18 2016,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998594522476196
696927,696927,708147.0,"Earnings Scheduled For October 18, 2016",2016-10-18 04:02:00-04:00,JNJ,earnings scheduled for october 18 2016,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998787641525269
696928,696928,708148.0,Technical Alert: Johnson & Johnson Finds Support,2016-10-17 13:07:00-04:00,JNJ,technical alert johnson and johnson finds support,"{'neg': 0.0, 'neu': 0.505, 'pos': 0.495, 'compound': 0.5994}",neutral,0.9867859482765198
696929,696929,708149.0,"Earnings: Who's At Bat Next? Netflix, IBM, And More.",2016-10-17 11:28:00-04:00,JNJ,earnings whos at bat next netflix ibm and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998694658279419
696930,696930,708150.0,Plenty To Chew On As Heart Of Earnings Season Approaches; Fed Speakers On Prowl,2016-10-17 09:01:00-04:00,JNJ,plenty to chew on as heart of earnings season approaches fed speakers on prowl,"{'neg': 0.0, 'neu': 0.756, 'pos': 0.244, 'compound': 0.6369}",neutral,0.9997372031211853
696931,696931,708151.0,Kevin Kelly's Johnson & Johnson Trade,2016-10-11 17:31:00-04:00,JNJ,kevin kellys johnson and johnson trade,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998598098754883
696932,696932,708152.0,Can You Guess This Chart?,2016-10-11 07:52:00-04:00,JNJ,can you guess this chart,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998624324798584
696933,696933,708153.0,J&J Warns Diabetic Patients that Insulin Pump is Vulnerable to Hacking -Reuters,2016-10-04 08:28:00-04:00,JNJ,j and j warns diabetic patients that insulin pump is vulnerable to hacking reuters,"{'neg': 0.216, 'neu': 0.784, 'pos': 0.0, 'compound': -0.3182}",negative,0.7854297161102295
696934,696934,708154.0,Here's Everything You Need To Know About Blue Chip Stocks,2016-09-28 14:02:00-04:00,JNJ,heres everything you need to know about blue chip stocks,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998632669448853
696935,696935,708155.0,"vTv Therapeutics Shares Initiated With Buy Rating, $13 Target",2016-09-26 11:46:00-04:00,JNJ,vtv therapeutics shares initiated with buy rating dollars 3 target,"{'neg': 0.0, 'neu': 0.804, 'pos': 0.196, 'compound': 0.296}",neutral,0.9998691082000732
696936,696936,708156.0,J&J's Janssen Reports FDA Approval of STELARA for Treatment of Adults With Moderately To Severely Active Crohn's Disease,2016-09-26 09:09:00-04:00,JNJ,j and js janssen reports fda approval of stelara for treatment of adults with moderately to severely active crohns disease,"{'neg': 0.116, 'neu': 0.659, 'pos': 0.225, 'compound': 0.4215}",positive,0.9970971345901489
696937,696937,708157.0,First Trust Gets Smart With New Sector ETFs,2016-09-26 08:24:00-04:00,JNJ,first trust gets smart with new sector etfs,"{'neg': 0.0, 'neu': 0.5, 'pos': 0.5, 'compound': 0.7184}",positive,0.9912315011024475
696938,696938,708158.0,The Market In 5 Minutes: No Interest Rate Hike...Yet,2016-09-22 09:04:00-04:00,JNJ,the market in 5 minutes no interest rate hike yet,"{'neg': 0.216, 'neu': 0.784, 'pos': 0.0, 'compound': -0.357}",neutral,0.9997932314872742
696939,696939,708159.0,Can You Guess This Chart?,2016-09-22 07:31:00-04:00,JNJ,can you guess this chart,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998624324798584
696940,696940,708160.0,"Shares of Johnson & Johnson Volatile, Traders Attribute Action To Negative Comments From Favus Research",2016-09-21 09:43:00-04:00,JNJ,shares of johnson and johnson volatile traders attribute action to negative comments from favus research,"{'neg': 0.196, 'neu': 0.688, 'pos': 0.116, 'compound': -0.3612}",negative,0.9890657663345337
696941,696941,708161.0,Credit Suisse Can Clearly See Why Johnson & Johnson Acquired Abbott's Optics Division,2016-09-19 10:16:00-04:00,JNJ,credit suisse can clearly see why johnson and johnson acquired abbotts optics division,"{'neg': 0.0, 'neu': 0.675, 'pos': 0.325, 'compound': 0.6486}",neutral,0.9998503923416138
696942,696942,708162.0,"Alere Shares Up ~$0.60 Over Last Few Mins as Traders Seemingly Responding to J&J, Abbott Deal",2016-09-16 15:05:00-04:00,JNJ,alere shares up dollars .60 over last few mins as traders seemingly responding to j and j abbott deal,"{'neg': 0.0, 'neu': 0.891, 'pos': 0.109, 'compound': 0.296}",positive,0.999675989151001
696943,696943,708163.0,UPDATE: Abbott Labs Says Net Impact Of J&J Transaction Will Not Effect Abbott's Targeted EPS In 2017,2016-09-16 15:03:00-04:00,JNJ,update abbott labs says net impact of j and j transaction will not effect abbotts targeted eps in 2017,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9995263814926147
696944,696944,708164.0,Johnson & Johnson To Acquire Abbott Medical Optics For $4.325B Cash,2016-09-16 15:01:00-04:00,JNJ,johnson and johnson to acquire abbott medical optics for dollars .325 billion cash,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998886585235596
696945,696945,708165.0,Hearing Johnson & Johnson Nearing Deal To Buy Abbott's Eye-Surgery Equipment Unit,2016-09-16 12:30:00-04:00,JNJ,hearing johnson and johnson nearing deal to buy abbotts eye surgery equipment unit,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9991310238838196
696946,696946,708166.0,"BZ NOTE: J&J Shares Appear Rangebound Over the Last Hour, Trading Between $118.40 and $118.60",2016-09-16 11:17:00-04:00,JNJ,bz note j and j shares appear rangebound over the last hour trading between dollars 18.40 and dollars 18.60,"{'neg': 0.0, 'neu': 0.825, 'pos': 0.175, 'compound': 0.3818}",neutral,0.9998823404312134
696947,696947,708167.0,J&J Shares Up ~$0.13 Over Last Min; Upside Attributing to Unconfirmed Chatter of Bill Ackman Stake,2016-09-16 11:17:00-04:00,JNJ,j and j shares up dollars .13 over last min upside attributing to unconfirmed chatter of bill ackman stake,"{'neg': 0.072, 'neu': 0.821, 'pos': 0.106, 'compound': 0.1779}",positive,0.9996719360351562
696948,696948,708168.0,"J&J's Janssen Says Following Positive CHMP Opinion on Ustekinumab, Final Decision from EC Expected Later in '16",2016-09-16 09:48:00-04:00,JNJ,j and js janssen says following positive chmp opinion on ustekinumab final decision from ec expected later in 16,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.5574}",positive,0.9740403890609741
696949,696949,708169.0,The Market In 5 Minutes: Apple Helps Lead Stocks Higher,2016-09-15 08:58:00-04:00,JNJ,the market in 5 minutes apple helps lead stocks higher,"{'neg': 0.0, 'neu': 0.776, 'pos': 0.224, 'compound': 0.3818}",positive,0.9993938207626343
696950,696950,708170.0,Can You Guess This Chart?,2016-09-15 07:22:00-04:00,JNJ,can you guess this chart,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998624324798584
696951,696951,708171.0,J&J Reports WHO Will Review Co.'s Ebola Vaccine Regiment for EUAL,2016-09-12 14:39:00-04:00,JNJ,j and j reports who will review co s ebola vaccine regiment for eual,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998798370361328
696952,696952,708172.0,Geron +13.64% @$3.25 Following Update on  Imetelstat,2016-09-12 07:38:00-04:00,JNJ,geron positive 13.64 percent dollars .25 following update on imetelstat,"{'neg': 0.0, 'neu': 0.714, 'pos': 0.286, 'compound': 0.5574}",positive,0.9993183612823486
696953,696953,708173.0,"Reads For The Weed-Kend: Marijuana Roadside Testing, Pregnancy And Depression",2016-09-11 17:09:00-04:00,JNJ,reads for the weed kend marijuana roadside testing pregnancy and depression,"{'neg': 0.27, 'neu': 0.73, 'pos': 0.0, 'compound': -0.5719}",neutral,0.9998657703399658
696954,696954,708174.0,"Achillion Pharma Reports 100% SVR Reported in Janssen's Phase 2a Trial Evaluating Triple Combination of Odalasvir, AL-335, and Simeprevir for Genotype 1 Treatment-Naive HCV",2016-09-09 06:20:00-04:00,JNJ,achillion pharma reports 100 percent svr reported in janssens phase 2 a trial evaluating triple combination of odalasvir al 335 and simeprevir for genotype 1 treatment naive hcv,"{'neg': 0.072, 'neu': 0.928, 'pos': 0.0, 'compound': -0.2732}",neutral,0.9998757839202881
696955,696955,708175.0,How Does Amazon's Meteoric Rise Compare To Those Of Its Mega-Cap Peers?,2016-09-08 11:34:00-04:00,JNJ,how does amazons meteoric rise compare to those of its mega cap peers,"{'neg': 0.084, 'neu': 0.916, 'pos': 0.0, 'compound': -0.0258}",positive,0.9992413520812988
696956,696956,708176.0,Another Election Year View On Healthcare ETFs,2016-09-08 11:12:00-04:00,JNJ,another election year view on healthcare etfs,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998784065246582
696957,696957,708177.0,FDA Orders Stores To Cleanse Their Shelves Of Ineffective Hand Soaps,2016-09-06 10:55:00-04:00,JNJ,fda orders stores to cleanse their shelves of ineffective hand soaps,"{'neg': 0.109, 'neu': 0.657, 'pos': 0.234, 'compound': 0.4019}",neutral,0.9942432045936584
696958,696958,708178.0,"Out With The Old, In With The New: State Agencies Seem To Prefer Marijuana Over Opioids",2016-09-06 10:26:00-04:00,JNJ,out with the old in with the new state agencies seem to prefer marijuana over opioids,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997089505195618
696959,696959,708179.0,Johnson & Johnson Gets Patent For Ortho Regenerate Technologies,2016-09-01 10:51:00-04:00,JNJ,johnson and johnson gets patent for ortho regenerate technologies,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.5828384160995483
696960,696960,708180.0,"Pre-Market Prep Host Dennis Dick Tweets Notable Opening Imbalance: Notable opening imbalances: $BAC +1.1M, $ABX -234K, $GE -56K, $JNJ +35K, $VEEV +40K, $F -90K, $MS -40K, $C +35K",2016-08-31 09:24:00-04:00,JNJ,pre market prep host dennis dick tweets notable opening imbalance notable opening imbalances bac positive 1.1 million abx negative 234 thousand ge negative 56 thousand jnj positive 35 thousand veev positive 40 thousand f negative 90 thousand ms negative 40 thousand c positive 35 thousand,"{'neg': 0.264, 'neu': 0.526, 'pos': 0.21, 'compound': -0.5719}",negative,0.9975804090499878
696961,696961,708181.0,Option Alert: JNJ Fri 8/26 119 Puts (Wkly): 2000 @  ASK  $0.55: 2398 traded vs 1999 OI:  Earnings 10/11  $118.80 Ref,2016-08-24 15:03:00-04:00,JNJ,option alert jnj fri 119 puts wkly 2000 ask dollars .55 2398 traded vs 1999 oi earnings dollars 18.80 ref,"{'neg': 0.0, 'neu': 0.896, 'pos': 0.104, 'compound': 0.296}",neutral,0.9998786449432373
696962,696962,708182.0,Write A Prescription For More Pharma M&A With This ETF,2016-08-24 10:00:00-04:00,JNJ,write a prescription for more pharma m and a with this etf,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998818635940552
696963,696963,708183.0,Janssen Submit European Application To Expand Darzalex Use - Reuters,2016-08-23 06:59:00-04:00,JNJ,janssen submit european application to expand darzalex use to reuters,"{'neg': 0.0, 'neu': 0.796, 'pos': 0.204, 'compound': 0.3182}",neutral,0.9858400821685791
696964,696964,708184.0,Goldman Sachs Talks Pfizer's Acquisition Deal Of Medivation,2016-08-22 08:17:00-04:00,JNJ,goldman sachs talks pfizers acquisition deal of medivation,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9905672669410706
696965,696965,708185.0,Geron Shares Seen Range-Bound On Lack Of Major Data Until Late 2017,2016-08-19 12:28:00-04:00,JNJ,geron shares seen range bound on lack of major data until late 2017,"{'neg': 0.148, 'neu': 0.71, 'pos': 0.142, 'compound': -0.0258}",neutral,0.9992974996566772
696966,696966,708186.0,"10 Notable Stocks Trading Ex-Dividend Friday, August 19",2016-08-18 15:59:00-04:00,JNJ,10 notable stocks trading ex dividend friday august 19,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999890923500061
696967,696967,708187.0,Deutsche Takes A Look At Johnson & Johnson's Patent Woes,2016-08-18 14:53:00-04:00,JNJ,deutsche takes a look at johnson and johnsons patent woes,"{'neg': 0.244, 'neu': 0.756, 'pos': 0.0, 'compound': -0.4404}",neutral,0.9990299940109253
696968,696968,708188.0,Recent Patent Ruling A Positive For Pfizer,2016-08-18 14:26:00-04:00,JNJ,recent patent ruling a positive for pfizer,"{'neg': 0.0, 'neu': 0.625, 'pos': 0.375, 'compound': 0.5574}",positive,0.9994921684265137
696969,696969,708189.0,"Johnson & Johnson Reaffirms Sales Guidance For FY16 Of 3-4%, Not Including Possibility Of A Biosimilar Launch On Or After Oct. 3th 2016",2016-08-17 13:57:00-04:00,JNJ,johnson and johnson reaffirms sales guidance for fy16 of 3 to 4 percent not including possibility of a biosimilar launch on or after oct 3 2016,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9939694404602051
696970,696970,708190.0,Johnson & Johnson Says Janssen Continuing Appeal Process In Proceedings Related To '471 Patent Before USPTO,2016-08-17 13:56:00-04:00,JNJ,johnson and johnson says janssen continuing appeal process in proceedings related to 471 patent before uspto,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999852180480957
696971,696971,708191.0,JNJ Spikes to High of $121.19 on Volume,2016-08-17 13:39:00-04:00,JNJ,jnj spikes to high of dollars 21.19 on volume,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9990760087966919
696972,696972,708192.0,J&J's Janssen R&D Unit Says Esketamine Receives Breakthrough Therapy Designation from FDA Related to Major Depressive Disorder with Imminent Risk for Suicide,2016-08-16 09:02:00-04:00,JNJ,j and js janssen r and d unit says esketamine receives breakthrough therapy designation from fda related to major depressive disorder with imminent risk for suicide,"{'neg': 0.362, 'neu': 0.638, 'pos': 0.0, 'compound': -0.9095}",positive,0.9995800852775574
696973,696973,708193.0,Biogen Cancels Out Of Citigroup Conference Following Weeks Of Rumors,2016-08-11 15:02:00-04:00,JNJ,biogen cancels out of citigroup conference following weeks of rumors,"{'neg': 0.174, 'neu': 0.826, 'pos': 0.0, 'compound': -0.2263}",negative,0.7684538960456848
696974,696974,708194.0,Canada's Plan To Fight Opioid Addiction Might Hurt Its Weakest Patients,2016-08-08 16:59:00-04:00,JNJ,canadas plan to fight opioid addiction might hurt its weakest patients,"{'neg': 0.538, 'neu': 0.462, 'pos': 0.0, 'compound': -0.8519}",negative,0.997748076915741
696975,696975,708195.0,"Biogen Shares Unaffected Amid Dealreporter Report Suggesting Pfizer, J&J Could Also Be Looking at Co.",2016-08-08 11:28:00-04:00,JNJ,biogen shares unaffected amid dealreporter report suggesting pfizer j and j could also be looking at co,"{'neg': 0.0, 'neu': 0.879, 'pos': 0.121, 'compound': 0.296}",negative,0.9920119643211365
696976,696976,708196.0,Deutsche Downgrades Ligand As Risk/Reward Becomes Challenging,2016-08-05 14:25:00-04:00,JNJ,deutsche downgrades ligand as risk and reward becomes challenging,"{'neg': 0.157, 'neu': 0.448, 'pos': 0.396, 'compound': 0.4939}",negative,0.9980691075325012
696977,696977,708197.0,Another Jobs Report Bonanza: Big July Job Gains Lend Support To Stock Market,2016-08-05 10:39:00-04:00,JNJ,another jobs report bonanza big july job gains lend support to stock market,"{'neg': 0.0, 'neu': 0.683, 'pos': 0.317, 'compound': 0.6249}",positive,0.9995977282524109
696978,696978,708198.0,3 Things The Market Is Focused On This Week,2016-07-25 12:35:00-04:00,JNJ,3 things the market is focused on this week,"{'neg': 0.0, 'neu': 0.755, 'pos': 0.245, 'compound': 0.3818}",neutral,0.9998822212219238
696979,696979,708199.0,Johnson & Johnson Subsidiary Acclarent To Pay $18M To Settle False Claims Act Allegations,2016-07-22 10:46:00-04:00,JNJ,johnson and johnson subsidiary acclarent to pay dollars 8 million to settle false claims act allegations,"{'neg': 0.085, 'neu': 0.915, 'pos': 0.0, 'compound': -0.1027}",neutral,0.9964039325714111
696980,696980,708200.0,"Opioid Addiction: What To Do When A Loved One Is Hooked, According To Science",2016-07-21 08:40:00-04:00,JNJ,opioid addiction what to do when a loved one is hooked according to science,"{'neg': 0.0, 'neu': 0.769, 'pos': 0.231, 'compound': 0.5994}",neutral,0.9998236298561096
696981,696981,708201.0,Argus Boosts Price Target On Johnson & Johnson Following Strong Quarter,2016-07-20 12:02:00-04:00,JNJ,argus boosts price target on johnson and johnson following strong quarter,"{'neg': 0.0, 'neu': 0.616, 'pos': 0.384, 'compound': 0.6808}",positive,0.9996939897537231
696982,696982,708202.0,Option Alert: JNJ Sep16 130 Calls: 2500 @  ASK  $0.41: 2556 traded vs 1057 OI: $125.51 Ref,2016-07-20 10:16:00-04:00,JNJ,option alert jnj sep16 130 calls 2500 ask dollars .41 2556 traded vs 1057 oi dollars 25.51 ref,"{'neg': 0.0, 'neu': 0.885, 'pos': 0.115, 'compound': 0.296}",neutral,0.9998781681060791
696983,696983,708203.0,7 Biggest Price Target Changes For Wednesday,2016-07-20 09:31:00-04:00,JNJ,7 biggest price target changes for wednesday,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999821126461029
696984,696984,708204.0,"The Market In 5 Minutes: Microsoft Beat, Disney Downgrade And Donald Trump",2016-07-20 09:09:00-04:00,JNJ,the market in 5 minutes microsoft beat disney downgrade and donald trump,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9975651502609253
696985,696985,708205.0,Benzinga's Top Upgrades,2016-07-20 08:51:00-04:00,JNJ,benzingas top upgrades,"{'neg': 0.0, 'neu': 0.526, 'pos': 0.474, 'compound': 0.2023}",positive,0.7773524522781372
696986,696986,708206.0,"Argus Research Upgrades Johnson & Johnson to Buy, Raises PT to $145.00",2016-07-20 07:08:00-04:00,JNJ,argus research upgrades johnson and johnson to buy raises point to dollars 45.00,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9992293119430542
696987,696987,708207.0,Earnings: HAL's Tie to Oil Prices Could Set Stage for Quarterly Loss,2016-07-19 12:06:00-04:00,JNJ,earnings hals tie to oil prices could set stage for quarterly loss,"{'neg': 0.173, 'neu': 0.827, 'pos': 0.0, 'compound': -0.3182}",negative,0.9982377290725708
696988,696988,708208.0,Stocks Hitting 52-Week Highs,2016-07-19 10:09:00-04:00,JNJ,stocks hitting 52 week highs,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9992315769195557
696989,696989,708209.0,"The Market In 5 Minutes: Netflix Earnings Disappoint, Goldman Sachs Has Big Beat",2016-07-19 08:48:00-04:00,JNJ,the market in 5 minutes netflix earnings disappoint goldman sachs has big beat,"{'neg': 0.184, 'neu': 0.816, 'pos': 0.0, 'compound': -0.4019}",positive,0.9996029734611511
696990,696990,708210.0,12 Stocks Moving In Tuesday's Pre-Market Session,2016-07-19 08:20:00-04:00,JNJ,12 stocks moving in tuesdays pre market session,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998739957809448
696991,696991,708211.0,A Peek Into The Markets: U.S. Stock Futures Down Ahead Of Earnings,2016-07-19 07:55:00-04:00,JNJ,a peek into the markets u s stock futures down ahead of earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9472407698631287
696992,696992,708212.0,Investors Cheer Johnson & Johnson's Q2 Results,2016-07-19 07:48:00-04:00,JNJ,investors cheer johnson and johnsons second quarter results,"{'neg': 0.0, 'neu': 0.68, 'pos': 0.32, 'compound': 0.5106}",neutral,0.9994359612464905
696993,696993,708213.0,Ionis Pharma Reports Licensing of First Oral Antisense Drug Acting Locally in GT Tract to J&J's Janssen,2016-07-19 07:06:00-04:00,JNJ,ionis pharma reports licensing of first oral antisense drug acting locally in gt tract to j and js janssen,"{'neg': 0.0, 'neu': 0.896, 'pos': 0.104, 'compound': 0.2732}",neutral,0.9998846054077148
696994,696994,708214.0,"Johnson & Johnson Q2 EPS $1.74 vs $1.68 est, Revenue $18.5B vs $18.0B est",2016-07-19 06:41:00-04:00,JNJ,johnson and johnson second quarter eps dollars .74 vs dollars .68 est revenue dollars 8.5 billion vs dollars 8.0 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998806715011597
696995,696995,708215.0,"Keep an Eye on These 12 Stocks for July 19, 2016",2016-07-19 05:02:00-04:00,JNJ,keep an eye on these 12 stocks for july 19 2016,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998526573181152
696996,696996,708216.0,"Earnings Scheduled For July 19, 2016",2016-07-19 04:09:00-04:00,JNJ,earnings scheduled for july 19 2016,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998812675476074
696997,696997,708217.0,Johnson & Johnson Dividend Offers 2.6% Yield,2016-07-18 15:35:00-04:00,JNJ,johnson and johnson dividend offers 2.6 percent yield,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997416138648987
696998,696998,708218.0,Can NFLX Grow its Subscriber Base?,2016-07-18 11:12:00-04:00,JNJ,can nflx grow its subscriber base,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9995946288108826
696999,696999,708219.0,"Bank Earnings Keep Coming In New Week, But Economic Data Flow to Slow",2016-07-18 10:32:00-04:00,JNJ,bank earnings keep coming in new week but economic data flow to slow,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9984421133995056
697000,697000,708220.0,The Market In 5 Minutes: Earnings Season Is Upon Us,2016-07-18 08:52:00-04:00,JNJ,the market in 5 minutes earnings season is upon us,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998574256896973
697001,697001,708221.0,A Shark Of An ETF In The Dividend ETF Tank,2016-07-18 08:16:00-04:00,JNJ,a shark of an etf in the dividend etf tank,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998871088027954
697002,697002,708222.0,Benzinga's Weekend M&A Chatter,2016-07-17 20:45:00-04:00,JNJ,benzingas weekend m and a chatter,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998726844787598
697003,697003,708223.0,Amazon Moves Cloud Service Focus From Startups Like Lyft To Big Enterprises Like Netflix And Capital One,2016-07-14 14:26:00-04:00,JNJ,amazon moves cloud service focus from startups like lyft to big enterprises like netflix and capital one,"{'neg': 0.0, 'neu': 0.676, 'pos': 0.324, 'compound': 0.6908}",neutral,0.9983217120170593
697004,697004,708224.0,"Amazon's Cloud Services Could Add $1 Billion To Revenue, Says Pacific Crest",2016-07-14 10:24:00-04:00,JNJ,amazons cloud services could add dollars billion to revenue says pacific crest,"{'neg': 0.091, 'neu': 0.909, 'pos': 0.0, 'compound': -0.0258}",positive,0.9994710087776184
697005,697005,708225.0,UPDATE: CI:Z Will Receive Two Board Members From Johnson & Johnson,2016-07-11 14:14:00-04:00,JNJ,update ci z will receive two board members from johnson and johnson,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998742341995239
697006,697006,708226.0,"UPDATE: A Johnson & Johnson Subsidiary Will Buy A 19.9% Stake In CI:Z, Becoming 2nd Largest Shareholder",2016-07-11 14:12:00-04:00,JNJ,update a johnson and johnson subsidiary will buy a 19.9 percent stake in ci z becoming 2 largest shareholder,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998840093612671
697007,697007,708227.0,Johnson & Johnson To Buy 20% Stake In Japanese Cosmetics Maker,2016-07-11 14:11:00-04:00,JNJ,johnson and johnson to buy 20 percent stake in japanese cosmetics maker,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998282194137573
697008,697008,708228.0,"Barclays Morning Research Summary: Commodities, Comcast And Healthcare In Focus",2016-07-08 13:35:00-04:00,JNJ,barclays morning research summary commodities comcast and healthcare in focus,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.99988853931427
697009,697009,708229.0,Achillion Shares Rally Following JMP's Upgrade To Market Outperform,2016-07-07 10:52:00-04:00,JNJ,achillion shares rally following jmps upgrade to market outperform,"{'neg': 0.0, 'neu': 0.784, 'pos': 0.216, 'compound': 0.296}",positive,0.9995923638343811
697010,697010,708230.0,Be Aware Of These Key Technical Levels As You Trade Today,2016-07-06 14:36:00-04:00,JNJ,be aware of these key technical levels as you trade today,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998824596405029
697011,697011,708231.0,Johnson & Johnson Subsidiary DePuy Orthopaedics Says Patients Suffering From Company's Pinnacle Metal-on-Metal Hip Implants Will Be Heard In September,2016-07-06 13:20:00-04:00,JNJ,johnson and johnson subsidiary depuy orthopaedics says patients suffering from companys pinnacle metal on metal hip implants will be heard in september,"{'neg': 0.129, 'neu': 0.871, 'pos': 0.0, 'compound': -0.4767}",neutral,0.9998507499694824
697012,697012,708232.0,No Tears In Johnson & Johnson,2016-06-27 12:54:00-04:00,JNJ,no tears in johnson and johnson,"{'neg': 0.0, 'neu': 0.75, 'pos': 0.25, 'compound': 0.1695}",neutral,0.9998014569282532
697013,697013,708233.0,Invega Trinza Approved By Health Canada For Schizophrenia,2016-06-27 07:09:00-04:00,JNJ,invega trinza approved by health canada for schizophrenia,"{'neg': 0.0, 'neu': 0.714, 'pos': 0.286, 'compound': 0.4215}",neutral,0.9998646974563599
697014,697014,708234.0,Baird Says Buy Cooper Companies At Current Levels,2016-06-24 09:48:00-04:00,JNJ,baird says buy cooper companies at current levels,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999823272228241
697015,697015,708235.0,Gilead Sciences Get European Commission Grant For Marketing Authorization Of Its Single Tablet Regimen Odefsey,2016-06-23 11:30:00-04:00,JNJ,gilead sciences get european commission grant for marketing authorization of its single tablet regimen odefsey,"{'neg': 0.0, 'neu': 0.848, 'pos': 0.152, 'compound': 0.3612}",positive,0.9979956150054932
697016,697016,708236.0,European Commission Grants Marketing Authorization for Gilead's Single Tablet Regimen Odefsey for the Treatment of HIV,2016-06-23 07:55:00-04:00,JNJ,european commission grants marketing authorization for gileads single tablet regimen odefsey for the treatment of hiv,"{'neg': 0.0, 'neu': 0.888, 'pos': 0.112, 'compound': 0.2263}",positive,0.994904637336731
697017,697017,708237.0,Technology Forces Advertisers To Get Creative,2016-06-22 14:12:00-04:00,JNJ,technology forces advertisers to get creative,"{'neg': 0.0, 'neu': 0.633, 'pos': 0.367, 'compound': 0.4404}",neutral,0.9935511350631714
697018,697018,708238.0,S&P 500 Index Futures Trading Higher,2016-06-22 10:48:00-04:00,JNJ,SP500 500 index futures trading higher,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9990843534469604
697019,697019,708239.0,A Peek Into The Markets: U.S. Stock Futures Edge Higher Ahead Of Yellen Speech,2016-06-22 07:54:00-04:00,JNJ,a peek into the markets u s stock futures edge higher ahead of yellen speech,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9994069337844849
697020,697020,708240.0,Johnson & Johnson Names Joseph Wolk As VP Of Investor Relations In Place Of Louise Mehrotra,2016-06-22 07:24:00-04:00,JNJ,johnson and johnson names joseph wolk as vp of investor relations in place of louise mehrotra,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998600482940674
697021,697021,708241.0,Arbutus Biopharma Taken Off Of Chardan's Sell List,2016-06-16 09:29:00-04:00,JNJ,arbutus biopharma taken off of chardans sell list,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998224377632141
697022,697022,708242.0,5 Pharmaceutical Price Target Raises From Jefferies,2016-06-14 15:13:00-04:00,JNJ,5 pharmaceutical price target raises from jefferies,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9995145797729492
697023,697023,708243.0,February 27 Earnings Update,2016-06-14 11:28:00-04:00,JNJ,february 27 earnings update,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998612403869629
697024,697024,708244.0,Janssen Announces EPREX Demonstrates Effectiveness as Treatment for Anaemia in Patients with Low or Intermediate-1 Risk Myelodysplastic Syndromes at EHA,2016-06-11 08:56:00-04:00,JNJ,janssen announces eprex demonstrates effectiveness as treatment for anaemia in patients with low or intermediate 1 risk myelodysplastic syndromes at eha,"{'neg': 0.181, 'neu': 0.819, 'pos': 0.0, 'compound': -0.4939}",positive,0.9995145797729492
697025,697025,708245.0,Johnson & Johnson's Janssen R&D Reports Phase 3 POLLUX Trial Shows daratumumab Achieved 63% Reduction In Risk Of Disease Progression or Death Compared To lenalidomide and dexamethasone Alone,2016-06-10 07:07:00-04:00,JNJ,johnson and johnsons janssen r and d reports phase 3 pollux trial shows daratumumab achieved 63 percent reduction in risk of disease progression or death compared to lenalidomide and dexamethasone alone,"{'neg': 0.222, 'neu': 0.778, 'pos': 0.0, 'compound': -0.7906}",positive,0.9996273517608643
697026,697026,708246.0,S&P 500 Index Futures Trading Lower,2016-06-09 10:37:00-04:00,JNJ,SP500 500 index futures trading lower,"{'neg': 0.306, 'neu': 0.694, 'pos': 0.0, 'compound': -0.296}",negative,0.9951500296592712
697027,697027,708247.0,4 Key Takeaways From ASCO,2016-06-06 17:32:00-04:00,JNJ,4 key takeaways from asco,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998791217803955
697028,697028,708248.0,"Johnson & Johnson Continues Winning Streak, Makes Another New All-Time High",2016-06-06 14:33:00-04:00,JNJ,johnson and johnson continues winning streak makes another new all time high,"{'neg': 0.0, 'neu': 0.764, 'pos': 0.236, 'compound': 0.5267}",positive,0.9995330572128296
697029,697029,708249.0,S&P 500 Index Futures Trading Higher,2016-06-06 11:32:00-04:00,JNJ,SP500 500 index futures trading higher,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9990843534469604
697030,697030,708250.0,Amyris +22% Premarket @ $0.65; Co Announced Collaboration With J&J on Biosynthetic Drug Discovery,2016-06-06 09:17:00-04:00,JNJ,amyris positive 22 percent premarket dollars .65 co announced collaboration with j and j on biosynthetic drug discovery,"{'neg': 0.0, 'neu': 0.825, 'pos': 0.175, 'compound': 0.5574}",positive,0.9994822144508362
697031,697031,708251.0,S&P 500 Index Futures Trading Lower In Choppy Session,2016-06-02 10:47:00-04:00,JNJ,SP500 500 index futures trading lower in choppy session,"{'neg': 0.216, 'neu': 0.784, 'pos': 0.0, 'compound': -0.296}",negative,0.9961406588554382
697032,697032,708252.0,"The Market In 5 Minutes: Draghi, iPhones And Warriors",2016-06-02 08:58:00-04:00,JNJ,the market in 5 minutes draghi iphones and warriors,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998863935470581
697033,697033,708253.0,Johnson & Johnson Announces Acquisition of Vogue International for $3.3B Cash,2016-06-02 06:45:00-04:00,JNJ,johnson and johnson announces acquisition of vogue international for dollars .3 billion cash,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998860359191895
697034,697034,708254.0,Janssen Pharmaceutica NV Idylla Ebola Virus Triage Test Granted Emergency Use Authorization by FDA -Reuters,2016-06-01 05:00:00-04:00,JNJ,janssen pharmaceutica nv idylla ebola virus triage test granted emergency use authorization by fda reuters,"{'neg': 0.148, 'neu': 0.739, 'pos': 0.114, 'compound': -0.1531}",positive,0.9968283772468567
697035,697035,708255.0,The Market In 5 Minutes: National Send A Nude Day?,2016-05-20 09:50:00-04:00,JNJ,the market in 5 minutes national send a nude day,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998853206634521
697036,697036,708256.0,Benzinga's Top Initiations,2016-05-20 09:30:00-04:00,JNJ,benzingas top initiations,"{'neg': 0.0, 'neu': 0.526, 'pos': 0.474, 'compound': 0.2023}",neutral,0.9998692274093628
697037,697037,708257.0,Standpoint Research Initiates Coverage on Johnson & Johnson at Sell,2016-05-20 07:37:00-04:00,JNJ,standpoint research initiates coverage on johnson and johnson at sell,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998764991760254
697038,697038,708258.0,One Analyst's Top 5 Takeaways From Johnson & Johnson's Analyst Day,2016-05-19 17:51:00-04:00,JNJ,one analysts top 5 takeaways from johnson and johnsons analyst day,"{'neg': 0.0, 'neu': 0.847, 'pos': 0.153, 'compound': 0.2023}",neutral,0.9998717308044434
697039,697039,708259.0,5 Reasons Arrowhead Pharma Is A Hepatitis B Leader,2016-05-19 12:38:00-04:00,JNJ,5 reasons arrowhead pharma is a hepatitis b leader,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998756647109985
697040,697040,708260.0,Johnson & Johnson Aligns With HP To Create Personalized Healthcare Solutions,2016-05-17 10:18:00-04:00,JNJ,johnson and johnson aligns with hp to create personalized healthcare solutions,"{'neg': 0.0, 'neu': 0.703, 'pos': 0.297, 'compound': 0.4215}",neutral,0.9998149275779724
697041,697041,708261.0,"Johnson & Johnson, HP Partner On 3D Printing Technologies  To Reduce Costs and Improve Healthcare",2016-05-17 08:49:00-04:00,JNJ,johnson and johnson hp partner on 3 days printing technologies to reduce costs and improve healthcare,"{'neg': 0.0, 'neu': 0.838, 'pos': 0.162, 'compound': 0.4404}",positive,0.9994698166847229
697042,697042,708262.0,An ETF That Takes Investors To Dividend Growth,2016-05-16 15:53:00-04:00,JNJ,an etf that takes investors to dividend growth,"{'neg': 0.0, 'neu': 0.729, 'pos': 0.271, 'compound': 0.3818}",positive,0.5227797627449036
697043,697043,708263.0,Benzinga's Top Downgrades,2016-05-13 09:19:00-04:00,JNJ,benzingas top downgrades,"{'neg': 0.0, 'neu': 0.526, 'pos': 0.474, 'compound': 0.2023}",negative,0.9905633926391602
697044,697044,708264.0,What To Expect This 13F Season (And Which Hedge Funds To Watch),2016-05-13 06:50:00-04:00,JNJ,what to expect this 13 f season and which hedge funds to watch,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999858021736145
697045,697045,708265.0,"BTIG Downgrades Johnson & Johnson, Admits Buy Thesis 'Had Some Hits & Misses'",2016-05-13 06:46:00-04:00,JNJ,btig downgrades johnson and johnson admits buy thesis had some hits and misses,"{'neg': 0.126, 'neu': 0.728, 'pos': 0.146, 'compound': 0.0772}",negative,0.9985707998275757
697046,697046,708266.0,BTIG Research Downgrades Johnson & Johnson to Neutral,2016-05-12 18:10:00-04:00,JNJ,btig research downgrades johnson and johnson to neutral,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9981333613395691
697047,697047,708267.0,"Jefferies Updates Price Targets In Global Pharma, Sees 'Rich Catalyst Environment' Ahead",2016-05-11 13:05:00-04:00,JNJ,jefferies updates price targets in global pharma sees rich catalyst environment ahead,"{'neg': 0.0, 'neu': 0.753, 'pos': 0.247, 'compound': 0.5574}",positive,0.9993461966514587
697048,697048,708268.0,The Market In 5 Minutes: Don't Stop Me Now,2016-05-11 09:34:00-04:00,JNJ,the market in 5 minutes dont stop me now,"{'neg': 0.0, 'neu': 0.809, 'pos': 0.191, 'compound': 0.2235}",neutral,0.9998656511306763
697049,697049,708269.0,A Trusted Dividend ETF,2016-05-10 09:48:00-04:00,JNJ,a trusted dividend etf,"{'neg': 0.0, 'neu': 0.492, 'pos': 0.508, 'compound': 0.4767}",neutral,0.9998775720596313
697050,697050,708270.0,J&J's Janssen Pharma Unit Reports Received CID in Mar. Related to Contractual Relationships with Pharmacy Benefit Managers,2016-05-10 07:30:00-04:00,JNJ,j and js janssen pharma unit reports received cid in mar related to contractual relationships with pharmacy benefit managers,"{'neg': 0.0, 'neu': 0.857, 'pos': 0.143, 'compound': 0.4588}",neutral,0.9998331069946289
697051,697051,708271.0,S&P 500 Index Futures Turn Lower,2016-05-05 13:56:00-04:00,JNJ,SP500 500 index futures turn lower,"{'neg': 0.306, 'neu': 0.694, 'pos': 0.0, 'compound': -0.296}",negative,0.9969573020935059
697052,697052,708272.0,Johnson & Johnson Loses Another Court Case Over Claims Its Talcum Powder Causes Cancer,2016-05-03 09:20:00-04:00,JNJ,johnson and johnson loses another court case over claims its talcum powder causes cancer,"{'neg': 0.358, 'neu': 0.642, 'pos': 0.0, 'compound': -0.7717}",negative,0.961132824420929
697053,697053,708273.0,GeoInvesting Says Anavex Life Sciences' Stock Has A Book Value Of Just $0.36,2016-05-02 12:25:00-04:00,JNJ,geoinvesting says anavex life sciences stock has a book value of just dollars .36,"{'neg': 0.0, 'neu': 0.844, 'pos': 0.156, 'compound': 0.34}",neutral,0.9998706579208374
697054,697054,708274.0,"JPMorgan Doesn't See A Competing Bid For St. Jude Medical, Downgrades To Neutral",2016-04-29 11:58:00-04:00,JNJ,jpmorgan doesnt see a competing bid for st jude medical downgrades to neutral,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.997350811958313
697055,697055,708275.0,Johnson & Johnson Boosts Dividend By 6.7%,2016-04-28 12:23:00-04:00,JNJ,johnson and johnson boosts dividend by 6.7 percent,"{'neg': 0.0, 'neu': 0.753, 'pos': 0.247, 'compound': 0.3182}",positive,0.9996649026870728
697056,697056,708276.0,Biotech Boom May Continue Through Earnings Season,2016-04-28 12:00:00-04:00,JNJ,biotech boom may continue through earnings season,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9980216026306152
697057,697057,708277.0,Johnson & Johnson Raises Dividend 6.7% from $0.75 to $0.80,2016-04-28 10:35:00-04:00,JNJ,johnson and johnson raises dividend 6.7 percent from dollars .75 to dollars .80,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9899291396141052
697058,697058,708278.0,"3 Put Spread Strategies For The Next Week: McDonald's, Johnson & Johnson And Nvidia",2016-04-27 17:04:00-04:00,JNJ,3 put spread strategies for the next week mcdonalds johnson and johnson and nvidia,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998718500137329
697059,697059,708279.0,"What's Weighing on Markets? AAPL, Tech Stocks",2016-04-27 11:18:00-04:00,JNJ,whats weighing on markets aapl tech stocks,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998447895050049
697060,697060,708280.0,"Johnson & Johnson Consumer Inc. to Acquire NeoStrata Company, Inc., Terms Not Disclosed",2016-04-26 16:08:00-04:00,JNJ,johnson and johnson consumer inc to acquire neostrata company inc terms not disclosed,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999885082244873
697061,697061,708281.0,"The Heart Of Major Pharma Q1 Earnings Season: Eli Lilly, AbbVie, Bristol-Myers",2016-04-25 13:57:00-04:00,JNJ,the heart of major pharma first quarter earnings season eli lilly abbvie bristol myers,"{'neg': 0.0, 'neu': 0.756, 'pos': 0.244, 'compound': 0.6369}",neutral,0.9998732805252075
697062,697062,708282.0,Cramer: What To Know About Perrigo,2016-04-22 14:07:00-04:00,JNJ,cramer what to know about perrigo,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998759031295776
697063,697063,708283.0,Johnson & Johnson Makes New All-Time High,2016-04-20 11:05:00-04:00,JNJ,johnson and johnson makes new all time high,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9991365075111389
697064,697064,708284.0,"Argus Research Maintains Buy on Johnson & Johnson, Raises PT to $130.00",2016-04-20 07:05:00-04:00,JNJ,argus research maintains buy on johnson and johnson raises point to dollars 30.00,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9992341995239258
697065,697065,708285.0,"Buy Bank Of America, Sell JPMorgan: Fast Money Picks For April 20",2016-04-20 06:21:00-04:00,JNJ,buy bank of america sell jpmorgan fast money picks for april 20,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998503923416138
697066,697066,708286.0,"Goldman Sachs Maintains Neutral on Johnson & Johnson, Raises PT to $114.00",2016-04-20 05:44:00-04:00,JNJ,goldman sachs maintains neutral on johnson and johnson raises point to dollars 14.00,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9983100891113281
697067,697067,708287.0,"Barclays Maintains Overweight on Johnson & Johnson, Raises PT to $120.00",2016-04-20 05:44:00-04:00,JNJ,barclays maintains overweight on johnson and johnson raises point to dollars 20.00,"{'neg': 0.185, 'neu': 0.815, 'pos': 0.0, 'compound': -0.3612}",negative,0.8658071160316467
697068,697068,708288.0,All Eyes on Markets: They're Reaching for Fresh Highs,2016-04-19 10:38:00-04:00,JNJ,all eyes on markets theyre reaching for fresh highs,"{'neg': 0.0, 'neu': 0.631, 'pos': 0.369, 'compound': 0.4767}",positive,0.9900278449058533
697069,697069,708289.0,"Johnson & Johnson Q1 Adjusted EPS Tops Estimations, Boosts Full Year Outlook",2016-04-19 07:49:00-04:00,JNJ,johnson and johnson first quarter adjusted eps tops estimations boosts full year outlook,"{'neg': 0.0, 'neu': 0.663, 'pos': 0.337, 'compound': 0.6808}",positive,0.999663233757019
697070,697070,708290.0,"Johnson & Johnson Sees FY 2016 EPS $6.53 to $6.68 vs $6.54 est, Revenue $71.2B to $71.9B vs $71.6B est",2016-04-19 06:44:00-04:00,JNJ,johnson and johnson sees fy 2016 eps dollars .53 to dollars .68 vs dollars .54 est revenue dollars 1.2 billion to dollars 1.9 billion vs dollars 1.6 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999871015548706
697071,697071,708291.0,"Johnson & Johnson Q1 EPS $1.68 vs $1.65 est, Revenue $17.5B vs $17.5B est",2016-04-19 06:42:00-04:00,JNJ,johnson and johnson first quarter eps dollars .68 vs dollars .65 est revenue dollars 7.5 billion vs dollars 7.5 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998812675476074
697072,697072,708292.0,"Disney, Twitter And More Fast Money Picks For April 19",2016-04-19 06:28:00-04:00,JNJ,disney twitter and more fast money picks for april 19,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999847412109375
697073,697073,708293.0,"Keep an Eye on These 10 Stocks for April 19, 2016",2016-04-19 04:56:00-04:00,JNJ,keep an eye on these 10 stocks for april 19 2016,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998568296432495
697074,697074,708294.0,"Earnings Scheduled For April 19, 2016",2016-04-19 04:01:00-04:00,JNJ,earnings scheduled for april 19 2016,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998817443847656
697075,697075,708295.0,Cost Efficiency And Quality With This Dividend ETF,2016-04-18 16:10:00-04:00,JNJ,cost efficiency and quality with this dividend etf,"{'neg': 0.0, 'neu': 0.737, 'pos': 0.263, 'compound': 0.3612}",positive,0.9758775234222412
697076,697076,708296.0,Flextronics Hires John Carlson As President For Flex Medical Solutions,2016-04-18 14:17:00-04:00,JNJ,flextronics hires john carlson as president for flex medical solutions,"{'neg': 0.0, 'neu': 0.841, 'pos': 0.159, 'compound': 0.1779}",neutral,0.9998644590377808
697077,697077,708297.0,"Earnings: IBM, NFLX, GS and JNJ Join the Earnings Parade",2016-04-18 12:08:00-04:00,JNJ,earnings ibm nflx gs and jnj join the earnings parade,"{'neg': 0.0, 'neu': 0.804, 'pos': 0.196, 'compound': 0.296}",neutral,0.9998830556869507
697078,697078,708298.0,"Notable Imbalances Before Friday's Open: Telecom Pair Trade, Health Care Stocks In Focus",2016-04-15 09:44:00-04:00,JNJ,notable imbalances before fridays open telecom pair trade health care stocks in focus,"{'neg': 0.0, 'neu': 0.789, 'pos': 0.211, 'compound': 0.4939}",negative,0.9692593216896057
697079,697079,708299.0,Johnson & Johnson Approaches All-Time High,2016-04-14 13:50:00-04:00,JNJ,johnson and johnson approaches all time high,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.967126190662384
697080,697080,708300.0,New Tax Inversions Rules: Threats To Healthcare ETFs?,2016-04-06 15:33:00-04:00,JNJ,new tax inversions rules threats to healthcare etfs,"{'neg': 0.286, 'neu': 0.714, 'pos': 0.0, 'compound': -0.4215}",negative,0.8902066946029663
697081,697081,708301.0,"PPH May Be Home To Hedge Fund Hotels, But This ETF Can Endure",2016-04-06 14:26:00-04:00,JNJ,pph may be home to hedge fund hotels but this etf can endure,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998045563697815
697082,697082,708302.0,SocGen Picks New Favorites In Big Pharma,2016-04-06 13:44:00-04:00,JNJ,socgen picks new favorites in big pharma,"{'neg': 0.0, 'neu': 0.682, 'pos': 0.318, 'compound': 0.4215}",neutral,0.9989866614341736
697083,697083,708303.0,3 Options Trades Goldman Is Watching With Catalysts Coming,2016-04-06 12:19:00-04:00,JNJ,3 options trades goldman is watching with catalysts coming,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998440742492676
697084,697084,708304.0,Societe Generale Initiates Coverage on Johnson & Johnson at Hold,2016-04-06 11:47:00-04:00,JNJ,societe generale initiates coverage on johnson and johnson at hold,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998811483383179
697085,697085,708305.0,Pfizer Receives FDA Approval For Cheaper Version Of Johnson & Johnson's Top Drug Remicade,2016-04-06 10:45:00-04:00,JNJ,pfizer receives fda approval for cheaper version of johnson and johnsons top drug remicade,"{'neg': 0.0, 'neu': 0.71, 'pos': 0.29, 'compound': 0.5994}",positive,0.9993880987167358
697086,697086,708306.0,"Goldman Offers 3 Options Trades For Upcoming Catalyst In AMG, JNJ, LPLA",2016-04-06 06:43:00-04:00,JNJ,goldman offers 3 options trades for upcoming catalyst in amg jnj lpla,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998817443847656
697087,697087,708307.0,Johnson & Johnson Launches New Global Public Health Strategy,2016-04-06 04:23:00-04:00,JNJ,johnson and johnson launches new global public health strategy,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9996204376220703
697088,697088,708308.0,"FDA Approved Inflectra (Infliximab-Dyyb) For Multiple Indications; Shares of JNJ Maker of Remicade, Sell off on News",2016-04-05 16:12:00-04:00,JNJ,fda approved inflectra infliximab dyyb for multiple indications shares of jnj maker of remicade sell off on news,"{'neg': 0.0, 'neu': 0.762, 'pos': 0.238, 'compound': 0.6124}",negative,0.9947693943977356
697089,697089,708309.0,"Inflectra, Biosimilar To Johnson and Johnson's Remicade, Approved By FDA; Shares Fell To $107.37 After Hours Before Trading Up Back At $108.7/Share",2016-04-05 16:11:00-04:00,JNJ,inflectra biosimilar to johnson and johnsons remicade approved by fda shares fell to dollars 07.37 after hours before trading up back at dollars 08,"{'neg': 0.0, 'neu': 0.815, 'pos': 0.185, 'compound': 0.6124}",negative,0.9983945488929749
697090,697090,708310.0,S&P 500 Index Futures Trading Lower,2016-04-05 10:50:00-04:00,JNJ,SP500 500 index futures trading lower,"{'neg': 0.306, 'neu': 0.694, 'pos': 0.0, 'compound': -0.296}",negative,0.9951500296592712
697091,697091,708311.0,"Genmab Announces Patent Infringement Suit Against Co., Janssen in US Related to DARZALEX",2016-04-04 14:13:00-04:00,JNJ,genmab announces patent infringement suit against co janssen in us related to darzalex,"{'neg': 0.205, 'neu': 0.795, 'pos': 0.0, 'compound': -0.4767}",neutral,0.9984748959541321
697092,697092,708312.0,MorphoSys Sues Janssen Biotech and Genmab for Patent Infringement,2016-04-04 11:52:00-04:00,JNJ,morphosys sues janssen biotech and genmab for patent infringement,"{'neg': 0.279, 'neu': 0.721, 'pos': 0.0, 'compound': -0.4767}",negative,0.7628745436668396
697093,697093,708313.0,Make A House Call With A Familiar Healthcare ETF,2016-04-04 08:28:00-04:00,JNJ,make a house call with a familiar healthcare etf,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998750686645508
697094,697094,708314.0,EU Medicines Agency Recommends Approval of JNJ & Genmab A/S's Daratumimab,2016-04-01 11:20:00-04:00,JNJ,eu medicines agency recommends approval of jnj and genmab a and ss daratumimab,"{'neg': 0.0, 'neu': 0.688, 'pos': 0.312, 'compound': 0.6124}",neutral,0.9981335997581482
697095,697095,708315.0,CORRECTION: Janssen Announces Discontinuation Of Fulranumab Phase 3 Development Program In Osteoarthritis Pain,2016-03-31 16:13:00-04:00,JNJ,correction janssen announces discontinuation of fulranumab phase 3 development program in osteoarthritis pain,"{'neg': 0.216, 'neu': 0.784, 'pos': 0.0, 'compound': -0.5106}",neutral,0.9395204782485962
697096,697096,708316.0,Janssen Announces Discontinuation Of Fulranumab Phase 3 Development Program In Osteoarthritis Pain,2016-03-31 16:10:00-04:00,JNJ,janssen announces discontinuation of fulranumab phase 3 development program in osteoarthritis pain,"{'neg': 0.231, 'neu': 0.769, 'pos': 0.0, 'compound': -0.5106}",neutral,0.9091669321060181
697097,697097,708317.0,Johnson & Johnson Approaches All-Time High,2016-03-23 13:30:00-04:00,JNJ,johnson and johnson approaches all time high,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.967126190662384
697098,697098,708318.0,UPDATE: Janssen Research & Development LLC Signs Clinical Trial Collaboration With Roche Group Memeber 'Genentech',2016-03-21 13:22:00-04:00,JNJ,update janssen research and development llc signs clinical trial collaboration with roche group memeber genentech,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9996793270111084
697099,697099,708319.0,Janssen Announces Initiation Of 2 Studies Evaluating Daratumumab & Atezolizumab In Multiple Myeloma & Solid Tumor,2016-03-21 13:21:00-04:00,JNJ,janssen announces initiation of 2 studies evaluating daratumumab and atezolizumab in multiple myeloma and solid tumor,"{'neg': 0.143, 'neu': 0.769, 'pos': 0.088, 'compound': -0.25}",neutral,0.9998778104782104
697100,697100,708320.0,Johnson & Johnson Phase 3 Data Shows Treatment W/ Stelara Induced Clinical Response And Clinical Remission,2016-03-18 09:04:00-04:00,JNJ,johnson and johnson phase 3 data shows treatment with stelara induced clinical response and clinical remission,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998182654380798
697101,697101,708321.0,J&J Unit Says to Appeal Jury Verdicts in Ultamet Metal-on-Metal Hip Trial -DJ,2016-03-17 15:35:00-04:00,JNJ,j and j unit says to appeal jury verdicts in ultamet metal on metal hip trial dj,"{'neg': 0.0, 'neu': 0.925, 'pos': 0.075, 'compound': 0.0772}",neutral,0.9996432065963745
697102,697102,708322.0,Dallas Jury Awards Nearly $500 Million Against J&J Unit in Bellwether Hip Implant Trial,2016-03-17 14:20:00-04:00,JNJ,dallas jury awards nearly dollars 00 million against j and j unit in bellwether hip implant trial,"{'neg': 0.0, 'neu': 0.842, 'pos': 0.158, 'compound': 0.4588}",positive,0.9953155517578125
697103,697103,708323.0,Option Alert: JNJ Mar16 106 Puts Sweep: 1000 @  ASK  $0.18: 1525 traded vs 2546 OI:  Earnings 4/19 Before Open  $106.78 Ref,2016-03-17 13:38:00-04:00,JNJ,option alert jnj mar16 106 puts sweep 1000 ask dollars .18 1525 traded vs 2546 oi earnings before open dollars 06.78 ref,"{'neg': 0.0, 'neu': 0.905, 'pos': 0.095, 'compound': 0.296}",neutral,0.9998750686645508
697104,697104,708324.0,Benzinga's Top Upgrades,2016-03-14 09:07:00-04:00,JNJ,benzingas top upgrades,"{'neg': 0.0, 'neu': 0.526, 'pos': 0.474, 'compound': 0.2023}",positive,0.7773524522781372
697105,697105,708325.0,"Goldman Upgrades Johnson & Johnson, Removes From America's Sell List",2016-03-14 08:13:00-04:00,JNJ,goldman upgrades johnson and johnson removes from americas sell list,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.8428247570991516
697106,697106,708326.0,"Goldman Sachs Says J&J Conglomerate Structure Has Caused Shareholder Value To Be Trapped, Goldman Continues To Advocate For A Break-Up Of Co To Maximize Value",2016-03-14 05:51:00-04:00,JNJ,goldman sachs says j and j conglomerate structure has caused shareholder value to be trapped goldman continues to advocate for a break up of co to maximize value,"{'neg': 0.102, 'neu': 0.753, 'pos': 0.145, 'compound': 0.1027}",negative,0.9980137348175049
697107,697107,708327.0,"Goldman Sachs Upgrades Johnson & Johnson to Neutral, Raises PT to $112.00",2016-03-14 05:40:00-04:00,JNJ,goldman sachs upgrades johnson and johnson to neutral raises point to dollars 12.00,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9995507597923279
697108,697108,708328.0,"The Market In 5 Minutes: Tuesday, March 8, 2016",2016-03-08 12:26:00-05:00,JNJ,the market in 5 minutes tuesday march 8 2016,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998810291290283
697109,697109,708329.0,Sum-Of-The-Parts Analysis Suggests J&J Stock Price Of $124,2016-03-08 08:49:00-05:00,JNJ,sum of the parts analysis suggests j and j stock price of dollars 24,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998922348022461
697110,697110,708330.0,The Other Sector ETF Player,2016-03-07 14:26:00-05:00,JNJ,the other sector etf player,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998953342437744
697111,697111,708331.0,A Winning Dividend ETF Idea For March,2016-03-03 09:52:00-05:00,JNJ,a winning dividend etf idea for march,"{'neg': 0.0, 'neu': 0.638, 'pos': 0.362, 'compound': 0.5267}",positive,0.9695374965667725
697112,697112,708332.0,"P&G Reports Divestiture of Hipoglos Brand to J&J Consumer, No Terms Disclosed",2016-03-02 09:02:00-05:00,JNJ,p and g reports divestiture of hipoglos brand to j and j consumer no terms disclosed,"{'neg': 0.128, 'neu': 0.872, 'pos': 0.0, 'compound': -0.296}",neutral,0.9998407363891602
697113,697113,708333.0,Galapagos Shares -$0.58 Premarket @$43.37; Co Announced Transparency Notification from JNJ on Tuesday,2016-03-02 07:37:00-05:00,JNJ,galapagos shares dollars .58 premarket dollars 3.37 co announced transparency notification from jnj on tuesday,"{'neg': 0.0, 'neu': 0.864, 'pos': 0.136, 'compound': 0.296}",neutral,0.999886155128479
697114,697114,708334.0,"Watch Pharma Names Following FDA Issuance Of New Mandatory Clinical Study For Bayer's 'Essure', Requires Product Labeling, Including Box Warnings And Patient Decision Checklist",2016-02-29 15:39:00-05:00,JNJ,watch pharma names following fda issuance of new mandatory clinical study for bayers essure requires product labeling including box warnings and patient decision checklist,"{'neg': 0.086, 'neu': 0.863, 'pos': 0.051, 'compound': -0.2263}",neutral,0.9998759031295776
697115,697115,708335.0,Cramer Says He Likes Bargain Stores: It's All About Value,2016-02-27 15:51:00-05:00,JNJ,cramer says he likes bargain stores its all about value,"{'neg': 0.0, 'neu': 0.5, 'pos': 0.5, 'compound': 0.7184}",neutral,0.9995079040527344
697116,697116,708336.0,Option Alert: JNJ Fri 3/4 106 Calls (Wkly): 4000 @  ASK  $0.86: 4024 traded vs 862 OI:  Earnings 4/12  $105.78 Ref,2016-02-26 10:29:00-05:00,JNJ,option alert jnj fri .75 106 calls wkly 4000 ask dollars .86 4024 traded vs 862 oi earnings dollars 05.78 ref,"{'neg': 0.0, 'neu': 0.901, 'pos': 0.099, 'compound': 0.296}",neutral,0.9998794794082642
697117,697117,708337.0,Love This Low Volatility Dividend ETF,2016-02-25 07:50:00-05:00,JNJ,love this low volatility dividend etf,"{'neg': 0.204, 'neu': 0.388, 'pos': 0.408, 'compound': 0.4767}",neutral,0.9944028258323669
697118,697118,708338.0,J&J Selling 2.5M Galapagos Shares-BBG,2016-02-22 12:43:00-05:00,JNJ,j and j selling 2.5 million galapagos shares bbg,"{'neg': 0.0, 'neu': 0.784, 'pos': 0.216, 'compound': 0.296}",neutral,0.9998844861984253
697119,697119,708339.0,Should Johnson & Johnson Break Up?,2016-02-22 09:01:00-05:00,JNJ,should johnson and johnson break up,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997366070747375
697120,697120,708340.0,"Morgan Stanley Says Johnson & Johnson Could Possibly Operate Better If Broken Up, Cautions Breakup Unlikely To Resonate WIth Investors",2016-02-22 06:19:00-05:00,JNJ,morgan stanley says johnson and johnson could possibly operate better if broken up cautions breakup unlikely to resonate with investors,"{'neg': 0.129, 'neu': 0.75, 'pos': 0.121, 'compound': -0.0516}",positive,0.9991951584815979
697121,697121,708341.0,New Dividend ETF Proves To Be A Worthy Hideout,2016-02-18 15:57:00-05:00,JNJ,new dividend etf proves to be a worthy hideout,"{'neg': 0.0, 'neu': 0.734, 'pos': 0.266, 'compound': 0.4404}",neutral,0.8399584293365479
697122,697122,708342.0,S&P 500 Index Futures Treading Water,2016-02-18 10:51:00-05:00,JNJ,SP500 500 index futures treading water,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998643398284912
697123,697123,708343.0,Everything You Might Have Missed This 13F Season: Part 2,2016-02-17 15:58:00-05:00,JNJ,everything you might have missed this 13 f season part 2,"{'neg': 0.18, 'neu': 0.82, 'pos': 0.0, 'compound': -0.296}",neutral,0.9998238682746887
697124,697124,708344.0,"The Stocks That Moved The S&P, Dow And Nasdaq Yesterday",2016-02-13 22:44:00-05:00,JNJ,the stocks that moved the SP500 dow and nasdaq yesterday,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998687505722046
697125,697125,708345.0,The Generic Drug Battle,2016-02-10 09:13:00-05:00,JNJ,the generic drug battle,"{'neg': 0.464, 'neu': 0.536, 'pos': 0.0, 'compound': -0.3818}",neutral,0.9998735189437866
697126,697126,708346.0,FDA Panel Has Backed Approval of Celltrion's Biosimilar Version of J&J's Remicade,2016-02-09 17:07:00-05:00,JNJ,fda panel has backed approval of celltrions biosimilar version of j and js remicade,"{'neg': 0.0, 'neu': 0.741, 'pos': 0.259, 'compound': 0.4939}",positive,0.9979656934738159
697127,697127,708347.0,"Icahn, Gilead, GE Lead Top Insider Trades Of The Week",2016-02-09 16:07:00-05:00,JNJ,icahn gilead ge lead top insider trades of the week,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.2023}",neutral,0.9998767375946045
697128,697128,708348.0,How To Invest In An Aging World With The 'Live Long & Prosper' ETF,2016-02-08 10:53:00-05:00,JNJ,how to invest in an aging world with the live long and prosper etf,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9994180202484131
697129,697129,708349.0,S&P 500 Index Futures Sharply Lower,2016-02-08 10:27:00-05:00,JNJ,SP500 500 index futures sharply lower,"{'neg': 0.306, 'neu': 0.694, 'pos': 0.0, 'compound': -0.296}",negative,0.9974806904792786
697130,697130,708350.0,A Checkup On A Big Healthcare ETF,2016-02-05 13:19:00-05:00,JNJ,a checkup on a big healthcare etf,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998867511749268
697131,697131,708351.0,How To Build A Defensive Portfolio,2016-02-04 15:13:00-05:00,JNJ,how to build a defensive portfolio,"{'neg': 0.0, 'neu': 0.82, 'pos': 0.18, 'compound': 0.0258}",neutral,0.9998394250869751
697132,697132,708352.0,"Bull Market, Bear Market Or Just A Trading Range?",2016-02-01 09:41:00-05:00,JNJ,bull market bear market or just a trading range,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998331069946289
697133,697133,708353.0,Warm Up With This Low Volatility ETF,2016-02-01 09:41:00-05:00,JNJ,warm up with this low volatility etf,"{'neg': 0.256, 'neu': 0.539, 'pos': 0.205, 'compound': -0.1217}",positive,0.995900571346283
697134,697134,708354.0,"Benzinga's M&A Chatter for Thursday January 28, 2015",2016-01-28 23:27:00-05:00,JNJ,benzingas m and a chatter for thursday january 28 2015,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998863935470581
697135,697135,708355.0,7 Biotech Traders Pick Their Favorite Stocks For 2016,2016-01-28 16:53:00-05:00,JNJ,7 biotech traders pick their favorite stocks for 2016,"{'neg': 0.0, 'neu': 0.727, 'pos': 0.273, 'compound': 0.4588}",neutral,0.999823272228241
697136,697136,708356.0,Large Johnson & Johnson Shareholder Just Revealed 8 Major Concerns,2016-01-28 15:27:00-05:00,JNJ,large johnson and johnson shareholder just revealed 8 major concerns,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9905486702919006
697137,697137,708357.0,Stocks To Play In A Zika Virus Pandemic,2016-01-28 13:25:00-05:00,JNJ,stocks to play in a zika virus pandemic,"{'neg': 0.0, 'neu': 0.745, 'pos': 0.255, 'compound': 0.34}",neutral,0.9998617172241211
697138,697138,708358.0,"TRXC Bidding War Ramping Up According To Report, JNJ/GOOGL Both Focused On TRXC According To MoneyMorning Report",2016-01-28 12:54:00-05:00,JNJ,trxc bidding war ramping up according to report jnj and googl both focused on trxc according to moneymorning report,"{'neg': 0.166, 'neu': 0.723, 'pos': 0.111, 'compound': -0.3182}",positive,0.991610586643219
697139,697139,708359.0,Hearing Unconfirmed Market Chatter of Potential JNJ Deal to Acquire GlaxoSmithKline,2016-01-28 11:19:00-05:00,JNJ,hearing unconfirmed market chatter of potential jnj deal to acquire glaxosmithkline,"{'neg': 0.13, 'neu': 0.87, 'pos': 0.0, 'compound': -0.128}",neutral,0.9994350075721741
697140,697140,708360.0,"Artisan Partners Urges J&J to Adopt New, Publicly-Disclosed Financial Targets for Medical Devices, Consumer Businesses",2016-01-28 09:56:00-05:00,JNJ,artisan partners urges j and j to adopt new publicly disclosed financial targets for medical devices consumer businesses,"{'neg': 0.0, 'neu': 0.909, 'pos': 0.091, 'compound': 0.1779}",neutral,0.9980694651603699
697141,697141,708361.0,UPDATE: Artisan Partners Global Value's Daniel O'Keefe Sends Letter to J&J Board,2016-01-28 09:53:00-05:00,JNJ,update artisan partners global values daniel okeefe sends letter to j and j board,"{'neg': 0.0, 'neu': 0.828, 'pos': 0.172, 'compound': 0.4019}",neutral,0.999840259552002
697142,697142,708362.0,Artisan Partners Global Value's Daniel O'Keefe Sends Letter to J&J Board,2016-01-28 09:52:00-05:00,JNJ,artisan partners global values daniel okeefe sends letter to j and j board,"{'neg': 0.0, 'neu': 0.816, 'pos': 0.184, 'compound': 0.4019}",neutral,0.9998212456703186
697143,697143,708363.0,UPDATE: FT Article Citing A Source Speculates On Turnaround Catalyst For JNJ's Recent Poor Performance,2016-01-27 13:46:00-05:00,JNJ,update ft article citing a source speculates on turnaround catalyst for jnjs recent poor performance,"{'neg': 0.181, 'neu': 0.819, 'pos': 0.0, 'compound': -0.4767}",negative,0.9948923587799072
697144,697144,708364.0,"Johnson & Johnson Shares Steadily Gain Over Past 20 Min, Reports Shareholders Pushing Activists For 'shake up'",2016-01-27 13:43:00-05:00,JNJ,johnson and johnson shares steadily gain over past 20 min reports shareholders pushing activists for shake up,"{'neg': 0.08, 'neu': 0.657, 'pos': 0.263, 'compound': 0.5994}",positive,0.999708354473114
697145,697145,708365.0,Johnson & Johnson Continues To Rally,2016-01-27 10:41:00-05:00,JNJ,johnson and johnson continues to rally,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.8291448950767517
697146,697146,708366.0,S&P 500 Index Futures Lower,2016-01-27 10:16:00-05:00,JNJ,SP500 500 index futures lower,"{'neg': 0.355, 'neu': 0.645, 'pos': 0.0, 'compound': -0.296}",negative,0.9964063763618469
697147,697147,708367.0,Earnings Recap For January 26,2016-01-26 17:15:00-05:00,JNJ,earnings recap for january 26,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998877048492432
697148,697148,708368.0,S&P 500 Index Futures Sharply Higher,2016-01-26 13:57:00-05:00,JNJ,SP500 500 index futures sharply higher,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9995520710945129
697149,697149,708369.0,"No Shortage of Stock Drivers: Oil Swivels, Fed Meets, Apple Reports",2016-01-26 10:59:00-05:00,JNJ,no shortage of stock drivers oil swivels fed meets apple reports,"{'neg': 0.0, 'neu': 0.852, 'pos': 0.148, 'compound': 0.1877}",neutral,0.9997205138206482
697150,697150,708370.0,"Johnson and Johnson Sees FY EPS $6.43 to $6.58 vs $6.38 est, Revenue $70.8B to $71.5B vs $71.9B est",2016-01-26 06:42:00-05:00,JNJ,johnson and johnson sees fy eps dollars .43 to dollars .58 vs dollars .38 est revenue dollars 0.8 billion to dollars 1.5 billion vs dollars 1.9 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998719692230225
697151,697151,708371.0,"Johnson and johnson Q4 EPS $1.44 vs $1.42 est, Revenue $17.8B vs $17.9B est",2016-01-26 06:41:00-05:00,JNJ,johnson and johnson fourth quarter eps dollars .44 vs dollars .42 est revenue dollars 7.8 billion vs dollars 7.9 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998809099197388
697152,697152,708372.0,7 Stocks You Should Be Watching Today,2016-01-26 04:15:00-05:00,JNJ,7 stocks you should be watching today,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998377561569214
697153,697153,708373.0,"Earnings Scheduled For January 26, 2016",2016-01-26 04:03:00-05:00,JNJ,earnings scheduled for january 26 2016,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998786449432373
697154,697154,708374.0,"JNJ Kicks Off Health Care Earnings—What About Deals, Buybacks?",2016-01-25 11:43:00-05:00,JNJ,jnj kicks off health care earnings—what about deals buybacks,"{'neg': 0.0, 'neu': 0.714, 'pos': 0.286, 'compound': 0.4939}",neutral,0.9993902444839478
697155,697155,708375.0,US Big Pharma: What To Watch For In Q4 Results,2016-01-25 11:16:00-05:00,JNJ,us big pharma what to watch for in fourth quarter results,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998005032539368
697156,697156,708376.0,"Johnson & Johnson Details $1 Billion Cost Saving Initiative For Its Medical Devices Segment, Will 'Deliver More Value To Customers'",2016-01-19 15:24:00-05:00,JNJ,johnson and johnson details dollars billion cost saving initiative for its medical devices segment will deliver more value to customers,"{'neg': 0.0, 'neu': 0.876, 'pos': 0.124, 'compound': 0.4005}",positive,0.9996083378791809
697157,697157,708377.0,"Najarian Brothers See Unusual Activity In Johnson & Johnson And Cisco Systems, Inc.",2016-01-19 15:23:00-05:00,JNJ,najarian brothers see unusual activity in johnson and johnson and cisco systems inc,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998549222946167
697158,697158,708378.0,"Johnson & Johnson Restructures Medical Devices Unit, Sees Nearly $1 Billion In Annual Cost Savings",2016-01-19 13:04:00-05:00,JNJ,johnson and johnson restructures medical devices unit sees nearly dollars billion in annual cost savings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996170997619629
697159,697159,708379.0,"UPDATE: J&J Reaffirms FY15 Adj. EPS Outlook of $6.15-$6.20 vs $6.18 Est., Sales $70B-$71B vs $70.1B Est.",2016-01-19 07:17:00-05:00,JNJ,update j and j reaffirms fy15 adj eps outlook of dollars .15 dollars .20 vs dollars .18 est sales dollars 0 billion dollars 1 billion vs dollars 0.1 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9945366382598877
697160,697160,708380.0,"UPDATE: J&J Restructuring Related to Medical Devices Unit; Consumer Medical Devices, Vision Care, Diabetes Care Units Will Not Be Impacted by Restructuring",2016-01-19 07:17:00-05:00,JNJ,update j and j restructuring related to medical devices unit consumer medical devices vision care diabetes care units will not be impacted by restructuring,"{'neg': 0.0, 'neu': 0.714, 'pos': 0.286, 'compound': 0.8126}",neutral,0.998508632183075
697161,697161,708381.0,"J&J Shares Indicated ~$1.25 Higher; Co. Announced Restructuring with Projected, Annualized Pre-Tax Cost Savings $800M-$1B, Sees $2B-$2.4B Charge; Affirms FY15 Outlook",2016-01-19 07:15:00-05:00,JNJ,j and j shares indicated dollars .25 higher co announced restructuring with projected annualized pre tax cost savings dollars 00 million dollars b sees dollars b dollars .4 billion charge affirms fy15 outlook,"{'neg': 0.0, 'neu': 0.936, 'pos': 0.064, 'compound': 0.296}",positive,0.9993884563446045
697162,697162,708382.0,Dividend Aristocrats ETF Joins The $1 Billion Club,2016-01-15 13:17:00-05:00,JNJ,dividend aristocrats etf joins the dollars billion club,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998778104782104
697163,697163,708383.0,Write A Prescription For This Healthcare ETF,2016-01-15 08:24:00-05:00,JNJ,write a prescription for this healthcare etf,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998854398727417
697164,697164,708384.0,11 Different Ways To Play The Bear Market (From 11 Traders),2016-01-14 14:38:00-05:00,JNJ,11 different ways to play the bear market from 11 traders,"{'neg': 0.0, 'neu': 0.806, 'pos': 0.194, 'compound': 0.34}",neutral,0.9998502731323242
697165,697165,708385.0,How Will Dividend Stocks Perform This Year?,2016-01-14 08:48:00-05:00,JNJ,how will dividend stocks perform this year,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998660087585449
697166,697166,708386.0,J&J's Janssen Reports Health Canada Has Approved Stelara for Treatment of Chronic Moderate-to-Severe Plaque Psoriasis in Adolescents,2016-01-13 07:06:00-05:00,JNJ,j and js janssen reports health canada has approved stelara for treatment of chronic moderate to severe plaque psoriasis in adolescents,"{'neg': 0.107, 'neu': 0.779, 'pos': 0.115, 'compound': 0.0516}",positive,0.9993602633476257
697167,697167,708387.0,Chemdiv Achieves Development Milestone In Drug Recovery Collaboration With Janssen,2016-01-11 14:01:00-05:00,JNJ,chemdiv achieves development milestone in drug recovery collaboration with janssen,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9994392991065979
697168,697168,708388.0,"For This Low Vol ETF, It's Not All About Sector Selection",2016-01-08 08:31:00-05:00,JNJ,for this low volume etf its not all about sector selection,"{'neg': 0.174, 'neu': 0.826, 'pos': 0.0, 'compound': -0.2732}",neutral,0.9998806715011597
697169,697169,708389.0,Sino Biopharmaceutical Says Chia Tai-Tianqing Pharmaceutical Entered Into Exclusive License Agreement With Janssen Pharmaceuticals Under Johnson & Johnson -Reuters,2016-01-08 06:14:00-05:00,JNJ,sino biopharmaceutical says chia tai tianqing pharmaceutical entered into exclusive license agreement with janssen pharmaceuticals under johnson and johnson reuters,"{'neg': 0.0, 'neu': 0.793, 'pos': 0.207, 'compound': 0.5719}",positive,0.9993265867233276
697170,697170,708390.0,Johnson and Johnson Along With Janssen Agree To Develop and Commercialize HBV Treatments WIth Chia Tai,2016-01-07 08:10:00-05:00,JNJ,johnson and johnson along with janssen agree to develop and commercialize hbv treatments with chia tai,"{'neg': 0.0, 'neu': 0.857, 'pos': 0.143, 'compound': 0.3612}",positive,0.9890913963317871
697171,697171,708391.0,Apple Is The Second Cheapest Mega-Cap On A Free Cash Flow Basis,2016-01-06 15:44:00-05:00,JNJ,apple is the second cheapest mega cap on a free cash flow basis,"{'neg': 0.0, 'neu': 0.784, 'pos': 0.216, 'compound': 0.5106}",neutral,0.999882698059082
697172,697172,708392.0,The Two Best Sector SPDR ETFs For January,2016-01-02 20:29:00-05:00,JNJ,the two best sector spdr etfs for january,"{'neg': 0.0, 'neu': 0.625, 'pos': 0.375, 'compound': 0.6369}",neutral,0.9998952150344849
697173,697173,708393.0,A Sound ETF Idea For 2016,2015-12-30 13:29:00-05:00,JNJ,a sound etf idea for 2016,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998605251312256
697174,697174,708394.0,"Hearing Kentucky Attorney General Announcing Settlement Related to Purdue Pharma, J&J's Janssen Case Related to Oxycontin, Risperdal",2015-12-23 16:45:00-05:00,JNJ,hearing kentucky attorney general announcing settlement related to purdue pharma j and js janssen case related to oxycontin risperdal,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9584315419197083
697175,697175,708395.0,Not All Of Clinton's Policies Are Bad For Pharmaceuticals,2015-12-23 14:13:00-05:00,JNJ,not all of clintons policies are bad for pharmaceuticals,"{'neg': 0.304, 'neu': 0.696, 'pos': 0.0, 'compound': -0.5423}",negative,0.7029528617858887
697176,697176,708396.0,Peering Through The Fog To Find The Best Sectors Into Year End,2015-12-23 13:08:00-05:00,JNJ,peering through the fog to find the best sectors into year end,"{'neg': 0.0, 'neu': 0.724, 'pos': 0.276, 'compound': 0.6369}",neutral,0.9992421865463257
697177,697177,708397.0,Intrexon To Partner With Johnson & Johnson For Type 2 Diabetes Innovative Therapies,2015-12-22 08:02:00-05:00,JNJ,intrexon to partner with johnson and johnson for type 2 diabetes innovative therapies,"{'neg': 0.0, 'neu': 0.805, 'pos': 0.195, 'compound': 0.4404}",neutral,0.9998453855514526
697178,697178,708398.0,Medivir Announces Development of AL-704 Terminated by Janssen Following Completion of Phase I Clinical Studies,2015-12-21 04:17:00-05:00,JNJ,medivir announces development of al 704 terminated by janssen following completion of phase i clinical studies,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998816251754761
697179,697179,708399.0,Dan Nathan Reduces Risk On His Utilities SPDR (ETF) Trade,2015-12-20 18:52:00-05:00,JNJ,dan nathan reduces risk on his utilities spdr etf trade,"{'neg': 0.189, 'neu': 0.811, 'pos': 0.0, 'compound': -0.2732}",positive,0.9986862540245056
697180,697180,708400.0,Credit Suisse Offers 2016 U.S. Large-Cap Pharma Outlook,2015-12-19 17:08:00-05:00,JNJ,credit suisse offers 2016 u s large cap pharma outlook,"{'neg': 0.0, 'neu': 0.776, 'pos': 0.224, 'compound': 0.3818}",neutral,0.7579898238182068
697181,697181,708401.0,"Atlantic Equities Initiates Coverage on Johnson & Johnson at Neutral, Announces $95.00 PT",2015-12-18 08:54:00-05:00,JNJ,atlantic equities initiates coverage on johnson and johnson at neutral announces dollars 5.00 point,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998811483383179
697182,697182,708402.0,"Janney Lists Top 'Bond Surrogate Stocks' By Sector, Identified By Beta, Dividend Yield, And Forward P/E",2015-12-16 15:31:00-05:00,JNJ,janney lists top bond surrogate stocks by sector identified by beta dividend yield and forward pe ratio,"{'neg': 0.0, 'neu': 0.899, 'pos': 0.101, 'compound': 0.2023}",neutral,0.999883770942688
697183,697183,708403.0,J&J Reports Formation of Verb Surgical,2015-12-10 09:01:00-05:00,JNJ,j and j reports formation of verb surgical,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998936653137207
697184,697184,708404.0,"J&J's Janssen Issues Release Showing IMBRUVICA RESONATE-2 Data Demonstrated Significant Improvements in Progression-Free, Overall Survival vs Chlorambucil",2015-12-08 09:16:00-05:00,JNJ,j and js janssen issues release showing imbruvica resonate 2 data demonstrated significant improvements in progression free overall survival vs chlorambucil,"{'neg': 0.0, 'neu': 0.709, 'pos': 0.291, 'compound': 0.7506}",positive,0.9996711015701294
697185,697185,708405.0,S&P 500 Index Futures Under Pressure,2015-12-07 11:24:00-05:00,JNJ,SP500 500 index futures under pressure,"{'neg': 0.306, 'neu': 0.694, 'pos': 0.0, 'compound': -0.296}",negative,0.9957427382469177
697186,697186,708406.0,Carter Worth And Mike Khouw's Johnson & Johnson Trade,2015-12-07 07:03:00-05:00,JNJ,carter worth and mike khouws johnson and johnson trade,"{'neg': 0.0, 'neu': 0.808, 'pos': 0.192, 'compound': 0.2263}",neutral,0.9998633861541748
697187,697187,708407.0,Barclays' Biopharmaceuticals Blueprint For 2016,2015-12-01 11:54:00-05:00,JNJ,barclays biopharmaceuticals blueprint for 2016,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998785257339478
697188,697188,708408.0,Benzinga's Top Upgrades,2015-12-01 08:55:00-05:00,JNJ,benzingas top upgrades,"{'neg': 0.0, 'neu': 0.526, 'pos': 0.474, 'compound': 0.2023}",positive,0.7773524522781372
697189,697189,708409.0,"J&J's 'Steady Cash Flow Is Key,' Barclays Upgrades To Overweight",2015-12-01 08:26:00-05:00,JNJ,j and js steady cash flow is key barclays upgrades to overweight,"{'neg': 0.185, 'neu': 0.815, 'pos': 0.0, 'compound': -0.3612}",positive,0.9996090531349182
697190,697190,708410.0,US Stock Futures Signal Higher Start On Wall Street,2015-12-01 06:55:00-05:00,JNJ,us stock futures signal higher start on wall street,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9995519518852234
697191,697191,708411.0,"Barclays Upgrades Johnson & Johnson to Overweight, Raises PT to $115.00",2015-12-01 05:04:00-05:00,JNJ,barclays upgrades johnson and johnson to overweight raises point to dollars 15.00,"{'neg': 0.185, 'neu': 0.815, 'pos': 0.0, 'compound': -0.3612}",positive,0.9994412064552307
697192,697192,708412.0,A Look At Investment Firms' Favorite Stocks In Q3,2015-11-21 13:58:00-05:00,JNJ,a look at investment firms favorite stocks in third quarter,"{'neg': 0.0, 'neu': 0.75, 'pos': 0.25, 'compound': 0.4588}",neutral,0.999861478805542
697193,697193,708413.0,8 Value Stocks For Investors Worried About Risk,2015-11-16 15:44:00-05:00,JNJ,8 value stocks for investors worried about risk,"{'neg': 0.368, 'neu': 0.427, 'pos': 0.205, 'compound': -0.2263}",neutral,0.9995306730270386
697194,697194,708414.0,"Hanmi Pharmaceuticals Signs an Exclusive License Agreement with Janssen to Develop Treatment for Diabetes, Obesity",2015-11-09 07:10:00-05:00,JNJ,hanmi pharmaceuticals signs an exclusive license agreement with janssen to develop treatment for diabetes obesity,"{'neg': 0.0, 'neu': 0.734, 'pos': 0.266, 'compound': 0.5719}",positive,0.9995637536048889
697195,697195,708415.0,Goldman's First ETF Is Off To A Stellar Start,2015-11-06 10:24:00-05:00,JNJ,goldmans first etf is off to a stellar start,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9990541338920593
697196,697196,708416.0,Johnson & Johnson to Acquire Novira Therapeutics; Financial Terms Not Dislcosed,2015-11-04 12:02:00-05:00,JNJ,johnson and johnson to acquire novira therapeutics financial terms not dislcosed,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998518228530884
697197,697197,708417.0,S&P 500 Index Futures Unchanged,2015-11-04 10:31:00-05:00,JNJ,SP500 500 index futures unchanged,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.998910665512085
697198,697198,708418.0,Johnson & Johnson Moves Up,2015-10-29 16:13:00-04:00,JNJ,johnson and johnson moves up,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9989160299301147
697199,697199,708419.0,Aduro Biotech Announces Received Up-Front $30M Milestone Payment from J&J's Janssen for Acceptance of IND App for ADU-214 in Lung Cancer,2015-10-29 08:14:00-04:00,JNJ,aduro biotech announces received up front dollars 0 million milestone payment from j and js janssen for acceptance of ind app for adu 214 in lung cancer,"{'neg': 0.136, 'neu': 0.772, 'pos': 0.093, 'compound': -0.34}",positive,0.9991428852081299
697200,697200,708420.0,Genmab Announces $3M Milestone Payment in DuoBody Platform Collaboration with Janssen,2015-10-25 17:52:00-04:00,JNJ,genmab announces dollars m milestone payment in duobody platform collaboration with janssen,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9956830739974976
697201,697201,708421.0,Some New Multi-Factor ETFs Look Appealing,2015-10-21 15:08:00-04:00,JNJ,some new multi factor etfs look appealing,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9983093738555908
697202,697202,708422.0,Counting On Quality With ETFs,2015-10-19 13:42:00-04:00,JNJ,counting on quality with etfs,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999879002571106
697203,697203,708423.0,"J&J's Janssen Reports R&D Segment Showed UNITI-2 Study Meet Primary Endpoint, Major Secondary Endpoints Showed Clinical Remission Significantly Higher Than Placebo",2015-10-19 08:14:00-04:00,JNJ,j and js janssen reports r and d segment showed uniti 2 study meet primary endpoint major secondary endpoints showed clinical remission significantly higher than placebo,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9991145730018616
697204,697204,708424.0,"Hearing J&J's Stelara for Crohn's Disease Showed Clinical Response, Statistically Higher Remission for Candidate Than Placebo",2015-10-19 08:05:00-04:00,JNJ,hearing j and js stelara for crohns disease showed clinical response statistically higher remission for candidate than placebo,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9993708729743958
697205,697205,708425.0,"Achillion Announces Janssen Initiated Phase 2a Study to Evaluate Combination of AL-335, ACH-3102, and Simeprevir for Treatment of Genotype 1 Chronic HCV",2015-10-16 06:07:00-04:00,JNJ,achillion announces janssen initiated phase 2 a study to evaluate combination of al 335 ach 3102 and simeprevir for treatment of genotype 1 chronic hcv,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998756647109985
697206,697206,708426.0,J&J's Janssen Reports Collaboration Deal with Novera for Acceleration of Development of Promising Small Molecule Drug Candidates for Hematological Cancers,2015-10-14 08:07:00-04:00,JNJ,j and js janssen reports collaboration deal with novera for acceleration of development of promising small molecule drug candidates for hematological cancers,"{'neg': 0.0, 'neu': 0.886, 'pos': 0.114, 'compound': 0.4019}",positive,0.999519944190979
697207,697207,708427.0,enGene Announces Strategic Collaboration With Johnson & Johnson Innovation To Develop Novel Gene Delivery Products For Inflammatory Bowel Disease,2015-10-14 08:06:00-04:00,JNJ,engene announces strategic collaboration with johnson and johnson innovation to develop novel gene delivery products for inflammatory bowel disease,"{'neg': 0.0, 'neu': 0.776, 'pos': 0.224, 'compound': 0.5994}",positive,0.9847094416618347
697208,697208,708428.0,Mid-Afternoon Market Update: Ryder System Declines On Lowered Forecast; NewBridge Bancorp Shares Spike Higher,2015-10-13 15:17:00-04:00,JNJ,mid afternoon market update ryder system declines on lowered forecast newbridge bancorp shares spike higher,"{'neg': 0.09, 'neu': 0.778, 'pos': 0.132, 'compound': 0.1779}",negative,0.9978358149528503
697209,697209,708429.0,Johnson & Johnson Sales Fall: What The Street Is Saying Now,2015-10-13 12:25:00-04:00,JNJ,johnson and johnson sales fall what the street is saying now,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9979891777038574
697210,697210,708430.0,Mid-Day Market Update: Wausau Paper Jumps On Acquisition News; AIXTRON Shares Slide,2015-10-13 12:18:00-04:00,JNJ,mid day market update wausau paper jumps on acquisition news aixtron shares slide,"{'neg': 0.0, 'neu': 0.845, 'pos': 0.155, 'compound': 0.296}",positive,0.998784601688385
697211,697211,708431.0,Mid-Morning Market Update: Markets Down; Johnson & Johnson Posts Mixed Q3 Results,2015-10-13 10:05:00-04:00,JNJ,mid morning market update markets down johnson and johnson posts mixed third quarter results,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9963349103927612
697212,697212,708432.0,"Johnson & Johnson Posts Upbeat Q3 Earnings, But Sales Drop",2015-10-13 08:02:00-04:00,JNJ,johnson and johnson posts upbeat third quarter earnings but sales drop,"{'neg': 0.209, 'neu': 0.791, 'pos': 0.0, 'compound': -0.3919}",negative,0.9977849125862122
697213,697213,708433.0,Johnson & Johnson Reports Q3 Adj Eps $1.49 Vs Est $1.45,2015-10-13 07:34:00-04:00,JNJ,johnson and johnson reports third quarter adj eps dollars .49 vs est dollars .45,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998741149902344
697214,697214,708434.0,J&J Raises FY15 EPS to $6.15-$6.20 vs $6.16 Est.,2015-10-13 07:31:00-04:00,JNJ,j and j raises fy15 eps to dollars .15 dollars .20 vs dollars .16 est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9956113696098328
697215,697215,708435.0,US Stock Futures Down; JPMorgan Earnings In Focus,2015-10-13 07:31:00-04:00,JNJ,us stock futures down jpmorgan earnings in focus,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9979085922241211
697216,697216,708437.0,JNJ Announces $10B Share Buyback Program,2015-10-13 06:45:00-04:00,JNJ,jnj announces dollars 0 billion share buyback program,"{'neg': 0.0, 'neu': 0.761, 'pos': 0.239, 'compound': 0.296}",neutral,0.9993402361869812
697217,697217,708438.0,J&J Announces $10B Buyback Plan,2015-10-13 06:45:00-04:00,JNJ,j and j announces dollars 0 billion buyback plan,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997796416282654
697218,697218,708439.0,7 Stocks You Should Be Watching Today,2015-10-13 04:55:00-04:00,JNJ,7 stocks you should be watching today,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998377561569214
697219,697219,708440.0,"Earnings Scheduled For October 13, 2015",2015-10-13 04:01:00-04:00,JNJ,earnings scheduled for october 13 2015,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998810291290283
697220,697220,708441.0,Johnson & Johnson Is First Of Big Pharma Earnings Reports: Will Price Debate Dominate?,2015-10-12 12:18:00-04:00,JNJ,johnson and johnson is first of big pharma earnings reports will price debate dominate,"{'neg': 0.103, 'neu': 0.897, 'pos': 0.0, 'compound': -0.128}",neutral,0.9998440742492676
697221,697221,708442.0,Johnson & Johnson Announces Start of Safety and Immunogenicity Clinical Trial of Ebola Vaccine Regimen in Sierra Leone,2015-10-09 04:21:00-04:00,JNJ,johnson and johnson announces start of safety and immunogenicity clinical trial of ebola vaccine regimen in sierra leone,"{'neg': 0.0, 'neu': 0.859, 'pos': 0.141, 'compound': 0.4215}",neutral,0.9998149275779724
697222,697222,708443.0,"Benzinga's M&A Chatter for Wednesday October 7, 2015",2015-10-07 19:27:00-04:00,JNJ,benzingas m and a chatter for wednesday october 7 2015,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998880624771118
697223,697223,708444.0,Singapore  Ministry of Health Convenes Independent Review Committee on Report of Cluster of 22 Acute Cases of Hepatitis C Among Kidney Patients -Reuters,2015-10-06 09:40:00-04:00,JNJ,singapore ministry of health convenes independent review committee on report of cluster of 22 acute cases of hepatitis c among kidney patients reuters,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998490810394287
697224,697224,708445.0,"Earnings Outlook: Is Street Already Positioned For Same Story Of Global Woes, Oil Stain?",2015-10-05 13:41:00-04:00,JNJ,earnings outlook is street already positioned for same story of global woes oil stain,"{'neg': 0.182, 'neu': 0.818, 'pos': 0.0, 'compound': -0.4404}",positive,0.9463241100311279
697225,697225,708446.0,Energy Weakness Skews Earnings View — Can The Rest Of Corporate America Deliver?,2015-10-05 13:29:00-04:00,JNJ,energy weakness skews earnings view — can the rest of corporate america deliver,"{'neg': 0.176, 'neu': 0.692, 'pos': 0.132, 'compound': -0.1779}",negative,0.9986030459403992
697226,697226,708447.0,Genmab Reaches $3M Milestone Payment in DuoBody Platform Collaboration with Janssen,2015-10-05 09:53:00-04:00,JNJ,genmab reaches dollars m milestone payment in duobody platform collaboration with janssen,"{'neg': 0.0, 'neu': 0.902, 'pos': 0.098, 'compound': 0.0516}",positive,0.9987708926200867
697227,697227,708448.0,Benzinga's Top Upgrades,2015-09-29 09:16:00-04:00,JNJ,benzingas top upgrades,"{'neg': 0.0, 'neu': 0.526, 'pos': 0.474, 'compound': 0.2023}",positive,0.7773524522781372
697228,697228,708449.0,Johnson & Johnson Collaborates With UBIVAC To Develop And Test A Oral Cancer Vaccine To be Tested In Preclinical Trials,2015-09-29 09:04:00-04:00,JNJ,johnson and johnson collaborates with ubivac to develop and test a oral cancer vaccine to be tested in preclinical trials,"{'neg': 0.188, 'neu': 0.812, 'pos': 0.0, 'compound': -0.6597}",neutral,0.9998687505722046
697229,697229,708450.0,Johnson & Johnson Seen As 'Safe Haven' By These Experts,2015-09-29 08:48:00-04:00,JNJ,johnson and johnson seen as safe haven by these experts,"{'neg': 0.0, 'neu': 0.756, 'pos': 0.244, 'compound': 0.4404}",neutral,0.9977587461471558
697230,697230,708451.0,Deutsche Bank Upgrades Johnson & Johnson to Buy,2015-09-29 06:28:00-04:00,JNJ,deutsche bank upgrades johnson and johnson to buy,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.984512209892273
697231,697231,708452.0,Patients To Benefit From Latest Tech Trends,2015-09-28 14:21:00-04:00,JNJ,patients to benefit from latest tech trends,"{'neg': 0.0, 'neu': 0.667, 'pos': 0.333, 'compound': 0.4588}",neutral,0.8011205196380615
697232,697232,708453.0,J&J's Consumer Unit Reports Closing of Divestiture of SPLENDA Brand,2015-09-25 16:15:00-04:00,JNJ,j and js consumer unit reports closing of divestiture of splenda brand,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998362064361572
697233,697233,708454.0,5 U.S. Stocks Likely To Hike Their Dividends,2015-09-25 10:24:00-04:00,JNJ,5 u s stocks likely to hike their dividends,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9857128858566284
697234,697234,708455.0,Genmab Announces CHMP Grants Accelerated Assessment for Daratumumab for Double Refractory Multiple Myeloma,2015-09-25 05:25:00-04:00,JNJ,genmab announces chmp grants accelerated assessment for daratumumab for double refractory multiple myeloma,"{'neg': 0.0, 'neu': 0.863, 'pos': 0.137, 'compound': 0.2263}",positive,0.9991770386695862
697235,697235,708456.0,UBS Initiates Coverage on Johnson & Johnson at Buy,2015-09-22 09:27:00-04:00,JNJ,ubs initiates coverage on johnson and johnson at buy,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998804330825806
697236,697236,708457.0,Make The World A Better Place With...Stock Picks?,2015-09-18 15:13:00-04:00,JNJ,make the world a better place with stock picks,"{'neg': 0.0, 'neu': 0.734, 'pos': 0.266, 'compound': 0.4404}",positive,0.9955406785011292
697237,697237,708458.0,Bearish On Bucks? Try This ETF,2015-09-18 07:50:00-04:00,JNJ,bearish on bucks try this etf,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998226761817932
697238,697238,708459.0,S&P 500 Index Futures Trading Higher,2015-09-09 10:38:00-04:00,JNJ,SP500 500 index futures trading higher,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9990843534469604
697239,697239,708460.0,MKM Partners Would Sell These Healthcare Stocks On Weaker Relative Trends,2015-09-08 07:59:00-04:00,JNJ,mkm partners would sell these healthcare stocks on weaker relative trends,"{'neg': 0.225, 'neu': 0.775, 'pos': 0.0, 'compound': -0.4404}",negative,0.9978803396224976
697240,697240,708461.0,S&P 500 Index Retreats From Highs,2015-09-02 10:31:00-04:00,JNJ,SP500 500 index retreats from highs,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9960468411445618
697241,697241,708462.0,"It's Not Shopping, It's Market Research: Talking Investing Trends With TD Ameritrade's Nicole Sherrod",2015-09-01 14:40:00-04:00,JNJ,its not shopping its market research talking investing trends with td ameritrades nicole sherrod,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998716115951538
697242,697242,708463.0,"Benzinga's M&A Chatter for Tuesday, August 25, 2015",2015-08-25 19:08:00-04:00,JNJ,benzingas m and a chatter for tuesday august 25 2015,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998878240585327
697243,697243,708464.0,"Heartland Food Products Group Reports Definitive Deal to Buy J&J Consumer's Splenda Brand, No Terms Disclosed",2015-08-25 13:00:00-04:00,JNJ,heartland food products group reports definitive deal to buy j and j consumers splenda brand no terms disclosed,"{'neg': 0.115, 'neu': 0.885, 'pos': 0.0, 'compound': -0.296}",neutral,0.9920646548271179
697244,697244,708465.0,Heartland Food Products to Acquire Splenda Brand From Johnson & Johnson Consumer Inc.,2015-08-25 13:00:00-04:00,JNJ,heartland food products to acquire splenda brand from johnson and johnson consumer inc,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9996827840805054
697245,697245,708466.0,Fast Money Traders Give Their Opinion On What To Buy In This Sell-Off,2015-08-24 06:37:00-04:00,JNJ,fast money traders give their opinion on what to buy in this sell off,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9995079040527344
697246,697246,708468.0,13F Recap: The Most Popular (And Unpopular) Stocks Of Q2,2015-08-19 08:48:00-04:00,JNJ,13 f recap the most popular and unpopular stocks of second quarter,"{'neg': 0.0, 'neu': 0.781, 'pos': 0.219, 'compound': 0.4754}",neutral,0.9998458623886108
697247,697247,708469.0,S&P 500 Index Futures Trading Lower,2015-08-18 10:43:00-04:00,JNJ,SP500 500 index futures trading lower,"{'neg': 0.306, 'neu': 0.694, 'pos': 0.0, 'compound': -0.296}",negative,0.9951500296592712
697248,697248,708470.0,"When Size Matters, Consider These ETFs",2015-08-13 07:29:00-04:00,JNJ,when size matters consider these etfs,"{'neg': 0.0, 'neu': 0.82, 'pos': 0.18, 'compound': 0.0258}",neutral,0.9998910427093506
697249,697249,708471.0,Johnson & Johnson Cashes Out Of Aquinox Pharmaceuticals' Parabolic Rally,2015-08-12 13:35:00-04:00,JNJ,johnson and johnson cashes out of aquinox pharmaceuticals parabolic rally,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998300075531006
697250,697250,708472.0,"Johnson & Johnson Sells 1,514,821 Shares Of Aquinox Pharmaceuticals @$22.41/Share -Form 4",2015-08-12 12:42:00-04:00,JNJ,johnson and johnson sells 1514821 shares of aquinox pharmaceuticals dollars 2. form 4,"{'neg': 0.0, 'neu': 0.845, 'pos': 0.155, 'compound': 0.296}",neutral,0.9998888969421387
697251,697251,708473.0,Here's Which IT Stocks Benefit From Healthcare M&A,2015-08-10 12:23:00-04:00,JNJ,heres which it stocks benefit from healthcare m and a,"{'neg': 0.0, 'neu': 0.75, 'pos': 0.25, 'compound': 0.4588}",neutral,0.9998736381530762
697252,697252,708474.0,20 Dividend Growth Stocks To Buy Today For Your Retirement Portfolio,2015-08-09 17:52:00-04:00,JNJ,20 dividend growth stocks to buy today for your retirement portfolio,"{'neg': 0.0, 'neu': 0.794, 'pos': 0.206, 'compound': 0.3818}",neutral,0.9998205304145813
697253,697253,708475.0,5 U.S. Mega Caps With Less Than 0.1% Insider Ownership,2015-08-04 11:15:00-04:00,JNJ,5 u s mega caps with less than 0.1 percent insider ownership,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998773336410522
697254,697254,708476.0,Achillion Announces Janssen Initiated Phase I Study to Evaluate Effect of Simeprevir and Odalasvir on AL-335 Pharmacokinetics,2015-08-03 04:20:00-04:00,JNJ,achillion announces janssen initiated phase i study to evaluate effect of simeprevir and odalasvir on al 335 pharmacokinetics,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998729228973389
697255,697255,708477.0,S&P 500 Index Futures Trading Higher,2015-07-29 10:26:00-04:00,JNJ,SP500 500 index futures trading higher,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9990843534469604
697256,697256,708478.0,ETFs For The Next Pharma Takeover Candidates,2015-07-28 13:08:00-04:00,JNJ,etfs for the next pharma takeover candidates,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998857975006104
697257,697257,708479.0,Johnson & Johnson Q2 Earnings Top Expectations,2015-07-14 08:12:00-04:00,JNJ,johnson and johnson second quarter earnings top expectations,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.2023}",positive,0.99945467710495
697258,697258,708480.0,"UPDATE: Johnson & Johnson 2Q Medical Devices Sales $6.36B, Cardiovascular Sales $544M, Orthopaedics Sales $2.33B",2015-07-14 07:48:00-04:00,JNJ,update johnson and johnson second quarter medical devices sales dollars .36 billion cardiovascular sales dollars 44 million orthopaedics sales dollars .33 billion,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998823404312134
697259,697259,708481.0,J&J Raises FY15 Adj. EPS $6.10-$6.20 vs $6.14 Est.,2015-07-14 07:46:00-04:00,JNJ,j and j raises fy15 adj eps dollars .10 dollars .20 vs dollars .14 est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999859094619751
697260,697260,708482.0,"Johnson & Johnson Reports Q2 EPS $1.71 vs. Est. $1.67, Rev. $17.8B vs.  Est. $17.57B",2015-07-14 07:45:00-04:00,JNJ,johnson and johnson reports second quarter eps dollars .71 vs est dollars .67 rev dollars 7.8 billion vs est dollars 7.57 billion,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999864935874939
697261,697261,708483.0,"Earning & Economic Calendar for Tuesday July 14, 2015",2015-07-14 05:34:00-04:00,JNJ,earning and economic calendar for tuesday july 14 2015,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998873472213745
697262,697262,708484.0,"Earnings Scheduled For July 14, 2015",2015-07-14 04:34:00-04:00,JNJ,earnings scheduled for july 14 2015,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998823404312134
697263,697263,708485.0,7 Stocks You Should Be Watching Today,2015-07-14 04:14:00-04:00,JNJ,7 stocks you should be watching today,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998377561569214
697264,697264,708486.0,"From JPMorgan To Johnson & Johnson, Options Activity Surrounds This Week's Earnings",2015-07-13 17:14:00-04:00,JNJ,from jpmorgan to johnson and johnson options activity surrounds this weeks earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998587369918823
697265,697265,708487.0,Can Johnson & Johnson Deliver Its Best Quarter Ever Despite FX Headwinds?,2015-07-13 14:58:00-04:00,JNJ,can johnson and johnson deliver its best quarter ever despite fx headwinds,"{'neg': 0.0, 'neu': 0.724, 'pos': 0.276, 'compound': 0.6369}",positive,0.9995613694190979
697266,697266,708488.0,Strong Dollar? Not So Good For Johnson & Johnson Earnings,2015-07-10 11:41:00-04:00,JNJ,strong dollar not so good for johnson and johnson earnings,"{'neg': 0.211, 'neu': 0.558, 'pos': 0.23, 'compound': 0.0699}",negative,0.993861198425293
697267,697267,708489.0,"TD Ameritrade Clients Are Buying Apple, Twitter; Selling Facebook, AOL",2015-07-07 15:11:00-04:00,JNJ,td ameritrade clients are buying apple twitter selling facebook aol,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998576641082764
697268,697268,708490.0,"J&J Reports 15.6% Passive Stake In Achillion Pharmaceuticals as of July 1, 2015",2015-07-07 06:06:00-04:00,JNJ,j and j reports 15.6 percent passive stake in achillion pharmaceuticals as of july 1 2015,"{'neg': 0.0, 'neu': 0.893, 'pos': 0.107, 'compound': 0.2023}",neutral,0.999889612197876
697269,697269,708491.0,S&P 500 Index Futures Trading Higher,2015-06-26 11:38:00-04:00,JNJ,SP500 500 index futures trading higher,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9990843534469604
697270,697270,708492.0,"A 'Gay Friendly' Portfolio Includes Apple, Microsoft & Disney...And It Beats The Market",2015-06-19 10:53:00-04:00,JNJ,a gay friendly portfolio includes apple microsoft and disney and it beats the market,"{'neg': 0.0, 'neu': 0.802, 'pos': 0.198, 'compound': 0.4939}",positive,0.9988430738449097
697271,697271,708493.0,S&P 500 Index Futures Trading Lower In Volatile Session,2015-06-15 12:27:00-04:00,JNJ,SP500 500 index futures trading lower in volatile session,"{'neg': 0.216, 'neu': 0.784, 'pos': 0.0, 'compound': -0.296}",negative,0.9973070621490479
697272,697272,708494.0,S&P 500 Index Futures Trading Higher,2015-06-11 11:45:00-04:00,JNJ,SP500 500 index futures trading higher,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9990843534469604
697273,697273,708495.0,Analyst: Cardinal Health Buying Spree To Boost FY17 EPS,2015-06-09 12:23:00-04:00,JNJ,analyst cardinal health buying spree to boost fy17 eps,"{'neg': 0.0, 'neu': 0.748, 'pos': 0.252, 'compound': 0.4019}",positive,0.9996091723442078
697274,697274,708496.0,"This Technology Could Disrupt U.S. Pharma Stocks, Credit Suisse Says",2015-06-08 14:03:00-04:00,JNJ,this technology could disrupt u s pharma stocks credit suisse says,"{'neg': 0.0, 'neu': 0.794, 'pos': 0.206, 'compound': 0.3818}",negative,0.9305116534233093
697275,697275,708497.0,S&P 500 Index Futures Trading Lower In Choppy Session,2015-06-08 10:47:00-04:00,JNJ,SP500 500 index futures trading lower in choppy session,"{'neg': 0.216, 'neu': 0.784, 'pos': 0.0, 'compound': -0.296}",negative,0.9961406588554382
697276,697276,708498.0,S&P 500 Index Futures Trading Lower In Volatile Session,2015-06-05 11:08:00-04:00,JNJ,SP500 500 index futures trading lower in volatile session,"{'neg': 0.216, 'neu': 0.784, 'pos': 0.0, 'compound': -0.296}",negative,0.9973070621490479
697277,697277,708499.0,JMP Securities Boosts Halozyme Price Target On 'Long-Term Value',2015-06-04 10:17:00-04:00,JNJ,jmp securities boosts halozyme price target on long term value,"{'neg': 0.0, 'neu': 0.504, 'pos': 0.496, 'compound': 0.7096}",positive,0.9996572732925415
697278,697278,708500.0,J&J's Janssen R&D LLC Reported Data from Phase 3 Multicenter Study SAR3007: Showed Significant Improvement in PFS with Trabectedin vs. Dacarbazine,2015-06-01 17:05:00-04:00,JNJ,j and js janssen r and d llc reported data from phase 3 multicenter study sar3007 showed significant improvement in pfs with trabectedin vs dacarbazine,"{'neg': 0.0, 'neu': 0.827, 'pos': 0.173, 'compound': 0.5859}",positive,0.9996775388717651
697279,697279,708501.0,"Healthcare, Yen And Oil ETFs To Watch This Week",2015-05-31 10:59:00-04:00,JNJ,healthcare yen and oil etfs to watch this week,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998658895492554
697280,697280,708502.0,Phase III HELIOS Study Results Show IMBRUVICA Combination Therapy Significantly Increased Progression-Free Survival in Previously-Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Patients,2015-05-30 09:25:00-04:00,JNJ,phase iii helios study results show imbruvica combination therapy significantly increased progression free survival in previously treated chronic lymphocytic leukemia and small lymphocytic lymphoma patients,"{'neg': 0.0, 'neu': 0.81, 'pos': 0.19, 'compound': 0.6597}",positive,0.9997007846832275
697281,697281,708503.0,"1 Positive, 1 Negative For Johnson & Johnson Stock",2015-05-29 08:19:00-04:00,JNJ,1 positive 1 negative for johnson and johnson stock,"{'neg': 0.259, 'neu': 0.49, 'pos': 0.252, 'compound': -0.0258}",negative,0.9958676099777222
697282,697282,708504.0,J&J Reports Acceptance of Binding Offer from Cordis,2015-05-28 08:00:00-04:00,JNJ,j and j reports acceptance of binding offer from cordis,"{'neg': 0.0, 'neu': 0.75, 'pos': 0.25, 'compound': 0.4588}",neutral,0.9986119270324707
697283,697283,708505.0,UPDATE: J&J Removed the Device from the Market Last Year,2015-05-27 13:10:00-04:00,JNJ,update j and j removed the device from the market last year,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998168349266052
697284,697284,708506.0,FBI Said to Be Investigating JNJ Surgical Device Tied to Cancer in Women -DJ,2015-05-27 13:09:00-04:00,JNJ,fbi said to be investigating jnj surgical device tied to cancer in women dj,"{'neg': 0.253, 'neu': 0.747, 'pos': 0.0, 'compound': -0.6597}",neutral,0.9998525381088257
697285,697285,708507.0,S&P 500 Index Futures Trading Lower In Quiet Session,2015-05-22 11:40:00-04:00,JNJ,SP500 500 index futures trading lower in quiet session,"{'neg': 0.216, 'neu': 0.784, 'pos': 0.0, 'compound': -0.296}",negative,0.9963668584823608
697286,697286,708508.0,"CHMP Gave Six Recommendations on Extensions of Therapeutic Indication for: Janssen's Simponi and Stelara, Pharmacyclics' Imbruvica, Eisai's Fycompa, BioMarin's Kuvan, Novo's Xultophy",2015-05-22 07:11:00-04:00,JNJ,chmp gave six recommendations on extensions of therapeutic indication for janssens simponi and stelara pharmacyclics imbruvica eisais fycompa biomarins kuvan novos xultophy,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997971653938293
697287,697287,708509.0,S&P 500 Index Futures Trading Higher,2015-05-21 11:14:00-04:00,JNJ,SP500 500 index futures trading higher,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9990843534469604
697288,697288,708510.0,Raymond James: Johnson & Johnson Has 'Innovation',2015-05-21 08:49:00-04:00,JNJ,raymond james johnson and johnson has innovation,"{'neg': 0.0, 'neu': 0.698, 'pos': 0.302, 'compound': 0.3818}",neutral,0.9998693466186523
697289,697289,708511.0,What Does The Johnson & Johnson/Achillion Deal Mean For HCV Competitors?,2015-05-21 08:27:00-04:00,JNJ,what does the johnson and johnson and achillion deal mean for hcv competitors,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9989249110221863
697290,697290,708512.0,The Most Popular Stocks Held By 4 Different Generations Of Investors,2015-05-21 07:45:00-04:00,JNJ,the most popular stocks held by 4 different generations of investors,"{'neg': 0.0, 'neu': 0.764, 'pos': 0.236, 'compound': 0.4754}",neutral,0.9998948574066162
697291,697291,708513.0,Novo Sells License On Autoimmune Disease To Janssen,2015-05-20 10:10:00-04:00,JNJ,novo sells license on autoimmune disease to janssen,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998818635940552
697292,697292,708514.0,Morning Market Losers,2015-05-20 09:56:00-04:00,JNJ,morning market losers,"{'neg': 0.63, 'neu': 0.37, 'pos': 0.0, 'compound': -0.5267}",neutral,0.5947672724723816
697293,697293,708515.0,JMP Says Stepping To The Sidelines On Achillion,2015-05-20 08:54:00-04:00,JNJ,jmp says stepping to the sidelines on achillion,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998679161071777
697294,697294,708516.0,Benzinga's Top #PreMarket Losers,2015-05-20 08:29:00-04:00,JNJ,benzingas top losers,"{'neg': 0.548, 'neu': 0.161, 'pos': 0.29, 'compound': -0.3818}",neutral,0.9998142123222351
697295,697295,708517.0,J&J Announces Pharma Unit Will Continue Driving Above-Industry Growth with Plans to File More than 10 New Products by '19,2015-05-20 07:32:00-04:00,JNJ,j and j announces pharma unit will continue driving above industry growth with plans to file more than 10 new products by 19,"{'neg': 0.0, 'neu': 0.894, 'pos': 0.106, 'compound': 0.3818}",positive,0.9996134638786316
697296,697296,708518.0,Achillion Pharmaceuticals Shares Fall ~2% Premarket Following Announcement of Hep C Collaboration With Janssen,2015-05-20 06:26:00-04:00,JNJ,achillion pharmaceuticals shares fall 2 percent premarket following announcement of hep c collaboration with janssen,"{'neg': 0.0, 'neu': 0.864, 'pos': 0.136, 'compound': 0.296}",negative,0.9983879327774048
697297,697297,708519.0,"UPDATE: Achillion, Janssen Deal Includes $225M Investment for ~18.4M Newly Issued, Unregistered Shares of Achillion at $12.25/Share",2015-05-19 16:09:00-04:00,JNJ,update achillion janssen deal includes dollars 25 million investment for 18.4 million newly issued unregistered shares of achillion at dollars 2,"{'neg': 0.0, 'neu': 0.901, 'pos': 0.099, 'compound': 0.296}",neutral,0.9998856782913208
697298,697298,708520.0,"UPDATE: Achillion, Janssen Collab Includes Up to $1.1B in Potential Development, Regulatory, Sales Milestone Payments, Separate Equity Investment",2015-05-19 16:07:00-04:00,JNJ,update achillion janssen collab includes up to dollars .1 billion in potential development regulatory sales milestone payments separate equity investment,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998834133148193
697299,697299,708521.0,Achillion Announces Collaboration for Hep C with J&J's Janssen Pharma,2015-05-19 16:05:00-04:00,JNJ,achillion announces collaboration for hep c with j and js janssen pharma,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998557567596436
697300,697300,708522.0,"From Achillion Events Page: Posts Link for Co., Janssen Discussion for HCV Collab Webcast",2015-05-19 16:05:00-04:00,JNJ,from achillion events page posts link for co janssen discussion for hcv collab webcast,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998853206634521
697301,697301,708523.0,J&J's Janssen Pharma Reports FDA Approval of INVEGA TRINZA for Treatment of Schizophrenia,2015-05-19 08:03:00-04:00,JNJ,j and js janssen pharma reports fda approval of invega trinza for treatment of schizophrenia,"{'neg': 0.0, 'neu': 0.819, 'pos': 0.181, 'compound': 0.4767}",positive,0.9992870688438416
697302,697302,708524.0,J&J's Janssen Reports Data Demonstrates Adults with Type 2 Diabetes Achieved Blood Glucose Treatment Goals with Use of INVOKANA,2015-05-18 08:48:00-04:00,JNJ,j and js janssen reports data demonstrates adults with type 2 diabetes achieved blood glucose treatment goals with use of invokana,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9931463003158569
697303,697303,708526.0,The FDA's Authority Challenged By Mallinckrodt,2015-05-15 15:07:00-04:00,JNJ,the fdas authority challenged by mallinckrodt,"{'neg': 0.209, 'neu': 0.597, 'pos': 0.194, 'compound': -0.0258}",neutral,0.9998730421066284
697304,697304,708527.0,These Charts Explain Why Johnson & Johnson Should Be Approached Tactically,2015-05-15 10:58:00-04:00,JNJ,these charts explain why johnson and johnson should be approached tactically,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998621940612793
697305,697305,708528.0,Morgan Stanley Has 'Cautious Optimism' On Johnson & Johnson,2015-05-15 08:27:00-04:00,JNJ,morgan stanley has cautious optimism on johnson and johnson,"{'neg': 0.118, 'neu': 0.588, 'pos': 0.294, 'compound': 0.4767}",positive,0.9991934895515442
697306,697306,708529.0,What Current Buyback Levels Mean For The Bull Market,2015-05-14 12:34:00-04:00,JNJ,what current buyback levels mean for the bull market,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9743196964263916
697307,697307,708530.0,Bavarian Nordic Announces Presentation of Preliminary Phase 1 Results for Ebola Prime-Boost Vaccine Regimen of MVA-BN Filo and Janssen's AdVac,2015-05-12 14:06:00-04:00,JNJ,bavarian nordic announces presentation of preliminary phase 1 results for ebola prime boost vaccine regimen of mva bn filo and janssens advac,"{'neg': 0.0, 'neu': 0.886, 'pos': 0.114, 'compound': 0.4019}",neutral,0.9811045527458191
697308,697308,708531.0,IPO Outlook: Galapagos Offers New Hope For CF And RA Sufferers,2015-05-12 13:45:00-04:00,JNJ,ipo outlook galapagos offers new hope for cf and ra sufferers,"{'neg': 0.222, 'neu': 0.588, 'pos': 0.19, 'compound': -0.128}",positive,0.9981222748756409
697309,697309,708532.0,Bavarian Nordic  Receives €50M Loan from the European Investment Bank to Help Co Develop Ebola Vaccine -Reuters,2015-05-12 10:21:00-04:00,JNJ,bavarian nordic receives 50 million loan from the european investment bank to help co develop ebola vaccine reuters,"{'neg': 0.0, 'neu': 0.863, 'pos': 0.137, 'compound': 0.4019}",positive,0.9065757393836975
697310,697310,708533.0,J&J's Janssen Pharma Announces FDA Issued CRL to sNDA for Expanded Labe on INVEGA SUSTENNA,2015-05-11 17:49:00-04:00,JNJ,j and js janssen pharma announces fda issued crl to snda for expanded labe on invega sustenna,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9972139000892639
697311,697311,708534.0,"Traders, Here's What You're Doing Wrong (And How To Fix It)",2015-05-11 14:24:00-04:00,JNJ,traders heres what youre doing wrong and how to fix it,"{'neg': 0.237, 'neu': 0.763, 'pos': 0.0, 'compound': -0.4767}",neutral,0.9998268485069275
697312,697312,708535.0,9 Hot (Or Not) IPOs Scheduled To Debut This Week,2015-05-11 08:30:00-04:00,JNJ,9 hot or not ipos scheduled to debut this week,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999890923500061
697313,697313,708536.0,Countdown To The Best Public Reputations Company,2015-05-07 14:46:00-04:00,JNJ,countdown to the best public reputations company,"{'neg': 0.0, 'neu': 0.588, 'pos': 0.412, 'compound': 0.6369}",neutral,0.9998564720153809
697314,697314,708537.0,"Johnson & Johnson, NYU School of Medicine Partner to Evaluate Compassionate Use of Investigational Medicines",2015-05-07 04:29:00-04:00,JNJ,johnson and johnson nyu school of medicine partner to evaluate compassionate use of investigational medicines,"{'neg': 0.0, 'neu': 0.814, 'pos': 0.186, 'compound': 0.4939}",neutral,0.9998408555984497
697315,697315,708538.0,"Credit Suisse: We Prefer Pfizer, Bristol Over Pharma Peers",2015-05-05 08:51:00-04:00,JNJ,credit suisse we prefer pfizer bristol over pharma peers,"{'neg': 0.0, 'neu': 0.755, 'pos': 0.245, 'compound': 0.3818}",neutral,0.9997997879981995
697316,697316,708539.0,"J&J Announces Further PTO Action Realted to REMICADE: Office Maintained Rejection of Patent, Patent '471 Remains Valid",2015-04-29 16:35:00-04:00,JNJ,j and j announces further point o action realted to remicade office maintained rejection of patent patent 471 remains valid,"{'neg': 0.156, 'neu': 0.844, 'pos': 0.0, 'compound': -0.5423}",neutral,0.9603874683380127
697317,697317,708540.0,Technician Breaks Down Johnson & Johnson,2015-04-23 12:22:00-04:00,JNJ,technician breaks down johnson and johnson,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998260140419006
697318,697318,708541.0,J&J Raises Qtr. Dividend from $0.70 to $0.75/Share,2015-04-23 10:59:00-04:00,JNJ,j and j raises qtr dividend from dollars .70 to dollars,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9992048144340515
697319,697319,708542.0,"J&J's Janssen Reports SVR12 Rates with Twelve Weeks of Treatment with All-Oral, Once-Daily Regimen of Simeprevir Plus Sofosbuvir",2015-04-23 09:19:00-04:00,JNJ,j and js janssen reports svr12 rates with twelve weeks of treatment with all oral once daily regimen of simeprevir plus sofosbuvir,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998730421066284
697320,697320,708543.0,Bank Of America Sees Big Divestitures Upcoming For Johnson & Johnson,2015-04-15 15:43:00-04:00,JNJ,bank of america sees big divestitures upcoming for johnson and johnson,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9996088147163391
697321,697321,708544.0,Morgan Stanley Shares What Johnson & Johnson Investors Should Focus On Now,2015-04-15 09:25:00-04:00,JNJ,morgan stanley shares what johnson and johnson investors should focus on now,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.296}",neutral,0.9998683929443359
697322,697322,708545.0,What Specific Role Will Apple Play In IBM's Watson Health Cloud Alliance?,2015-04-15 08:51:00-04:00,JNJ,what specific role will apple play in ibms watson health cloud alliance,"{'neg': 0.0, 'neu': 0.821, 'pos': 0.179, 'compound': 0.34}",neutral,0.9998890161514282
697323,697323,708546.0,J&J's Janssen Highlights Study Published in JCP Showing Long-Acting INVEGA SUSTENNA Effective Six Months Longer Than Other Oral Antipsychotics,2015-04-15 08:40:00-04:00,JNJ,j and js janssen highlights study published in jcp showing long acting invega sustenna effective six months longer than other oral antipsychotics,"{'neg': 0.0, 'neu': 0.871, 'pos': 0.129, 'compound': 0.4767}",positive,0.8392288088798523
697324,697324,708547.0,Why Johnson & Johnson's Strong Pharmaceutical Business Is A Concern,2015-04-14 14:45:00-04:00,JNJ,why johnson and johnsons strong pharmaceutical business is a concern,"{'neg': 0.0, 'neu': 0.732, 'pos': 0.268, 'compound': 0.5106}",neutral,0.996905505657196
697325,697325,708548.0,The Big Health Data Orgy Happening In The Cloud,2015-04-14 10:14:00-04:00,JNJ,the big health data orgy happening in the cloud,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998910427093506
697326,697326,708549.0,US Stock Futures Down Ahead Of Business Inventories Data,2015-04-14 09:21:00-04:00,JNJ,us stock futures down ahead of business inventories data,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9821658730506897
697327,697327,708550.0,From J&J Earnings Conference Call: Expecting FY15 Constant Currency Sales $75B-$76B vs $74B Est.,2015-04-14 08:54:00-04:00,JNJ,from j and j earnings conference call expecting fy15 constant currency sales dollars 5 billion dollars 6 billion vs dollars 4 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998818635940552
697328,697328,708551.0,"Johnson & Johnson Posts Upbeat Q1 Earnings, But Lowers FY15 Forecast",2015-04-14 08:10:00-04:00,JNJ,johnson and johnson posts upbeat first quarter earnings but lowers fy15 forecast,"{'neg': 0.137, 'neu': 0.863, 'pos': 0.0, 'compound': -0.1901}",negative,0.987464427947998
697329,697329,708552.0,UPDATE: J&J Cuts FY EPS Outlook from $6.12-$6.27 Previously to $6.04-$6.19 vs $6.16 Est.,2015-04-14 07:46:00-04:00,JNJ,update j and j cuts fy eps outlook from dollars .12 dollars .27 previously to dollars .04 dollars .19 vs dollars .16 est,"{'neg': 0.091, 'neu': 0.909, 'pos': 0.0, 'compound': -0.296}",neutral,0.9780235886573792
697330,697330,708553.0,Johnson & Johnson Cuts Outlook,2015-04-14 07:46:00-04:00,JNJ,johnson and johnson cuts outlook,"{'neg': 0.355, 'neu': 0.645, 'pos': 0.0, 'compound': -0.296}",negative,0.983324408531189
697331,697331,708554.0,"Johnson & Johnson Reports Q1 EPS $1.56 Vs Est $1.54, Sales $17.37B Vs Est $17.31B",2015-04-14 07:45:00-04:00,JNJ,johnson and johnson reports first quarter eps dollars .56 vs est dollars .54 sales dollars 7.37 billion vs est dollars 7.31 billion,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998748302459717
697332,697332,708555.0,"Earnings Scheduled For April 14, 2015",2015-04-14 04:53:00-04:00,JNJ,earnings scheduled for april 14 2015,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998828172683716
697333,697333,708556.0,7 Stocks You Should Be Watching Today,2015-04-14 04:01:00-04:00,JNJ,7 stocks you should be watching today,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998377561569214
697334,697334,708557.0,"Stock Investors Dig In For Bank Earnings, Ready For Next SPX Test",2015-04-13 13:59:00-04:00,JNJ,stock investors dig in for bank earnings ready for next spx test,"{'neg': 0.0, 'neu': 0.815, 'pos': 0.185, 'compound': 0.3612}",neutral,0.99974125623703
697335,697335,708558.0,"Ichor Medical Systems Announces Entering Into Product Development Collaboration, Global License Deal with J&J's Janssen Pharma",2015-04-13 08:05:00-04:00,JNJ,ichor medical systems announces entering into product development collaboration global license deal with j and js janssen pharma,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.7083539366722107
697336,697336,708559.0,MorphoSys AG to Receive Milestone Payment for Guselkumab Program in Psoriatic Arthritis,2015-04-13 05:25:00-04:00,JNJ,morphosys ag to receive milestone payment for guselkumab program in psoriatic arthritis,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9990529417991638
697337,697337,708560.0,13 Stocks To Watch As Earnings Season Ramps Up,2015-04-12 14:57:00-04:00,JNJ,13 stocks to watch as earnings season ramps up,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9983548521995544
697338,697338,708561.0,Sector ETFs And Earnings,2015-04-07 14:19:00-04:00,JNJ,sector etfs and earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998875856399536
697339,697339,708562.0,"JPMorgan Cut Its Johnson & Johnson Forecast Before Earnings, But Why?",2015-04-06 15:00:00-04:00,JNJ,jpmorgan cut its johnson and johnson forecast before earnings but why,"{'neg': 0.134, 'neu': 0.866, 'pos': 0.0, 'compound': -0.1406}",negative,0.9797278046607971
697340,697340,708563.0,"Janssen Pharmaceuticals, Inc. Finalizes Divestiture of U.S. License Rights to NUCYNTA® (tapentadol), NUCYNTA® ER (tapentadol) extended-release tablets and NUCYNTA® (tapentadol) Oral Solution to Depomed, Inc For $1.05B",2015-04-02 16:10:00-04:00,JNJ,janssen pharmaceuticals inc finalizes divestiture of u s license rights to nucynta® tapentadol nucynta® er tapentadol extended release tablets and nucynta® tapentadol oral solution to depomed inc for dollars .05 billion,"{'neg': 0.0, 'neu': 0.935, 'pos': 0.065, 'compound': 0.3182}",positive,0.8641592264175415
697341,697341,708564.0,Hearing Unconfirmed Market Chatter JNJ to Spinoff Pharma Business from Medical Device Business,2015-04-02 10:17:00-04:00,JNJ,hearing unconfirmed market chatter jnj to spinoff pharma business from medical device business,"{'neg': 0.111, 'neu': 0.889, 'pos': 0.0, 'compound': -0.128}",neutral,0.9996106028556824
697342,697342,708566.0,J&J's Janssen Announces FDA Approval for Label Update for ZYTIGA to Include Statistically Significant Overall Survival Results in Chemotherapy-Naive Men with Metastatic Castration-Resistant Prostate Cancer,2015-03-30 08:06:00-04:00,JNJ,j and js janssen announces fda approval for label update for zytiga to include statistically significant overall survival results in chemotherapy naive men with metastatic castration resistant prostate cancer,"{'neg': 0.179, 'neu': 0.687, 'pos': 0.135, 'compound': -0.3818}",positive,0.9984461665153503
697343,697343,708567.0,Johnson & Johnson Teams With Google On Surgery Robot Development,2015-03-27 10:34:00-04:00,JNJ,johnson and johnson teams with google on surgery robot development,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998713731765747
697344,697344,708568.0,"Watch Shares of Intuitive Surgical Here as Bloomberg Reporting J&J In a Deal with Google Related to Surgical Robotics, Terms Not Disclosed",2015-03-27 09:12:00-04:00,JNJ,watch shares of intuitive surgical here as bloomberg reporting j and j in a deal with google related to surgical robotics terms not disclosed,"{'neg': 0.0, 'neu': 0.913, 'pos': 0.087, 'compound': 0.296}",neutral,0.9998950958251953
697345,697345,708569.0,"J&J, Bausch & Lomb Accused Of Price Fixing, Antitrust Suit Claims Contact Lens Makers Set Minimum Resale Prices",2015-03-24 13:19:00-04:00,JNJ,j and j bausch and lomb accused of price fixing antitrust suit claims contact lens makers set minimum resale prices,"{'neg': 0.104, 'neu': 0.896, 'pos': 0.0, 'compound': -0.296}",negative,0.7418217062950134
697346,697346,708570.0,"Benzinga's M&A Chatter for Thursday March 19, 2015",2015-03-19 18:40:00-04:00,JNJ,benzingas m and a chatter for thursday march 19 2015,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998887777328491
697347,697347,708571.0,J&J Announces Janssen Purchase of XO1 Limited,2015-03-19 08:04:00-04:00,JNJ,j and j announces janssen purchase of xo1 limited,"{'neg': 0.192, 'neu': 0.808, 'pos': 0.0, 'compound': -0.2263}",neutral,0.9998608827590942
697348,697348,708572.0,Janssen Acquires XO1 Limited; Terms Not Disclosed,2015-03-19 05:20:00-04:00,JNJ,janssen acquires xo1 limited terms not disclosed,"{'neg': 0.241, 'neu': 0.759, 'pos': 0.0, 'compound': -0.2263}",neutral,0.9998897314071655
697349,697349,708573.0,FDA Panel to Discuss Development of Ebola Vaccines in May -Reuters,2015-03-18 08:17:00-04:00,JNJ,fda panel to discuss development of ebola vaccines in may reuters,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998706579208374
697350,697350,708574.0,PREVIEW: Pharmacyclics Shares to Resume Trading at 3:30 PM ET,2015-03-16 15:07:00-04:00,JNJ,preview pharmacyclics shares to resume trading at 0 pm et,"{'neg': 0.0, 'neu': 0.804, 'pos': 0.196, 'compound': 0.296}",neutral,0.9998705387115479
697351,697351,708575.0,UPDATE: Independent Data Monitoring Committee Unanimously Recommends Unblinding of IMBRUVICA,2015-03-16 15:01:00-04:00,JNJ,update independent data monitoring committee unanimously recommends unblinding of imbruvica,"{'neg': 0.0, 'neu': 0.826, 'pos': 0.174, 'compound': 0.2263}",neutral,0.9989933371543884
697352,697352,708576.0,Johnson and Johnson's Janssen Unit Loses Appeal For $11M Topamax Verdict,2015-03-16 14:25:00-04:00,JNJ,johnson and johnsons janssen unit loses appeal for dollars 1 million topamax verdict,"{'neg': 0.154, 'neu': 0.738, 'pos': 0.107, 'compound': -0.1779}",negative,0.9916418790817261
697353,697353,708577.0,Lifetime Income Payments Or Lump Sum: How To Decide?,2015-03-10 16:55:00-04:00,JNJ,lifetime income payments or lump sum how to decide,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998844861984253
697354,697354,708578.0,"J&J's McNeil Consumer Healthcare Unit Announces Deal for Resolution of US DoJ Probe: Will Pay $25M Settlement, Enter Plea for Single Misdemeanor Violation",2015-03-10 15:00:00-04:00,JNJ,j and js mcneil consumer healthcare unit announces deal for resolution of us doj probe will pay dollars 5 million settlement enter plea for single misdemeanor violation,"{'neg': 0.155, 'neu': 0.845, 'pos': 0.0, 'compound': -0.5574}",positive,0.9848185777664185
697355,697355,708579.0,McNeil Consumer Healthcare Resolves U.S. DOJ Investigation; To Pay Settlement of $25M,2015-03-10 14:58:00-04:00,JNJ,mcneil consumer healthcare resolves u s doj investigation to pay settlement of dollars 5 million,"{'neg': 0.087, 'neu': 0.807, 'pos': 0.106, 'compound': 0.0772}",positive,0.9507631659507751
697356,697356,708580.0,J&J Ordered To Pay $5.7M For Incontinence Implant,2015-03-05 15:43:00-05:00,JNJ,j and j ordered to pay dollars .7 million for incontinence implant,"{'neg': 0.113, 'neu': 0.887, 'pos': 0.0, 'compound': -0.1027}",neutral,0.9997883439064026
697357,697357,708581.0,Johnson & Johnson's Ethicon Unit Ordered to Pay $5.6M from Trial ver Transvaginal Mesh Injuries -Reuters,2015-03-05 14:34:00-05:00,JNJ,johnson and johnsons ethicon unit ordered to pay dollars .6 million from trial ver transvaginal mesh injuries reuters,"{'neg': 0.076, 'neu': 0.924, 'pos': 0.0, 'compound': -0.1027}",neutral,0.989997923374176
697358,697358,708582.0,"Benzinga's M&A Chatter for Wednesday March 4, 2015",2015-03-04 20:47:00-05:00,JNJ,benzingas m and a chatter for wednesday march 4 2015,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998897314071655
697359,697359,708583.0,Report: Pharmacyclics Inc. To Be Acquired By Johnson & Johnson,2015-03-04 18:13:00-05:00,JNJ,report pharmacyclics inc to be acquired by johnson and johnson,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998817443847656
697360,697360,708584.0,UPDATE: J&J's Purchase of Pharmacyclics May Be Announced as Soon as Thursday,2015-03-04 17:09:00-05:00,JNJ,update j and js purchase of pharmacyclics may be announced as soon as thursday,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998891353607178
697361,697361,708585.0,Hearing J&J Has Agreed to Purchase Pharmacyclics,2015-03-04 17:08:00-05:00,JNJ,hearing j and j has agreed to purchase pharmacyclics,"{'neg': 0.0, 'neu': 0.792, 'pos': 0.208, 'compound': 0.2732}",positive,0.9966979026794434
697362,697362,708586.0,Fast Money Halftime Report Final Trade From March 4,2015-03-04 16:36:00-05:00,JNJ,fast money halftime report final trade from march 4,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998874664306641
697363,697363,708587.0,Hearing FT Reporting J&J Near Deal to Purchase Pharmacyclics,2015-03-04 16:02:00-05:00,JNJ,hearing ft reporting j and j near deal to purchase pharmacyclics,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9990881681442261
697364,697364,708588.0,"Benzinga's M&A Chatter for Monday March 2, 2015",2015-03-02 19:29:00-05:00,JNJ,benzingas m and a chatter for monday march 2 2015,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998860359191895
697365,697365,708589.0,"'Merger Monday' Lives Up To Name: From NXP Semiconductors To eBay, There's At Least $20 Billon In Total Deals",2015-03-02 13:19:00-05:00,JNJ,merger monday lives up to name from nxp semiconductors to ebay theres at least dollars 0 billon in total deals,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998873472213745
697366,697366,708590.0,UPDATE: Johnson & Johnson Announces Binding Offer from Cardinal Health to Acquire Cordis,2015-03-02 07:31:00-05:00,JNJ,update johnson and johnson announces binding offer from cardinal health to acquire cordis,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.7080761790275574
697367,697367,708591.0,Johnson & Johnson Announces Binding Offer from Cardinal Health to Acquire Cordis,2015-03-02 07:30:00-05:00,JNJ,johnson and johnson announces binding offer from cardinal health to acquire cordis,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.7832911610603333
697368,697368,708592.0,WHO Says Independent Advisory Body to Decide No Earlier than August on Recommendation of Widespread Ebola Vaccinations,2015-02-27 05:30:00-05:00,JNJ,who says independent advisory body to decide no earlier than august on recommendation of widespread ebola vaccinations,"{'neg': 0.121, 'neu': 0.879, 'pos': 0.0, 'compound': -0.296}",neutral,0.999869704246521
697369,697369,708593.0,"J&J Announces Formation of New Health and Wellness Platform Aimed at Transforming Health Care Delivery, Improve the Patient Experience",2015-02-26 08:04:00-05:00,JNJ,j and j announces formation of new health and wellness platform aimed at transforming health care delivery improve the patient experience,"{'neg': 0.0, 'neu': 0.667, 'pos': 0.333, 'compound': 0.8402}",positive,0.9972706437110901
697370,697370,708594.0,"Benzinga's M&A Chatter for Wednesday February 25, 2015",2015-02-25 21:26:00-05:00,JNJ,benzingas m and a chatter for wednesday february 25 2015,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999887228012085
697371,697371,708595.0,Deutsche Bank On Pharmacyclics: 'We Do Not See Much Upside',2015-02-25 17:05:00-05:00,JNJ,deutsche bank on pharmacyclics we do not see much upside,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.995980978012085
697372,697372,708596.0,Bloomberg Reporting JNJ Loses Bid To Get South Carolina Risperdal Verdict Tossed,2015-02-25 12:09:00-05:00,JNJ,bloomberg reporting jnj loses bid to get south carolina risperdal verdict tossed,"{'neg': 0.165, 'neu': 0.719, 'pos': 0.115, 'compound': -0.1779}",negative,0.9898911714553833
697373,697373,708597.0,Ontario Institute for Cancer Research Extends Collaboration With Janssen on Developing Clinical Trials for Prostate Cancer,2015-02-25 09:05:00-05:00,JNJ,ontario institute for cancer research extends collaboration with janssen on developing clinical trials for prostate cancer,"{'neg': 0.378, 'neu': 0.558, 'pos': 0.064, 'compound': -0.8519}",positive,0.9357356429100037
697374,697374,708598.0,Johnson & Johnson To Pay $2.5M For Failing to Properly Warn About Risperdal Risks,2015-02-24 14:27:00-05:00,JNJ,johnson and johnson to pay dollars .5 million for failing to properly warn about risperdal risks,"{'neg': 0.406, 'neu': 0.594, 'pos': 0.0, 'compound': -0.7351}",negative,0.9859404563903809
697375,697375,708599.0,JNJ Shares Spike Higher After-Hours,2015-02-23 16:40:00-05:00,JNJ,jnj shares spike higher after hours,"{'neg': 0.0, 'neu': 0.694, 'pos': 0.306, 'compound': 0.296}",positive,0.9995418787002563
697376,697376,708600.0,3 Companies That Could Be Negatively Impacted By Johnson & Johnson Sale Of Cordis,2015-02-23 13:57:00-05:00,JNJ,3 companies that could be negatively impacted by johnson and johnson sale of cordis,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9912030696868896
697377,697377,708601.0,Morgan Stanley Analyst Sees Higher Net For Cardinal Health In Johnson & Johnson Deal,2015-02-23 11:45:00-05:00,JNJ,morgan stanley analyst sees higher net for cardinal health in johnson and johnson deal,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.999607264995575
697378,697378,708602.0,J&J Has Agreed to Pay Additional $420M Related to Deal in ASR Hip Settlement Case,2015-02-23 07:45:00-05:00,JNJ,j and j has agreed to pay additional dollars 20 million related to deal in asr hip settlement case,"{'neg': 0.068, 'neu': 0.829, 'pos': 0.102, 'compound': 0.1779}",positive,0.999411940574646
697379,697379,708603.0,Cardnial Health Potential Buyer for J&J's Cordis Unit -Bloomberg,2015-02-23 04:55:00-05:00,JNJ,cardnial health potential buyer for j and js cordis unit bloomberg,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998456239700317
697380,697380,708604.0,"Jefferies Names AbbVie As Top Pharmaceutical Pick, Offers Alternative Choices",2015-02-20 13:10:00-05:00,JNJ,jefferies names abbvie as top pharmaceutical pick offers alternative choices,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.2023}",neutral,0.9998370409011841
697381,697381,708605.0,10 Stocks Institutional Investors Loved Last Quarter,2015-02-20 11:38:00-05:00,JNJ,10 stocks institutional investors loved last quarter,"{'neg': 0.0, 'neu': 0.606, 'pos': 0.394, 'compound': 0.5994}",positive,0.5297223329544067
697382,697382,708606.0,Sterne Agee To Investors: Caution! Boston Scientific Priced To Perfection,2015-02-20 09:08:00-05:00,JNJ,sterne agee to investors caution boston scientific priced to perfection,"{'neg': 0.0, 'neu': 0.709, 'pos': 0.291, 'compound': 0.5719}",neutral,0.9994202852249146
697383,697383,708607.0,Boston Scientific Closes Up 12%,2015-02-18 16:44:00-05:00,JNJ,boston scientific closes up 12 percent,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996352195739746
697384,697384,708609.0,Boston Scientific Soars 11% After Settling Dispute With Johnson & Johnson,2015-02-18 14:42:00-05:00,JNJ,boston scientific soars 11 percent after settling dispute with johnson and johnson,"{'neg': 0.197, 'neu': 0.803, 'pos': 0.0, 'compound': -0.4019}",positive,0.9993521571159363
697385,697385,708610.0,Mid-Day Market Update: Angie's List Jumps On Upbeat Earnings; MedAssets Shares Tumble,2015-02-18 12:51:00-05:00,JNJ,mid day market update angies list jumps on upbeat earnings medassets shares tumble,"{'neg': 0.0, 'neu': 0.845, 'pos': 0.155, 'compound': 0.296}",positive,0.9926751255989075
697386,697386,708611.0,Sterne Agree Weighs In On Boston Scientific-Johnson & Johnson Litigation Settlement,2015-02-18 10:24:00-05:00,JNJ,sterne agree weighs in on boston scientific johnson and johnson litigation settlement,"{'neg': 0.126, 'neu': 0.699, 'pos': 0.175, 'compound': 0.1779}",neutral,0.9618465304374695
697387,697387,708612.0,Stocks Hitting 52-Week Highs,2015-02-18 10:05:00-05:00,JNJ,stocks hitting 52 week highs,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9992315769195557
697388,697388,708613.0,Morning Market Gainers,2015-02-18 09:38:00-05:00,JNJ,morning market gainers,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9994286894798279
697389,697389,708614.0,Benzinga's Top #PreMarket Gainers,2015-02-18 08:11:00-05:00,JNJ,benzingas top gainers,"{'neg': 0.0, 'neu': 0.526, 'pos': 0.474, 'compound': 0.2023}",positive,0.8080791234970093
697390,697390,708615.0,Fast Money Halftime Report Final Trade From February 17,2015-02-17 17:50:00-05:00,JNJ,fast money halftime report final trade from february 17,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998854398727417
697391,697391,708616.0,Boston Scientific Shares Rise 12% After-Hours on JNJ Settlement News,2015-02-17 17:28:00-05:00,JNJ,boston scientific shares rise 12 percent after hours on jnj settlement news,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.296}",positive,0.9996877908706665
697392,697392,708617.0,"Boston Scientific Reports Deal with J&J for Resolution of Guidant Litigation, Will Make $600M in Payments, Sees Pretax Charge $600M",2015-02-17 16:06:00-05:00,JNJ,boston scientific reports deal with j and j for resolution of guidant litigation will make dollars 00 million in payments sees pretax charge dollars 00 million,"{'neg': 0.067, 'neu': 0.933, 'pos': 0.0, 'compound': -0.2023}",neutral,0.9998319149017334
697393,697393,708618.0,8 Stocks Going Ex-Dividend This Week (And 1 Trading Idea),2015-02-16 13:27:00-05:00,JNJ,8 stocks going ex dividend this week and 1 trading idea,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998821020126343
697394,697394,708619.0,American Firms In China Feel Anti-Foreign Sentiment Rising In The Wake Of Qualcomm Settlement,2015-02-13 14:25:00-05:00,JNJ,american firms in china feel anti foreign sentiment rising in the wake of qualcomm settlement,"{'neg': 0.141, 'neu': 0.859, 'pos': 0.0, 'compound': -0.3182}",negative,0.9827311635017395
697395,697395,708620.0,"Bill Ackman Thinks Valeant Is 'Incredibly Disciplined,' And Says He'd Own McDonald's If 3G Capital Was In Charge",2015-02-13 13:06:00-05:00,JNJ,bill ackman thinks valeant is incredibly disciplined and says hed own mcdonalds if 3 g capital was in charge,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.8497658371925354
697396,697396,708621.0,Johnson & Johnson Faces Pressure From U.S. Patent Office,2015-02-13 11:18:00-05:00,JNJ,johnson and johnson faces pressure from u s patent office,"{'neg': 0.196, 'neu': 0.804, 'pos': 0.0, 'compound': -0.296}",neutral,0.5050147175788879
697397,697397,708622.0,"ITC to Acquire JNJ's Savlon, Shower to Shower Brands -Business Standard",2015-02-13 07:25:00-05:00,JNJ,itc to acquire jnjs savlon shower to shower brands business standard,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9994571805000305
697398,697398,708623.0,J&J Announces PTO Action Related to REMICADE: Co. Has 60 Days To Respond,2015-02-12 14:35:00-05:00,JNJ,j and j announces point o action related to remicade co has 60 days to respond,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998639822006226
697399,697399,708624.0,Johnson & Johnson Under Selling Pressure,2015-02-12 12:01:00-05:00,JNJ,johnson and johnson under selling pressure,"{'neg': 0.306, 'neu': 0.694, 'pos': 0.0, 'compound': -0.296}",negative,0.9656022787094116
697400,697400,708625.0,J&J Shares Plunge Below $100 Level Few Mins Ahead of Bloomberg Headline Suggesting Co.'s Remicade Patent Claims Have Been Given Final Patent Office Rejection,2015-02-12 11:56:00-05:00,JNJ,j and j shares plunge below dollars 00 level few mins ahead of bloomberg headline suggesting co s remicade patent claims have been given final patent office rejection,"{'neg': 0.11, 'neu': 0.82, 'pos': 0.069, 'compound': -0.3182}",negative,0.9983154535293579
697401,697401,708626.0,JNJ Shares Selling Off,2015-02-12 11:21:00-05:00,JNJ,jnj shares selling off,"{'neg': 0.0, 'neu': 0.577, 'pos': 0.423, 'compound': 0.296}",negative,0.961470365524292
697402,697402,708627.0,Hearing Unconfirmed Market Chatter JNJ has Hired Goldman Sachs to Explore Breakup into 3 Cos,2015-02-10 11:14:00-05:00,JNJ,hearing unconfirmed market chatter jnj has hired goldman sachs to explore breakup into 3 cos,"{'neg': 0.097, 'neu': 0.903, 'pos': 0.0, 'compound': -0.128}",neutral,0.9997925162315369
697403,697403,708628.0,J&J Reports 15.1% Passive Stake in Aquinox Pharmaceuticals as of December 31,2015-02-06 06:24:00-05:00,JNJ,j and j reports 15.1 percent passive stake in aquinox pharmaceuticals as of december 31,"{'neg': 0.0, 'neu': 0.886, 'pos': 0.114, 'compound': 0.2023}",neutral,0.9998921155929565
697404,697404,708629.0,U.S. FDA Grants Priority Review for YONDELIS,2015-02-03 12:38:00-05:00,JNJ,u s fda grants priority review for yondelis,"{'neg': 0.0, 'neu': 0.787, 'pos': 0.213, 'compound': 0.2263}",neutral,0.8287839293479919
697405,697405,708630.0,J&J Sarcoma Drug Yondelis Gets FDA Priority Review,2015-02-03 07:13:00-05:00,JNJ,j and j sarcoma drug yondelis gets fda priority review,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.7234015464782715
697406,697406,708631.0,ETF Spotlight: Dividend Aristocrat Index,2015-01-29 14:58:00-05:00,JNJ,etf spotlight dividend aristocrat index,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998843669891357
697407,697407,708632.0,#Premarket Prep Technical Update - Johnson & Johnson Lower,2015-01-29 13:04:00-05:00,JNJ,prep technical update to johnson and johnson lower,"{'neg': 0.239, 'neu': 0.761, 'pos': 0.0, 'compound': -0.296}",neutral,0.999822199344635
697408,697408,708633.0,WHO's Aylward Says Running Out of Cash Needed to Fight Ebola; Needs $260M; 4-5 Months Best Case for Virus to Stop -Reuters,2015-01-23 08:56:00-05:00,JNJ,whos aylward says running out of cash needed to fight ebola needs dollars 60 million 4 to 5 months best case for virus to stop reuters,"{'neg': 0.15, 'neu': 0.719, 'pos': 0.131, 'compound': 0.1027}",neutral,0.9210907220840454
697409,697409,708634.0,Morgan Stanley Analyst Sees FY15 'Trough' For Johnson & Johnson Pharma Growth,2015-01-22 11:54:00-05:00,JNJ,morgan stanley analyst sees fy15 trough for johnson and johnson pharma growth,"{'neg': 0.0, 'neu': 0.809, 'pos': 0.191, 'compound': 0.3818}",negative,0.9428010582923889
697410,697410,708635.0,Why Minerva Neurosciences Is Trading Higher,2015-01-21 21:21:00-05:00,JNJ,why minerva neurosciences is trading higher,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9995583891868591
697411,697411,708636.0,ECB Easing Could Strengthen Headwinds For U.S. Firms,2015-01-21 11:23:00-05:00,JNJ,ecb easing could strengthen headwinds for u s firms,"{'neg': 0.0, 'neu': 0.619, 'pos': 0.381, 'compound': 0.5106}",positive,0.9986985921859741
697412,697412,708637.0,UN's David Nabarro Cites Need for $1B to Fight Ebola -Reuters,2015-01-21 10:06:00-05:00,JNJ,uns david nabarro cites need for dollars b to fight ebola reuters,"{'neg': 0.191, 'neu': 0.809, 'pos': 0.0, 'compound': -0.3818}",neutral,0.9984128475189209
697413,697413,708638.0,Morgan Stanley Sees Balance Sheet & Pipeline As More Critical For Johnson & Johnson,2015-01-21 07:54:00-05:00,JNJ,morgan stanley sees balance sheet and pipeline as more critical for johnson and johnson,"{'neg': 0.166, 'neu': 0.834, 'pos': 0.0, 'compound': -0.3804}",neutral,0.9393946528434753
697414,697414,708639.0,CNBC's Stock Pops & Drops From January 20,2015-01-20 20:35:00-05:00,JNJ,cnbcs stock pops and drops from january 20,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.8740696310997009
697415,697415,708640.0,4 Companies Capturing Social Media Attention On Tuesday Morning,2015-01-20 09:57:00-05:00,JNJ,4 companies capturing social media attention on tuesday morning,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998108744621277
697416,697416,708641.0,Morning Market Losers,2015-01-20 09:57:00-05:00,JNJ,morning market losers,"{'neg': 0.63, 'neu': 0.37, 'pos': 0.0, 'compound': -0.5267}",neutral,0.5947672724723816
697417,697417,708642.0,"From Conf Call: J&J CFO Says Expects Better Growth Outlook for Medical Devices, Consumer Products for 2015 vs 2014",2015-01-20 09:43:00-05:00,JNJ,from conf call j and j cfo says expects better growth outlook for medical devices consumer products for 2015 vs 2014,"{'neg': 0.0, 'neu': 0.776, 'pos': 0.224, 'compound': 0.6705}",positive,0.9996432065963745
697418,697418,708643.0,UPDATE: Johnson & Johnson Posts Upbeat Q4 Earnings,2015-01-20 08:41:00-05:00,JNJ,update johnson and johnson posts upbeat fourth quarter earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.999546229839325
697419,697419,708644.0,Benzinga's Top #PreMarket Losers,2015-01-20 08:24:00-05:00,JNJ,benzingas top losers,"{'neg': 0.548, 'neu': 0.161, 'pos': 0.29, 'compound': -0.3818}",neutral,0.9998142123222351
697420,697420,708645.0,"Earning & Economic Calendar for Tuesday January 20, 2015",2015-01-20 05:18:00-05:00,JNJ,earning and economic calendar for tuesday january 20 2015,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998865127563477
697421,697421,708646.0,"Woman Who Worked with Ebola Patients Taken off United Airlines Flight Monday in Newark, After Showing Ebola Signs; Being Tested at Hackensack University Medical Center",2015-01-20 04:45:00-05:00,JNJ,woman who worked with ebola patients taken off united airlines flight monday in newark after showing ebola signs being tested at hackensack university medical center,"{'neg': 0.0, 'neu': 0.896, 'pos': 0.104, 'compound': 0.4215}",neutral,0.9997288584709167
697422,697422,708647.0,"Earnings Scheduled For January 20, 2015",2015-01-20 04:40:00-05:00,JNJ,earnings scheduled for january 20 2015,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998805522918701
697423,697423,708648.0,7 Stocks You Should Be Watching Today,2015-01-20 04:01:00-05:00,JNJ,7 stocks you should be watching today,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998377561569214
697424,697424,708649.0,Mid-Afternoon Market Update: Precision Castparts Slides After Weak Q3 Outlook; Schlumberger Shares Spike Higher,2015-01-16 15:36:00-05:00,JNJ,mid afternoon market update precision castparts slides after weak third quarter outlook schlumberger shares spike higher,"{'neg': 0.152, 'neu': 0.733, 'pos': 0.115, 'compound': -0.1779}",negative,0.8422507643699646
697425,697425,708650.0,NIH DIrector Says Study of Experimental Ebola Drug ZMapp Could Start Next Month in West Africa -DJ,2015-01-16 14:43:00-05:00,JNJ,nih director says study of experimental ebola drug zmapp could start next month in west africa dj,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998779296875
697426,697426,708651.0,Mid-Day Market Update: U.S. Stocks Rise; SunTrust Shares Surge On Upbeat Earnings,2015-01-16 14:04:00-05:00,JNJ,mid day market update u s stocks rise suntrust shares surge on upbeat earnings,"{'neg': 0.0, 'neu': 0.855, 'pos': 0.145, 'compound': 0.296}",positive,0.9996742010116577
697427,697427,708652.0,Benzinga's Volume Movers,2015-01-16 11:09:00-05:00,JNJ,benzingas volume movers,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998672008514404
697428,697428,708653.0,Knuckman On Johnson & Johnson And Ford: Surprise Movers?,2015-01-16 11:02:00-05:00,JNJ,knuckman on johnson and johnson and ford surprise movers,"{'neg': 0.0, 'neu': 0.792, 'pos': 0.208, 'compound': 0.2732}",neutral,0.999879002571106
697429,697429,708654.0,Stocks Hitting 52-Week Highs,2015-01-16 10:34:00-05:00,JNJ,stocks hitting 52 week highs,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9992315769195557
697430,697430,708655.0,Morning Market Gainers,2015-01-16 09:49:00-05:00,JNJ,morning market gainers,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9994286894798279
697431,697431,708656.0,Depomed Surges 8% Following NUCYNTA Acquisition From Janssen Pharmaceuticals,2015-01-16 08:58:00-05:00,JNJ,depomed surges 8 percent following nucynta acquisition from janssen pharmaceuticals,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996353387832642
697432,697432,708657.0,Benzinga's Top #PreMarket Gainers,2015-01-16 08:11:00-05:00,JNJ,benzingas top gainers,"{'neg': 0.0, 'neu': 0.526, 'pos': 0.474, 'compound': 0.2023}",positive,0.8080791234970093
697433,697433,708658.0,US Stock Futures Slip Ahead Of Goldman Sachs Earnings,2015-01-16 07:01:00-05:00,JNJ,us stock futures slip ahead of goldman sachs earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9975622892379761
697434,697434,708659.0,UPDATE: J&J Announces Formation of Ebola Vaccine Development Consortia; IMI to Award Consortia Grants Totaling €100M+,2015-01-16 06:34:00-05:00,JNJ,update j and j announces formation of ebola vaccine development consortia imi to award consortia grants totaling 100 million,"{'neg': 0.0, 'neu': 0.759, 'pos': 0.241, 'compound': 0.6597}",neutral,0.9996415376663208
697435,697435,708660.0,Johnson & Johnson Announces Formation Of Ebola Vaccine Development Consortia,2015-01-16 06:29:00-05:00,JNJ,johnson and johnson announces formation of ebola vaccine development consortia,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999879002571106
697436,697436,708661.0,A Pair Trade With Eli Lilly And Johnson & Johnson? Goldman Just Explained Why It's A Solid Idea,2015-01-15 17:40:00-05:00,JNJ,a pair trade with eli lilly and johnson and johnson goldman just explained why its a solid idea,"{'neg': 0.0, 'neu': 0.914, 'pos': 0.086, 'compound': 0.1531}",neutral,0.9149301052093506
697437,697437,708662.0,Depomed To Acquire Rights To NUCYNTA Franchise For $1.05 Billion,2015-01-15 17:23:00-05:00,JNJ,depomed to acquire rights to nucynta franchise for dollars .05 billion,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998558759689331
697438,697438,708663.0,"DepoMed Shares Resume Trading, Now Up 15%",2015-01-15 16:36:00-05:00,JNJ,depomed shares resume trading now up 15 percent,"{'neg': 0.0, 'neu': 0.761, 'pos': 0.239, 'compound': 0.296}",positive,0.999661922454834
697439,697439,708664.0,PREVIEW: Depomed to Resume Trading at 4:30 PM ET,2015-01-15 16:08:00-05:00,JNJ,preview depomed to resume trading at 0 pm et,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998767375946045
697440,697440,708665.0,#Premarket Prep Technical Update - Johnson & Johnson Lower,2015-01-15 12:07:00-05:00,JNJ,prep technical update to johnson and johnson lower,"{'neg': 0.239, 'neu': 0.761, 'pos': 0.0, 'compound': -0.296}",neutral,0.999822199344635
697441,697441,708666.0,"Goldman Sachs Downgrades Johnson & Johnson to Sell, Maintains $97.00 PT",2015-01-15 07:16:00-05:00,JNJ,goldman sachs downgrades johnson and johnson to sell maintains dollars 7.00 point,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9976091384887695
697442,697442,708667.0,Wall Street's Wheelings And Dealings,2015-01-13 14:49:00-05:00,JNJ,wall streets wheelings and dealings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998841285705566
697443,697443,708668.0,"J&J's Janssen, Johnson & Johnson Innovation Report License Deal with Vedanta Related to Microbiome Pharma Candidate for Inflammatory Bowel Disease",2015-01-13 08:07:00-05:00,JNJ,j and js janssen johnson and johnson innovation report license deal with vedanta related to microbiome pharma candidate for inflammatory bowel disease,"{'neg': 0.0, 'neu': 0.89, 'pos': 0.11, 'compound': 0.3818}",positive,0.9987995624542236
697444,697444,708669.0,"Bloomberg Reporting Johnson & Johnson, AC Immune Enter Alzheimer's Disease Vaccines Pact",2015-01-12 15:17:00-05:00,JNJ,bloomberg reporting johnson and johnson ac immune enter alzheimers disease vaccines pact,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.296}",neutral,0.9998681545257568
697445,697445,708670.0,JNJ CEO 'Intends $1B In Operational Savings Over Next 3 Years',2015-01-12 13:40:00-05:00,JNJ,jnj ceo intends dollars b in operational savings over next 3 years,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9995996356010437
697446,697446,708671.0,Johnson & Johnson Webcast Presentation Begins,2015-01-12 13:31:00-05:00,JNJ,johnson and johnson webcast presentation begins,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998605251312256
697447,697447,708672.0,What Investors Should Expect From Portola Pharmaceutical's Upcoming Data Readouts,2015-01-09 12:43:00-05:00,JNJ,what investors should expect from portola pharmaceuticals upcoming data readouts,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998499155044556
697448,697448,708673.0,#Premarket Prep Technical Update - Johnson & Johnson Higher,2015-01-08 13:33:00-05:00,JNJ,prep technical update to johnson and johnson higher,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998267292976379
697449,697449,708674.0,3 Sectors That Could Survive A Correction,2015-01-07 08:11:00-05:00,JNJ,3 sectors that could survive a correction,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9852906465530396
697450,697450,708675.0,Healthcare Sector Survives Europe's Slide,2015-01-06 15:58:00-05:00,JNJ,healthcare sector survives europes slide,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9982473850250244
697451,697451,708676.0,J&J Reports Commencement of Phase 1 Trial of Ebola Virus Vaccine Regimen,2015-01-06 07:53:00-05:00,JNJ,j and j reports commencement of phase 1 trial of ebola virus vaccine regimen,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998764991760254
697452,697452,708677.0,Johnson & Johnson Announces Commencement of Phase 1 Clinical Trial of Ebola Vaccine Regimen,2015-01-06 02:53:00-05:00,JNJ,johnson and johnson announces commencement of phase 1 clinical trial of ebola vaccine regimen,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999861478805542
697453,697453,708678.0,Isis Pharmaceuticals Shares Rise 4.5% Premarket Following Announcement of Deal with JNJ,2015-01-05 08:14:00-05:00,JNJ,isis pharmaceuticals shares rise 4.5 percent premarket following announcement of deal with jnj,"{'neg': 0.0, 'neu': 0.845, 'pos': 0.155, 'compound': 0.296}",positive,0.9997225403785706
697454,697454,708679.0,Isis Pharmaceuticals Announces Collaboration With Janssen on RNA-Targeted Therapeutics for Autoimmune Diseases in the GI Tract,2015-01-05 07:05:00-05:00,JNJ,isis pharmaceuticals announces collaboration with janssen on rna targeted therapeutics for autoimmune diseases in the gi tract,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9936321377754211
697455,697455,708680.0,Gilead Reports Amended Deals with J&J's Janssen to Develop PREZISTA-Based Single-Tablet Regimen for Treatment of People Living with HIV,2014-12-29 08:31:00-05:00,JNJ,gilead reports amended deals with j and js janssen to develop prezista based single tablet regimen for treatment of people living with hiv,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9986822009086609
697456,697456,708681.0,#Premarket Prep Technical Update - Johnson & Johnson Higher,2014-12-26 11:41:00-05:00,JNJ,prep technical update to johnson and johnson higher,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998267292976379
697457,697457,708682.0,#Premarket Prep Technical Update - Johnson & Johnson Higher,2014-12-24 11:16:00-05:00,JNJ,prep technical update to johnson and johnson higher,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998267292976379
697458,697458,708683.0,"MacroGenics Enters Collaboration, License Agreement with Janssen to Develop MGD011 for Multiple B-Cell Malignancies, MacroGenics to Receive $50M Upfront License Fee, $75M Equity Investment by JNJ",2014-12-22 06:06:00-05:00,JNJ,macrogenics enters collaboration license agreement with janssen to develop mgd011 for multiple b cell malignancies macrogenics to receive dollars 0 million upfront license fee dollars 5 million equity investment by jnj,"{'neg': 0.0, 'neu': 0.904, 'pos': 0.096, 'compound': 0.4939}",positive,0.9989571571350098
697459,697459,708684.0,Analysts See No Sweeter Deal For Volcano,2014-12-17 15:34:00-05:00,JNJ,analysts see no sweeter deal for volcano,"{'neg': 0.268, 'neu': 0.732, 'pos': 0.0, 'compound': -0.296}",positive,0.9973732233047485
697460,697460,708685.0,UPDATE: Geron Says Initial Payment of $35M Due,2014-12-16 07:17:00-05:00,JNJ,update geron says initial payment of dollars 5 million due,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998672008514404
697461,697461,708686.0,Geron Reports Early HSR Clearance for Global Strategic Collaboration with J&J's Janssen,2014-12-16 07:16:00-05:00,JNJ,geron reports early hsr clearance for global strategic collaboration with j and js janssen,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.5346847176551819
697462,697462,708687.0,Janssen Research Announces Presentation Of Data At SABCS From The Phase 3 EPO-ANE-3010 Study,2014-12-12 12:19:00-05:00,JNJ,janssen research announces presentation of data at sabcs from the phase 3 epo ane 3010 study,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998905658721924
697463,697463,708688.0,Market Mixed Amid Plan To Spend $300 Million On Ebola Vaccines,2014-12-11 14:14:00-05:00,JNJ,market mixed amid plan to spend dollars 00 million on ebola vaccines,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9993176460266113
697464,697464,708689.0,#Premarket Prep Technical Update - Johnson & Johnson Lower,2014-12-10 11:31:00-05:00,JNJ,prep technical update to johnson and johnson lower,"{'neg': 0.239, 'neu': 0.761, 'pos': 0.0, 'compound': -0.296}",neutral,0.999822199344635
697465,697465,708690.0,#Premarket Prep Technical Update - Johnson & Johnson Lower,2014-12-09 12:26:00-05:00,JNJ,prep technical update to johnson and johnson lower,"{'neg': 0.239, 'neu': 0.761, 'pos': 0.0, 'compound': -0.296}",neutral,0.999822199344635
697466,697466,708691.0,J&J's Janssen Reports IMBRUVICA 'Shows Sustained Progression-Free Survival in Patients with High-Risk Chronic Lymphocytic Leukemia with Genetic Mutation',2014-12-09 07:39:00-05:00,JNJ,j and js janssen reports imbruvica shows sustained progression free survival in patients with high risk chronic lymphocytic leukemia with genetic mutation,"{'neg': 0.083, 'neu': 0.787, 'pos': 0.13, 'compound': 0.296}",positive,0.9994716048240662
697467,697467,708692.0,New ETF For Environmentalists,2014-12-05 12:36:00-05:00,JNJ,new etf for environmentalists,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998736381530762
697468,697468,708693.0,Markets Marginally Lower Ahead Of Friday's Jobs Report,2014-12-04 17:00:00-05:00,JNJ,markets marginally lower ahead of fridays jobs report,"{'neg': 0.214, 'neu': 0.786, 'pos': 0.0, 'compound': -0.228}",negative,0.998273491859436
697469,697469,708694.0,Markets Inch Higher Following Encouraging Beige Book Commentary,2014-12-03 17:11:00-05:00,JNJ,markets inch higher following encouraging beige book commentary,"{'neg': 0.0, 'neu': 0.673, 'pos': 0.327, 'compound': 0.5267}",positive,0.9996383190155029
697470,697470,708695.0,Report: Johnson & Johnson May Put Splenda On Block,2014-12-03 11:21:00-05:00,JNJ,report johnson and johnson may put splenda on block,"{'neg': 0.266, 'neu': 0.734, 'pos': 0.0, 'compound': -0.4404}",neutral,0.9998821020126343
697471,697471,708696.0,"Reuters Reports Johnson & Johnson Hired Goldman Sachs to Explore Sale of Splenda, According to Sources",2014-12-03 09:43:00-05:00,JNJ,reuters reports johnson and johnson hired goldman sachs to explore sale of splenda according to sources,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998469352722168
697472,697472,708697.0,Top 4 Stocks In The Drug Manufacturers-Major Industry With The Highest Operating Margin,2014-12-02 04:38:00-05:00,JNJ,top 4 stocks in the drug manufacturers major industry with the highest operating margin,"{'neg': 0.0, 'neu': 0.878, 'pos': 0.122, 'compound': 0.2023}",neutral,0.9995666146278381
697473,697473,708698.0,"S&P 500 Stocks With Most Active Options Today: PWR, XEL, NSc, BSX, LLTC, JNJ",2014-12-01 13:19:00-05:00,JNJ,SP500 500 stocks with most active options today pwr xel nsc bsx lltc jnj,"{'neg': 0.0, 'neu': 0.813, 'pos': 0.187, 'compound': 0.4576}",neutral,0.9998857975006104
697474,697474,708699.0,CORRECTION: FDA Says JNJ's Hysterectomy Device Shouldn't Be Used By Most Women,2014-11-24 10:53:00-05:00,JNJ,correction fda says jnjs hysterectomy device shouldnt be used by most women,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998812675476074
697475,697475,708700.0,FDA Says JNJ's Hysterectomy Device Shouldn't Be Used By Most Women,2014-11-24 10:50:00-05:00,JNJ,fda says jnjs hysterectomy device shouldnt be used by most women,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998805522918701
697476,697476,708701.0,Riding The Bull Market With These 2 Momentum ETFs,2014-11-20 15:10:00-05:00,JNJ,riding the bull market with these 2 momentum etfs,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.6812519431114197
697477,697477,708702.0,J&J's Janssen Reports Submission of NDA for Three-Mo. Paliperidone Palmitate to Treat Schizophrenia,2014-11-19 09:01:00-05:00,JNJ,j and js janssen reports submission of nda for three mo paliperidone palmitate to treat schizophrenia,"{'neg': 0.0, 'neu': 0.847, 'pos': 0.153, 'compound': 0.4019}",neutral,0.999858021736145
697478,697478,708703.0,What Johnson & Johnson's 'Chart Watchers' Need To Know,2014-11-12 12:28:00-05:00,JNJ,what johnson and johnsons chart watchers need to know,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998589754104614
697479,697479,708704.0,Jim Cramer Weighs In On Johnson & Johnson And Toyota Motor,2014-11-10 21:09:00-05:00,JNJ,jim cramer weighs in on johnson and johnson and toyota motor,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998459815979004
697480,697480,708705.0,"#PreMarket Primer: Monday, November 10: Nuclear Talks Enter Second Day",2014-11-10 07:54:00-05:00,JNJ,primer monday november 10 nuclear talks enter second day,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998847246170044
697481,697481,708706.0,Johnson & Johnson CEO Says Seeks Acquisitions in China -WSJ,2014-11-10 05:03:00-05:00,JNJ,johnson and johnson ceo says seeks acquisitions in china wsj,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998192191123962
697482,697482,708707.0,#Premarket Prep Technical Update - Johnson & Johnson Lower,2014-11-07 12:22:00-05:00,JNJ,prep technical update to johnson and johnson lower,"{'neg': 0.239, 'neu': 0.761, 'pos': 0.0, 'compound': -0.296}",neutral,0.999822199344635
697483,697483,708708.0,#Premarket Prep Technical Update - Facebook Trading Higher,2014-11-07 12:18:00-05:00,JNJ,prep technical update to facebook trading higher,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.970277726650238
697484,697484,708709.0,Reuters Reports Group of Scientists Proposes US Health Officials Find Ebola Treatment in Survivor's Antibodies -Reuters,2014-11-07 09:27:00-05:00,JNJ,reuters reports group of scientists proposes us health officials find ebola treatment in survivors antibodies reuters,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997664093971252
697485,697485,708710.0,#Premarket Prep Technical Update - Johnson & Johnson Makes New All Time High And Retreats,2014-11-05 14:14:00-05:00,JNJ,prep technical update to johnson and johnson makes new all time high and retreats,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9956496357917786
697486,697486,708711.0,Which Mega-Caps Aren't Paying Taxes?,2014-11-05 09:04:00-05:00,JNJ,which mega caps arent paying taxes,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998575448989868
697487,697487,708712.0,Ebola Vaccine Contenders,2014-10-30 10:44:00-04:00,JNJ,ebola vaccine contenders,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998289346694946
697488,697488,708713.0,"UPDATE: GTCR Announces Devicor Medical Products to be Acquired by Danaher Corporation's Leica Biosystems,",2014-10-28 07:36:00-04:00,JNJ,update gtcr announces devicor medical products to be acquired by danaher corporations leica biosystems,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999891996383667
697489,697489,708714.0,"WHO Says Ebola Death Toll Rises to 4,922 from 10,141 Cases in Eight Countries Through October 23",2014-10-25 07:13:00-04:00,JNJ,who says ebola death toll rises to 4922 from 10141 cases in eight countries through october 23,"{'neg': 0.196, 'neu': 0.804, 'pos': 0.0, 'compound': -0.5994}",positive,0.7630227208137512
697490,697490,708715.0,"Report Mali's First Ebola Case, A 2-Year Old Girl has Died, According to Health Official -Reuters",2014-10-24 15:33:00-04:00,JNJ,report malis first ebola case a 2 year old girl has died according to health official reuters,"{'neg': 0.184, 'neu': 0.816, 'pos': 0.0, 'compound': -0.5574}",neutral,0.9871073365211487
697491,697491,708716.0,"Ebola Related Stocks Move Off Lows on Report of Potential New Ebola Case in Houston, TX",2014-10-24 15:14:00-04:00,JNJ,ebola related stocks move off lows on report of potential new ebola case in houston tx,"{'neg': 0.098, 'neu': 0.765, 'pos': 0.137, 'compound': 0.1779}",negative,0.9978944659233093
697492,697492,708717.0,CDC Spokesperson Says a Number of Options for Returnees from Africa are on the Table; Changes to Policy Likely,2014-10-24 15:01:00-04:00,JNJ,cdc spokesperson says a number of options for returnees from africa are on the table changes to policy likely,"{'neg': 0.0, 'neu': 0.933, 'pos': 0.067, 'compound': 0.0772}",neutral,0.9998434782028198
697493,697493,708718.0,NIH Says Did Not Administer Experimental Drugs to Nina Pham While She Was in Maryland Hospital,2014-10-24 12:06:00-04:00,JNJ,nih says did not administer experimental drugs to nina pham while she was in maryland hospital,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998764991760254
697494,697494,708719.0,"Dallas Nurse Nina Pham Declared Virus Free, Being Discharged -DJ",2014-10-24 10:49:00-04:00,JNJ,dallas nurse nina pham declared virus free being discharged dj,"{'neg': 0.0, 'neu': 0.732, 'pos': 0.268, 'compound': 0.5106}",neutral,0.998630702495575
697495,697495,708720.0,UPDATE: WHO Expects First Data on Efficacy of Ebola Vaccines By April 2015,2014-10-24 08:40:00-04:00,JNJ,update who expects first data on efficacy of ebola vaccines by april 2015,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998784065246582
697496,697496,708721.0,WHO Says at Least Five More Experimental Ebola Vaccines Scheduled to Begin Clinical Trials Soon; Says 100K Does of Vaccine Should be Ready in H1 2015 -Reuters,2014-10-24 08:17:00-04:00,JNJ,who says at least five more experimental ebola vaccines scheduled to begin clinical trials soon says 100 thousand does of vaccine should be ready in h1 2015 reuters,"{'neg': 0.0, 'neu': 0.915, 'pos': 0.085, 'compound': 0.3612}",neutral,0.9998651742935181
697497,697497,708722.0,Procter & Gamble Co Shares Lower Following Management Change,2014-10-23 13:42:00-04:00,JNJ,procter and gamble co shares lower following management change,"{'neg': 0.193, 'neu': 0.614, 'pos': 0.193, 'compound': 0.0}",negative,0.9953083395957947
697498,697498,708723.0,Genmab to Receive $10M Milestone Payment for Daratumumab Collaboration With Janssen,2014-10-23 12:53:00-04:00,JNJ,genmab to receive dollars 0 million milestone payment for daratumumab collaboration with janssen,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.8565287590026855
697499,697499,708724.0,Drug ETFs Attractive Buys On Pullback,2014-10-22 17:10:00-04:00,JNJ,drug etfs attractive buys on pullback,"{'neg': 0.0, 'neu': 0.633, 'pos': 0.367, 'compound': 0.4404}",positive,0.9996484518051147
697500,697500,708725.0,Markets Reverse Early Morning Gains Following Canadian Shooting,2014-10-22 16:43:00-04:00,JNJ,markets reverse early morning gains following canadian shooting,"{'neg': 0.0, 'neu': 0.745, 'pos': 0.255, 'compound': 0.34}",positive,0.9993755221366882
697501,697501,708726.0,"#PreMarket Primer: Wednesday, October 22: Johnson & Johnson Develops Ebola Vaccine",2014-10-22 08:13:00-04:00,JNJ,primer wednesday october 22 johnson and johnson develops ebola vaccine,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998742341995239
697502,697502,708727.0,Johnson & Johnson Commits Up to $200M to Speed Ebola Vaccine Development,2014-10-22 05:00:00-04:00,JNJ,johnson and johnson commits up to dollars 00 million to speed ebola vaccine development,"{'neg': 0.0, 'neu': 0.922, 'pos': 0.078, 'compound': 0.0258}",positive,0.9991393089294434
697503,697503,708728.0,J&J's Janssen Announces IMBRUVICA sNDA Submitted to FDA for Waldenstrom's Macroglobulinemia,2014-10-20 08:06:00-04:00,JNJ,j and js janssen announces imbruvica snda submitted to fda for waldenstroms macroglobulinemia,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998681545257568
697504,697504,708729.0,Benzinga Weekly Preview: Earnings Season Is In Full Swing,2014-10-19 10:19:00-04:00,JNJ,benzinga weekly preview earnings season is in full swing,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998430013656616
697505,697505,708730.0,Sometimes You Need To Close Your Eyes And Buy,2014-10-17 13:22:00-04:00,JNJ,sometimes you need to close your eyes and buy,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998588562011719
697506,697506,708731.0,"#PreMarket Primer: Thursday, October 16: This Year's Spending Season Could Be Muted",2014-10-16 07:40:00-04:00,JNJ,primer thursday october 16 this years spending season could be muted,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.8785168528556824
697507,697507,708732.0,Barclays: Johnson & Johnson's Q3 Could Be 'High Water Mark',2014-10-15 16:42:00-04:00,JNJ,barclays johnson and johnsons third quarter could be high water mark,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9909167885780334
697508,697508,708733.0,UPDATE: Bank Of America Reiterates On Johnson & Johnson On Likely EPS Headwinds,2014-10-15 07:52:00-04:00,JNJ,update bank of america reiterates on johnson and johnson on likely eps headwinds,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9987585544586182
697509,697509,708734.0,Markets Unable To Hold On To Gains As Oil Continues To Plunge,2014-10-14 16:47:00-04:00,JNJ,markets unable to hold on to gains as oil continues to plunge,"{'neg': 0.0, 'neu': 0.821, 'pos': 0.179, 'compound': 0.34}",negative,0.9607356786727905
697510,697510,708735.0,Johnson & Johnson Conference Call Highlights,2014-10-14 15:21:00-04:00,JNJ,johnson and johnson conference call highlights,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998599290847778
697511,697511,708736.0,#Premarket Prep Technical Update - Johnson & Johnson Trading Lower,2014-10-14 14:43:00-04:00,JNJ,prep technical update to johnson and johnson trading lower,"{'neg': 0.216, 'neu': 0.784, 'pos': 0.0, 'compound': -0.296}",negative,0.9958646297454834
697512,697512,708737.0,Deutsche Bank Says Gilead Sciences Stock Reaction Is Overdone,2014-10-14 13:59:00-04:00,JNJ,deutsche bank says gilead sciences stock reaction is overdone,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9162562489509583
697513,697513,708738.0,"Deutsche Bank Just Out with Mid-Day Defense on Gilead, 'weakness on Irish tax, JNJ comments is overdone'",2014-10-14 11:13:00-04:00,JNJ,deutsche bank just out with mid day defense on gilead weakness on irish tax jnj comments is overdone,"{'neg': 0.138, 'neu': 0.788, 'pos': 0.074, 'compound': -0.3182}",negative,0.9974167346954346
697514,697514,708739.0,"UPDATE: Johnson & Johnson Posts Better-Than-Expected Q3 Earnings, Lifts Full-Year Forecast",2014-10-14 09:03:00-04:00,JNJ,update johnson and johnson posts better than expected third quarter earnings lifts full year forecast,"{'neg': 0.0, 'neu': 0.828, 'pos': 0.172, 'compound': 0.4404}",positive,0.999640941619873
697515,697515,708740.0,From J&J Earnings Conference Call: Expecting FY14 Operating Sales Growth (on a Constant Currency Basis) 5.5-6.5%,2014-10-14 08:56:00-04:00,JNJ,from j and j earnings conference call expecting fy14 operating sales growth on a constant currency basis 5.5 to 6.5 percent,"{'neg': 0.0, 'neu': 0.885, 'pos': 0.115, 'compound': 0.3818}",positive,0.9996556043624878
697516,697516,708741.0,J&J Worldwide Pharama Sales Growth YoY,2014-10-14 07:55:00-04:00,JNJ,j and j worldwide pharama sales growth yoy,"{'neg': 0.0, 'neu': 0.729, 'pos': 0.271, 'compound': 0.3818}",positive,0.9994022846221924
697517,697517,708742.0,Johnson & Johnson 3Q Orthopaedics Sales $2.34B ,2014-10-14 07:48:00-04:00,JNJ,johnson and johnson third quarter orthopaedics sales dollars .34 billion,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998841285705566
697518,697518,708743.0,Johnson & Johnson 3Q RisperdalConsta Sales $284M,2014-10-14 07:48:00-04:00,JNJ,johnson and johnson third quarter risperdalconsta sales dollars 84 million,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998812675476074
697519,697519,708744.0,Johnson & Johnson 3Q Worldwide Pharmaceutical Sales $8.31B,2014-10-14 07:46:00-04:00,JNJ,johnson and johnson third quarter worldwide pharmaceutical sales dollars .31 billion,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998878240585327
697520,697520,708745.0,Johnson & Johnson 3Q Worldwide Consumer Sales $3.59B,2014-10-14 07:45:00-04:00,JNJ,johnson and johnson third quarter worldwide consumer sales dollars .59 billion,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.99988853931427
697521,697521,708746.0,Johnson & Johnson Sees FY2014 EPS $5.92-5.97 vs $5.93 Est,2014-10-14 07:45:00-04:00,JNJ,johnson and johnson sees fy2014 eps dollars .92 to 5.97 vs dollars .93 est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998424053192139
697522,697522,708747.0,Johnson & Johnson Reports Q3 EPS of $1.50 vs $1.43 Est; Revenue of $18.47B vs $18.36B Est.  Raising Guidance,2014-10-14 07:45:00-04:00,JNJ,johnson and johnson reports third quarter eps of dollars .50 vs dollars .43 est revenue of dollars 8.47 billion vs dollars 8.36 billion est raising guidance,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9102615118026733
697523,697523,708748.0,"Earnings Scheduled For October 14, 2014",2014-10-14 05:23:00-04:00,JNJ,earnings scheduled for october 14 2014,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998823404312134
697524,697524,708749.0,"Stocks To Watch For October 14, 2014",2014-10-14 04:09:00-04:00,JNJ,stocks to watch for october 14 2014,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998811483383179
697525,697525,708750.0,J&J's Alios BioPharma Reports Presented Positive Results of Anti-RSV Nucleoside Analog AL-8176,2014-10-13 08:35:00-04:00,JNJ,j and js alios biopharma reports presented positive results of anti rsv nucleoside analog al 8176,"{'neg': 0.116, 'neu': 0.704, 'pos': 0.181, 'compound': 0.3182}",positive,0.9995744824409485
697526,697526,708751.0,"Bristol-Myers, Pharmacyclics, Janssen Report Clinical Collaboration of Evaluate OPDIVO, IMBRUVICA in NHL",2014-10-13 08:01:00-04:00,JNJ,bristol myers pharmacyclics janssen report clinical collaboration of evaluate opdivo imbruvica in nhl,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998779296875
697527,697527,708752.0," Bavarian Nordic's Shares Rise 8% in Copenhagen on CEO Comments its MVA Technology Can be Used to Improve Ebola Vaccines from JNJ, GSK, Create Biodefense Business",2014-10-13 05:57:00-04:00,JNJ,bavarian nordics shares rise 8 percent in copenhagen on ceo comments its mva technology can be used to improve ebola vaccines from jnj gsk create biodefense business,"{'neg': 0.0, 'neu': 0.769, 'pos': 0.231, 'compound': 0.7351}",positive,0.999722421169281
697528,697528,708753.0,Earnings Expectations For The Week Of October 13: The Crunch Is On,2014-10-12 11:54:00-04:00,JNJ,earnings expectations for the week of october 13 the crunch is on,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998273849487305
697529,697529,708754.0,"Janssen Presents Data from Hepatitis C in European, Israeli Patients at Viral Hepatitis Congress ",2014-10-10 05:34:00-04:00,JNJ,janssen presents data from hepatitis c in european israeli patients at viral hepatitis congress,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998764991760254
697530,697530,708755.0,#Premarket Prep Technical Update - Johnson & Johnson Trading Sharply Lower,2014-10-09 14:27:00-04:00,JNJ,prep technical update to johnson and johnson trading sharply lower,"{'neg': 0.196, 'neu': 0.804, 'pos': 0.0, 'compound': -0.296}",negative,0.9979687333106995
697531,697531,708756.0,Strike While the Iron is Hot: Stryker (SYK),2014-10-08 15:36:00-04:00,JNJ,strike while the iron is hot stryker syk,"{'neg': 0.176, 'neu': 0.824, 'pos': 0.0, 'compound': -0.128}",neutral,0.9998863935470581
697532,697532,708757.0,"#PreMarket Primer: Wednesday, October 8: IMF Cuts Global Growth Prospects, Puts A Damper On Wall Street",2014-10-08 08:19:00-04:00,JNJ,primer wednesday october 8 imf cuts global growth prospects puts a damper on wall street,"{'neg': 0.116, 'neu': 0.632, 'pos': 0.253, 'compound': 0.3818}",negative,0.9984642267227173
697533,697533,708758.0,"#PreMarket Primer: Friday, October 3: JP Morgan Suffers Largest Cyberattack Against A Financial Institution",2014-10-03 07:03:00-04:00,JNJ,primer friday october 3 jp morgan suffers largest cyberattack against a financial institution,"{'neg': 0.195, 'neu': 0.692, 'pos': 0.113, 'compound': -0.3182}",negative,0.9967600703239441
697534,697534,708759.0,Markets Little Changed Ahead Of Friday's Jobs Report,2014-10-02 17:10:00-04:00,JNJ,markets little changed ahead of fridays jobs report,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9993316531181335
697535,697535,708760.0,Benzinga's Top Initiations,2014-10-02 09:03:00-04:00,JNJ,benzingas top initiations,"{'neg': 0.0, 'neu': 0.526, 'pos': 0.474, 'compound': 0.2023}",neutral,0.9998692274093628
697536,697536,708761.0,Guggenheim Securities Initiates Johnson & Johnson At Neutral,2014-10-02 09:00:00-04:00,JNJ,guggenheim securities initiates johnson and johnson at neutral,"{'neg': 0.0, 'neu': 0.761, 'pos': 0.239, 'compound': 0.296}",neutral,0.9998676776885986
697537,697537,708762.0,"Guggenheim Securities Initiates Coverage on Johnson & Johnson at Neutral, Announces $115.00 PT",2014-10-02 06:09:00-04:00,JNJ,guggenheim securities initiates coverage on johnson and johnson at neutral announces dollars 15.00 point,"{'neg': 0.0, 'neu': 0.855, 'pos': 0.145, 'compound': 0.296}",neutral,0.9998806715011597
697538,697538,708763.0,Johnson & Johnson Falls On Bernstein Downgrade,2014-10-01 15:09:00-04:00,JNJ,johnson and johnson falls on bernstein downgrade,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9977293610572815
697539,697539,708764.0,Benzinga's Top Downgrades,2014-10-01 08:53:00-04:00,JNJ,benzingas top downgrades,"{'neg': 0.0, 'neu': 0.526, 'pos': 0.474, 'compound': 0.2023}",negative,0.9905633926391602
697540,697540,708765.0,"Bernstein Downgrades Johnson & Johnson To Market Perform, Shares Drop",2014-10-01 08:13:00-04:00,JNJ,bernstein downgrades johnson and johnson to market perform shares drop,"{'neg': 0.171, 'neu': 0.65, 'pos': 0.179, 'compound': 0.0258}",negative,0.9982033967971802
697541,697541,708766.0,Bernstein Downgrades Johnson & Johnson to Market Perform,2014-10-01 06:48:00-04:00,JNJ,bernstein downgrades johnson and johnson to market perform,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9983503818511963
697542,697542,708767.0,"Achillion Pharmaceuticals, Inc. Less Attractive Amid Johnson & Johnson/Alios BioPharma Deal",2014-09-30 12:19:00-04:00,JNJ,achillion pharmaceuticals inc less attractive amid johnson and johnson and alios biopharma deal,"{'neg': 0.0, 'neu': 0.822, 'pos': 0.178, 'compound': 0.3832}",negative,0.998468816280365
697543,697543,708768.0,J&J Announces Deal to Buy Alios Biopharma for ~$1.75B in Cash,2014-09-30 08:30:00-04:00,JNJ,j and j announces deal to buy alios biopharma for dollars .75 billion in cash,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9838669300079346
697544,697544,708769.0,#Premarket Prep Technical Update - Johnson & Johnson Trading Lower,2014-09-29 15:16:00-04:00,JNJ,prep technical update to johnson and johnson trading lower,"{'neg': 0.216, 'neu': 0.784, 'pos': 0.0, 'compound': -0.296}",negative,0.9958646297454834
697545,697545,708770.0,J&J's Janssen Says ZYTIGA Plus Prednisone Shows Statistically Significant Overall Survival in Men with Advanced Prostate Cancer Prior to Chemotherapy,2014-09-29 07:16:00-04:00,JNJ,j and js janssen says zytiga plus prednisone shows statistically significant overall survival in men with advanced prostate cancer prior to chemotherapy,"{'neg': 0.162, 'neu': 0.699, 'pos': 0.14, 'compound': -0.3818}",positive,0.9996310472488403
697546,697546,708771.0,"#PreMarket Primer: Thursday, September 25: US Airstrikes Do Little To Stem ISIS Advances",2014-09-25 07:27:00-04:00,JNJ,primer thursday september 25 us airstrikes do little to stem isis advances,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.5974451303482056
697547,697547,708772.0,"J&J's Janssen Reports Research Demonstrated Association Between CONNECT Injection Centers, Increased Adherence to Healthcare Provider-Ordered Janssen Long-Acting Treatment for Schizophrenia",2014-09-24 16:42:00-04:00,JNJ,j and js janssen reports research demonstrated association between connect injection centers increased adherence to healthcare provider ordered janssen long acting treatment for schizophrenia,"{'neg': 0.0, 'neu': 0.916, 'pos': 0.084, 'compound': 0.2732}",positive,0.9995494484901428
697548,697548,708773.0,#Premarket Prep Technical Update - Johnson & Johnson Approaches All Time High,2014-09-24 11:24:00-04:00,JNJ,prep technical update to johnson and johnson approaches all time high,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.99097740650177
697549,697549,708774.0,#Premarket Prep Technical Update - Johnson & Johnson Makes New All-Time High,2014-09-19 15:38:00-04:00,JNJ,prep technical update to johnson and johnson makes new all time high,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9990819692611694
697550,697550,708775.0,Stocks Hitting 52-Week Highs ,2014-09-19 10:02:00-04:00,JNJ,stocks hitting 52 week highs,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9992315769195557
697551,697551,708776.0,New Active ETF for All Risk Environments,2014-09-17 10:05:00-04:00,JNJ,new active etf for all risk environments,"{'neg': 0.214, 'neu': 0.51, 'pos': 0.276, 'compound': 0.1531}",neutral,0.9998903274536133
697552,697552,708777.0,#Premarket Prep Technical Update - Johnson & Johnson Trading Higher,2014-09-16 15:51:00-04:00,JNJ,prep technical update to johnson and johnson trading higher,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9915347695350647
697553,697553,708778.0,3 Companies Investing In Stem Cell Research,2014-09-14 16:34:00-04:00,JNJ,3 companies investing in stem cell research,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998816251754761
697554,697554,708779.0,"Janssen, J&J Innovation Announce Establishment of Research Collaboration with University of Toronto",2014-09-08 08:10:00-04:00,JNJ,janssen j and j innovation announce establishment of research collaboration with university of toronto,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.3818}",neutral,0.9996554851531982
697555,697555,708780.0,"Jury Finds J&J's Incontinence Sling Caused Woman's Injuries, Co. Ordered to Pay $3.25M - Bloomberg",2014-09-05 12:44:00-04:00,JNJ,jury finds j and js incontinence sling caused womans injuries co ordered to pay dollars .25 million to bloomberg,"{'neg': 0.072, 'neu': 0.928, 'pos': 0.0, 'compound': -0.1027}",negative,0.8621528744697571
697556,697556,708781.0,WHO Says Available Supply of Ebola Drugs Will Be Used in the Field,2014-09-05 12:30:00-04:00,JNJ,who says available supply of ebola drugs will be used in the field,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998792409896851
697557,697557,708782.0,"WHO Says Two Promising Ebola Vaccines Identified; Safety Results from Clinical Trials May be Available in Nov 2015, Paving Way for Use",2014-09-05 12:11:00-04:00,JNJ,who says two promising ebola vaccines identified safety results from clinical trials may be available in nov 2015 paving way for use,"{'neg': 0.0, 'neu': 0.784, 'pos': 0.216, 'compound': 0.6705}",neutral,0.9667651057243347
697558,697558,708783.0,"Johnson & Johnson Metal Hip Might Lead To Poisoning, Facing 6,000+ Suits",2014-09-04 17:16:00-04:00,JNJ,johnson and johnson metal hip might lead to poisoning facing 6000 suits,"{'neg': 0.257, 'neu': 0.743, 'pos': 0.0, 'compound': -0.5859}",negative,0.9597142338752747
697559,697559,708784.0,"US Stock Futures Gain; ADP, Jobless Claims Data In Focus",2014-09-04 07:35:00-04:00,JNJ,us stock futures gain adp jobless claims data in focus,"{'neg': 0.0, 'neu': 0.726, 'pos': 0.274, 'compound': 0.5267}",positive,0.9995074272155762
697560,697560,708785.0,Johnson & Johnson to Fast-Track Development of Ebola Vaccine,2014-09-04 05:28:00-04:00,JNJ,johnson and johnson to fast track development of ebola vaccine,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9709101319313049
697561,697561,708786.0,Morgan Stanley Sees Johnson & Johnson Taking Rx Estimates Higher,2014-09-02 09:10:00-04:00,JNJ,morgan stanley sees johnson and johnson taking rx estimates higher,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.999642014503479
697562,697562,708787.0,Bank Of America Remains Optimistic On Johnson & Johnson,2014-08-29 09:13:00-04:00,JNJ,bank of america remains optimistic on johnson and johnson,"{'neg': 0.0, 'neu': 0.777, 'pos': 0.223, 'compound': 0.3182}",positive,0.9993970394134521
697563,697563,708788.0,Morgan Stanley Sees More Focused Device Strategy Continue For Johnson & Johnson,2014-08-29 08:47:00-04:00,JNJ,morgan stanley sees more focused device strategy continue for johnson and johnson,"{'neg': 0.0, 'neu': 0.792, 'pos': 0.208, 'compound': 0.4391}",neutral,0.7639668583869934
697564,697564,708789.0,"WSJ Reporting J&J Looking for Buyers for Cordis Unit, Deal Could Be for Up to $2B",2014-08-28 17:22:00-04:00,JNJ,wsj reporting j and j looking for buyers for cordis unit deal could be for up to dollars b,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998551607131958
697565,697565,708790.0,The 4 Companies Teaming Up For A New Tool To Fight Cancer,2014-08-25 16:03:00-04:00,JNJ,the 4 companies teaming up for a new tool to fight cancer,"{'neg': 0.412, 'neu': 0.588, 'pos': 0.0, 'compound': -0.7906}",neutral,0.9998074173927307
697566,697566,708791.0,"VIVUS Announces Purchase of Topiramate-Related Patents from J&J's Janssen Pharma, Will Dismiss Suit Against VIVUS",2014-08-25 07:12:00-04:00,JNJ,vivus announces purchase of topiramate related patents from j and js janssen pharma will dismiss suit against vivus,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9804024696350098
697567,697567,708792.0,"#PreMarket Primer: Friday, August 22: Draghi, Yellen Set To Speak At Jackson Hole",2014-08-22 07:07:00-04:00,JNJ,primer friday august 22 draghi yellen set to speak at jackson hole,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998546838760376
697568,697568,708793.0,"Illumina Announces Strategic Partnerships with AstraZeneca, Janssen, Sanofi",2014-08-21 05:21:00-04:00,JNJ,illumina announces strategic partnerships with astrazeneca janssen sanofi,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9996036887168884
697569,697569,708794.0,#Premarket Prep Technical Update - Johnson & Johnson Trading Lower,2014-08-15 13:29:00-04:00,JNJ,prep technical update to johnson and johnson trading lower,"{'neg': 0.216, 'neu': 0.784, 'pos': 0.0, 'compound': -0.296}",negative,0.9958646297454834
697570,697570,708795.0,Earnings Season Is The Right Prescription For Health Care ETFs,2014-08-12 16:53:00-04:00,JNJ,earnings season is the right prescription for health care etfs,"{'neg': 0.0, 'neu': 0.738, 'pos': 0.262, 'compound': 0.4939}",neutral,0.9993719458580017
697571,697571,708796.0,Genmab Announces Jannsen to Start New Phase III Study of Daratumumab in Front Line Multiple Myeloma ,2014-08-11 09:26:00-04:00,JNJ,genmab announces jannsen to start new phase iii study of daratumumab in front line multiple myeloma,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998185038566589
697572,697572,708797.0,3 Companies That Should Benefit From The New Initiative In Africa,2014-08-07 09:40:00-04:00,JNJ,3 companies that should benefit from the new initiative in africa,"{'neg': 0.0, 'neu': 0.769, 'pos': 0.231, 'compound': 0.4588}",positive,0.7121052742004395
697573,697573,708798.0,"#PreMarket Primer: Thursday, August 7: Russia Set To Release A List Of Banned Goods",2014-08-07 07:03:00-04:00,JNJ,primer thursday august 7 russia set to release a list of banned goods,"{'neg': 0.2, 'neu': 0.8, 'pos': 0.0, 'compound': -0.4588}",neutral,0.9998575448989868
697574,697574,708799.0,#Premarket Prep Technical Update - Johnson & Johnson Trading Higher,2014-08-06 14:10:00-04:00,JNJ,prep technical update to johnson and johnson trading higher,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9915347695350647
697575,697575,708800.0,Unique 3D Startups And The Public Companies That Should Buy Them,2014-08-01 10:31:00-04:00,JNJ,unique 3 days startups and the public companies that should buy them,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998854398727417
697576,697576,708801.0,#Premarket Prep Technical Update - Johnson & Johnson Trading Lower,2014-07-31 13:44:00-04:00,JNJ,prep technical update to johnson and johnson trading lower,"{'neg': 0.216, 'neu': 0.784, 'pos': 0.0, 'compound': -0.296}",negative,0.9958646297454834
697577,697577,708802.0,"IBM Announces Alex Gorsky, CEO of Johnson & Johnson Joining Board, Peter Voser Will Also Join Board",2014-07-29 16:36:00-04:00,JNJ,ibm announces alex gorsky ceo of johnson and johnson joining board peter voser will also join board,"{'neg': 0.0, 'neu': 0.879, 'pos': 0.121, 'compound': 0.296}",neutral,0.9998563528060913
697578,697578,708803.0,"FDA Expands Approved Use, Labeling of Imbruvica For Chronic Lymphocytic Leukemia",2014-07-28 12:20:00-04:00,JNJ,fda expands approved use labeling of imbruvica for chronic lymphocytic leukemia,"{'neg': 0.0, 'neu': 0.682, 'pos': 0.318, 'compound': 0.4939}",positive,0.9980676770210266
697579,697579,708804.0,Phase 2 COSMOS Study Results Published in The Lancet Demonstrate Efficacy and Safety of Janssen's Once-Daily Simeprevir in All Oral 12-Week Combination with Sofosbuvir for Genotype 1 Chronic Hepatitis C ,2014-07-28 06:16:00-04:00,JNJ,phase 2 cosmos study results published in the lancet demonstrate efficacy and safety of janssens once daily simeprevir in all oral 12 week combination with sofosbuvir for genotype 1 chronic hepatitis c,"{'neg': 0.0, 'neu': 0.917, 'pos': 0.083, 'compound': 0.4215}",positive,0.9840130805969238
697580,697580,708805.0,"EU Medicines Agency Recommends Johnson & Johnson, Pharmacyclics Leukaemia Drug Ibrutinib",2014-07-25 07:11:00-04:00,JNJ,eu medicines agency recommends johnson and johnson pharmacyclics leukaemia drug ibrutinib,"{'neg': 0.0, 'neu': 0.84, 'pos': 0.16, 'compound': 0.2263}",neutral,0.9998642206192017
697581,697581,708806.0,YTD Biggest Buyback Companies Trailing S&P In Stock Appreciation,2014-07-24 16:16:00-04:00,JNJ,ytd biggest buyback companies trailing SP500 in stock appreciation,"{'neg': 0.0, 'neu': 0.708, 'pos': 0.292, 'compound': 0.5106}",positive,0.9980385899543762
697582,697582,708807.0,Organovo Up 19% #PreMarket; In Research Pact With Johnson & Johnson Unit,2014-07-24 09:32:00-04:00,JNJ,organovo up 19 percent in research pact with johnson and johnson unit,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9997194409370422
697583,697583,708808.0,Organovo Holdings Enters Agreement With Janssen R&D To Evaluate Use of 3D Bio-Printed Tissue In Drug Discovery Setting,2014-07-24 08:11:00-04:00,JNJ,organovo holdings enters agreement with janssen r and d to evaluate use of 3 days bio printed tissue in drug discovery setting,"{'neg': 0.0, 'neu': 0.868, 'pos': 0.132, 'compound': 0.4939}",positive,0.9451549053192139
697584,697584,708809.0,The 10 Most-Respected Corporate Brands ,2014-07-22 10:18:00-04:00,JNJ,the 10 most respected corporate brands,"{'neg': 0.0, 'neu': 0.596, 'pos': 0.404, 'compound': 0.5256}",neutral,0.999889612197876
697585,697585,708810.0,"Stocks To Watch For July 22, 2014",2014-07-22 04:12:00-04:00,JNJ,stocks to watch for july 22 2014,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998795986175537
697586,697586,708811.0,J&J Announces $5B Buyback Plan,2014-07-21 17:00:00-04:00,JNJ,j and j announces dollars b buyback plan,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997038245201111
697587,697587,708812.0,Why Has Wall Street Punished Johnson & Johnson For Its Earnings Beat?,2014-07-18 16:12:00-04:00,JNJ,why has wall street punished johnson and johnson for its earnings beat,"{'neg': 0.214, 'neu': 0.786, 'pos': 0.0, 'compound': -0.4588}",positive,0.5053526163101196
697588,697588,708813.0,"#PreMarket Primer: Friday, July 18: Tension Between Russia And The West At An All Time High",2014-07-18 07:16:00-04:00,JNJ,primer friday july 18 tension between russia and the west at an all time high,"{'neg': 0.141, 'neu': 0.859, 'pos': 0.0, 'compound': -0.3182}",negative,0.9916592240333557
697589,697589,708814.0,#Premarket Prep Technical Update - Johnson & Johnson Trading Lower,2014-07-17 14:26:00-04:00,JNJ,prep technical update to johnson and johnson trading lower,"{'neg': 0.216, 'neu': 0.784, 'pos': 0.0, 'compound': -0.296}",negative,0.9958646297454834
697590,697590,708815.0,"Alzheimer's Rates Falling, But Pharma's Search For A Cure Yields No Results",2014-07-17 11:12:00-04:00,JNJ,alzheimers rates falling but pharmas search for a cure yields no results,"{'neg': 0.291, 'neu': 0.709, 'pos': 0.0, 'compound': -0.4767}",negative,0.9984373450279236
697591,697591,708816.0,Shares of Minerva Neurosciences Moving Higher Following 13G Filing from J&J Showing 18% Stake in Co.,2014-07-17 11:00:00-04:00,JNJ,shares of minerva neurosciences moving higher following 13 g filing from j and j showing 18 percent stake in co,"{'neg': 0.0, 'neu': 0.896, 'pos': 0.104, 'compound': 0.296}",positive,0.9995301961898804
697592,697592,708817.0,Earnings Continue Driving Markets Higher,2014-07-16 17:23:00-04:00,JNJ,earnings continue driving markets higher,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996606111526489
697593,697593,708818.0,Which Matters More: Janet Yellen Or Earnings & Economic Data?,2014-07-16 13:08:00-04:00,JNJ,which matters more janet yellen or earnings and economic data,"{'neg': 0.0, 'neu': 0.891, 'pos': 0.109, 'compound': 0.0258}",neutral,0.9998868703842163
697594,697594,708819.0,Morgan Stanley Sees Meaningful '15 Headwind For Johnson & Johnson,2014-07-16 09:10:00-04:00,JNJ,morgan stanley sees meaningful 15 headwind for johnson and johnson,"{'neg': 0.0, 'neu': 0.796, 'pos': 0.204, 'compound': 0.3182}",positive,0.9972689747810364
697595,697595,708820.0,"#PreMarket Primer: Wednesday, July 16: Yellen Hints At Sooner Than Expected Rate Hike",2014-07-16 07:19:00-04:00,JNJ,primer wednesday july 16 yellen hints at sooner than expected rate hike,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.7967681884765625
697596,697596,708821.0,"Markets Mixed, NASDAQ Lower As Yellen Suggests Valuations Are Stretched",2014-07-15 16:35:00-04:00,JNJ,markets mixed nasdaq lower as yellen suggests valuations are stretched,"{'neg': 0.196, 'neu': 0.804, 'pos': 0.0, 'compound': -0.296}",negative,0.9983893632888794
697597,697597,708822.0,"Goldman Sachs, JPMorgan Chase Report Strong Earnings; Retail Numbers Fall Below Estimates",2014-07-15 15:20:00-04:00,JNJ,goldman sachs jpmorgan chase report strong earnings retail numbers fall below estimates,"{'neg': 0.0, 'neu': 0.769, 'pos': 0.231, 'compound': 0.5106}",negative,0.9985368251800537
697598,697598,708823.0,U.S. Stocks Sink; JPMorgan Shares Surge On Upbeat Earnings,2014-07-15 13:19:00-04:00,JNJ,u s stocks sink jpmorgan shares surge on upbeat earnings,"{'neg': 0.0, 'neu': 0.804, 'pos': 0.196, 'compound': 0.296}",positive,0.9995734095573425
697599,697599,708824.0,Markets Rise; Goldman Sachs Profit Beats Estimates,2014-07-15 10:31:00-04:00,JNJ,markets rise goldman sachs profit beats estimates,"{'neg': 0.0, 'neu': 0.674, 'pos': 0.326, 'compound': 0.4404}",positive,0.9996376037597656
697600,697600,708825.0,From J&J Call: Sees Sales $74.50B-75.30B vs $74.91B Est,2014-07-15 09:29:00-04:00,JNJ,from j and j call sees sales dollars 4.50 billion 75.30 billion vs dollars 4.91 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998770952224731
697601,697601,708826.0,"Johnson & Johnson, Goldman Sachs Pushing These ETFs Upward",2014-07-15 09:24:00-04:00,JNJ,johnson and johnson goldman sachs pushing these etfs upward,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.998907208442688
697602,697602,708827.0,"UPDATE: Johnson & Johnson Posts Upbeat Q2 Earnings, Lifts Outlook",2014-07-15 08:05:00-04:00,JNJ,update johnson and johnson posts upbeat second quarter earnings lifts outlook,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996009469032288
697605,697605,708829.0,UPDATE: Johnson & Johnson Raises FY2014 EPS Guidance from $5.80-5.90 to $5.85-5.92 vs $5.90 Est,2014-07-15 07:47:00-04:00,JNJ,update johnson and johnson raises fy2014 eps guidance from dollars .80 to 5.90 to dollars .85 to 5.92 vs dollars .90 est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.999658465385437
697606,697606,708830.0,Johnson & Johnson Reports Q2 EPS of $1.66 vs $1.54 Est; Revenue of $19.50B vs $18.86B Est; Raises Outlook,2014-07-15 07:45:00-04:00,JNJ,johnson and johnson reports second quarter eps of dollars .66 vs dollars .54 est revenue of dollars 9.50 billion vs dollars 8.86 billion est raises outlook,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9994041919708252
697607,697607,708831.0,US Stock Futures Mostly Higher Ahead Of Goldman Sachs Earnings,2014-07-15 07:34:00-04:00,JNJ,us stock futures mostly higher ahead of goldman sachs earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.999545156955719
697608,697608,708832.0,"#PreMarket Primer: Tuesday, July 15: Citigroup Settles Mortgage Probe",2014-07-15 07:18:00-04:00,JNJ,primer tuesday july 15 citigroup settles mortgage probe,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9991932511329651
697609,697609,708833.0,"Earnings Scheduled For July 15, 2014",2014-07-15 05:01:00-04:00,JNJ,earnings scheduled for july 15 2014,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998832941055298
697610,697610,708834.0,"Stocks To Watch For July 15, 2014",2014-07-15 04:11:00-04:00,JNJ,stocks to watch for july 15 2014,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998794794082642
697611,697611,708835.0,Dow Sets New Intraday High; Citigroup Impresses With Earnings,2014-07-14 16:44:00-04:00,JNJ,dow sets new intraday high citigroup impresses with earnings,"{'neg': 0.0, 'neu': 0.721, 'pos': 0.279, 'compound': 0.4767}",positive,0.9996429681777954
697612,697612,708836.0,J&J's Janssen Pharma Announces Seeking Expanded Label for Once-Monthly INVEGA Sustenna,2014-07-14 08:06:00-04:00,JNJ,j and js janssen pharma announces seeking expanded label for once monthly invega sustenna,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9985396862030029
697613,697613,708837.0,"Earnings Expectations For The Week Of July 14: Big Banks, Tech Giants And More",2014-07-14 06:54:00-04:00,JNJ,earnings expectations for the week of july 14 big banks tech giants and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9990750551223755
697614,697614,708838.0,Benzinga Weekly Preview: Earnings Season Kicks Into High Gear,2014-07-11 16:44:00-04:00,JNJ,benzinga weekly preview earnings season kicks into high gear,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9834181666374207
697615,697615,708839.0,#Premarket Prep Technical Update - Johnson & Johnson Trading Lower,2014-07-11 13:52:00-04:00,JNJ,prep technical update to johnson and johnson trading lower,"{'neg': 0.216, 'neu': 0.784, 'pos': 0.0, 'compound': -0.296}",negative,0.9958646297454834
697616,697616,708840.0,J.P. Morgan: Johnson & Johnson's Drug Segment May Beat Q2 Street Views,2014-07-10 16:31:00-04:00,JNJ,j p morgan johnson and johnsons drug segment may beat second quarter street views,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9983711838722229
697617,697617,708841.0,#Premarket Prep Technical Update - Johnson & Johnson Makes New All-Time High,2014-07-07 13:56:00-04:00,JNJ,prep technical update to johnson and johnson makes new all time high,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9990819692611694
697618,697618,708842.0,Genmab Announces Has Reached $25M Milestone in Daratumumab Deal with J&J's Janssen,2014-07-07 10:25:00-04:00,JNJ,genmab announces has reached dollars 5 million milestone in daratumumab deal with j and js janssen,"{'neg': 0.0, 'neu': 0.915, 'pos': 0.085, 'compound': 0.1027}",positive,0.9991235136985779
697619,697619,708843.0,#Premarket Prep Technical Update - Johnson & Johnson Finds Resistance,2014-07-03 11:55:00-04:00,JNJ,prep technical update to johnson and johnson finds resistance,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9954711198806763
697620,697620,708844.0,"J&J Settles with State of Oregon, First State Deal Related to Co.'s Hip Implants - Bloomberg",2014-07-02 17:21:00-04:00,JNJ,j and j settles with state of oregon first state deal related to co s hip implants to bloomberg,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9989597797393799
697621,697621,708845.0,Markets Little Changed Ahead Of 4th Of July Break,2014-07-02 16:34:00-04:00,JNJ,markets little changed ahead of 4 of july break,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997647404670715
697622,697622,708846.0,Barclays Downgrades Pharmaceutical Sector,2014-07-02 15:31:00-04:00,JNJ,barclays downgrades pharmaceutical sector,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9981548190116882
697623,697623,708847.0,AbbVie Has Lost US Court Bid to Revive Patent Case Against J&J - Bloomberg,2014-07-01 11:13:00-04:00,JNJ,abbvie has lost us court bid to revive patent case against j and j to bloomberg,"{'neg': 0.123, 'neu': 0.749, 'pos': 0.128, 'compound': 0.0258}",negative,0.9574800133705139
697624,697624,708848.0,Markets Little Changed As The Quarter Comes To An End,2014-06-30 16:34:00-04:00,JNJ,markets little changed as the quarter comes to an end,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9996782541275024
697625,697625,708849.0,Johnson & Johnson Completes Divestiture Of Ortho-Clinical Diagnostics To The Carlyle Group For $4B,2014-06-30 16:31:00-04:00,JNJ,johnson and johnson completes divestiture of ortho clinical diagnostics to the carlyle group for dollars b,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9895616173744202
697626,697626,708850.0,Johnson and Johnson Submits Marketing Application for Velcade in Europe,2014-06-27 08:19:00-04:00,JNJ,johnson and johnson submits marketing application for velcade in europe,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998716115951538
697627,697627,708851.0,#Premarket Prep Technical Update - Johnson & Johnson Trading Lower,2014-06-23 14:30:00-04:00,JNJ,prep technical update to johnson and johnson trading lower,"{'neg': 0.216, 'neu': 0.784, 'pos': 0.0, 'compound': -0.296}",negative,0.9958646297454834
697628,697628,708852.0,#Premarket Prep Technical Update - Johnson & Johnson Makes New All-Time High,2014-06-20 14:22:00-04:00,JNJ,prep technical update to johnson and johnson makes new all time high,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9990819692611694
697629,697629,708853.0,#Premarket Prep Technical Update - Johnson & Johnson Trading Higher,2014-06-19 14:14:00-04:00,JNJ,prep technical update to johnson and johnson trading higher,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9915347695350647
697630,697630,708854.0,"Advances In HIV, Hep C Treatments Could Spark Renewed Interest In Biotech Stocks",2014-06-18 09:38:00-04:00,JNJ,advances in hiv hep c treatments could spark renewed interest in biotech stocks,"{'neg': 0.0, 'neu': 0.692, 'pos': 0.308, 'compound': 0.5994}",positive,0.9992743134498596
697631,697631,708855.0,J&J's Janssen Announces License Deal with Vertex to Develop Novel Treatment for Influenza A,2014-06-18 08:32:00-04:00,JNJ,j and js janssen announces license deal with vertex to develop novel treatment for influenza a,"{'neg': 0.0, 'neu': 0.867, 'pos': 0.133, 'compound': 0.3182}",positive,0.9995627999305725
697632,697632,708856.0,"J&J Offers New Long-Term Data Showing INVOKANA Reduces Blood Glucose, Also Demonstrates Reductions in Secondary Endpoints",2014-06-16 17:05:00-04:00,JNJ,j and j offers new long term data showing invokana reduces blood glucose also demonstrates reductions in secondary endpoints,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9995017051696777
697633,697633,708857.0,#Premarket Prep Technical Update - Johnson & Johnson Trading Lower,2014-06-12 13:12:00-04:00,JNJ,prep technical update to johnson and johnson trading lower,"{'neg': 0.216, 'neu': 0.784, 'pos': 0.0, 'compound': -0.296}",negative,0.9958646297454834
697634,697634,708858.0,UPDATE: Viiv Healthcare Collaborates With Janssen to Investigate Single-Tablet Regimen for Maintenance Treatment Of HIV-1,2014-06-12 06:31:00-04:00,JNJ,update viiv healthcare collaborates with janssen to investigate single tablet regimen for maintenance treatment of hiv 1,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998767375946045
697635,697635,708859.0,Janssen Collaborates With Viiv Healthcare to Develop Two-Drug Single Tablet Regimen for Maintenance Treatment HIV,2014-06-12 06:12:00-04:00,JNJ,janssen collaborates with viiv healthcare to develop two drug single tablet regimen for maintenance treatment hiv,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998723268508911
697636,697636,708860.0,Takeover Whispers Add To Achillion Pharmaceuticals' Momentum,2014-06-11 16:22:00-04:00,JNJ,takeover whispers add to achillion pharmaceuticals momentum,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9995856881141663
697637,697637,708861.0,#Premarket Prep Technical Update - Johnson & Johnson Trading Lower,2014-06-11 14:50:00-04:00,JNJ,prep technical update to johnson and johnson trading lower,"{'neg': 0.216, 'neu': 0.784, 'pos': 0.0, 'compound': -0.296}",negative,0.9958646297454834
697638,697638,708862.0,#Premarket Prep Technical Update - Johnson & Johnson Makes New All-Time High,2014-06-10 13:46:00-04:00,JNJ,prep technical update to johnson and johnson makes new all time high,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9990819692611694
697639,697639,708863.0,"Hearing Leering Says JNJ, AbbVie, Bristol-Myers Squibb Could Target Achillion Pharmaceuticals",2014-06-09 13:25:00-04:00,JNJ,hearing leering says jnj abbvie bristol myers squibb could target achillion pharmaceuticals,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9907213449478149
697640,697640,708864.0,"Medical Device Companies' Future Remains Bright, Albeit Slow Penetration",2014-06-09 07:54:00-04:00,JNJ,medical device companies future remains bright albeit slow penetration,"{'neg': 0.0, 'neu': 0.734, 'pos': 0.266, 'compound': 0.4404}",positive,0.9962010979652405
697641,697641,708865.0,#Premarket Prep Technical Update - Johnson & Johnson Trading Lower,2014-06-06 10:48:00-04:00,JNJ,prep technical update to johnson and johnson trading lower,"{'neg': 0.216, 'neu': 0.784, 'pos': 0.0, 'compound': -0.296}",negative,0.9958646297454834
697642,697642,708866.0,#Premarket Prep Technical Update - Johnson & Johnson Makes New All-Time High,2014-06-05 13:39:00-04:00,JNJ,prep technical update to johnson and johnson makes new all time high,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9990819692611694
697643,697643,708867.0,Hearing Unconfirmed Market Chatter Circulating in Chat Rooms of Potential JNJ Interest in Isoray,2014-06-05 11:01:00-04:00,JNJ,hearing unconfirmed market chatter circulating in chat rooms of potential jnj interest in isoray,"{'neg': 0.091, 'neu': 0.727, 'pos': 0.182, 'compound': 0.3612}",neutral,0.9997556805610657
697644,697644,708868.0,#Premarket Prep Technical Update - Johnson & Johnson Makes New All-Time High,2014-06-04 13:40:00-04:00,JNJ,prep technical update to johnson and johnson makes new all time high,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9990819692611694
697645,697645,708869.0,ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica & Targeted Therapy,2014-06-04 10:32:00-04:00,JNJ,asco meeting day 2 promising results from jnjs imbruvica and targeted therapy,"{'neg': 0.0, 'neu': 0.803, 'pos': 0.197, 'compound': 0.4019}",positive,0.9993769526481628
697646,697646,708870.0,#Premarket Prep Technical Update - Johnson & Johnson Makes New All-Time High,2014-06-03 14:25:00-04:00,JNJ,prep technical update to johnson and johnson makes new all time high,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9990819692611694
697647,697647,708871.0,UPDATE: Jim Cramer Says JNJ Should Spinoff their Medical Device Business and Merge it with Smith & Nephew,2014-06-02 18:32:00-04:00,JNJ,update jim cramer says jnj should spinoff their medical device business and merge it with smith and nephew,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998561143875122
697648,697648,708872.0,Jim Cramer Says JNJ Could be a Potential Suitor for Smith & Nephew,2014-06-02 18:28:00-04:00,JNJ,jim cramer says jnj could be a potential suitor for smith and nephew,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9995297193527222
697649,697649,708873.0,"Is This Time Really Going To Be Different? A True Look at Current Financial Asset Valuations (PG, WMT, JNJ)",2014-06-02 13:35:00-04:00,JNJ,is this time really going to be different a true look at current financial asset valuations pg wmt jnj,"{'neg': 0.0, 'neu': 0.762, 'pos': 0.238, 'compound': 0.6486}",neutral,0.9998494386672974
697650,697650,708874.0,#Premarket Prep Technical Update - Johnson & Johnson Trading Higher,2014-06-02 13:01:00-04:00,JNJ,prep technical update to johnson and johnson trading higher,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9915347695350647
697651,697651,708875.0,"J&J's Janssen Announces Data on Ibrutinib RESONATE(TM) Showed Significant Improvements in Progression-Free Survival, Overall Survival in Patients with CLL, SLL",2014-06-02 08:08:00-04:00,JNJ,j and js janssen announces data on ibrutinib resonatetm showed significant improvements in progression free survival overall survival in patients with cll sll,"{'neg': 0.0, 'neu': 0.73, 'pos': 0.27, 'compound': 0.7506}",positive,0.9996798038482666
697652,697652,708876.0,UPDATE: Pharmacyclics Shares Rise 9% on Positive IMBRUVICA Data Presented at ASCO,2014-06-02 07:55:00-04:00,JNJ,update pharmacyclics shares rise 9 percent on positive imbruvica data presented at asco,"{'neg': 0.0, 'neu': 0.655, 'pos': 0.345, 'compound': 0.7003}",positive,0.9997114539146423
697653,697653,708877.0,"Pharmacyclics, JNJ Announce IMBRUVICA Shows Durable, Long-Term Responses for Patients with CLL ",2014-05-31 08:07:00-04:00,JNJ,pharmacyclics jnj announce imbruvica shows durable long term responses for patients with cll,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9994623064994812
697654,697654,708878.0,"#PreMarket Primer: Wednesday, May 28: Poroshenko Moves To End Pro-Russian Rebellion",2014-05-28 07:04:00-04:00,JNJ,primer wednesday may 28 poroshenko moves to end pro russian rebellion,"{'neg': 0.13, 'neu': 0.87, 'pos': 0.0, 'compound': -0.128}",neutral,0.999817430973053
697655,697655,708879.0,Morgan Stanley Sees Three Debate-Worthy Topics For Johnson & Johnson,2014-05-23 10:32:00-04:00,JNJ,morgan stanley sees three debate worthy topics for johnson and johnson,"{'neg': 0.0, 'neu': 0.775, 'pos': 0.225, 'compound': 0.4404}",neutral,0.9998812675476074
697656,697656,708880.0,"J&J's Medical Devices & Diagnostics Announces Expansion with Innovative Products, Customer-Focused Solutions",2014-05-22 08:46:00-04:00,JNJ,j and js medical devices and diagnostics announces expansion with innovative products customer focused solutions,"{'neg': 0.0, 'neu': 0.625, 'pos': 0.375, 'compound': 0.7351}",positive,0.9994670748710632
697657,697657,708881.0,UPDATE: Actavis Shows Co. J&J's Janssen Have Amended Supply Deal for Generic Concerta,2014-05-20 16:22:00-04:00,JNJ,update actavis shows co j and js janssen have amended supply deal for generic concerta,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9992838501930237
697658,697658,708882.0,Form 8-K from Actavis Shows Co. J&J's Janssen Have Amended Supply Deal for Generic Concerta,2014-05-20 16:21:00-04:00,JNJ,form 8 k from actavis shows co j and js janssen have amended supply deal for generic concerta,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9992269277572632
697659,697659,708883.0,Dissecting Dividend Growth ETFs,2014-05-20 16:08:00-04:00,JNJ,dissecting dividend growth etfs,"{'neg': 0.0, 'neu': 0.536, 'pos': 0.464, 'compound': 0.3818}",neutral,0.9978042244911194
697660,697660,708884.0,J&J's Janssen Announces Withdraws Application in EU for Approval of IV-Administered SIMPONI,2014-05-19 07:45:00-04:00,JNJ,j and js janssen announces withdraws application in eu for approval of iv administered simponi,"{'neg': 0.0, 'neu': 0.819, 'pos': 0.181, 'compound': 0.4767}",neutral,0.9962615370750427
697661,697661,708885.0,"R&D Tax Credit Passed In The House, Faces Challenges Ahead",2014-05-14 12:08:00-04:00,JNJ,r and d tax credit passed in the house faces challenges ahead,"{'neg': 0.0, 'neu': 0.719, 'pos': 0.281, 'compound': 0.4404}",neutral,0.754792332649231
697662,697662,708886.0,Google Celebrates Dorothy Hodgkin & Her Contributions To Chemistry,2014-05-12 16:27:00-04:00,JNJ,google celebrates dorothy hodgkin and her contributions to chemistry,"{'neg': 0.0, 'neu': 0.684, 'pos': 0.316, 'compound': 0.5719}",neutral,0.9998584985733032
697663,697663,708887.0,Benzinga's Weekend M&A Chatter,2014-05-11 22:28:00-04:00,JNJ,benzingas weekend m and a chatter,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998726844787598
697664,697664,708888.0,"Sanofi Rumored Not to Be Interested in Allergan, J&J Said to Demur on Co.'s Breast Implant Business - Bloomberg",2014-05-09 14:03:00-04:00,JNJ,sanofi rumored not to be interested in allergan j and j said to demur on co s breast implant business to bloomberg,"{'neg': 0.097, 'neu': 0.903, 'pos': 0.0, 'compound': -0.3089}",negative,0.6500575542449951
697665,697665,708889.0,JNJ's Ortho Caps Gmbh Gets Favorable Decision In Patent Dispute in Federal Patent Court In Germany -Reuters,2014-05-09 09:50:00-04:00,JNJ,jnjs ortho caps gmbh gets favorable decision in patent dispute in federal patent court in germany reuters,"{'neg': 0.13, 'neu': 0.721, 'pos': 0.149, 'compound': 0.1027}",positive,0.9994271993637085
697666,697666,708890.0,UPDATE: J&J's Janssen Submits sNDA for Olysio,2014-05-07 07:49:00-04:00,JNJ,update j and js janssen submits snda for olysio,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998756647109985
697667,697667,708891.0,J&J's Janssen Submits sNDA for Olysio,2014-05-07 07:45:00-04:00,JNJ,j and js janssen submits snda for olysio,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999872088432312
697668,697668,708892.0,"Market Wrap For May 5: Dow Erases Triple-Digit Loss, All Three Major Indices Positive",2014-05-05 16:36:00-04:00,JNJ,market wrap for may 5 dow erases triple digit loss all three major indices positive,"{'neg': 0.12, 'neu': 0.678, 'pos': 0.202, 'compound': 0.3774}",positive,0.9994822144508362
697669,697669,708893.0,5 Top Dow Stocks With The Most Upside Potential,2014-05-05 15:41:00-04:00,JNJ,5 top dow stocks with the most upside potential,"{'neg': 0.0, 'neu': 0.816, 'pos': 0.184, 'compound': 0.2023}",positive,0.9923931360244751
697670,697670,708894.0,#Premarket Technical Update - Johnson & Johnson Trading Higher,2014-05-05 14:16:00-04:00,JNJ,technical update to johnson and johnson trading higher,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.906624436378479
697671,697671,708895.0,"Benzinga's M&A Chatter for Tuesday April 29, 2014",2014-04-29 20:07:00-04:00,JNJ,benzingas m and a chatter for tuesday april 29 2014,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998877048492432
697672,697672,708896.0,"UPDATE: JNJ, Sanofi Spokespersons Decline Comment on Rumored Contact from Allergan",2014-04-29 10:02:00-04:00,JNJ,update jnj sanofi spokespersons decline comment on rumored contact from allergan,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999824583530426
697673,697673,708897.0,"Allergan Could Explore Sale to Sanofi, J&J Instead of Valeant - Bloomberg",2014-04-29 09:23:00-04:00,JNJ,allergan could explore sale to sanofi j and j instead of valeant to bloomberg,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998757839202881
697674,697674,708898.0,J&J Reports New Collaboration with Stop TB Partnership's Global Drug Facility to Enhance Access to Anti-TB Compound,2014-04-29 08:35:00-04:00,JNJ,j and j reports new collaboration with stop tb partnerships global drug facility to enhance access to anti tb compound,"{'neg': 0.2, 'neu': 0.8, 'pos': 0.0, 'compound': -0.5423}",positive,0.999589741230011
697675,697675,708899.0,"3 Mega Cap ETFs For Your Portfolio (MGC, OEF, XLG, AAPL, MSFT)",2014-04-28 14:04:00-04:00,JNJ,3 mega cap etfs for your portfolio mgc oef xlg aapl msft,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998830556869507
697676,697676,708900.0,Form 8-K from J&J Includes Proxy Materials for Annual Shareholder Meeting,2014-04-25 16:35:00-04:00,JNJ,form 8 k from j and j includes proxy materials for annual shareholder meeting,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998862743377686
697677,697677,708901.0,J&J Raises Qtr. Dividend from $0.66 to $0.70/Share,2014-04-24 10:25:00-04:00,JNJ,j and j raises qtr dividend from dollars .66 to dollars,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9992836117744446
697678,697678,708902.0,FDA Approves J&J's Janssen's Sylvant for Rare Castleman's Disease,2014-04-23 17:35:00-04:00,JNJ,fda approves j and js janssens sylvant for rare castlemans disease,"{'neg': 0.0, 'neu': 0.787, 'pos': 0.213, 'compound': 0.4019}",neutral,0.9764857292175293
697679,697679,708903.0,Johnson & Johnson Crosses Above $100,2014-04-21 15:54:00-04:00,JNJ,johnson and johnson crosses above dollars 00,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999862790107727
697680,697680,708904.0,"#PreMarket Primer: Thursday, April 17: Violence In Ukraine Could Deter Thursday's Negotiations",2014-04-17 07:05:00-04:00,JNJ,primer thursday april 17 violence in ukraine could deter thursdays negotiations,"{'neg': 0.291, 'neu': 0.709, 'pos': 0.0, 'compound': -0.6249}",negative,0.9923245906829834
697681,697681,708905.0,Market Wrap For April 16: Markets Hold On To Gains On Positive Yellen Comments And Economic Data,2014-04-16 16:50:00-04:00,JNJ,market wrap for april 16 markets hold on to gains on positive yellen comments and economic data,"{'neg': 0.0, 'neu': 0.714, 'pos': 0.286, 'compound': 0.7184}",positive,0.9996421337127686
697682,697682,708906.0,Mylan Launches First Generic ORTHO EVRA Patch,2014-04-16 16:14:00-04:00,JNJ,mylan launches first generic ortho evra patch,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998759031295776
697683,697683,708907.0,UPDATE: Bank of America Reiterates on Johnson & Johnson Following Strong Q1 Performance,2014-04-16 10:02:00-04:00,JNJ,update bank of america reiterates on johnson and johnson following strong first quarter performance,"{'neg': 0.0, 'neu': 0.798, 'pos': 0.202, 'compound': 0.5106}",positive,0.9994163513183594
697684,697684,708908.0,UPDATE: Deutsche Bank Reiterates on Johnson & Johnson as Defensive Stock,2014-04-16 09:28:00-04:00,JNJ,update deutsche bank reiterates on johnson and johnson as defensive stock,"{'neg': 0.0, 'neu': 0.901, 'pos': 0.099, 'compound': 0.0258}",neutral,0.9995954632759094
697685,697685,708909.0,"Credit Suisse Maintains Underperform on Johnson & Johnson, Raises PT to $100.00",2014-04-16 07:13:00-04:00,JNJ,credit suisse maintains underperform on johnson and johnson raises point to dollars 00.00,"{'neg': 0.0, 'neu': 0.822, 'pos': 0.178, 'compound': 0.3818}",positive,0.9990405440330505
697686,697686,708910.0,"Bank of America Maintains Neutral on Johnson & Johnson, Raises PO to $106.00",2014-04-16 07:11:00-04:00,JNJ,bank of america maintains neutral on johnson and johnson raises po to dollars 06.00,"{'neg': 0.217, 'neu': 0.783, 'pos': 0.0, 'compound': -0.5574}",positive,0.9990743398666382
697687,697687,708911.0,"#PreMarket Primer: Wednesday, April 16: Chinese GDP Slows, But Surpasses Expectations",2014-04-16 07:03:00-04:00,JNJ,primer wednesday april 16 chinese gdp slows but surpasses expectations,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.8695788383483887
697688,697688,708912.0,Market Wrap For April 15: Who Doesn't Love A Turnaround?,2014-04-15 16:30:00-04:00,JNJ,market wrap for april 15 who doesnt love a turnaround,"{'neg': 0.272, 'neu': 0.728, 'pos': 0.0, 'compound': -0.5216}",neutral,0.9975985884666443
697689,697689,708913.0,Mid-Afternoon Market Update: Markets Trade in Highly Volatile Session as Talk of a Pull-Back is Widespread,2014-04-15 15:59:00-04:00,JNJ,mid afternoon market update markets trade in highly volatile session as talk of a pull back is widespread,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9761733412742615
697690,697690,708914.0,#Premarket Prep Technical Update - Johnson & Johnson Trading Sharply Higher,2014-04-15 13:53:00-04:00,JNJ,prep technical update to johnson and johnson trading sharply higher,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9993942975997925
697691,697691,708915.0,Mid-Day Market Update: US Stocks Turn Red; Pep Boys Shares Drop After Q4 Results,2014-04-15 12:54:00-04:00,JNJ,mid day market update us stocks turn red pep boys shares drop after fourth quarter results,"{'neg': 0.115, 'neu': 0.765, 'pos': 0.12, 'compound': 0.0258}",negative,0.9978125095367432
697692,697692,708916.0,The Market Is Not Acting Right,2014-04-15 11:50:00-04:00,JNJ,the market is not acting right,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9924986958503723
697693,697693,708917.0,Mid-Morning Market Update: Markets Gain; Johnson & Johnson Profit Beats Street View,2014-04-15 10:27:00-04:00,JNJ,mid morning market update markets gain johnson and johnson profit beats street view,"{'neg': 0.0, 'neu': 0.636, 'pos': 0.364, 'compound': 0.743}",positive,0.9996709823608398
697694,697694,708918.0,"UPDATE: Johnson & Johnson Shares Rise 2.5% Premarket on Earnings Beat, Raised Guidance",2014-04-15 08:44:00-04:00,JNJ,update johnson and johnson shares rise 2.5 percent premarket on earnings beat raised guidance,"{'neg': 0.0, 'neu': 0.855, 'pos': 0.145, 'compound': 0.296}",positive,0.999721109867096
697695,697695,708919.0,"UPDATE: Johnson & Johnson Posts Upbeat Q1 Earnings, Lifts FY14 Outlook",2014-04-15 08:24:00-04:00,JNJ,update johnson and johnson posts upbeat first quarter earnings lifts fy14 outlook,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996163845062256
697696,697696,708920.0,"Johnson & Johnson Q1 Xarel Sales $319M, Risperdal $310M, Velcade $408M, Remicade $1.61B",2014-04-15 07:54:00-04:00,JNJ,johnson and johnson first quarter xarel sales dollars 19 million risperdal dollars 10 million velcade dollars 08 million remicade dollars .61 billion,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998762607574463
697697,697697,708921.0,Johnson & Johnson Raises FY2014 EPS Guidance to $5.80-5.90,2014-04-15 07:46:00-04:00,JNJ,johnson and johnson raises fy2014 eps guidance to dollars .80 to 5.90,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996665716171265
697698,697698,708922.0,Johnson & Johnson Reports Q1 EPS of $1.54 vs $1.48 Est; Revenue of $18.12B vs $18.0B Est,2014-04-15 07:45:00-04:00,JNJ,johnson and johnson reports first quarter eps of dollars .54 vs dollars .48 est revenue of dollars 8.12 billion vs dollars 8.0 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998831748962402
697699,697699,708923.0,"ETF Outlook for Tuesday, April 15, 2014 (EWH, FCG, PSP, HDV)",2014-04-15 07:37:00-04:00,JNJ,etf outlook for tuesday april 15 2014 ewh fcg psp hdv,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998689889907837
697700,697700,708924.0,"#PreMarket Primer: Tuesday, April 15: Hopes For Diplomacy In Ukraine Help Settle Markets",2014-04-15 07:20:00-04:00,JNJ,primer tuesday april 15 hopes for diplomacy in ukraine help settle markets,"{'neg': 0.0, 'neu': 0.645, 'pos': 0.355, 'compound': 0.6705}",positive,0.999292254447937
697701,697701,708925.0,"Earning, Economic and IPO Calendar for Tuesday April 15, 2014",2014-04-15 06:14:00-04:00,JNJ,earning economic and ipo calendar for tuesday april 15 2014,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999889612197876
697702,697702,708926.0,"Earnings Scheduled For April 15, 2014",2014-04-15 05:11:00-04:00,JNJ,earnings scheduled for april 15 2014,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998831748962402
697703,697703,708927.0,"Stocks To Watch For April 15, 2014",2014-04-15 04:11:00-04:00,JNJ,stocks to watch for april 15 2014,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998799562454224
697704,697704,708928.0,"Jefferies Downgrades Johnson & Johnson to Hold, Maintains $105.00 PT",2014-04-14 08:50:00-04:00,JNJ,jefferies downgrades johnson and johnson to hold maintains dollars 05.00 point,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9976855516433716
697705,697705,708929.0,"#PreMarket Primer: Monday, April 14: Military Action In Ukraine Looking More Likely",2014-04-14 07:14:00-04:00,JNJ,primer monday april 14 military action in ukraine looking more likely,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.8788323998451233
697706,697706,708930.0,"Earnings Expectations For The Week Of April 14: Coca-Cola, Goldman Sachs, Google And More",2014-04-14 06:33:00-04:00,JNJ,earnings expectations for the week of april 14 coca cola goldman sachs google and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998200535774231
697707,697707,708931.0,"Benzinga Weekly Preview: Short, But Action Packed Week Ahead",2014-04-11 16:57:00-04:00,JNJ,benzinga weekly preview short but action packed week ahead,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999833345413208
697708,697708,708932.0,Top 40 Upcoming Earnings Releases  ,2014-04-11 16:08:00-04:00,JNJ,top 40 upcoming earnings releases,"{'neg': 0.0, 'neu': 0.69, 'pos': 0.31, 'compound': 0.2023}",neutral,0.9998894929885864
697709,697709,708933.0,"#PreMarket Primer: Thursday, April 10: Job Creation Will Be China's Main Focus",2014-04-10 07:02:00-04:00,JNJ,primer thursday april 10 job creation will be chinas main focus,"{'neg': 0.0, 'neu': 0.826, 'pos': 0.174, 'compound': 0.2732}",neutral,0.9998760223388672
697710,697710,708934.0,"#PreMarket Primer: Wednesday, April 9: John Kerry Accuses Russia Of Stirring Trouble In Ukraine",2014-04-09 07:18:00-04:00,JNJ,primer wednesday april 9 john kerry accuses russia of stirring trouble in ukraine,"{'neg': 0.317, 'neu': 0.683, 'pos': 0.0, 'compound': -0.6249}",negative,0.9883458614349365
697711,697711,708935.0,Pharmacyclics Says sNDA for Imbruvica Submitted to US FDA,2014-04-08 08:08:00-04:00,JNJ,pharmacyclics says snda for imbruvica submitted to us fda,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998822212219238
697712,697712,708936.0,Is The Market Still Playing Defense?,2014-04-07 14:24:00-04:00,JNJ,is the market still playing defense,"{'neg': 0.0, 'neu': 0.548, 'pos': 0.452, 'compound': 0.3182}",neutral,0.999881386756897
697713,697713,708937.0,J&J's Janssen Submits NDA for Fixed-Dose Combo Tablet of Darunavir with Cobicistat to FDA ,2014-04-01 07:46:00-04:00,JNJ,j and js janssen submits nda for fixed dose combo tablet of darunavir with cobicistat to fda,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998705387115479
697714,697714,708938.0,"Benzinga's M&A Chatter for Monday March 31, 2014",2014-03-31 18:28:00-04:00,JNJ,benzingas m and a chatter for monday march 31 2014,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998862743377686
697715,697715,708939.0,Market Wrap For March 31: Stocks Rally As Yellen Confirms Support For Economy,2014-03-31 16:37:00-04:00,JNJ,market wrap for march 31 stocks rally as yellen confirms support for economy,"{'neg': 0.0, 'neu': 0.816, 'pos': 0.184, 'compound': 0.4019}",positive,0.999535083770752
697716,697716,708940.0,Stocks Hitting 52-Week Highs,2014-03-31 10:15:00-04:00,JNJ,stocks hitting 52 week highs,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9992315769195557
697717,697717,708941.0,UPDATE: J&J Announces Acceptance of Binding Offer from Carlyle Group to Buy Ortho-Clinical Diagnostics for ~$4B,2014-03-31 07:46:00-04:00,JNJ,update j and j announces acceptance of binding offer from carlyle group to buy ortho clinical diagnostics for dollars b,"{'neg': 0.0, 'neu': 0.864, 'pos': 0.136, 'compound': 0.4588}",positive,0.999254047870636
697718,697718,708942.0,J&J Announces Acceptance of Binding Offer from Carlyle Group to Buy Ortho-Clinical Diagnostics for ~$4B,2014-03-31 07:45:00-04:00,JNJ,j and j announces acceptance of binding offer from carlyle group to buy ortho clinical diagnostics for dollars b,"{'neg': 0.0, 'neu': 0.857, 'pos': 0.143, 'compound': 0.4588}",positive,0.9992825388908386
697719,697719,708943.0,FDA Okays Janssen's Topamax for Migraine Prevention in Adolescents,2014-03-28 15:38:00-04:00,JNJ,fda okays janssens topamax for migraine prevention in adolescents,"{'neg': 0.0, 'neu': 0.721, 'pos': 0.279, 'compound': 0.4767}",neutral,0.9998563528060913
697720,697720,708944.0,Fitch Affirms AAA Rating on J&J; Outlook Stable,2014-03-27 14:58:00-04:00,JNJ,fitch affirms aaa rating on j and j outlook stable,"{'neg': 0.0, 'neu': 0.804, 'pos': 0.196, 'compound': 0.296}",positive,0.9962918758392334
697721,697721,708945.0,"ETFs Shrugging Off The Selling (DHS, SMH, IGF, INTC)",2014-03-27 13:23:00-04:00,JNJ,etfs shrugging off the selling dhs smh igf intc,"{'neg': 0.223, 'neu': 0.777, 'pos': 0.0, 'compound': -0.3182}",neutral,0.671578049659729
697722,697722,708946.0,Stocks Hitting 52-Week Highs,2014-03-25 10:14:00-04:00,JNJ,stocks hitting 52 week highs,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9992315769195557
697723,697723,708947.0,Google Honors Activist Dorothy Height & Her Contributions,2014-03-24 14:56:00-04:00,JNJ,google honors activist dorothy height and her contributions,"{'neg': 0.0, 'neu': 0.68, 'pos': 0.32, 'compound': 0.5106}",neutral,0.9998409748077393
697724,697724,708948.0,AP Reporting J&J $1.2B Judgement Overturned by Arkansas Supreme Court,2014-03-20 10:21:00-04:00,JNJ,ap reporting j and j dollars .2 billion judgement overturned by arkansas supreme court,"{'neg': 0.0, 'neu': 0.783, 'pos': 0.217, 'compound': 0.5574}",neutral,0.9582257270812988
697725,697725,708949.0,"J&J's Janssen Investigational Treatment for SchizophreniaShows Positive Efficacy, Delays Relapse",2014-03-20 08:05:00-04:00,JNJ,j and js janssen investigational treatment for schizophreniashows positive efficacy delays relapse,"{'neg': 0.0, 'neu': 0.753, 'pos': 0.247, 'compound': 0.5574}",positive,0.9984160661697388
697726,697726,708950.0,Slap The Floor: Market Playing Defense,2014-03-13 15:01:00-04:00,JNJ,slap the floor market playing defense,"{'neg': 0.0, 'neu': 0.38, 'pos': 0.62, 'compound': 0.4404}",neutral,0.9830474257469177
697727,697727,708951.0,JNJ's Janssen Receives Positive Recommendation On Stelara From SMC,2014-03-10 13:18:00-04:00,JNJ,jnjs janssen receives positive recommendation on stelara from smc,"{'neg': 0.0, 'neu': 0.69, 'pos': 0.31, 'compound': 0.5574}",positive,0.9995220899581909
697728,697728,708952.0,Reckitt Benckiser to Acquire K-Y Brand from Mcneil PPC; Terms Not Disclosed,2014-03-10 05:52:00-04:00,JNJ,reckitt benckiser to acquire k y brand from mcneil ppc terms not disclosed,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998871088027954
697729,697729,708953.0,Cramer Recommends J&J For Best Big Pharma Pipeline Play,2014-03-05 14:38:00-05:00,JNJ,cramer recommends j and j for best big pharma pipeline play,"{'neg': 0.0, 'neu': 0.485, 'pos': 0.515, 'compound': 0.8176}",neutral,0.9996059536933899
697730,697730,708954.0,J&J Says New Data on XEPLION Significantly Delays Time to Relapse,2014-03-04 09:22:00-05:00,JNJ,j and j says new data on xeplion significantly delays time to relapse,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9835388660430908
697731,697731,708955.0,What Companies Stand To Benefit From The 86th Academy Awards? ,2014-02-28 13:23:00-05:00,JNJ,what companies stand to benefit from the 86 academy awards,"{'neg': 0.167, 'neu': 0.449, 'pos': 0.385, 'compound': 0.5267}",positive,0.9899236559867859
697732,697732,708956.0,J&J Files Automatic Mixed Securities Shelf,2014-02-26 16:28:00-05:00,JNJ,j and j files automatic mixed securities shelf,"{'neg': 0.0, 'neu': 0.761, 'pos': 0.239, 'compound': 0.296}",neutral,0.9998910427093506
697733,697733,708957.0,J&J's Biosense Webster Receives FDA Approval for First Catheer Ablation Therapy,2014-02-25 09:04:00-05:00,JNJ,j and js biosense webster receives fda approval for first catheer ablation therapy,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.4767}",positive,0.9991807341575623
697734,697734,708958.0,J&J's Cordis Receives CE Mark for Renlane Renal Deneveration System,2014-02-21 09:59:00-05:00,JNJ,j and js cordis receives ce mark for renlane renal deneveration system,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998691082000732
697735,697735,708959.0,EMA Isuses New Compassionate-Use Programme,2014-02-21 08:09:00-05:00,JNJ,ema isuses new compassionate use programme,"{'neg': 0.0, 'neu': 0.61, 'pos': 0.39, 'compound': 0.4939}",neutral,0.9997887015342712
697736,697736,708960.0,"Pharma ETFs On The Move Again (IHE, PJP, PPH, ACT, FRX)",2014-02-20 14:17:00-05:00,JNJ,pharma etfs on the move again ihe pjp pph act frx,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998281002044678
697737,697737,708961.0,Jefferies: 3D Printers Are About To Burst Across Many Fields,2014-02-19 15:43:00-05:00,JNJ,jefferies 3 days printers are about to burst across many fields,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998829364776611
697738,697738,708962.0,Bloomberg Reporting J&J Has Persuaded Judge to Throw Out Suit Related to Vaginal-Mesh Sling,2014-02-18 13:51:00-05:00,JNJ,bloomberg reporting j and j has persuaded judge to throw out suit related to vaginal mesh sling,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.997174859046936
697739,697739,708963.0,Market Wrap For February 14: Markets End The Week Positive,2014-02-14 16:50:00-05:00,JNJ,market wrap for february 14 markets end the week positive,"{'neg': 0.0, 'neu': 0.714, 'pos': 0.286, 'compound': 0.5574}",positive,0.9995390176773071
697740,697740,708964.0,UPDATE: Pharmacyclics Announces Will Receive $60M Milestone Payment Related to J&J's Imbruvica Deal,2014-02-12 13:22:00-05:00,JNJ,update pharmacyclics announces will receive dollars 0 million milestone payment related to j and js imbruvica deal,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9233525395393372
697741,697741,708965.0,Shares of Pharmacyclics On the Move Higher Following FDA Okay for Imbruvica,2014-02-12 12:53:00-05:00,JNJ,shares of pharmacyclics on the move higher following fda okay for imbruvica,"{'neg': 0.0, 'neu': 0.709, 'pos': 0.291, 'compound': 0.4767}",positive,0.9988993406295776
697742,697742,708966.0,FDA Issues Okay for JanssenMD's Imbruvica for Chronic Lymphcytic Leukemia,2014-02-12 12:48:00-05:00,JNJ,fda issues okay for janssenmds imbruvica for chronic lymphcytic leukemia,"{'neg': 0.0, 'neu': 0.826, 'pos': 0.174, 'compound': 0.2263}",positive,0.9765027761459351
697743,697743,708967.0,An Investor's Guide to Hot In Vitro Diagnostics Market,2014-02-12 11:04:00-05:00,JNJ,an investors guide to hot in vitro diagnostics market,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9983124732971191
697744,697744,708968.0,Three Steps to Overcoming Losses in a Declining Market,2014-02-06 14:31:00-05:00,JNJ,three steps to overcoming losses in a declining market,"{'neg': 0.252, 'neu': 0.748, 'pos': 0.0, 'compound': -0.4019}",positive,0.9881133437156677
697745,697745,708969.0,Bloomberg Reporting Judge in J&J Vaginal-Mesh Case Found Co. Improperly Destroyed Documents,2014-02-05 15:12:00-05:00,JNJ,bloomberg reporting judge in j and j vaginal mesh case found co improperly destroyed documents,"{'neg': 0.186, 'neu': 0.814, 'pos': 0.0, 'compound': -0.4939}",negative,0.7522463798522949
697746,697746,708970.0,Market Wrap For January 30: Markets Focus on Good News,2014-01-30 17:06:00-05:00,JNJ,market wrap for january 30 markets focus on good news,"{'neg': 0.0, 'neu': 0.756, 'pos': 0.244, 'compound': 0.4404}",neutral,0.9981802701950073
697747,697747,708971.0,Bloomberg Reporting J&J Escapes $482M Verdict Following Rejection of Patent Appeal,2014-01-27 09:31:00-05:00,JNJ,bloomberg reporting j and j escapes dollars 82 million verdict following rejection of patent appeal,"{'neg': 0.188, 'neu': 0.645, 'pos': 0.167, 'compound': -0.34}",neutral,0.9968061447143555
697748,697748,708972.0,"#PreMarket Primer: Monday, January 27: Markets Open The Week On Edge",2014-01-27 07:16:00-05:00,JNJ,primer monday january 27 markets open the week on edge,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998832941055298
697749,697749,708973.0,Is It Time To Worry Again?,2014-01-24 14:12:00-05:00,JNJ,is it time to worry again,"{'neg': 0.367, 'neu': 0.633, 'pos': 0.0, 'compound': -0.4404}",neutral,0.9981600642204285
697750,697750,708974.0,J&J's Flubendazole Wins FDA Orphan Drug Designation,2014-01-24 11:07:00-05:00,JNJ,j and js flubendazole wins fda orphan drug designation,"{'neg': 0.0, 'neu': 0.684, 'pos': 0.316, 'compound': 0.5719}",positive,0.9970988035202026
697751,697751,708975.0,Court Rules in Favor of Covidien in Ethicon Patent Infringement Lawsuit ,2014-01-23 16:10:00-05:00,JNJ,court rules in favor of covidien in ethicon patent infringement lawsuit,"{'neg': 0.318, 'neu': 0.51, 'pos': 0.172, 'compound': -0.3182}",neutral,0.9994693398475647
697752,697752,708976.0,Morgan Stanley Maintains on Johnson & Johnson as 2014 Looks Promising,2014-01-22 09:25:00-05:00,JNJ,morgan stanley maintains on johnson and johnson as 2014 looks promising,"{'neg': 0.0, 'neu': 0.787, 'pos': 0.213, 'compound': 0.4019}",positive,0.9992064833641052
697753,697753,708977.0,J&J's Janssen Announces Health Canada Approval for Stelara,2014-01-22 08:05:00-05:00,JNJ,j and js janssen announces health canada approval for stelara,"{'neg': 0.0, 'neu': 0.744, 'pos': 0.256, 'compound': 0.4767}",neutral,0.9973032474517822
697754,697754,708978.0,"#PreMarket Primer: Wednesday, January 22: Syrian Peace Talks Kick Off Surrounded By Doubt",2014-01-22 07:04:00-05:00,JNJ,primer wednesday january 22 syrian peace talks kick off surrounded by doubt,"{'neg': 0.156, 'neu': 0.625, 'pos': 0.219, 'compound': 0.25}",neutral,0.998626708984375
697755,697755,708979.0,Market Wrap For January 21: Dow Hit by Earnings; S&P And Nasdaq End The Day Positive,2014-01-21 16:51:00-05:00,JNJ,market wrap for january 21 dow hit by earnings SP500 and nasdaq end the day positive,"{'neg': 0.0, 'neu': 0.806, 'pos': 0.194, 'compound': 0.5574}",positive,0.9995493292808533
697756,697756,708980.0,Johnson & Johnson Earnings Recap: Beats Estimates By Four Cents,2014-01-21 14:49:00-05:00,JNJ,johnson and johnson earnings recap beats estimates by four cents,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9992409944534302
697757,697757,708981.0,Johnson & Johnson Shares Lower After Earnngs,2014-01-21 13:43:00-05:00,JNJ,johnson and johnson shares lower after earnngs,"{'neg': 0.234, 'neu': 0.532, 'pos': 0.234, 'compound': 0.0}",negative,0.9983494281768799
697758,697758,708982.0,UPDATE: Johnson & Johnson Posts Higher Q4 Earnings,2014-01-21 10:51:00-05:00,JNJ,update johnson and johnson posts higher fourth quarter earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.999663233757019
697759,697759,708983.0,Johnson & Johnson Sees FY2014 Sales $73.50B-74.30B vs $73.90B Est,2014-01-21 09:54:00-05:00,JNJ,johnson and johnson sees fy2014 sales dollars 3.50 billion 74.30 billion vs dollars 3.90 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998538494110107
697760,697760,708984.0,Johnson & Johnson Sees FY2014 EPS $5.75-5.85 vs $5.85 Est,2014-01-21 07:46:00-05:00,JNJ,johnson and johnson sees fy2014 eps dollars .75 to 5.85 vs dollars .85 est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999860405921936
697761,697761,708985.0,Johnson & Johnson Reports Q4 EPS of $1.24 vs $1.20 Est; Revenue of $18.40B vs $17.95B Est,2014-01-21 07:45:00-05:00,JNJ,johnson and johnson reports fourth quarter eps of dollars .24 vs dollars .20 est revenue of dollars 8.40 billion vs dollars 7.95 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998810291290283
697762,697762,708986.0,"#PreMarket Primer: Tuesday, January 21: China's Central Bank Adds Record Amount Of Cash To Markets",2014-01-21 07:09:00-05:00,JNJ,primer tuesday january 21 chinas central bank adds record amount of cash to markets,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9606245756149292
697763,697763,708987.0,"Earnings Scheduled For January 21, 2014",2014-01-21 04:13:00-05:00,JNJ,earnings scheduled for january 21 2014,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998781681060791
697764,697764,708988.0,"Stocks To Watch For January 21, 2014",2014-01-21 04:04:00-05:00,JNJ,stocks to watch for january 21 2014,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998713731765747
697765,697765,708989.0,Economic Outlook For The Week of January 20: How To Trade With Binary Options  ,2014-01-20 10:36:00-05:00,JNJ,economic outlook for the week of january 20 how to trade with binary options,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998761415481567
697766,697766,708990.0,"Earnings Expectations For The Week Of January 20: Microsoft, McDonald's, Netflix And More",2014-01-19 13:27:00-05:00,JNJ,earnings expectations for the week of january 20 microsoft mcdonalds netflix and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998599290847778
697767,697767,708991.0,Benzinga Weekly Preview: Earnings Season Continues,2014-01-18 09:28:00-05:00,JNJ,benzinga weekly preview earnings season continues,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998692274093628
697768,697768,708992.0,J&J's Janssen Confirms FDA Panel Votes Against Approval of XARELTO for Use in Patients with ACS,2014-01-16 16:48:00-05:00,JNJ,j and js janssen confirms fda panel votes against approval of xarelto for use in patients with acs,"{'neg': 0.0, 'neu': 0.846, 'pos': 0.154, 'compound': 0.4767}",neutral,0.813195526599884
697769,697769,708993.0,FDA Advisory Panel Votes 10-0 J&J/Bayer's Xarelto Should NOT Be Approved,2014-01-16 15:55:00-05:00,JNJ,fda advisory panel votes 10 to 0 j and j and bayers xarelto should not be approved,"{'neg': 0.127, 'neu': 0.873, 'pos': 0.0, 'compound': -0.3252}",neutral,0.9998610019683838
697770,697770,708994.0,J&J Announces Binding Offer from Carlyle Group to Buy Ortho-Clinical Diagnostics Unit for $4.15B,2014-01-16 07:45:00-05:00,JNJ,j and j announces binding offer from carlyle group to buy ortho clinical diagnostics unit for dollars .15 billion,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9941761493682861
697771,697771,708995.0,UPDATE: J&J Could Sell Ortho Unit to Carlyle for $4B,2014-01-15 15:28:00-05:00,JNJ,update j and j could sell ortho unit to carlyle for dollars b,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998735189437866
697772,697772,708996.0,Bloomberg Reporting J&J Could Announce Deal with Carlyle as Soon as Tomorrow (Thursday),2014-01-15 15:27:00-05:00,JNJ,bloomberg reporting j and j could announce deal with carlyle as soon as tomorrow thursday,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998766183853149
697773,697773,708997.0,WSJ Reporting Carlyle Paying $4-4.2B for J&J's Blood-Testing Unit,2014-01-15 12:54:00-05:00,JNJ,wsj reporting carlyle paying dollars to 4.2 billion for j and js blood testing unit,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999861478805542
697774,697774,708998.0,"Carlyle Paying $4B-$4.2B for J&J Blood-Testing Unit, According to Sources -DJ",2014-01-15 12:18:00-05:00,JNJ,carlyle paying dollars b dollars .2 billion for j and j blood testing unit according to sources dj,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998635053634644
697775,697775,708999.0,Market Wrap For January 14: Markets Rebound On Earnings Season Kickoff,2014-01-14 17:19:00-05:00,JNJ,market wrap for january 14 markets rebound on earnings season kickoff,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996402263641357
697776,697776,709000.0,Reuters Reporting Carlyle Readying $3.7B in Financing for Bid for J&J Unit,2014-01-13 16:36:00-05:00,JNJ,reuters reporting carlyle readying dollars .7 billion in financing for bid for j and j unit,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998540878295898
697777,697777,709001.0,Market Consolidates Ahead Of Major Earnings Reports    ,2014-01-13 13:26:00-05:00,JNJ,market consolidates ahead of major earnings reports,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9956409931182861
697778,697778,709002.0,"Barclays Downgrades Johnson & Johnson to Equalweight, Maintains $99.00 PT",2014-01-10 08:54:00-05:00,JNJ,barclays downgrades johnson and johnson to equalweight maintains dollars 9.00 point,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9976812601089478
697779,697779,709003.0,Market Wrap For January 9: All Eyes on Tomorrow's Job Report,2014-01-09 16:43:00-05:00,JNJ,market wrap for january 9 all eyes on tomorrows job report,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999854326248169
697780,697780,709004.0,"Jefferies Upgrades Johnson & Johnson to Buy, Raises PT to $108.00",2014-01-09 08:20:00-05:00,JNJ,jefferies upgrades johnson and johnson to buy raises point to dollars 08.00,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9980176687240601
697781,697781,709005.0,Procter & Gamble vs. Johnson & Johnson: Which is the Better Bet?,2014-01-08 15:42:00-05:00,JNJ,procter and gamble vs johnson and johnson which is the better bet,"{'neg': 0.0, 'neu': 0.791, 'pos': 0.209, 'compound': 0.4404}",neutral,0.9258614182472229
697782,697782,709006.0,Johnson & Johnson: Off To A Good Start In 2014,2014-01-08 13:08:00-05:00,JNJ,johnson and johnson off to a good start in 2014,"{'neg': 0.0, 'neu': 0.756, 'pos': 0.244, 'compound': 0.4404}",positive,0.9993521571159363
697783,697783,709007.0,Market Wrap For January 7: Markets Reverse 3-Day Slump,2014-01-07 16:39:00-05:00,JNJ,market wrap for january 7 markets reverse 3 day slump,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9966511130332947
697784,697784,709008.0,UPDATE: RBC Capital Markets Upgrades Johnson & Johnson,2014-01-07 10:50:00-05:00,JNJ,update rbc capital markets upgrades johnson and johnson,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998295307159424
697785,697785,709009.0,J&J Says IDMC Recommends Early Stopping of Pharmacyclics' Phase 3 Study,2014-01-07 09:43:00-05:00,JNJ,j and j says idmc recommends early stopping of pharmacyclics phase 3 study,"{'neg': 0.11, 'neu': 0.759, 'pos': 0.131, 'compound': 0.0772}",neutral,0.9998290538787842
697786,697786,709010.0,"RBC Capital Upgrades Johnson & Johnson to Outperform, Raises PT to $104.00",2014-01-07 07:57:00-05:00,JNJ,rbc capital upgrades johnson and johnson to outperform raises point to dollars 04.00,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996458292007446
697787,697787,709011.0,"Stocks to Watch for December 27, 2013",2013-12-27 11:44:00-05:00,JNJ,stocks to watch for december 27 2013,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998844861984253
697788,697788,709012.0,Hearing Carlyle Group Favorite to Acquire Johnson & Johnson's Clinical Diagnostics Unit -Sources,2013-12-23 15:34:00-05:00,JNJ,hearing carlyle group favorite to acquire johnson and johnsons clinical diagnostics unit sources,"{'neg': 0.0, 'neu': 0.8, 'pos': 0.2, 'compound': 0.4588}",neutral,0.9978073239326477
697789,697789,709013.0,EMA Issues Positive Opinion on Bedaquiline,2013-12-20 07:09:00-05:00,JNJ,ema issues positive opinion on bedaquiline,"{'neg': 0.0, 'neu': 0.581, 'pos': 0.419, 'compound': 0.5574}",positive,0.9425626993179321
697790,697790,709014.0,GlaxoSmithKline Rocked By China Bribery Scandal,2013-12-19 15:48:00-05:00,JNJ,glaxosmithkline rocked by china bribery scandal,"{'neg': 0.367, 'neu': 0.633, 'pos': 0.0, 'compound': -0.4404}",negative,0.5885322690010071
697791,697791,709015.0,"Orion Signs License Pact with Janssen Pharma for Alzheimer's Treatment, Will Receive Upfront Payment of $31M",2013-12-19 12:55:00-05:00,JNJ,orion signs license pact with janssen pharma for alzheimers treatment will receive upfront payment of dollars 1 million,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9534786343574524
697792,697792,709016.0,Which Companies Hoarded The Most Cash In 2013?,2013-12-18 13:53:00-05:00,JNJ,which companies hoarded the most cash in 2013,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9982652068138123
697793,697793,709017.0,"UPDATE: EMA Says Will Discuss Voluntary Withdrawal of Janssen's Doribax, Risk-Benefit Balance of ARIAD's Iclusig",2013-12-17 11:55:00-05:00,JNJ,update ema says will discuss voluntary withdrawal of janssens doribax risk benefit balance of ariads iclusig,"{'neg': 0.109, 'neu': 0.677, 'pos': 0.214, 'compound': 0.25}",neutral,0.9997919201850891
697794,697794,709018.0,FDA Issues Complete Response Letter for Canagliflozin/Metformin Fixed-Dose Combination Therapy for Type 2 Diabetes,2013-12-12 17:30:00-05:00,JNJ,fda issues complete response letter for canagliflozin and metformin fixed dose combination therapy for type 2 diabetes,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998723268508911
697795,697795,709019.0,Johnson & Johnson Shares Under Pressure For Second Day in a Row,2013-12-12 12:48:00-05:00,JNJ,johnson and johnson shares under pressure for second day in a row,"{'neg': 0.153, 'neu': 0.694, 'pos': 0.153, 'compound': 0.0}",negative,0.9983114004135132
697796,697796,709020.0,Myriad Genetics Announces Collaboration With Janssen ,2013-12-09 07:01:00-05:00,JNJ,myriad genetics announces collaboration with janssen,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998630285263062
697797,697797,709021.0,"FDA Announces $1.25M Settlement with J&J's Advanced Sterilization Products, Execs",2013-12-04 16:50:00-05:00,JNJ,fda announces dollars .25 million settlement with j and js advanced sterilization products execs,"{'neg': 0.0, 'neu': 0.867, 'pos': 0.133, 'compound': 0.25}",positive,0.8604912161827087
697798,697798,709022.0,"J&J Files for Two-Part Note Offering via BofA, Goldman, JP Morgan",2013-12-02 08:57:00-05:00,JNJ,j and j files for two part note offering via bofa goldman jp morgan,"{'neg': 0.0, 'neu': 0.878, 'pos': 0.122, 'compound': 0.2023}",neutral,0.9998841285705566
697799,697799,709023.0,J&J Says May Pay $1B in Medical Costs Related to Hip Settlement,2013-11-27 11:48:00-05:00,JNJ,j and j says may pay dollars b in medical costs related to hip settlement,"{'neg': 0.091, 'neu': 0.909, 'pos': 0.0, 'compound': -0.1027}",neutral,0.9984862804412842
697800,697800,709024.0,"Benzinga's M&A Chatter for Monday November 25, 2013",2013-11-25 17:41:00-05:00,JNJ,benzingas m and a chatter for monday november 25 2013,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998855590820312
697801,697801,709025.0,Form 8-K from Vertex Pharma Shows J&J's Janssen Will Make $152M Payment Related to Incivo Sales Royalties During Q4,2013-11-22 16:22:00-05:00,JNJ,form 8 k from vertex pharma shows j and js janssen will make dollars 52 million payment related to incivo sales royalties during fourth quarter,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998869895935059
697802,697802,709026.0,Reuters Reporting J&J Has Chosen Two Possible Bidders for its Diagnostics Unit Sale,2013-11-21 15:50:00-05:00,JNJ,reuters reporting j and j has chosen two possible bidders for its diagnostics unit sale,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998489618301392
697803,697803,709027.0,"Hearing Carlyle Group, Danaher, Blackstone Group in Final Stage of Negotiations for J&J's Diagnostics Unit, According to Sources",2013-11-21 15:46:00-05:00,JNJ,hearing carlyle group danaher blackstone group in final stage of negotiations for j and js diagnostics unit according to sources,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998778104782104
697804,697804,709028.0,"Market Wrap For November 20: Inflation Data Points To ""No"" Tapering, Fed Meeting Notes Points To ""Yes"" Tapering",2013-11-20 17:02:00-05:00,JNJ,market wrap for november 20 inflation data points to no tapering fed meeting notes points to yes tapering,"{'neg': 0.105, 'neu': 0.766, 'pos': 0.129, 'compound': 0.128}",neutral,0.9989911913871765
697805,697805,709029.0,J&J's Janssen Says Galexos Approved by CAnada Priority Review,2013-11-20 07:49:00-05:00,JNJ,j and js janssen says galexos approved by canada priority review,"{'neg': 0.0, 'neu': 0.781, 'pos': 0.219, 'compound': 0.4215}",neutral,0.9994449019432068
697806,697806,709030.0,Vertex Sells INCIVO Product Royalty Rights to  Janssen Pharmaceutica for $152M,2013-11-20 05:46:00-05:00,JNJ,vertex sells incivo product royalty rights to janssen pharmaceutica for dollars 52 million,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998880624771118
697807,697807,709031.0,Bloomberg Reporting J&J Will Pay $2.47B to Settle First Round of Hip Suits,2013-11-19 17:06:00-05:00,JNJ,bloomberg reporting j and j will pay dollars .47 billion to settle first round of hip suits,"{'neg': 0.08, 'neu': 0.92, 'pos': 0.0, 'compound': -0.1027}",neutral,0.9994637370109558
697808,697808,709032.0,WSJ Breaking News Tweets: 'Johnson & Johnson has agreed to pay at least $2.5 billion to settle hip lawsuits.',2013-11-19 09:37:00-05:00,JNJ,wsj breaking news tweets johnson and johnson has agreed to pay at least dollars .5 billion to settle hip lawsuits,"{'neg': 0.136, 'neu': 0.769, 'pos': 0.095, 'compound': 0.0258}",positive,0.9994868040084839
697809,697809,709033.0,Top Four Overlooked Stocks for Income-Seeking Investors,2013-11-18 09:36:00-05:00,JNJ,top four overlooked stocks for income seeking investors,"{'neg': 0.124, 'neu': 0.674, 'pos': 0.202, 'compound': 0.1779}",neutral,0.9998718500137329
697810,697810,709034.0,Bloomberg Reporting J&J Said Set to Announce ASR Hip-Implant Settlement on Nov. 19th,2013-11-15 16:09:00-05:00,JNJ,bloomberg reporting j and j said set to announce asr hip implant settlement on nov 19,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998683929443359
697811,697811,709035.0,"#PreMarket Primer: Thursday, November 14: Markets Primed For Yellen's Big Day",2013-11-14 06:40:00-05:00,JNJ,primer thursday november 14 markets primed for yellens big day,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998584985733032
697812,697812,709036.0,Pharmacyclics Resumes Trading,2013-11-13 13:10:00-05:00,JNJ,pharmacyclics resumes trading,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9994961023330688
697813,697813,709037.0,UPDATE: Pharmacyclics Will Hold 1PM Call to Discuss FDA Approval of IMBRUVICA,2013-11-13 12:46:00-05:00,JNJ,update pharmacyclics will hold 1 pm call to discuss fda approval of imbruvica,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.4767}",neutral,0.999862790107727
697814,697814,709038.0,"Pharmacyclics, J&J's Janssen Now Confirming FDA Approval of IMBRUVICA",2013-11-13 12:42:00-05:00,JNJ,pharmacyclics j and js janssen now confirming fda approval of imbruvica,"{'neg': 0.0, 'neu': 0.763, 'pos': 0.237, 'compound': 0.4767}",positive,0.9994103908538818
697815,697815,709039.0,Pharmacyclics Halted News Pending,2013-11-13 12:20:00-05:00,JNJ,pharmacyclics halted news pending,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.5726457238197327
697816,697816,709040.0,FDA Approves Ibrutinib for MCL,2013-11-13 12:20:00-05:00,JNJ,fda approves ibrutinib for mcl,"{'neg': 0.0, 'neu': 0.597, 'pos': 0.403, 'compound': 0.4019}",positive,0.7997925281524658
697817,697817,709041.0,October Job Numbers a Tale of Two Economies,2013-11-13 10:36:00-05:00,JNJ,october job numbers a tale of two economies,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999821126461029
697818,697818,709042.0,Bloomberg Reporting J&J Said to Reach $4B Deal to Settle Hip-Implant Suits,2013-11-12 15:50:00-05:00,JNJ,bloomberg reporting j and j said to reach dollars b deal to settle hip implant suits,"{'neg': 0.0, 'neu': 0.932, 'pos': 0.068, 'compound': 0.0258}",positive,0.9990801811218262
697819,697819,709043.0,"Johnson & Johnson, Amazon at Odds Over 3rd Party Sales",2013-11-11 14:20:00-05:00,JNJ,johnson and johnson amazon at odds over 3 party sales,"{'neg': 0.0, 'neu': 0.645, 'pos': 0.355, 'compound': 0.5267}",neutral,0.9998407363891602
697820,697820,709044.0,Why Did Institutions Sell 29 Million Apple Shares?,2013-11-11 10:14:00-05:00,JNJ,why did institutions sell 29 million apple shares,"{'neg': 0.0, 'neu': 0.761, 'pos': 0.239, 'compound': 0.296}",neutral,0.9998741149902344
697821,697821,709045.0,Market Wrap For November 8: Markets Erase Thursday's Losses; Dow Companies Dominate Headlines,2013-11-08 16:57:00-05:00,JNJ,market wrap for november 8 markets erase thursdays losses dow companies dominate headlines,"{'neg': 0.276, 'neu': 0.724, 'pos': 0.0, 'compound': -0.4939}",positive,0.9260557889938354
697822,697822,709046.0,Johnson & Jonhson Unit Could Fetch Over $4 Billion in Sale ,2013-11-08 14:07:00-05:00,JNJ,johnson and jonhson unit could fetch over dollars billion in sale,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997908473014832
697823,697823,709047.0,"#PreMarket Primer: Tuesday, November 5: Fed Speakers Calm Taper Nerves",2013-11-05 06:39:00-05:00,JNJ,primer tuesday november 5 fed speakers calm taper nerves,"{'neg': 0.131, 'neu': 0.654, 'pos': 0.215, 'compound': 0.2263}",neutral,0.5531604886054993
697824,697824,709048.0,"J&J, Gilead Report HCV Combo Shows 93% SVR12 Rate Prior Null Responders, Says Medivir Showed No Benefit from Ribavirin, 12-Week Regimen Similar to 24",2013-11-04 16:34:00-05:00,JNJ,j and j gilead report hcv combo shows 93 percent svr12 rate prior null responders says medivir showed no benefit from ribavirin 12 week regimen similar to 24,"{'neg': 0.084, 'neu': 0.916, 'pos': 0.0, 'compound': -0.357}",positive,0.9897640943527222
697825,697825,709049.0,J&J Said to Pay More Than $2.2 Billion in Risperdal Accord ,2013-11-04 13:05:00-05:00,JNJ,j and j said to pay more than dollars .2 billion in risperdal accord,"{'neg': 0.097, 'neu': 0.903, 'pos': 0.0, 'compound': -0.1027}",neutral,0.9998562335968018
697826,697826,709050.0,"US DoJ Says J&J Will Pay $2.2B+ Related to Drug Cases, Co. Has Admitted to Promoting Risperdal for Non-Schizophrenic Uses",2013-11-04 11:21:00-05:00,JNJ,us doj says j and j will pay dollars .2 billion related to drug cases co has admitted to promoting risperdal for non schizophrenic uses,"{'neg': 0.051, 'neu': 0.806, 'pos': 0.143, 'compound': 0.3612}",neutral,0.9976475834846497
697827,697827,709051.0,Bloomberg Reporting J&J's Settlement Related to Risperdal Said to Be Announced Today,2013-11-04 10:33:00-05:00,JNJ,bloomberg reporting j and js settlement related to risperdal said to be announced today,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998747110366821
697828,697828,709052.0,DJ Reporting J&J to Pay $2B to Settle Marketing Probes,2013-11-04 10:01:00-05:00,JNJ,dj reporting j and j to pay dollars b to settle marketing probes,"{'neg': 0.104, 'neu': 0.896, 'pos': 0.0, 'compound': -0.1027}",neutral,0.999125063419342
697829,697829,709053.0,J&J's Janssen Must Pay $4.02M Related to Topamax Seizure Case,2013-10-30 14:47:00-04:00,JNJ,j and js janssen must pay dollars .02 million related to topamax seizure case,"{'neg': 0.097, 'neu': 0.903, 'pos': 0.0, 'compound': -0.1027}",neutral,0.9998282194137573
697830,697830,709054.0,First Trial Related to J&J's Janssen Product Topamax Seizure Drug Goes to Jury Today,2013-10-30 13:19:00-04:00,JNJ,first trial related to j and js janssen product topamax seizure drug goes to jury today,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998602867126465
697831,697831,709055.0,"#PreMarket Primer: Tuesday, October 29: Fed Meeting Likely Uneventful",2013-10-29 06:47:00-04:00,JNJ,primer tuesday october 29 fed meeting likely uneventful,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.7315296530723572
697832,697832,709056.0,Think Silver: Top Stocks Catering to Seniors,2013-10-28 17:43:00-04:00,JNJ,think silver top stocks catering to seniors,"{'neg': 0.0, 'neu': 0.769, 'pos': 0.231, 'compound': 0.2023}",neutral,0.9998792409896851
697833,697833,709057.0,J&J's Janssen Reports Nearly 70% on Simponi Aria at Two Years Had ACR 20 Response,2013-10-28 08:13:00-04:00,JNJ,j and js janssen reports nearly 70 percent on simponi aria at two years had acr 20 response,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998717308044434
697834,697834,709058.0,"Market Primer: Wednesday, October 16: Markets Wobble On Debt Deal Setback",2013-10-16 06:49:00-04:00,JNJ,market primer wednesday october 16 markets wobble on debt deal setback,"{'neg': 0.2, 'neu': 0.8, 'pos': 0.0, 'compound': -0.3612}",negative,0.997956395149231
697835,697835,709059.0,"Market Wrap For Tuesday, October 15: Earnings Reports And White House Progress Send Markets Down",2013-10-15 16:36:00-04:00,JNJ,market wrap for tuesday october 15 earnings reports and white house progress send markets down,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.4215}",negative,0.9957721829414368
697836,697836,709060.0,"PreMarket Info Recap for October 15, 2013: Earnings Kick Off Tuesday",2013-10-15 09:28:00-04:00,JNJ,premarket info recap for october 15 2013 earnings kick off tuesday,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999874472618103
697837,697837,709061.0,UPDATE: Johnson & Johnson Posts Higher Q3 Profit,2013-10-15 08:21:00-04:00,JNJ,update johnson and johnson posts higher third quarter profit,"{'neg': 0.0, 'neu': 0.734, 'pos': 0.266, 'compound': 0.4404}",positive,0.9996929168701172
697838,697838,709062.0,Benzinga's Top Pre-Market Gainers,2013-10-15 08:09:00-04:00,JNJ,benzingas top pre market gainers,"{'neg': 0.0, 'neu': 0.69, 'pos': 0.31, 'compound': 0.2023}",positive,0.9995827078819275
697839,697839,709063.0,"UPDATE: J&J Reported Q3 Remicade Sales $1.69B, Zytiga Sales $464M, Prezista $410M, Velcade $404M, Stelara $370M, Risperdal Consta $326M",2013-10-15 07:59:00-04:00,JNJ,update j and j reported third quarter remicade sales dollars .69 billion zytiga sales dollars 64 million prezista dollars 10 million velcade dollars 04 million stelara dollars 70 million risperdal consta dollars 26 million,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998811483383179
697840,697840,709064.0,Johnson & Johnson Raises FY2013 EPS Guidance from $5.40-5.47 to $5.44-5.49 vs $5.46 Est,2013-10-15 07:50:00-04:00,JNJ,johnson and johnson raises fy2013 eps guidance from dollars .40 to 5.47 to dollars .44 to 5.49 vs dollars .46 est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.999647855758667
697841,697841,709065.0,Johnson & Johnson Reports Q3 EPS of $1.36 vs $1.32 Est; Revenue of $17.60B vs $17.42B Est; Raises Outlook,2013-10-15 07:45:00-04:00,JNJ,johnson and johnson reports third quarter eps of dollars .36 vs dollars .32 est revenue of dollars 7.60 billion vs dollars 7.42 billion est raises outlook,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9993559718132019
697842,697842,709066.0,"ETF Outlook for October 15, 2013 (IHE, ITB, EWZ, SMH)",2013-10-15 06:57:00-04:00,JNJ,etf outlook for october 15 2013 ihe itb ewz smh,"{'neg': 0.204, 'neu': 0.796, 'pos': 0.0, 'compound': -0.3182}",neutral,0.9998636245727539
697843,697843,709067.0,"Market Primer: Tuesday, October 15: Tuesday Could Be 'Deal Day'",2013-10-15 06:50:00-04:00,JNJ,market primer tuesday october 15 tuesday could be deal day,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998893737792969
697844,697844,709068.0,"Earnings Scheduled For October 15, 2013",2013-10-15 04:56:00-04:00,JNJ,earnings scheduled for october 15 2013,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999881386756897
697845,697845,709069.0,"Stocks To Watch For October 15, 2013",2013-10-15 04:33:00-04:00,JNJ,stocks to watch for october 15 2013,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998815059661865
697846,697846,709070.0,"Earnings Expectations For The Week Of October 14: Financials, Tech and Consumer Goods",2013-10-13 13:13:00-04:00,JNJ,earnings expectations for the week of october 14 financials tech and consumer goods,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999859094619751
697847,697847,709071.0,Benzinga Weekly Preview: Earnings Season Gets Into Full Swing,2013-10-11 16:29:00-04:00,JNJ,benzinga weekly preview earnings season gets into full swing,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9994489550590515
697848,697848,709072.0,UPDATE: Goldman Sachs Upgrades Johnson & Johnson Based on Solid Pharma Business,2013-10-11 10:24:00-04:00,JNJ,update goldman sachs upgrades johnson and johnson based on solid pharma business,"{'neg': 0.0, 'neu': 0.873, 'pos': 0.127, 'compound': 0.1531}",neutral,0.9989179372787476
697849,697849,709073.0,Benzinga's Top Upgrades,2013-10-11 07:21:00-04:00,JNJ,benzingas top upgrades,"{'neg': 0.0, 'neu': 0.526, 'pos': 0.474, 'compound': 0.2023}",positive,0.7773524522781372
697850,697850,709074.0,US Stock Futures Up; J.P. Morgan Earnings In Focus,2013-10-11 07:13:00-04:00,JNJ,us stock futures up j p morgan earnings in focus,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996733665466309
697851,697851,709075.0,"Goldman Sachs Upgrades Johnson & Johnson to Neutral, Raises PT to $95.00",2013-10-11 06:28:00-04:00,JNJ,goldman sachs upgrades johnson and johnson to neutral raises point to dollars 5.00,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9995468258857727
697852,697852,709076.0,J&J's Janssen Buys Investigational NS5A Inhibitor from Glaxo,2013-10-08 08:03:00-04:00,JNJ,j and js janssen buys investigational ns5 a inhibitor from glaxo,"{'neg': 0.115, 'neu': 0.885, 'pos': 0.0, 'compound': -0.0772}",neutral,0.9971537590026855
697853,697853,709077.0,"Playing Momentum With ETFs (PDP, PIE, MTUM)",2013-10-07 15:52:00-04:00,JNJ,playing momentum with etfs pdp pie mtum,"{'neg': 0.0, 'neu': 0.769, 'pos': 0.231, 'compound': 0.2023}",positive,0.9697728753089905
697854,697854,709078.0,J&J Says Boehringer Doxil Dispute May Cause Year-Long Shortage,2013-10-01 11:57:00-04:00,JNJ,j and j says boehringer doxil dispute may cause year long shortage,"{'neg': 0.32, 'neu': 0.68, 'pos': 0.0, 'compound': -0.5719}",negative,0.9970478415489197
697855,697855,709079.0,"Form 8-K from Endocyte Shows Janssen Pharma Informed Co. of Estimated Doxil Supply Interruption, Sees Sufificient Doxil Supply to Support Patients on Trials",2013-09-26 16:45:00-04:00,JNJ,form 8 k from endocyte shows janssen pharma informed co of estimated doxil supply interruption sees sufificient doxil supply to support patients on trials,"{'neg': 0.092, 'neu': 0.809, 'pos': 0.099, 'compound': 0.0516}",negative,0.9862030744552612
697856,697856,709080.0,"BioMarin, Celgene Lead Trend in Biotech Short Interest (BRMN, CELG, REGN)",2013-09-25 12:52:00-04:00,JNJ,biomarin celgene lead trend in biotech short interest brmn celg regn,"{'neg': 0.0, 'neu': 0.769, 'pos': 0.231, 'compound': 0.4588}",positive,0.9980233907699585
697857,697857,709081.0,Write A Prescription For Health Care ETFs,2013-09-19 08:06:00-04:00,JNJ,write a prescription for health care etfs,"{'neg': 0.0, 'neu': 0.652, 'pos': 0.348, 'compound': 0.4939}",neutral,0.9998834133148193
697858,697858,709082.0,Johnson and Johnson near Major Resistance Level,2013-09-18 14:31:00-04:00,JNJ,johnson and johnson near major resistance level,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9996926784515381
697859,697859,709083.0,"Alexion, Pharmacyclics Buck Trend in Biotech Short Interest (ALXN, CELG, PCYC)",2013-09-14 11:47:00-04:00,JNJ,alexion pharmacyclics buck trend in biotech short interest alxn celg pcyc,"{'neg': 0.0, 'neu': 0.769, 'pos': 0.231, 'compound': 0.4588}",positive,0.9994763731956482
697860,697860,709084.0,Some New ETFs Off To Impressive Starts,2013-09-12 13:18:00-04:00,JNJ,some new etfs off to impressive starts,"{'neg': 0.0, 'neu': 0.645, 'pos': 0.355, 'compound': 0.5106}",positive,0.9988288283348083
697861,697861,709085.0,"Duke Energy, VIVUS And Others Insiders Have Been Buying",2013-09-07 15:22:00-04:00,JNJ,duke energy vivus and others insiders have been buying,"{'neg': 0.0, 'neu': 0.792, 'pos': 0.208, 'compound': 0.2732}",neutral,0.9995926022529602
697862,697862,709086.0,AP Reporting J&J Has Recalled 200K Bottles of Infant Motrin,2013-09-06 16:13:00-04:00,JNJ,ap reporting j and j has recalled 200 thousand bottles of infant motrin,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998786449432373
697863,697863,709087.0,DJ Reporting J&J Rumored to Hold Talks to Sell Diagnostics Unit,2013-09-06 13:10:00-04:00,JNJ,dj reporting j and j rumored to hold talks to sell diagnostics unit,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9996100068092346
697864,697864,709088.0,Plenty Of ETFs With Favorable Risk Traits,2013-08-30 07:59:00-04:00,JNJ,plenty of etfs with favorable risk traits,"{'neg': 0.206, 'neu': 0.49, 'pos': 0.304, 'compound': 0.25}",neutral,0.9974080920219421
697865,697865,709089.0,"Short Interest In Celgene, Onyx Continues To Shrink (CELG, ONXX, VRTX)",2013-08-27 13:29:00-04:00,JNJ,short interest in celgene onyx continues to shrink celg onxx vrtx,"{'neg': 0.0, 'neu': 0.769, 'pos': 0.231, 'compound': 0.4588}",negative,0.9981592297554016
697866,697866,709090.0,"Hearing Symbols Impacted by Options Issues: IBKR, IVZ, JLL, JNJ, JNPR, JOE, JOY, JPM, JWN, K, KBR, KEY",2013-08-20 12:23:00-04:00,JNJ,hearing symbols impacted by options issues ibkr ivz jll jnj jnpr joe joy jpm jwn k kbr key,"{'neg': 0.0, 'neu': 0.817, 'pos': 0.183, 'compound': 0.5859}",neutral,0.9998346567153931
697867,697867,709091.0,J&J Closes Purchase of Aragon Pharma,2013-08-19 16:30:00-04:00,JNJ,j and j closes purchase of aragon pharma,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998708963394165
697868,697868,709092.0,Nordstrom Joins UBS List Of Top Dividend Payers,2013-08-17 12:01:00-04:00,JNJ,nordstrom joins ubs list of top dividend payers,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.2023}",neutral,0.9998631477355957
697869,697869,709093.0,Has Johnson & Johnson Peaked? Time to Book Profits?,2013-08-15 11:22:00-04:00,JNJ,has johnson and johnson peaked time to book profits,"{'neg': 0.0, 'neu': 0.734, 'pos': 0.266, 'compound': 0.4404}",positive,0.9598953723907471
697870,697870,709094.0,"UPDATE: Berkshire Hathaway Shows Increased Stakes In American Express, ConocoPhillips, Costco, Davita Healthcare, Deere, DirecTV, GE, GM, GlaxoSmithKline, J&J, Liberty Media, M&T Bank",2013-08-15 07:14:00-04:00,JNJ,update berkshire hathaway shows increased stakes in american express conocophillips costco davita healthcare deere directv ge gm glaxosmithkline j and j liberty media m and t bank,"{'neg': 0.0, 'neu': 0.82, 'pos': 0.18, 'compound': 0.6705}",positive,0.9985828399658203
697871,697871,709095.0,How Much Does It Cost To Develop A New Drug?,2013-08-14 09:32:00-04:00,JNJ,how much does it cost to develop a new drug,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997467398643494
697872,697872,709096.0,Royalty Pharma Partners with Aisling Capital and Clarus Ventures in Recent Ibrutinib Royalty Purchase ,2013-08-12 07:03:00-04:00,JNJ,royalty pharma partners with aisling capital and clarus ventures in recent ibrutinib royalty purchase,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998682737350464
697873,697873,709097.0,"Johnson and Johnson Wins Appeal Over Rembrandt's Contact Lens Patent, Court Says JNJ Did Not Infringe On Patent",2013-08-07 11:37:00-04:00,JNJ,johnson and johnson wins appeal over rembrandts contact lens patent court says jnj did not infringe on patent,"{'neg': 0.0, 'neu': 0.821, 'pos': 0.179, 'compound': 0.5719}",positive,0.9980326294898987
697874,697874,709098.0,Buyback ETF Defies Logic,2013-08-06 09:22:00-04:00,JNJ,buyback etf defies logic,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.998346209526062
697875,697875,709099.0,Biotechnology Stock Wins,2013-08-05 10:41:00-04:00,JNJ,biotechnology stock wins,"{'neg': 0.0, 'neu': 0.351, 'pos': 0.649, 'compound': 0.5719}",positive,0.9988811612129211
697876,697876,709100.0,Deferred Tax Assets and Liabilities,2013-08-05 09:38:00-04:00,JNJ,deferred tax assets and liabilities,"{'neg': 0.277, 'neu': 0.462, 'pos': 0.262, 'compound': -0.0258}",neutral,0.9998538494110107
697877,697877,709101.0,Is Procter & Gamble a Strategic Bet?,2013-08-05 09:16:00-04:00,JNJ,is procter and gamble a strategic bet,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997109770774841
697878,697878,709102.0,S&P: Heaping Praise For Some Health Care ETFs,2013-08-02 16:00:00-04:00,JNJ,SP500 heaping praise for some health care etfs,"{'neg': 0.0, 'neu': 0.469, 'pos': 0.531, 'compound': 0.7783}",positive,0.9989239573478699
697879,697879,709103.0,"Three Soaring, But Overlooked Health Care ETFs",2013-08-02 14:19:00-04:00,JNJ,three soaring but overlooked health care etfs,"{'neg': 0.11, 'neu': 0.478, 'pos': 0.411, 'compound': 0.631}",neutral,0.9997554421424866
697880,697880,709104.0,SLIDESHOW: 8 Stocks to Benefit From a Repatriation Deal In Congress,2013-07-30 13:06:00-04:00,JNJ,slideshow 8 stocks to benefit from a repatriation deal in congress,"{'neg': 0.0, 'neu': 0.769, 'pos': 0.231, 'compound': 0.4588}",positive,0.9950826168060303
697881,697881,709105.0,"FDA Issues Warning on J&J's Nizoral Tablets, Says Could Cause Severe Liver Injuries, Could Have Harmful Interactions with Medications",2013-07-26 10:08:00-04:00,JNJ,fda issues warning on j and js nizoral tablets says could cause severe liver injuries could have harmful interactions with medications,"{'neg': 0.208, 'neu': 0.792, 'pos': 0.0, 'compound': -0.6124}",negative,0.9883899688720703
697882,697882,709106.0,Rookie ETF Offers Exposure to Rising EM Dividends,2013-07-19 16:29:00-04:00,JNJ,rookie etf offers exposure to rising em dividends,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9993764758110046
697883,697883,709107.0,J&J Agrees to Pay $22.9M to Settle Case Over Drug Recalls,2013-07-17 16:48:00-04:00,JNJ,j and j agrees to pay dollars 2.9 million to settle case over drug recalls,"{'neg': 0.086, 'neu': 0.802, 'pos': 0.111, 'compound': 0.1027}",positive,0.9920490384101868
697884,697884,709108.0,UPDATE: Citigroup Raises PT on Johnson & Johnson Following Good 2Q Results,2013-07-17 10:43:00-04:00,JNJ,update citigroup raises point on johnson and johnson following good second quarter results,"{'neg': 0.0, 'neu': 0.805, 'pos': 0.195, 'compound': 0.4404}",positive,0.9995471835136414
697885,697885,709109.0,UPDATE: Deutsche Bank Downgrades Johnson & Johnson on Valuation,2013-07-17 08:27:00-04:00,JNJ,update deutsche bank downgrades johnson and johnson on valuation,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9971709847450256
697886,697886,709110.0,Benzinga's Top Downgrades,2013-07-17 07:42:00-04:00,JNJ,benzingas top downgrades,"{'neg': 0.0, 'neu': 0.526, 'pos': 0.474, 'compound': 0.2023}",negative,0.9905633926391602
697887,697887,709111.0,A Peek Into The Market Before The Trading Starts,2013-07-17 07:41:00-04:00,JNJ,a peek into the market before the trading starts,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998680353164673
697888,697888,709112.0,"Deutsche Bank Downgrades Johnson & Johnson to Hold, Raises PT to $93.00",2013-07-17 06:41:00-04:00,JNJ,deutsche bank downgrades johnson and johnson to hold raises point to dollars 3.00,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9973849654197693
697889,697889,709113.0,"Benzinga Market Primer: Wednesday, July 17: Bernanke Is Back",2013-07-17 06:30:00-04:00,JNJ,benzinga market primer wednesday july 17 bernanke is back,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998310804367065
697890,697890,709114.0,Eli Lilly Tries Again with Alzheimer's Drug as the Race for a Cure Continues (LLY),2013-07-16 11:30:00-04:00,JNJ,eli lilly tries again with alzheimers drug as the race for a cure continues lly,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997602105140686
697891,697891,709115.0,UPDATE: Johnson & Johnson Posts Upbeat Q2 Profit,2013-07-16 08:34:00-04:00,JNJ,update johnson and johnson posts upbeat second quarter profit,"{'neg': 0.0, 'neu': 0.734, 'pos': 0.266, 'compound': 0.4404}",positive,0.9995822310447693
697892,697892,709116.0,"UPDATE: Johnson and Johnson Q2 EPS Includes Gain On Sale of Elan Stake, Saw Negative Currency Impact of 0.9%",2013-07-16 07:51:00-04:00,JNJ,update johnson and johnson second quarter eps includes gain on sale of elan stake saw negative currency impact of 0.9 percent,"{'neg': 0.142, 'neu': 0.728, 'pos': 0.13, 'compound': -0.0772}",positive,0.9995278120040894
697893,697893,709117.0,Johnson & Johnson Raises FY2013 EPS Guidance from $5.35-5.45 to $5.40-5.47 vs $5.42 Est,2013-07-16 07:49:00-04:00,JNJ,johnson and johnson raises fy2013 eps guidance from dollars .35 to 5.45 to dollars .40 to 5.47 vs dollars .42 est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996476173400879
697894,697894,709118.0,Johnson & Johnson Reports Q2 EPS of $1.48 vs $1.39 Est; Revenue of $17.90B vs $17.71B Est; Raising Guidance,2013-07-16 07:48:00-04:00,JNJ,johnson and johnson reports second quarter eps of dollars .48 vs dollars .39 est revenue of dollars 7.90 billion vs dollars 7.71 billion est raising guidance,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.8851434588432312
697895,697895,709119.0,"Benzinga Market Primer: Tuesday, July 16: Futures Flat Ahead of Earnings",2013-07-16 06:35:00-04:00,JNJ,benzinga market primer tuesday july 16 futures flat ahead of earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9984563589096069
697896,697896,709120.0,"US Stock Futures Edge Higher; Goldman Sachs Earnings, CPI In Focus",2013-07-16 06:18:00-04:00,JNJ,us stock futures edge higher goldman sachs earnings cpi in focus,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9994284510612488
697897,697897,709121.0,"Earnings Scheduled For July 16, 2013",2013-07-16 05:06:00-04:00,JNJ,earnings scheduled for july 16 2013,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998834133148193
697898,697898,709122.0,"Stocks To Watch For July 16, 2013",2013-07-16 05:01:00-04:00,JNJ,stocks to watch for july 16 2013,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998818635940552
697899,697899,709123.0,Health Care ETFs Looking Healthy Ahead of Earnings,2013-07-15 15:43:00-04:00,JNJ,health care etfs looking healthy ahead of earnings,"{'neg': 0.0, 'neu': 0.504, 'pos': 0.496, 'compound': 0.7096}",positive,0.9995512366294861
697900,697900,709124.0,Earnings Expectations for the Week of July 15,2013-07-14 20:43:00-04:00,JNJ,earnings expectations for the week of july 15,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998418092727661
697901,697901,709125.0,A Look Ahead: This Week's ETFs to Watch,2013-07-14 20:34:00-04:00,JNJ,a look ahead this weeks etfs to watch,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998588562011719
697902,697902,709126.0,Weekly Preview: Earnings Back With A Bang,2013-07-12 16:47:00-04:00,JNJ,weekly preview earnings back with a bang,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9905233979225159
697903,697903,709127.0,UPDATE: Jefferies Raises PT on Johnson & Johnson on Challenges Ahead,2013-07-12 08:49:00-04:00,JNJ,update jefferies raises point on johnson and johnson on challenges ahead,"{'neg': 0.0, 'neu': 0.885, 'pos': 0.115, 'compound': 0.0772}",neutral,0.9983934760093689
697904,697904,709128.0,"Jefferies Maintains Hold on Johnson & Johnson, Raises PT to $92.00",2013-07-12 07:26:00-04:00,JNJ,jefferies maintains hold on johnson and johnson raises point to dollars 2.00,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9980456829071045
697905,697905,709129.0,"Earnings Expectations for the Week of July 8 (AA, JPM, WFC)",2013-07-07 20:02:00-04:00,JNJ,earnings expectations for the week of july 8 aa jpm wfc,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998219609260559
697906,697906,709130.0,5 Healthcare Stocks With The Highest Revenue,2013-07-05 07:27:00-04:00,JNJ,5 healthcare stocks with the highest revenue,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.997554361820221
697907,697907,709131.0,ETFs For an Onyx Takeover Battle,2013-07-01 13:02:00-04:00,JNJ,etfs for an onyx takeover battle,"{'neg': 0.342, 'neu': 0.658, 'pos': 0.0, 'compound': -0.3818}",neutral,0.9998685121536255
697908,697908,709132.0,Barron's Recap: World's Most Respected Companies,2013-06-30 20:37:00-04:00,JNJ,barrons recap worlds most respected companies,"{'neg': 0.0, 'neu': 0.596, 'pos': 0.404, 'compound': 0.5256}",neutral,0.9998779296875
697909,697909,709133.0,"Short Interest in Biogen Idec and Vertex Shrinks (BIIB, CELG, VRTX)",2013-06-26 13:17:00-04:00,JNJ,short interest in biogen idec and vertex shrinks biib celg vrtx,"{'neg': 0.0, 'neu': 0.769, 'pos': 0.231, 'compound': 0.4588}",negative,0.9952569603919983
697910,697910,709134.0,"Abbott Wins Appeal in Heart Stent Dispute with J&J, Pfizer",2013-06-26 11:12:00-04:00,JNJ,abbott wins appeal in heart stent dispute with j and j pfizer,"{'neg': 0.138, 'neu': 0.459, 'pos': 0.403, 'compound': 0.7351}",positive,0.9980518817901611
697911,697911,709135.0,Rising 10-Year Yields Could Crush Popular Dividend ETFs,2013-06-21 13:21:00-04:00,JNJ,rising 10 year yields could crush popular dividend etfs,"{'neg': 0.14, 'neu': 0.614, 'pos': 0.246, 'compound': 0.296}",positive,0.5158013105392456
697912,697912,709136.0,One Simple Measure for Investing in a Volatile Market,2013-06-18 09:28:00-04:00,JNJ,one simple measure for investing in a volatile market,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998488426208496
697913,697913,709137.0,"Benzinga's M&A Chatter for Monday June 17, 2013",2013-06-17 17:33:00-04:00,JNJ,benzingas m and a chatter for monday june 17 2013,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998798370361328
697914,697914,709138.0,"Market Wrap for Monday, June 17: Stocks Jump to Start Trading Week; Dow Rallies Triple Digits ",2013-06-17 16:21:00-04:00,JNJ,market wrap for monday june 17 stocks jump to start trading week dow rallies triple digits,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9994943141937256
697915,697915,709139.0,Siemens to Create Companion Diganostic Test for In-Development Janssen Heart Failure Drug,2013-06-17 09:02:00-04:00,JNJ,siemens to create companion diganostic test for in development janssen heart failure drug,"{'neg': 0.168, 'neu': 0.51, 'pos': 0.321, 'compound': 0.4588}",neutral,0.9998587369918823
697916,697916,709140.0,UPDATE: Johnson & Johnson Announces Definitive Agreement To Acquire Aragon Pharma For $650M; Includes Contingent for Possible Additional Payments of up to $350M,2013-06-17 08:03:00-04:00,JNJ,update johnson and johnson announces definitive agreement to acquire aragon pharma for dollars 50 million includes contingent for possible additional payments of up to dollars 50 million,"{'neg': 0.0, 'neu': 0.89, 'pos': 0.11, 'compound': 0.4939}",positive,0.9428892135620117
697917,697917,709141.0,"J&J Announces Definitive Deal to Buy Aragon Pharma, to Make $650M Upfront Payment",2013-06-17 08:02:00-04:00,JNJ,j and j announces definitive deal to buy aragon pharma to make dollars 50 million upfront payment,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9990189075469971
697918,697918,709142.0,"Bloomberg Reporting a J&J Spokesperson Has Said the Company Sold 25.4M Elan Shares Today, This Would Be Nearly Entire Stake",2013-06-13 17:21:00-04:00,JNJ,bloomberg reporting a j and j spokesperson has said the company sold 25.4 million elan shares today this would be nearly entire stake,"{'neg': 0.0, 'neu': 0.909, 'pos': 0.091, 'compound': 0.296}",neutral,0.9998829364776611
697919,697919,709143.0,J&J's Janssen Issues Research Study Results for Simponi in Active RA,2013-06-12 08:11:00-04:00,JNJ,j and js janssen issues research study results for simponi in active ra,"{'neg': 0.0, 'neu': 0.816, 'pos': 0.184, 'compound': 0.4019}",neutral,0.999884843826294
697920,697920,709144.0,UPDATE: Jefferies Lowers PT on Johnson & Johnson Following Global Pharma Review,2013-06-07 12:31:00-04:00,JNJ,update jefferies lowers point on johnson and johnson following global pharma review,"{'neg': 0.12, 'neu': 0.88, 'pos': 0.0, 'compound': -0.128}",neutral,0.9997979998588562
697921,697921,709145.0,"Jefferies Maintains Hold on Johnson & Johnson, Lowers PT to $91.00",2013-06-07 07:50:00-04:00,JNJ,jefferies maintains hold on johnson and johnson lowers point to dollars 1.00,"{'neg': 0.12, 'neu': 0.88, 'pos': 0.0, 'compound': -0.128}",neutral,0.996822714805603
697924,697924,709147.0,"J&J Innovation Announces Opening of California Innovation Center, Janssen, Second Genome Announce Deal on Microbiome Drug Discovery",2013-06-05 08:04:00-04:00,JNJ,j and j innovation announces opening of california innovation center janssen second genome announce deal on microbiome drug discovery,"{'neg': 0.0, 'neu': 0.766, 'pos': 0.234, 'compound': 0.6369}",neutral,0.9737039804458618
697925,697925,709148.0,"With Bond Yields So Low, Reluctant Investors Are Now Making the Move into These Stocks",2013-06-04 09:44:00-04:00,JNJ,with bond yields so low reluctant investors are now making the move into these stocks,"{'neg': 0.279, 'neu': 0.721, 'pos': 0.0, 'compound': -0.6149}",neutral,0.5885869860649109
697926,697926,709149.0,"CVR Energy, Warner Chilcott and Other Top Performers in May",2013-06-02 09:35:00-04:00,JNJ,cvr energy warner chilcott and other top performers in may,"{'neg': 0.0, 'neu': 0.672, 'pos': 0.328, 'compound': 0.4404}",neutral,0.9998581409454346
697927,697927,709150.0,Valeant Pharmaceuticals to Buy Bausch & Lomb,2013-05-28 12:20:00-04:00,JNJ,valeant pharmaceuticals to buy bausch and lomb,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998788833618164
697928,697928,709151.0,UPDATE: Jefferies Raises PT on Johnson & Johnson Following SOTP Analysis,2013-05-28 10:49:00-04:00,JNJ,update jefferies raises point on johnson and johnson following sotp analysis,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998469352722168
697929,697929,709152.0,"Jefferies Maintains Hold on Johnson & Johnson, Raises PT to $97.00",2013-05-28 08:28:00-04:00,JNJ,jefferies maintains hold on johnson and johnson raises point to dollars 7.00,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9973451495170593
697930,697930,709153.0,"J&J's Janssen Poised to Continue Driving Growth, Outlines 10+ Potential New Product Filings by 2017",2013-05-23 07:33:00-04:00,JNJ,j and js janssen poised to continue driving growth outlines 10 potential new product filings by 2017,"{'neg': 0.0, 'neu': 0.765, 'pos': 0.235, 'compound': 0.5574}",positive,0.9995352029800415
697931,697931,709154.0,"J&J's Janssen Announces Primary Efficacy, Safety Findings from Phase 3 Study of Simeprevir Once Daily",2013-05-21 08:18:00-04:00,JNJ,j and js janssen announces primary efficacy safety findings from phase 3 study of simeprevir once daily,"{'neg': 0.0, 'neu': 0.851, 'pos': 0.149, 'compound': 0.4215}",neutral,0.9990921020507812
697932,697932,709155.0,How Understanding the Investment Climate Equals Stock Market Success,2013-05-20 09:34:00-04:00,JNJ,how understanding the investment climate equals stock market success,"{'neg': 0.0, 'neu': 0.684, 'pos': 0.316, 'compound': 0.5719}",neutral,0.8936238288879395
697933,697933,709156.0,Johnson & Johnson Stops Selling Metal Liners in Metal on Metal Hip Replacement Product; Says Decision Stemmed From Low Sales -Bloomberg,2013-05-16 13:29:00-04:00,JNJ,johnson and johnson stops selling metal liners in metal on metal hip replacement product says decision stemmed from low sales bloomberg,"{'neg': 0.163, 'neu': 0.837, 'pos': 0.0, 'compound': -0.4019}",negative,0.9968749284744263
697934,697934,709157.0,"Short Interest in Vertex Rises, in Celgene Falls",2013-05-11 10:45:00-04:00,JNJ,short interest in vertex rises in celgene falls,"{'neg': 0.0, 'neu': 0.7, 'pos': 0.3, 'compound': 0.4588}",positive,0.5707152485847473
697935,697935,709158.0,S&P Highlights Biotech ETFs,2013-05-10 07:39:00-04:00,JNJ,SP500 highlights biotech etfs,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998881816864014
697936,697936,709159.0,DJ Reporting J&J Potential $2.2B Settlement with DoJ Help Up,2013-05-09 14:52:00-04:00,JNJ,dj reporting j and j potential dollars .2 billion settlement with doj help up,"{'neg': 0.0, 'neu': 0.828, 'pos': 0.172, 'compound': 0.4019}",positive,0.99542635679245
697937,697937,709160.0,Stock Market Fake-Out: Where Is the Retrenchment?,2013-05-08 12:47:00-04:00,JNJ,stock market fake out where is the retrenchment,"{'neg': 0.307, 'neu': 0.693, 'pos': 0.0, 'compound': -0.4767}",neutral,0.8712766766548157
697938,697938,709161.0,Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With The Lowest PEG Ratio,2013-05-08 04:51:00-04:00,JNJ,top 4 nyse stocks in the drug manufacturers major industry with the lowest peg ratio,"{'neg': 0.149, 'neu': 0.747, 'pos': 0.103, 'compound': -0.2023}",neutral,0.9998480081558228
697939,697939,709162.0,Three Top Performing Healthcare Stocks to Watch,2013-05-06 15:53:00-04:00,JNJ,three top performing healthcare stocks to watch,"{'neg': 0.0, 'neu': 0.769, 'pos': 0.231, 'compound': 0.2023}",neutral,0.9998189806938171
697940,697940,709163.0,"DJ Reporting J&J Recalls All Children's Tylenol in South Korea, Recall Doesn't Affect US Products",2013-05-03 15:27:00-04:00,JNJ,dj reporting j and j recalls all childrens tylenol in south korea recall doesnt affect us products,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999523401260376
697941,697941,709164.0,Earnings Trigger Volume Spike in Pharma ETF,2013-05-01 14:41:00-04:00,JNJ,earnings trigger volume spike in pharma etf,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.999292254447937
697942,697942,709165.0,Daratumumab Receives Breakthrough Therapy Designation in Double Refractory Multiple Myeloma from U.S. Food and Drug Administration,2013-05-01 12:08:00-04:00,JNJ,daratumumab receives breakthrough therapy designation in double refractory multiple myeloma from u s food and drug administration,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9994300007820129
697943,697943,709166.0,"First Manhattan Responds to VIVUS Board Additions, Says Board Still Needs Overhaul",2013-05-01 08:49:00-04:00,JNJ,first manhattan responds to vivus board additions says board still needs overhaul,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9996758699417114
697944,697944,709167.0,Form 8-K: J&J Holders Didn't Okay Holder Bid Related to Independent Chair,2013-04-26 16:43:00-04:00,JNJ,form 8 k j and j holders didnt okay holder bid related to independent chair,"{'neg': 0.106, 'neu': 0.894, 'pos': 0.0, 'compound': -0.1695}",neutral,0.9998568296432495
697945,697945,709168.0,"Short Sellers Move into Celgene, Regeneron",2013-04-26 13:25:00-04:00,JNJ,short sellers move into celgene regeneron,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998480081558228
697946,697946,709169.0,"Yes, This ETF Offers Dividend Growth",2013-04-25 14:00:00-04:00,JNJ,yes this etf offers dividend growth,"{'neg': 0.0, 'neu': 0.43, 'pos': 0.57, 'compound': 0.6486}",positive,0.999480664730072
697947,697947,709170.0,Johnson & Johnson Announces Dividend Increase of 8.2% to $0.66 per Share,2013-04-25 10:38:00-04:00,JNJ,johnson and johnson announces dividend increase of 8.2 percent to dollars .66 per share,"{'neg': 0.0, 'neu': 0.727, 'pos': 0.273, 'compound': 0.5423}",positive,0.9995323419570923
697948,697948,709171.0,J&J Raises Qtr. Dividend from $0.61 to $0.66/Share,2013-04-25 10:37:00-04:00,JNJ,j and j raises qtr dividend from dollars .61 to dollars,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9992120265960693
697949,697949,709172.0,Go Beyond Large-Cap ETFs For Dividends,2013-04-22 15:06:00-04:00,JNJ,go beyond large cap etfs for dividends,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999869704246521
697950,697950,709173.0,Non-Streak Dividend ETFs Impress,2013-04-19 13:56:00-04:00,JNJ,non streak dividend etfs impress,"{'neg': 0.0, 'neu': 0.58, 'pos': 0.42, 'compound': 0.4404}",positive,0.9989559650421143
697951,697951,709174.0,"UPDATE: Jefferies Raises PT on Johnson & Johnson on Unimpressive Q1'13 Earnings, But Strong Sentiment",2013-04-19 10:13:00-04:00,JNJ,update jefferies raises point on johnson and johnson on unimpressive first quarter 13 earnings but strong sentiment,"{'neg': 0.08, 'neu': 0.709, 'pos': 0.21, 'compound': 0.5789}",positive,0.9994722008705139
697952,697952,709175.0,"Jefferies Maintains Hold on Johnson & Johnson, Raises PT to $90.00",2013-04-19 07:38:00-04:00,JNJ,jefferies maintains hold on johnson and johnson raises point to dollars 0.00,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9988793730735779
697953,697953,709176.0,iShares Bolsters Factor ETF Lineup With 5 New Funds,2013-04-18 14:03:00-04:00,JNJ,ishares bolsters factor etf lineup with 5 new funds,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9886553287506104
697954,697954,709177.0,"UPDATE: J&J's Janssen to Get $11.25 Per Elan Share, to Record Gain ~$213M in Q2 from Sale",2013-04-18 09:55:00-04:00,JNJ,update j and js janssen to get dollars 1.25 per elan share to record gain dollars 13 million in second quarter from sale,"{'neg': 0.0, 'neu': 0.789, 'pos': 0.211, 'compound': 0.6808}",positive,0.999174177646637
697955,697955,709178.0,J&J Reports Sale of 82M Elan ADS Held by Janssen Pharma,2013-04-18 09:51:00-04:00,JNJ,j and j reports sale of 82 million elan ads held by janssen pharma,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998875856399536
697956,697956,709179.0,Fitch Affirms J&J IDRs at AAA/F1+; Outlook Stable,2013-04-17 09:53:00-04:00,JNJ,fitch affirms j and j idrs at aaa and f1 outlook stable,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.296}",positive,0.9965280890464783
697957,697957,709180.0,"Benzinga Market Primer: Wednesday, April 17",2013-04-17 06:45:00-04:00,JNJ,benzinga market primer wednesday april 17,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998759031295776
697958,697958,709181.0,Johnson & Johnson Rises on Healthy Earnings,2013-04-16 10:17:00-04:00,JNJ,johnson and johnson rises on healthy earnings,"{'neg': 0.0, 'neu': 0.69, 'pos': 0.31, 'compound': 0.4019}",positive,0.9996795654296875
697959,697959,709182.0,UPDATE: Johnson & Johnson Posts Drop In Q1 Profit,2013-04-16 09:30:00-04:00,JNJ,update johnson and johnson posts drop in first quarter profit,"{'neg': 0.162, 'neu': 0.615, 'pos': 0.223, 'compound': 0.2023}",negative,0.9987240433692932
697960,697960,709183.0,From J&J Call: Sees FY13 Sales $70.4B-71.1B vs $71.1B Est,2013-04-16 09:06:00-04:00,JNJ,from j and j call sees fy13 sales dollars 0.4 billion 71.1 billion vs dollars 1.1 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998742341995239
697961,697961,709184.0,Johnson & Johnson Reports Q1 EPS of $1.44 vs $1.40 Est; Revenue of $17.50B vs $17.46B Est,2013-04-16 07:45:00-04:00,JNJ,johnson and johnson reports first quarter eps of dollars .44 vs dollars .40 est revenue of dollars 7.50 billion vs dollars 7.46 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998830556869507
697962,697962,709185.0,"Benzinga Market Primer: Tuesday, April 16",2013-04-16 06:31:00-04:00,JNJ,benzinga market primer tuesday april 16,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999875545501709
697963,697963,709186.0,US Stock Futures Signal Higher Start On Wall Street,2013-04-16 06:18:00-04:00,JNJ,us stock futures signal higher start on wall street,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9995519518852234
697964,697964,709187.0,"Earnings Scheduled For April 16, 2013",2013-04-16 04:13:00-04:00,JNJ,earnings scheduled for april 16 2013,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999882698059082
697965,697965,709188.0,"Stocks To Watch For April 16, 2013",2013-04-16 03:36:00-04:00,JNJ,stocks to watch for april 16 2013,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998809099197388
697966,697966,709189.0,Lawyer Says J&J Jury Should Award $5M for Defective Hip,2013-04-15 15:13:00-04:00,JNJ,lawyer says j and j jury should award dollars m for defective hip,"{'neg': 0.167, 'neu': 0.632, 'pos': 0.201, 'compound': 0.1531}",neutral,0.9961044788360596
697967,697967,709190.0,Earnings Expectations for the Week of April 15,2013-04-14 19:58:00-04:00,JNJ,earnings expectations for the week of april 15,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998452663421631
697968,697968,709191.0,A Look Ahead: This Week's ETFs to Watch ,2013-04-14 19:52:00-04:00,JNJ,a look ahead this weeks etfs to watch,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998588562011719
697969,697969,709192.0,Weekly Preview: Earnings Season Kicks Into High Gear,2013-04-12 16:24:00-04:00,JNJ,weekly preview earnings season kicks into high gear,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.8847739100456238
697970,697970,709193.0,"Deutsche Bank Maintains Buy on Johnson & Johnson, Raises PT to $87.00",2013-04-12 07:28:00-04:00,JNJ,deutsche bank maintains buy on johnson and johnson raises point to dollars 7.00,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9994972944259644
697971,697971,709194.0,ETF Showdown: A Pharma Fight,2013-04-11 16:21:00-04:00,JNJ,etf showdown a pharma fight,"{'neg': 0.394, 'neu': 0.606, 'pos': 0.0, 'compound': -0.3818}",neutral,0.9997988343238831
697972,697972,709195.0,S&P Bullish on an Array of Dividend ETFs,2013-04-11 12:41:00-04:00,JNJ,SP500 bullish on an array of dividend etfs,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9992861151695251
697973,697973,709196.0,"Short Sellers Move Out of Amgen, Celgene, Pharmacyclics",2013-04-10 13:30:00-04:00,JNJ,short sellers move out of amgen celgene pharmacyclics,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997356534004211
697974,697974,709197.0,UPDATE: Jefferies Raises PT on Johnson & Johnson on Attractive Valuation,2013-04-10 12:11:00-04:00,JNJ,update jefferies raises point on johnson and johnson on attractive valuation,"{'neg': 0.0, 'neu': 0.775, 'pos': 0.225, 'compound': 0.4404}",positive,0.9993917942047119
697975,697975,709198.0,"Jefferies Maintains Hold on Johnson & Johnson, Raises PT to $85.00",2013-04-10 08:04:00-04:00,JNJ,jefferies maintains hold on johnson and johnson raises point to dollars 5.00,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.996894121170044
697976,697976,709199.0,Johnson & Johnson Receives Positive Mad Money/Jim Cramer Mention -CNBC,2013-04-08 19:15:00-04:00,JNJ,johnson and johnson receives positive mad money and jim cramer mention cnbc,"{'neg': 0.19, 'neu': 0.595, 'pos': 0.214, 'compound': 0.1027}",positive,0.9995689988136292
697977,697977,709200.0,"JNJ Finds Support AT 20 EMA $80.29, MACD Forming a Bearish Cross, RSI Retreats Out Of Overbought Territory",2013-04-08 12:38:00-04:00,JNJ,jnj finds support at 20 ema dollars 0.29 macd forming a bearish cross rsi retreats out of overbought territory,"{'neg': 0.0, 'neu': 0.87, 'pos': 0.13, 'compound': 0.4019}",neutral,0.9255329966545105
697978,697978,709201.0,Benzinga's Top Pre-Market Losers,2013-04-08 08:50:00-04:00,JNJ,benzingas top pre market losers,"{'neg': 0.415, 'neu': 0.366, 'pos': 0.22, 'compound': -0.3818}",neutral,0.996982753276825
697979,697979,709202.0,UPDATE: J.P. Morgan Downgrades Johnson & Johnson to Neutral on Trading Premium,2013-04-08 08:24:00-04:00,JNJ,update j p morgan downgrades johnson and johnson to neutral on trading premium,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9983423948287964
697980,697980,709203.0,"JP Morgan Downgrades Johnson & Johnson to Neutral, Raises PT to $83.00",2013-04-08 06:06:00-04:00,JNJ,jp morgan downgrades johnson and johnson to neutral raises point to dollars 3.00,"{'neg': 0.0, 'neu': 0.87, 'pos': 0.13, 'compound': 0.2023}",negative,0.9818593859672546
697981,697981,709204.0,Earnings Expectations for the Week of April 8,2013-04-07 14:25:00-04:00,JNJ,earnings expectations for the week of april 8,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998403787612915
697982,697982,709205.0,"Four Dow Components Due for a Dividend Hike (CVX, XOM, IBM, JNJ)",2013-04-04 12:41:00-04:00,JNJ,four dow components due for a dividend hike cvx xom ibm jnj,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998525381088257
697983,697983,709206.0,"J&J Wins Reversal of $482M Patent Verdict Over Stents, Judge SAys J&J Didnt' Infringe Doctor's Patent",2013-04-04 11:07:00-04:00,JNJ,j and j wins reversal of dollars 82 million patent verdict over stents judge says j and j didnt infringe doctors patent,"{'neg': 0.0, 'neu': 0.791, 'pos': 0.209, 'compound': 0.6486}",positive,0.9980260133743286
697984,697984,709207.0,FDA Approves J&J's Invokana Tablets for Adults with Type 2 Diabetes,2013-03-29 15:23:00-04:00,JNJ,fda approves j and js invokana tablets for adults with type 2 diabetes,"{'neg': 0.0, 'neu': 0.816, 'pos': 0.184, 'compound': 0.4019}",neutral,0.9998026490211487
697985,697985,709208.0,"Short Sellers Dump Amgen, Focus on Celgene, Gilead Sciences",2013-03-28 08:18:00-04:00,JNJ,short sellers dump amgen focus on celgene gilead sciences,"{'neg': 0.245, 'neu': 0.755, 'pos': 0.0, 'compound': -0.3818}",neutral,0.9998831748962402
697986,697986,709209.0,Embrace These 2 Mega-Cap ETFs,2013-03-26 17:19:00-04:00,JNJ,embrace these 2 mega cap etfs,"{'neg': 0.0, 'neu': 0.685, 'pos': 0.315, 'compound': 0.3182}",neutral,0.9998600482940674
697987,697987,709210.0,13 Drugs Pending FDA Approval in 2013,2013-03-26 13:19:00-04:00,JNJ,13 drugs pending fda approval in 2013,"{'neg': 0.0, 'neu': 0.659, 'pos': 0.341, 'compound': 0.4767}",neutral,0.9998776912689209
697988,697988,709211.0,Risk On Rally? These ETFs Say No,2013-03-26 11:37:00-04:00,JNJ,risk on rally these etfs say no,"{'neg': 0.462, 'neu': 0.538, 'pos': 0.0, 'compound': -0.5106}",neutral,0.9995473027229309
697989,697989,709212.0,"UBS Maintains Buy on Johnson & Johnson, Raises PT to $87.00",2013-03-26 09:38:00-04:00,JNJ,ubs maintains buy on johnson and johnson raises point to dollars 7.00,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9990843534469604
697990,697990,709213.0,What Type of Dividend ETFs Are Winning in 2013?,2013-03-25 13:49:00-04:00,JNJ,what type of dividend etfs are winning in 2013,"{'neg': 0.0, 'neu': 0.702, 'pos': 0.298, 'compound': 0.5267}",neutral,0.99858558177948
697991,697991,709214.0,LifeScan Announces Voluntary Recall of All OneTouch Verio IQ Blood Glucose Meters,2013-03-25 08:49:00-04:00,JNJ,lifescan announces voluntary recall of all onetouch verio iq blood glucose meters,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997522234916687
697992,697992,709215.0,Johnson & Johnson's Quest to Knock Botox off the Pedestal ,2013-03-22 14:51:00-04:00,JNJ,johnson and johnsons quest to knock botox off the pedestal,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9996250867843628
697993,697993,709216.0,S&P Likes a Pair of Low Vol ETFs,2013-03-19 13:44:00-04:00,JNJ,SP500 likes a pair of low volume etfs,"{'neg': 0.193, 'neu': 0.55, 'pos': 0.257, 'compound': 0.1779}",neutral,0.9998667240142822
697994,697994,709217.0,PowerShares Low Volatility ETF Tops $4B in AUM,2013-03-18 11:58:00-04:00,JNJ,powershares low volatility etf tops dollars b in aum,"{'neg': 0.169, 'neu': 0.565, 'pos': 0.266, 'compound': 0.296}",positive,0.9730571508407593
697995,697995,709218.0,"Short Interest Swings in Biotech Stocks (AMGN, CELG, PCYC)",2013-03-12 13:19:00-04:00,JNJ,short interest swings in biotech stocks amgn celg pcyc,"{'neg': 0.0, 'neu': 0.727, 'pos': 0.273, 'compound': 0.4588}",negative,0.8788819313049316
697996,697996,709219.0,"J&J's Cordis Buys Flexible Stenting Solutions, No Terms Disclosed",2013-03-12 09:12:00-04:00,JNJ,j and js cordis buys flexible stenting solutions no terms disclosed,"{'neg': 0.159, 'neu': 0.58, 'pos': 0.261, 'compound': 0.1027}",neutral,0.9998801946640015
697997,697997,709220.0,Are Scientists Edging Closer to a Cure for Alzheimer's?,2013-03-11 08:58:00-04:00,JNJ,are scientists edging closer to a cure for alzheimers,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9147303700447083
697998,697998,709221.0,UPDATE: J&J Did Not Fail to Warn But Must Pay $8.3M in Damages in Hip Case,2013-03-08 12:49:00-05:00,JNJ,update j and j did not fail to warn but must pay dollars .3 million in damages in hip case,"{'neg': 0.222, 'neu': 0.652, 'pos': 0.125, 'compound': -0.5231}",neutral,0.9752489924430847
697999,697999,709222.0,California Jury Finds J&J Defectively Designed ASR Hip Device,2013-03-08 12:45:00-05:00,JNJ,california jury finds j and j defectively designed asr hip device,"{'neg': 0.237, 'neu': 0.763, 'pos': 0.0, 'compound': -0.4767}",neutral,0.9989097118377686
698000,698000,709223.0,"J&J Hip Implant Jury Has Reached Verdict in Montana Case, to Read Verdict at 9:30AM PST",2013-03-08 12:23:00-05:00,JNJ,j and j hip implant jury has reached verdict in montana case to read verdict at pst,"{'neg': 0.0, 'neu': 0.753, 'pos': 0.247, 'compound': 0.3818}",neutral,0.9985527396202087
698001,698001,709224.0,J&J's Janssen Launches EXPLORER Research Program,2013-03-08 07:33:00-05:00,JNJ,j and js janssen launches explorer research program,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998666048049927
698002,698002,709225.0,3 Sector ETFs Outpacing Larger Rivals,2013-03-06 13:39:00-05:00,JNJ,3 sector etfs outpacing larger rivals,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9982808828353882
698003,698003,709226.0,3 International Dividend ETFs Your Broker Forgot to Mention,2013-03-06 12:45:00-05:00,JNJ,3 international dividend etfs your broker forgot to mention,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998906850814819
698004,698004,709227.0,Hedging The Dow At Its All-Time High,2013-03-06 08:29:00-05:00,JNJ,hedging the dow at its all time high,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.8422382473945618
698005,698005,709228.0,An HIV Cure Is Great News For These Drug Manufacturers,2013-03-04 15:22:00-05:00,JNJ,an hiv cure is great news for these drug manufacturers,"{'neg': 0.0, 'neu': 0.687, 'pos': 0.313, 'compound': 0.6249}",positive,0.9993938207626343
698006,698006,709229.0,"If The Market Falls, Try These Low Beta ETFs",2013-02-28 18:27:00-05:00,JNJ,if the market falls try these low beta etfs,"{'neg': 0.208, 'neu': 0.792, 'pos': 0.0, 'compound': -0.2732}",negative,0.9038760662078857
698007,698007,709230.0,"Short Interest Swings in Biotech Stocks (ALXN, AMGN, CELG)",2013-02-28 15:13:00-05:00,JNJ,short interest swings in biotech stocks alxn amgn celg,"{'neg': 0.0, 'neu': 0.727, 'pos': 0.273, 'compound': 0.4588}",negative,0.8842850923538208
698008,698008,709231.0,J&J Jury Reaches Verdict on Punitive Win in First Mesh Trial,2013-02-28 11:35:00-05:00,JNJ,j and j jury reaches verdict on punitive win in first mesh trial,"{'neg': 0.175, 'neu': 0.476, 'pos': 0.349, 'compound': 0.3182}",positive,0.9405998587608337
698009,698009,709232.0,J&J Trial Expert Says Infection -- Not Defect -- Lead to Hip Failure,2013-02-26 17:10:00-05:00,JNJ,j and j trial expert says infection not defect lead to hip failure,"{'neg': 0.202, 'neu': 0.673, 'pos': 0.125, 'compound': -0.3103}",negative,0.7834745049476624
698010,698010,709233.0,Bloomberg Reporting J&J Looking to Avoid Punitive Damages After Losing Mesh Trial Verdict,2013-02-26 12:36:00-05:00,JNJ,bloomberg reporting j and j looking to avoid punitive damages after losing mesh trial verdict,"{'neg': 0.487, 'neu': 0.442, 'pos': 0.071, 'compound': -0.8555}",positive,0.9803085327148438
698011,698011,709234.0,Bloomberg Reporting J&J Judge Rules Jury Can Weigh Punitive Damages in Mesh Case,2013-02-25 15:22:00-05:00,JNJ,bloomberg reporting j and j judge rules jury can weigh punitive damages in mesh case,"{'neg': 0.323, 'neu': 0.677, 'pos': 0.0, 'compound': -0.7351}",neutral,0.999618411064148
698012,698012,709235.0,J&J Ordered to Pay $3.35M to South Dakota Nurse,2013-02-25 11:04:00-05:00,JNJ,j and j ordered to pay dollars .35 million to south dakota nurse,"{'neg': 0.104, 'neu': 0.896, 'pos': 0.0, 'compound': -0.1027}",neutral,0.999790608882904
698013,698013,709236.0,NJ Jury Says J&J Failed to Warn of Vaginal Mesh Risks,2013-02-25 11:01:00-05:00,JNJ,nj jury says j and j failed to warn of vaginal mesh risks,"{'neg': 0.405, 'neu': 0.595, 'pos': 0.0, 'compound': -0.7003}",negative,0.9498945474624634
698014,698014,709237.0,Hearing Jury in J&J's New Jersey Case Has Verdict in First Vaginal Mesh Case,2013-02-25 10:59:00-05:00,JNJ,hearing jury in j and js new jersey case has verdict in first vaginal mesh case,"{'neg': 0.0, 'neu': 0.904, 'pos': 0.096, 'compound': 0.1531}",neutral,0.9977622032165527
698015,698015,709238.0,"J&J Comments on Venezuelan Currency Devaluation, Sees $0.04/Share Charge in Q4, Reaffirms FY EPS Outlook",2013-02-25 07:47:00-05:00,JNJ,j and j comments on venezuelan currency devaluation sees dollars . charge in fourth quarter reaffirms fy eps outlook,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9993917942047119
698016,698016,709239.0,"J&J Discloses Government Investigations Related to False Claims Related to Hips, Surgical Mesh - Bloomberg",2013-02-22 07:52:00-05:00,JNJ,j and j discloses government investigations related to false claims related to hips surgical mesh to bloomberg,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998751878738403
698017,698017,709240.0,Under The Hood: A New Dividend ETF Diva,2013-02-19 17:33:00-05:00,JNJ,under the hood a new dividend etf diva,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998868703842163
698018,698018,709241.0,Investment Style Rankings For ETFs & Mutual Funds,2013-02-19 14:12:00-05:00,JNJ,investment style rankings for etfs and mutual funds,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998879432678223
698019,698019,709242.0,"Berkshire Adds Archer-Daniels, Verisign; Boosts GM Stake",2013-02-14 17:23:00-05:00,JNJ,berkshire adds archer daniels verisign boosts gm stake,"{'neg': 0.0, 'neu': 0.753, 'pos': 0.247, 'compound': 0.3182}",positive,0.9996209144592285
698020,698020,709243.0,AP Reporting J&J Unit DePuy Orthopaedics Recalling 'Thousands' of Adept Hip Implants ,2013-02-14 13:54:00-05:00,JNJ,ap reporting j and j unit depuy orthopaedics recalling thousands of adept hip implants,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997931122779846
698021,698021,709244.0,"Short Interest Swings in Biotech Stocks (AMGN, CELG, ONXX)",2013-02-12 13:29:00-05:00,JNJ,short interest swings in biotech stocks amgn celg onxx,"{'neg': 0.0, 'neu': 0.727, 'pos': 0.273, 'compound': 0.4588}",neutral,0.864847719669342
698022,698022,709245.0,UPDATE: Credit Suisse Downgrades Johnson & Johnson to Underperform on Valuation,2013-02-07 10:39:00-05:00,JNJ,update credit suisse downgrades johnson and johnson to underperform on valuation,"{'neg': 0.0, 'neu': 0.794, 'pos': 0.206, 'compound': 0.3818}",negative,0.9983968138694763
698023,698023,709246.0,"Credit Suisse Downgrades Johnson & Johnson to Underperform, Raises PT to $73.00",2013-02-07 08:14:00-05:00,JNJ,credit suisse downgrades johnson and johnson to underperform raises point to dollars 3.00,"{'neg': 0.0, 'neu': 0.822, 'pos': 0.178, 'compound': 0.3818}",negative,0.9976040720939636
698024,698024,709247.0,Johnson & Johnson Breaks Out Over $75 Resistance,2013-02-06 17:04:00-05:00,JNJ,johnson and johnson breaks out over dollars 5 resistance,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999833345413208
698025,698025,709248.0,Buying What Buffett Sells? Sometimes it Works,2013-02-03 16:19:00-05:00,JNJ,buying what buffett sells sometimes it works,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998480081558228
698026,698026,709249.0,2 Attractively Valued Blue Chips,2013-01-27 19:19:00-05:00,JNJ,2 attractively valued blue chips,"{'neg': 0.0, 'neu': 0.33, 'pos': 0.67, 'compound': 0.7269}",neutral,0.9991461038589478
698027,698027,709250.0,"Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)",2013-01-26 12:17:00-05:00,JNJ,short interest swings in biotech stocks biib celg vvus,"{'neg': 0.0, 'neu': 0.727, 'pos': 0.273, 'compound': 0.4588}",negative,0.9728958606719971
698028,698028,709251.0,California Jury Finds J&J Failed to Warn of Hip Implant's Risks,2013-01-25 12:42:00-05:00,JNJ,california jury finds j and j failed to warn of hip implants risks,"{'neg': 0.405, 'neu': 0.595, 'pos': 0.0, 'compound': -0.7003}",negative,0.9800832271575928
698029,698029,709252.0,J&J Sees FY13 Sales $70.9-71.6B vs $72B Est,2013-01-22 09:56:00-05:00,JNJ,j and j sees fy13 sales dollars 0.9 to 71.6 billion vs dollars 2 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998527765274048
698030,698030,709253.0,From J&J's Qtr. Conference Call: Will Explore Options for Ortho Clinical Diagnostics Unit,2013-01-22 09:27:00-05:00,JNJ,from j and js qtr conference call will explore options for ortho clinical diagnostics unit,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998688697814941
698031,698031,709254.0,UPDATE: Johnson & Johnson Posts Higher Q4 Profit,2013-01-22 08:01:00-05:00,JNJ,update johnson and johnson posts higher fourth quarter profit,"{'neg': 0.0, 'neu': 0.734, 'pos': 0.266, 'compound': 0.4404}",positive,0.9996933937072754
698032,698032,709255.0,"J&J Reports Velcade Sales $502M, Remicade Sales $1.504B, Prezista Sales $353M",2013-01-22 07:49:00-05:00,JNJ,j and j reports velcade sales dollars 02 million remicade sales dollars .504 billion prezista sales dollars 53 million,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998824596405029
698033,698033,709256.0,Johnson & Johnson Sees FY2013 EPS $5.35-5.45 vs $5.49 Est,2013-01-22 07:47:00-05:00,JNJ,johnson and johnson sees fy2013 eps dollars .35 to 5.45 vs dollars .49 est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998542070388794
698034,698034,709257.0,Johnson & Johnson Reports Q4 EPS of $1.19 vs $1.17 Est; Revenue of $17.60B vs $17.67B Est,2013-01-22 07:46:00-05:00,JNJ,johnson and johnson reports fourth quarter eps of dollars .19 vs dollars .17 est revenue of dollars 7.60 billion vs dollars 7.67 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998818635940552
698035,698035,709258.0,"Benzinga Market Primer: Tuesday, January 22",2013-01-22 06:30:00-05:00,JNJ,benzinga market primer tuesday january 22,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998766183853149
698036,698036,709259.0,"US Stock Futures Flat Ahead Of Economic Data, Earnings",2013-01-22 05:53:00-05:00,JNJ,us stock futures flat ahead of economic data earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9932445883750916
698037,698037,709260.0,"Earnings Scheduled For January 22, 2013",2013-01-22 01:25:00-05:00,JNJ,earnings scheduled for january 22 2013,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998794794082642
698038,698038,709261.0,"Stocks To Watch For January 22, 2013",2013-01-22 01:05:00-05:00,JNJ,stocks to watch for january 22 2013,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998742341995239
698039,698039,709262.0,Earnings Expectations for the Week of January 21,2013-01-20 13:14:00-05:00,JNJ,earnings expectations for the week of january 21,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998534917831421
698040,698040,709263.0,The Week Ahead: Tech Earnings in Focus,2013-01-18 17:17:00-05:00,JNJ,the week ahead tech earnings in focus,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998296499252319
698041,698041,709264.0,S&P Highlights 1 ETF For Lengthy Streaks of Dividend Increases,2013-01-18 15:37:00-05:00,JNJ,SP500 highlights 1 etf for lengthy streaks of dividend increases,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.5774253010749817
698042,698042,709265.0,J&J Said to Have Offered to Pay More Than $200K per Hip Case; May Total $2B -Bloomberg,2013-01-18 14:14:00-05:00,JNJ,j and j said to have offered to pay more than dollars 00 thousand per hip case may total dollars b bloomberg,"{'neg': 0.062, 'neu': 0.938, 'pos': 0.0, 'compound': -0.1027}",neutral,0.9998551607131958
698043,698043,709266.0,"UPDATE: Jefferies & Company Reiterates Hold Rating, Raises PT on Johnson & Johnson",2013-01-16 09:31:00-05:00,JNJ,update jefferies and company reiterates hold rating raises point on johnson and johnson,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.999439537525177
698044,698044,709267.0,"Jefferies Maintains Hold on Johnson & Johnson, Raises PT to $79.00",2013-01-16 08:52:00-05:00,JNJ,jefferies maintains hold on johnson and johnson raises point to dollars 9.00,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9964665174484253
698045,698045,709268.0,J&J's Janssen-Cilag Drug Zytiga Approved in EU for Use in Treatment of Metastatic Cancer,2013-01-11 10:38:00-05:00,JNJ,j and js janssen cilag drug zytiga approved in eu for use in treatment of metastatic cancer,"{'neg': 0.198, 'neu': 0.676, 'pos': 0.126, 'compound': -0.3818}",neutral,0.9997454285621643
698046,698046,709269.0,"UBS Maintains Buy on Johnson & Johnson, Raises PT to $78.00",2013-01-11 10:34:00-05:00,JNJ,ubs maintains buy on johnson and johnson raises point to dollars 8.00,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9990420937538147
698047,698047,709270.0,FDA Panel Backs J&J's New Type of Diabetes Drug,2013-01-10 16:20:00-05:00,JNJ,fda panel backs j and js new type of diabetes drug,"{'neg': 0.107, 'neu': 0.893, 'pos': 0.0, 'compound': -0.0516}",neutral,0.9998788833618164
698048,698048,709271.0,FDA Panel Votes 8-7 J&J's Canagliflozin Has Heart Concerns,2013-01-10 15:59:00-05:00,JNJ,fda panel votes 8 to 7 j and js canagliflozin has heart concerns,"{'neg': 0.0, 'neu': 0.741, 'pos': 0.259, 'compound': 0.6369}",neutral,0.9960312247276306
698049,698049,709272.0,FDA Posts Briefing Documents for J&J's Canagliflozin,2013-01-08 08:00:00-05:00,JNJ,fda posts briefing documents for j and js canagliflozin,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998856782913208
698050,698050,709273.0,4 Health Care ETFs Your Broker Forgot to Mention,2013-01-07 15:52:00-05:00,JNJ,4 health care etfs your broker forgot to mention,"{'neg': 0.0, 'neu': 0.714, 'pos': 0.286, 'compound': 0.4939}",neutral,0.9998798370361328
698051,698051,709274.0,Sanofi Buys OTC Antacid Rolaids from J&J's McNeil-PPC,2013-01-07 08:08:00-05:00,JNJ,sanofi buys otc antacid rolaids from j and js mcneil ppc,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998664855957031
698052,698052,709275.0,A Look Ahead: This Week's ETFs to Watch,2013-01-07 07:17:00-05:00,JNJ,a look ahead this weeks etfs to watch,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998588562011719
698053,698053,709276.0,UPDATE: Deutsche Bank Upgrades Johnson & Johnson to Buy on Improving Trends  ,2013-01-04 08:34:00-05:00,JNJ,update deutsche bank upgrades johnson and johnson to buy on improving trends,"{'neg': 0.0, 'neu': 0.797, 'pos': 0.203, 'compound': 0.4215}",positive,0.9996471405029297
698054,698054,709277.0,A Peek Into The Market Before The Trading Starts,2013-01-04 07:23:00-05:00,JNJ,a peek into the market before the trading starts,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998680353164673
698055,698055,709278.0,Benzinga's Top Upgrades,2013-01-04 07:18:00-05:00,JNJ,benzingas top upgrades,"{'neg': 0.0, 'neu': 0.526, 'pos': 0.474, 'compound': 0.2023}",positive,0.7773524522781372
698056,698056,709279.0,"Deutsche Bank Upgrades Johnson & Johnson to Buy, Raises PT to $82.00",2013-01-04 07:04:00-05:00,JNJ,deutsche bank upgrades johnson and johnson to buy raises point to dollars 2.00,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.99937903881073
698057,698057,709280.0,"Merck, Pfizer, Abbott, J&J, Sanofi Said to Show Interest in Bausch & Lomb Bid - Bloomberg",2013-01-03 16:00:00-05:00,JNJ,merck pfizer abbott j and j sanofi said to show interest in bausch and lomb bid to bloomberg,"{'neg': 0.0, 'neu': 0.85, 'pos': 0.15, 'compound': 0.4588}",positive,0.9992297887802124
698058,698058,709281.0,J&J Declares $0.61/Share Q1 Dividend,2013-01-02 09:27:00-05:00,JNJ,j and j declares dollars . first quarter dividend,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998900890350342
698059,698059,709282.0,US Stock Futures Higher On Fiscal-Cliff Deal,2013-01-02 07:13:00-05:00,JNJ,us stock futures higher on fiscal cliff deal,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9994753003120422
698060,698060,709283.0,"Stocks To Watch For January 2, 2013",2013-01-02 01:44:00-05:00,JNJ,stocks to watch for january 2 2013,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998719692230225
698061,698061,709284.0,"Short Interest Swings in Biotech Stocks (CELG, GILD, REGN)",2012-12-28 11:10:00-05:00,JNJ,short interest swings in biotech stocks celg gild regn,"{'neg': 0.0, 'neu': 0.727, 'pos': 0.273, 'compound': 0.4588}",negative,0.8715499639511108
698062,698062,709285.0,A Growth ETF for 2013 ,2012-12-26 07:48:00-05:00,JNJ,a growth etf for 2013,"{'neg': 0.0, 'neu': 0.606, 'pos': 0.394, 'compound': 0.3818}",neutral,0.9986754059791565
698063,698063,709286.0,J&J to Host Analyst Meeting at 8:30AM EST on Jan. 22nd,2012-12-21 08:11:00-05:00,JNJ,j and j to host analyst meeting at est on jan 22,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998846054077148
698064,698064,709287.0,How To Avoid the Worst Sector ETFs,2012-12-19 16:06:00-05:00,JNJ,how to avoid the worst sector etfs,"{'neg': 0.558, 'neu': 0.442, 'pos': 0.0, 'compound': -0.743}",neutral,0.9998160004615784
698065,698065,709288.0,S&P Sees Better 2013 For Health Insurance Providers,2012-12-19 07:19:00-05:00,JNJ,SP500 sees better 2013 for health insurance providers,"{'neg': 0.0, 'neu': 0.707, 'pos': 0.293, 'compound': 0.4404}",positive,0.9996516704559326
698066,698066,709289.0,These 2 Dow Laggards Could Rebound in 2013,2012-12-16 13:41:00-05:00,JNJ,these 2 dow laggards could rebound in 2013,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9995577931404114
698067,698067,709290.0,Barron's Recap (12/15/12): Outlook for 2013,2012-12-15 13:47:00-05:00,JNJ,barrons recap outlook for 2013,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998730421066284
698068,698068,709291.0,"Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)",2012-12-12 12:57:00-05:00,JNJ,short interest swings in biotech stocks biib celg vvus,"{'neg': 0.0, 'neu': 0.727, 'pos': 0.273, 'compound': 0.4588}",negative,0.9728958606719971
698069,698069,709292.0,J&J's Janssen R&D Submits NDA for Canagliflozin/Metformin Fixed-Dose Combo Therapy,2012-12-12 09:05:00-05:00,JNJ,j and js janssen r and d submits nda for canagliflozin and metformin fixed dose combo therapy,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998652935028076
698070,698070,709293.0,FDA Expands J&J's Zytiga's Use for Late-Stage Prostate Cancer,2012-12-10 13:16:00-05:00,JNJ,fda expands j and js zytigas use for late stage prostate cancer,"{'neg': 0.278, 'neu': 0.633, 'pos': 0.089, 'compound': -0.6124}",neutral,0.5581244230270386
698071,698071,709294.0,Davenport Upgrades Johnson & Johnson to Buy,2012-12-10 11:12:00-05:00,JNJ,davenport upgrades johnson and johnson to buy,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.8746705055236816
698072,698072,709295.0,"A Look at Fortune's Health Care Picks for 2013 (ALGN, FMS, GILD)",2012-12-08 23:17:00-05:00,JNJ,a look at fortunes health care picks for 2013 algn fms gild,"{'neg': 0.0, 'neu': 0.775, 'pos': 0.225, 'compound': 0.4939}",neutral,0.9998607635498047
698073,698073,709296.0,J&J's EVARREST Fibrin Sealant Patch Approved by FDA,2012-12-07 08:17:00-05:00,JNJ,j and js evarrest fibrin sealant patch approved by fda,"{'neg': 0.0, 'neu': 0.763, 'pos': 0.237, 'compound': 0.4215}",neutral,0.9993979930877686
698074,698074,709297.0,"J&J's Janssen Submits Applications Requesting Approval of STELARA in US, Europe",2012-12-06 08:08:00-05:00,JNJ,j and js janssen submits applications requesting approval of stelara in us europe,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.4767}",neutral,0.9997621178627014
698075,698075,709298.0,J&J Says New Long-Term Study Suggests Lower Morality in Alzheimer's Patients Treated with Galantamine vs Placebo,2012-12-05 17:32:00-05:00,JNJ,j and j says new long term study suggests lower morality in alzheimers patients treated with galantamine vs placebo,"{'neg': 0.109, 'neu': 0.891, 'pos': 0.0, 'compound': -0.296}",negative,0.9419644474983215
698076,698076,709299.0,How To Find the Best Sector ETFs,2012-12-03 16:28:00-05:00,JNJ,how to find the best sector etfs,"{'neg': 0.0, 'neu': 0.588, 'pos': 0.412, 'compound': 0.6369}",neutral,0.9998645782470703
698077,698077,709300.0,"BioMarin, Prestige Brands and Other Top Performing Health Care Stocks in November",2012-12-02 20:29:00-05:00,JNJ,biomarin prestige brands and other top performing health care stocks in november,"{'neg': 0.0, 'neu': 0.667, 'pos': 0.333, 'compound': 0.6124}",neutral,0.9998874664306641
698078,698078,709301.0,Mid-Cap Dividend Stocks For 2013,2012-12-02 20:23:00-05:00,JNJ,mid cap dividend stocks for 2013,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998939037322998
698079,698079,709302.0,J&J Wins Reversal of $1.1M Levaquin punitive Verdict,2012-11-30 11:58:00-05:00,JNJ,j and j wins reversal of dollars .1 million levaquin punitive verdict,"{'neg': 0.187, 'neu': 0.511, 'pos': 0.301, 'compound': 0.25}",positive,0.9936068058013916
698080,698080,709303.0,J&J's Bill Weldon to Retire as Chairman in Q1; Names CEO Alex Gorsky Chair,2012-11-30 08:55:00-05:00,JNJ,j and js bill weldon to retire as chairman in first quarter names ceo alex gorsky chair,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998742341995239
698081,698081,709304.0,J&J's Janssen Announces Intent Not to Enforce Patents for Darunavir,2012-11-29 09:03:00-05:00,JNJ,j and js janssen announces intent not to enforce patents for darunavir,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9995548129081726
698082,698082,709305.0,J&J Says FDA Panel Recommends Accelerated Approval of Bedaquiuline,2012-11-28 17:46:00-05:00,JNJ,j and j says fda panel recommends accelerated approval of bedaquiuline,"{'neg': 0.0, 'neu': 0.643, 'pos': 0.357, 'compound': 0.6124}",neutral,0.9840542674064636
698083,698083,709306.0,UPDATE: Stifel Nicolaus Initiates Johnson & Johnson at Hold; Fairly Valued  ,2012-11-20 12:23:00-05:00,JNJ,update stifel nicolaus initiates johnson and johnson at hold fairly valued,"{'neg': 0.0, 'neu': 0.775, 'pos': 0.225, 'compound': 0.4404}",neutral,0.9646656513214111
698084,698084,709307.0,Stifel Nicolaus Initiates Coverage on Johnson & Johnson at Hold,2012-11-20 08:27:00-05:00,JNJ,stifel nicolaus initiates coverage on johnson and johnson at hold,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998723268508911
698085,698085,709308.0,"J&J's Cordis Says INCRAFT AAA Stent-Graft System INNOVATION Study Shows Safety, Efficacy",2012-11-19 17:00:00-05:00,JNJ,j and js cordis says incraft aaa stent graft system innovation study shows safety efficacy,"{'neg': 0.0, 'neu': 0.707, 'pos': 0.293, 'compound': 0.6597}",positive,0.9989963173866272
698086,698086,709309.0,J&J's Janssen-Cilag's ZYTIGA Receives Positive EU Recommendation,2012-11-19 07:45:00-05:00,JNJ,j and js janssen cilags zytiga receives positive eu recommendation,"{'neg': 0.0, 'neu': 0.714, 'pos': 0.286, 'compound': 0.5574}",positive,0.999450147151947
698087,698087,709310.0,Mid-Cap Dividend Dynamos,2012-11-18 18:52:00-05:00,JNJ,mid cap dividend dynamos,"{'neg': 0.0, 'neu': 0.698, 'pos': 0.302, 'compound': 0.0772}",neutral,0.9998825788497925
698088,698088,709311.0,S&P Reiterates Bullish View on Health Care ETFs,2012-11-16 12:56:00-05:00,JNJ,SP500 reiterates bullish view on health care etfs,"{'neg': 0.0, 'neu': 0.686, 'pos': 0.314, 'compound': 0.4939}",positive,0.9995137453079224
698089,698089,709312.0,Berkshire Dumps Most of J&J and GE Stakes; Adds Deere & Co. ,2012-11-15 07:27:00-05:00,JNJ,berkshire dumps most of j and j and ge stakes adds deere and co,"{'neg': 0.172, 'neu': 0.828, 'pos': 0.0, 'compound': -0.4019}",neutral,0.9998687505722046
698090,698090,709313.0,"Buffett's Berkshire Hathaway Cuts Stakes in GE, Visa, J&J, Conoco",2012-11-14 16:45:00-05:00,JNJ,buffetts berkshire hathaway cuts stakes in ge visa j and j conoco,"{'neg': 0.167, 'neu': 0.833, 'pos': 0.0, 'compound': -0.296}",negative,0.9594112038612366
698091,698091,709314.0,These ETFs Offer Solid Yield in Uncertain Times,2012-11-14 08:58:00-05:00,JNJ,these etfs offer solid yield in uncertain times,"{'neg': 0.224, 'neu': 0.612, 'pos': 0.163, 'compound': -0.1531}",positive,0.999207079410553
698092,698092,709315.0,New Phase 3 Findings Show STELARA® Significantly Reduced Signs and Symptoms of Active Psoriatic Arthritis,2012-11-12 08:10:00-05:00,JNJ,new phase 3 findings show stelara® significantly reduced signs and symptoms of active psoriatic arthritis,"{'neg': 0.0, 'neu': 0.847, 'pos': 0.153, 'compound': 0.4019}",positive,0.999570906162262
698093,698093,709316.0,"UPDATE: Jefferies Downgrades Johnson & Johnson to Hold, Lowers PT",2012-11-12 07:33:00-05:00,JNJ,update jefferies downgrades johnson and johnson to hold lowers point,"{'neg': 0.143, 'neu': 0.857, 'pos': 0.0, 'compound': -0.128}",negative,0.9985509514808655
698094,698094,709317.0,Benzinga's Top Downgrades,2012-11-12 07:25:00-05:00,JNJ,benzingas top downgrades,"{'neg': 0.0, 'neu': 0.526, 'pos': 0.474, 'compound': 0.2023}",negative,0.9905633926391602
698095,698095,709318.0,"Jefferies & Company Downgrades Johnson & Johnson from Buy to Hold, Lowers PT from $78 to $75",2012-11-12 06:10:00-05:00,JNJ,jefferies and company downgrades johnson and johnson from buy to hold lowers point from dollars 8 to dollars 5,"{'neg': 0.077, 'neu': 0.923, 'pos': 0.0, 'compound': -0.128}",negative,0.9983048439025879
698096,698096,709319.0,SMART Vascular Stent Systems Gets FDA Approval,2012-11-08 17:55:00-05:00,JNJ,smart vascular stent systems gets fda approval,"{'neg': 0.0, 'neu': 0.463, 'pos': 0.537, 'compound': 0.7003}",positive,0.9983021020889282
698097,698097,709320.0,Mylan Announces Settlement with Janssen Related to Ortho Tri-Cyclen Lo,2012-11-08 15:31:00-05:00,JNJ,mylan announces settlement with janssen related to ortho tri cyclen lo,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.864190399646759
698098,698098,709321.0,More Pain Awaits Medical Device ETFs,2012-11-07 13:55:00-05:00,JNJ,more pain awaits medical device etfs,"{'neg': 0.392, 'neu': 0.436, 'pos': 0.172, 'compound': -0.4615}",neutral,0.8228002190589905
698099,698099,709322.0,J&J Settles Suits Related to Levaquin and Tendon Injuries -Bloomberg,2012-11-01 13:34:00-04:00,JNJ,j and j settles suits related to levaquin and tendon injuries bloomberg,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998459815979004
698100,698100,709323.0,"Vertex, JNJ's Janssen Enter Agreement for Phase 2 Hepatitis C Study",2012-11-01 07:39:00-04:00,JNJ,vertex jnjs janssen enter agreement for phase 2 hepatitis c study,"{'neg': 0.0, 'neu': 0.758, 'pos': 0.242, 'compound': 0.4939}",neutral,0.9223790764808655
698101,698101,709324.0,More Equal-Weight ETFs Your Broker Forgot to Mention ,2012-10-30 15:01:00-04:00,JNJ,more equal weight etfs your broker forgot to mention,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998846054077148
698102,698102,709325.0,Johnson & Johnson Postpones November 1 Medical Devices & Diagnostics Review ,2012-10-30 10:46:00-04:00,JNJ,johnson and johnson postpones november 1 medical devices and diagnostics review,"{'neg': 0.174, 'neu': 0.826, 'pos': 0.0, 'compound': -0.2732}",neutral,0.9998419284820557
698103,698103,709326.0,How To Find the Best ETFs,2012-10-25 13:46:00-04:00,JNJ,how to find the best etfs,"{'neg': 0.0, 'neu': 0.543, 'pos': 0.457, 'compound': 0.6369}",neutral,0.9998537302017212
698104,698104,709327.0,Sector Rankings For ETFs  &  Mutual Funds,2012-10-24 17:44:00-04:00,JNJ,sector rankings for etfs and mutual funds,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998903274536133
698105,698105,709328.0,Rating Breakdown: Best & Worst ETFs & Mutual Funds by Sector,2012-10-24 17:44:00-04:00,JNJ,rating breakdown best and worst etfs and mutual funds by sector,"{'neg': 0.237, 'neu': 0.52, 'pos': 0.243, 'compound': 0.0258}",neutral,0.9998772144317627
698106,698106,709329.0,"Top Performing Dividend Payers in Health Care with the Most Upside Potential (TRIB, STE, CMN)",2012-10-23 17:42:00-04:00,JNJ,top performing dividend payers in health care with the most upside potential trib ste cmn,"{'neg': 0.0, 'neu': 0.722, 'pos': 0.278, 'compound': 0.6124}",positive,0.9976771473884583
698107,698107,709330.0,"Barclays Maintains Johnson & Johnson at Overweight, Raises PT from $75 to $85",2012-10-17 12:15:00-04:00,JNJ,barclays maintains johnson and johnson at overweight raises point from dollars 5 to dollars 5,"{'neg': 0.152, 'neu': 0.848, 'pos': 0.0, 'compound': -0.3612}",positive,0.9989272952079773
698108,698108,709331.0,"UPDATE: Deutsche Bank Reiterates Hold Rating, Raises PT on Johnson & Johnson",2012-10-17 10:49:00-04:00,JNJ,update deutsche bank reiterates hold rating raises point on johnson and johnson,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9986911416053772
698109,698109,709332.0,"Deutsche Bank Maintains Johnson & Johnson at Hold, Raises PT from $72 to $75",2012-10-17 06:54:00-04:00,JNJ,deutsche bank maintains johnson and johnson at hold raises point from dollars 2 to dollars 5,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9977849721908569
698110,698110,709333.0,Upbeat Earnings Reports Spark Triple Digit Gain in the Dow,2012-10-16 16:59:00-04:00,JNJ,upbeat earnings reports spark triple digit gain in the dow,"{'neg': 0.0, 'neu': 0.602, 'pos': 0.398, 'compound': 0.6486}",positive,0.9996777772903442
698111,698111,709334.0,"Johnson & Johnson Rises 1% After Topping Estimates, Raising Guidance",2012-10-16 15:01:00-04:00,JNJ,johnson and johnson rises 1 percent after topping estimates raising guidance,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9997058510780334
698112,698112,709335.0,"Johnson & Johnson Guides FY Revenue $67-67.6B, Had Seen $66.7-67.3B vs $67.22B Est",2012-10-16 09:09:00-04:00,JNJ,johnson and johnson guides fy revenue dollars 7 to 67.6 billion had seen dollars 6.7 to 67.3 billion vs dollars 7.22 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998506307601929
698113,698113,709336.0,"Johnson & Johnson Guides FY EPS $5.05-5.10, Had Seen $5.05-5.07 vs $5.08 Est",2012-10-16 07:47:00-04:00,JNJ,johnson and johnson guides fy eps dollars .05 to 5.10 had seen dollars .05 to 5.07 vs dollars .08 est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998387098312378
698114,698114,709337.0,Johnson & Johnson Reports Q3 EPS $1.25 vs $1.29 Est; Revenues $17.1B vs $16.70B Est,2012-10-16 07:46:00-04:00,JNJ,johnson and johnson reports third quarter eps dollars .25 vs dollars .29 est revenues dollars 7.1 billion vs dollars 6.70 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998817443847656
698115,698115,709338.0,"Benzinga Market Primer, Tuesday October 16",2012-10-16 06:12:00-04:00,JNJ,benzinga market primer tuesday october 16,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998793601989746
698116,698116,709339.0,"US Stock Futures Up Ahead Of Earnings, Economic Data",2012-10-16 05:53:00-04:00,JNJ,us stock futures up ahead of earnings economic data,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9986138343811035
698117,698117,709340.0,"Earnings Scheduled For October 16, 2012 ",2012-10-16 02:26:00-04:00,JNJ,earnings scheduled for october 16 2012,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998811483383179
698118,698118,709341.0,"Stocks To Watch For October 16, 2012",2012-10-16 02:09:00-04:00,JNJ,stocks to watch for october 16 2012,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998805522918701
698119,698119,709342.0,The Gores Group Extends Binding Offer to Acquire Therakos,2012-10-15 08:05:00-04:00,JNJ,the gores group extends binding offer to acquire therakos,"{'neg': 0.0, 'neu': 0.842, 'pos': 0.158, 'compound': 0.128}",positive,0.8511090278625488
698120,698120,709343.0,"Short Interest Swings in Biotech Stocks (BIIB, CELG, GILD)",2012-10-15 06:59:00-04:00,JNJ,short interest swings in biotech stocks biib celg gild,"{'neg': 0.0, 'neu': 0.727, 'pos': 0.273, 'compound': 0.4588}",negative,0.9627909660339355
698121,698121,709344.0,Earnings Expectations for the Week of October 15,2012-10-15 06:54:00-04:00,JNJ,earnings expectations for the week of october 15,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998557567596436
698122,698122,709345.0,"Jefferies & Company Maintains Johnson & Johnson at Buy, Raises PT from $76 to $78",2012-10-12 06:59:00-04:00,JNJ,jefferies and company maintains johnson and johnson at buy raises point from dollars 6 to dollars 8,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.6499245762825012
698123,698123,709346.0,Part I: Must Know ETFs For Q3 Earnings ,2012-10-09 14:37:00-04:00,JNJ,part i must know etfs for third quarter earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998873472213745
698124,698124,709347.0,Benzinga's Top Downgrades,2012-10-09 07:24:00-04:00,JNJ,benzingas top downgrades,"{'neg': 0.0, 'neu': 0.526, 'pos': 0.474, 'compound': 0.2023}",negative,0.9905633926391602
698125,698125,709348.0,S&P Index and Big 10 Weekly Outlook ,2012-10-02 12:23:00-04:00,JNJ,SP500 index and big 10 weekly outlook,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998718500137329
698126,698126,709349.0,From Earlier: J&J Says Phase 3 Trial for Canagliflozin Met Secondary Endpoints,2012-10-02 08:45:00-04:00,JNJ,from earlier j and j says phase 3 trial for canagliflozin met secondary endpoints,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998807907104492
698127,698127,709350.0,From Earlier: Janssen-Cilag Says Velcade Approved in EU,2012-09-28 07:52:00-04:00,JNJ,from earlier janssen cilag says velcade approved in eu,"{'neg': 0.0, 'neu': 0.741, 'pos': 0.259, 'compound': 0.4215}",neutral,0.6173753142356873
698128,698128,709351.0,Amazon Could Relinquish Key Trademark to Apple,2012-09-27 08:51:00-04:00,JNJ,amazon could relinquish key trademark to apple,"{'neg': 0.0, 'neu': 0.779, 'pos': 0.221, 'compound': 0.1779}",neutral,0.9996669292449951
698129,698129,709352.0,S&P Highlights Election ETFs,2012-09-25 16:24:00-04:00,JNJ,SP500 highlights election etfs,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998899698257446
698130,698130,709353.0,Knee Replacements Have Doubled -Bloomberg,2012-09-25 16:00:00-04:00,JNJ,knee replacements have doubled bloomberg,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9994914531707764
698131,698131,709354.0,Janssen Research & Development Says Will Present Latest Phase 3 Results  for Canagliflozin October 1-5,2012-09-25 09:13:00-04:00,JNJ,janssen research and development says will present latest phase 3 results for canagliflozin october 1 to 5,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998891353607178
698132,698132,709355.0,Johnson & Johnson is Facing Trial Over Risperdal; Lawyer Says Company Hid Fact Caused Female Breasts in Boys,2012-09-24 12:58:00-04:00,JNJ,johnson and johnson is facing trial over risperdal lawyer says company hid fact caused female breasts in boys,"{'neg': 0.076, 'neu': 0.924, 'pos': 0.0, 'compound': -0.1027}",neutral,0.998745322227478
698133,698133,709356.0,"S&P 500 Index and Big 10 Weekly Outlook-Week of September 24, 2012",2012-09-24 10:34:00-04:00,JNJ,SP500 500 index and big 10 weekly outlook week of september 24 2012,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998890161514282
698134,698134,709357.0,Johnson & Johnson Finding Support at $68,2012-09-18 14:07:00-04:00,JNJ,johnson and johnson finding support at dollars 8,"{'neg': 0.0, 'neu': 0.722, 'pos': 0.278, 'compound': 0.4019}",neutral,0.9997478127479553
698135,698135,709358.0,Defensive Stocks Maintain Gains in Mixed Market,2012-09-18 13:57:00-04:00,JNJ,defensive stocks maintain gains in mixed market,"{'neg': 0.0, 'neu': 0.588, 'pos': 0.412, 'compound': 0.3612}",positive,0.9996715784072876
698136,698136,709359.0,Johnson & Johnson Establishing 4 Innovation Centers ,2012-09-18 08:32:00-04:00,JNJ,johnson and johnson establishing 4 innovation centers,"{'neg': 0.0, 'neu': 0.698, 'pos': 0.302, 'compound': 0.3818}",neutral,0.9998799562454224
698137,698137,709360.0,Sandra Peterson to Join Johnson & Johnson as Group Worldwide Chairman and Member of the Executive Committee,2012-09-13 08:44:00-04:00,JNJ,sandra peterson to join johnson and johnson as group worldwide chairman and member of the executive committee,"{'neg': 0.0, 'neu': 0.879, 'pos': 0.121, 'compound': 0.296}",neutral,0.9998725652694702
698138,698138,709361.0,Johnson&Johnson Has Right to Buy Vascular After Phase 2,2012-09-12 08:39:00-04:00,JNJ,johnson and johnson has right to buy vascular after phase 2,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998264908790588
698139,698139,709362.0,"Credit Suisse Reinstates Coverage on Johnson & Johnson at Neutral, Announces PT of $70",2012-09-11 06:06:00-04:00,JNJ,credit suisse reinstates coverage on johnson and johnson at neutral announces point of dollars 0,"{'neg': 0.0, 'neu': 0.843, 'pos': 0.157, 'compound': 0.3818}",neutral,0.9928459525108337
698140,698140,709363.0,These 4 Companies Have Been Increasing Their Dividends for Decades,2012-09-10 17:45:00-04:00,JNJ,these 4 companies have been increasing their dividends for decades,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996218681335449
698141,698141,709364.0,This Dividend ETF Isn't The Same Old Song,2012-09-06 14:27:00-04:00,JNJ,this dividend etf isnt the same old song,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998773336410522
698142,698142,709365.0,U.S. FDA Grants Priority Review to Bedaquiline for Multi-Drug Resistant Tuberculosis Treatment ,2012-09-05 07:36:00-04:00,JNJ,u s fda grants priority review to bedaquiline for multi drug resistant tuberculosis treatment,"{'neg': 0.0, 'neu': 0.872, 'pos': 0.128, 'compound': 0.2263}",positive,0.9947758913040161
698143,698143,709366.0,Transvaginal Mesh Suit Filed Against Johnson & Johnson ,2012-09-04 09:43:00-04:00,JNJ,transvaginal mesh suit filed against johnson and johnson,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9996917247772217
698144,698144,709367.0,Delaware Nets $4.2 Million Settlement from Johnson & Johnson Subsidiary,2012-08-31 08:12:00-04:00,JNJ,delaware nets dollars .2 million settlement from johnson and johnson subsidiary,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999578058719635
698145,698145,709368.0,U.S. FDA Grants Priority Review of Johnson & Johnson's ZYTIGA,2012-08-29 08:17:00-04:00,JNJ,u s fda grants priority review of johnson and johnsons zytiga,"{'neg': 0.0, 'neu': 0.84, 'pos': 0.16, 'compound': 0.2263}",neutral,0.9937408566474915
698146,698146,709369.0,FDA Approves Johnson and Johnson's NUCYNTA ER,2012-08-29 08:04:00-04:00,JNJ,fda approves johnson and johnsons nucynta er,"{'neg': 0.0, 'neu': 0.69, 'pos': 0.31, 'compound': 0.4019}",neutral,0.9998201727867126
698147,698147,709370.0,Xarel Helped to Stemi Heart Attack Patients; Xarel Group Had Better Survival Rate Without Another Attack,2012-08-27 08:12:00-04:00,JNJ,xarel helped to stemi heart attack patients xarel group had better survival rate without another attack,"{'neg': 0.125, 'neu': 0.485, 'pos': 0.39, 'compound': 0.7618}",positive,0.9996509552001953
698148,698148,709371.0,     ORTHOCON Announces Uninterrupted Availability of HEMASORB Resorbable Hemostatic Bone Putty,2012-08-23 07:55:00-04:00,JNJ,orthocon announces uninterrupted availability of hemasorb resorbable hemostatic bone putty,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9591524004936218
698149,698149,709372.0,Five Practical Books &  5 Investment Lessons,2012-08-17 11:15:00-04:00,JNJ,five practical books and 5 investment lessons,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998716115951538
698150,698150,709373.0,S&P Still Bullish on Health Care ETFs,2012-08-16 17:03:00-04:00,JNJ,SP500 still bullish on health care etfs,"{'neg': 0.0, 'neu': 0.652, 'pos': 0.348, 'compound': 0.4939}",positive,0.9992945194244385
698151,698151,709374.0,Berkshire Hathaway Sells Intel; Buys National-Oilwell Varco,2012-08-14 16:47:00-04:00,JNJ,berkshire hathaway sells intel buys national oilwell varco,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998413324356079
698152,698152,709375.0,"UPDATE: Berkshire Reduced Stake in Visa, UPS, J&J, P&G; Increased Stake in Lee Enterprises, IBM",2012-08-14 16:16:00-04:00,JNJ,update berkshire reduced stake in visa ups j and j p and g increased stake in lee enterprises ibm,"{'neg': 0.0, 'neu': 0.896, 'pos': 0.104, 'compound': 0.2732}",positive,0.8398107886314392
698153,698153,709376.0,Elan Shares Fall 11% After-Hours on Disappointing Pfizer Bapineuzumab Study,2012-08-06 17:08:00-04:00,JNJ,elan shares fall 11 percent after hours on disappointing pfizer bapineuzumab study,"{'neg': 0.208, 'neu': 0.649, 'pos': 0.143, 'compound': -0.25}",negative,0.9987462759017944
698154,698154,709377.0,Teva Pharmaceutical Subpoenaed By SEC in Bribery Charge,2012-08-06 09:13:00-04:00,JNJ,teva pharmaceutical subpoenaed by sec in bribery charge,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9996289014816284
698155,698155,709378.0,Johnson & Johnson Reaches Risperdal Lawsuit Agreement,2012-08-03 12:56:00-04:00,JNJ,johnson and johnson reaches risperdal lawsuit agreement,"{'neg': 0.184, 'neu': 0.388, 'pos': 0.427, 'compound': 0.3612}",positive,0.9960112571716309
698156,698156,709379.0,"UBS Maintains Johnson & Johnson at Buy, Raises PT from $70 to $76",2012-08-01 11:14:00-04:00,JNJ,ubs maintains johnson and johnson at buy raises point from dollars 0 to dollars 6,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9995538592338562
698157,698157,709380.0,Long Term Bull in Johnson & Johnson,2012-07-31 13:22:00-04:00,JNJ,long term bull in johnson and johnson,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998739957809448
698158,698158,709381.0,"Option Alert: Johnson & Johnson January 2014 77.5 Call; Block Trade: 16,000 Contracts; Currently $69.46",2012-07-31 11:15:00-04:00,JNJ,option alert johnson and johnson january 2014 77.5 call block trade 16000 contracts currently dollars 9.46,"{'neg': 0.152, 'neu': 0.733, 'pos': 0.115, 'compound': -0.1779}",neutral,0.999871015548706
698159,698159,709382.0,UPDATE: Dendreon on Call Says Provenge Should be Sequenced Upfront Before J&J's Zytiga,2012-07-30 17:36:00-04:00,JNJ,update dendreon on call says provenge should be sequenced upfront before j and js zytiga,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999882698059082
698160,698160,709383.0,J&J's Synthes Sued for Wrongful Death/Fraud -Bloomberg,2012-07-30 11:46:00-04:00,JNJ,j and js synthes sued for wrongful death and fraud bloomberg,"{'neg': 0.461, 'neu': 0.539, 'pos': 0.0, 'compound': -0.8271}",neutral,0.990183413028717
698161,698161,709384.0,"S&P Likes Some ""Young"" ETFs",2012-07-25 15:16:00-04:00,JNJ,SP500 likes some young etfs,"{'neg': 0.0, 'neu': 0.588, 'pos': 0.412, 'compound': 0.4215}",neutral,0.9997541308403015
698162,698162,709385.0,What You Need in Order to Retire Before Age 60,2012-07-24 16:09:00-04:00,JNJ,what you need in order to retire before age 60,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998664855957031
698163,698163,709386.0," J&J, DoJ Settlement for as Much as $2.2 Billion -WSJ, Sources",2012-07-19 15:40:00-04:00,JNJ,j and j doj settlement for as much as dollars .2 billion wsj sources,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998822212219238
698164,698164,709387.0,"Kapito: 'We Like ATT, VZ, MRK, JNJ for Yields''",2012-07-18 12:23:00-04:00,JNJ,kapito we like att vz mrk jnj for yields,"{'neg': 0.0, 'neu': 0.762, 'pos': 0.238, 'compound': 0.3612}",neutral,0.9998544454574585
698165,698165,709388.0,"UPDATE: Jefferies Reiterates Buy Rating, Raises PT on Johnson & Johnson",2012-07-18 11:26:00-04:00,JNJ,update jefferies reiterates buy rating raises point on johnson and johnson,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9995431900024414
698166,698166,709389.0,"Piper Jaffray Maintains Johnson & Johnson at Neutral, Raises PT from $68 to $74",2012-07-18 10:11:00-04:00,JNJ,piper jaffray maintains johnson and johnson at neutral raises point from dollars 8 to dollars 4,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9995217323303223
698167,698167,709390.0,Johnson and Johnson's Janssen Diagnostic's AVIGA™ Receives Complete ONC-ATCB Certification by Drummond Group,2012-07-18 08:49:00-04:00,JNJ,johnson and johnsons janssen diagnostics aviga receives complete onc atcb certification by drummond group,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9951620697975159
698168,698168,709391.0,"Jefferies & Company Maintains Johnson & Johnson at Buy, Raises PT from $75 to $76",2012-07-18 06:27:00-04:00,JNJ,jefferies and company maintains johnson and johnson at buy raises point from dollars 5 to dollars 6,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.645499050617218
698169,698169,709392.0,"Deutsche Bank Maintains Johnson & Johnson at Hold, Raises PT from $69 to $72",2012-07-18 06:16:00-04:00,JNJ,deutsche bank maintains johnson and johnson at hold raises point from dollars 9 to dollars 2,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9974852800369263
698170,698170,709393.0,Johnson & Johnson Beats on EPS but Fails to Impress,2012-07-17 10:19:00-04:00,JNJ,johnson and johnson beats on eps but fails to impress,"{'neg': 0.238, 'neu': 0.514, 'pos': 0.248, 'compound': 0.0387}",negative,0.9862047433853149
698171,698171,709394.0,J&J CEO Expects More Consolidation Among Hospitals      ,2012-07-17 09:45:00-04:00,JNJ,j and j ceo expects more consolidation among hospitals,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9986031651496887
698172,698172,709395.0,UPDATE: J&J Sees Pretax Operating Margin Improving by 100-150 Basis Points,2012-07-17 09:27:00-04:00,JNJ,update j and j sees pretax operating margin improving by 100 to 150 basis points,"{'neg': 0.0, 'neu': 0.833, 'pos': 0.167, 'compound': 0.4215}",positive,0.999702513217926
698173,698173,709396.0,"J&J Sees Year Reported Sales $66.7-$67.3 Billion, Says Any 2012 Guidance Will Include Forex Impact, Sees Future Earnings Affected by Forex, Sees Net Interest Expense $500-$550 Million",2012-07-17 09:24:00-04:00,JNJ,j and j sees year reported sales dollars 6.7 dollars 7.3 billion says any 2012 guidance will include forex impact sees future earnings affected by forex sees net interest expense dollars 00 dollars 50 million,"{'neg': 0.043, 'neu': 0.878, 'pos': 0.08, 'compound': 0.34}",neutral,0.9718795418739319
698174,698174,709397.0,  J&J Sees $600 Million in Restructuring Charges Ahes,2012-07-17 09:21:00-04:00,JNJ,j and j sees dollars 00 million in restructuring charges ahes,"{'neg': 0.174, 'neu': 0.826, 'pos': 0.0, 'compound': -0.2732}",neutral,0.9998393058776855
698175,698175,709398.0,UPDATE: J&J CEO Says Pharma Ops Will Continue to Be Strong Driver of Sales,2012-07-17 09:06:00-04:00,JNJ,update j and j ceo says pharma ops will continue to be strong driver of sales,"{'neg': 0.0, 'neu': 0.82, 'pos': 0.18, 'compound': 0.5106}",positive,0.9996711015701294
698176,698176,709399.0,UPDATE: Johnson and Johnson to Report Top-Line Results on Bapineuzumab This Quarter at Meeting in September,2012-07-17 08:50:00-04:00,JNJ,update johnson and johnson to report top line results on bapineuzumab this quarter at meeting in september,"{'neg': 0.0, 'neu': 0.899, 'pos': 0.101, 'compound': 0.2023}",neutral,0.9998689889907837
698177,698177,709400.0,Johnson and Johnson Plans to Resume Supply of Doxil in Q4,2012-07-17 08:47:00-04:00,JNJ,johnson and johnson plans to resume supply of doxil in fourth quarter,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997448325157166
698178,698178,709401.0,Johnson & Johnson Falls On Weak Guidance,2012-07-17 08:43:00-04:00,JNJ,johnson and johnson falls on weak guidance,"{'neg': 0.326, 'neu': 0.674, 'pos': 0.0, 'compound': -0.4404}",negative,0.9985290765762329
698179,698179,709402.0,"UPDATE: Johnson & Johnson Posts Drop In Q2 Profit, Lowers Full-Year Forecast",2012-07-17 08:26:00-04:00,JNJ,update johnson and johnson posts drop in second quarter profit lowers full year forecast,"{'neg': 0.206, 'neu': 0.629, 'pos': 0.166, 'compound': 0.0772}",negative,0.9986627101898193
698180,698180,709403.0,Benzinga's Top Pre-Market Losers,2012-07-17 08:21:00-04:00,JNJ,benzingas top pre market losers,"{'neg': 0.415, 'neu': 0.366, 'pos': 0.22, 'compound': -0.3818}",neutral,0.996982753276825
698181,698181,709404.0,Johnson & Johnson Guides FY EPS $5.00-5.07 vs $5.14 Est,2012-07-17 07:48:00-04:00,JNJ,johnson and johnson guides fy eps dollars .00 to 5.07 vs dollars .14 est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998809099197388
698182,698182,709405.0,Popular Drug Manufacturing Stocks Among Hedge Funds,2012-07-17 07:47:00-04:00,JNJ,popular drug manufacturing stocks among hedge funds,"{'neg': 0.0, 'neu': 0.682, 'pos': 0.318, 'compound': 0.4215}",neutral,0.9998536109924316
698183,698183,709406.0,Johnson & Johnson Reports Q2 EPS $1.30 vs $1.29 Est; Revenues $16.5B vs $16.69B Est,2012-07-17 07:45:00-04:00,JNJ,johnson and johnson reports second quarter eps dollars .30 vs dollars .29 est revenues dollars 6.5 billion vs dollars 6.69 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998810291290283
698184,698184,709407.0,"Benzinga Market Primer, Tuesday July 17",2012-07-17 06:54:00-04:00,JNJ,benzinga market primer tuesday july 17,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998800754547119
698185,698185,709408.0,US Stock Futures Up; All Eyes On Bernanke,2012-07-17 06:37:00-04:00,JNJ,us stock futures up all eyes on bernanke,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9947009086608887
698186,698186,709409.0,Earnings Scheduled For July 17,2012-07-17 02:39:00-04:00,JNJ,earnings scheduled for july 17,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998780488967896
698187,698187,709410.0,Stocks To Watch For July 17,2012-07-17 02:04:00-04:00,JNJ,stocks to watch for july 17,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998699426651001
698188,698188,709411.0,Earnings Expectations for the Week of July 16,2012-07-16 09:02:00-04:00,JNJ,earnings expectations for the week of july 16,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998382329940796
698189,698189,709412.0,"Low Volume, High Returns for These ETFs (BIB, FHC, DRW)",2012-07-13 15:25:00-04:00,JNJ,low volume high returns for these etfs bib fhc drw,"{'neg': 0.189, 'neu': 0.811, 'pos': 0.0, 'compound': -0.2732}",positive,0.9982067346572876
698190,698190,709413.0,"Jefferies & Company Maintains Johnson & Johnson at Buy, Raises PT from $72 to $75",2012-07-13 07:00:00-04:00,JNJ,jefferies and company maintains johnson and johnson at buy raises point from dollars 2 to dollars 5,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.8705505728721619
698191,698191,709414.0,"J&J Agrees To Corporate Governance Changes, Drug Marketing Changes as Part of NJ Settlement - Bloomberg Headlines",2012-07-11 14:38:00-04:00,JNJ,j and j agrees to corporate governance changes drug marketing changes as part of nj settlement to bloomberg headlines,"{'neg': 0.0, 'neu': 0.909, 'pos': 0.091, 'compound': 0.2023}",neutral,0.9362792372703552
698192,698192,709415.0,Johnson & Johnson Receives Positive Mad Money/Jim Cramer Mention -CNBC,2012-07-09 18:04:00-04:00,JNJ,johnson and johnson receives positive mad money and jim cramer mention cnbc,"{'neg': 0.19, 'neu': 0.595, 'pos': 0.214, 'compound': 0.1027}",positive,0.9995689988136292
698193,698193,709416.0,J&J Unit: Stent Thrombosis sNDA Contingent On ACS sNDA,2012-07-09 07:37:00-04:00,JNJ,j and j unit stent thrombosis snda contingent on acs snda,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998836517333984
698194,698194,709417.0,J&J: FDA Grants Priority Review For Xarelto Supplemental NDAs,2012-07-09 07:34:00-04:00,JNJ,j and j fda grants priority review for xarelto supplemental ndas,"{'neg': 0.0, 'neu': 0.84, 'pos': 0.16, 'compound': 0.2263}",neutral,0.8984842896461487
698195,698195,709418.0,"Benzinga's M&A Chatter for Tuesday July 3, 2012",2012-07-04 15:08:00-04:00,JNJ,benzingas m and a chatter for tuesday july 3 2012,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998873472213745
698196,698196,709419.0,Elan Spokesperson Would Not Comment on Earlier Chatter of JNJ Offer,2012-07-03 10:32:00-04:00,JNJ,elan spokesperson would not comment on earlier chatter of jnj offer,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998646974563599
698197,698197,709420.0,"Hearing Unconfirmed Chatter of Johnson and Johnson Offer for Elan, $19/Share",2012-07-03 10:22:00-04:00,JNJ,hearing unconfirmed chatter of johnson and johnson offer for elan dollars,"{'neg': 0.13, 'neu': 0.87, 'pos': 0.0, 'compound': -0.128}",neutral,0.9998261332511902
698198,698198,709421.0,ALPS Unveils Dogs of the Dow ETF,2012-06-29 12:51:00-04:00,JNJ,alps unveils dogs of the dow etf,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998754262924194
698199,698199,709422.0,Leveraged ETFs for the Obamacare Ruling,2012-06-26 18:07:00-04:00,JNJ,leveraged etfs for the obamacare ruling,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998636245727539
698200,698200,709423.0,The New High Frequency Trading Landscape: Man Versus Machine,2012-06-26 08:22:00-04:00,JNJ,the new high frequency trading landscape man versus machine,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999871015548706
698201,698201,709424.0,"Ahead of Obamacare Ruling, S&P Likes Health Care SPDR",2012-06-25 14:02:00-04:00,JNJ,ahead of obamacare ruling SP500 likes health care spdr,"{'neg': 0.0, 'neu': 0.538, 'pos': 0.462, 'compound': 0.7184}",neutral,0.9998542070388794
698202,698202,709425.0,Saving More Vs. Seeking Higher Returns for Retirement,2012-06-25 12:20:00-04:00,JNJ,saving more vs seeking higher returns for retirement,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.988104522228241
698203,698203,709426.0,"Premarket Stock Talk: Sell the Market, Buy.. Facebook?",2012-06-22 09:00:00-04:00,JNJ,premarket stock talk sell the market buy facebook,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998175501823425
698204,698204,709427.0,Premarket Stock Talk: Beyond a Best Bed and Bath Buy,2012-06-21 08:48:00-04:00,JNJ,premarket stock talk beyond a best bed and bath buy,"{'neg': 0.0, 'neu': 0.682, 'pos': 0.318, 'compound': 0.6369}",positive,0.9818830490112305
698205,698205,709428.0,Study Says J&J Vaginal Sling Cuts Incontinence Risk in Half,2012-06-20 17:01:00-04:00,JNJ,study says j and j vaginal sling cuts incontinence risk in half,"{'neg': 0.301, 'neu': 0.699, 'pos': 0.0, 'compound': -0.5106}",positive,0.9992939233779907
698206,698206,709429.0,Arkansas Judge Who Fined J&J $1.2 Billion Denies Request for New Trial in Risperdal Case -AP,2012-06-20 13:02:00-04:00,JNJ,arkansas judge who fined j and j dollars .2 billion denies request for new trial in risperdal case ap,"{'neg': 0.135, 'neu': 0.865, 'pos': 0.0, 'compound': -0.4215}",neutral,0.9076440930366516
698207,698207,709430.0,"Goldman Sachs Raises PT on Johnson & Johnson from $65 to $67, Maintains Neutral",2012-06-15 16:16:00-04:00,JNJ,goldman sachs raises point on johnson and johnson from dollars 5 to dollars 7 maintains neutral,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9890512824058533
698208,698208,709431.0,Johnson & Johnson to Complete Synthes Acquisition ,2012-06-14 08:25:00-04:00,JNJ,johnson and johnson to complete synthes acquisition,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998492002487183
698209,698209,709432.0,UPDATE: Jefferies Upgrades Johnson & Johnson,2012-06-13 10:24:00-04:00,JNJ,update jefferies upgrades johnson and johnson,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998505115509033
698210,698210,709433.0,UPDATE: JP Morgan Upgrades Johnson & Johnson to Overweight; Discounted Valuation Compared to Peers  ,2012-06-13 09:29:00-04:00,JNJ,update jp morgan upgrades johnson and johnson to overweight discounted valuation compared to peers,"{'neg': 0.152, 'neu': 0.667, 'pos': 0.182, 'compound': -0.128}",positive,0.9994542002677917
698211,698211,709434.0,"Financial Breakfast: Morning News Summary for June 13, 2012",2012-06-13 07:30:00-04:00,JNJ,financial breakfast morning news summary for june 13 2012,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998712539672852
698212,698212,709435.0,"Jefferies & Company Upgrades Johnson & Johnson from Hold to Buy, Raises PT from $68 to $72",2012-06-13 07:07:00-04:00,JNJ,jefferies and company upgrades johnson and johnson from hold to buy raises point from dollars 8 to dollars 2,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9904735684394836
698213,698213,709436.0,"JP Morgan Upgrades Johnson & Johnson from Neutral to Overweight, PT Raised from $74 to $69",2012-06-13 05:58:00-04:00,JNJ,jp morgan upgrades johnson and johnson from neutral to overweight point raised from dollars 4 to dollars 9,"{'neg': 0.123, 'neu': 0.788, 'pos': 0.089, 'compound': -0.1779}",positive,0.9995009899139404
698214,698214,709437.0,Johnson & Johnson Receives US Regulatory Clearance for Synthes Acquisition,2012-06-12 17:26:00-04:00,JNJ,johnson and johnson receives us regulatory clearance for synthes acquisition,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9979419112205505
698215,698215,709438.0,"Johnson and Johnson Receives US Regulatory Approval for Synthes Acquisition, Closing Date for Acquisition Set for June 14.",2012-06-12 17:22:00-04:00,JNJ,johnson and johnson receives us regulatory approval for synthes acquisition closing date for acquisition set for june 14,"{'neg': 0.0, 'neu': 0.846, 'pos': 0.154, 'compound': 0.4767}",neutral,0.9652453064918518
698216,698216,709439.0,Johnson and Johnson Announces $12.9B Accelerated Buyback Plan,2012-06-12 17:20:00-04:00,JNJ,johnson and johnson announces dollars 2.9 billion accelerated buyback plan,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.963386595249176
698217,698217,709440.0,5 Healthcare Stocks With The Highest Revenue,2012-06-12 07:45:00-04:00,JNJ,5 healthcare stocks with the highest revenue,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.997554361820221
698218,698218,709441.0,Johnson&Johnson Reports Positive Results from First Human Clinical Trials of a First-Generation Artificial Pancreas System,2012-06-11 09:05:00-04:00,JNJ,johnson and johnson reports positive results from first human clinical trials of a first generation artificial pancreas system,"{'neg': 0.0, 'neu': 0.825, 'pos': 0.175, 'compound': 0.5574}",positive,0.9995480179786682
698219,698219,709442.0,Johnson & Johnson to Incur Special Charge in Q2 Due to Legal Matters -8K,2012-06-08 16:58:00-04:00,JNJ,johnson and johnson to incur special charge in second quarter due to legal matters negative 8 thousand,"{'neg': 0.168, 'neu': 0.591, 'pos': 0.241, 'compound': -0.1027}",neutral,0.9988603591918945
698220,698220,709443.0,Elan Spokesperson Says Company is Not Involved in Actual Data of Alzheimer Treatment. Says Data is Handled by Johnson & Johnson and Pfizer,2012-06-07 11:54:00-04:00,JNJ,elan spokesperson says company is not involved in actual data of alzheimer treatment says data is handled by johnson and johnson and pfizer,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998794794082642
698221,698221,709444.0,Three Keys to Finding Good Dividend Stocks,2012-06-06 12:37:00-04:00,JNJ,three keys to finding good dividend stocks,"{'neg': 0.0, 'neu': 0.674, 'pos': 0.326, 'compound': 0.4404}",neutral,0.9996944665908813
698222,698222,709445.0,Dendreon Jumps 10% ,2012-06-05 13:37:00-04:00,JNJ,dendreon jumps 10 percent,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996352195739746
698223,698223,709446.0,The US Economy and the United Nations: Bold Strategies Needed - Tax Reform and Benefits Reform,2012-06-04 12:16:00-04:00,JNJ,the us economy and the united nations bold strategies needed to tax reform and benefits reform,"{'neg': 0.0, 'neu': 0.619, 'pos': 0.381, 'compound': 0.7906}",neutral,0.8739069104194641
698224,698224,709447.0,"UPDATE: J&J's Zytiga Slows Cancer Growth In Men With Prostate Cancer; Negative for Dendreon, Positive for Medivation",2012-06-04 09:07:00-04:00,JNJ,update j and js zytiga slows cancer growth in men with prostate cancer negative for dendreon positive for medivation,"{'neg': 0.382, 'neu': 0.428, 'pos': 0.19, 'compound': -0.8074}",positive,0.9861384034156799
698225,698225,709448.0,ZYTIGA Plus Prednisone Show Improvements in Asymptomatic or Mildly Symptomatic Chemotherapy-Naive Patients with Metastatic Castration-Resistant Prostate Cancer,2012-06-02 20:13:00-04:00,JNJ,zytiga plus prednisone show improvements in asymptomatic or mildly symptomatic chemotherapy naive patients with metastatic castration resistant prostate cancer,"{'neg': 0.262, 'neu': 0.645, 'pos': 0.093, 'compound': -0.6369}",positive,0.9996919631958008
698226,698226,709449.0,Johnson & Johnson Receives Positive Mad Money/Jim Cramer Mention -CNBC,2012-06-01 20:26:00-04:00,JNJ,johnson and johnson receives positive mad money and jim cramer mention cnbc,"{'neg': 0.19, 'neu': 0.595, 'pos': 0.214, 'compound': 0.1027}",positive,0.9995689988136292
698227,698227,709450.0,"5 Risky Dividend Stocks (WIN, EXC, FTR, HAS, JNJ)",2012-05-31 16:55:00-04:00,JNJ,5 risky dividend stocks win exc ftr has jnj,"{'neg': 0.143, 'neu': 0.556, 'pos': 0.302, 'compound': 0.4588}",positive,0.9910668730735779
698228,698228,709451.0,Goldman Sachs Comments on Breaking Up of Johnson & Johnson,2012-05-31 06:37:00-04:00,JNJ,goldman sachs comments on breaking up of johnson and johnson,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999860405921936
698229,698229,709452.0,FDA Issues Complete Response Letter for 800mg PREZISTA,2012-05-29 09:02:00-04:00,JNJ,fda issues complete response letter for 800 million g prezista,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998810291290283
698230,698230,709453.0,5 Healthcare Stocks With The Highest Cash,2012-05-29 07:32:00-04:00,JNJ,5 healthcare stocks with the highest cash,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998593330383301
698231,698231,709454.0,S&P 500 Undex And Big 10 Weekly Outlook-Week of May 28th,2012-05-28 14:48:00-04:00,JNJ,SP500 500 undex and big 10 weekly outlook week of may 28,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998874664306641
698232,698232,709455.0,"Three Stocks from Goldman's Hedge Fund Short List, Will They Pop or Flop?",2012-05-24 16:37:00-04:00,JNJ,three stocks from goldmans hedge fund short list will they pop or flop,"{'neg': 0.167, 'neu': 0.833, 'pos': 0.0, 'compound': -0.34}",neutral,0.9997091889381409
698233,698233,709456.0,FDA Advisory Panel Votes 6-4-1 Against the Approval of Johnson & Johnson's and Bayer's XARETO Pill,2012-05-23 16:19:00-04:00,JNJ,fda advisory panel votes 6 to 4 1 against the approval of johnson and johnsons and bayers xareto pill,"{'neg': 0.0, 'neu': 0.853, 'pos': 0.147, 'compound': 0.4767}",neutral,0.9998409748077393
698234,698234,709457.0,Health Care SPDR In Focus Ahead Of Obamacare Decision,2012-05-22 12:34:00-04:00,JNJ,health care spdr in focus ahead of obamacare decision,"{'neg': 0.0, 'neu': 0.714, 'pos': 0.286, 'compound': 0.4939}",neutral,0.9997588992118835
698235,698235,709458.0,Prostate Cancer Companies Suffer When They Ignore Urologists,2012-05-22 11:47:00-04:00,JNJ,prostate cancer companies suffer when they ignore urologists,"{'neg': 0.675, 'neu': 0.325, 'pos': 0.0, 'compound': -0.886}",negative,0.9885780811309814
698236,698236,709459.0,S&P 500 Index and Big 10 Weekly Outlook-Week of May 14th,2012-05-14 11:23:00-04:00,JNJ,SP500 500 index and big 10 weekly outlook week of may 14,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998846054077148
698237,698237,709460.0,ETFs on the Market that will Line Your Pockets 12 Times a Year,2012-05-09 15:01:00-04:00,JNJ,etfs on the market that will line your pockets 12 times a year,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998800754547119
698238,698238,709461.0,"Option Alert: Johnson & Johnson July 67.5 Calls; Block Trade: 10,000 Contracts; Currently $64.41",2012-05-09 11:08:00-04:00,JNJ,option alert johnson and johnson july 67.5 calls block trade 10000 contracts currently dollars 4.41,"{'neg': 0.16, 'neu': 0.718, 'pos': 0.122, 'compound': -0.1779}",neutral,0.9998527765274048
698239,698239,709462.0,Buffett's Holdings Beat the S&P 500 One Month After Meeting,2012-05-07 14:45:00-04:00,JNJ,buffetts holdings beat the SP500 500 one month after meeting,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9991115927696228
698240,698240,709463.0,"S&P 500 Index and Big Ten Analysis - Week of May 7, 2012",2012-05-07 14:35:00-04:00,JNJ,SP500 500 index and big ten analysis to week of may 7 2012,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998914003372192
698241,698241,709464.0,S&P 500 Index and Big Ten Weekly Outlook - April 30th,2012-04-30 11:38:00-04:00,JNJ,SP500 500 index and big ten weekly outlook to april 30,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998530149459839
698242,698242,709465.0,Johnson & Johnson Announces Dividend Increase of 7.0% to $0.61,2012-04-26 10:48:00-04:00,JNJ,johnson and johnson announces dividend increase of 7.0 percent to dollars .61,"{'neg': 0.0, 'neu': 0.827, 'pos': 0.173, 'compound': 0.3182}",positive,0.9995220899581909
698243,698243,709466.0,Fitch Removes Johnson & Johnson from Watch Negative,2012-04-25 17:37:00-04:00,JNJ,fitch removes johnson and johnson from watch negative,"{'neg': 0.346, 'neu': 0.654, 'pos': 0.0, 'compound': -0.5719}",neutral,0.9994804263114929
698244,698244,709467.0,"Five Cheap Stocks Under $15 (BAC, NAK, SD, RIMM, ELN)",2012-04-25 14:37:00-04:00,JNJ,five cheap stocks under dollars 5 bac nak sd rimm eln,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9994637370109558
698245,698245,709468.0,"Colgate-Palmolive Earnings Preview: Q1 EPS, Sales Expected to Be Higher",2012-04-25 06:55:00-04:00,JNJ,colgate palmolive earnings preview first quarter eps sales expected to be higher,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996652603149414
698246,698246,709469.0,S&P Futures and Big 10 Weekly Analysis - Week of April 23,2012-04-23 12:09:00-04:00,JNJ,SP500 futures and big 10 weekly analysis to week of april 23,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998917579650879
698247,698247,709470.0,Street Yearning For Better Earnings?,2012-04-19 17:41:00-04:00,JNJ,street yearning for better earnings,"{'neg': 0.0, 'neu': 0.405, 'pos': 0.595, 'compound': 0.5267}",positive,0.9993985891342163
698248,698248,709471.0,S&P: Bullish On Pharma ETFs Long-Term,2012-04-19 14:45:00-04:00,JNJ,SP500 bullish on pharma etfs long term,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9994325041770935
698249,698249,709472.0,"UBS Maintains Johnson & Johnson at Buy, Lowers PT from $71 to $70",2012-04-18 11:42:00-04:00,JNJ,ubs maintains johnson and johnson at buy lowers point from dollars 1 to dollars 0,"{'neg': 0.097, 'neu': 0.903, 'pos': 0.0, 'compound': -0.128}",neutral,0.9998810291290283
698250,698250,709473.0,UPDATE: Goldman Sachs Lowers Johnson & Johnson's PT,2012-04-18 11:04:00-04:00,JNJ,update goldman sachs lowers johnson and johnsons point,"{'neg': 0.176, 'neu': 0.824, 'pos': 0.0, 'compound': -0.128}",neutral,0.9998218417167664
698251,698251,709474.0,"UPDATE: Citigroup Reiterates Buy Rating, Raises PT on Johnson & Johnson",2012-04-18 10:12:00-04:00,JNJ,update citigroup reiterates buy rating raises point on johnson and johnson,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.999535322189331
698252,698252,709475.0,"Citigroup Maintains Johnson & Johnson at Buy, Raises PT from $76 to $77",2012-04-18 07:19:00-04:00,JNJ,citigroup maintains johnson and johnson at buy raises point from dollars 6 to dollars 7,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9983812570571899
698253,698253,709476.0,"Goldman Sachs Maintains Johnson & Johnson at Neutral, Lowers PT from $70 to $65",2012-04-18 06:54:00-04:00,JNJ,goldman sachs maintains johnson and johnson at neutral lowers point from dollars 0 to dollars 5,"{'neg': 0.091, 'neu': 0.909, 'pos': 0.0, 'compound': -0.128}",neutral,0.9997876286506653
698254,698254,709477.0,"Checking In: Turn Down The ""Vol"" (LVOL, SPLV)",2012-04-17 22:51:00-04:00,JNJ,checking in turn down the volume lvol splv,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9993444085121155
698255,698255,709478.0,"Deutsche Bank: Johnson & Johnson Beat EPS, Misses Sales",2012-04-17 09:30:00-04:00,JNJ,deutsche bank johnson and johnson beat eps misses sales,"{'neg': 0.192, 'neu': 0.808, 'pos': 0.0, 'compound': -0.2263}",positive,0.9964978694915771
698256,698256,709479.0,J&J Says Will File Motion to Dismiss Risperdal Ruling; Will Appeal if Dismissal Fails,2012-04-17 09:24:00-04:00,JNJ,j and j says will file motion to dismiss risperdal ruling will appeal if dismissal fails,"{'neg': 0.157, 'neu': 0.843, 'pos': 0.0, 'compound': -0.4215}",neutral,0.9997561573982239
698257,698257,709480.0,Earnings Roundup,2012-04-17 09:02:00-04:00,JNJ,earnings roundup,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998680353164673
698258,698258,709481.0,"UPDATE: Johnson & Johnson Posts 12% Rise In Q1 Earnings, Lifts Forecast",2012-04-17 08:29:00-04:00,JNJ,update johnson and johnson posts 12 percent rise in first quarter earnings lifts forecast,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996873140335083
698259,698259,709482.0,Johnson & Johnson Reports Q1 EPS $1.37 vs $1.35 Est; Revenues $16.1B vs $16.26B Est,2012-04-17 07:46:00-04:00,JNJ,johnson and johnson reports first quarter eps dollars .37 vs dollars .35 est revenues dollars 6.1 billion vs dollars 6.26 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999882698059082
698260,698260,709483.0,Stocks To Watch For April 17,2012-04-17 06:47:00-04:00,JNJ,stocks to watch for april 17,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998717308044434
698261,698261,709484.0,Earnings Scheduled For April 17,2012-04-17 06:46:00-04:00,JNJ,earnings scheduled for april 17,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998782873153687
698262,698262,709485.0,US Stock Futures Up Ahead Of Earnings,2012-04-17 06:44:00-04:00,JNJ,us stock futures up ahead of earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9985622763633728
698263,698263,709486.0,US Stock Futures Up Ahead Of Earnings,2012-04-17 06:26:00-04:00,JNJ,us stock futures up ahead of earnings,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9985622763633728
698264,698264,709487.0,Earnings Scheduled For April 17,2012-04-17 04:31:00-04:00,JNJ,earnings scheduled for april 17,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998782873153687
698265,698265,709488.0,Earnings Scheduled For April 17,2012-04-17 04:23:00-04:00,JNJ,earnings scheduled for april 17,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998782873153687
698266,698266,709489.0,Stocks To Watch For April 17,2012-04-17 04:05:00-04:00,JNJ,stocks to watch for april 17,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998717308044434
698267,698267,709490.0,S&P Futures and Big 10 Weekly Analysis - Week of April 16,2012-04-16 08:45:00-04:00,JNJ,SP500 futures and big 10 weekly analysis to week of april 16,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998916387557983
698268,698268,709491.0,UPDATE: Citi Raises Johnson & Johnson's PT,2012-04-16 08:14:00-04:00,JNJ,update citi raises johnson and johnsons point,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998082518577576
698269,698269,709492.0,"Citigroup Maintains Johnson & Johnson at Buy, Raises PT from $75 to $76",2012-04-16 06:27:00-04:00,JNJ,citigroup maintains johnson and johnson at buy raises point from dollars 5 to dollars 6,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9985699653625488
698270,698270,709493.0,"Earnings Expectations for the Week of April 16 (GS, MSFT, MCD)",2012-04-15 10:45:00-04:00,JNJ,earnings expectations for the week of april 16 gs msft mcd,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998062252998352
698271,698271,709494.0,Volatility Is Not Risk,2012-04-12 11:32:00-04:00,JNJ,volatility is not risk,"{'neg': 0.0, 'neu': 0.623, 'pos': 0.377, 'compound': 0.2057}",neutral,0.9998520612716675
698272,698272,709495.0,Judge Awards Arkansas $1.1B Over Johnson & Johnson's Risperdal Sales,2012-04-11 10:55:00-04:00,JNJ,judge awards arkansas dollars .1 billion over johnson and johnsons risperdal sales,"{'neg': 0.0, 'neu': 0.786, 'pos': 0.214, 'compound': 0.4588}",neutral,0.999869704246521
698273,698273,709496.0,We like these proven performers in this market,2012-04-10 21:35:00-04:00,JNJ,we like these proven performers in this market,"{'neg': 0.0, 'neu': 0.737, 'pos': 0.263, 'compound': 0.3612}",neutral,0.9831281900405884
698274,698274,709497.0,S&P 500 Index and Big Ten Analysis - Week of April 9th,2012-04-09 13:19:00-04:00,JNJ,SP500 500 index and big ten analysis to week of april 9,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998862743377686
698275,698275,709498.0,Avon's New CEO to Cleanse Brand Image as L'Oreal Sparks Upgrade Rumors,2012-04-09 12:32:00-04:00,JNJ,avons new ceo to cleanse brand image as loreal sparks upgrade rumors,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9965792298316956
698276,698276,709499.0,Morgan Stanley Comments on Johnson & Johnson's First 100 Days in 2012,2012-04-09 08:50:00-04:00,JNJ,morgan stanley comments on johnson and johnsons first 100 days in 2012,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998807907104492
698277,698277,709500.0,Johnson & Johnson Announces Resignation of Sheri S. McCoy ,2012-04-09 07:02:00-04:00,JNJ,johnson and johnson announces resignation of sheri s mccoy,"{'neg': 0.216, 'neu': 0.784, 'pos': 0.0, 'compound': -0.296}",neutral,0.9994933605194092
698278,698278,709501.0,Biomet in Pact to Buy J&J's Depuy Trauma Business,2012-04-03 08:37:00-04:00,JNJ,biomet in pact to buy j and js depuy trauma business,"{'neg': 0.219, 'neu': 0.781, 'pos': 0.0, 'compound': -0.4215}",neutral,0.9998737573623657
698279,698279,709502.0,Is 1400 The Top For Now?,2012-03-29 18:06:00-04:00,JNJ,is 1400 the top for now,"{'neg': 0.0, 'neu': 0.735, 'pos': 0.265, 'compound': 0.2023}",neutral,0.9998824596405029
698280,698280,709503.0,Arkansas Seeking $1.25B in Penalties Over Marketing for J&J Antipsychotic Drug,2012-03-27 10:33:00-04:00,JNJ,arkansas seeking dollars .25 billion in penalties over marketing for j and j antipsychotic drug,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.5793192982673645
698281,698281,709504.0,FDA Approves INTELENCE Tablets for Treatment-Experienced Pediatric Patients with HIV-1,2012-03-27 08:06:00-04:00,JNJ,fda approves intelence tablets for treatment experienced pediatric patients with hiv 1,"{'neg': 0.0, 'neu': 0.803, 'pos': 0.197, 'compound': 0.4019}",positive,0.6203152537345886
698282,698282,709505.0,Brean Murray Carret: Johnson & Johnson's EINSTEIN-PE Results Overshadowed,2012-03-27 07:56:00-04:00,JNJ,brean murray carret johnson and johnsons einstein pe results overshadowed,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998471736907959
698283,698283,709506.0,S&P 500 Index and Big 10 Weekly Outlook - March 26th,2012-03-26 16:26:00-04:00,JNJ,SP500 500 index and big 10 weekly outlook to march 26,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998641014099121
698284,698284,709507.0,UPDATE: Bayer's Xarelto Comparable to Standard Therapy; Blood Thinner Treats Blood Clots with Less Bleeding,2012-03-26 09:04:00-04:00,JNJ,update bayers xarelto comparable to standard therapy blood thinner treats blood clots with less bleeding,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.7340474724769592
698285,698285,709508.0,Bayer's Xarelto Comparable to Standard Therapy; Blood Thinner Treats Blood Clots with Less Bleeding,2012-03-26 09:03:00-04:00,JNJ,bayers xarelto comparable to standard therapy blood thinner treats blood clots with less bleeding,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.6885370016098022
698286,698286,709509.0,Three Effective Tools For Controlling Portfolio Risk Without Relying Purely on Fixed Income ,2012-03-23 11:24:00-04:00,JNJ,three effective tools for controlling portfolio risk without relying purely on fixed income,"{'neg': 0.13, 'neu': 0.679, 'pos': 0.191, 'compound': 0.25}",neutral,0.9998661279678345
698287,698287,709510.0,"Fast Money Picks For March 23rd (FCX, CHD, JNJ)",2012-03-22 21:43:00-04:00,JNJ,fast money picks for march 23 fcx chd jnj,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998688697814941
698288,698288,709511.0,"St. Jude, Novo Nordisk and Other Health Care Stocks Worth a Look Now",2012-03-21 07:20:00-04:00,JNJ,st jude novo nordisk and other health care stocks worth a look now,"{'neg': 0.0, 'neu': 0.683, 'pos': 0.317, 'compound': 0.6249}",neutral,0.9998235106468201
698289,698289,709512.0,"S&P 500 and Big 10 Weekly Outlook - March 19, 2012",2012-03-19 10:32:00-04:00,JNJ,SP500 500 and big 10 weekly outlook to march 19 2012,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998724460601807
698290,698290,709513.0,"ETF Showdown: Dividend Dilemma (HDV, HDIV, JNJ)",2012-03-16 14:55:00-04:00,JNJ,etf showdown dividend dilemma hdv hdiv jnj,"{'neg': 0.221, 'neu': 0.779, 'pos': 0.0, 'compound': -0.1779}",neutral,0.9998466968536377
698291,698291,709514.0,"Accenture, Covidien, Seagate and Other St. Patrick's Stock Picks",2012-03-16 06:49:00-04:00,JNJ,accenture covidien seagate and other st patricks stock picks,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998725652694702
698292,698292,709515.0,"A Look At The New Russell High Yield ETF (HDIV, ABT, KFT)",2012-03-15 14:55:00-04:00,JNJ,a look at the new russell high yield etf hdiv abt kft,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998459815979004
698293,698293,709516.0,Investor Alert: Xerox is a Cash Machine  ,2012-03-14 08:29:00-04:00,JNJ,investor alert xerox is a cash machine,"{'neg': 0.0, 'neu': 0.732, 'pos': 0.268, 'compound': 0.296}",neutral,0.9998811483383179
698294,698294,709517.0,"Painkillers Win FDA Panel Backing to Continue Development; Pfizer, JNJ, Regeneron Pain Drugs Should Resume Halted Studies -Bloomberg",2012-03-12 15:59:00-04:00,JNJ,painkillers win fda panel backing to continue development pfizer jnj regeneron pain drugs should resume halted studies bloomberg,"{'neg': 0.142, 'neu': 0.647, 'pos': 0.211, 'compound': 0.1531}",positive,0.9993478655815125
698295,698295,709518.0,"Option Alert: Johnson & Johnson July 70 Call; Block Trade, 10,000 Contracts",2012-03-12 14:07:00-04:00,JNJ,option alert johnson and johnson july 70 call block trade 10000 contracts,"{'neg': 0.192, 'neu': 0.662, 'pos': 0.146, 'compound': -0.1779}",neutral,0.9998346567153931
698296,698296,709519.0,S&P 500 and Big 10 Weekly Outlook - March 12th,2012-03-12 11:18:00-04:00,JNJ,SP500 500 and big 10 weekly outlook to march 12,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998610019683838
698297,698297,709520.0,Will Johnson & Johnson Cure Cancer?,2012-03-08 12:57:00-05:00,JNJ,will johnson and johnson cure cancer,"{'neg': 0.468, 'neu': 0.532, 'pos': 0.0, 'compound': -0.6597}",neutral,0.999786913394928
698298,698298,709521.0,Medivation Rises 17% on Positive J&J Zytiga,2012-03-08 11:02:00-05:00,JNJ,medivation rises 17 percent on positive j and j zytiga,"{'neg': 0.0, 'neu': 0.714, 'pos': 0.286, 'compound': 0.5574}",positive,0.9997091889381409
698299,698299,709522.0,"Medivation Shares Rise 10% on J&J's Zytiga Data, Dendreon Falls 12%",2012-03-08 09:00:00-05:00,JNJ,medivation shares rise 10 percent on j and js zytiga data dendreon falls 12 percent,"{'neg': 0.0, 'neu': 0.864, 'pos': 0.136, 'compound': 0.296}",positive,0.9996398687362671
698300,698300,709523.0,"J&J's Zytiga Study to be Unblinded on Committee Recommendation; Interim Data Could Show Clinical Benefit; Could be Positive for Medivation, Negative for Dendreon",2012-03-08 08:44:00-05:00,JNJ,j and js zytiga study to be unblinded on committee recommendation interim data could show clinical benefit could be positive for medivation negative for dendreon,"{'neg': 0.115, 'neu': 0.681, 'pos': 0.204, 'compound': 0.4404}",positive,0.999489426612854
698301,698301,709524.0,Pfizer Sues Johnson & Johnson Over Heat Patch Patent,2012-03-05 13:15:00-05:00,JNJ,pfizer sues johnson and johnson over heat patch patent,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9996680021286011
698302,698302,709525.0,"S&P 500 And Big 10 Weekly Outlook - March 5, 2012",2012-03-04 19:41:00-05:00,JNJ,SP500 500 and big 10 weekly outlook to march 5 2012,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998667240142822
698303,698303,709526.0,U.S. FDA Grants Priority Review for XARELTO to Reduce Secondary Cardiovascular Events in Patients with Acute,2012-02-27 16:32:00-05:00,JNJ,u s fda grants priority review for xarelto to reduce secondary cardiovascular events in patients with acute,"{'neg': 0.0, 'neu': 0.894, 'pos': 0.106, 'compound': 0.2263}",positive,0.999351441860199
698304,698304,709527.0,S&P 500 & Big 10 Analysis - Week of February 27,2012-02-27 12:06:00-05:00,JNJ,SP500 500 and big 10 analysis to week of february 27,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998865127563477
698305,698305,709528.0,"Buffett On Johnson & Johnson: Still An Attractive Business At This Price, But Would Sell If He Needed Capital -CNBC",2012-02-27 08:46:00-05:00,JNJ,buffett on johnson and johnson still an attractive business at this price but would sell if he needed capital cnbc,"{'neg': 0.0, 'neu': 0.907, 'pos': 0.093, 'compound': 0.2382}",positive,0.996967613697052
698306,698306,709529.0,"Option Alert: Johnson & Johnson January 2013 50 Call; Block Trade, 2X 12,000; 2X 10,000 Contracts",2012-02-23 15:47:00-05:00,JNJ,option alert johnson and johnson january 2013 50 call block trade 2 times 12000 2 times 10000 contracts,"{'neg': 0.137, 'neu': 0.758, 'pos': 0.104, 'compound': -0.1779}",neutral,0.9998761415481567
698307,698307,709530.0,"Financial Breakfast: Morning News Summary for February 22, 2012",2012-02-22 07:33:00-05:00,JNJ,financial breakfast morning news summary for february 22 2012,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998733997344971
698308,698308,709531.0,"Johnson & Johnson Says Bill Weldon Will Retire in April, Gorsky Will Succeed as CEO",2012-02-21 17:08:00-05:00,JNJ,johnson and johnson says bill weldon will retire in april gorsky will succeed as ceo,"{'neg': 0.0, 'neu': 0.814, 'pos': 0.186, 'compound': 0.4939}",neutral,0.99983811378479
698309,698309,709532.0,Johnson & Johnson to Name Vice Chairman Gorsky CEO -WSJ,2012-02-21 16:33:00-05:00,JNJ,johnson and johnson to name vice chairman gorsky ceo wsj,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998617172241211
698310,698310,709533.0,US High Court Rejects J&J's Bid To Save Patent Case Against Abbott,2012-02-21 10:02:00-05:00,JNJ,us high court rejects j and js bid to save patent case against abbott,"{'neg': 0.174, 'neu': 0.652, 'pos': 0.174, 'compound': 0.0}",positive,0.9618254899978638
698311,698311,709534.0,S&P Futures & Big 10 Analysis - Week of February 20,2012-02-20 12:01:00-05:00,JNJ,SP500 futures and big 10 analysis to week of february 20,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998903274536133
698312,698312,709535.0,Johnson & Johnson Wins First Personal Injury Trial Over Risperdal Risk,2012-02-16 11:43:00-05:00,JNJ,johnson and johnson wins first personal injury trial over risperdal risk,"{'neg': 0.295, 'neu': 0.482, 'pos': 0.223, 'compound': -0.0516}",positive,0.894631028175354
698313,698313,709536.0,"Hedge Fund 13-F Updates: Berkshire, Greenlight, Paulson & Co., Appaloosa and More!",2012-02-14 17:44:00-05:00,JNJ,hedge fund 13 f updates berkshire greenlight paulson and co appaloosa and more,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998703002929688
698314,698314,709537.0,Berkshire Filing Shows Reduced JNJ Stake,2012-02-14 16:36:00-05:00,JNJ,berkshire filing shows reduced jnj stake,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9924679398536682
698315,698315,709538.0,S&P Futures & Big 10 Analysis - Week of February 13,2012-02-13 11:13:00-05:00,JNJ,SP500 futures and big 10 analysis to week of february 13,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998908042907715
698316,698316,709539.0,Healthcare Analyst: Contraceptive Costs Are Not Issue; Birth Statistics Can be Manipulated,2012-02-10 15:20:00-05:00,JNJ,healthcare analyst contraceptive costs are not issue birth statistics can be manipulated,"{'neg': 0.191, 'neu': 0.809, 'pos': 0.0, 'compound': -0.3818}",neutral,0.9998778104782104
698317,698317,709540.0,Grandpa's 2012 ETF Portfolio,2012-02-10 13:48:00-05:00,JNJ,grandpas 2012 etf portfolio,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999881386756897
698318,698318,709541.0,"S&P Futures & Big 10 Analysis - Week of Feb 6, 2012",2012-02-06 11:19:00-05:00,JNJ,SP500 futures and big 10 analysis to week of feb 6 2012,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998886585235596
698319,698319,709542.0,"Benzinga's M&A Chatter for Thursday February 2, 2012",2012-02-02 19:57:00-05:00,JNJ,benzingas m and a chatter for thursday february 2 2012,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998887777328491
698320,698320,709543.0,UPDATE: First Global Downgrades Johnson & Johnson to Market Perform,2012-02-02 10:02:00-05:00,JNJ,update first global downgrades johnson and johnson to market perform,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.978147566318512
698321,698321,709544.0,First Global Downgrades Johnson & Johnson to Market Perform,2012-02-02 09:21:00-05:00,JNJ,first global downgrades johnson and johnson to market perform,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9976436495780945
698322,698322,709545.0,"S&P Futures & Big 10 Analysis - Week of Jan 30th, 2012",2012-01-31 16:10:00-05:00,JNJ,SP500 futures and big 10 analysis to week of jan 30 2012,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998904466629028
698323,698323,709546.0,"Benzinga's M&A Chatter for Thursday January 26, 2012",2012-01-26 18:24:00-05:00,JNJ,benzingas m and a chatter for thursday january 26 2012,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998865127563477
698324,698324,709547.0,Johnson & Johnson Wins Jury Verdict Over Levaquin Warning Claim,2012-01-26 14:09:00-05:00,JNJ,johnson and johnson wins jury verdict over levaquin warning claim,"{'neg': 0.163, 'neu': 0.476, 'pos': 0.361, 'compound': 0.4404}",positive,0.9972798824310303
698325,698325,709548.0,Elan Spokesperson Will Not Comment on Rumor of Johnson & Johnson Offer,2012-01-26 07:44:00-05:00,JNJ,elan spokesperson will not comment on rumor of johnson and johnson offer,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998631477355957
698326,698326,709549.0,Hearing Chatter Johnson & Johnson to Bid for Elan,2012-01-26 07:23:00-05:00,JNJ,hearing chatter johnson and johnson to bid for elan,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998061060905457
698327,698327,709550.0,Johnson & Johnson Receives Positive Mad Money/Jim Cramer Mention -CNBC ,2012-01-25 18:27:00-05:00,JNJ,johnson and johnson receives positive mad money and jim cramer mention cnbc,"{'neg': 0.19, 'neu': 0.595, 'pos': 0.214, 'compound': 0.1027}",positive,0.9995689988136292
698328,698328,709551.0,Piper Jaffray Lowers PT on Johnson & Johnson to $68,2012-01-25 08:34:00-05:00,JNJ,piper jaffray lowers point on johnson and johnson to dollars 8,"{'neg': 0.13, 'neu': 0.87, 'pos': 0.0, 'compound': -0.128}",neutral,0.9904295206069946
698329,698329,709552.0,Morgan Stanley Concerned with Johnson & Johnson Sustaining a Path to Leverage,2012-01-25 08:10:00-05:00,JNJ,morgan stanley concerned with johnson and johnson sustaining a path to leverage,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9745005369186401
698330,698330,709553.0,Morgan Keegan Maintains Market Perform Rating on Johnson & Johnson,2012-01-25 08:01:00-05:00,JNJ,morgan keegan maintains market perform rating on johnson and johnson,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.616146981716156
698331,698331,709554.0,Morgan Keegan Maintains Market Perform Rating on Johnson & Johnson,2012-01-25 08:01:00-05:00,JNJ,morgan keegan maintains market perform rating on johnson and johnson,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.616146981716156
698332,698332,709555.0,"Benzinga's M&A Chatter for Tuesday January 24, 2012",2012-01-24 18:53:00-05:00,JNJ,benzingas m and a chatter for tuesday january 24 2012,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998834133148193
698333,698333,709556.0,Hearing William Blair Making Negative Comments on Mako Surgical; Johnson  & Johnson Not Interested in Acquistion,2012-01-24 14:48:00-05:00,JNJ,hearing william blair making negative comments on mako surgical johnson and johnson not interested in acquistion,"{'neg': 0.299, 'neu': 0.701, 'pos': 0.0, 'compound': -0.7147}",neutral,0.988512396812439
698334,698334,709557.0,JP Morgan Reiterates Neutral on Johnson & Johnson,2012-01-24 13:34:00-05:00,JNJ,jp morgan reiterates neutral on johnson and johnson,"{'neg': 0.0, 'neu': 0.795, 'pos': 0.205, 'compound': 0.2023}",neutral,0.9996234178543091
698335,698335,709558.0,Earnings Roundup,2012-01-24 10:01:00-05:00,JNJ,earnings roundup,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998680353164673
698336,698336,709559.0,Achillion Pharmaceuticals Spiking Higher on Renewed Takeover Chatter,2012-01-24 09:49:00-05:00,JNJ,achillion pharmaceuticals spiking higher on renewed takeover chatter,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996098875999451
698337,698337,709560.0,UPDATE: Johnson & Johnson Q4 Net Income Drops 89%,2012-01-24 08:01:00-05:00,JNJ,update johnson and johnson fourth quarter net income drops 89 percent,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9985425472259521
698338,698338,709561.0,Johnson & Johnson Guides FY2011 EPS $5.05-5.15 vs $5.20 Est,2012-01-24 07:48:00-05:00,JNJ,johnson and johnson guides fy2011 eps dollars .05 to 5.15 vs dollars .20 est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998770952224731
698339,698339,709562.0,Johnson & Johnson Reports Q4 EPS $1.13 vs $1.10 Est; Revenues $16.30B vs $16.28B Est	 		,2012-01-24 07:46:00-05:00,JNJ,johnson and johnson reports fourth quarter eps dollars .13 vs dollars .10 est revenues dollars 6.30 billion vs dollars 6.28 billion est	 		,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998810291290283
698340,698340,709563.0,"US Stock Futures Down; McDonald's, Johnson & Johnson In Focus",2012-01-24 06:37:00-05:00,JNJ,us stock futures down mcdonalds johnson and johnson in focus,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.8737420439720154
698341,698341,709564.0,Earnings Scheduled For January 24,2012-01-24 06:03:00-05:00,JNJ,earnings scheduled for january 24,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998745918273926
698342,698342,709565.0,Stocks To Watch For January 24,2012-01-24 05:46:00-05:00,JNJ,stocks to watch for january 24,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998530149459839
698343,698343,709566.0,Johnson & Johnson Earnings Preview,2012-01-24 03:40:00-05:00,JNJ,johnson and johnson earnings preview,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998369216918945
698344,698344,709567.0,Earnings Expectations for the Week of January 23,2012-01-22 14:13:00-05:00,JNJ,earnings expectations for the week of january 23,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998512268066406
698345,698345,709568.0,"Democrats Seeks Hearing on Hazardous Medical Devices; Says Studies Show Risks wit J&J, Allergan Devices",2012-01-20 13:27:00-05:00,JNJ,democrats seeks hearing on hazardous medical devices says studies show risks wit j and j allergan devices,"{'neg': 0.116, 'neu': 0.884, 'pos': 0.0, 'compound': -0.2732}",negative,0.7847805619239807
698346,698346,709569.0,"Benzinga's M&A Chatter for Wednesday January 18, 2012",2012-01-18 18:53:00-05:00,JNJ,benzingas m and a chatter for wednesday january 18 2012,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998855590820312
698347,698347,709570.0,Positive Rumors Circulate About Vertex Pharmaceuticals,2012-01-18 09:43:00-05:00,JNJ,positive rumors circulate about vertex pharmaceuticals,"{'neg': 0.0, 'neu': 0.581, 'pos': 0.419, 'compound': 0.5574}",neutral,0.9998123049736023
698348,698348,709571.0,"Hearing Wedbush Says Idenix Pharmaceuticals Takeover Target of Merck, Johnson & Johnson, Abbott Labs; $24/Share",2012-01-18 08:07:00-05:00,JNJ,hearing wedbush says idenix pharmaceuticals takeover target of merck johnson and johnson abbott labs dollars,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998549222946167
698349,698349,709572.0,Going Nuc-lear on Hepatitis C -- Is Idenix the Next Target?,2012-01-10 14:54:00-05:00,JNJ,going nuc lear on hepatitis c is idenix the next target,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998757839202881
698350,698350,709573.0,Dividend Champions a Rare Undervalued Opportunity,2012-01-06 13:41:00-05:00,JNJ,dividend champions a rare undervalued opportunity,"{'neg': 0.0, 'neu': 0.392, 'pos': 0.608, 'compound': 0.7351}",positive,0.998584508895874
698351,698351,709574.0,FDA Says Johnson & Johnson Doribax Trial Was Recently Stopped Early Because of Significant Safety Concerns -Reuters  ,2012-01-05 15:37:00-05:00,JNJ,fda says johnson and johnson doribax trial was recently stopped early because of significant safety concerns reuters,"{'neg': 0.093, 'neu': 0.683, 'pos': 0.224, 'compound': 0.4019}",negative,0.9568061828613281
698352,698352,709575.0,J&J Said to Agree to $1B Accord in Risperdal Sales Probe,2012-01-05 14:50:00-05:00,JNJ,j and j said to agree to dollars b accord in risperdal sales probe,"{'neg': 0.0, 'neu': 0.839, 'pos': 0.161, 'compound': 0.3612}",positive,0.9971184730529785
698353,698353,709576.0,J&J and CR Bard Ordered to Study Injuries from Vaginal Implants,2012-01-04 15:00:00-05:00,JNJ,j and j and cr bard ordered to study injuries from vaginal implants,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998509883880615
698354,698354,709577.0,Bark At The Dow's Dogs With These ETFs,2012-01-04 13:40:00-05:00,JNJ,bark at the dows dogs with these etfs,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998688697814941
698355,698355,709578.0,ETF Showdown: Fun With Pharma,2011-12-30 16:10:00-05:00,JNJ,etf showdown fun with pharma,"{'neg': 0.0, 'neu': 0.548, 'pos': 0.452, 'compound': 0.5106}",neutral,0.9996960163116455
698356,698356,709579.0,Benzinga's Top Pre-Market Losers,2011-12-30 08:22:00-05:00,JNJ,benzingas top pre market losers,"{'neg': 0.415, 'neu': 0.366, 'pos': 0.22, 'compound': -0.3818}",neutral,0.996982753276825
698357,698357,709580.0,Five ETFs For Fans Of Extreme Couponing,2011-12-28 13:12:00-05:00,JNJ,five etfs for fans of extreme couponing,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998687505722046
698358,698358,709581.0,"Fast Money Picks For December 28th (CP, TSM, SLB, SBUX, JNJ, ANF)",2011-12-27 21:03:00-05:00,JNJ,fast money picks for december 28 cp tsm slb sbux jnj anf,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998778104782104
698359,698359,709582.0,Will This Company's Drug Cure Your Allergies?,2011-12-27 12:32:00-05:00,JNJ,will this companys drug cure your allergies,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9991870522499084
698360,698360,709583.0,Best Biotech Stocks of 2011,2011-12-27 10:39:00-05:00,JNJ,best biotech stocks of 2011,"{'neg': 0.0, 'neu': 0.488, 'pos': 0.512, 'compound': 0.6369}",neutral,0.9998670816421509
698361,698361,709584.0,FDA Advisers Vote That Current Label Adequately Reflects Risks and Benefits of Johnson & Johnson's Ortho Evra Contraceptive Patch  ,2011-12-09 15:38:00-05:00,JNJ,fda advisers vote that current label adequately reflects risks and benefits of johnson and johnsons ortho evra contraceptive patch,"{'neg': 0.097, 'neu': 0.783, 'pos': 0.12, 'compound': 0.128}",neutral,0.9762929677963257
698362,698362,709585.0,Mad Money Lightning Round: Cramer Likes Johnson & Johnson,2011-12-09 03:43:00-05:00,JNJ,mad money lightning round cramer likes johnson and johnson,"{'neg': 0.246, 'neu': 0.538, 'pos': 0.215, 'compound': -0.1027}",neutral,0.9998384714126587
698363,698363,709586.0,Janssen Says Deal to Cut Johnson & Johnson 2011 EPS by $0.04-$0.05,2011-12-08 16:25:00-05:00,JNJ,janssen says deal to cut johnson and johnson 2011 eps by dollars .04 dollars .05,"{'neg': 0.13, 'neu': 0.87, 'pos': 0.0, 'compound': -0.2732}",neutral,0.8874663710594177
698364,698364,709587.0,Pharmacyclics Forms Pact to Develop and Commercialize PCI-32765 for Hematologic Cancers with Janssen Biotech ,2011-12-08 16:08:00-05:00,JNJ,pharmacyclics forms pact to develop and commercialize pci 32765 for hematologic cancers with janssen biotech,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9994737505912781
698365,698365,709588.0,Affymax Wins FDA Panel Backing on Anemia Drug to Rival Amgen's,2011-12-07 16:53:00-05:00,JNJ,affymax wins fda panel backing on anemia drug to rival amgens,"{'neg': 0.0, 'neu': 0.652, 'pos': 0.348, 'compound': 0.5859}",positive,0.9995751976966858
698366,698366,709589.0,Biotech Stocks On the Move,2011-12-05 17:26:00-05:00,JNJ,biotech stocks on the move,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998315572738647
698367,698367,709590.0,Are the Samsung M&A Rumors True?,2011-12-01 14:52:00-05:00,JNJ,are the samsung m and a rumors true,"{'neg': 0.0, 'neu': 0.714, 'pos': 0.286, 'compound': 0.4215}",neutral,0.999884843826294
698368,698368,709591.0,Piper Jaffray Maintains Neutral Rating and $69 PT on Johnson & Johnson ,2011-12-01 07:26:00-05:00,JNJ,piper jaffray maintains neutral rating and dollars 9 point on johnson and johnson,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9947386384010315
698369,698369,709592.0,These Stocks May Be Better Than Their Dow Equivalents,2011-12-01 04:03:00-05:00,JNJ,these stocks may be better than their dow equivalents,"{'neg': 0.0, 'neu': 0.734, 'pos': 0.266, 'compound': 0.4404}",positive,0.9994631409645081
698370,698370,709593.0,UPDATE: Citi Lowers PT to $70 on Johnson & Johnson ,2011-11-29 09:48:00-05:00,JNJ,update citi lowers point to dollars 0 on johnson and johnson,"{'neg': 0.13, 'neu': 0.87, 'pos': 0.0, 'compound': -0.128}",neutral,0.9886647462844849
698371,698371,709594.0,Citigroup Lowers PT on Johnson & Johnson to $70,2011-11-29 07:23:00-05:00,JNJ,citigroup lowers point on johnson and johnson to dollars 0,"{'neg': 0.143, 'neu': 0.857, 'pos': 0.0, 'compound': -0.128}",negative,0.4714380204677582
698372,698372,709595.0,Stocks Going Ex Dividend the Fourth Week of November,2011-11-16 22:16:00-05:00,JNJ,stocks going ex dividend the fourth week of november,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998884201049805
698373,698373,709596.0,"Moving Away From The Materials Sector, Toward A Growth/Momentum Style",2011-11-16 02:41:00-05:00,JNJ,moving away from the materials sector toward a growth and momentum style,"{'neg': 0.0, 'neu': 0.809, 'pos': 0.191, 'compound': 0.3818}",neutral,0.999241828918457
698374,698374,709597.0,Invest Like Buffett...With ETFs,2011-11-15 14:03:00-05:00,JNJ,invest like buffett with etfs,"{'neg': 0.0, 'neu': 0.615, 'pos': 0.385, 'compound': 0.3612}",neutral,0.9998685121536255
698375,698375,709598.0,"Brean Murray Carret & Co maintain Buy, $77 Target on Johnson & Johnson ",2011-11-14 11:06:00-05:00,JNJ,brean murray carret and co maintain buy dollars 7 target on johnson and johnson,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.7107244729995728
698376,698376,709599.0,Citi Has Buy on J&J,2011-11-14 07:38:00-05:00,JNJ,citi has buy on j and j,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998065829277039
698377,698377,709600.0,Maintaining Stability in My Dividends and Yield Portfolio,2011-11-11 04:18:00-05:00,JNJ,maintaining stability in my dividends and yield portfolio,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9972208738327026
698378,698378,709601.0,"Four Defensive ETFs You're Not Considering, But Should",2011-11-09 14:06:00-05:00,JNJ,four defensive etfs youre not considering but should,"{'neg': 0.0, 'neu': 0.87, 'pos': 0.13, 'compound': 0.0129}",neutral,0.9998756647109985
698379,698379,709602.0,JNJ's Sterilmed Gets FDA Letter on Lack of Approval for Device,2011-11-08 09:28:00-05:00,JNJ,jnjs sterilmed gets fda letter on lack of approval for device,"{'neg': 0.16, 'neu': 0.625, 'pos': 0.215, 'compound': 0.2023}",negative,0.9893012642860413
698380,698380,709603.0,FDA Approves Bayer/J&J's Xarelto for Stroke Prevention,2011-11-04 20:21:00-04:00,JNJ,fda approves bayer and j and js xarelto for stroke prevention,"{'neg': 0.0, 'neu': 0.787, 'pos': 0.213, 'compound': 0.4019}",neutral,0.9997963309288025
698381,698381,709604.0,J&J-Synthes Deal Will Get Extend EU Antitrust Review,2011-11-03 18:22:00-04:00,JNJ,j and j synthes deal will get extend eu antitrust review,"{'neg': 0.0, 'neu': 0.855, 'pos': 0.145, 'compound': 0.1779}",positive,0.8210169672966003
698382,698382,709605.0,Mad Money Lightning Round: Cramer Advises Investors Not To Buy Microsoft,2011-11-01 03:32:00-04:00,JNJ,mad money lightning round cramer advises investors not to buy microsoft,"{'neg': 0.242, 'neu': 0.758, 'pos': 0.0, 'compound': -0.4939}",neutral,0.9995923638343811
698383,698383,709606.0,A Look at The New DRGS ETN,2011-10-31 13:34:00-04:00,JNJ,a look at the new drgs etn,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998879432678223
698384,698384,709607.0,How We Pick Stocks: The Case of Johnson & Johnson,2011-10-31 09:44:00-04:00,JNJ,how we pick stocks the case of johnson and johnson,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998828172683716
698385,698385,709608.0,"Merck Earnings Preview: Analysts Expect Higher EPS, Revenue",2011-10-25 12:10:00-04:00,JNJ,merck earnings preview analysts expect higher eps revenue,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.99959796667099
698386,698386,709609.0,"Bristol-Myers Squibb Earnings Preview: Analysts Expect Rising Revenue, Falling EPS",2011-10-24 10:16:00-04:00,JNJ,bristol myers squibb earnings preview analysts expect rising revenue falling eps,"{'neg': 0.138, 'neu': 0.862, 'pos': 0.0, 'compound': -0.1531}",negative,0.9986401200294495
698387,698387,709610.0,The Donald Trump Bottom? 2 Months Later,2011-10-21 14:06:00-04:00,JNJ,the donald trump bottom 2 months later,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998794794082642
698388,698388,709611.0,"Earnings Preview: Analysts Expect Boston Scientific's Revenue, Earnings to Dip",2011-10-19 16:13:00-04:00,JNJ,earnings preview analysts expect boston scientifics revenue earnings to dip,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9987951517105103
698389,698389,709612.0,JP Morgan Maintains Neutral on Johnson & Johnson's Mixed 3Q Results,2011-10-19 11:06:00-04:00,JNJ,jp morgan maintains neutral on johnson and johnsons mixed third quarter results,"{'neg': 0.0, 'neu': 0.859, 'pos': 0.141, 'compound': 0.2023}",positive,0.9948999285697937
698390,698390,709613.0,Piper Jaffray Raises PT on Johnson & Johnson to $69,2011-10-19 08:21:00-04:00,JNJ,piper jaffray raises point on johnson and johnson to dollars 9,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9895312786102295
698391,698391,709614.0,Morgan Stanley Maintains Equal Weight Rating on Johnson & Johnson ,2011-10-19 07:56:00-04:00,JNJ,morgan stanley maintains equal weight rating on johnson and johnson,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998729228973389
698392,698392,709615.0,Deutsche Bank Reiterates Hold Rating on Johnson & Johnson,2011-10-19 07:10:00-04:00,JNJ,deutsche bank reiterates hold rating on johnson and johnson,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9930689334869385
698393,698393,709616.0,"End-of-Day Market Summary for October 18, 2011",2011-10-18 16:15:00-04:00,JNJ,end of day market summary for october 18 2011,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998869895935059
698394,698394,709617.0,Earnings Roundup For October 18,2011-10-18 09:11:00-04:00,JNJ,earnings roundup for october 18,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999883770942688
698395,698395,709618.0,Johnson & Johnson Sees Net Income Climb,2011-10-18 08:22:00-04:00,JNJ,johnson and johnson sees net income climb,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.999671459197998
698396,698396,709619.0,UPDATE: Johnson & Johnson Reports Drop In Q3 Profit,2011-10-18 08:04:00-04:00,JNJ,update johnson and johnson reports drop in third quarter profit,"{'neg': 0.162, 'neu': 0.615, 'pos': 0.223, 'compound': 0.2023}",negative,0.998683750629425
698397,698397,709620.0,Johnson & Johnson Guides FY2011 EPS $4.95-5.00 vs $4.96 Est,2011-10-18 07:46:00-04:00,JNJ,johnson and johnson guides fy2011 eps dollars .95 to 5.00 vs dollars .96 est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998840093612671
698398,698398,709621.0,Johnson & Johnson Guides FY2011 EPS $4.95-5.00 vs $4.96 Est,2011-10-18 07:46:00-04:00,JNJ,johnson and johnson guides fy2011 eps dollars .95 to 5.00 vs dollars .96 est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998840093612671
698399,698399,709622.0,Johnson & Johnson Reports Q3 EPS $1.24 vs $1.21 Est; Revenues $16.0B vs $16.02B Est		,2011-10-18 07:45:00-04:00,JNJ,johnson and johnson reports third quarter eps dollars .24 vs dollars .21 est revenues dollars 6.0 billion vs dollars 6.02 billion est		,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999880313873291
698400,698400,709623.0,US Stock Futures Mixed Ahead Of Earnings Reports; IBM Shares Down In Pre-Market,2011-10-18 06:02:00-04:00,JNJ,us stock futures mixed ahead of earnings reports ibm shares down in pre market,"{'neg': 0.0, 'neu': 0.855, 'pos': 0.145, 'compound': 0.296}",negative,0.9891735315322876
698401,698401,709624.0,Earnings Scheduled For October 18,2011-10-18 04:45:00-04:00,JNJ,earnings scheduled for october 18,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998775720596313
698402,698402,709625.0,Brean Murray Carret & Co. Reiterates Buy Rating on J&J,2011-10-17 15:08:00-04:00,JNJ,brean murray carret and co reiterates buy rating on j and j,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9991944432258606
698403,698403,709626.0,UBS Lowers PT on Johnson & Johnson to $72,2011-10-17 10:14:00-04:00,JNJ,ubs lowers point on johnson and johnson to dollars 2,"{'neg': 0.143, 'neu': 0.857, 'pos': 0.0, 'compound': -0.128}",neutral,0.9984343647956848
698404,698404,709627.0,Earnings Expectations for the Week of October 17,2011-10-16 09:36:00-04:00,JNJ,earnings expectations for the week of october 17,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998537302017212
698405,698405,709628.0,"Abbott Laboratories Earnings Preview: Analysts Expect Higher EPS, Revenue",2011-10-14 17:54:00-04:00,JNJ,abbott laboratories earnings preview analysts expect higher eps revenue,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996125102043152
698406,698406,709629.0,"Johnson & Johnson Earnings Preview: Analysts Expect Rising Revenue, Falling EPS",2011-10-14 10:19:00-04:00,JNJ,johnson and johnson earnings preview analysts expect rising revenue falling eps,"{'neg': 0.138, 'neu': 0.862, 'pos': 0.0, 'compound': -0.1531}",negative,0.9987446069717407
698407,698407,709630.0,Under The Hood: Emerging Markets Health Care,2011-10-13 13:01:00-04:00,JNJ,under the hood emerging markets health care,"{'neg': 0.0, 'neu': 0.652, 'pos': 0.348, 'compound': 0.4939}",neutral,0.9998903274536133
698408,698408,709631.0,Piper Jaffray Neutral on Johnson & Johnson,2011-10-13 07:45:00-04:00,JNJ,piper jaffray neutral on johnson and johnson,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998670816421509
698409,698409,709632.0,Boston Scientific Announces Favorable Appellate Court Ruling Affirming Non-Infringement of Johnson & Johnson Patent ,2011-09-29 06:49:00-04:00,JNJ,boston scientific announces favorable appellate court ruling affirming non infringement of johnson and johnson patent,"{'neg': 0.161, 'neu': 0.677, 'pos': 0.161, 'compound': 0.0}",positive,0.9991865754127502
698410,698410,709633.0,Remicade Receives FDA Approval as First Biologic Treatment for Pediatric Ulcerative Colitis,2011-09-24 10:37:00-04:00,JNJ,remicade receives fda approval as first biologic treatment for pediatric ulcerative colitis,"{'neg': 0.0, 'neu': 0.78, 'pos': 0.22, 'compound': 0.4767}",positive,0.9894437789916992
698411,698411,709634.0,Charles Sizemore Quoted in Smart Money,2011-09-23 14:33:00-04:00,JNJ,charles sizemore quoted in smart money,"{'neg': 0.0, 'neu': 0.649, 'pos': 0.351, 'compound': 0.4019}",neutral,0.99985671043396
698412,698412,709635.0,"Johnson & Johnson Recalls 200,000 Syringes of Eprex Anemia Drug",2011-09-23 11:39:00-04:00,JNJ,johnson and johnson recalls 200000 syringes of eprex anemia drug,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998787641525269
698413,698413,709636.0,5 Exceptional Dividend Growth Stocks - Lower Volatility and Higher Total Return,2011-09-22 14:46:00-04:00,JNJ,5 exceptional dividend growth stocks to lower volatility and higher total return,"{'neg': 0.146, 'neu': 0.663, 'pos': 0.191, 'compound': 0.1725}",positive,0.9996298551559448
698414,698414,709637.0,UPDATE: Goldman Sachs Downgrades Johnson & Johnson to $63.13,2011-09-22 09:14:00-04:00,JNJ,update goldman sachs downgrades johnson and johnson to dollars 3.13,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9972875118255615
698415,698415,709638.0,"Financial Breakfast: Morning News Summary for September 22, 2011",2011-09-22 07:54:00-04:00,JNJ,financial breakfast morning news summary for september 22 2011,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998759031295776
698416,698416,709639.0,"Goldman Sachs Downgrades Johnson & Johnson to Neutral, $74 PT",2011-09-22 07:28:00-04:00,JNJ,goldman sachs downgrades johnson and johnson to neutral dollars 4 point,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9985118508338928
698417,698417,709640.0,Piper Jaffray Comments on Johnson & Johnson,2011-09-19 16:00:00-04:00,JNJ,piper jaffray comments on johnson and johnson,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998701810836792
698418,698418,709641.0,Johnson & Johnson CEO Weldon Says Too Early to Tell on US Economy,2011-09-16 11:46:00-04:00,JNJ,johnson and johnson ceo weldon says too early to tell on us economy,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999818742275238
698419,698419,709642.0,Greece: The Questions Investors Should be Asking,2011-09-14 23:09:00-04:00,JNJ,greece the questions investors should be asking,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998753070831299
698420,698420,709643.0,Johnson & Johnson to Face Arkansas Trial Over Risperdal -Bloomberg,2011-09-14 19:15:00-04:00,JNJ,johnson and johnson to face arkansas trial over risperdal bloomberg,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997689127922058
698421,698421,709644.0,S&P Likes Three Health Care ETFs,2011-09-14 16:18:00-04:00,JNJ,SP500 likes three health care etfs,"{'neg': 0.0, 'neu': 0.4, 'pos': 0.6, 'compound': 0.7184}",neutral,0.9998891353607178
698422,698422,709645.0,"UPDATE: J&J Unit To Pay $85M Fine, Plead Guilty To Charge",2011-09-14 15:57:00-04:00,JNJ,update j and j unit to pay dollars 5 million fine plead guilty to charge,"{'neg': 0.233, 'neu': 0.667, 'pos': 0.1, 'compound': -0.34}",neutral,0.9850687384605408
698423,698423,709646.0,"J&J Unit, US In Plea Pact For Natrecor Marketing Probe - Court Filing",2011-09-14 15:56:00-04:00,JNJ,j and j unit us in plea pact for natrecor marketing probe to court filing,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9996762275695801
698424,698424,709647.0,What If I'm Wrong?,2011-09-13 00:11:00-04:00,JNJ,what if im wrong,"{'neg': 0.508, 'neu': 0.492, 'pos': 0.0, 'compound': -0.4767}",neutral,0.9950473308563232
698425,698425,709648.0,Is Hansen Medical a Takeover Target?,2011-09-12 15:28:00-04:00,JNJ,is hansen medical a takeover target,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998519420623779
698426,698426,709649.0,Citi Has Buy On Johnson & Johnson ,2011-09-09 07:51:00-04:00,JNJ,citi has buy on johnson and johnson,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997487664222717
698427,698427,709650.0,Benzinga's Top Pre-Market Gainers,2011-09-09 07:46:00-04:00,JNJ,benzingas top pre market gainers,"{'neg': 0.0, 'neu': 0.69, 'pos': 0.31, 'compound': 0.2023}",positive,0.9995827078819275
698428,698428,709651.0,FDA Advisory Committee Recommends Approval of Johnson & Johnson Oral Anticoagulant,2011-09-08 17:39:00-04:00,JNJ,fda advisory committee recommends approval of johnson and johnson oral anticoagulant,"{'neg': 0.0, 'neu': 0.643, 'pos': 0.357, 'compound': 0.6124}",neutral,0.9997878670692444
698429,698429,709652.0,S&P Endorses Two Dividend ETFs,2011-09-07 12:01:00-04:00,JNJ,SP500 endorses two dividend etfs,"{'neg': 0.0, 'neu': 0.625, 'pos': 0.375, 'compound': 0.34}",neutral,0.9998854398727417
698430,698430,709653.0,Johnson & Johnson's Zytiga Prostate-Cancer Drug Gets European Approval,2011-09-07 07:57:00-04:00,JNJ,johnson and johnsons zytiga prostate cancer drug gets european approval,"{'neg': 0.284, 'neu': 0.516, 'pos': 0.2, 'compound': -0.3182}",positive,0.9936262369155884
698431,698431,709654.0,Citi Maintains Buy on Johnson & Johnson,2011-08-30 09:21:00-04:00,JNJ,citi maintains buy on johnson and johnson,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9988184571266174
698432,698432,709655.0,"Groupon's Andrew Mason: ""I've Never Been More Confident and Excited about the Future of our Business""",2011-08-26 10:54:00-04:00,JNJ,groupons andrew mason ive never been more confident and excited about the future of our business,"{'neg': 0.146, 'neu': 0.718, 'pos': 0.137, 'compound': -0.0467}",positive,0.9992480874061584
698433,698433,709656.0,12 Most Popular Healthcare Stocks Among Hedge Funds,2011-08-25 17:10:00-04:00,JNJ,12 most popular healthcare stocks among hedge funds,"{'neg': 0.0, 'neu': 0.694, 'pos': 0.306, 'compound': 0.4754}",neutral,0.9998897314071655
698434,698434,709657.0,12 Most Popular Healthcare Stocks Among Hedge Funds,2011-08-25 11:36:00-04:00,JNJ,12 most popular healthcare stocks among hedge funds,"{'neg': 0.0, 'neu': 0.694, 'pos': 0.306, 'compound': 0.4754}",neutral,0.9998897314071655
698435,698435,709658.0,The Greatest Risk We Face: To Again Falling Into a Recession,2011-08-23 17:55:00-04:00,JNJ,the greatest risk we face to again falling into a recession,"{'neg': 0.367, 'neu': 0.395, 'pos': 0.237, 'compound': -0.0772}",negative,0.9945612549781799
698436,698436,709659.0,The Global Meltdown of Confidence,2011-08-15 14:00:00-04:00,JNJ,the global meltdown of confidence,"{'neg': 0.0, 'neu': 0.548, 'pos': 0.452, 'compound': 0.5106}",negative,0.9971833825111389
698437,698437,709660.0,Johnson & Johnson's McNeil Healthcare Division Recalling Tylenol Cold Nighttime Gelcaps,2011-08-15 13:11:00-04:00,JNJ,johnson and johnsons mcneil healthcare division recalling tylenol cold nighttime gelcaps,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998810291290283
698438,698438,709661.0,Perrigo Earnings Preview,2011-08-15 09:55:00-04:00,JNJ,perrigo earnings preview,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999840259552002
698439,698439,709662.0,The Donald Trump Bottom,2011-08-11 10:19:00-04:00,JNJ,the donald trump bottom,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998792409896851
698440,698440,709663.0,Warren Buffett Said Ignore Political and Economic Forecasts,2011-08-10 16:54:00-04:00,JNJ,warren buffett said ignore political and economic forecasts,"{'neg': 0.263, 'neu': 0.737, 'pos': 0.0, 'compound': -0.3612}",neutral,0.998568058013916
698441,698441,709664.0,Embrace Your Inner Spock: Three Questions Investors Should be Asking,2011-08-10 10:33:00-04:00,JNJ,embrace your inner spock three questions investors should be asking,"{'neg': 0.0, 'neu': 0.796, 'pos': 0.204, 'compound': 0.3182}",neutral,0.9998511075973511
698442,698442,709665.0,"UPDATE: Goldman Sachs Reiterates Buy on Johnson & Johnson, Reduces PT to $74",2011-08-09 09:28:00-04:00,JNJ,"update goldman sachs reiterates buy on johnson and johnson reduces point to dollars 4","{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9981324076652527
698443,698443,709666.0,Goldman Sachs Lowers PT on Johnson & Johnson To $74,2011-08-09 08:46:00-04:00,JNJ,goldman sachs lowers point on johnson and johnson to dollars 4,"{'neg': 0.13, 'neu': 0.87, 'pos': 0.0, 'compound': -0.128}",neutral,0.9981417655944824
698444,698444,709667.0,Where to Invest When the Market Crashes,2011-08-08 22:37:00-04:00,JNJ,where to invest when the market crashes,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997331500053406
698445,698445,709668.0,"S&P States that Recent US Downgrade Won't Affect Rating of these Six Top-Tier Companies: ADP, XOM, JNJ, MSFT, GE, GWW",2011-08-08 15:09:00-04:00,JNJ,SP500 states that recent us downgrade wont affect rating of these six top tier companies adp xom jnj msft ge gww,"{'neg': 0.0, 'neu': 0.917, 'pos': 0.083, 'compound': 0.2023}",negative,0.9896889925003052
698448,698448,709670.0,The New World Order of Global Sovereigns,2011-08-02 18:06:00-04:00,JNJ,the new world order of global sovereigns,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998780488967896
698449,698449,709671.0,Hold These Funds Forever! Really? Forever?,2011-08-01 08:16:00-04:00,JNJ,hold these funds forever really forever,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998093247413635
698450,698450,709672.0,Benzinga's Top Pre-Market Losers,2011-08-01 07:58:00-04:00,JNJ,benzingas top pre market losers,"{'neg': 0.415, 'neu': 0.366, 'pos': 0.22, 'compound': -0.3818}",neutral,0.996982753276825
698451,698451,709673.0,The Best 8 Stocks in the Dow,2011-07-29 17:06:00-04:00,JNJ,the best 8 stocks in the dow,"{'neg': 0.0, 'neu': 0.588, 'pos': 0.412, 'compound': 0.6369}",neutral,0.9998486042022705
698452,698452,709674.0,10 Wall Street All-Stars With Money-Making Potential,2011-07-29 17:02:00-04:00,JNJ,10 wall street all stars with money making potential,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997721314430237
698453,698453,709675.0,Trading Weekly Options to Extract Profit from Amazon (AMZN),2011-07-29 17:00:00-04:00,JNJ,trading weekly options to extract profit from amazon amzn,"{'neg': 0.0, 'neu': 0.603, 'pos': 0.397, 'compound': 0.5574}",neutral,0.9998531341552734
698454,698454,709676.0,7 'Buy Rated' Stocks Trading Under $20,2011-07-29 16:57:00-04:00,JNJ,7 buy rated stocks trading under dollars 0,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998897314071655
698455,698455,709677.0,15 Safe Dividend Kings for This Summer: Part 2,2011-07-29 16:53:00-04:00,JNJ,15 safe dividend kings for this summer part 2,"{'neg': 0.0, 'neu': 0.734, 'pos': 0.266, 'compound': 0.4404}",neutral,0.9998037219047546
698456,698456,709678.0,Central Bank of Colombia Raises Rate 25bps to 4.50%,2011-07-29 16:51:00-04:00,JNJ,central bank of colombia raises rate 25 billion ps to 4.50 percent,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.7872238159179688
698457,698457,709679.0,15 Safe Dividend Kings for This Summer: Part 1,2011-07-29 16:50:00-04:00,JNJ,15 safe dividend kings for this summer part 1,"{'neg': 0.0, 'neu': 0.734, 'pos': 0.266, 'compound': 0.4404}",neutral,0.9998422861099243
698458,698458,709680.0,7 Fortune 500 Companies That Are Hiring: Time to Jump in and Buy?,2011-07-29 16:45:00-04:00,JNJ,7 fortune 500 companies that are hiring time to jump in and buy,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997316002845764
698459,698459,709681.0,What Investors Should Know About Apple but Often Don't,2011-07-29 16:40:00-04:00,JNJ,what investors should know about apple but often dont,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.99986732006073
698460,698460,709682.0,High Yield Birth Control Stocks,2011-07-28 21:45:00-04:00,JNJ,high yield birth control stocks,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998666048049927
698461,698461,709683.0,How to Profit from Exploding Government Healthcare Costs ,2011-07-28 09:37:00-04:00,JNJ,how to profit from exploding government healthcare costs,"{'neg': 0.0, 'neu': 0.707, 'pos': 0.293, 'compound': 0.4404}",neutral,0.9869688153266907
698462,698462,709684.0,Top Yield Stocks of Warren Buffett,2011-07-28 01:19:00-04:00,JNJ,top yield stocks of warren buffett,"{'neg': 0.0, 'neu': 0.735, 'pos': 0.265, 'compound': 0.2023}",neutral,0.9998654127120972
698463,698463,709685.0,Hearing Supreme Court Asked to Overturn Obama's Health Care Reform,2011-07-27 15:19:00-04:00,JNJ,hearing supreme court asked to overturn obamas health care reform,"{'neg': 0.0, 'neu': 0.541, 'pos': 0.459, 'compound': 0.7783}",neutral,0.9994025230407715
698464,698464,709686.0,"Earnings Preview: Merck EPS, Revenue Expected to Rise from Previous Quarter",2011-07-26 13:00:00-04:00,JNJ,earnings preview merck eps revenue expected to rise from previous quarter,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9997236132621765
698465,698465,709687.0,Ratchet Back The Risk With These ETFs,2011-07-25 14:00:00-04:00,JNJ,ratchet back the risk with these etfs,"{'neg': 0.259, 'neu': 0.741, 'pos': 0.0, 'compound': -0.2732}",neutral,0.8611461520195007
698466,698466,709688.0,"Boston Scientific Earnings Preview: Analysts Expect Rising Revenue, Falling EPS Over Previous Quarter",2011-07-25 13:49:00-04:00,JNJ,boston scientific earnings preview analysts expect rising revenue falling eps over previous quarter,"{'neg': 0.118, 'neu': 0.882, 'pos': 0.0, 'compound': -0.1531}",negative,0.9987643957138062
698467,698467,709689.0,"Bristol-Myers Squibb Earnings Preview: Analysts Expect Rising Revenue, Falling EPS Over Previous Quarter",2011-07-25 12:45:00-04:00,JNJ,bristol myers squibb earnings preview analysts expect rising revenue falling eps over previous quarter,"{'neg': 0.11, 'neu': 0.89, 'pos': 0.0, 'compound': -0.1531}",negative,0.9987515211105347
698468,698468,709690.0,Nothing To Sneeze At Here,2011-07-25 08:35:00-04:00,JNJ,nothing to sneeze at here,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999864935874939
698469,698469,709691.0,No Respect: The Rodney Dangerfield of the Investment World,2011-07-22 18:11:00-04:00,JNJ,no respect the rodney dangerfield of the investment world,"{'neg': 0.242, 'neu': 0.758, 'pos': 0.0, 'compound': -0.3724}",neutral,0.9998593330383301
698470,698470,709692.0,Johnson and Johnson: FDA Panel Backs Additional Use Of Remicade For Pediatric Patients,2011-07-21 15:25:00-04:00,JNJ,johnson and johnson fda panel backs additional use of remicade for pediatric patients,"{'neg': 0.091, 'neu': 0.909, 'pos': 0.0, 'compound': -0.0516}",neutral,0.9984775185585022
698471,698471,709693.0,Fifteen Health Care ETFs Trading Near 52-Week Highs,2011-07-21 13:57:00-04:00,JNJ,fifteen health care etfs trading near 52 week highs,"{'neg': 0.0, 'neu': 0.714, 'pos': 0.286, 'compound': 0.4939}",positive,0.9993300437927246
698472,698472,709694.0,"Earnings Preview: Gilead Sciences EPS, Revenue Expected to Rise from Previous Quarter",2011-07-21 13:12:00-04:00,JNJ,earnings preview gilead sciences eps revenue expected to rise from previous quarter,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9997164607048035
698473,698473,709695.0,Deutsche Bank Comments on Johnson & Johnson,2011-07-20 09:02:00-04:00,JNJ,deutsche bank comments on johnson and johnson,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998655319213867
698474,698474,709696.0,Gabelli Maintains Earnings Estimates On Johnson & Johnson ,2011-07-20 08:59:00-04:00,JNJ,gabelli maintains earnings estimates on johnson and johnson,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998416900634766
698475,698475,709697.0,JP Morgan Reiterates JNJ Neutral Rating,2011-07-20 08:07:00-04:00,JNJ,jp morgan reiterates jnj neutral rating,"{'neg': 0.0, 'neu': 0.735, 'pos': 0.265, 'compound': 0.2023}",positive,0.9272632002830505
698476,698476,709698.0,UPDATE: Citi Raises PT on Johnson & Johnson to $73,2011-07-20 08:07:00-04:00,JNJ,update citi raises point on johnson and johnson to dollars 3,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.7239558100700378
698477,698477,709699.0,Morgan Stanley Comments on Johnson & Johnson,2011-07-20 07:35:00-04:00,JNJ,morgan stanley comments on johnson and johnson,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998646974563599
698478,698478,709700.0,Citigroup Raises PT On Johnson & Johnson To $73,2011-07-20 06:43:00-04:00,JNJ,citigroup raises point on johnson and johnson to dollars 3,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9979267120361328
698479,698479,709701.0,Is It Time To Buy Cisco?,2011-07-19 19:05:00-04:00,JNJ,is it time to buy cisco,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998124241828918
698480,698480,709702.0,Malus domestica Produces  07-19-2011,2011-07-19 18:41:00-04:00,JNJ,malus domestica produces 07 to 19 to 2011,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998911619186401
698481,698481,709703.0,Will AAPL Succumb to Gravity?  07-19-2011,2011-07-19 15:21:00-04:00,JNJ,will aapl succumb to gravity 07 to 19 to 2011,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998229146003723
698482,698482,709704.0,Dow Jones Industrial Average Companies Increase Expected Dividend Distribution by 12.66% From a Year Ago,2011-07-19 10:14:00-04:00,JNJ,dow jones industrial average companies increase expected dividend distribution by 12.66 percent from a year ago,"{'neg': 0.0, 'neu': 0.867, 'pos': 0.133, 'compound': 0.3182}",positive,0.9997022747993469
698483,698483,709705.0,Earnings Roundup ,2011-07-19 09:01:00-04:00,JNJ,earnings roundup,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998680353164673
698484,698484,709706.0,UPDATE: Johnson & Johnson Reports Upbeat Q2 Profit,2011-07-19 08:35:00-04:00,JNJ,update johnson and johnson reports upbeat second quarter profit,"{'neg': 0.0, 'neu': 0.734, 'pos': 0.266, 'compound': 0.4404}",positive,0.9996079802513123
698485,698485,709707.0,Benzinga's Top Pre-Market Losers,2011-07-19 08:22:00-04:00,JNJ,benzingas top pre market losers,"{'neg': 0.415, 'neu': 0.366, 'pos': 0.22, 'compound': -0.3818}",neutral,0.996982753276825
698486,698486,709708.0,FDA Posts Staff Review of Study of J&J's Remicade in Children,2011-07-19 08:10:00-04:00,JNJ,fda posts staff review of study of j and js remicade in children,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999886155128479
698487,698487,709709.0,Johnson & Johnson Guides 2011 EPS $4.90-5.00 vs $4.96 Est.,2011-07-19 07:51:00-04:00,JNJ,johnson and johnson guides 2011 eps dollars .90 to 5.00 vs dollars .96 est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999884843826294
698488,698488,709710.0,Johnson & Johnson Reports Q2 EPS of $1.28 vs. $1.23 Est; Revenues $16.6B vs. $16.22B Est,2011-07-19 07:49:00-04:00,JNJ,johnson and johnson reports second quarter eps of dollars .28 vs dollars .23 est revenues dollars 6.6 billion vs dollars 6.22 billion est,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998819828033447
698489,698489,709711.0,US Stock Futures Up As Investors Await Earnings Reports,2011-07-19 06:26:00-04:00,JNJ,us stock futures up as investors await earnings reports,"{'neg': 0.0, 'neu': 0.851, 'pos': 0.149, 'compound': 0.1027}",neutral,0.6567028760910034
698490,698490,709712.0,Earnings Scheduled For July 19,2011-07-19 03:20:00-04:00,JNJ,earnings scheduled for july 19,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998772144317627
698491,698491,709713.0,Johnson & Johnson Announces Third-Quarter 2011 Quarterly Dividend of $0.57/Share,2011-07-18 14:56:00-04:00,JNJ,johnson and johnson announces third quarter 2011 quarterly dividend of dollars,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998805522918701
698492,698492,709714.0,Earnings Expectations for the Week of July 18,2011-07-17 09:18:00-04:00,JNJ,earnings expectations for the week of july 18,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998407363891602
698493,698493,709715.0,"Boston Scientific Earnings Preview: Revenue, Earnings Expected to Fall from Previous Quarter",2011-07-15 11:00:00-04:00,JNJ,boston scientific earnings preview revenue earnings expected to fall from previous quarter,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9987209439277649
698494,698494,709716.0,Forest Laboratories Earnings Preview: Analysts Expect Rising Revenue,2011-07-15 10:55:00-04:00,JNJ,forest laboratories earnings preview analysts expect rising revenue,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9996452331542969
698495,698495,709717.0,"Earnings Preview: Johnson & Johnson EPS, Revenue Expected to Rise from Previous Quarter",2011-07-15 10:36:00-04:00,JNJ,earnings preview johnson and johnson eps revenue expected to rise from previous quarter,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.999721348285675
698496,698496,709718.0,"Earnings Preview: Analysts Expect Abbott Laboratories Revenue, Earnings to Dip from Previous Quarter",2011-07-15 10:13:00-04:00,JNJ,earnings preview analysts expect abbott laboratories revenue earnings to dip from previous quarter,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9988222718238831
698497,698497,709719.0,Benzinga's Top Pre-Market Losers,2011-07-15 08:19:00-04:00,JNJ,benzingas top pre market losers,"{'neg': 0.415, 'neu': 0.366, 'pos': 0.22, 'compound': -0.3818}",neutral,0.996982753276825
698498,698498,709720.0,5 High Dividend Names For Sound Sleeping,2011-07-14 14:30:00-04:00,JNJ,5 high dividend names for sound sleeping,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999862790107727
698499,698499,709721.0,"Boston Scientific Earnings Preview: Revenue, Earnings Expected to Fall from Previous Quarter",2011-07-13 12:44:00-04:00,JNJ,boston scientific earnings preview revenue earnings expected to fall from previous quarter,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",negative,0.9987209439277649
698500,698500,709722.0,Twelve Health Care ETFs Trading Near 52-Week Highs,2011-07-13 07:38:00-04:00,JNJ,twelve health care etfs trading near 52 week highs,"{'neg': 0.0, 'neu': 0.714, 'pos': 0.286, 'compound': 0.4939}",positive,0.9992815852165222
698501,698501,709723.0,J.P. Morgan Previews 2Q Results For JNJ,2011-07-12 07:16:00-04:00,JNJ,j p morgan previews second quarter results for jnj,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998694658279419
698502,698502,709724.0,Twelve ETFs Trading Near 52-Week Highs,2011-07-12 06:56:00-04:00,JNJ,twelve etfs trading near 52 week highs,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",positive,0.9988911747932434
698503,698503,709725.0,UPDATE: Deutsche Bank Initiates Johnson & Johnson at Hold,2011-07-08 07:44:00-04:00,JNJ,update deutsche bank initiates johnson and johnson at hold,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.999859094619751
698504,698504,709726.0,"Deutsche Bank Initiates Johnson & Johnson At Hold, $73 PT",2011-07-08 06:47:00-04:00,JNJ,deutsche bank initiates johnson and johnson at hold dollars 3 point,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998716115951538
698505,698505,709727.0,Stocks to Watch for 07/8/11: Fresh 52 Week Highs and Lows,2011-07-08 00:59:00-04:00,JNJ,stocks to watch for fresh 52 week highs and lows,"{'neg': 0.149, 'neu': 0.661, 'pos': 0.19, 'compound': 0.128}",neutral,0.7627729773521423
698506,698506,709728.0,Court of Appeals Affirms $16.56 Million Judgment Against Johnson & Johnson in Defective Fentanyl Patch Case ,2011-07-07 15:54:00-04:00,JNJ,court of appeals affirms dollars 6.56 million judgment against johnson and johnson in defective fentanyl patch case,"{'neg': 0.153, 'neu': 0.847, 'pos': 0.0, 'compound': -0.4404}",neutral,0.6309324502944946
698507,698507,709729.0,Johnson & Johnson Announces Global Sponsorship of the 2014 FIFA World Cup Brazil ,2011-07-07 10:01:00-04:00,JNJ,johnson and johnson announces global sponsorship of the 2014 fifa world cup brazil,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998817443847656
698508,698508,709730.0,"""Can Stocks Be Safer than Bonds?""",2011-07-06 08:14:00-04:00,JNJ,can stocks be safer than bonds,"{'neg': 0.0, 'neu': 0.641, 'pos': 0.359, 'compound': 0.4215}",positive,0.9925678968429565
698509,698509,709731.0,Piper Jaffray Remains Neutral On Johnson & Johnson,2011-07-05 09:27:00-04:00,JNJ,piper jaffray remains neutral on johnson and johnson,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997898936271667
698510,698510,709732.0,UPDATE: Johnson & Johnson: FDA Approves XARELTO,2011-07-01 15:14:00-04:00,JNJ,update johnson and johnson fda approves xarelto,"{'neg': 0.0, 'neu': 0.69, 'pos': 0.31, 'compound': 0.4019}",neutral,0.9998090863227844
698511,698511,709733.0,Time To Look At Boston Scientific?,2011-07-01 13:10:00-04:00,JNJ,time to look at boston scientific,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998781681060791
698512,698512,709734.0,High Yield Big Pharmaceutical Stocks,2011-06-24 01:19:00-04:00,JNJ,high yield big pharmaceutical stocks,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998749494552612
698513,698513,709735.0,"Morgan Stanley Provides Color on Johnson & Johnson, Equal-Weight",2011-06-23 07:18:00-04:00,JNJ,morgan stanley provides color on johnson and johnson equal weight,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998778104782104
698514,698514,709736.0,3 High Dividend Stocks The Smart Money Is Buying,2011-06-20 11:59:00-04:00,JNJ,3 high dividend stocks the smart money is buying,"{'neg': 0.0, 'neu': 0.748, 'pos': 0.252, 'compound': 0.4019}",neutral,0.9998534917831421
698515,698515,709737.0,Ortho-McNeil-Janssen Pharmaceuticals Voluntarily Recalls One Lot of RISPERDAL® Tablets and One Lot of Risperidone Tablets,2011-06-17 13:39:00-04:00,JNJ,ortho mcneil janssen pharmaceuticals voluntarily recalls one lot of risperdal® tablets and one lot of risperidone tablets,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.6788759231567383
698516,698516,709738.0,Goldman Sachs Maintains Buy on Johnson & Johnson,2011-06-16 08:00:00-04:00,JNJ,goldman sachs maintains buy on johnson and johnson,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9997820258140564
698517,698517,709739.0,Johnson & Johnson Announces Special Charge of $500-$600 Million Related to Restructuring Plans for Cordis Corporation Subsidiary ,2011-06-15 09:03:00-04:00,JNJ,johnson and johnson announces special charge of dollars 00 dollars 00 million related to restructuring plans for cordis corporation subsidiary,"{'neg': 0.0, 'neu': 0.876, 'pos': 0.124, 'compound': 0.4019}",neutral,0.9998754262924194
698518,698518,709740.0,The 8 Most Appropriate Strategies,2011-06-15 08:07:00-04:00,JNJ,the 8 most appropriate strategies,"{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}",neutral,0.9998775720596313
698519,698519,709741.0,Hearing that J&J's Depuy has Won U.S. Approval for the First Ceramic-on-Metal Hip,2011-06-14 11:54:00-04:00,JNJ,hearing that j and js depuy has won u s approval for the first ceramic on metal hip,"{'neg': 0.0, 'neu': 0.702, 'pos': 0.298, 'compound': 0.7783}",positive,0.9994982481002808
